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UPDATE STATEMENT
A toxicological Profile for PCBs, Draft for Public Comment, was released in December 1998.  This
edition supercedes any previously released draft or final profile.  Toxicological profiles are revised and
republished as necessary, but no less than once every three years.  
For information regarding the update status of previously released profiles, contact ATSDR at:
Agency for Toxic Substances and Disease Registry
Division of Toxicology/Toxicology Information Branch







The toxicological profiles are developed in response to the Superfund Amendments and
Reauthorization Act (SARA) of 1986 (Public law 99-499) which amended the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund).  This
public law directed ATSDR to prepared toxicological profiles for hazardous substances most commonly
found at facilities on the CERCLA National Priorities List and that pose the most significant potential
threat to human health, as determined by ATSDR and the EPA.  The availability of the revised priority
list of 275 hazardous substances was announced in the Federal Register on November 17, 1997 (62 FR
61332).  For prior versions of the list of substances, see Federal Register notices dated April 29, 1996 (61
FR 18744); April 17, 1987 (52 FR 12866); October 20, 1988 (53 FR 41280); October 26, 1989 (54 FR
43619); October 17, 1990 (55 FR 42067); October 17, 1991 (56 FR 52166); October 28, 1992 (57 FR
48801); and February 28, 1994 (59 FR 9486).  Section 104(i)(3) of CERCLA, as amended, directs the
Administrator of ATSDR to prepare a toxicological profile for each substance on the list.
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QUICK REFERENCE FOR HEALTH CARE PROVIDERS
Toxicological Profiles are a unique compilation of toxicological information on a given hazardous
substance. Each profile reflects a comprehensive and extensive evaluation, summary, and interpretation of
available toxicologic and epidemiologic information on a substance.  Health care providers treating
patients potentially exposed to hazardous substances will find the following information helpful for fast
answers to often-asked questions.
Primary Chapters/Sections of Interest
Chapter 1:  Public Health Statement: The Public Health Statement can be a useful tool for educating
patients about possible exposure to a hazardous substance.  It explains a substance’s relevant
toxicologic properties in a nontechnical, question-and-answer format, and it includes a review of
the general health effects observed following exposure.
Chapter 2:  Relevance to Public Health: The Relevance to Public Health Section evaluates, interprets,
and assesses the significance of toxicity data to human health.
Chapter 3:  Health Effects: Specific health effects of a given hazardous compound are reported by type
of health effect (death, systemic, immunologic, reproductive), by route of exposure, and by length
of exposure (acute, intermediate, and chronic). In addition, both human and animal studies are
reported in this section. 
NOTE: Not all health effects reported in this section are necessarily observed in
the clinical setting.  Please refer to the Public Health Statement to identify
general health effects observed following exposure.
Pediatrics:  Four new sections have been added to each Toxicological Profile to address child health
issues:
Section 1.6 How Can (Chemical X) Affect Children?
Section 1.7 How Can Families Reduce the Risk of Exposure to (Chemical X)?
Section 3.7 Children’s Susceptibility
Section 6.6 Exposures of Children
Other Sections of Interest:
Section 3.8 Biomarkers of Exposure and Effect
Section 3.11 Methods for Reducing Toxic Effects
ATSDR Information Center 
Phone:  1-888-42-ATSDR or (404) 639-6357  Fax:    (404) 639-6359
E-mail:  atsdric@cdc.gov  Internet:  http://www.atsdr.cdc.gov
The following additional material can be ordered through the ATSDR Information Center:
Case Studies in Environmental Medicine: Taking an Exposure History—The importance of taking an
exposure history and how to conduct one are described, and an example of a thorough exposure
history is provided. Other case studies of interest include Reproductive and Developmental
Hazards; Skin Lesions and Environmental Exposures; Cholinesterase-Inhibiting Pesticide
Toxicity; and numerous chemical-specific case studies.
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Managing Hazardous Materials Incidents is a three-volume set of recommendations for on-scene
(prehospital) and hospital medical management of patients exposed during a hazardous materials incident. 
Volumes I and II are planning guides to assist first responders and hospital emergency department
personnel in planning for incidents that involve hazardous materials.  Volume III—Medical Management
Guidelines for Acute Chemical Exposures—is a guide for health care professionals treating patients
exposed to hazardous materials.
Fact Sheets (ToxFAQs) provide answers to frequently asked questions about toxic substances.
Other Agencies and Organizations
The National Center for Environmental Health (NCEH) focuses on preventing or controlling disease,
injury, and disability related to the interactions between people and their environment outside the
workplace.  Contact: NCEH, Mailstop F-29, 4770 Buford Highway, NE, Atlanta, GA 30341-
3724 • Phone: 770-488-7000 • FAX: 770-488-7015.
The National Institute for Occupational Safety and Health (NIOSH) conducts research on occupational
diseases and injuries, responds to requests for assistance by investigating problems of health and
safety in the workplace, recommends standards to the Occupational Safety and Health
Administration (OSHA) and the Mine Safety and Health Administration (MSHA), and trains
professionals in occupational safety and health.     Contact: NIOSH, 200 Independence Avenue,
SW, Washington, DC 20201 • Phone: 800-356-4674 or  NIOSH Technical Information Branch,
Robert A. Taft Laboratory, Mailstop C-19, 4676 Columbia Parkway, Cincinnati, OH 45226-1998
• Phone: 800-35-NIOSH.
 The National Institute of Environmental Health Sciences (NIEHS) is the principal federal agency for
biomedical research on the effects of chemical, physical, and biologic environmental agents on
human health and well-being. Contact: NIEHS, PO Box 12233, 104 T.W. Alexander Drive,
Research Triangle Park, NC 27709 • Phone: 919-541-3212.
Referrals
The Association of Occupational and Environmental Clinics (AOEC) has developed a network of clinics
in the United States to provide expertise in occupational and environmental issues.  Contact: 
AOEC, 1010 Vermont Avenue, NW, #513, Washington, DC 20005 •   Phone: 202-347-4976 •
FAX: 202-347-4950 • e-mail: aoec@dgs.dgsys.com  •      AOEC Clinic Director: http://occ-env-
med.mc.duke.edu/oem/aoec.htm.
 
The American College of Occupational and Environmental Medicine (ACOEM) is an association of
physicians and other health care providers specializing in the field of occupational and
environmental medicine.  Contact:  ACOEM, 55 West Seegers Road, Arlington Heights, IL













THE PROFILE HAS UNDERGONE THE FOLLOWING ATSDR INTERNAL REVIEWS:
1. Green Border Review.  The Green Border Review assures the consistency of the profile with
ATSDR policy.
2. Health Effects Review.  The Health Effects Review Committee examines the health effects
chapter of each profile for consistency and accuracy in interpreting health effects and classifying
end points.
3. Minimal Risk Level Review.  The Minimal Risk Level Workgroup considers issues relevant to
substance-specific minimal risk levels (MRLs), reviews the health effects database of each
profile, and makes recommendations for derivation of MRLs.
4. Data Needs Review.  The Research Implementation Branch reviews data needs sections to assure




A peer review panel was assembled for polychlorinated biphenyls (PCBs).  The panel consisted of the
following members: 
1. Larry Hansen, University of Illinois, College of Veterinary Medicine, Urbana, Illinois;
2. Joseph Jacobson, Wayne State University, Detroit, Michigan;
3. Helen Tryphonas, Bureau of Chemical Safety, Frederick G. Banting Research Center, Ottawa,
Ontario, Canada;
4. John Vena, University at Buffalo, Social and Preventive Medicine, Buffalo, New York
These experts collectively have knowledge of PCBs physical and chemical properties, toxicokinetics, key
health end points, mechanisms of action, human and animal exposure, and quantification of risk to
humans.  All reviewers were selected in conformity with the conditions for peer review specified in
Section 104(I)(13) of the Comprehensive Environmental Response, Compensation, and Liability Act, as
amended.
Scientists from the Agency for Toxic Substances and Disease Registry (ATSDR) have reviewed the peer
reviewers' comments and determined which comments will be included in the profile.  A listing of the
peer reviewers' comments not incorporated in the profile, with a brief explanation of the rationale for their
exclusion, exists as part of the administrative record for this compound.  A list of databases reviewed and
a list of unpublished documents cited are also included in the administrative record.
The citation of the peer review panel should not be understood to imply its approval of the profile's final
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 1.  PUBLIC HEALTH STATEMENT
This public health statement tells you about polychlorinated biphenyls (PCBs) and the effects of
exposure.  
The Environmental Protection Agency (EPA) identifies the most serious hazardous waste sites in
the nation.  These sites make up the National Priorities List (NPL) and are the sites targeted for
long-term federal cleanup activities.  PCBs have been found in at least 500 of the 1,598 current
or former NPL sites.  However, the total number of NPL sites evaluated for PCBs is not known. 
As more sites are evaluated, the sites at which PCBs are found may increase.  This information is
important because exposure to PCBs may harm you and because these sites may be sources of
exposure.
When a substance is released from a large area, such as an industrial plant, or from a container,
such as a drum or bottle, it enters the environment.  This release does not always lead to
exposure.  You are exposed to a substance only when you come in contact with it.  You may be
exposed by breathing, eating, or drinking the substance, or by skin contact.
If you are exposed to PCBs, many factors determine whether you’ll be harmed.  These factors
include the dose (how much), the duration (how long), and how you come in contact with them. 
You must also consider the other chemicals you’re exposed to and your age, sex, diet, family
traits, lifestyle, and state of health.
1.1 WHAT ARE POLYCHLORINATED BIPHENYLS?
PCBs are a group of synthetic organic chemicals that can cause a number of different harmful
effects.  There are no known  natural sources of PCBs in the environment.  PCBs are either oily
liquids or solids and are colorless to light yellow.  Some PCBs are volatile and may exist as a
vapor in air.  They have no known smell or taste.  PCBs enter the environment as mixtures
containing a variety of individual chlorinated biphenyl components, known as congeners, as well
as impurities.  Because the health effects of environmental mixtures of PCBs are difficult to
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evaluate, most of the information in this toxicological profile is about seven types of PCB
mixtures that were commercially produced.  These seven kinds of PCB mixtures include 35% of
all the PCBs commercially produced and 98% of PCBs sold in the United States since 1970. 
Some commercial PCB mixtures are known in the United States by their industrial trade name,
Aroclor.  For example, the name Aroclor 1254 means that the mixture contains approximately
54% chlorine by weight, as indicated by the second two digits in the name.  Because they don't
burn easily and are good insulating materials, PCBs were used widely as coolants and lubricants
in transformers, capacitors, and other electrical equipment.  The manufacture of PCBs stopped in
the United States in August 1977 because there was evidence that PCBs build up in the
environment and may cause harmful effects.  Consumer products that may contain PCBs include
old fluorescent lighting fixtures, electrical devices or appliances containing PCB capacitors made
before PCB use was stopped, old microscope oil, and old hydraulic oil.  You can find further
information on the physical properties and uses of PCBs in Chapters 4 and 5.
1.2 WHAT HAPPENS TO POLYCHLORINATED BIPHENYLS WHEN THEY ENTER
THE ENVIRONMENT?
Before 1977, PCBs entered the air, water, and soil during their manufacture and use in the
United States.  Wastes that contained PCBs were generated at that time, and these wastes were
often placed in landfills.  PCBs also entered the environment from accidental spills and leaks
during the transport of the chemicals, or from leaks or fires in transformers, capacitors, or other
products containing PCBs.  Today, PCBs can still be released into the environment from poorly
maintained hazardous waste sites that contain PCBs; illegal or improper dumping of PCB
wastes, such as old transformer fluids; leaks or releases from electrical transformers containing
PCBs; and disposal of PCB-containing consumer products into municipal or other landfills not
designed to handle hazardous waste.  PCBs may be released into the environment by the burning
of some wastes in municipal and industrial incinerators.
Once in the environment, PCBs do not readily break down and therefore may remain for very
long periods of time.  They can easily cycle between air, water, and soil.  For example, PCBs can
enter the air by evaporation from both soil and water.  In air, PCBs can be carried long distances
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and have been found in snow and sea water in areas far away from where they were released into
the environment, such as in the arctic.  As a consequence, PCBs are found all over the world.  In
general, the lighter the type of PCBs, the further they may be transported from the source of
contamination.  PCBs are present as solid particles or as a vapor in the atmosphere.  They will
eventually return to land and water by settling as dust or in rain and snow.  In water, PCBs may
be transported by currents, attach to bottom sediment or particles in the water, and evaporate into
air.   Heavy kinds of PCBs are more likely to settle into sediments while lighter PCBs are more
likely to evaporate to air.  Sediments that contain PCBs can also release the PCBs into the
surrounding water.  PCBs stick strongly to soil and will not usually be carried deep into the soil
with rainwater.  They do not readily break down in soil and may stay in the soil for months or
years; generally, the more chlorine atoms that the PCBs contain, the more slowly they break
down.  Evaporation appears to be an important way by which the lighter PCBs leave soil.  As a
gas, PCBs can accumulate in the leaves and above-ground parts of plants and food crops. 
PCBs are taken up into the bodies of small organisms and fish in water.  They are also taken up
by other animals that eat these aquatic animals as food.  PCBs especially accumulate in fish and
marine mammals (such as seals and whales) reaching levels that may be many thousands of
times higher than in water.  PCB levels are highest in animals high up in the food chain.  You
can find more information about what happens to PCBs in the environment in Chapter 6.
1.3 HOW MIGHT I BE EXPOSED TO POLYCHLORINATED BIPHENYLS?
Although PCBs are no longer made in the United States, people can still be exposed to them. 
Many older transformers and capacitors may still contain PCBs, and this equipment can be used
for 30 years or more.  Old fluorescent lighting fixtures and old electrical devices and appliances,
such as television sets and refrigerators, therefore may contain PCBs if they were made before
PCB use was stopped.  When these electric devices get hot during operation, small amounts of
PCBs may get into the air and raise the level of PCBs in indoor air.  Because devices that contain
PCBs can leak with age, they could also be a source of skin exposure to PCBs.
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Small amounts of PCBs can be found in almost all outdoor and indoor air, soil, sediments,
surface water, and animals.  However, PCB levels have generally decreased since PCB
production stopped in 1977.  People are exposed to PCBs primarily from contaminated food and
breathing contaminated air.  The major dietary sources of PCBs are fish (especially sportfish that
were caught in contaminated lakes or rivers), meat, and dairy products.  Between 1978 and 1991,
the estimated daily intake of PCBs in adults from dietary sources declined from about
1.9 nanograms (a nanogram is a billionth part of a gram) to less than 0.7 nanograms.  PCB levels
in sportfish are still high enough so that eating PCB-contaminated fish may be an important
source of exposure for some people.  Recent studies on fish indicate maximum concentrations of
PCBs are a few parts of PCBs in a million parts (ppm) of fish, with higher levels found in
bottom-feeders such as carp.  Meat and dairy products are other important sources of PCBs in
food, with PCB levels in meat and dairy products usually ranging from less than 1 part in a
billion parts (ppb) of food to a few ppb.
Concentrations of PCBs in subsurface soil at a Superfund site have been as high as 750 ppm.
People who live near hazardous waste sites may be exposed to PCBs by consuming PCB-
contaminated sportfish and game animals, by breathing PCBs in air, or by drinking
PCB-contaminated well water.  Adults and children may come into contact with PCBs when
swimming in contaminated water and by accidentally swallowing water during swimming. 
However, both of these exposures are far less serious than exposures from ingesting
PCB-contaminated food (particularly sportfish and wildlife) or from breathing PCB-
contaminated air.  
Workplace exposure to PCBs can occur during repair and maintenance of PCB transformers;
accidents, fires, or spills involving PCB transformers and older computers and instruments; and
disposal of PCB materials.  In addition to older electrical instruments and fluorescent lights that
contain PCB-filled capacitors, caulking materials, elastic sealants, and heat insulation have also
been known to contain PCBs.  Contact with PCBs at hazardous waste sites can happen when
workers breathe air and touch soil containing PCBs.  Exposure in the contaminated workplace
occurs mostly by breathing air containing PCBs and by touching substances that contain PCBs. 
You can find more information about exposure to PCBs in Chapter 6.
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1.4 HOW CAN POLYCHLORINATED BIPHENYLS ENTER AND LEAVE MY BODY?
If you breathe air that contains PCBs, they can enter your body through your lungs and pass into
the bloodstream.  We do not know how fast or how much of the PCBs that are breathed will pass
into the blood.  A common way for PCBs to enter your body is by eating meat or fish products or
other foods that contain PCBs.  Exposure from drinking water is less than from food.  It is also
possible that PCBs can enter your body by breathing indoor air or by skin contact in buildings
that have the kinds of old electrical devices that contain and can leak PCBs.  For people living
near waste sites or processing or storage facilities, and for people who work with or around
PCBs, the most likely ways that PCBs will enter their bodies are from skin contact with
contaminated soil and from breathing PCB vapors.  Once PCBs are in your body, some may be
changed by your body into other related chemicals called metabolites.  Some metabolites of
PCBs may have the potential to be as harmful as some unchanged PCBs.  Some of the
metabolites may leave your body in the feces in a few days, but others may remain in your body
fat for months.  Unchanged PCBs may also remain in your body and be stored for years mainly
in the fat and liver, but smaller amounts can be found in other organs as well.  PCBs collect in
milk fat and can enter the bodies of infants through breast-feeding.  For more information on
how PCBs can enter and leave your body, see Chapter 3.
1.5 HOW CAN POLYCHLORINATED BIPHENYLS AFFECT MY HEALTH?
Many studies have looked at how PCBs can affect human health.  Some of these studies
investigated people exposed in the workplace, and others have examined members of the general
population.  Skin conditions, such as acne and rashes, may occur in people exposed to high
levels of PCBs.  These effects on the skin are well documented, but are not likely to result from
exposures in the general population.  Most of the human studies have many shortcomings, which
make it difficult for scientists to establish a clear association between PCB exposure levels and
health effects.  Some studies in workers suggest that exposure to PCBs may also cause irritation
of the nose and lungs, gastrointestinal discomfort, changes in the blood and liver, and depression
and fatigue.  Workplace concentrations of PCBs, such as those in areas where PCB transformers
are repaired and maintained, are higher than levels in other places, such as air in buildings that
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have electrical devices containing PCBs or in outdoor air, including air at hazardous waste sites. 
Most of the studies of health effects of PCBs in the general population examined children of
mothers who were exposed to PCBs.  The possible health effects of PCBs in children are
discussed in Section 1.6.
To protect the public from the harmful effects of toxic chemicals and to find ways to treat people
who have been harmed, scientists use many tests.
One way to see if a chemical will hurt people is to learn how the chemical is absorbed, used, and
released by the body; for some chemicals, animal testing may be necessary.  Animal testing may
also be used to identify health effects such as cancer or birth defects.  Without laboratory
animals, scientists would lose a basic method to get information needed to make wise decisions
to protect public health.  Scientists have the responsibility to treat research animals with care and
compassion.  Laws today protect the welfare of research animals, and scientists must comply
with strict animal care guidelines.
Rats that ate food containing large amounts of PCBs for short periods of time had mild liver
damage, and some died.  Rats, mice, or monkeys that ate smaller amounts of PCBs in food over
several weeks or months developed various kinds of health effects, including anemia, acne-like
skin conditions, and liver, stomach, and thyroid gland injuries.  Other effects caused by PCBs in
animals include reductions in the immune system function, behavioral alterations, and impaired
reproduction.  Some PCBs can mimic or block the action of hormones from the thyroid and other
endocrine glands.  Because hormones influence the normal functioning of many organs, some of
the effects of PCBs may result from endocrine changes.  PCBs are not known to cause birth
defects.  Only a small amount of information exists on health effects in animals exposed to PCBs
by skin contact or breathing.  This information indicates that liver, kidney, and skin damage
occurred in rabbits following repeated skin exposures, and that a single exposure to a large
amount of PCBs on the skin caused death in rabbits and mice.  Breathing PCBs over several
months also caused liver and kidney damage in rats and other animals, but the levels necessary
to produce these effects were very high.  For more information on how PCBs can affect your
health, see Chapters 2 and 3.
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Studies of workers provide evidence that PCBs were associated with certain types of cancer in
humans, such as cancer of the liver and biliary tract.  Rats that ate commercial PCB mixtures
throughout their lives developed liver cancer.  Based on the evidence for cancer in animals, the
Department of Health and Human Services (DHHS) has stated that PCBs may reasonably be
anticipated to be carcinogens.  Both EPA and the International Agency for Research on Cancer
(IARC) have determined that PCBs are probably carcinogenic to humans.
1.6 HOW CAN POLYCHLORINATED BIPHENYLS AFFECT CHILDREN?
This section discusses potential health effects from exposures during the period from conception
to maturity at 18 years of age in humans.
Children are exposed to PCBs in the same way as are adults: by eating contaminated food,
breathing indoor air in buildings that have electrical devices containing PCBs, and drinking
contaminated water.  Because of their smaller weight, children’s intake of PCBs per kilogram of
body weight may be greater than that of adults.  In addition, a child’s diet often differs from that
of adults.  A Food and Drug Administration (FDA) study in 1991 estimated dietary intakes of
PCBs for infants (6 months) and toddlers (2 years) of less than 0.001 and 0.002 µg/kg/day. 
Children who live near hazardous waste sites may accidentally eat some PCBs through hand-to-
mouth behavior, such as by putting dirty hands or other soil/dirt covered objects in their mouths,
or eating without washing their hands.  Some children also eat dirt on purpose; this behavior is
called pica.  Children could also be exposed by playing with old appliances or electrical devices
that contain PCBs. 
It is possible that children could be exposed to PCBs following transport of the chemical on
clothing from the parent’s workplace to the home.  House dust in homes of workers exposed to
PCBs contained higher than average levels of PCBs.  PCBs have also been found on the clothing
of firefighters following transformer fires.  The most likely way infants will be exposed is from
breast milk that contains PCBs.  Fetuses in the womb are also exposed from the exposed mother.
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In one study of women exposed to relatively high concentrations of PCBs in the workplace
during pregnancy, their babies weighed slightly less at birth than babies born to women exposed
to lower concentrations of PCBs.  Studies of women who consumed high amounts of fish
contaminated with PCBs and other chemicals also had babies that weighed less than babies from
women who did not eat fish.  Similar observations have been made in some studies of women
with no known high exposure to PCBs, but not all studies have confirmed these findings.  Babies
born to women who ate fish contaminated with PCBs before and during pregnancy showed
abnormal responses to tests of infant behavior.  Some of these behaviors, such as problems with
motor skills and a decrease in short-term memory, persisted for several years.  However, in these
studies, the women may have been exposed to other chemicals.  Other studies suggest that the
immune system may be affected in children born to and nursed by mothers exposed to increased
levels of PCBs.  There are no reports of structural birth defects in humans caused by exposure to
PCBs or of health effects of PCBs in older children.  It is not known whether PCB exposure can
cause in skin acne and rashes in children as occurs in some adults, although it is likely that the
same effects would occur at very high PCB exposure levels.  
Animal studies have shown harmful effects in the behavior of very young animals when their
mothers were exposed to PCBs and they were exposed in the womb or by nursing.  In addition,
some animal studies suggest that exposure to PCBs causes an increased incidence of prenatal
death and changes in the immune system, thyroid, and reproductive organs.  Studies in monkeys
showed that young animals developed skin effects from nursing after their mothers were exposed
to PCBs.  Some studies indicate that very high doses of PCBs may cause structural birth defects
in animals.
Children can be exposed to PCBs both prenatally and from breast milk.  PCBs are stored in the
mother’s body and can be released during pregnancy, cross the placenta, and enter fetal tissues. 
Because PCBs dissolve readily in fat, they can accumulate in breast milk fat and be transferred
to babies and young children.  PCBs have been measured in umbilical cord blood and in breast
milk.  Some studies have estimated that an infant who is breast fed for 6 months may accumulate
in this period 6–12% of the total PCBs that will accumulate during its lifetime.  However, in
most cases, the benefits of breast-feeding outweigh any risks from exposure to PCBs in mother’s
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milk.  You should consult your health care provider if you have any concerns about PCBs and
breast feeding.  Because the brain, nervous system, immune system, thyroid, and reproductive
organs are still developing in the fetus and child, the effects of PCBs on these target systems may
be more profound after exposure during the prenatal and neonatal periods, making fetuses and
children more susceptible to PCBs than adults. 
More information regarding children’s health and PCBs can be found in Chapter 3 (Section 3.7).
1.7 HOW CAN FAMILIES REDUCE THE RISK OF EXPOSURE TO
POLYCHLORINATED BIPHENYLS?
If your doctor finds that you have been exposed to significant amounts of polychlorinated
biphenyls, ask whether your children might also be exposed.  Your doctor might need to ask
your state health department to investigate.
You and your children may be exposed to PCBs by eating fish or wildlife caught from
contaminated locations.  Certain states, Native American tribes, and U.S. territories have issued
fish and wildlife advisories to warn people about PCB-contaminated fish and fish-eating
wildlife.  These advisories will tell you what types and sizes of fish and game animals are of
concern.  An advisory may completely ban eating fish or game or tell you to limit your meals of
a certain fish or game type.  For example, an advisory may tell you not to eat a certain type of
fish or game more than once a month.  The advisory may tell you only to eat certain parts of the
fish or game and how to prepare or cook the fish or game to decrease your exposure to PCBs. 
The fish or wildlife advisory may have special restrictions to protect pregnant women, nursing
mothers, and young children.  To reduce your children’s exposure to PCBs, obey these
advisories.  Additional information on fish and wildlife advisories for PCBs, including states that
have advisories,  is provided in Chapter 6 (Section 6.7) and Chapter 8.  You can consult your
local and state health departments or state natural resources department on how to obtain PCB
advisories, as well as other important information, such as types of fish and wildlife and the
locations that the advisories apply to. 
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Children should be told that they should not play with old appliances, electrical equipment, or
transformers, since they may contain PCBs.  Children who live near hazardous waste sites
should be discouraged from playing in the dirt near these sites and should not play in areas
where there was a transformer fire.  In addition, children should be discouraged from eating dirt,
and careful handwashing practices should be followed. 
As mentioned in Section 1.3, workplace exposure to PCBs can still occur during repair and
maintenance of old PCB transformers; accidents, fires, or spills involving these transformers or
other PCB-containing items; and disposal of PCB materials.  If you are exposed to PCBs in the
workplace, it may be possible to carry them home from work.  Your occupational health and
safety officer at work can tell you whether the chemicals you work with may contain PCBs and
are likely to be carried home on your clothes, body, or tools.  If this is the case, you should
shower and change clothing before leaving work, and your work clothes should be kept separate
from other clothes and laundered separately.  
 
1.8 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN
EXPOSED TO POLYCHLORINATED BIPHENYLS?
Levels of PCBs in the environment were zero before PCBs were manufactured.  Now, all people
in industrial countries have some PCBs in their bodies.  There are tests to determine whether
PCBs are in the blood, body fat, and breast milk.  These are not regular or routine clinical tests,
such as the one for cholesterol, but could be ordered by a doctor to detect PCBs in people
exposed to them in the environment and at work.  If your PCB levels are higher than the
background levels, this will show that you have been exposed to high levels of PCBs.  However,
these measurements cannot determine the exact amount or type of PCBs that you have been
exposed to, or how long you have been exposed.  Although these tests can indicate whether you
have been exposed to PCBs to a greater extent than the general population, they do not predict
whether you will develop harmful health effects.  Blood tests are the easiest, safest, and probably
the best method for detecting recent exposures to large amounts of PCBs.  Results of such tests
should be reviewed and carefully interpreted by physicians with a background in environmental
and occupational medicine.  Nearly everyone has been exposed to PCBs because they are found
PCBs 11
1.  PUBLIC HEALTH STATEMENT
throughout the environment, and people are likely to have detectable amounts of PCBs in their
blood, fat, and breast milk.  Recent studies have shown that PCB levels in tissues from United
States population are now declining.  Additional information on tests used to determine whether
you have been exposed to PCBs can be found in Chapter 3 (Section 3.11) and Chapter 7
(Section 7.1).
1.9 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO
PROTECT HUMAN HEALTH?
The federal government develops regulations and recommendations to protect public health . 
Regulations can be enforced by law.  Federal agencies that develop regulations for toxic
substances include the Environmental Protection Agency (EPA), the Occupational Safety and
Health Administration (OSHA), and the Food and Drug Administration (FDA). 
Recommendations provide valuable guidelines to protect public health but cannot be enforced by
law.  Federal organizations that develop recommendations for toxic substances include the
Agency for Toxic Substances and Disease Registry (ATSDR) and the National Institute for
Occupational Safety and Health (NIOSH).
Regulations and recommendations can be expressed in not-to-exceed levels in air, water, soil, or
food that are usually based on levels that affect animals; then they are adjusted to help protect
people.  Sometimes these not-to-exceed levels differ among federal organizations because of
different exposure times (an 8-hour workday or a 24-hour day), the use of different animal
studies, or other factors.
Recommendations and regulations are periodically updated as more information becomes
available.  For the most current information, check with the federal agency or organization that
provides it.  Some regulations and recommendations for PCBs include the following:
The EPA standard for PCBs in drinking water is 0.5 parts of PCBs per billion parts (ppb) of
water.  For the protection of human health from the possible effects of drinking the water or
eating the fish or shellfish from lakes and streams that are contaminated with PCBs, the EPA
PCBs 12
1.  PUBLIC HEALTH STATEMENT
regulates that the level of PCBs in these waters be no greater than 0.17 parts of PCBs per trillion
parts (ppt) of water.  States with fish and wildlife consumption advisories for PCBs are identified
in Chapter 6 (Section 6.7) and Chapter 8. 
The FDA has set residue limits for PCBs in various foods to protect from harmful health effects.  
FDA required limits include 0.2 parts of PCBs per million parts (ppm) in infant and junior foods,
0.3 ppm in eggs, 1.5 ppm in milk and other dairy products (fat basis), 2 ppm in fish and shellfish
(edible portions), and 3 ppm in poultry and red meat (fat basis).
OSHA regulates that workers not be exposed by inhalation over a period of 8 hours for 5 days
per week to more than 1 milligram per cubic meter of air (mg/m3) for 42% chlorine PCBs, or to
0.5 mg/m3 for 54% chlorine PCBs.  
NIOSH recommends that workers not breathe air containing 42 or 54% chlorine PCB levels
higher than 1 microgram per cubic meter of air (µg/m3) for a 10-hour workday, 40-hour
workweek.
EPA requires that companies that transport, store, or dispose of PCBs follow the rules and
regulations of the federal hazardous waste management program.  EPA also limits the amount of
PCBs put into publicly owned waste water treatment plants.  To minimize exposure of people to
PCBs, EPA requires that industry tell the National Response Center each time 1 pound or more
of PCBs have been released to the environment.
For more information on federal and state regulations and guidelines for PCBs, see Chapter 8.
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1.10 WHERE CAN I GET MORE INFORMATION?
If you have any more questions or concerns, please contact your community or state health or
environmental quality department or
Agency for Toxic Substances and Disease Registry
Division of Toxicology
1600 Clifton Road NE, Mailstop E-29
Atlanta, GA 30333




ATSDR can also tell you the location of occupational and environmental health clinics.  These
clinics specialize in recognizing, evaluating, and treating illnesses resulting from exposure to
hazardous substances.
* To order toxicological profiles, contact
National Technical Information Service
5285 Port Royal Road
Springfield, VA 22161
Phone: 1-800-553-6847 or 1-703-605-6000
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2.1 Background and Environmental Exposures to PCBs in the United States
PCBs are a category of chemicals that were manufactured in the United States between about 1930 and
1977, predominantly for use as coolants and lubricants in electrical equipment such as capacitors and
transformers due to their general chemical inertness and heat stability.  PCBs are complex mixtures of
chlorinated biphenyls that vary in the degree of chlorination.  For example, the commercial product
Aroclor 1254 is a mixture of mono- through heptachlorinated biphenyl congeners with an average
chlorine content of approximately 54%.  However, significant lot-to-lot differences in congeneric
composition occurred among similar mixtures.  The manufacture of PCBs in the United States was
stopped due to evidence that they accumulate and persist in the environment and can cause toxic effects.
No known consumer product currently manufactured in the United States contains PCBs, but PCBs are
still released during some industrial processes.  Once released into the environment, the compositions of
commercial PCB mixtures are altered through processes such as volatilization and other kinds of
partitioning, chemical or biological transformation, and preferential bioaccumulation.  These processes
are dependent upon the degree of chlorination of the biphenyl molecule.  PCBs, particularly the higher
chlorinated congeners, adsorb strongly to sediment and soil, where they tend to persist with half-lives of
months to years.  PCBs bioaccumulate in food chains and are stored in fatty tissues due to their stability
and lipophilicity.  Bioaccumulated PCBs are of particular relevance to human health because of their
persistence in the body.
The general population may be exposed to PCBs by ingesting contaminated food and by inhaling
contaminated air (see Chapter 6).  Food consumption has been and continues to be the major source of
body burden of PCBs in the general population.  The estimated dietary intake of PCBs for an average
adult was about 0.03 µg/kg/day in 1978, but this had declined to <0.001 µg/kg/day by 1991.  There is
evidence that diets high in fish from PCB-contaminated waters, such as in the Great Lakes-St. Lawrence
River basins, can significantly increase a person’s dietary intake of PCBs.  Breast-fed infants of mothers
who have diets high in contaminated fish may have a particularly increased risk for PCB exposure due to
its presence in the milk.  Human PCB exposure has also been attributed to inhalation of indoor air,
especially at locations that still use electrical equipment containing PCBs.
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An important issue related to evaluating health effects of PCBs in humans is exposure assessment. 
Exposure to PCBs has been assessed by measuring PCBs in blood, breast milk, and adipose tissue.  
Umbilical cord blood also has been used to estimate exposure in utero.  In addition, fish consumption has 
been utilized as surrogate of PCB exposure in some studies, but this measure of exposure has not always
been reliable.  Mean serum PCB levels range from 0.9–1.5 ppb (µg/L), in recent years, in individuals who
do not have diets high in fish from waters contaminated with PCBs.  In the absence of human data,
environmental sampling (soil, sediment, air, food, water) has also been used to estimate exposure.
2.2 Summary of Health Effects
The preponderance of the biomedical data from human and laboratory mammal studies provide strong
evidence of the toxic potential of exposure to PCBs.  Information on health effects of PCBs is available
from studies of people exposed in the workplace, by consumption of contaminated rice oil in Japan (the
Yusho incident) and Taiwan (the Yu-Cheng incident), by consumption of contaminated fish, and via
general environmental exposures, as well as food products of animal origin.  As summarized below and
detailed in Chapter 3, health effects that have been associated with exposure to PCBs in humans and/or
animals include liver, thyroid, dermal and ocular changes, immunological alterations, neurodevelop-
mental changes, reduced birth weight, reproductive toxicity, and cancer.  The human studies of the Yusho
and Yu-Cheng poisoning incidents, contaminated fish consumption, and general populations are
complicated by the mixture nature of PCB exposure and possible interactions between the congeneric
components and other chemicals (see Chapter 3 for additional information).  Therefore, although PCBs
may have contributed to adverse health effects in these human populations, it cannot be determined with
certainty which congeners may have caused the effects.  Animal studies have shown that PCBs induce
effects in monkeys at lower doses than in other species, and that immunological, dermal/ocular, and
neurobehavioral changes are particularly sensitive indicators of toxicity in monkeys exposed either as
adults, or during pre- or postnatal periods.
Hepatic Effects.    The hepatotoxic potential of PCB mixtures is well-documented in animals by oral
and other routes of exposure.  The spectrum of possible hepatic effects in animals is broad and includes
microsomal enzyme induction, liver enlargement, increased serum levels of liver enzymes and lipids, and
histopathologic alterations that progress to fatty and necrotic lesions and tumors.  The findings of human
studies, however, are not as obvious.  Many of the human studies involving worker and other populations
with high body burdens of PCBs report associations between PCBs and hepatic indices such as liver
enzymes, lipids, and cholesterol.  Studies of people exposed to PCBs by ingestion of contaminated fish or
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contaminated rice oil in the Yusho or Yu-Cheng incidents have reported increases in serum levels of some
liver enzymes (e.g., γ-glutamyltranspeptidase [GGT], aspartate aminotransferase [AST], and/or alanine
aminotransferase [ALT]) that are suggestive of microsomal enzyme induction or possible liver damage. 
Tests for some nonroutinely-studied liver indices (e.g., accelerated erythrocyte sedimentation rate, high
titer in thymol turbidity, increased M fraction of lactate dehydrogenase, and increased alkaline
phosphatase and ribonuclease levels) also indicate possible liver damage in some Yusho patients.
Definitive conclusions regarding human hepatotoxiciy are hampered by limitations in study design of
available studies, such as exposure misclassification, lack of controls, lack of correction for common
confounding variables (e.g., age and alcohol consumption), and natural partitioning of PCBs to serum
lipids.  The lack of unequivocal evidence in humans that is seen in laboratory animals may result from
many factors, including species differences in susceptibility or sensitivity to PCBs, and dissimilarities in
exposure levels, durations, and mixture compositions.
Hepatotoxic effects commonly induced in laboratory animals exposed to commercial PCB mixtures
include increased serum levels of liver enzymes indicative of hepatocellular damage (e.g., AST and
ALT), serum and tissue biochemical changes indicative of liver dysfunction (e.g., altered levels of lipids,
cholesterol, porphyrins, and vitamin A), and histopathologic changes (particularly fat deposition),
fibrosis, and necrosis.  Intermediate- and chronic-duration oral studies have shown hepatotoxic effects in
monkeys that include fatty degeneration, hepatocellular necrosis, and hypertrophic and hyperplastic
changes in the bile duct at oral doses of PCBs as low as 0.1–0.2 mg/kg/day (Aroclor 1254 or 1248). 
Induction of microsomal enzymes appears to be the most sensitive hepatic alteration produced by
Aroclors and other PCB mixtures in laboratory animals.  While microsomal enzyme induction is not
necessarily adverse, it may have indirect implications for human health through protective or toxic effects
that are secondary to enhanced metabolic detoxification or bioactivation of exogenous or endogenous
substances.  Examples of this include possible interference with medical therapy due to increased
metabolism of administered drugs, the possibility of disease secondary to the altered metabolism of
endogenous substances such as hormones, and increased activation of promutagens and procarcinogens as
shown, for example, for the secondary carcinogen dimethylnitrosamine.
Hepatic porphyria is an indicator of liver dysfunction that has been induced in animals following
intermediate-duration oral or dermal exposure to Aroclors and other PCB mixtures.  Increased urinary
excretion of porphyrins has been reported in two studies of PCB workers, and Type B hepatic porphyria
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(a uroporphyrin/coproporphyrin ratio >1) was a consistent finding in Yu-Cheng patients, including
children born to exposed mothers.  However, clinically evident porphyrias have not been reported in
people with occupational or Yusho/Yu-Cheng PCB exposures.
The liver, which is the site of approximately 90% of the vitamin A in the body, has a major role in
vitamin A metabolism.  Altered vitamin A homeostasis, primarily manifested as decreased hepatic storage
of vitamin A, is another demonstrated effect of PCB mixtures and single congeners in orally-exposed rats
and rabbits.  Vitamin A is essential for normal growth and cell differentiation, particularly differentiation
of epithelial cells, and PCB-induced epithelial lesions in monkeys have been observed to resemble those
produced by vitamin A deficiency.  Whether the PCB-related disturbances in vitamin A homeostasis are
due to a direct effect on hepatic regulation or to effects on extrahepatic feedback processes has not been
established.
Endocrine Effects.    Concern about potential effects of PCBs on thyroid hormones is based on two
main considerations: (1) extensively corroborated findings in experimental animals that exposure to PCBs
in utero and/or during early development (e.g., through breast milk) can deplete levels of circulating
thyroid hormones in the fetus or neonate, which may give rise to a hypothyroid state during development;
and (2) the recognition of the importance of thyroid hormones in normal development of the brain, as is
evident from neurodevelopmental disorders and deficits associated with hypothyroidism.  The latter are
typified by iodine deficiency (e.g., endemic cretinism), which can produce a wide range of
neurodevelopmental deficits, including auditory, motor, and intellectual deficits.  These outcomes
underscore the importance of thyroid hormones in the normal development of the fetal cochlea, basal
ganglia, and cerebral cortex, which begin to develop in humans during the second trimester of gestation. 
This is also the time period during which the fetal thyroid gland becomes functional.
Direct evidence linking PCB exposures to thyroid morbidity in humans is limited.  The risk for goiter was
significantly increased among the Yu-Cheng cohort, indicating the possibility of excess thyroid disease in
an adult population that experienced relatively high exposures to mixtures of PCBs and polychlorinated
dibenzofurans (PCDFs).  Other more limited observations in adults include reports of increased thyroid
gland volume among workers and nearby residents of a PCB production facility.  Studies that examined
relationships between PCB exposure and thyroid hormone status in children or adults reported a variety of
different results, with findings of both positive and negative correlations between PCB exposure and
circulating levels of thyroid stimulating hormone (TSH) or thyroxine (T4) or triiodothyronine (T3)
hormones.
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The most compelling evidence for a potential thyroid hormone involvement in PCB toxicity in humans is
based on observations made in experimental animals, including rodents and nonhuman primates.  Major
findings include (1) histological changes in the thyroid gland indicative of both stimulation of the gland
(similar to that induced by TSH or a hypothyroid state) and a disruption of the processing of follicular
colloid needed for normal production and secretion thyroid hormone; (2) depression of T4 and T3
hormone levels, which may effectively create a hypothyroid state; (3) increased rates of elimination of T4
and T3 from serum; (4) increased activities of T4-UDP-glucuronyl transferase (UDP-GT) in liver, which is
an important metabolic elimination pathway for T4 and T3; (5) decreased activity of iodothyronine
sulfotransferases in liver, which are also important in the metabolic elimination of iodothyronines; (6)
decreased activity of iodothyronine deiodinases including brain Type-2 deiodinase, which provide the
major pathways for the production of the active thyroid hormone, T3; and (7) decreased binding of T4 to
transthyretin, which is an important transport protein for both T4 and T3.  These observations indicate that
PCBs can disrupt the production of thyroid hormones, both in the thyroid and in peripheral tissues, can
interfere with their transport to peripheral tissues, and can accelerate the metabolic clearance of thyroid
hormones. 
The most convincing evidence that PCBs can exert toxicity by disrupting thyroid hormone system derives
from two studies in rats.  In one study, neurobehavioral deficits in pups exposed to Aroclor 1254 in utero
and during nursing, were significantly attenuated by subcutaneous injections of T4 that increased serum T4
and T3 concentrations that were otherwise depressed in the PCB-exposed animals.  While this study
examined relatively high doses of Aroclor 1254, it nevertheless demonstrated neurodevelopmental effects
that are directly relevant to observations made in epidemiological studies and to neurological sequelae of
fetal hypothyrodism, including disturbances of motor function and hearing.  In the second study,
increased testes weight and sperm production in rats that were administered Aroclor 1254 on postnatal
days 1–25 were attenuated by injections of T4 on postnatal days 1–25, which also prevented the
depression in serum T4 concentrations.  These observed effects may reflect a disruption of the normal
sexual maturation process, which is known to be associated with neonatal hypothyroidism in humans. 
Other effects of PCBs on endocrine function that have been observed in experimental animals include
effects on the adrenal glands and serum adrenal steroid levels.
There is suggestive evidence that PCBs can produce both agonistic and antagonistic estrogenic responses. 
A wide variability of responses observed across PCB type and assays indicates the involvement of
multiple mechanisms.  The specific mechanism of action appears to vary, with competitive binding to
estrogen receptors being congener/metabolite specific.  Anti-estrogenic activities appear to be more
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strongly associated with PCBs that are Ah receptor agonists, whereas hydroxylated metabolites of PCBs
seem to be at least partly responsible for responses to PCBs that may involve changes in estrogen
receptor-dependent physiological processes.  In general, results from both in vitro and in vivo studies
indicate that PCBs have much lower estrogenic potency than the endogenous hormone, 17β-estradiol. 
PCB mixtures have been shown to produce comparatively weak estrogenic responses, and mixtures
having multiple ortho chlorines (or their hydroxylated metabolites) have been suggested to be to partly
responsible for some observed estrogenic responses.   For example, immature female offspring of
laboratory animals exposed to a PCB congener mixture simulating the congener content of human milk
from 50 days prior to mating until birth showed significantly increased uterine weights, a parameter
known to be under estrogenic influence.  In the case of anti-estrogenic responses to PCBs, effects appear
to be concentration dependent.  Anti-estrogenic responses have been observed in studies using tissues
from both humans and rodents.
Dermal and Ocular Effects.    Dermal lesions including skin irritation, chloracne, and pigmentation
of nails and skin have been observed in humans following occupational exposure to PCBs, and from the
accidental ingestion of rice oil contaminated with high concentrations of PCBs, chlorinated dibenzofurans
(CDFs) and other halogenated chemicals during the Yusho and Yu-Cheng poisoning incidents.  Of the
dermal effects observed in workers, chloracne (a dermatologic condition that starts with formation of
comedones [keratin plugs in the pilosebaceous orifices] and inflammatory folliculitis) is the most likely to
have been associated with exposure to PCBs.
Ocular effects including hypersecretion of the Meibomian glands, abnormal pigmentation of the
conjunctiva, and swollen eyelids have also been observed in humans occupationally exposed to PCBs. 
These ocular alterations almost always accompany chloracne.  Ocular effects may continue to appear after
exposure has ceased, possibly as a result of accumulation of the causative agent in skin adipose.  Chronic-
duration oral exposure studies in monkeys showed that adverse dermal and ocular effects can occur at
dose levels as low as 0.005 mg/kg/day.
Immunological Effects.    There are indications of altered immune status in adult and infant human
populations that were orally exposed to mixtures of PCBs and other chemicals.  The most conclusive
findings were in the Yusho and Yu-Cheng populations that experienced the highest levels of PCB
exposure and least complex exposure mixture.  Interpretation of the data from the other human studies is
complicated by responses that were generally subtle and exposures that included a number of persistent
toxic substances in addition to PCBs that are also potentially immunotoxic.  As detailed in Chapter 3
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(Section 3.2.3.2), there appears to be an overall consistency of effects among the human studies
supporting sensitivity of the immune system to PCBs and these other chemicals, particularly in infants
exposed in utero and/or via breast feeding.  For example, susceptibility to respiratory tract infections was
increased in Yusho/Yu-Cheng adults and their children, and there was an association between infectious
illnesses and PCBs in the children of the mothers who consumed Lake Michigan or Sheboygan River fish. 
Children born to Yu-Cheng mothers also had an increased prevalence of middle ear infections, and the
incidence of acute otitis media was increased in Inuit infants of mothers whose diets were based on
marine mammal fat.  Serum IgA and/or IgM antibody levels were decreased in the Yusho and Yu-Cheng
populations as well as in the Inuit children.  Monocyte counts were reduced in Yu-Cheng patients and in
the infants of a Dutch mother-child study, and changes in T lymphocyte subsets were found in the
Yu-Cheng, Inuit child, and Dutch child populations. 
Substantial evidence of the immunotoxicity of PCBs in research animals lends strong support to the
human data.  Particularly relevant findings in animals include reduced antibody responses and levels of
T-lymphocytes and their subsets, which are similar to changes observed in some of the human
populations.  The antibody response to sheep red blood cell (SRBC) antigens is the immune parameter
most commonly and consistently shown to be affected by PCBs in animals; reduced responses have been
demonstrated in most tested species, including adult and infant monkeys, which are sensitive to this effect
at chronic PCB doses as low as 0.005 mg/kg/day (Aroclor 1254).  A no observed adverse effect level for
immunological effects was not identified.
Studies of rats, mice, guinea pigs, and rabbits showed that intermediate-duration exposures to relatively
high doses of commercial PCB mixtures caused morphological and functional alterations in the immune
system.  Effects observed in these species included thymic and splenic atrophy, reduced antibody
responses to SRBC and other foreign antigens, increased susceptibility to infection by viruses and other
microbes, reduced skin reactivity to tuberculin, and increased proliferation of splenic lymphocytes in
response to mitogenic stimulation.
Oral studies of Aroclor mixtures in monkeys confirm that the immune system is sensitive to PCBs. 
Immunological effects of PCBs in monkeys include decreased antibody responses to SRBC, increased
susceptibility to bacterial infections, altered lymphocyte T-cell subsets, decreased lymphoproliferative
response to mitogens, and histopathologic changes in the thymus, spleen, and lymph nodes.  Results of
studies in gestationally- and lactationally-exposed infant monkeys are consistent with the data in adult
animals showing immunosuppressive effects of PCBs at doses as low as 0.005 mg/kg/day (Aroclor 1254), 
PCBs 22
2.  RELEVANCE TO PUBLIC HEALTH
with reductions in IgM and IgG antibody levels to SRBC and mitogen-induced lymphocyte
transformation that generally paralleled the findings in maternal animals.  Immunological alterations were
induced in infant monkeys that were orally exposed to a PCB congener mixture simulating the congener
content of human milk at a dose level of 0.0075 mg/kg/day for the first 20 weeks of life.
Neurological Effects.    The neurological effects of PCBs have been extensively investigated in
humans and animals.  Substantial data suggest that PCBs play a role in neurobehavioral alterations
observed in newborns and young children of women with PCB burdens near background levels.  In
general, the observed alterations are subtle.  In some studies, those alterations were found to disappear as
the children grow older (2–4 years old), while other studies have reported neurobehavioral deficits still
present in 11-year-old children mostly due to in utero exposure to PCBs.  Laboratory animal studies
provide strong substantiating evidence that PCBs can induce adverse neurological effects in developing
animals as well as in adults.
Epidemiological findings in infants and children include abnormal reflexes and deficits in memory,
learning, and IQ.  Prospective studies of children born to mothers exposed to PCBs by consumption of
contaminated fish from the Great Lakes and of children from women in North Carolina, the Netherlands,
and Germany strongly suggest that PCBs play a significant role in neurodevelopmental toxicity observed
in some of these children at birth and continuing during early life.  In the various cohorts studied, some
common findings of neurodevelopmental effects have been reported, although affected end points have
not been the same in all studies.  For example, newborns from women who ate high amounts of
contaminated Lake Michigan fish (high PCB exposure) had a greater number of abnormal reflexes and
more motor immaturity than newborns of mothers who consumed less fish (low PCB exposure).  Similar
observations were made in a North Carolina study of children born to women with low PCB levels, and in
an Oswego, New York study of children from women with high consumption of PCB-contaminated fish
from Lake Ontario.  There was a significant association between poorer habituation and autonomic scores
for the newborns and highly chlorinated (7–9 chlorines) PCB congeners in umbilical cord blood of Lake
Ontario fisheaters, but not with abnormal reflexes.  No significant association was found between any
neurological scores in newborns of the Lake Ontario fisheaters and lightly (1–3 chlorines) or  moderately
(4–6 chlorines) chlorinated PCBs, DDE, lead, mercury, or hexachlorobenzene.  A study of Dutch children
found that neither reflex nor postural cluster scores of a neurological examination were associated with
prenatal exposure to four predominant nonplanar PCB congeners (measured in maternal or umbilical cord
plasma).  However, hypotonia, although not with abnormal reflexes, was related to levels of coplanar
(dioxin-like) PCBs in breast milk.  
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Assessment of infants from the various cohorts with the Bayley Scales of Infant Development has
revealed additional consistency across studies.  This group of tests yields a mental development index
(MDI) and a psychomotor development index (PDI) score, both of which are scaled like a standard IQ
test.  In the North Carolina cohort, a significant decrease in PDI scores at the ages of 6 and 12 months was
associated with prenatal exposure to PCBs (assessed as PCBs in maternal milk at birth), but the
association lost statistical significance at the ages of 18 and 24 months.  No significant association was
observed between PDI scores between 6 and 24 months of age and postnatal exposure to PCBs (in milk
during breast feeding).  There was no significant association between MDI scores and either prenatal or
postnatal exposure to PCBs.
Alterations in memory functions were reported in children from the Michigan cohort at 7 months, 4 years,
and 11 years of age.  Memory and IQ score deficits were associated with prenatal exposure to PCBs, as
measured by PCBs in umbilical cord blood.  The most highly exposed children were 3 times as likely to
have low average IQ scores and twice as likely to be at least 2 years behind in reading comprehension.
Central nervous system effects of PCBs have been confirmed in laboratory animals.  For example,
decreased performance on a memory task was reported in 60-day-old rats exposed in utero to ortho-
substituted PCB congeners.  In monkeys, effects included neurobehavioral changes in juvenile animals
that were treated postnatally for 20 weeks with a low-dose (7.5 µg/kg/day) of a mixture of PCB congeners
representing 80% of the congeners found in human milk.  At age 20 weeks PCB levels were 1.7–3.5 ppm
in fat and 1.84–2.84 ppb in blood, which are very similar to levels found in the general population.  These
monkeys showed deficits in several tasks, including spatial delayed alternation, acquisition of fixed
interval, and differential reinforcement of low rate performance, which were indicative of impaired
learning, perseveration, and ability to inhibit inappropriate responding.  Numerous studies have
investigated neurotransmitter levels in the prefrontal cortex (important in the regulation of short-term
memory or representational memory for spatial information) and other brain areas following exposure of
laboratory mammals to PCBs.  The most consistent finding in such studies has been a decrease in the
concentration of dopamine in different areas of the brain; however, more information is necessary to
associate specific behavioral alterations with specific neurochemical changes.
It is unknown which specific PCB congeners may be neurodevelopmental toxicants in humans.  Data
from the Oswego fisheater study showed that behavioral alterations in newborn children were associated
with the presence of highly chlorinated (7–9 chlorines) PCB congeners in umbilical cord blood.  This is
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consistent with findings that the distribution of PCB congeners in Great Lakes contaminated fish is
shifted toward more highly chlorinated congeners.  Studies with single PCB congeners suggest that both
dioxin-like (coplanar) and non-dioxin-like PCB congeners are capable of inducing neurobehavioral
alterations in animals, but it appears that ortho-substituted PCB congeners are more active than coplanar
PCBs in modifying cognitive processes.  
A relatively small amount of information is available on neurological effects of PCBs in adult humans.  In
a study of aging adults exposed to PCBs through consumption of contaminated sportfish from Lake
Michigan, no adverse neurological effects were found attributable to exposure to PCBs.  Other studies of
adult populations with occupational exposure to PCBs have not been as conclusive for adverse
neurological effects attributable solely to PCB exposure. 
Reproductive Effects.    Limited data indicate that menstrual disturbances in women and effects on
sperm morphology and production, which are effects that can result in difficulty in a couple conceiving,
may be associated with exposure to PCBs .  Overall, the studies of reproductive end points in humans are
limited; however, the weight of the existing human and animal data suggests that PCBs present a potential
reproductive hazard to humans.
In a small number of occupationally-exposed women, there was no apparent effect of Aroclors 1254,
1242, and/or 1016 on mean number of pregnancies.  A study of the general population found that blood
PCB levels were higher in women who had repeated miscarriages, but levels of other organochlorine
compounds were also elevated.  Studies that examined reproductive end points in women whose diets
contained Great Lakes fish found suggestive evidence that consumption of the fish may be associated
with a slightly shorter length of menstrual cycle and reduced fecundability among couples attempting
pregnancy, but not with increased risk of conception delay.  The slight decreases in menstrual length seen
in this population were considered of unknown clinical relevance.  Menstrual cycle changes (altered
intervals, duration, and flow) have also been observed in women exposed to higher doses of PCBs during
the Yusho poisoning incident.  However, another general population study did not find an association
between endometriosis or increased risk for spontaneous fetal death and concentrations of PCBs in the
blood.
These reproductive effects are supported by a number of studies in laboratory animals.  Menstrual
alterations in monkeys and estrus changes in rats have been observed following oral exposure to Aroclor
PCB mixtures.  For example, high doses of Aroclor 1254 causes prolonged estrus cycle in adult rats
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exposed for several weeks, delayed first estrus in offspring of rats following gestational and lactational or
lactational-only exposure, and altered estrus cycle patterns in young and mature offspring of rats
following lactational exposure.  In monkeys, menstrual cycle durations became erratic or longer following
exposure to $0.1 mg/kg/day Aroclor 1248 for 7–9 months, although no clear changes in menstrual
cyclicity resulted from chronic exposure to lower dose levels (0.005–0.08 mg/kg/day) of Aroclor 1254. 
In addition, delayed onset of estrus was also observed in adult mink and their offspring in a 2-generation
reproduction study involving exposure to Great Lakes fish.  
The reproductive toxicity of commercial PCB mixtures in female animals is well-established.  In addition
to estrus and menstrual changes, effects that have been observed in various species include reduced
implantation rate in adult rats and/or their offspring exposed during gestation and lactation, decreased
conception in mice, partial or total reproductive inhibition in minks, and decreased fertility in monkeys. 
Minks and monkeys are particularly sensitive, with effects occurring in these species at oral doses of
Aroclor 1254 and 1248 in the range of 0.1–1 mg/kg/day in intermediate-duration studies, and as low as
0.02 mg/kg/day in monkeys following chronic exposure to Aroclor 1254.  Reproductive failure in minks
associated with fetal death was attributed to degenerative changes in the placental vasculature.  Impaired
ability to conceive and decreased fetal survival are well-documented in female monkeys following
repeated oral exposure to Aroclors 1254 and 1248.  Reduced conception rates, as well as increased
incidences of abortions, resorptions, or stillbirths, were observed in monkeys fed Aroclor 1254 at dose
levels as low as 0.02 mg/kg/day for 37 months before breeding and subsequently throughout mating and
gestation.  
The ability of PCBs to cause reproductive effects in males is less clear-cut than in females.  Sperm counts,
fertility history, and testicular examinations were normal in workers who were exposed to Aroclor PCBs
for several years.  However, analysis of semen showed that increasing concentrations of some individual
congeners, but not total PCBs, were associated with decreasing sperm motility in infertile men.
A limited amount of information is available on reproductive effects of PCBs in male laboratory animals.
Four monkeys chronically exposed to 0.1 mg/kg/day Aroclor 1248 developed effects that included
clinical signs of toxicity, decreased libido, and marked hypoactivity of the seminiferous tubules, including
an absence of mature spermatozoa, after the first year of exposure.  Fertility was markedly reduced in
male offspring of rats that were lactationally exposed to relatively high doses of Aroclor 1254.  The
reduction in male fertility appears to be due to impaired ability of sperm to fertilize eggs because sperm
production, morphology, and motility were not affected and plasma follicle-stimulating hormone (FSH)
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and testosterone concentrations were not reduced.  Oral and subcutaneous studies with single congeners
have also shown that gestational and neonatal exposures can adversely affect morphology and production
of sperm and fertility in male rats and mice.
Developmental Effects.    This section summarizes effects of PCBs on anthropometric measures at
birth as well as physical growth during infancy.  Effects of perinatal exposure to PCBs on other end
points in the offspring, such as the thyroid gland and thyroid hormone status, end points known to be very
important for structural and functional aspects of normal development of the brain and sexual organs, are
discussed in the Endocrine Effects and Reproductive Effects sections, respectively.  Neurodevelopmental
effects of PCBs are summarized in the Neurological Effects section.
Studies of the children of environmentally-exposed women have produced mixed results.  While some
studies have shown significant, negative associations between anthropometric measures at birth (and at
early ages) and exposure to PCBs, other studies have reported either significant positive associations or 
no associations at all.  The wide range of results may reflect the different degree of controlling for
confounders and/or the different exposure measures.  For example, of the studies of women who
consumed contaminated fish from the Great Lakes, the study of Lake Michigan fisheaters found that
reduced birth weight, head circumference, and gestational age in newborns, as well as body weight at
4 years, were associated with prenatal exposure to PCBs (measured in umbilical cord blood).  In the
Oswego cohort (Lake Ontario fish consumption), there was no significant association between birth
weight, head circumference, or gestational age and prenatal exposure to PCBs, as assessed by the same
fish consumption measures used in the Michigan study, which had higher levels of PCB exposure.  In two
additional studies of Lake Michigan women, fish consumption had a positive effect on birth weight.  It
has been postulated that this may be related to the beneficial effects of certain fatty acids in fish.  A study
of Swedish wives of Baltic Sea fishermen found an increased risk of low birth weight with increasing
maternal blood concentrations of a PCB congener used as surrogate of PCB exposure during the year of
childbirth.  In a Dutch general population cohort, a reduced birth weight, but not head circumference or
body length at 10 days of age, was associated with prenatal exposure to PCBs (measured in umbilical
cord blood).  Reduced growth between birth and 3 months was associated with prenatal exposure in
formula-fed children, but no such association was seen in breast-fed children, suggesting that any
detrimental effect observed in newborns due to prenatal exposure to PCBs may have been counteracted
by the benefits of breast feeding.  In the Dutch children, no significant association was seen between
growth between the ages of 3–7 months, 7–18 months, or 18–42 months and any measure of exposure to
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PCBs.  In addition, a study of the general population in Finland found no significant association between
birth weight and the concentration of PCBs in breast milk.
Studies of rodents exposed to relatively high doses of PCBs have commonly found decreased birth
weight, and reduced weight gain after birth following exposure in utero and through suckling.  The latter
finding suggests that significant transfer of PCBs may occur through breast feeding.  Long-term studies
with much lower doses of Aroclors 1016 and 1248 in monkeys also reported decreased birth weight. 
Studies with low doses of Aroclor 1254 (0.0005–0.08 mg/kg/day) in monkeys found no significant effects
on anthropometric measures at birth or on growth thereafter, although dermal and ocular signs of PCB
intoxication were noted.
Cancer.    Carcinogenicity of PCBs in humans has been investigated in retrospective occupational
studies that evaluated cancer mortality in workers exposed during capacitor manufacturing and repairing,
and in case-control studies of the general population that examined associations between cancer and
serum or adipose tissue levels of PCBs resulting from environmental exposures.  Based on indications of
PCB-related cancer at several sites, particularly the liver, biliary tract, intestines, and skin (melanoma),
the human studies provide suggestive evidence that PCBs are carcinogenic.  There is unequivocal
evidence that PCBs are hepatocarcinogenic in animals. 
The suggestive evidence for the carcinogencity of PCBs in humans is supported by extensive conclusive
evidence in animals.  PCBs have been classified as probable human carcinogens by both IARC and EPA,
based mainly on the sufficient evidence of carcinogenicity in animals.  The human evidence of
carcinogenicity is regarded as limited by IARC and inadequate but suggestive by EPA, although neither
assessment is based on all currently available studies.  NTP similarly concluded that PCBs are reasonably
anticipated to be carcinogenic in humans based on sufficient evidence of carcinogenicity in animals. (See
Chapter 3 [Section 3.2.8] for a detailed discussion of the bases for these determinations.)
2.3 Minimal Risk Levels
As indicated above in the beginning of Section 2.1, people are environmentally exposed to PCB mixtures
of different congeneric composition than commercial PCB mixtures.  Although the toxicity or potency of
environmental PCB mixtures consequently may be greater or less than that of commercial mixtures, there
are insufficient mixture toxicity data on which to directly base minimal risk levels (MRLs) for
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environmental PCBs.  One approach that has been widely considered for estimating the risk from
environmental exposure to PCBs is the toxic equivalency factor (TEF) method.  As discussed in
Chapter 3 (Section 3.5.2), the TEF approach can be used to estimate the potency of PCB mixtures by
comparing the relative toxicity of individual PCB congeners to that of 2,3,7,8-tetrachlorodibenzo-
p-dioxin (2,3,7,8-TCDD), which is the most toxic and extensively studied of these structurally-related
halogenated aromatic hydrocarbons.  Although TEFs are used to some extent to guide public health
decisions because of the limited toxicological data for complex environmental mixtures and many of their
components, the approach has received limited validation and has a number of limitations related to
assumptions that the components jointly act in an additive manner through a common Ah-receptor
mechanism of toxicity.  In particular, the TEF approach does not account for evidence that non-Ah-
receptor-binding congeners are major components in PCB-containing environmental mixtures that may
contribute to induction of health effects (Hansen 1998; Safe 1998a, 1998b).  Although there is certainly a
large body of data to support the TEF approach to assessing PCB toxicity, this is by no means without
question, primarily because of evidence of non-additive interactions between specific PCB congeners and
between some PCB congeners and 2,3,7,8-TCDD (see Chapter 3, Section 3.9), as well as increasing
evidence that PCB-induced effects may involve Ah-receptor-dependent mechanisms, Ah-receptor-
independent mechanisms, or both.  Because of the likelihoods that (1) multiple mechanisms may be
involved in PCB-induced health effects, (2) different PCB congeners may produce effects by different
mechanisms, and (3) humans are exposed to complex mixtures of interacting PCBs with differing
biological activities, commercial PCB mixtures (e.g., Aroclor 1254) and experimental PCB mixtures (e.g.,
formulations representing the congeners found in human breast milk) are used to develop health guidance
values, such as MRLs, for environmental mixtures in assessing health risks from exposure.
Inhalation MRLs
No inhalation MRLs were derived for PCB mixtures due to lack of adequate human and animal data.
Oral MRLs
• An MRL of 0.03 µg/kg/day has been derived for intermediate-duration oral exposure
(15–364 days) to PCBs.
The intermediate oral MRL is based on a LOAEL of 0.0075 mg/kg/day for neurobehavioral alterations in
infant monkeys that were exposed to a PCB congener mixture representing 80% of the congeners
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typically found in human breast milk (Rice 1997, 1998, 1999b; Rice and Hayward 1997, 1999a).  The
MRL was estimated by dividing this LOAEL by an uncertainty factor of 300 (10 for extrapolation from a
LOAEL to a NOAEL, 3 for extrapolation from monkeys to humans, and 10 for human variability). 
Groups of five and eight male monkeys were orally administered doses of 0 or 0.0075 mg/kg/day,
respectively, from birth to 20 weeks of age.  The dose level represents the approximate daily intake of a
nursing human infant whose mother’s milk contains 50 ppb PCBs.  Beginning at 3 years of age, the
monkeys were tested for behavioral effects using a series of nonspatial discrimination reversal problems
followed by a spatial delayed alternation task.  Additional testing was done at 4.5 and 5 years of age. 
Treated monkeys showed decreases and variable increases in response latencies across three tasks of
nonspatial discrimination reversal, as well as retarded acquisition of a delayed alternation task and
increased errors at short delay task responses (Rice 1997). These findings were interpreted as a
learning/performance decrement rather than an effect on memory per se.  Treated monkeys also displayed
alterations in fixed-interval and fixed-ratio performance tasks that were interpreted as impaired learning,
perseverative behavior, and/or inability to inhibit inappropriate responding as a result of postnatal PCB
exposure (Rice 1997).  Testing of the monkeys at 4.5–5 years of age showed that treated animals
performed in a less efficient manner than controls under a differential reinforcement of low rate (DRL)
schedule of reinforcement (Rice 1998).  There were no differences between groups on the accuracy of
performance on a series of spatial discrimination reversal tasks, although some treated monkeys made
more errors than others on certain parts of the experiment.  Further tests conducted at about 5 years of age
did not find treatment-related effects on a series of concurrent RI-RI (random interval) schedules of
reinforcement (Rice and Hayward 1999a).  This schedule was designed to study behavior in transition
(learning) as well as at steady state.  However, there was a difference between treated and control
monkeys on performance on a progressive ratio (PR) schedule, which may be indicative of retarded
acquisition of the steady-state PR performance.
The 0.0075 mg/kg/day LOAEL is a particularly relevant basis for MRL derivation due to the composition
of the PCBs (a congener mixture analogous to that in human breast milk), dose level (approximate daily
intake of a nursing human infant whose mother’s milk contains 50 ppb PCBs), and resulting PCB adipose
tissue and blood levels (near background concentrations found in the general human population).  Support
for the 0.0075 mg/kg/day LOAEL is provided by occurrence of minimal immunological alterations in the
same monkeys (Arnold et al. 1999), as well as clinical signs of toxicity (ocular and dermal changes) and
decreased antibody responses in offspring of other monkeys that were exposed to a similarly low dose
level of a commercial PCB mixture (0.005 mg/kg/day Aroclor 1254) for approximately 46 weeks during
gestation and nursing (Arnold et al. 1995).  The next highest intermediate-duration dose level (i.e., above
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0.0075 mg/kg/day) tested in any species is 0.02 mg/kg/day, which is a serious LOAEL for fetal toxicity in
monkeys (Arnold et al. 1995).  Additional information on the critical and supporting studies used to
derive the intermediate-duration MRL is provided in Appendix A.
• An MRL of 0.02 µg/kg/day has been derived for chronic-duration oral exposure (365 days or
more) to PCBs.
The chronic oral MRL was is based on a LOAEL of 0.005 mg/kg/day for immunological effects in adult
monkeys that were evaluated after 23 and 55 months of exposure to Aroclor 1254 (Tryphonas et al. 1989,
1991a).  The MRL was estimated by dividing this LOAEL by an uncertainty factor of 300 (10 for
extrapolation from a LOAEL to a NOAEL, 3 for extrapolation from monkeys to humans, and 10 for
human variability).  This study included groups of 16 female Rhesus monkeys that self-ingested capsules
containing 0, 0.005, 0.02, 0.04, or 0.08 mg/kg/day doses of the PCBs.  Comprehensive immunological
evaluations showed that IgM (all doses except 0.02 mg/kg/day) and IgG (all doses) antibody levels to
SRBC were significantly reduced compared to controls after 23 months (Tryphonas et al. 1989). 
Secondary challenge with SRBC after 55 months showed decreasing dose-related trends in the IgM and
IgG anamnestic responses, although only IgM was significantly lower than controls at all dose levels
(Tryphonas et al. 1991a).  Other immunologic changes included changes in numbers of lymphocyte T-cell
subsets (significantly decreased ratio of T-inducer/helper cells to T-cytotoxic/suppressor cells) at
0.08 mg/kg/day (only dose level tested) after 23 months, and dose-related trends for several endpoints
(e.g., decreasing lymphocyte proliferation in response to mitogenic stimulation, decreasing phagocytic
activity of peripheral blood monocytes) after 55 months.  Support for the critical LOAEL is provided by
mild dermal and ocular manifestations of PCB toxicity, including eyelid swelling and various finger and
toe nail changes, in the same monkeys at 0.005 mg/kg/day and higher doses (Arnold et al. 1993a). 
Additionally, a number of other studies using higher dose levels of PCB have demonstrated
immunological and dermal/ocular effects in monkeys following intermediate or chronic exposures.  The
LOAEL resulted in PCB tissue and blood levels that are near background concentrations found in the
general human population (Kimbrough 1995).  The next highest dose level, 0.02 mg/kg/day, is a serious
LOAEL for reproductive toxicity (reduced conception) and fetal toxicity when monkeys from the same
study were bred after 37 months of exposure (Arnold et al. 1995).  Additional information on the critical
and supporting studies used to derive the chronic-duration MRL is provided in Appendix A.
As affirmed by a panel of international experts (see Appendix E), human data provide support for this
chronic oral MRL.  Using data from the North Carolina cohort (Gladen et al. 1988; Rogan et al. 1986a,
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1986b), Tilson et al. (1990) estimated a NOAEL of 0.093 µg/kg/day for developmental effects in humans. 
This NOAEL was calculated by first estimating the concentration of PCBs in breast milk that resulted in
no significant neurodevelopmental alterations in neonates as assessed with the Brazelton Scale; this
concentration was 3.4 ppm (Gladen et al. 1988; Rogan et al. 1986a).  The assumption was then made that
the concentration of PCBs in women’s breast milk is equal to the concentration of PCBs in the fat
throughout the rest of the body.  It can then be calculated that for 25-year-old women who weigh 60 kg
and have 25% body fat, 3.4 ppm would result from a lifetime daily PCB dose of 0.093 µg/kg/day (Tilson
et al. 1990).  Since the analytical method might have caused the researchers to overestimate the
concentration of PCBs in breast milk by a factor of 2 (Tilson et al. 1990), this NOAEL may be
appropriately estimated to be 0.05 µg/kg/day, rather than 0.093 µg/kg/day.  If an uncertainty factor of
3 were applied to the NOAEL of 0.05 µg/kg/day to account for intraspecies variation, this would result in
a rounded dose of 0.02 µg/kg/day, which is exactly equivalent to the chronic-duration oral MRL derived
above from data in monkeys.  It should be pointed out that because losses of PCBs through excretion,
lactation, and metabolism were not factored in the dose calculations, the actual dose that results in
3.4 ppm in breast milk fat would be higher than the reported NOAEL.  Also, if dose calculations were
based on women older than 25 years, the estimated daily dose would be lower than the reported NOAEL. 
Finally, it is possible that exposure to other bioaccumulative toxic substances could, in part, have
contributed to other effects seen in this study.  Nonetheless, it is both meaningful and relevant that the
chronic oral MRL for PCBs is lower than the estimated NOAEL for the most sensitive human population
in the Tilson et al. (1991) cohort.
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3.1 INTRODUCTION
The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and
other interested individuals and groups with an overall perspective on the toxicology and epidemiology of
polychlorinated biphenyls (PCBs).  It contains descriptions and evaluations of toxicological studies and
epidemiological investigations, as well as toxicokinetic and other kinds of data pertinent to assessing the
health effects of PCBs.  Conclusions on the relevance of this information to public health, where possible,
are discussed in Chapter 2 (Relevance to Public Health).
A glossary and list of acronyms, abbreviations, and symbols can be found at the end of this profile.
The health effects of PCBs have been extensively tested.  Most studies investigated commercial PCBs
mixtures that were produced in the United States before 1977 under Aroclor trade names.  Health effects
studies are also available for PCB mixtures produced in foreign countries.  Among the most common
tested foreign commercial PCB mixtures are Kanechlors, which were produced in Japan, and Clophens,
which were produced in Germany.  As in the United States, PCBs are no longer produced in Japan or
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Germany.  Foreign PCB mixtures differed from Aroclors mainly in percentages of individual chlorinated
biphenyls, method of production, and level of contaminants.  As discussed in Chapter 4, commercial PCB
mixtures are comprised of various PCB congeners (there are 209 possible individual chlorinated
biphenyls), as well as contaminants from the manufacturing process, particularly chlorinated
dibenzofurans (CDFs).  Information regarding the numbering system for PCBs and other chemical terms
used to define the position of the chlorines on the biphenyl structure are provided in Chapter 4.  The
acronym PCBs is a general term used to refer to any commercial or other kind of mixture of congeners,
such as environmental mixtures or animal tissue residues.
Evaluation of the health effects of PCB mixtures is complicated by numerous factors, particularly their
congeneric composition, since ultimately, the toxicity of the mixture is due to the toxicity of the
individual congeners, their interactions, and interactions with other structurally related chemicals such as
CDFs and dioxins.  For example, lot-to-lot differences in the congener distribution of commercial PCBs
have been reported, which could contribute to some variations in toxicity observed among studies.  The
degree of CDF contamination is also a consideration in assessing the toxicity of commercial PCBs,
because reported concentrations of CDFs varied among Aroclor formulations as well as with time period
of manufacture.  Concentrations of CDFs usually were higher in the Japanese and European PCBs than in
Aroclors, and PCBs manufactured in the late 1970s had lower levels of contaminates than those produced
earlier.  In general, this profile is concerned with effects of PCBs in the presence of minimal CDF
contamination.  However, most health effects studies of PCB mixtures did not determine or report purity,
or provide lot numbers that could be used to locate information on CDF contamination or congener
distribution.  Toxicological data for Kanechlors and Clophens are included in this chapter when these data
provide information on effects that are not fully characterized for Aroclors because effects produced by
Aroclors, Kanechlors, and Clophens are generally considered to be similar, at least for mixtures with
equivalent percentages of chlorine (Kimbrough 1987).  In addition, the lowest observed adverse effect
levels for commercial PCB mixtures have been determined with Aroclors.  Selected toxicity and
mechanistic data on individual chlorinated biphenyl congeners also are included in this chapter because
this information is potentially useful for assessing health effects and interactions of environmental
mixtures of PCBs.  
Using current health effects evaluation procedures, toxicity data for individual congeners may over- or
underestimate the actual risk of PCB mixtures because the toxicity of congeners may be influenced by
other congeners and chemicals in an additive, more than additive (synergistic), or less than additive
(antagonistic) way.  As discussed in Chapter 2 (Section 2.3), the current approach to assessing risks uses a
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commercial mixture (Aroclor 1254) and an experimental mixture (a formulation representing the
congeners found in breast milk) to develop health guidance values for environmental exposure to PCBs.  
Information on health effects of PCBs in humans is available from studies of people exposed
occupationally, by consumption of contaminated rice oil in Japan (the Yusho incident) and Taiwan (the
Yu-Cheng incident), by consumption of contaminated fish and other food products of animal origin, and
via general environmental exposures.  As discussed in Chapter 6, people are environmentally exposed to
PCBs that differ from commercial PCB mixtures due to changes in congener and impurity composition
resulting from  processes such as volatilization and other kinds of partitioning, chemical or biological
transformation, and preferential bioaccumulation.  Due to their stability and lipophilicity, PCBs usually
accumulate in higher food-chain organisms and are stored in fatty tissues.  Food consumption has been
and continues to be the major source of body burden of PCBs in the general population.  There is
evidence that diets high in fish from PCB-contaminated waters, such as those in the Great Lakes and
St. Lawrence River basins, can significantly increase a person’s dietary intake of PCBs.  Breast-fed
infants of mothers who have diets high in contaminated fish may have a particularly increased risk for
PCB exposure due to its presence in the milk.
PCBs are 1 of 11 persistent toxic substances that have been identified as critical Great Lakes pollutants by
the International Joint Commission Water Quality Board (GLWQB 1985).  In 1990, Congress amended
the Federal Water Pollution Control Act and mandated the Environmental Protection Agency (EPA), in
consultation with the Agency for Toxic Substances and Disease Registry (ATSDR) and the Great Lakes
states, to submit a research report on the adverse human health effects related to water pollutants in the
Great Lakes.  Since then, ATSDR has awarded research grants and established cooperative agreements to
coordinate basin-wide human health effects research.  The primary interests of ATSDR’s Great Lakes
Human Health Effects Research Program are to document and characterize the exposure, identify
populations at higher risk, identify associations between the consumption of contaminated Great Lakes
fish and short and long-term harmful health effects, identify the most sensitive end points, establish
registries and surveillance cohorts, and identify ways to prevent or mitigate exposure and resulting health
effects (Johnson and DeRosa 1999; Johnson et al. 1998, 1999, 2000).  PCB-related findings from the
Great Lakes Research Program, as well as results from a number of other studies on health effects
associated with exposures to PCBs through fish consumption, are included in this chapter.
Health effects have been observed in humans who consumed rice oil contaminated with heat-degraded
Kanechlors in the Yusho and Yu-Cheng poisoning incidents.  There is a historical linkage between
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Yusho/Yu-Cheng and PCBs, and some health assessment documents ascribe effects from these incidents
to PCBs.  Unlike usual PCB mixtures, the Yusho and Yu-Cheng Kanechlors were heated in thermal heat
exchangers (before rice oil contamination occurred) and also during cooking, resulting in the production
of relatively high concentrations of CDF and polychlorinated quarterphenyl (PCQ) impurities.  The
concentrations of PCBs and PCQs in the rice oils were 100- to 500-fold greater than the CDFs.  CDFs are
generally considered the main causal agent, based on the following evidence: comparisons with Japanese
workers with higher PCB blood levels who had few or none of the symptoms present in the rice oil
poisonings; decreasing serum levels of PCBs in victims with persistent health effects; induction of Yusho
health effects in animals exposed to reconstituted mixtures of CDF congeners similar to those in Yusho
oils, but not by exposure to PCBs or PCQs alone; and comparative toxicity evaluations of PCB and CDF
congeners in the unheated source mixture, contaminated rice oil, and tissues of victims (Bandiera et al.
1984; Kunita et al. 1985; Ryan et al. 1990; Safe 1990; Tanabe et al. 1989).  Although there is a general
consensus that CDFs were main contributors to the health effects in the Yusho and Yu-Cheng victims,
certain PCB congeners have the same mechanism of action as CDFs and polychlorinated dibenzo-
p-dioxins (CDDs).  Effects of Yusho and Yu-Cheng exposure, therefore, are indirectly relevant to
assessing health effects of PCBs because they demonstrate the sensitivity of humans to dioxin-like
toxicity and suggest that humans might respond to dioxin-like PCB congeners in a similar manner. 
Additionally, recent evidence indicates that some of the subtle effects can be attributed to non-dioxin-like
PCB congeners (Guo et al. 1996; Soong and Ling 1997).  Brief summaries of the effects from the Yusho
and Yu-Cheng incidents are presented in this profile; a more complete discussion of the health effects
associated with the Yusho and Yu-Cheng incidents can be found in the ATSDR toxicological profile on
CDFs (ATSDR 1994) and CDDs (ATSDR 1998), and reviews by Hsu et al. (1994) and Masuda (1994).
Fires and other sources of high temperatures, such as hazardous waste incinerators and electrical
transformer fires, also can greatly increase the toxicity of PCB mixtures by formation of CDFs (Rappe
and Buser 1989).  For example, in a transformer fire in the Binghamton (New York) State Office Building
(BSOB), dielectric fluid composed of 65% Aroclor 1254 and 35% polychlorinated benzenes was
pyrolyzed.  The pyrolysis led to the formation of a fine, oily soot, which was distributed throughout the
building via ventilation shafts.  In addition to PCBs, the soot contained high levels of CDFs, CDDs,
including 2,3,7,8-tetrachlorodibenzodioxin (TCDD), chlorinated biphenylenes, and other chemicals. 
Limited information is available on health effects in people who were exposed to this soot dermally, by
inhalation, or by ingestion from eating with dirty hands.  A discussion of the health effects associated
with the BSOB incident can be found in the ATSDR toxicological profile for CDFs and reports by
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Schecter (1983, 1986, 1987), Schecter and Tiernan (1985), Schecter et al. (1985a, 1985b), and Fitzgerald
et al. (1986, 1989).
To help public health professionals and others address the needs of persons living or working near
hazardous waste sites, the information in this section is organized first by health effect (death, systemic,
immunological, neurological, reproductive, developmental, genotoxic, and carcinogenic effects), and then
by human and animal studies subdivided by type of exposure (e.g., occupational, contaminated fish
consumption, inhalation, oral, and dermal).  These data are discussed in terms of three exposure periods:
acute (14 days or less), intermediate (15–364 days), and chronic (365 days or more).
Levels of significant exposure for each route and duration are presented in tables and illustrated in
figures.  The points in the figures showing no-observed-adverse-effect levels (NOAELs) or
lowest-observed-adverse-effect levels (LOAELs) reflect the actual doses (levels of exposure) used in the
studies.  LOAELS have been classified into "less serious" or "serious" effects.  "Serious" effects are those
that evoke failure in a biological system and can lead to morbidity or mortality (e.g., acute respiratory
distress or death).  "Less serious" effects are those that are not expected to cause significant dysfunction
or death, or those whose significance to the organism is not entirely clear.  ATSDR acknowledges that a
considerable amount of judgment may be required in establishing whether an end point should be
classified as a NOAEL, "less serious" LOAEL, or "serious" LOAEL, and that in some cases, there will be
insufficient data to decide whether the effect is indicative of significant dysfunction.  However, the
Agency has established guidelines and policies that are used to classify these end points.  ATSDR
believes that there is sufficient merit in this approach to warrant an attempt at distinguishing between
"less serious" and "serious" effects.  The distinction between "less serious" effects and "serious" effects is
considered to be important because it helps the users of the profiles to identify levels of exposure at which
major health effects may start to appear.  LOAELs or NOAELs should also help in determining whether
or not the effects vary with dose and/or duration, and place into perspective the possible significance of
these effects to human health.  
The significance of the exposure levels shown in the Levels of Significant Exposure (LSE) tables and
figures may differ depending on the user's perspective.  Public health officials and others concerned with
appropriate actions to take at hazardous waste sites may want information on levels of exposure
associated with more subtle effects in humans or animals (LOAEL) or exposure levels at or below which
no adverse effects (NOAELs) have been observed.  Estimates of levels posing minimal risk to humans
(Minimal Risk Levels or MRLs) may be of interest to health professionals and citizens alike.
PCBs 38
3.  HEALTH EFFECTS
Levels of exposure associated with carcinogenic effects (Cancer Effect Levels, CELs) of polychlorinated
biphenyls are indicated in Table 3-2 and Figure 3-2.  Because cancer effects could occur at lower
exposure levels, Figure 3-2 also shows a range for the upper bound of estimated excess risks, ranging
from a risk of 1 in 10,000 to 1 in 10,000,000 (10-4 to 10-7), as developed by EPA.
Estimates of exposure levels posing minimal risk to humans (Minimal Risk Levels or MRLs) have been
made for PCBs as discussed in Chapter 2 (Section 2.3) .  An MRL is defined as an estimate of daily
human exposure to a substance that is likely to be without an appreciable risk of adverse effects
(noncarcinogenic) over a specified duration of exposure.  MRLs are derived when reliable and sufficient
data exist to identify the target organ(s) of effect or the most sensitive health effect(s) for a specific
duration within a given route of exposure.  MRLs are based on noncancerous health effects only and do
not consider carcinogenic effects.  MRLs can be derived for acute, intermediate, and chronic duration
exposures for inhalation and oral routes.  Appropriate methodology does not exist to develop MRLs for
dermal exposure.
Although methods have been established to derive these levels (Barnes and Dourson 1988; EPA 1990),
uncertainties are associated with these techniques.  Furthermore, ATSDR acknowledges additional
uncertainties inherent in the application of the procedures to derive less than lifetime MRLs.  As an
example, acute inhalation MRLs may not be protective for health effects that are delayed in development
or are acquired following repeated acute insults, such as hypersensitivity reactions, asthma, or chronic
bronchitis.  As these kinds of health effects data become available and methods to assess levels of
significant human exposure improve, these MRLs will be revised.
A User's Guide has been provided at the end of this profile (see Appendix B).  This guide should aid in
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3.2 DISCUSSION OF HEALTH EFFECTS
3.2.1 Death
3.2.1.1 Human Studies
No studies were located regarding deaths in humans from acute exposure by any route.  Some studies of
longer-term occupational exposures found increased mortality from cardiovascular disease and cancer, as
discussed in Sections 3.2.2.2.1 and 3.2.8.2, respectively.
3.2.1.2 Animal Studies
Inhalation Exposure.  Intermittent exposure to near-saturation vapor concentrations of heated
Aroclor 1242 (8.6 mg/m3) over 24 days was not lethal in rats, mice, rabbits, or guinea pigs, and no signs
of intoxication were reported (Treon et al. 1956).  Pneumonia, apparently unrelated to PCB exposure,
caused death in some of the test and control animals except those exposed to 8.6 mg/m3 Aroclor 1242. 
The vapor concentrations are unknown, as the technique used to estimate them has since been shown to
be invalid; possible CDF contamination was not reported because CDFs had not then been discovered. 
Similar exposures to lower concentrations of heated Aroclors 1242 and 1254 were also found not to
produce lethality in these species.  No data were located regarding lethality or decreased longevity of
animals due to acute or chronic inhalation of PCBs.
Oral Exposure.  There are no marked differences in acute LD50 values of Aroclor PCB mixtures for
observation periods of <30 days.  Single-dose LD50 values of 4,250 mg/kg for Aroclor 1242 (Bruckner et
al. 1973), 1,010 to 1,295 mg/kg for Aroclor 1254 (Garthoff et al. 1981; Linder et al. 1974), and
1,315 mg/kg for Aroclor 1260 (Linder et al. 1974) have been reported in rats.  In minks, single-dose LD50
values ranged between 750 and 1,000 mg/kg for Aroclor 1221, and were >3,000 mg/kg for Aroclor 1242
and 4,000 mg/kg for Aroclor 1254 (Aulerich and Ringer 1977).  In addition to differences in PCB
congener composition, the variation in LD50 values may be related to factors such as animal strain, age,
sex, or formulation purity.  There is evidence, for example, that immature rats (3–4 weeks old) are more
susceptible than adults (Grant and Phillips 1974; Linder et al. 1974).  Causes of death from acute
exposure are unclear, but principal signs of toxicity in rats included diarrhea and respiratory depression,
and dehydration may be a principal contributing factor (Bruckner et al. 1973).  Single-dose oral lethality
data for species other than rats and minks were not located.
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Three of five mice fed Aroclor 1254 in the diet at an estimated dose of 130 mg/kg/day for 14 days died of
unspecified causes by day 15 (Sanders et al. 1974).  At the highest Aroclor 1254 dose of 520 mg/kg/day,
5 of 5 mice died within 7 days, but none of the 5 mice treated with 2.5 mg/kg/day died.
Estimated dietary doses of 4 mg/kg/day Aroclor 1248 for 2–3 months (Allen 1975; Allen and Norback
1976) and 0.12–4 mg/kg/day Aroclor 1242 for 92–245 days were lethal for monkeys (Becker et al. 1979). 
Survival effects were not clearly related to dose in the Becker et al. (1979) study, but this could be due to
the small numbers tested (one per dose), which is not unusual in studies of nonhuman primates. 
Tryphonas et al. (1984) dosed Cynomolgus monkeys (Macaca fasicicularis) with Aroclors 1248 and
1254 at 2 and 5 mg/kg/day for 3 days/week for 4 weeks.  Aroclor 1248 was more toxic than
Aroclor 1254.  Minks and monkeys appear to have similar susceptibility to lethal effects of intermediate-
duration oral PCB exposure (Aulerich and Ringer 1977; Aulerich et al. 1986; Bleavins et al. 1980;
Hornshaw et al. 1986; Ringer et al. 1981).  LD50 values of 7.1–7.3 and 1 mg/kg/day were determined for
minks fed Aroclor 1254 for 28 days (Aulerich et al. 1986; Hornshaw et al. 1986) and 9 months (Ringer
et al. 1981), respectively.  Death occurred in 33% of the minks fed 2.8 mg/kg/day Aroclor 1254 for
4 months (Aulerich and Ringer 1977).  The average time to death in minks fed 1.9 mg/kg/day
Aroclor 1242 ranged from 156 to 171 days, with .67% mortality occurring by 247 days (Bleavins et al.
1980).  Death in minks was generally due to visceral hemorrhagic lesions.  Female minks are more
sensitive than males.  Intermediate-duration gavage and feed studies in rats and mice reported that much
higher doses of Aroclor 1254 or 1260 caused death (Garthoff et al. 1981; Kimbrough et al. 1972; Koller
1977).  Although this may be due to species differences in susceptibility, the shorter and intermittent
duration of exposure (2.5 weeks, 2 days/week) and mode of administration (gavage) in rats may account
for some of the apparent differences.
Decreased survival occurred in male rats fed diets containing estimated doses $1.25 mg/kg/day
Aroclor 1254 for 104–105 weeks (NCI 1978).  A dose of 2.5 mg/kg/day induced a 34% decrease in
survival.  The cause of death was not specified.  There was no effect on survival in similarly treated
female rats, and a NOAEL for mortality was not identified.  There was no attempt to identify or quantitate
impurities in the Aroclor 1254 test compound.  Decreased survival is not a universal finding in chronic
PCB studies, as survival was unchanged or lifespan was extended in rats treated with estimated doses of
3.45–5 mg/kg/day 60% chlorine PCB mixtures (Aroclor 1260 and Clophen A60) via diet (Norback and
Weltman 1985; Schaeffer et al. 1984).
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Dermal Exposure.  A single topical dose of 2,273 mg/kg Aroclor 1254 was fatal to hairless mice within
24 hours (Puhvel et al. 1982).  It was not specified whether all three treated mice died or whether the
Aroclor was administered in pure acetone or in acetone-mineral oil emulsion.  Median lethal doses for
single dermal applications of PCBs to rabbits were between 794 and 1,269 mg/kg for Aroclors 1242 and
1248, between 1,260 and 3,169 mg/kg for Aroclors 1221 and 1262, and between 1,260 and 2,000 mg/kg
for Aroclors 1232 and 1260 (Fishbein 1974; Nelson et al. 1972).  These PCBs were applied undiluted
except for Aroclors 1260 and 1262, which were administered in corn oil.  Other details regarding the
exposure protocol were not provided.  Cause of death was not reported, and there was no clear trend of
toxicity with degree of chlorination.  Lethality data for other species or durations of exposure were not
located.  The lethal dose from the Puhvel et al. (1982) study is recorded in Table 3-3.
3.2.2 Systemic Effects
3.2.2.1 Respiratory
3.2.2.1.1  Human Studies
There are limited data on potential respiratory effects of PCB exposure in humans.  Cross-sectional
studies provide suggestive evidence for an association.  Upper respiratory tract or eye irritation (48%),
cough (14%), and tightness of the chest (10%) were noted among 326 capacitor workers exposed to
0.007–11 mg/m3 mean air concentrations of various Aroclors for >5 years (Fischbein et al. 1979;
Warshaw et al. 1979).  The significance of these effects is unknown due to lack of a control group;
however, the prevalence of upper respiratory tract or eye irritation (48%) raises concern that they are
exposure-related.  Other limitations of this study include discrepancies between the reports of Fischbein et
al. (1979) and Warshaw et al. (1979), poor definition of the cohort, and failure to distinguish between past
and present symptoms.  Additionally, capacitor manufacturing plants typically used large amounts of
volatile degreasing agents that may have contributed to pulmonary symptom complaints.  Chest pain
while walking occurred more frequently (16%) in a group of 55 male transformer workers exposed to
Aroclor/trichlorobenzene mixtures (Askarels) than in age-matched workers never occupationally exposed
to PCBs (Emmett et al. 1988a).  The workers were employed for a mean duration of 3.75 years, and the
range of PCB personal exposures (primarily Aroclor 1260) measured in the breathing zone was
0.00001–0.012 mg/m3.  CDF contamination ranged from 13 to 116 ppb by weight.  The chest pain
symptom was not investigated further and was not attributed to a specific cause.  A correlation between
coughing on the job or soon after work and PCB blood levels in electrical capacitor manufacturing
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workers has been reported (Smith et al. 1982).  These workers were exposed to various Aroclors and
Askarels, in PCB concentrations ranging from 0.003 to 0.08 mg/m3 (duration of exposure was not
reported).
In addition to these reported respiratory tract symptoms, changes in lung function were observed in the
PCB workers discussed above.  These include a significant decrease in 1-second forced expiratory
volume (FEV1) in the transformer workers (Emmett et al. 1988b); this is the same cohort evaluated by
Emmett et al. (1988a).  However, when adjusted for smoking habits, FEV was not statistically significant. 
Fourteen percent of 243 workers examined in the Warshaw et al. (1979) study showed reduced forced
vital capacity (FVC) as compared to standard values.  Decreased FVC was noted in 8% of the
nonsmokers (12.5% males, 4.3% females) and in 17% of the current and former smokers (16% males,
18.7% females).  Of all workers with reduced FVC, 80% demonstrated a restrictive pattern of impairment
(increased FEV1/FVC) without radiologic changes.  Similar results were initially found in another
spirometry study of 179 workers from the same plant population as that studied by Warshaw et al. (1979)
(Lawton et al. 1986).  The 1976 findings were not confirmed by followup evaluations performed in 1979
and 1983 after no further PCB exposure, and were considered to be artifactual due to deficient pulmonary
function testing in 1976 and lack of radiologic changes to account for the restrictive impairment observed
(Lawton et al. 1986).  The workers had a history of clinically recognized respiratory illness and/or
symptomatology, and obstructive impairment (increased FVC, decreased FEV1/FVC) was found in about
15% of the workers in the initial and followup evaluations (1976 and 1979), but these effects could not be
attributed solely to PCB exposure.  The occurrence of self-reported respiratory effects was not elevated
among residents who lived within 0.5 mile of three PCB-contaminated waste sites (Stehr-Green et al.
1986a).  
Potential respiratory effects have also been reported in Yusho and Yu-Cheng patients.  More frequent or
severe respiratory infections (Kuratsune 1989; Rogan 1989) and chronic bronchitis accompanied by
persistent cough and sputum production (Nakanishi et al. 1985; Shigematsu et al. 1971, 1977) have been
reported.  
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3.2.2.1.2  Animal Studies
No studies were located regarding respiratory effects in animals after inhalation exposure to PCBs.  There
were no histological alterations in the lungs of rats administered a single 4,000 mg/kg dose of
Aroclor 1242 by gavage and evaluated 24 hours posttreatment or in rats treated with 100 mg/kg/day
Aroclor 1242 by gavage every other day for 3 weeks (Bruckner et al. 1973).  Mice fed a diet that provided
.22 mg Aroclor/kg/day for 6 weeks had no changes in lung weight or histology (Loose et al. 1978a,
1978b).  Lung inflammation was observed in rats that died following dietary exposure to Phenoclor DP6
at .25 mg/kg/day for 8 days or .50 mg/kg/day for 6 days (Narbonne et al. 1978).  Other respiratory end
points were not examined in these studies.  No histopathologic changes were observed in the trachea or
lungs of male or female rats that were fed Aroclor 1016, 1242, 1254, or 1260 for 24 months at intake
levels of 8.0–11.2, 4.0–5.7, 4.3–6.1, or 4.1–5.8 mg/kg/day, respectively (Mayes et al. 1998).  Rhesus
monkeys receiving daily doses of 0.005, 0.020, 0.040, or 0.080 mg/kg/day Aroclor 1254 for 72 months
showed no effects on lung tissue (Arnold et al. 1997).  
Intermediate-duration dietary exposure to single congeners did not result in histological damage in the
lungs of rats fed diets providing #4.1 mg/kg/day of PCB 153 (Chu et al. 1996a), #4.2 mg/kg/day of
PCB 128 (Lecavalier et al. 1997), #7.4 mg/kg/day of PCB 126 (Chu et al. 1994), #4.0 mg/kg/day of
PCB 105 (Chu et al. 1998b), #3.7 mg/kg/day of PCB 28 (Chu et al. 1996b), #0.77 mg/kg/day of PCB 77
(Chu et al. 1995), or #0.17 mg/kg/day of PCB 118 (Chu et al. 1995).
The highest NOAEL values and all reliable LOAEL values for respiratory effects for each study are
recorded in Table 3-2 and plotted in Figure 3-2.
3.2.2.2 Cardiovascular
3.2.2.2.1  Human Studies
A number of occupational exposure studies have investigated the possible relationship between PCB
exposure and increased risk of cardiovascular disease or altered blood pressure; the inconsistency of the
results precludes drawing conclusions from these studies.  Mortality from circulatory diseases was
significantly increased in the high exposure subgroup of a cohort of 242 male capacitor manufacturing
workers with >5 years exposure and >20 years latency (Gustavsson and Hogstedt 1997).  The
standardized mortality ratio (SMR) in the subgroup was 328 (5 observed/1.52 expected deaths, 95%
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confidence interval [CI] 33–61, p value not reported).  Kimbrough et al. (1999a) found no significant
increases in mortality related to ischemic heart disease, hypertension with heart disease, other diseases of
the heart, cerebrovascular disease, or circulatory system (arteries, veins, pulmonary circulation) in a study
of 7,075 male and female capacitor workers.  One of the subgroups (male salaried workers) in this study
had a significantly decreased risk of mortality from ischemic heart as indicated by an SMR lower than
100 (44 observed/97.5 expected deaths, SMR=45, 95% CI 107–766, p<0.01).  Neither of these studies
reported adequate quantitative exposure data.  The inconsistent results of these studies could be due to
differences in exposure levels, durations, and latencies, as well as types of Aroclors and cohort sizes. 
Additional information on these studies is provided in Section 3.2.8.2.1.  
Blood pressure measurements (systolic and diastolic) and electrocardiograms were normal in
194 capacitor plant workers (152 male, 43 female) who were exposed to Aroclors 1254, 1242, and
1016 for an average duration of 17 years (Lawton et al. 1985a).  Limited exposure characterization,
consisting of monitoring in one area of the plant several months prior to the cardiovascular evaluations,
showed a geometric mean PCB concentration of 0.69 mg/m3.  No correlation was found between diastolic
blood pressure in capacitor manufacturing workers, when adjusted for age and sex, and serum PCBs
(Smith et al. 1982).  Abnormal blood pressure measurements or other cardiovascular abnormalities were
not reported in other studies of PCB-exposed workers that underwent general physical examinations and
medical histories (Baker et al. 1980; Chase et al. 1982; Emmett et al. 1988a; Fischbein et al. 1979).  
A 30% increase over the national average incidence of borderline and definite hypertension was observed
in Triana, Alabama, residents (Kreiss et al. 1981).  Increased systolic and diastolic blood pressure were
significantly associated with serum PCB levels.  However, the relationship between systolic blood
pressure and serum PCB levels disappeared when serum cholesterol and triglyceride levels were factored
in, but that between diastolic blood pressure and PCBs remained significant.  Consumption of
contaminated fish was the only known source of PCB exposure; the actual intake of PCBs was not
reported.  The population was also exposed to dichlorodiphenyltrichloroethane (DDT) via consumption of
fish.  Serum DDT and serum PCB levels were highly correlated.  Multivariate analysis showed that the
PCB-blood pressure association was independent of serum DDT levels, age, sex, and weight.  The excess
prevalence of hypertension cannot be attributed solely to PCBs (or DDT) with any degree of certainty due
to the lack of a matched control group, co-linearity of DDT and PCB serum concentrations, and unknown
effects of DDT residues on the metabolism or toxicity of PCBs (Kreiss 1985).  Subsequent studies of
environmentally exposed populations without exposure to DDT have failed to show an association
between hypertension and PCBs.  No excess of hypertension was found in 106 people who had lived near
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PCB-containing hazardous waste sites for at least 5 years (Stehr-Green et al. 1986a).  Mean PCB blood
levels were <10 ppb.  A significant association between increased diastolic blood pressure and serum
PCB levels was observed, but the association failed to achieve statistical significance (p=0.08) when
possible confounding effects of both age and smoking were controlled.  There was no association
between elevated systolic or diastolic blood pressure and serum levels of PCBs in 840 residents of New
Bedford, Massachusetts, who were exposed via consumption of contaminated fish (Massachusetts
Department of Public Health 1987).  However, most subjects in this study had serum PCB levels that
were within the typical range of the U.S. population.
3.2.2.2.2  Animal Studies
Data on the cardiovascular toxicity of PCBs in animals are limited to several oral exposure studies
conducting histological examinations of the heart and blood vessels.  Pericardial edema occurred in four
of six monkeys given 12 mg/kg/day Aroclor 1248 in the diet for 3 months (Allen et al. 1973).  However,
Rhesus monkeys receiving daily doses of 0.005, 0.020, 0.040, or 0.080 mg/kg/day Aroclor 1254 for
25 months showed no effects on cardiac tissue (Arnold et al. 1997).  Histological examination of the heart
was normal in rats evaluated 24 hours following a single 4,000 mg/kg dose of Aroclor 1242 or
100 mg/kg/day Aroclor 1242 every other day for 3 weeks administered by gavage (Bruckner et al. 1973). 
No histopathologic changes were observed in the heart of male or female rats that were fed Aroclor 1016,
1242, 1254, or 1260 for 24 months at dose levels of 8.0–11.2, 4.0–5.7, 4.3–6.1, or 4.1–5.8 mg/kg/day,
respectively (Mayes et al. 1998).  Rhesus monkeys receiving daily doses of 0.005, 0.020, 0.040, or
0.080 mg/kg/day Aroclor 1254 for 25 months showed no effect on cardiac tissue (Arnold et al. 1997). 
In a series of 13-week dietary exposure studies using single PCB congeners, no histological alterations in
the heart or thoracic aorta were observed in rats fed diets providing #4.1 mg/kg/day of PCB 153 (Chu et
al. 1996a), #4.2 mg/kg/day of PCB 128 (Lecavalier et al. 1997), #7.4 mg/kg/day of PCB 126 (thoracic
aorta was not examined) (Chu et al. 1994), #4.0 mg/kg/day of PCB 105 (Chu et al. 1998b),
#3.7 mg/kg/day of PCB 28 (Chu et al. 1996b), #0.77 mg/kg/day of PCB 77 (Chu et al. 1995), or
#0.17 mg/kg/day of PCB 118 (Chu et al. 1995). 
Hennig and associates (Hennig et al. 1999; Slim et al. 1999) demonstrated in in vitro studies that exposure
to PCB 77 disrupts endothelial barrier function in the vascular endothelium; this was not seen for
PCB 153.
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The highest NOAEL values and all reliable LOAEL values for cardiovascular effects for each study are
recorded in Table 3-2 and plotted in Figure 3-2.
3.2.2.3 Gastrointestinal
3.2.2.3.1  Human Studies
Clinical observations suggestive of gastrointestinal damage have been reported in workers exposed to
airborne PCBs and in the Yusho cohort.  A statistically significant increase in loss of appetite was
reported by PCB-exposed transformer workers (20%) as compared to the control group (4%) (Emmett
et al. 1988a).  PCB levels, primarily Aroclor 1260, ranged from 0.00001 to 0.012 mg/m3.  Gastrointestinal
symptoms (anorexia, nausea, vomiting, and abdominal pain) and weight loss were also reported in 18% of
capacitor workers exposed to various Aroclors at mean concentrations of 0.007–11 mg/m3 (Fischbein
et al. 1979).  The statistical significance of the effects cannot be determined since a control group was not
examined.  A significant association was found between loss of appetite and increasing PCB blood levels
in electrical equipment manufacturing workers who were exposed to various Aroclors and Askarels at
PCB concentrations of 0.003–0.08 mg/m3 (Smith et al. 1982).
Postprandial epigastric distress, epigastric pain with or without a burning sensation, postprandial
headache, and intolerance to fatty foods were noted in 50% of workers exhibiting liver effects (Maroni
et al. 1981a).  The workers (40 males and 40 females) were exposed to concentrations of Pyralene 3010 or
Apirolio (Italian PCB formulations) ranging from 0.048 to 0.275 mg/m3 for an average duration of
12 years.  Both of these products were PCB mixtures of unreported purity that had a 42% chlorine
content.  Some of these workers were also exposed to a PCB mixture containing 54% chlorine.  There
was no control group in this study, precluding a determination of the significance of the results. 
Gastrointestinal effects (vomiting and diarrhea) have been observed in Yusho patients (Kuratsune 1989). 
No signs of gastrointestinal effects were reported in community members exposed to PCB-contaminated
sludge or in PCB exposed workers (Baker et al. 1980).
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3.2.2.3.2  Animal Studies
No histopathologic effects were observed in the stomach or intestines of six rats 24 hours following a
single near-lethal dose of 4,000 mg/kg of Aroclor 1242 by gavage (Bruckner et al. 1973).  In contrast,
hemorrhage into the stomach and foci of ulceration in the stomach and duodenum were observed in rats
given a single lethal gavage dose (inadequately quantified) of Aroclor 1254 or 1260 (Kimbrough et al.
1972).  Gastric ulcers were observed in two pigs that were treated with 100 mg/kg/day Aroclor 1254 for
11 days (Hansen et al. 1976).  The lesions in the pigs were similar in gross and histological appearance to
those observed in intermediate-duration studies with monkeys discussed below.
Intermediate-duration dietary administration of Aroclor 1248 (Allen 1975; Allen and Norback 1973,
1976; Allen et al. 1973, 1974a) and Aroclor 1242 (Becker et al. 1979) to monkeys produced gastritis with
hypertrophy and hyperplasia of the gastric mucosa.  The gastric changes progressed to include mucous-
filled cysts in the mucosa penetrating into the submucosa, ulceration of the gastric mucosa resulting from
ruptured cysts or erosion, and hemorrhage.  Estimated doses of $1.3 mg/kg/day Aroclor 1248 or
$0.12 mg/kg/day Aroclor 1242 for 2 months produced these gastric changes in monkeys (Allen 1975;
Allen and Norback 1976; Allen et al. 1974a; Becker et al. 1979).  Only a minimal number of
Aroclor 1242-exposed animals were tested (mostly one monkey per dose group), although the severity of
the histopathologic changes was dependent on both exposure length and dose.  Gastric ulcers also
occurred in minks at similar dietary doses of Aroclor 1016, 1242, or 1254 (Bleavins et al. 1980;
Hornshaw et al. 1986), and there is evidence of gastric erosion and necrosis in pigs treated with
9.2 mg/kg/day Aroclor 1242 or 1254 for 91 days (Hansen et al. 1976).  In seasoned sows, which are prone
to gastric hyperemia, erosions were more severe in two of five sows receiving 9.2 mg/kg/day
Aroclor 1242 (Hansen et al. 1975).  Gastrointestinal lesions were also observed in Baltic seals, and found
to be directly associated with body burdens of PCBs and/or metabolites (Bergman and Olsson 1985;
Olsson et al. 1994).  There were no histological changes in the stomach or intestines of rats treated with
100 mg/kg/day Aroclor 1242 by gavage 3 times/week for 3 weeks (Bruckner et al. 1973). 
Re-examination of the National Cancer Institute (NCI 1978) cancer bioassay showed Aroclor 1254-
induced intestinal metaplasia and some adenocarcinoma in the glandular stomach of Fischer 344 rats
following chronic dietary treatment (Morgan et al. 1981; Ward 1985) (see Section 3.2.8.3.2).  The
intestinal metaplasia appeared to be dose-related.  Nonproliferative gastric lesions were not observed.  No
histopathologic changes were observed in the gastrointestinal tract of male or female rats that were fed
Aroclor 1016, 1242, 1254, or 1260 for 24 months at dose levels of 8.0–11.2, 4.0–5.7, 4.3–6.1, or
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4.1–5.8 mg/kg/day, respectively (Mayes et al. 1998).  Moderate mucinous hypertrophic gastropathy was
evident in three of four Cynomolgus monkeys treated with 0.2 mg/kg/day Aroclor 1254 in the diet for
12–13 months (Tryphonas et al. 1984, 1986a) and in two of four Rhesus monkeys treated similarly for
28 months (Tryphonas et al. 1986b).  No effects on stomach tissue were observed in Rhesus monkeys
receiving daily doses of #0.080 mg/kg/day Aroclor 1254 for 72 months (Arnold et al. 1997).  
No histological alterations were observed in the organs and tissues of the gastrointestinal tract of rats
following a 13-week dietary exposure to #4.1 mg/kg/day of PCB 153 (Chu et al. 1996a), #4.2 mg/kg/day
of PCB 128 (Lecavalier et al. 1997), #7.4 mg/kg/day of PCB 126 (Chu et al. 1994), #4.0 mg/kg/day of
PCB 105 (Chu et al. 1998b), #3.7 mg/kg/day of PCB 28 (Chu et al. 1996b), #0.77 mg/kg/day of
PCB 77 (Chu et al. 1995), or #0.17 mg/kg/day of PCB 118 (Chu et al. 1995).
The highest NOAEL values and all reliable LOAEL values for gastrointestinal effects for each study are
recorded in Table 3-2 and plotted in Figure 3-2.
3.2.2.4 Hematological
3.2.2.4.1  Human Studies
In general, hematological effects have not been observed in humans occupationally exposed to PCBs. 
Capacitor plant workers (152 males, 43 females) exposed to Aroclors 1254, 1242, and 1016 for an
average duration of 17 years showed slightly decreased numbers of polymorphonuclear neutrophil (PMN)
white cells and slightly increased lymphocyte, monocyte, and eosinophil counts when compared to
normal values (Lawton et al. 1985a).  Limited exposure characterization, consisting of monitoring in one
area of the plant several months prior to hematological evaluation, showed a geometric mean PCB
concentration of 0.69 mg/m3.  Values for other white cells, erythrocytes, hemoglobin, and hematocrit
were within normal ranges.  Other studies of PCB-exposed workers have reported essentially normal
hematology including total and differential white blood cell counts (Chase et al. 1982; Emmett et al.
1988b; Fischbein et al. 1979; Maroni et al. 1981b; Ouw et al. 1976; Smith et al. 1982).  Mild normocytic
anemia and leukocytosis have been reported in Yu-Cheng patients (Rogan 1989).
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3.2.2.4.2  Animal Studies
Erythrocyte count, leukocyte count, and hemoglobin level were evaluated in 3–6 rabbits and guinea pigs
intermittently exposed to chamber concentrations of 5.4 mg/m3 Aroclor 1254 or 6.8 mg/m3 Aroclor 1242
over a period of 120 or 121 days, respectively (Treon et al. 1956).  Alterations included increased
erythrocytes in the rabbits (Aroclor 1254) and increased hemoglobin in the guinea pigs (both Aroclors);
however, although statistically significant, neither change was regarded as physiologically significant.
Packed blood cell volume was increased in male rats given single lethal doses of 4,000 or 6,000 mg/kg
Aroclor 1242 by gavage (Bruckner et al. 1973, 1974).  Crenated erythrocytes and increased PMNs were
observed at 4,000 mg/kg, but not at 6,000 mg/kg.  The investigators indicated that the effect on cell
volume reflected dehydration rather than a direct hematologic effect.
Anemia has been observed in monkeys treated with Aroclor 1248 or 1254 in intermediate-duration
studies (Allen 1975; Allen and Norback 1973, 1976; Allen et al. 1973, 1974a) and chronic-duration
studies (Allen 1975; Arnold et al. 1990; Tryphonas et al. 1984, 1986a, 1986b).  The anemia was
manifested by decreased hemoglobin content, decreased hematocrit, and hypocellularity of erythrocytic
and other precursor cells in the bone marrow, occurred at doses of $4 mg/kg/day for 2 months (Allen
1975; Allen and Norback 1976) and $0.2 mg/kg/day for 12–28 months (Arnold et al. 1990; Tryphonas
et al. 1986a, 1986b), and may be related to moribund condition of the monkeys.  The anemia was not
quantified in all studies, but the existing data indicate that it was moderate to severe after intermediate and
chronic exposure.  Numbers of circulating neutrophils were generally increased and lymphocytes were
decreased in these studies.  Hematological changes consistent with a picture of anemia have also been
observed in monkeys treated with 0.08 mg/kg/day Aroclor 1254 for 37 months; a dose of 0.02 mg/kg/day
produced a decrease in mean platelet volume (Arnold et al. 1993b).  Rhesus monkeys receiving daily
doses of #0.080 mg/kg/day Aroclor 1254 for 72 months, however, showed no effect on hematological
parameters (Arnold et al. 1997).  
Hematological changes do not appear to be a clear effect of PCB exposure in animals.  Small numbers of
rats (four per PCB) fed 50 mg/kg/day Aroclor 1248, 1254, or 1262 for 4–6 weeks showed marked
neutrophilia and slightly increased hemoglobin and hematocrit (Allen and Abrahamson 1973).  No
consistent hematologic effects were observed in rats (6 per dose) fed #1.5 mg/kg/day Aroclor 1242 for
2–6 months (Bruckner et al. 1974), in guinea pigs (12 per dose) fed #4 mg/kg/day Aroclor 1260 for
8 weeks (Vos and de Roij 1972), or in rabbits (7 per dose) fed #6.5 mg/kg/day Aroclor 1254 for 8 weeks
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(Street and Sharma 1975).  There were no treatment-related changes in hemoglobin levels or hematocrit
in minks (10 per PCB) fed 0.4 mg/kg/day Aroclor 1016, 1221, 1242, or 1254 for #39 weeks (Aulerich
and Ringer 1977).  Red blood cell count and hemoglobin concentration were reduced in female rats (50
per group) that were fed Aroclor 1016 or 1260 for 24 months at intake levels $2.7 or $1.4 mg/kg/day,
respectively (Mayes et al. 1998).  No hematologic effects were observed in female rats that were similarly
exposed to #5.7 mg/kg/day Aroclor 1242 or #6.1 mg/kg/day Aroclor 1254, or in male rats exposed to
Aroclor 1016, 1242, 1254, or 1260 at intake levels of #8.0, #5.7, #6.1, or #4.1 mg/kg/day, respectively.
Intermediate-duration exposure to single congeners has resulted in hematological effects in rats. 
Significant decreases in hemoglobin, hematocrit, mean corpuscular hemoglobin, mean corpuscular
volume, and decreased eosinophils were observed in rats treated with 4.0 mg/kg/day of PCB 105 (Chu et
al. 1998b).  Decreases in hemoglobin, hematocrit erythrocyte count, mean corpuscular hemoglobin, mean
corpuscular volume, and platelets were observed after exposure to 7.4 mg/kg/day of PCB 126 (Chu et al.
1994).  In contrast, no hematological effects were observed similarly treated rats exposed to
#0.77 mg/kg/day of PCB 77 (Chu et al. 1995), #0.17 mg/kg/day of PCB 118 (Chu et al. 1995),
#3.7 mg/kg/day of PCB 28 (Chu et al. 1996b), or #4.2 mg/kg/day of PCB 128 (Lecavalier et al. 1997).
No effects on hemoglobin, hematocrit, or differential leukocyte count were observed in rabbits exposed to
60% chlorine PCBs in isopropanol (Aroclor 1260, Clophen A60, or Phenoclor DP6) applied to the shaved
back skin 5 days/week for 38 days at estimated doses of 42 mg/kg/day (Vos and Beems 1971).  Total
leukocyte count was reduced, but insufficient information was provided to determine whether this effect
was adverse, whether it was due to a direct effect on the reticuloendothelial system, or if it was secondary
to other toxicity (hepatic and renal damage also occurred).  CDFs were found only in the non-Aroclor
PCBs (detection limit, 1 ppm). 
The highest NOAEL values and all reliable LOAEL values for hematological effects for each study are
recorded in Tables 3-1, 3-2, and 3-3, and plotted in Figures 3-1 and 3-2.  
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3.2.2.5 Musculoskeletal
3.2.2.5.1  Human Studies
There are limited data on the musculoskeletal toxicity of PCBs in humans.  Only one report of
musculoskeletal effects was located (Fischbein et al. 1979).  Joint pain was reported by .11% of the
workers exposed to various Aroclors at mean area concentrations of 0.007–11 mg/m3.  A higher
prevalence was noted in female workers (15.2%) than in males (7.7%).  Muscle pain was reported by
<4% of the males and females.  Information on the severity or constancy of the joint and muscle pain was
not reported, physiological testing was not performed, and there was failure to distinguish between past
and present symptoms.  The statistical significance of these symptoms cannot be determined because a
control group was not examined.  No studies were located regarding musculoskeletal effects in humans
after oral exposure to PCBs, although a 10% prevalence of unspecified joint problems was reported
among farm families who consumed dairy products and beef that were contaminated with PCBs
(Humphrey 1983).
3.2.2.5.2  Animal Studies
Little information exists regarding musculoskeletal effects of PCBs in animals.  Changes in femur bone
morphology resulting in weaker bones occurred in growing (28-day-old) rats (10 per dose) that were
treated with Aroclor 1254 by gavage for 10–15 weeks (Andrews 1989).  Effects included increased femur
density at $0.1 mg/kg/day; decreased cross-sectional and medullary areas at $10 mg/kg/day; and
decreased femur weight, volume, length, and cortical area and strength at 25 mg/kg/day.  No definite
effects on bone flexibility were observed.  Serum and urinary calcium levels were increased, but there
were no treatment-related alterations in serum parathyroid hormone concentration
No histopathologic changes were observed in skeletal muscle of male or female rats that were fed
Aroclor 1016, 1242, 1254, or 1260 for 24 months at dose levels of 8.0–11.2, 4.0–5.7, 4.3–6.1, or
4.1–5.8 mg/kg/day, respectively (Mayes et al. 1998).  Similarly, there were no histological alterations in
skeletal muscle of rats exposed to #4.1 mg/kg/day of PCB 153 (Chu et al. 1996a), #4.2 mg/kg/day of
PCB 128 (Lecavalier et al. 1997), #4.0 mg/kg/day of PCB 105 (Chu et al. 1998b), #3.7 mg/kg/day of
PCB 28 (Chu et al. 1996b), #0.77 mg/kg/day of PCB 77 (Chu et al. 1995), or #0.17 mg/kg/day of
PCB 118 (Chu et al. 1995) in the diet for 13 weeks. 
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The highest NOAEL values and all reliable LOAEL values for musculoskeletal effects for each study are
recorded in Table 3-2 and plotted in Figure 3-2.
3.2.2.6 Hepatic Effects
3.2.2.6.1  Summary
In humans, clinical studies of PCB workers reported associations between increased serum levels of liver-
related enzymes, lipids, and cholesterol and serum PCBs.  Studies of people exposed to PCBs by
ingestion of contaminated fish in Triana, Alabama or contaminated rice oil in the Yusho or Yu-Cheng
incidents have reported increases in serum levels of some liver enzymes characteristic of microsomal
enzyme induction or liver damage, but these effects cannot be attributed solely to PCBs due to the mixed
chemical nature of the contaminated fish and heated rice oil exposures.  Serum cholesterol, but not
triglycerides, was increased in consumers of contaminated fish, whereas increased serum triglycerides,
but not cholesterol, were associated with Yusho and Yu-Cheng exposure. 
Hepatotoxicity of PCBs is well-documented in animals exposed to commercial mixtures or single
congeners for acute, intermediate, or chronic durations by oral and other routes of exposure.  PCB-
induced liver effects in animals seem to be reversible when mild and include microsomal enzyme
induction, liver enlargement, increased serum levels of liver-related enzymes and lipids, altered porphyrin
and vitamin A metabolism, and histopathologic alterations that progress to non-neoplastic degenerative
lesions (particularly fatty and necrotic changes) and/or tumors with higher doses or longer duration
exposures.  Intermediate- and chronic-duration oral studies indicate that monkeys are more sensitive than
rats to PCB hepatotoxicity.
3.2.2.6.2  Human Studies
3.2.2.6.2.1  Liver Enzymes, Enlargement, and Pathology
Occupational Exposure.  Hepatic effects have been investigated in a number of epidemiology studies and
clinical surveys of PCB-exposed workers.  Increased serum levels of liver-related enzymes, particularly
gamma-glutamyl transpeptidase (GTP), alanine aminotransferase (ALT), aspartate aminotransferase
(AST), alkaline phosphatase (AP), and/or lactate dehydrogenase (LDH), were reported in many of these
studies (Chase et al. 1982; Emmett et al. 1988b; Fischbein 1985; Fischbein et al. 1979; Lawton et al.
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1985a; Maroni et al. 1981a, 1981b; Ouw et al. 1976).  Additionally, increases in levels of these serum
enzymes have been correlated with serum PCB levels (Baker et al. 1980; Chase et al. 1982; Emmett et al.
1988b; Fischbein 1985; Fischbein et al. 1979; Lawton et al. 1985a; Smith et al. 1982). 
Asymptomatic hepatomegaly and increased serum levels (elevated to slightly above normal range) of
GTP, AST, and/or ALT were found in 14 of 80 capacitor manufacturing or repair workers who were
exposed to non-Aroclor PCB mixtures with a 42% chlorine content (Italian formulations Pyralene 3010 or
Apirolio) for an average of 12 years (Maroni et al. 1981a, 1981b).  Two other workers had increased
serum enzyme levels without liver enlargement.  PCB levels ranged from 48 to 275 µg/m3 in the
workroom air, 2–28 µg/cm2 on the skin surface (palms), and 41–1,319 µg/kg in the blood.  The
investigators considered the liver enlargement indicative of hepatic microsomal induction.  Comparison
of the 16 workers with abnormal liver findings and the 64 without abnormal findings showed that those
with the abnormalities had statistically significant (p<0.01) higher mean concentrations of
trichlorobiphenyls, pentachlorobiphenyls, and total PCBs in the blood.  Additionally, significant positive
correlations were found between the frequency of workers with the abnormal liver findings and
increasing levels of blood trichlorobiphenyls (p<0.001), pentachlorobiphenyls (p<0.05), and total PCBs
(p<0.001).  No matched control group was included in the study, there was no apparent association
between severity of hepatomegaly and blood PCB levels, and hepatomegaly was not reported in other
studies that included physical examinations conducted even at similar or higher serum PCB levels (e.g.,
Fischbein et al. 1979; Smith et al. 1982).
Serum enzyme (AST, ALT, LDH, AP) and bilirubin levels were within normal limits in 16 workers
exposed to PCBs (type not reported) primarily via dermal contact with used transformer oil containing
.600,000 ppm PCBs or secondary contact with contaminated clothes or shoes (Brandt-Rauf and Niman
1988).  No correlation between serum triglyceride levels and serum PCB levels was found.  Physical
examinations showed no dermal or other abnormalities consistent with PCB exposure, but it is not
specifically mentioned if the examinations looked for liver enlargement.  Serum PCB concentrations in
the study group were low (generally <10 ppb) in comparison to other occupational studies.
Clearance of antipyrine, a known substrate for microsomal hepatic enzymes, was used to test liver
function in two studies of PCB-exposed workers (Alvares et al. 1977; Emmett et al. 1988b).  A
significantly lower mean half-life of antipyrine clearance from blood was found in five workers exposed
for an average of 9 years to various Aroclors, including Aroclor 1260, compared to five control subjects
matched for age, sex, and smoking/drinking habits (Alvares et al. 1977).  The antipyrine clearance half-
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lives were 10.8 and 15.6 hours in the exposed and control subjects (p<0.005), respectively, suggesting
that exposure induced hepatic microsomal enzymes.  The exposed workers were a subgroup of the
population studied by Fischbein et al. (1979) who were exposed to mean PCB concentrations ranging
from 0.007 to 11 mg/m3.  The second study (Emmett et al. 1988b) found no difference in antipyrine
plasma half-life in transformer maintenance workers primarily exposed to lower concentrations of
Aroclor 1260 (#0.012 mg/m3) for an average of 3.75 years compared with controls matched for age, race,
and marital status, but not for current smoking and drinking habits (Emmett et al. 1988b).  The reason for
the different antipyrine liver function test findings in these studies is not clear, but is most likely due to
levels and durations of exposure since serum PCB levels were higher (up to 125 ppb) in the responding
group (Fischbein et al. 1979) and (<15 ppb) in the Emmett et al. (1988b) group.  The difference might
also be related to smoking and/or drinking habits.  
Contaminated Fish Consumption.  Limited information is available on hepatic end points in populations
who consumed fish contaminated with PCBs and other chemicals in Triana, Alabama (Kreiss et al. 1981)
and the Baltic Sea area (Svensson et al. 1994).  No data were located on liver effects in fisheaters from the
Great Lakes/St. Lawrence River basin.
Serum γ-glutamyl transpeptidase (GGT) and cholesterol (Section 3.2.2.6.2.2), but not serum ALT or
bilirubin, were positively correlated with serum PCB levels in 458 residents of Triana, Alabama (Kreiss
et al. 1981).  These associations were independent of factors such as age and alcohol and fish
consumption, although the natural partitioning of PCBs into serum lipids could contribute to the
correlation.  Consumption of contaminated fish was the only known source of PCB exposure.  The mean
serum concentration of PCBs (analyzed as Aroclor 1260) was 17.2 ppb.  Levels of  DDT were also
increased in residents and fish, and there was a strong positive correlation between serum concentrations
of DDT and PCB.  Serum DDT levels did contribute to the variance in serum GGT and other effects, but
this does not preclude the possibility of an interaction between PCB and DDT.
A comparison of 23 Swedish males with a high consumption of Baltic Sea fish and 20 men with virtually
no fish consumption showed no statistically significant differences in serum levels of AST, ALT, GGT,
AP, or bilirubin (Svensson et al. 1994).  The fisheaters had elevated blood levels of PCBs and other
organochlorines, as well as increased erythrocyte levels of methylmercury.
Yusho and Yu-Cheng Exposures.  Clinical alterations that have been observed in people exposed during
the Yusho and Yu-Cheng PCB accidental ingestion incidents include increases in serum liver-related
3.  HEALTH EFFECTS - Systemic
PCBs 106
enzymes and triglycerides and urinary uroporphyrins (Kuratsune 1989; Rogan 1989).  Elevations in
serum AST and ALT are generally consistent findings in Yu-Cheng patients (Rogan 1989), although few
abnormalities in AST and ALT and other basic liver function indices have been associated with Yusho
exposure (Kuratsune 1989; Masuda 1994).  Results of non-routine serum tests (e.g., accelerated
erythrocyte sedimentation rate, high titer in thymol turbidity, increased M fraction of lactate
dehydrogenase, and increased alkaline phosphatase and ribonuclease levels) suggested liver damage in
some Yusho patients, particularly severe cases (Masuda 1994).  
The predominant morphological finding in the liver of Yusho patients appears to be ultrastructural
changes suggestive of microsomal enzyme induction, particularly alterations in the endoplasmic reticulum
and pleomorphic and enlarged mitochondria (Kuratsune 1989; Masuda 1994).  Mortality from cirrhosis of
the liver and from liver diseases excluding cirrhosis was increased in both sexes in a cohort of
1,940 Yu-Cheng victims (>95% of all registered cases) followed for 12 years after exposure (Hsieh et al.
1996).  SMRs for cirrhosis and other liver diseases were 2.79 (95% CI 1.39–5.00) and 5.40 (CI
1.47–13.82), respectively, compared to the Taiwan national populations; rates were similarly increased
compared to local populations.  Mortality from all liver diseases during the first 3 years after exposure
(SMR=10.76, 5.37–19.26) was more than 8 times higher than in the subsequent 9 years.
3.2.2.6.2.2  Serum Lipids, Triglycerides, and Cholesterol
Occupational Exposure.  Levels of liver-regulated serum lipids, particularly triglycerides and cholesterol,
have been studied in PCB-exposed workers.  Serum triglycerides, total cholesterol, ALT, and
albumin/globulin ratio were increased in capacitor plant workers with a mean length of employment of
17 years (Lawton et al. 1985a).  These workers were exposed to various Aroclor mixtures at a mean
concentration of 0.69 mg/m3 (range, 0.2–2.0), based on monitoring performed in only one area of the
plant several months prior to clinical evaluation.  In other studies, no changes in serum cholesterol,
triglycerides, high-density lipoproteins (HDL), low-density lipoproteins (LDL), very low-density
lipoproteins (VLDL), and/or serum albumin levels were found in workers exposed primarily to
Aroclor 1260 (#0.012 mg/m3) for a mean of 3.75 years (Emmett et al. 1988b) or to an unspecified Aroclor
mixture (PCB air concentration not reported) in transformer fluids for 4–17 years (Chase et al. 1982).  
Significant positive correlations between serum triglyceride or cholesterol levels and serum PCBs in
PCB-exposed workers have been reported (Baker et al. 1980; Chase et al. 1982; Emmett 1985; Emmett et
al. 1988b; Lawton et al. 1985a; Smith et al. 1982), but not all studies were adjusted for all major
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confounding variables.  For example, when adjusted for all confounders, Emmett et al. (1988b) found no
correlation between serum lipids and serum PCBs.  Evidence from this and other studies indicates that
correlations between serum lipids and PCBs may be due to the partitioning of PCBs between adipose
tissue and lipids in the blood (Brown and Lawton 1984; Emmett 1985; Emmett et al. 1988b; Lawton et al.
1985a).  Data from the Yusho and Yu-Cheng incidents (see subsection below) and animal studies (see
Section 3.2.2.6.3.2), however, indicate that elevated serum lipids are an effect of oral exposure to high
levels of PCBs.  
Contaminated Fish Consumption.  Serum cholesterol, serum GGT, and blood pressure, but not serum
HDL cholesterol or triglycerides, were positively correlated with serum PCB levels in 458 residents of
Triana, Alabama (Kreiss et al. 1981).  These associations were independent of age, sex, fish consumption,
body mass index, and alcohol consumption.  Consumption of contaminated fish was the only known
source of PCB exposure, but PCB intake was not estimated.  DDT was also increased in the serum of the
people and in the fish, and serum DDT and serum PCB levels were highly correlated.  Serum DDT levels
did not contribute to the variance in serum cholesterol, serum GGT, or blood pressure.
General Population Exposures.  Serum cholesterol and triglycerides were increased in individuals with
elevated serum PCB levels who had resided near waste sites for 5 years (Steer-Green et al. 1986a, 1986b). 
The increases were not substantially greater than normal, however, and neither levels of cholesterol nor
triglycerides correlated with serum PCB concentrations.  Other findings included a significant positive
correlation of total bilirubin with serum PCB levels, and significant negative correlations of serum
albumin with serum PCBs and of AST with serum lipid fraction-adjusted PCB levels.  This study used
pooled data from combined residential and occupational exposure.  Similar results were reported by
Steinberg et al. (1986) using uncorrected data.  In addition, a positive correlation between the activities of
ß-glucuronidase and 5N-nucleotidase and total serum PCBs was observed in individuals who lived or
worked near an electrical equipment manufacturing plant.  Similar positive correlations were also found
with serum dichlorodiphenyl dichloroethene (DDE) (a metabolite of DDT); no correlations were observed
when potential confounding factors (e.g., age, cholesterol) were removed.
Yusho and Yu-Cheng Exposures.  Markedly elevated serum triglyceride levels with unchanged total
serum cholesterol was a laboratory finding characteristic of Yusho and Yu-Cheng exposures (Oxymora et
al. 1979; Masuda et al. 1994; Uzawa et al. 1969).  The elevated triglycerides generally persisted for
several years following exposure and subsequently declined to normal levels.
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3.2.2.6.2.3  Porphyria
Occupational Exposure.  Sixty-seven PCB-exposed workers with a mean employment length of 12 years
(range, 2–32 years) exhibited increased urinary excretion of total porphyrins and porphyrin homologues
(coproporphyrin, pentaporphyrin, hexaporphyrin, heptaporphyrin, and uroporphyrin) compared to a
control population of unexposed electrical workers (Colombi et al. 1982).  No shift in the relative urinary
levels of porphyrin homologues was observed between the exposed and control groups.  The exposed
workers were exposed to Aroclor 1254 (unquantitated) for up to 17 years and, subsequently, to
0.048–0.275 mg/m3 Pyralene 3010 (42% chlorine content) for an unspecified duration; dermal exposure
to both PCB mixtures could not be ruled out.  In another study, urinary coproporphyrin, uroporphyrin,
and porphobilinogen did not correlate with serum PCB levels in workers exposed to various Aroclors and
Askarels in concentrations ranging from 0.003 to 0.08 mg/m3 for >13 years (Smith et al. 1982).
Urinary porphyrin excretion and serum GGT activity were significantly increased in 51 workers who
were exposed for a mean duration of 10 years, and 28 of 51 subjects had elevated concentrations of PCBs
in the blood (Maroni et al. 1984).  As discussed by James et al. (1993), average urinary excretion of
porphyrins was almost twice as high as unexposed control group values, but no correlation was found
between porphyrin excretion and blood PCB levels.
Yusho and Yu-Cheng Exposures.  Type B hepatic porphyria (i.e., a uroporphyrin/coproporphyrin ratio
greater than 1) is a consistent finding in Yu-Cheng patients, including children born to exposed mothers
(Chang et al. 1980; Gladen et al. 1988; Hsu et al. 1994; Lu et al. 1980).  Abnormal urinary porphyrin
levels have rarely been associated with Yusho exposure (Masuda et al. 1994).
3.2.2.6.2.4  Evaluation of Human Studies
There is no clear indication that environmental exposure to PCBs has caused adverse liver effects in
humans.  Evidence for liver effects of PCBs in humans has been sought in numerous studies of exposed
workers.  Hepatic end points in these studies are essentially limited to serum enzymes (e.g., AST, ALT,
and GGT) and other biochemical indices (e.g., bilirubin, serum lipids, and cholesterol) that are routinely-
examined in clinical assays.  Antipyrine elimination was evaluated in two studies of PCB workers
(Alvares et al. 1977; Emmett et al. 1988b).  Results suggest a threshold of 100 ppb in serum for
phenobarbital-type induction in humans (Brown 1994).  A positive correlation between the frequency of
workers with hepatomegaly and elevated serum enzyme values and increasing levels of PCBs in the blood
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was reported in one study (Maroni et al. 1981a, 1981b), but there was no apparent relationship between
severity of the effect and PCB levels, and no matched control group was included in the study.  Studies of
people exposed to PCBs by ingestion of contaminated fish (Kreiss et al. 1981) or contaminated rice oil in
the Yusho or Yu-Cheng incidents (Kuratsune 1989; Masuda 1994; Rogan 1989) have shown increases in
serum levels of some liver enzymes and other hepatic indices that are indicative of microsomal enzyme
induction or liver damage.  Ultrastructural changes indicative of microsomal enzyme induction are
predominant hepatic morphological findings in Yusho patients.  Due to the mixed chemical nature of the
fish and rice oil exposures, the results cannot be attributed solely to PCBs.
Increased levels of serum triglycerides and cholesterol have not been reported consistently in workers
with long-term occupational exposure to PCBs.  As discussed by James et al. (1993), the variable results
can be explained, at least partially, by failure of the studies to control for variables known to affect serum
lipid levels, particularly age, alcohol consumption, and medical history.  Because tissue concentrations
are generally considered to be a better measure of body burdens and dose received than serum lipid levels,
this may explain the difficulty in showing a correlation between serum lipid levels and PCB dose. 
Additionally, both Emmett et al. (1988b) and Lawton et al. (1985a) showed that associations with serum
lipid levels and serum PCB levels can be explained by the partitioning behavior of PCBs, suggesting that
serum lipid levels may affect serum PCB levels rather than PCB exposure affecting serum lipid levels. 
However, as described in the following section, animal data indicate that exposure to PCBs can indeed
increase serum lipid levels.  A limited  amount of information is available on serum lipid effects of PCBs
in nonoccupational populations.  Serum cholesterol, but not triglycerides, was increased in Triana,
Alabama, consumers of contaminated fish (Kreiss et al. 1981), and increases in serum triglycerides, but
not cholesterol, were associated with Yusho and Yu-Cheng exposure (Masuda et al. 1994; Oxymora et al.
1979; Uzawa et al. 1969). 
Increased urinary excretion of porphyrins appears to be associated with occupational exposure to PCBs
(Colombi et al. 1982; Maroni et al. 1984; Smith et al. 1982).  Hepatic porphyria was commonly observed
in people exposed during the Yu-Cheng PCB incident, although it was not a usual finding in Yusho cases
(Chang et al. 1980; Gladen et al. 1988; Hsu et al. 1994; Lu et al. 1980; Masuda et al. 1994).
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3.2.2.6.3  Animal Studies
The highest NOAEL values and all reliable LOAEL values for hepatic effects for each study are recorded
in Tables 3-1, 3-2, and 3-3, and plotted in Figures 3-1 and 3-2.
3.2.2.6.3.1  Liver Enzymes, Enlargement, and Pathology
Inhalation Exposure    
No histological changes occurred in the liver of adolescent male rats that were whole-body exposed to
0 or 900 ng/m3 Aroclor 1242 vapor 23 hours/day for 30 days (Casey et al. 1999).  The generation of the
vapor-phase test atmosphere was based entirely on the evaporation of a liquid PCB mixture using a
system that did not create aerosol droplets, and the concentration and congener composition of the test
atmosphere was well characterized.  Limitations of this study include only one exposure level and liver
end point and a relatively small number of animals (8/group); however, uptake of PCBs in the liver was
confirmed by tissue analysis, and the exposure was sufficient to induce effects in other tissues, including
the thyroid, which is known to be particularly sensitive to PCBs.  
Histopathologic lesions were found in the livers of rats, mice, rabbits, and guinea pigs that were
intermittently exposed to chamber concentrations of 1.5 mg/m3 Aroclor 1254 for 7 hours/day for 150 days
over a total of 213 days (Treon et al. 1956).  Alterations varied in severity depending upon species,
ranging from cytoplasmic vacuolation in guinea pigs to fatty metamorphosis and other degenerative
lesions in rats.  Similar exposures of rats, mice, rabbits, or guinea pigs to Aroclor 1242 for 7 hours/day at
1.9 mg/m3 for 150 of 214 days, or 8.6 mg/m3 for 17 of 24 days, did not produce histopathology in the
liver or other viscera.  Relative liver weight, measured in rats, guinea pigs, and rabbits exposed for
7 hours/day to 6.8 mg/m3 Aroclor 1242 for 82 of 120 days or 5.4 mg/m3 Aroclor 1254 for 83 of 121 days
was increased only in the rats exposed to Aroclor 1254; liver histology was not evaluated in these studies. 
None of the exposure scenarios produced treatment-related gross liver pathology in any of the species.  It
was necessary to vaporize the Aroclors by heating to 55–138 EC to attain the concentrations used in the
study, although these temperatures are too low to cause formation of CDFs (Morita et al. 1978).
No information was located on hepatotoxicity in animals following acute- or chronic-duration inhalation
exposure to PCBs.
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Oral Exposure      
Commercial PCB Mixtures.  Relatively little information is available on hepatic effects of acute-duration
oral exposure to PCBs.  Liver microsomal enzyme activity (aminopyrine N-demethylation and acetanilide
hydroxylation) was increased in rats exposed to 0.5 mg/kg/day (lowest tested level) Aroclor 1254 for
durations as short as 1–3 days (Bruckner et al. 1977); no other hepatic end points were evaluated in this
study.  Relative liver weight and serum total cholesterol were increased in rats that were fed estimated
doses of $1 mg/kg/day Aroclor 1254 for 4 days, but not 0.5 mg/kg/day (Carter 1984, 1985); histology
was not evaluated.  Acute-duration studies evaluating hepatic effects of PCBs other than microsomal
enzyme induction at doses lower than those in the Carter (1984, 1985) studies were not located.  Effects
in rats exposed to higher doses of PCBs in acute-duration studies included increased liver weight,
decreased liver glucose 6-phosphatase, and/or decreased serum cholesterol at $1.9 mg/kg/day
Aroclor 1254 (Carter and Koo 1984; Price et al. 1988) and 50 mg/kg/day Aroclor 1248 (Kato and
Yoshida 1980), as well as degenerative hepatic histopathological changes at PCB doses $50 mg/kg/day as
discussed below.  Additional information on PCB-induced hypercholesterolemia is included in
Section 3.2.2.6.3.2.  
The lowest reported hepatic effect levels in intermediate-duration oral studies are NOAELs for
microsomal enzyme induction in rats (Bruckner et al. 1974, 1977; Litterst et al. 1972).  Liver microsomal
nitroreductase and demethylase were induced in rats that were fed $0.03 mg/kg/day (lowest tested dose)
Aroclor 1242, 1248, 1254, or 1260 for 4 weeks (Litterst et al. 1972).  All of these PCB mixtures also
caused increased relative liver weight at $2.5 mg/kg/day and increased liver triglycerides at
$25 mg/kg/day; however, histology was not evaluated.  The effects were generally dose-related among
the mixtures and the maximum increase in liver triglycerides was caused by Aroclor 1248.  No
histological changes were found in the liver of adolescent rats exposed to dietary doses of 0 or
0.033 mg/kg/day Aroclor 1242 for 30 days (Casey et al. 1999).  Limitations of this study include a
relatively small number of animals (8/group) and the lack of more than one dose level and hepatic end
point, although tissue congener analyses confirmed uptake of PCBs in the liver.  Hepatic microsomal
enzymes, liver weight, and lipid deposition in the liver were increased in rats fed $0.25 mg/kg/day
Aroclor 1242 for $2 months; no other hepatic histopathologic changes were observed, and serum levels of
AST and ALT were not increased (Bruckner et al. 1974).  Dietary ingestion of $0.25 mg/kg/day
Aroclor 1254 for $35 days similarly induced hepatic microsomal enzymes in rats, but other liver effects
(increased liver weight and triglyceride content; histology was not evaluated) only occurred at a higher
dose of 1.25 mg/kg/day (Bruckner et al. 1977).  Another study with Aroclor 1254 found no significant
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change in liver weight in rats fed up to 2.5 mg/kg/day for 5 months (Byrne et al. 1988); no other hepatic
end points were evaluated.  
Increased relative liver weight and hepatocellular hypertrophy, but no additional histological changes in
the liver, occurred in mice that were fed 22 mg/kg/day Aroclor 1242 for 6 weeks (Loose et al. 1978a,
1978b).  Microsomal enzyme activity (as indicated by decreased pentobarbital-induced sleeping time) and
liver weight were increased in mice fed 32.5 or 130 mg/kg/day Aroclor 1254 for 2 weeks (Sanders et al.
1974).  No other liver end points (e.g., serum indices, histology) were evaluated, precluding the
determination of whether these doses were hepatotoxic in mice.  Liver weights were also increased in
mice that were fed an estimated dose of 37.5 mg/kg/day Aroclor 1260 for 14 days, but not in mice
administered a single 50 mg/kg dose by gavage (Whysner et al. 1998); no other liver toxicity end points
were included in either study.
Fatty degeneration and necrotic changes are characteristic hepatic histopathological effects of PCBs that
have been induced in rats and mice exposed to relatively high oral doses, including rats given a single
4,000 mg/kg dose of Aroclor 1242 by gavage (Bruckner et al. 1973); rats fed 100 mg/kg/day
Aroclor 1242 for 3 weeks (Bruckner et al. 1973), 50 mg/kg/day Aroclor 1248 or 1254 for 2–4 weeks
(Allen and Abrahamson 1973; Kling et al. 1978), or $6.5–7.5 mg/kg/day Aroclor 1254 or 1260 for
8 months (Kimbrough et al. 1972), and mice fed 4.88 mg/kg/day Aroclor 1254 for 6 months or
49.8 mg/kg/day for 11 months (Kimbrough and Linder 1974; Koller 1977).  Additionally, lipid
accumulation occurred in the liver of offspring of rats that were fed 1.5 mg/kg/day Aroclor 1254 or
1260 (Linder et al. 1974), and hepatocellular hypertrophy and vacuolar degeneration developed in
weanling rats that ingested $1.0 mg/kg/day Aroclor 1254 for 10 weeks (Gray et al. 1993).  Rabbits fed
2.1 or 6.5 mg/kg/day Aroclor 1254 for 8 weeks had increased relative liver weight, but no treatment-
related histological alterations (Street and Sharma 1975); other hepatic end points were not evaluated. 
Similarly, there were no histological changes in the livers of guinea pigs with significantly increased
relative liver weight fed #4 mg/kg/day Aroclor 1260 for 8 weeks (Vos and de Roij 1972).
The most comprehensive chronic toxicity study of PCBs in rodents provides comparative clinical and
histology data on four Aroclor mixtures (Fish et al. 1997; General Electric Co. 1997a, 1997b; Mayes et al.
1998).  Rats were fed Aroclor 1016, 1242, 1254, or 1260 for 24 months at two (Aroclor 1242) or three
dose levels per sex at ranges of 2.0–11.2, 2.0–5.7, 1.0–6.1, or 1.0–5.8 mg/kg/day, respectively.  Each lot
of the basal feed contained <0.15 ppm of PCBs (estimated dose <0.01 mg/kg/day).  As discussed in
Section 3.2.8.3.2, the Aroclor 1254 test mixture had levels of congener 3,3',4,4',5-pentaCB (PCB 126)
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that were about 2 times greater than that of “ordinary” Aroclor 1254.  The liver was a target of all four
PCB mixtures as indicated by increases in relative liver weight and hepatic mixed-function oxidases,
serum enzyme and cholesterol levels, nonneoplastic lesions, and/or tumors.  Hepatic enzyme induction
varied with time and declined after reaching maxima, demonstrating the dynamic nature of the CYP end
points (Fish et al. 1997).  These effects were usually much more severe in females than in males and
showed the following general pattern of Aroclor toxicity: 1254>1260.1242>1016.  Carcinogenicity data
from this study are summarized in Section 3.2.8.3.2.  Nonneoplastic liver effects induced by Aroclor 1016
included increased hepatocellular hypertrophy and vacuolization at $2.0 mg/kg/day, and increased
relative liver weight and bile duct hyperplasia at $2.7 mg/kg/day.  Effects caused by Aroclor 1242
included increased hepatocellular hypertrophy and vacuolization, altered hepatocellular foci, and bile duct
hyperplasia at $2.0 mg/kg/day, with increased liver weight, serum cholesterol, and bilirubin occurring at
5.7 mg/kg/day.  Aroclor 1254 induced hepatocellular changes (hypertrophy, vacuolization, altered foci),
bile duct hyperplasia, and increased serum cholesterol and liver weight at $1.0 mg/kg/day, with increases
in serum AST, ALT, and GGT occurring at $2.9 mg/kg/day.  Aroclor 1260 caused hepatocellular changes
(hypertrophy, vacuolization, altered foci), bile duct hyperplasia, and increased liver weight at
$1.4 mg/kg/day, and increased serum GGT and cholesterol at $2.8 mg/kg/day.
Histopathological changes in the liver also occurred in rats exposed to dietary Aroclor 1254 at
1.25–5 mg/kg/day for 2 years (Morgan et al. 1981; NCI 1978; Ward 1985), Aroclor 1260 at 5 mg/kg/day
for 16 months followed by 2.5 mg/kg/day for 8 months and then no treatment for 5 months (Norback and
Weltman 1985), or Aroclor 1260 at 5 mg/kg/day for 21 months (Kimbrough et al. 1975).  Although
preneoplastic and neoplastic liver lesions were induced in these as well as other rat studies (see
Section 3.2.8.3.2), no nonproliferative changes, or nonproliferative lesions that did not progress to liver
neoplasms after 1 year, were described.  
Intermediate- and chronic-duration studies in monkeys indicate that this species is more sensitive than
rodents to the hepatotoxic effects of PCBs.  For example, lipid accumulation and focal necrosis were
found in one female monkey that died after administration of 0.1 mg/kg/day Aroclor 1248 for 173 days
and in one female monkey that died after being fed 0.2 mg/kg/day Aroclor 1248 for 310 days (Barsotti
et al. 1976).  Although only one animal per dose was examined, it is likely that these effects are treatment
related due to the characteristic nature of the hepatic response and because similar effects on the liver
occurred in monkeys at higher doses in other intermediate-duration studies (Allen 1975; Allen and
Norback 1976; Allen et al. 1974a). 
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Cynomolgus monkeys that were fed relatively high doses of 2 mg/kg/day Aroclor 1248 or 5 mg/kg/day
Aroclor 1254 for up to 20–23 weeks had serum biochemistry changes (increased ALT, AST, AP, LDH,
cholesterol, triglycerides, and bilirubin) and histopathologic changes in the liver, including hyperplasia,
fatty degeneration and degeneration of hepatocytes, and gall duct/gall bladder epithelial cell hypertrophy
hyperplasia (Tryphonas et al. 1984).  Hepatic effects observed in Rhesus monkeys after 12–28 months of
dietary exposure to 0.2 mg/kg/day Aroclor 1254 included liver enlargement, fatty degeneration,
hepatocellular necrosis, and hypertrophic and hyperplastic changes in the bile duct (Tryphonas et al.
1986a, 1986b).  Rhesus monkeys that ingested capsules containing 0.005, 0.02, 0.04, or 0.08 mg/kg/day
Aroclor 1254 for 72 months had increased liver weight attributed to hyperplasia (unspecified) at
0.08 mg/kg/day, as well as decreased serum levels of total bilirubin and cholesterol and increased serum
triglycerides as summarized in Section 3.2.2.6.3.2 (Arnold et al. 1993b, 1997; Bell et al. 1994).
Defined Experimental Mixtures.  Female Long-Evans rats were pre- and postnatally exposed to pelleted
food containing Aroclor 1254 or a laboratory PCB mixture of 14 congeners resembling the congener
pattern in human breast milk (Hany et al. 1999b).  Exposure began 50 days prior to mating and was
terminated at the day of birth (postnatal day [PND] 0), and the offspring were subsequently exposed via
maternal milk until PND 21.  The reported estimated average daily PCB intake by the dams was the same
for both mixtures at 4 mg/kg/day.  Relative liver weight was significantly higher than controls on
PND 0 in both Aroclor 1254-exposed dams and their offspring, on PND 0 in offspring of the rats exposed
to the simulated mixture, and on PND 21 in nonpregnant (unsuccessfully mated) females exposed to
Aroclor 1254 or the simulated mixture.  Additional information on the experimental design and results of
this study, including the congener composition of the simulated mixture and nonhepatic data, are
summarized in Section 3.2.6 (Developmental Effects).  
Toxicity of a mixture of PCB congeners analogous to that in human breast milk (Canadian women) was
studied in monkeys (Arnold et al. 1999).  Groups of infant Cynomolgus monkeys (6 control males,
10 treated males) and Rhesus monkeys (2 control and 3 treated males, 1 control and 3 treated females)
ingested the congener mixture in a total daily dose of 0 or 7.5 µg PCBs/kg/day from birth until 20 weeks
old, and were observed until they were at least 66 weeks old.  The dose represented the approximate daily
intake of a nursing human infant whose mother’s milk contained 50 ppb PCBs (the Health Canada
guideline for maximum concentration in breast milk).  Reported hepatotoxicity-related end points are
limited to serum biochemical indices, including liver enzymes (ALT, AST, GGT, AP), bilirubin,
triglycerides, and cholesterol; data for liver weight and histology are not yet published (as of July 2000). 
Although there were no statistically significant differences between the exposed and control groups for
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any of the individual hepatic end points, significant increasing trends with time were found for serum
cholesterol in both strains of monkeys and serum GGT in Rhesus monkeys.  
Single Congeners.  Multiple hepatic end points were evaluated in comparative studies of individual
congeners in rats, mice, and monkeys.  In the most comprehensive series of studies, rats were exposed to
diets containing four dose levels of a congener for 13 weeks (Chu et al. 1994, 1995, 1996a, 1996b, 1998b;
Gilroy et al. 1996, 1998; Lecavalier et al. 1997; MacLellan et al. 1994a, 1994b, 1994c; Peng et al. 1997;
Singh et al. 1996, 1997).  Eight congeners were tested based on frequent occurrence in environmental
samples and human tissues or toxic potency.  Hepatic effects included increased liver weight, biochemical
changes (e.g., increased serum enzymes and cholesterol, increased liver porphyrins, and decreased liver
vitamin A), and histopathology (e.g., cytoplasmic vacuolation and fatty alterations).  The most toxic
congener was PCB 126 with a LOAEL of 0.74 µg/kg/day, which was approximately 1/50 of the LOAEL
of 39 µg/kg/day for PCB 105 (the next most toxic congener) and 1/500 of the LOAEL of 425 µg/kg/day
for PCB 128 (the least toxic congener).  Considering dose-response and severity of liver effects, the order
of toxicity was PCB 126 > PCB 105 > PCB 118 . PCB 77 > PCB 153 . PCB 28 > PCB 128.  In general,
the non-ortho and mono-ortho substituted congeners were more potent than the di-ortho substituted
congeners.  
The comparative toxicity of four symmetrical hexachlorobiphenyl isomers was studied in mice (Biocca et
al. 1981).  Male mice were fed several dose levels of PCB 136, PCB 153, PCB 155, and PCB 169 daily
for 28 days.  The hepatic LOAEL (foamy cells and microabscesses) was 200 µg/kg/day for PCB 169 and
much higher for the other congeners at 21.4 mg/kg/day.  Liver effects induced at doses higher than the
LOAEL included fatty metamorphosis (PCBs 155 and 169) and increased liver porphyrins (PCB 169).  
Rhesus monkeys were exposed to PCB 52 or PCB 77 in estimated dietary doses of 0 or 60 µg/kg/day for
133 days (McNulty et al. 1980).  Pathologic changes, including dilation of the extrahepatic biliary tree
and hyperplastic intrahepatic biliary vessels, were induced by PCB 77 but not PCB 52.  Additional liver
data were not obtained for PCB 77 due to high systemic toxicity manifested as clinical signs, general
emaciation, and marked effects in nonhepatic tissues.
Dermal Exposure.    Limited information is available on liver toxicity of PCBs in dermally-exposed
animals.  Aroclor 1260, Clophen A60, or Phenoclor Dpb (all 60% chlorine PCB mixtures) was applied in
isopropanol to the shaved back skin of female New Zealand rabbits (four/group) on 5 days/week for 28 or
38 days at estimated doses of 0 or 42–44 mg/kg/day (Vos and Beems 1971; Vos and Notenboom-Ram
3.  HEALTH EFFECTS - Systemic
PCBs 116
1972).  Hepatic effects included increased relative liver weights, histopathologic changes (e.g.,
centrilobular degeneration and hepatocyte atrophy, focal necrosis, and cytoplasmic hyalin degeneration),
and increased fecal porphyrin levels.  In general, the effects occurred in all treated animals and were least
and most pronounced in the Aroclor 1260 and Clophen A60 groups, respectively.  The CDF content of
the Aroclor 1260 used in these experiments was below the detection limit (1 ppm); however, the
analytical techniques available then were relatively insensitive.
3.2.2.6.3.2  Serum Lipids, Triglycerides, and Cholesterol
Oral Exposure    
Commercial PCB Mixtures.  Serum total cholesterol, HDL-cholesterol, and relative liver weight were
increased in rats that were fed estimated doses of $1 mg/kg/day Aroclor 1254 for 4 days; no effects
occurred at 0.5 mg/kg/day (Carter 1984, 1985).  Serum LDL- and VLDL-cholesterol fractions were not
increased in any dose group (#3.9 mg/kg/day).  The lowest level causing increased HDL-cholesterol and
liver weight was 1 mg/kg/day in the Carter (1984) study and 1.9 mg/kg/day in the Carter (1985) studies. 
Effects in rats exposed to PCBs in other acute-duration studies included increased serum cholesterol and
liver weight at $1.9 mg/kg/day Aroclor 1254 (Carter and Koo 1984; Price et al. 1988) and 50 mg/kg/day
Aroclor 1248 for 4 days (Kato and Yoshida 1980), as well as degenerative hepatic histopathological
changes at 50 mg/kg/day Aroclor 1254 and 4,000 mg/kg/day Aroclor 1242 (Bruckner et al. 1973; Kling
et al. 1978) as summarized above in Section 3.2.2.6.3.1.
Changes in serum lipid profiles commonly occurred in rats exposed to PCBs in intermediate-duration
dietary studies (Andrews 1989; Bruckner et al. 1974, 1977; Gray et al. 1993; Kato et al. 1981a, 1981b,
1982b; Kling and Gamble 1982; Litterst et al. 1972).  Effects included increased liver lipids at
$0.3 mg/kg/day Aroclor 1242 for 2–6 months (Bruckner et al. 1974), increased liver triglycerides at
1.25 mg/kg/day Aroclor 1254 for 35 days (Bruckner et al. 1977), increased serum cholesterol at
$10 mg/kg/day Aroclor 1254 for 5 weeks (Andrews et al. 1989), and increased liver lipids and liver and
serum cholesterol at $15 mg/kg/day Aroclor 1248 for 20–24 days (Kato et al. 1981b, 1982b).  Serum
cholesterol, phospholipids, and triglycerides were similarly increased in rats fed 15 mg/kg/day
Aroclor 1248 for 68 days (Oda and Yoshida 1994).  Additional analyses performed by Oda and Yoshida
(1994) showed that serum total lipoproteins were also elevated, with increases in protein, cholesterol,
phospholipid, and triglycerides occurring among the lipoprotein fractions (VLDL, LDL, HDL1, HDL2).
3.  HEALTH EFFECTS - Systemic
PCBs 117
Increased serum cholesterol was one of several manifestations of liver toxicity in rats found in the
24-month comparative study of several Aroclor mixtures (General Electric Co. 1997a, 1997b; Mayes et
al. 1998) summarized in Section 3.2.2.6.3.1.  Serum cholesterol was increased in females exposed to
Aroclors 1242, 1254, and 1260 at  5.7, $1.4, and $2.8 mg/kg/day, respectively; no serum cholesterol
changes were induced by Aroclor 1016 at doses as high as 11.2 mg/kg/day.  Increased serum cholesterol
levels observed in most PCB-exposed males appeared to be treatment-related only for Aroclor 1254.  The
effect in Aroclor 1254 males was minimal as the increase was slight and not clearly dose-related
(statistically significant at 1.0 and 4.3 mg/kg/day, but not at 2.0 mg/kg/day).  Increases in serum
cholesterol in males exposed to Aroclor 1016, 1242, and 1260 were not consistently dose- or time-related
and were considered to be equivocal.  Considering the effect levels and sizes of increases in females, the
order of toxicity was Aroclor 1254 followed by 1260, 1242, and 1016.
  
Effects in monkeys that ingested Aroclor 1254 in capsules daily for 37 months included normal plasma
lipid profiles at doses #0.02 mg/kg/day, decreased total and VLDL + LDL cholesterol at
$0.04 mg/kg/day, and decreased HDL cholesterol and total carnitine (which is involved in fatty acid
metabolism) at 0.08 mg/kg/day (Arnold et al. 1993b; Bell et al. 1994).  Plasma triglycerides were
significantly elevated an apparent maximum of 30–40% at all tested doses (0.005–0.08 mg/kg/day) except
0.04 mg/kg/day.  Bell et al. (1994) found statistically significant correlations supporting a causal
relationship between PCB intake and the plasma lipid/lipoprotein changes, including an indication that
the elevation in plasma triglycerides was not due to the partitioning of PCBs between adipose tissues and
blood lipids.  No correlation was found between the increases in triglycerides and HDL cholesterol.
Single Congeners.  A comprehensive series of toxicity studies was performed in rats that were fed
various individual congeners for 13 weeks, as detailed in Section 3.2.2.6.3.1 (Chu et al. 1994, 1995,
1996a, 1996b, 1998b; Gilroy et al. 1996, 1998; Lecavalier et al. 1997; MacLellan et al. 1994a, 1994b,
1994c; Peng et al. 1997; Singh et al. 1996, 1997).  Effects included increased serum cholesterol levels that
were caused by exposure to PCB 126 at $7.4 µg/kg/day and PCB 105 at $3,960 µg/kg/day.  No changes
in serum cholesterol were induced by PCB 28 at #3,956 µg/kg/day, PCB 77 at #892 µg/kg/day, PCB 118
at #683 µg/kg/day, PCB 128 at #4,397 µg/kg/day, or PCB 153 at #4,125 µg/kg/day.
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3.2.2.6.3.3  Porphyria
Oral Exposure    
Commercial PCB Mixtures.  Urinary coproporphyrin levels were increased in rats that ingested 0.3 or
1.5 mg/kg/day Aroclor 1242 in the diet for 2–6 months (Bruckner et al. 1974).  Rats treated with
5 mg/kg/day Aroclor 1254 in the diet had maximum increases in liver microsomal P-450 concentration
and liver weight after 1 week, but onset of porphyria and induction of δ-aminolevulinic acid (ALA)
synthetase was delayed until 2–7 months of treatment (Goldstein et al. 1974).  A marked accumulation of
uroporphyrins occurred in the liver, and urinary excretion of coproporphyrin and other porphyrins was
increased; the largest increase was in uroporphyrins.  The uroporphyrins in the liver and urine of the
treated rats consisted primarily of 8- and 7-carboxyporphyrins.
Single Congeners.  Increased hepatic uroporphyin is one of the effects observed in rats that were fed
various single PCB congeners for 13 weeks (Chu et al. 1994, 1995, 1996a, 1996b, 1998b; Gilroy et al.
1996, 1998; Lecavalier et al. 1997; MacLellan et al. 1994a, 1994b, 1994c; Peng et al. 1997; Singh et al.
1996, 1997).  Liver uroporphyrin was increased by exposure to PCB 126 at $0.74 µg/kg/day, PCB 105 at
$3,960 µg/kg/day, or PCB 128 at $4,210 µg/kg/day, but not by PCB 28 at #3,956 µg/kg/day, PCB 77 at
#892 µg/kg/day, PCB 118 at #683 µg/kg/day, or PCB 153 at #4,125 µg/kg/day.  Additional information
on the design and results of these studies is summarized in Section 3.2.2.6.3.1.
Dermal Exposure.    Groups of four New Zealand rabbits were dermally treated with 0 or
42–44 mg/kg/day estimated doses of Aroclor 1260, Clophen A60, or Phenoclor Dpb (all 60% chlorine
PCB mixtures), on 5 days/week for 28 or 38 days (Vos and Beems 1971; Vos and Notenboom-Ram
1972).  The PCBs were dissolved in isopropanol and applied to shaved back skin.  All three PCB
mixtures caused significantly increased fecal levels of coproporphyrin and protoporphyrin, and ultraviolet
fluorescence, indicative of porphyrin accumulation, was increased in the liver and other tissues.  Similar
dermal exposure to the congener PCB 153 caused higher fecal levels of coproporphyrin and
protoporphyrin than those in rabbits exposed to the same dose of Aroclor 1260 (Vos and Notenboom-
Ram 1972).
3.  HEALTH EFFECTS - Systemic
PCBs 119
3.2.2.6.3.4  Other Hepatic Effects
Vitamin A homeostasis was altered in rats that were exposed to 100 mg/kg/day (only tested dose) of
PCB 169 in the diet for 77 days (Bank et al. 1989).  Effects included significantly decreased hepatic
vitamin A, increased renal vitamin A, increased serum retinol, decreased plasma clearance and half-time
of injected retinol (i.e., intravenously administered [3H]retinol-labeled retinol binding protein-
transthyretin complex), decreased hepatic and increased renal uptake uptake of injected retinol, and
increased urinary and fecal excretion of injected retinol.
Vitamin A levels in the liver were also reduced in rats following oral exposure to various other congeners
for 13 weeks (Chu et al. 1994, 1995, 1996a, 1996b, 1998b; Gilroy et al. 1996, 1998; Lecavalier et al.
1997; MacLellan et al. 1994a, 1994b, 1994c; Peng et al. 1997; Singh et al. 1996, 1997).  This effect
occurred following ingestion of PCB 126 at $0.74 µg/kg/day, PCB 77 at $768 µg/kg/day, and PCB 153
at $4,125 µg/kg/day), but not by exposure to PCB 28 at #3,956 µg/kg/day, PCB 105 at
#4,327 µg/kg/day, PCB 118 at #683 µg/kg/day, or PCB 128 at #4,397 µg/kg/day.
3.2.2.6.3.5  Evaluation of Animal Studies
The hepatotoxicity of commercial PCBs is well-documented in numerous intermediate- and chronic-
duration studies in animals, particularly in rats and monkeys, which are the most extensively tested
species.  These studies also indicate that monkeys are more sensitive to PCBs than rats and other
laboratory species.  Liver effects are similar in nature among species, appear to be reversible when mild,
and characteristically include hepatic microsomal enzyme induction, increased serum levels of liver-
related enzymes indicative of possible hepatocellular damage, liver enlargement, fat deposition, fibrosis,
and necrosis.  Ultrastructural changes include hepatocyte alterations associated with microsomal enzyme
induction (e.g., proliferation of endoplasmic reticulum, enlarged and pleomorphic mitochondria), lipid
droplets, and enlarged parenchymal cells.  There is relatively little information on hepatic effects of
commercial PCB mixtures in animals exposed by acute-duration oral exposure or the inhalation or dermal
routes, although available data are consistent with the findings of the intermediate- and chronic-duration
oral studies.  The results of a comprehensive comparative 24-month oral toxicity study in rats indicate
that the general pattern of hepatotoxicity was Aroclor 1254 > Aroclor 1260 . Aroclor 1242 >
Aroclor 1016 (Mayes et al. 1998).
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Other liver-related effects of PCBs include altered lipid and porphyrin metabolism.  Increased serum
levels of total lipids, triglycerides, and/or cholesterol are characteristic effects of short- and long-term oral
exposures to PCBs that are well-documented in rats and monkeys (Carter 1984, 1985; Kato and Yoshida
1980; Kato et al. 1982a, 1982b; Oda and Yoshida 1994; Quazi et al. 1984).  The results of comparative
studies in rats exposed to various Aroclor mixtures for 24 months (Mayes et al. 1998) or single congeners
for 13 weeks (Chu et al. 1994, 1995, 1996a, 1996b, 1998b; Gilroy et al. 1996, 1998; Lecavalier et al.
1997; MacLellan et al. 1994; Peng et al. 1997; Singh et al. 1996, 1997) indicate that Aroclor 1254 and
3,3',4,4',5-pentaCB (PCB 126) are particularly effective in increasing serum cholesterol.  Hepatic
porphyria is a well-documented effect that has been induced in rats, rabbits, and other species following
oral or dermal exposure to PCBs (Bruckner et al. 1974; Chu et al. 1994, 1995, 1996a, 1996b, 1998b;
Gilroy et al. 1996, 1998; Goldstein et al. 1974; Lecavalier et al. 1997; MacLellan et al. 1994a, 1994b,
1994c; Peng et al. 1997; Singh et al. 1996, 1997; Vos and Beems 1971; Vos and Notenboom-Ram 1972).
3.2.2.7 Renal Effects
3.2.2.7.1  Human Studies
Urinalysis of PCB-exposed capacitor plant workers showed no abnormalities in blood urea nitrogen
(BUN) or other routinely-examined kidney function indices (Fischbein et al. 1979; Lawton et al. 1985a). 
Most of the workers studied by Fischbein et al. (1979) were exposed to mean concentrations of
Aroclors 1254 and 1242 and/or other PCBs ranging from 0.007 to 11 mg/m3 for $5 years; 40% of the
workers were employed for $20 years.  The workers in the Lawton et al. (1985a) study were exposed to
various Aroclor mixtures for a mean duration of 17 years; the mean PCB concentration was 0.69 mg/m3
(range, 0.2–2.0), based on monitoring performed in only one area of the plant several months prior to
clinical evaluation.
3.2.2.7.2  Animal Studies
Information on the renal toxicity of PCBs comes from an inhalation study, a number of oral exposure
studies, and several dermal exposure studies involving PCB mixtures or single congeners.  Slight
degeneration of the renal tubules was observed in rats exposed to chamber concentrations of 1.5 mg/m3
Aroclor 1254 over 213 days (Treon et al. 1956).  No information was reported on renal histological
effects in other species (mice, guinea pigs, and rabbits) exposed to Aroclor 1254 under the same
conditions or in rats, mice, guinea pigs, or rabbits similarly exposed to 1.9 mg/m3 Aroclor 1242. 
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Interpretation of gross pathology data in this study is complicated by imprecise reporting and/or small
numbers of animals, but it appears that there were no gross renal changes.  The concentrations of PCBs
are uncertain due to an invalid analytical technique and differential enrichment of the more volatile PCB
congeners in the vapor phase.
A single near-lethal gavage dose of 4,000 mg/kg of Aroclor 1242 produced renal tubular damage in an
unreported percentage of rats evaluated 24 hours following treatment (Bruckner et al. 1973).  Effects
included vacuolated tubular epithelial cells with fatty deposits and epithelial cells and proteinaceous casts
in the tubular lumens and urine.  Neither serum sodium or potassium ion concentrations or blood pH
values were altered significantly by treatment, but lack of changes in these indices does not necessarily
indicate that there was no functional damage in the kidney.  No effect on kidney weight was observed in
pregnant C57BL/6J mice given #21 mg/kg PCB by gavage on 5 consecutive days beginning on day 1, 6,
or 11 of pregnancy (Rodriguez et al. 1997).  
Cortical tubular protein casts were observed in the kidneys of rats treated with $1.0 mg/kg/day
Aroclor 1254 for 15 weeks (Gray et al. 1993).  The same group of investigators had previously observed
increased kidney weight and biochemical alterations suggestive of functional renal damage, including
increased urinary lactate dehydrogenase and urinary protein in rats treated with $10 mg/kg/day
Aroclor 1254 by gavage for 5–15 weeks (Andrews 1989).  Histology was not evaluated in the Andrews
(1989) study.  Renal histopathologic changes (lipid vacuolization and sloughing of the tubular epithelium)
occurred in rats with no increase in kidney weight when treated with 100 mg/kg/day Aroclor 1242,
3 days/week for 3 weeks (Bruckner et al. 1973); these degenerative effects are similar to those observed
in the acute study described above.  No histological effects were observed in the kidneys of rats treated
with 1.5 mg/kg/day Aroclor 1242 in the diet for 2–6 months (Bruckner et al. 1974).  Similarly, no renal
histopathologic changes were observed in male or female rats that were fed Aroclor 1016, 1242, 1254, or
1260 for 24 months at dose levels of 8.0–11.2, 4.0–5.7, 4.3–6.1, or 4.1–5.8 mg/kg/day, respectively
(Mayes et al. 1998).  There were no treatment-related renal organ weight changes or histological effects in
rabbits fed #6.5 mg/kg/day Aroclor 1254 for 8 weeks (Street and Sharma 1975) or guinea pigs fed
#4 mg/kg/day Aroclor 1260 for 8 weeks (Vos and de Roij 1972).  No renal histological effects were
observed in one monkey that died after 128 days of dietary treatment with 1.3 mg/kg/day Aroclor 1248
(Allen et al. 1974a).  Rhesus monkeys receiving daily doses of 0.005, 0.020, 0.040, or 0.080 mg/kg/day
Aroclor 1254 for 72 months also showed no effects on renal tissue (Arnold et al. 1997).
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In a series of 13-week dietary exposure studies using single PCB congeners, no histological alterations in
the kidneys were observed in rats fed diets providing #4.1 mg/kg/day of PCB 153 (Chu et al. 1996a),
#4.2 mg/kg/day of PCB 128 (Lecavalier et al. 1997), #7.4 mg/kg/day of PCB 126 (Chu et al. 1994),
#4.0 mg/kg/day of PCB 105 (Chu et al. 1998b), #3.7 mg/kg/day of PCB 28 (Chu et al. 1996b), or
#0.77 mg/kg/day of PCB 77 (Chu et al. 1995).  In similarly treated rats exposed to PCB 118, minimal
histological damage (cytoplasmic shedding and inclusions in the renal tubules) was observed at
0.17 mg/kg/day (Chu et al. 1995). 
Hydropic degeneration of the convoluted tubules, destruction of tubular epithelial cells, tubular dilation,
and proteinaceous casts were observed in half of the rabbits treated with Aroclor 1260 in an isopropanol
vehicle applied 5 days/week for 38 days at an estimated dose of 42 mg/kg/day (Vos and Beems 1971). 
No kidney effects were observed in a similar study in which 44 mg/kg/day Aroclor 1260 was applied in
the same manner to adult female New Zealand rabbits 5 days/week for 28 days (Vos and Notenboom-
Ram 1972).  The reason for the discrepancy in the results is unclear since the doses are essentially the
same, but it may be related to the small numbers treated (four per study) and to the longer duration of the
1971 study.  The Aroclor 1260 used in both studies had undetectable (<1 ppm) levels of CDFs.
The highest NOAEL values and all reliable LOAEL values for renal effects for each study are recorded in
Tables 3-1, 3-2, and 3-3, and plotted in Figures 3-1 and 3-2.
3.2.2.8 Endocrine Effects
This section describes effects of exposure to PCBs on the thyroid and other non-reproductive endocrine
systems.  Estrogenic, anti-estrogenic, and anti-androgenic effects of PCBs are discussed in Sections 3.2.5
(Reproductive Effects), 3.5.2 (Mechanisms of Toxicity), and 3.6 (Endocrine Disruption).
3.2.2.8.1  Summary
A number of studies have examined the relationships between PCB exposure and thyroid hormone status
in both children and adults.  The results suggest that PCBs can induce thyroid toxicity as well as a variety
of changes in thyroid hormone levels.  Differing results have been reported for differing Aroclor mixtures
and PCB congeners, as well as for differing exposure scenarios and differing ages at the time of exposure. 
Increased thyroid gland volume has been found among workers at a  PCB production facility as well as
among nearby residents.  An elevated odds ratio for goiter has been found among the Yu-Cheng cohort. 
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In addition, numerous statistically significant positive and/or negative correlations (for a number of
different age groups) have been reported between circulating levels of TSH, T4, and T3, and varying
measures of PCB exposure.
Evidence for a thyroid hormone involvement in PCB toxicity in animals is much stronger and includes
findings in rodents and nonhuman primates.  Depending on dose and duration, PCBs can disrupt the
production and disposition of thyroid hormones at a variety of levels.  The major findings include
(1) histological changes in the thyroid gland indicative of both stimulation of the gland (e.g., similar to
that induced by TSH or a hypothyroid state) and a disruption of the processing of follicular colloid
needed for normal production and secretion of thyroid hormone; (2) depression of serum T4 and T3 levels,
which may effectively create a hypothyroid state (in some studies, low doses resulted in elevated serum
T4 levels while depressed levels occurred at higher PCB doses); (3) increased rates of elimination of T4
and T3  from serum; (4) increased activities of T4-uridine diphosphate-glucuronyl transferase (UDP-GT)
in liver, which is an important metabolic elimination pathway for T4 and T3; (5) decreased activity of
iodothyronine sulfotransferases in liver which are also important in the metabolic elimination of
iodothyronines; (6) decreased activity of iodothyronine deiodinases  including brain Type-2 deiodinase,
which provide the major pathways for the production of the active thyroid hormone, T3; and (7) decreased
binding of T4 to transthyretin, an important transport protein for both T4 and T3.  Other effects of PCBs on
endocrine function that have been observed in experimental animals include effects on the adrenal glands
and serum adrenal steroid levels.
3.2.2.8.2  Human Studies
Occupational Exposures.  Total thyroxine (T4) and free T4 (T4 index) were significantly lower
(approximately 10%)  in a group of 55 transformer maintenance workers compared to a comparison
control group of workers (Emmett et al. 1988b), even though thyroid hormone levels were in the normal
range for adults in both groups.  The transformer workers were primarily exposed to Aroclor 1260 at
levels ranging from 0.00001 to 0.012 mg/m3; the mean length of exposure was approximately 4 years. 
Although there was a statistically significant increase in thyroxine levels in the PCB-exposed cohort,
there was no correlation between PCB levels in serum or adipose tissue and serum T4 concentrations
(adjusted for age, smoking, and alcohol consumption). 
Langer et al. (1998) measured thyroid volumes in 238 employees of a factory that produced PCBs, and in
572 adults from “less polluted areas” of Slovakia, which formed a sex- and age-matched control group.
3.  HEALTH EFFECTS - Systemic
PCBs 124
Various serum indices of thyroid status were measured in subsamples of these groups, including total
serum T4, serum TSH, thyroglobulin (TGB); and antibodies for thyroid peroxidase (TPO Ab),
thyroglobulin (Tg Ab), and TSH receptor (TSHR Ab).  Mean thyroid volume was significantly greater in
the workers compared to the control group (18.85±0.69 mL vs. 13.47±0.48 mL, p<0.001).  Workers also
had a significantly elevated prevalence of TPO Ab, Tg Ab, and TSHR Ab.  There were no differences
between the worker and control groups with regard to serum T4, TSH, or TGB concentrations.  Although
larger thyroid volume could reflect a difference in the iodine intakes between the two groups, the
investigators indicated that this was not likely because iodine intakes were considered sufficient in
Slovakia and urinary iodine concentrations were similar in the worker and control groups (data not
reported).
Yusho and Yu-Cheng Exposures.  In a case-control study of the Taiwan Yu-Cheng cohort, 795 exposed
subjects and 693 sex- and age-matched controls were interviewed for information about health and
medical history (Guo et al. 1999).  The odds ratio (OR) for goiter (men and women combined) was
2.8 (CI, 1.2–7.1) and 4.0 (CI, 1.5–13.9) for goiter that was treated with medication or surgery.  The ORs
for hypothyroidism or hyperthyroidism were not significant (males, 0.95; females, 1.7).
General Population Exposures.  Several studies have examined relationships between indices of PCB
exposure and thyroid hormone status, as indicated from measurements of serum thyroid hormones.  The
results of these studies have been mixed, with negative, positive, or no correlations observed.  Osius et al.
(1999) examined the relationship between whole blood concentrations of various PCB congeners and
serum TSH, free T4, and free T3 in children who lived near a hazardous waste incinerator.  Although the
median and 5th–95th percentile ranges of the hormone concentrations in the study population
(671 children, ages 7–10 years) were within expected ranges for children, a significant positive (β=7.129,
p=0.039) association was found between concentrations of TSH in serum and PCB 118 in blood. 
Significant negative associations were found between serum T3 and PCBs 138, 153, 180, 183, and 187.
Several studies have examined relationships between thyroid hormone levels in infants and maternal or
neonatal PCB concentrations, or mixed PCB and CDD concentrations (Koopman-Esseboom et al. 1994a;
Longnecker et al. 2000; Nagayama et al. 1998a; Winneke et al. 1998a).  Hormone levels were within
normal ranges in these studies.  In describing hormone levels in the serum or plasma, the designations TT4
or TT3 have been used to denote total hormone concentrations, whereas free concentrations are denoted as
FT4 or FT3.  If  not specified in the report, the notations T4 or T3 have been used.  Longnecker et al. (2000)
compared PCB concentrations in breast milk of 880 mothers to serum TSH, TT4, and FT4 concentrations
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in cord blood at delivery.  The subjects in this study are from the North Carolina Breast Milk and Formula
Project cohort summarized in Section 3.2.4.2.1.2.  Concentrations of T4 and TSH were not shown to be
related to breast milk PCB concentrations.  However, a significant positive correlation (r=0.15,
p=0.029)was found between TSH concentrations in cord blood and total serum PCBs in 170 infants from
the German cohort in the European Background PCB Study summarized in Section 3.2.4.2.1.2 (Winneke
et al. 1998b).  Nagayama et al. (1998) examined the relationship between serum TSH, TT4, and TT3 in
infants and estimated intake of 2,3,7,8-TCDD toxic equivalent (TEQ) in breast milk during the first year
of postnatal life.  Significant negative correlations were found for serum TT4 and TT3; no relationship was
apparent between infant serum TSH or thyroxine binding globulin (TBG) and TEQ intake.  The mean
total TEQ intake was 34 ng/kg; however, the co-planar PCB contribution to the estimated TEQ intake,
and intakes of other PCBs were not reported.  As part of the Dutch Mother-Child Study cohort
summarized in Section 3.2.4.2.1.2, Koopman-Esseboom et al. (1994a) compared TEQ levels of PCBs and
dioxins in maternal milk with TT3 and TT4 concentrations in maternal plasma, TSH concentrations in cord
plasma at delivery, and TSH concentrations in venous plasma of the infants at ages 2 weeks and
3 months.  Higher levels of total PCB-dioxin TEQ, dioxin TEQ, and both planar and non-planar-PCB
TEQ in milk were significantly correlated with lower maternal plasma TT3 concentrations in the last
month of pregnancy, lower maternal plasma TT3 and TT4 concentrations in the 2nd week after delivery,
and higher plasma TSH concentrations in the infants at 2 weeks and 3 months of age.
 
Langer et al. (1998) measured thyroid volumes in 454 adolescents in Slovakia who lived near a factory
that produced PCBs, and in 956 adolescents who lived in “less polluted areas” of Slovakia, which formed
a sex- and age-matched control group.  Various serum indices of thyroid status were measured in
subsamples of these groups, including TSH and TPO Ab.  Mean thyroid volume was significantly greater
in the group who lived near the factory compared to the control group (9.37±0.17 mL vs. 8.07±0.10 mL,
p<0.001).  There were no differences between the groups with regard to serum TSH or TPO Ab
concentrations.  As with the worker cohort (discussed with the occupational studies), the investigators
indicated that a difference in the iodine intakes between the two groups was not likely because iodine
intakes were considered to be sufficient and urinary iodine concentrations were similar in the two groups
(data were not reported).
An ongoing epidemiologic study is investigating the potential for health effects in Native Americans from
exposure to persistent toxic substances (Dellinger et al. 1997; Tarvis et al. 1997).  Fish consumption,
species consumed, and medical histories were obtained from 541 Native Americans on eight reservations
in Minnesota, Wisconsin, and Michigan.  Preliminary results indicated elevated serum PCB levels (mean
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was 3.7 ppb and the maximum was 9.6 ppb) were correlated with self-reported diabetes and liver disease
in two of the cohorts (Ojibwa and Red Cliff).  The average annual fish consumption rate was 23 g/day. 
No additional information was available regarding the potential link between PCBs and diabetes,
although there is growing evidence of an association between dioxin exposure and diabetes (ATSDR
1998).
Evaluation of Human Studies.  The epidemiological literature suggests a link between PCBs exposure
and thyroid hormone anomalies in humans.  Studies that have examined relationships between PCB
exposure and thyroid hormone status, in children or adults, have reported a variety of different results,
with findings of both negative and positive significant correlations between PCB exposure and circulating
levels of TSH, T4 or T3 depending on the specific type of analysis for PCB exposure, the age of the
cohort, and the specific exposure scenario (Emmett et al. 1988b; Koopman-Esseboom et al. 1994a;
Langer et al. 1998; Longnecker et al. 2000; Nagayama et al. 1998; Osius et al. 1999; Winneke et al.
1998a).  A comparison of PCB levels in blood and breast milk in some of these studies is included in
Appendix A.  Although many of the populations examined had thyroid hormone levels within normal
ranges, many of these studies also showed statistically significant differences in circulatory thyroid
hormone levels in exposed cohorts compared to unexposed controls.  In addition, a significantly elevated
OR for goiter was found among the Yu-Cheng cohort (Guo et al. 1999), suggesting the possibility of
excess thyroid disease in a population that experienced relatively high exposures to mixtures of PCBs and
CDDs.  Other observations include reports of increased thyroid gland volume among workers at a  PCB
production facility, as well as among nearby residents (Langer et al. 1998).  Considering the
epidemiologic data as well as the much stronger findings in thyroid studies in animals discussed in the
following section, there is mounting evidence of thyroid hormone involvement in PCB toxicity in
humans.
3.2.2.8.3  Animal Studies
The highest NOAEL values and all reliable LOAEL values for endocrine effects for each study are
recorded in Tables 3-1 and 3-2, and plotted in Figures 3-1 and 3-2.
Effects on Thyroid Gland and Hormones    
Commercial PCB Mixtures.  Various effects on the thyroid gland and thyroid hormone system have been
observed in rats exposed to Aroclor 1254 by the oral route.  Descriptions of the histological changes in
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the rat are reasonably consistent across studies.  Typical findings, depending on the dose, include
hyperplasia, hypertrophy, and increased vacuolization of follicular cells, depletion of follicular colloid
and reduced follicular size, and thyroid enlargement (Collins and Capen 1980a; Collins et al. 1977). 
These changes are similar to the histological appearance of the gland during prolonged TSH stimulation
(Capen 2000).  Additional abnormalities have also been noted when the gland has been examined at the
ultrastructural level.  Collins and Capen (1980a) observed in PCB-treated rats the accumulation of colloid
droplets and large, abnormally shaped lysosomes in the follicular cells that were indicative of a disruption
of the normal lysosomal processing of colloid.  They also noted distinct abnormalities in follicular
microvilli (shortening and abnormal branching) that were uncharacteristic of the TSH-stimulated or
iodide-stimulated gland.  Thus, the effects of Aroclor 1254 on the thyroid gland are not completely
explained solely by a direct or indirect stimulation of the gland through a TSH mechanism.  A complex
mechanism is further indicated from observations of the forementioned structural changes with or without
concurrent changes in circulating thyroid hormone (T4 or T3) or TSH levels, or changes in hormone levels
without changes in thyroid gland, or changes in hormone levels that vary in magnitude and direction over
time (Hood et al. 1999; Saeed and Hansen 1997).  Thus, while a general consensus has emerged that
Aroclor 1254 produces a stimulation of the thyroid gland and thyroid hormone production (Byrne et al.
1987), it is not clear to what extent this results from a direct effect on the thyroid gland or as an indirect
effect resulting from changes in circulating thyroid hormone and induction of TSH.  It is likely that both
contribute to varying degrees depending on the dosage and duration of exposure (Saeed and Hansen
1997).  It is important to emphasize that characteristic structural changes that have been attributed to
Aroclor 1254 may not be apparent when the gland is viewed only at the light microscopic level, which
has been the approach used in most studies.  Furthermore, histopathology of the gland should not be
inferred from observed changes in circulating thyroid hormone or TSH levels, alone.  Experimental
studies that provide evidence for Aroclor-mediated effects on the thyroid gland and/or thyroid hormone
status are noted below.  In describing hormone levels in the serum or plasma, the designations TT4 or TT3
have been used to denote total hormone concentrations, whereas free concentrations are denoted as FT4 or
FT3.  If  not specified in the report, the notations T4 or T3 have been used.
In an acute-duration study, Hood et al. (1999) observed significant depression of serum TT4 and FT4 in
rats fed $25 ppm Aroclor 1254 in food (2.3 mg/kg/day) for 7 days and depression of TT3, but not FT3 in
rats fed $50 ppm (4.6 mg/kg/day).  PCBs at exposure levels up to 200 ppm (18 mg/kg/day) had no effect
of serum TSH levels or on thyroid structure.  TT4 levels were reduced in rats fed $2.5 mg/kg/day for
7 days, but there were no treatment-related changes in serum TT3 (Price et al. 1988).  This study reports
histological changes in the thyroid gland that are typical of Aroclor 1254-related changes that have been
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observed in intermediate- and chronic-duration studies; however, it is not clear from the report whether
the changes occurred at the 2.5 mg/kg/day dosage or at higher dosages. 
Collins et al. (1977) conducted one of the more comprehensive evaluations of the histopathology of
intermediate-duration exposures to Aroclor 1254 in rats.  Rats were fed 5, 50, or 500 ppm Aroclor 1254 in
food for 4 weeks (approximately 0.44, 4.4, or 44 mg/kg/day).  Ultrastructural changes in the thyroid were
evident at the lowest exposure level and became more pronounced and evident with light microscopy at
the 50 ppm exposure level (4.4 mg/kg/day).  Serum concentrations of TT4 were significantly depressed
(42%) at the 50 ppm level and both TT4 and TT3 were depressed (79 and 13%, respectively) at the
500 ppm level.  Thyroid lesions in rats that were exposed to 500 ppm for 6 weeks followed by 250 ppm
for 6 weeks were largely absent after a subsequent 12 weeks on a control diet, suggesting substantial
recovery, and were not evident at all after a period of 35 weeks on the control diet (Collins and Capen
1980a).  A similar time course of recovery of serum TT4 concentrations was observed.  Thus, the
observed lesions in this study and at these doses appeared to be reversible. 
In other intermediate-duration studies, oral exposures of rats for 1–5 months decreased serum levels of T4
and T3 and/or produced histological changes in the thyroid (Byrne et al. 1987; Gray et al. 1993; Kasza
et al. 1978). Thyroid effects in rats occurred at oral doses as low as 0.09 mg/kg/day for 35 days (Byrne
et al. 1987).  In Sprague-Dawley rats, serum levels of T4 decreased when rats received daily gavage
dosages of $0.1 mg/kg/day Aroclor 1254 for 15 weeks; however, no histopathologic alterations were
observed in the thyroid after gavage dosages of up to 25 mg/kg/day Aroclor 1254 (Gray et al. 1993).  The
lack of effect of this dose of Aroclor 1254 on the histological status of the thyroid in the Sprague-Dawley
rat, in comparison to histological changes observed in Osborne-Mendel rats at similar dosages and
durations (Collins and Capen 1980a; Collins et al. 1977), suggests a possible strain-related difference, or
some other unaccounted variable in either study.  Byrne et al. (1987) attempted to discern the relative
contributions of production and metabolism in the depression of serum T4 concentrations that occur
during Aroclor 1254 exposure.  In rats exposed to Aroclor 1254 in diet at concentrations $1 ppm
(0.09 mg/kg/day) for $35 days, serum TT4 and TT3 levels were depressed; however, the rate of clearance
of injected radiolabeled T4 was not changed by the PCB exposures, relative to a control group, suggesting
that the decline in T4, and possibly T3 concentrations, was primarily the result of a decline in T4
production in the thyroid.
In chronic-duration studies, enlarged thyroid glands and follicles with desquamated cells were observed
in Rhesus monkeys exposed to 0.2 mg/kg/day Aroclor 1254 for 28 months (Tryphonas et al. 1986b);
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serum levels of thyroid hormones were not evaluated.  In Cynomolgus monkeys, treatment for 12 months
with 0.2 mg/kg/day Aroclor 1254 did not induce histological alterations in the thyroid (Tryphonas et al.
1986a).  Rhesus monkeys receiving daily doses of 0.005, 0.020, 0.040, or 0.080 mg/kg/day Aroclor 1254
for 72 months showed no effect on thyroid tissue (Arnold et al. 1997).  After 37-months of exposure to
0.08 mg/kg/day Aroclor 1254, serum TT4 and FT4 (T4 index) were not different from controls (Arnold et
al. 1993b).  The incidence of follicular cell hyperplasia (generally minimal or mild) was increased in a
non-dose-related pattern in male rats that were fed Aroclor 1242, 1254, or 1260 for 24 months at dose
levels of $2.0, $1.0, and $1.0 mg/kg/day, respectively (Mayes et al. 1998).  This thyroid lesion was not
observed following exposure to similar doses of Aroclor 1016 in male rats or Aroclor 1016, 1242, 1254,
or 1260 in female rats.  Thyroid follicular cell adenomas were also increased in the male rats as discussed
in the animal cancer section (3.2.8.3.2).
The effects of gestational exposures to Aroclor 1254 on the thyroid gland and thyroid hormone status of
neonates have been examined in numerous studies.  Lesions in the thyroid were observed in pups born to
dams that were exposed to 50 or 500 ppm Aroclor 1254 (2.5 or 25 mg/kg/day) from gestation
day 1 through postnatal day 21 (Collins and Capen 1980c).  The pups also had depressed serum levels of
TT4 and TT3.  Aroclor 1254 (3.1, 6.2, or 12.5 mg/kg/day, oral) administered to rats during gestation and
lactation depressed serum TT4, but not TT3, in the neonatal rats (Juarez de Ku et al. 1994).  Aroclor 1254
administered to rats on days 10–16 of gestation (5 or 25 mg/kg/day, oral) depressed plasma TT3 in the
dams and both plasma TT4 and FT4 in fetuses and 5-day neonates (Morse et al. 1996c).  Fetal brain levels
of T4, but not T3, were also depressed.  No changes were detected in fetal or neonatal plasma TSH
concentration.  Other effects observed that are relevant to the thyroid hormone system included an
increase in Type II thyroxine 5'-deiodinase activity in fetal brain and depression of activity in 21-day-old
pups, and an increase in T4-UDP-GT activity in fetal and pup liver.  Provost et al. (1999) observed a
depression in both serum total T4 and T3 concentrations in rats that had been exposed to 1.25 or 12.5 ppm
Aroclor 1254 (approximately 0.1 or 1 mg/kg/day) during gestation and through postnatal day 30.  Zoeller
et al. (2000) fed pregnant rats 0, 1, 4, or 8 mg/kg/day Aroclor 1254 beginning on day 6 of gestation
through weaning of pups.  Dosages $1 mg/kg/day depressed serum TT4 levels in the pups.  Serum
concentrations of TT4 and FT4 were depressed in dams and fetuses after gavage doses of 25 mg/kg/day
Aroclor 1254 on gestation days 10–20 (Schuur et al. 1998a).  Although serum concentrations of the
sulfate ester of T4 were not affected by Aroclor 1254 treatment, the activity of 3,3'-T2-sulfotransferase in
liver cytosol preparations was lower in the treatment group relative to the control group.  Activities of
iodothyronine deiodinase in liver was also decreased in the dams and fetuses in the treatment group. 
Type II deiodinase activity was significantly increased in fetal, but not maternal brain in the treatment
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group.  T4-UDP-GT activity in maternal liver was significantly increased in the treatment group.  These
observations suggest that Aroclor 1254 can potentially affect thyroid hormone status by modifying
several different metabolic pathways for T4, including glucuronide and sulfate conjugation, and
deiodination of iodothyronines.
Aroclor 1254 (1, 4, or 10 mg/kg/day, oral) administered on gestation day 6 through postnatal
day 21 depressed postnatal (day 7–21) serum TT4 concentration ($1 mg/kg/day) and T3 concentration
($4 mg/kg/day), without a change in serum TSH concentration (Goldey et al. 1995).  Thyroid hormone
levels recovered from depressed levels with time and were nearly at control levels by postnatal day 45. 
Neurobehavioral deficits were observed in the pups, including decreased motor activity and changes in
acoustic startle response (see Section 3.2.4.3.3); these changes were significantly attenuated in pups that
received subcutaneous injections of T4 that increased serum T4 and T3 concentrations (Goldey and
Crofton 1998).  Rates of elimination of both hormones from serum were accelerated in the pups that had
been exposed to Aroclor 1254, relative to controls.  These observations suggest that the observed
neurobehavioral deficits may have been attributable to deficits in thyroid hormones.  The increased
elimination of T4 and T3 from serum is consistent with an induction of UDP-GT or other elimination
pathways for thyroid hormones (e.g., deiodination of T4 to T3).
In a longer feeding study, pregnant rats were exposed to 125 or 250 ppm Aroclor 1254 in food from
gestation day 1 through weaning of pups (Corey et al. 1996).  The weaned pups either continued the
exposure until postnatal day 60 or were fed the control diet.  Reported dosages during gestation were 8 or
18 mg/kg/day, and during lactation were 37 or 62 mg/kg/day.  Serum TT4 concentrations, but not TT3,
were depressed (>90% decrease) at postnatal day 60 in all of the exposure groups.  In pups that were
removed from the PCB exposure after weaning, serum TT4 concentrations partially recovered, but, unlike
the Collins and Capen (1980a) study previously discussed, remained significantly lower than control
levels.
Seo and Meserve (1995) reported the effects of maternal ingestion of Aroclor 1254 in pregnant and
lactating rats on the development of thermoregulation in neonates.  Female pregnant Sprague-Dawley rats
(n=6–8) were fed ad libitum 125 or 250 ppm (6.3 or 12.5 mg/kg/day) Aroclor 1254 and continued on the
diet from conception to completion of the experiment when pups were 15 days old.  Serum TT4 levels
were depressed in female rats treated with 6.3 and 12.5 mg/kg/day during pregnancy and lactation. 
Relative thyroid weight increased (19 mg/100 g ±1.3) significantly in animals given 6.5 mg/kg/day
compared to controls, but not at the 12.5 mg/kg/day dose.
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In contrast to the depression of circulating levels of thyroid hormone levels that has been observed in rats
exposed to Aroclor 1254, rats exposed to Aroclor 1242 (32 µg/kg/day in food or 900 ng/m3 vapor, whole
body exposure) for 30 days had higher serum concentrations of TT3 and TT4 than rats in a control group
(Casey et al. 1999).  Histological changes in the thyroid observed in the rats exposed to the aerosol
included increased vacuolization of thyroid follicle cells with reduced follicular colloid, changes that are
typical of TSH stimulation of the gland.  The elevation in thyroid hormone levels observed in this study
supports earlier observations of increased serum T4 levels following low doses of PCB 153 (Li et al.
1994), PCB 110 (Li et al. 1998), a mixture of PCBs collected in the air over a landfill (Li and Hansen
1996b), and Aroclor 1242, but not Aroclor 1254, in chick embryos (Gould et al. 1997).  The rats exposed
to the Aroclor 1242 vapor may have received a substantial ingestion dose, because of deposition of PCBs
on the fur and because the animals were exposed and housed two animals per cage.
Cooke et al. (1996) demonstrated a possible thyroid hormone-mediated response of the testes to
Aroclor 1254.  This study found increased testes weight and sperm production in 135-day-old rats that
were administered subcutaneous doses of Aroclor 1254 (.40 mg/kg/day) or Aroclor 1242
(.80 mg/kg/day) on postnatal days 1–25.  Serum TT4 concentrations were also depressed in these rats,
and the effects on the testes were attenuated by injections of T4 on postnatal days 1–25.  In contrast to the
results of this study, Gray et al. (1993) found no effect of oral exposure to Aroclor 1254 (up to
25 mg/kg/day) on testes weights or sperm numbers in rats that had substantially depressed levels of serum
TT4 and TT3; however, the study initiated the dosing of the rats on postnatal day 31, after the
development of Sertoli cells is complete in the rat, and, thus, may have missed a vulnerable period in the
postnatal development of the testes.
Defined Experimental Mixtures.  PCBs were extracted from an NPL site and doses ranging from 3 to
96 mg/kg were administered to 20-day-old female rats for 2 days (Hansen et al. 1995).  The animals were
sacrificed 24 hours after the last dose.  Serum total T4 declined significantly at doses of $36 mg/kg/day;
however, at doses >12 mg/kg/day, thyroid follicular cells increased in size, while the colloid area
decreased to <60% of control values, indicative of thyroid gland stimulation.  Depression of serum T4 was
also observed in 21-day-old rats that received the same soil mixture and a charcoal filtered mixture, which
had considerably lower TCDD equivalents (Li and Hansen 1996a).  When compared to extracts of
superficial dust and debris and airborne PCBs, the soil extract was somewhat less potent than the air
extract (Li and Hansen 1996b).
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Single Congeners.  Histopathologic lesions of the thyroid gland developed in rats that were exposed to
single PCB congeners in food for 13 weeks (Chu et al. 1994, 1995, 1996a, 1996b, 1998b; Lecavalier et al.
1997).  The lesions consisted of a reduction in size and collapse of the thyroid follicles, reduced follicle
colloid density, and cellular changes, including cytoplasmic vacuolization and nuclear vesiculation of
follicle cells.  These changes were evident to varying degrees of severity at the following dosages:
PCB 28 at $36 mg/kg/day; PCB 77 at $0.070 mg/kg/day; PCB 105 at $0.039 mg/kg/day; PCB 118 at
$0.17 mg/kg/day; PCB 126 at $0.00074 mg/kg/day; PCB 128 at $0.43 mg/kg/day; and PCB 153 at
$0.35 mg/kg/day.  
Depressed concentrations of T4 have been observed in rats exposed to single PCB congeners in food for
13 weeks (Desaulniers et al. 1997; Van Birgelen et al. 1992, 1994a, 1994b, 1995).  Effective dosages
were as follows: 75 µg/kg/day PCB 77 decreased serum TT4, but not serum TSH (Desaulniers et al.
1997); 50 µg/kg/day PCB 126 decreased FT4and TT4 plasma concentrations; 1.2 mg/kg/day; PCB 156
decreased plasma FT4 concentration; and 6 mg/kg/day of PCB 156 depressed both free and TT4
concentrations (Van Birgelen et al. 1995).  These same dosages increased activity of UDP-GT in liver
homogenate, including activity when either T4, p-nitrophenol, or 1-naphthol were the substrates
(Desaulniers et al. 1997; Van Birgelen et al. 1995).  This is consistent with the induction of UDP-GT1A1,
which utilizes T4 and simple phenols as a substrate, and with the induction of cytochrome P-450 1A1 at
these same dosages of PCB congeners (Chu et al. 1995; Van Birgelen et al. 1995).  These observations
suggest a possible involvement of the Ah receptor in modifying the metabolism and, thereby circulating
levels of T4. 
Rice (1999a) administered oral doses (0.25 or 1.0 µg/kg/day) of 3,3',4,4',5-pentaCB (PCB 126) to female
rats, 5 days/week beginning 5 weeks prior to and through pregnancy, gestation, and lactation.  Serum T4
levels were depressed in 21-day-old pups, but not in 60-day-old pups or in the dams.  Darnerud et al.
(1996a) found no changes in plasma FT4 or TT4 concentrations in maternal mice given a single oral dose
of up to 10 mg/kg PCB 77 in corn oil on day 13 of gestation; however, FT4 and TT4 concentrations in
plasma of the 13-day-old fetus were depressed (36 and 45%, respectively).  This study also found
substantial binding of 4-hydroxylated metabolites of PCB 77 in fetal serum to serum transthyretin and
that binding of T4 to transthyretin was substantially decreased in serum of the exposed pups, relative to
the control group.  This observation suggests that hydroxylated metabolites of certain PCBs may compete
for binding of T4 to transthyretin, and is consistent with the results of in vitro binding studies that have
estimated transthryretin binding affinities of 4-OH metabolites of PCB congeners to be similar to that of
T4 (Cheek et al. 1999; Lars et al. 1994).  
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An intraperitoneal dose of 8 mg/kg/day of 2,3,3',4',6-pentaCB (PCB 110), administered to female rat pups
on postnatal days 21 and 22, increased serum TT4 levels, while higher doses resulted in a dose-dependent
decrease in serum TT4 levels ( Li et al. 1998).  A PCB 110 preparation contaminated with 0.4%
3,3',4,4',5-pentaCD (PCB 126) produced a dose-dependent decrease in serum T4 levels (4 mg/kg/day or
higher) without an increase in serum T4 levels.
Effects on the Adrenal Gland and other Endocrine Systems    
Commercial PCB Mixtures.  PCB-related effects on the adrenal gland have been reported after repeated
oral exposure to PCBs; however, a single dose of 4,000 mg Aroclor 1242/kg did not induce histological
alterations in the adrenals or pancreas in rats (Bruckner et al. 1973).  Significantly increased serum
corticosterone levels were reported in mice following $8.1 mg/kg/day Aroclor 1254 for 2 weeks (Sanders
et al. 1974); adrenal weight was increased at 130 mg/kg, but histology was not evaluated.  Intermediate-
duration studies with rats found that serum corticosterone levels were increased by dietary exposure to
15 mg/kg/day Aroclor 1248 for 20 days (Kato et al. 1982a), 35 mg/kg/day Aroclor 1221 for 10 weeks
(Wassermann et al. 1973), and 0.1 mg/kg/day Aroclor 1254 for 15 weeks (Miller et al. 1993b).  Bergman
and Olsson (1984) have attributed much of the pathology in PCB-contaminated Baltic seals to adrenal
cortical hyperplasia.  Rats fed 0.05–2.5 mg/kg/day Aroclor 1242 or 1221 for 5 months had decreased
serum levels of the adrenal cortex hormones, dehydroepiandrosterone (DHEA) and dehydroepiandro-
sterone sulfate (DHS).  The decreases in DHEA, DHS, and corticosterone occurred at $0.25 mg/kg/day
Aroclor 1254, but not at 0.05 mg/kg/day; no corticosterone data were reported for Aroclor 1242 or
1221 (Byrne et al. 1988).  The degree of hormone inhibition was dose related and generally increased
with increasing degree of mixture chlorination.  These reductions in circulating hormones were
accompanied by decreased adrenal weight with Aroclor 1254 (not evaluated with Aroclor 1242 or 1221). 
There were no changes in plasma corticosteroids in rats fed #1.5 mg/kg/day Aroclor 1242 for 2–6 months
or in adrenal weight in rats fed 100 mg/kg/day Aroclor 1242 for 3 weeks (Bruckner et al. 1973, 1974).  In
another study (Miller et al. 1993b), no histopathological changes were observed in the adrenals from
Fischer 344 rats treated with up to 25 mg/kg/day Aroclor 1254 by gavage for 15 weeks.  Rao and Banerji
(1993), however, reported degenerative changes in the adrenals of Wistar rats treated with
$7.1 mg/kg/day Aroclor 1260 in the diet for 120 days.  The differing results from these two studies may
reflect differences in the congeneric composition of the Aroclors, in strains of animals, and/or in the
methods of administration.
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Adrenal weight was unchanged in rabbits fed #6.5 mg/kg/day Aroclor 1254 for 8 weeks (Street and
Sharma 1975), and adrenal cortex histology was normal in monkeys fed 0.2 mg/kg/day Aroclor 1254 for
12 months (Tryphonas et al. 1986a), but hormone evaluations were not performed.  Pigs treated with
9.2 mg/kg/day Aroclor 1242 for 91 days exhibited increased relative weight of the adrenals (Hansen et al.
1976).  No histological alterations were observed in adrenals from guinea pigs treated with
#4.0 mg/kg/day Aroclor 1260 in the diet for 8 weeks (Vos and de Roij 1972).  Monkeys treated with
dietary doses of #0.08 mg/kg/day Aroclor 1254 for up to 22 months showed no treatment-related changes
in serum hydrocortisone levels (Loo et al. 1989).  Histological examinations and higher doses were not
tested, and levels of other adrenal cortex hormones were not evaluated.  However, Arnold et al. (1997)
reported that Rhesus monkeys that received daily doses of 0.005, 0.020, 0.040, or 0.080 mg/kg/day
Aroclor 1254 for 72 months showed no effect on adrenal tissue.
No histopathologic changes were observed in the adrenal, pancreas, pituitary, or parathyroid glands of
male or female rats that were fed Aroclor 1016, 1242, 1254, or 1260 for 24 months at dose levels of
8.0–11.2, 4.0–5.7, 4.3–6.1, or 4.1–5.8 mg/kg/day, respectively (Mayes et al. 1998).  Serum parathyroid
hormone levels were not affected in rats treated with up to 25 mg/kg/day Aroclor 1254 for up to 15 weeks
(Andrews 1989).
Single Congeners.  Histopathologic evaluations of the adrenal glands, ovary, parathyroid, pancreas, and
pituitary revealed no treatment-related changes in rats that were exposed to single PCB congeners in food
for 13 weeks (Chu et al. 1994, 1995, 1996a, 1996b, 1998b; Lecavalier et al. 1997).  The highest dosages
in the studies were as follows: PCB 28, 3.8 (males) and 4.0 (females) mg/kg/day; PCB 77, 0.77 (males)
and 0.89 (females) mg/kg/day; PCB 105, 4.0 (females) and 4.3 (males) mg/kg/day; PCB 118,
0.17 (females) and 0.68 (males) mg/kg/day; PCB 126, 7.4 (males) and 8.7 (females) µg/kg/day; PCB 128,
4.2 (males) and 4.4 (females) mg/kg/day; and PCB 153, 3.5 (males) and 4.1 (females) mg/kg/day.  
Serum concentrations of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone
concentrations were measured in rats exposed for 13 weeks to PCB 28 or PCB 77 in food (Desaulniers et
al. 1997).  No changes, relative to the control group, were observed at doses of 500 µg/kg/day PCB 28 or
75 µg/kg/day PCB 77.  Acute intraperitoneal administration of PCB 126 in adult rats caused decreased
serum concentrations of T4 at $6.25 µg/kg/day, T3 at $25 µg/kg/day, LH at $100 µg/kg/day, and FSH at
400 µg/kg/day (Desaulniers et al. 1999).  Similar administration of PCB 153 caused an increase in serum
T4 and decrease in serum LH at a dose level of 25 mg/kg/day.
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Evaluation of Animal Studies.  Studies in animals, including rodents and nonhuman primates, provide
strong evidence of thyroid hormone involvement in PCB toxicity.  Although the studies differ in design
and, the emerging picture is that, depending of dose and duration, PCBs can disrupt the production and
levels of thyroid hormones, both in the thyroid and in peripheral tissues, can interfere with their transport
to peripheral tissues, and can accelerate the metabolic clearance of thyroid hormones.  Exposure to PCBs
in utero and/or during early development (e.g., through breast milk) can deplete levels of circulating
thyroid hormones in the fetus or neonate, which may give rise to effectively a hypothyroid state during
development.  The most convincing evidence that PCBs can exert toxicity by disrupting thyroid hormone
system derives from two studies in rats.  In one study, neurobehavioral deficits in pups that experienced
exposures to Aroclor 1254 in utero and during nursing were significantly attenuated by subcutaneous
injections of T4 that increased serum T4 and T3 concentrations that were otherwise depressed in the PCB-
exposed animals (Goldey and Crofton 1998).  While this study examined relatively high doses of
Aroclor 1254 ($1 mg/kg/day), it nevertheless demonstrated neurodevelopmental effects that are directly
relevant to observations made in epidemiological studies and to neurological sequelae of fetal
hypothyroidism, including disturbances of motor function and hearing.  In the second study, increased
testes weight and sperm production in rats that were administered Aroclor 1254 on postnatal days 1–25
were attenuated by injections of T4 on postnatal days 1–25, which also prevented the depression in serum
T4 concentrations (Cooke et al. 1996).  Here again, although produced by relatively large doses of
Aroclor 1254 (.40 mg/kg/day, subcutaneous), similar effects can be produced by other hypothyroid-
inducing agents, including 6-propyl-2-thiouracil (PTU).  Furthermore, the effects observed may reflect a
disruption of the normal sexual maturation process, which is known to be associated with neonatal
hypothyroidism in humans (Longcope 2000).
Certain PCBs or certain exposures to PCBs may increase serum T4 levels at low doses and decrease serum
T4 in a dose-dependent manner at higher doses (Gould et al. 1997; Li and Hansen, 1996b; Li et al. 1994,
1998).  This effect may reflect stimulation of the thyroid gland as suggested by concurrent morphological
changes in the thyroid follicles. 
Other effects of PCBs on endocrine function that have been observed in experimental animals include
effects on the adrenal glands and serum adrenal steroid levels (Byrne et al. 1988; Kato et al. 1982a; Miller
et al. 1993b; Rao ad Banerji 1993; Sanders et al. 1974; Wasserman et al. 1973).  Studies that have shown
depressed levels of adrenal cortical steroids in PCB-exposed animals are also relevant because depressed
levels of adrenal steroids have been associated with hypothyroidism in humans (Dluhy 2000).  In
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Chloracne and other dermal alterations are well known markers of exposure to PCBs and structurally-
related halogenated aromatic hydrocarbons.  Chloracne and other dermal alterations have been reported in
subjects occupationally exposed to PCBs and in individuals exposed by accidental ingestion of rice oil
contaminated with high concentrations of PCBs, CDFs, and related chemicals (Yusho and Yu-Cheng).  In
general, chloracne appears in individuals with serum PCB levels 10–20 times higher than those of the
general population, but there is great variability among individuals.  Therefore, chloracne is not a
sensitive marker of PCB exposure.  Long-term oral administration of relatively low doses of PCBs to
monkeys resulted in dermal alterations similar to those observed in humans exposed to high
concentrations of PCBs.  The dermal effects were observed in the monkeys at serum PCB levels not much
higher than serum PCB levels in humans with no known point source exposure to PCBs.  Offspring from
monkeys exposed during gestation and nursed by exposed mothers also developed dermal alterations after
a few weeks of suckling.   There are reports of rodents also developing skin alterations, but only after
high exposures to PCB.
3.2.2.9.2  Human Studies
3.2.2.9.2.1  Occupational Exposure  
Chloracne is the most easily recognized effect of exposure to PCBs and structurally-related chlorinated
organic chemicals (Rice and Cohen 1996).  Chloracne is a high-dose response in animals and humans;
and its presence in humans indicates exposure to PCBs and/or other chlorinated organic compounds, but
its absence does not preclude such exposure.  Furthermore, the variability of the response in more highly
exposed individuals suggests that susceptibility varies greatly among individuals.  Chloracne can first
occur on the face, particularly under the eyes and behind the ears.  With increasing exposure, the rest of
the face and neck, upper arms, chest, back, abdomen, outer thighs, and genitalia may be affected.  When
severe, chloracne can cover the entire body.  Clinically, changes vary from an eruption of comedones to
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the occurrence of papules and pustules.  Histologically, the lesions consist of keratinous cysts caused by
squamous metaplasia of sebaceous glands.  The acute stage is followed by vermiculite skin atrophy.  
Mild to moderate chloracne was observed in 7 of 14 workers exposed to 0.1 mg/m3 Aroclors (formulation
not specified) for an average duration of 14.3 months (Meigs et al. 1954).  Because PCBs were used as a
heat exchange material, it is possible that the workers were exposed to such pyrolysis products as CDFs.
In these workers, the chloracne was found primarily on the face, especially the cheeks, forehead, and ears. 
Three cases of chloracne occurred among an unspecified number of autoclave operators exposed to
5.2–6.8 mg/m3 Aroclor 1254 for 4–7 months in 1954 (Bertazzi et al. 1987), but pyrolytic formation of
CDFs is a confounding factor.  In 1977, four more cases of chloracne were diagnosed among 67 workers
from the same plant who were engaged in impregnating capacitors with Pyralene 3010
(0.048–0.275 mg/m3) and had skin contact confirmed as a major exposure route.  An increased incidence
of nonadolescent acneform eruptions was reported in workers exposed to 0.007–11 mg/m3 mean
concentrations of various Aroclors for >5 years; 40% of the workers were exposed for >20 years
(Fischbein et al. 1979, 1982).  Maroni et al. (1981a, 1981b) reported 10 cases of acne and/or folliculitis
and 5 cases of dermatitis among 80 capacitor manufacturing workers examined in Italy.  All of the
workers with chloracne were employed in high exposure jobs.  Their blood PCB concentrations ranged
from 300 to 500 ppb.  
Other dermal effects reported in workers include skin rashes, pigmentation disturbances of skin and nails,
erythema and thickening of the skin, and burning sensations (Fischbein et al. 1979, 1982; Ouw et al.
1976, 1982; Smith et al. 1982).  In these studies, the workers were exposed to various Aroclors at levels
as low as 0.003 mg/m3 for >5 years.  Statistically significant associations between dermatologic effects
and plasma levels of higher chlorinated PCB congeners have been reported (Fischbein et al. 1979, 1982;
Smith et al. 1982).  No relationships between the incidence of skin rash or dermatitis and plasma levels of
lower chlorinated PCBs were found (Smith et al. 1982).
3.2.2.9.2.2  Accidental Exposure
Effects in the skin were widely reported among victims of the Yusho and Yu-Cheng poisoning episodes
exposure (Guo et al. 1999; Kuratsune 1989; Lu and Wu 1985; Rogan 1989).  It is important to mention,
however, that the findings from the studies of these groups cannot be attributed solely to exposure to
PCBs since the victims also were exposed to CDFs and other chlorinated chemicals (ATSDR 1994). 
Characteristic skin changes included marked enlargement, elevation and keratotic plugging of follicular
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orifices, comedo formation, acneform eruptions, hyperpigmentation, hyperkeratosis, and deformed nails. 
The acne most commonly developed on the face and other parts of the head, axillae, trunk, and external
genitalia, with follicular plugging occurring in the axillae, groin, glenoid regions such as elbow and knee
flexures, trunk, thigh, and outer aspect of the forearm.  Dark-colored pigmentation frequently occurred in
the gingival and buccal mucosa, lips, and nails, and improved only gradually in most patients (Fu 1984;
Kuratsune 1989; Lu and Wu 1985; Rogan 1989).   Improvement of the dermal changes was gradual. 
Evaluation of Yu-Cheng subjects 14 years after the poisoning incident showed that men and women
exposed to PCBs/PCDFs had a higher lifetime prevalence of chloracne, abnormal nails, hyperkeratosis,
and gum pigmentation (Guo et al. 1999).  Skin lesions were commonly observed in children born to
mothers with Yusho or Yu-Cheng exposure.  The dermal changes are consistent with those observed in
exposed adults and included hyperpigmentation of the skin, nails and gingivae, deformed nails, and acne
(Funatsu et al. 1971; Gladen et al. 1990; Hsu et al. 1985; Rogan et al. 1988; Taki et al. 1969; Yamaguchi
et al. 1971; Yoshimura 1974).  These effects generally diminished as the babies grew older. 
3.2.2.9.2.3  Evaluation of Human Studies
There is conclusive evidence that exposure to high concentrations of PCBs (and other chlorinated
hydrocarbons) induce adverse dermal effects in humans.  A typical dermal sign of exposure is chloracne
and is generally present in individuals with blood PCB levels several times higher than background levels
as observed among capacitor workers in the past and in Yusho and Yu-Cheng victims (Fischbein et al.
1979, 1982; Guo et al. 1999; Hsu et al. 1994; Maroni et al. 1981a, 1981b; Masuda 1994).  It is generally
accepted that chloracne is induced by exposure to dioxin-like substances (ATSDR 1998); therefore, the
contribution of PCBs to this effect in Yusho and Yu-Cheng was probably minor compared to that of
CDFs, which were the main contributors to the total dioxin TEQs of the rice oil.  High incidence of
chloracne was seen among Yu-Cheng victims 14 years after exposure, at a time when the body burden of
PCBs and CDFs was still considerably higher than local controls (Guo et al. 1997).  No adverse dermal
effects have been reported in subjects with high consumption of Great Lakes fish contaminated with
PCBs and other environmentally persistent chemicals or in other cohorts from the general population,
although it is unknown if this outcome was systematically studied in these cohorts.
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3.2.2.9.3  Animal Studies
The highest NOAEL values and all reliable LOAEL values for dermal effects for each study are recorded
in Tables 3-2 and 3-3, and plotted in Figure 3-2.
Oral Exposure    
Commercial Mixtures.  Very limited information is available regarding dermal effects of commercial
PCB mixtures following acute-duration oral exposure.  Skin histology was normal in rats that were
treated with a single gavage dose of 4,000 mg Aroclor 1242/kg and evaluated after 24 hours, no follow-
up observations were conducted (Bruckner et al. 1973).  Treatment of rats with 100 mg
Aroclor 1242/kg/day by gavage every other day for 3 weeks did not result in histological alterations in the
skin (Bruckner et al. 1973).  Rats exposed in the diet to 2.5 mg/kg/day Aroclor 1254 for 104 weeks or to
5 mg/kg/day for 72 weeks developed alopecia and facial edema (NCI 1978); these effects did not occur
after 104 weeks at 1.25 mg/kg/day.  No histopathologic changes were observed in the skin of rats that
were fed Aroclor 1016, 1242, 1254, or 1260 for 24 months at dose levels of 8.0–11.2, 4.0–5.7, 4.3–6.1, or
4.1–5.8 mg/kg/day, respectively (Mayes et al. 1998).  Guinea pigs fed a diet that provided up to
approximately 4 mg Aroclor 1260/kg/day for 8 weeks showed no treatment-related gross or microscopical
alterations of the skin (Vos and de Roij 1972).  Mice treated with 26 mg Aroclor 1254/kg/day in the diet
for 23 weeks developed erythema, altered sebaceous gland differentiation, and thickening with occasional
hyperkeratosis and cysts in the pinna; other skin areas were not examined (Bell 1983).
Dermal effects were reported in Rhesus monkeys fed diets containing Aroclors for intermediate durations
(Allen and Norback 1973, 1976; Allen et al. 1973, 1974a; Barsotti et al. 1976; Becker et al. 1979; Ohnishi
and Kohno 1979; Thomas and Hinsdill 1978).  These include facial edema (particularly in the periorbital
area), acne, folliculitis, and alopecia.  The effects appear to be reversible and have been produced by
estimated doses as low as 0.1 mg/kg/day Aroclor 1248 for 2 months (Barsotti et al. 1976) and
0.12 mg/kg/day Aroclor 1242 for 2 months (Becker et al. 1979).  NOAELs for these effects in monkeys
cannot be identified from the available studies.  Chronic dietary treatment with 0.1 mg
Aroclor 1248/kg/day for 12 months (Allen and Norback 1976) or 0.2 mg/kg/day Aroclor 1254 for
12–28 months (Arnold et al. 1990; Tryphonas et al. 1986a, 1986b) produced progressive dermal effects in
monkeys, including alopecia, periorbital edema, acne, fingernail loss, and gingival hyperplasia and
necrosis of varying severity (Tryphonas et al. 1986b).  The same group of investigators also reported
fingernail and toenail changes in monkeys during treatment with as little as 0.005 mg/kg/day
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Aroclor 1254 over a 37-month period or 0.04 mg/kg/day over a 72-month period (Arnold et al. 1993a,
1997).  Offspring from Rhesus monkeys treated before mating and during gestation with 0.03 mg
Aroclor 1016/kg/day showed hyperpigmentation (Barsotti and Van Miller 1984).  Doses even smaller of
Aroclor 1254 (0.005 mg/kg/day) produced clear signs of PCB intoxication manifested as inflammation
and/or enlargement of the tarsal glands, and nail and gum lesions (but not acne or hyperpigmentation) in
monkeys exposed during gestation and via breast milk for 22 weeks (Arnold et al. 1995, 1997).  Most of
these alterations were seen after the infants had been weaned.  The concentration of PCBs in breast milk
from dams treated with 0.005 mg/kg/day ranged from 5.6 to 15.6 ppm.  The geometric mean
concentration of PCBs in the blood of these infants after 22 weeks of nursing was 47 ppb (Arnold et al.
1995).
Single Congeners.  Treatment of female and male weanling Sprague-Dawley rats for 90 days with several
PCB congeners in the diet, both dioxin-like and nondioxin-like (PCBs 28, 77, 105, 118, 126, 128, 153),
did not result in any treatment-related histological alterations in the skin (Chu et al. 1994, 1995, 1996a,
1996b, 1998a, 1998b; Lecavalier et al. 1997).  Doses ranged from 0.009 mg/kg/day for the dioxin-like
PCB 126 to approximately 4 mg/kg/day for some mono- and di-ortho-substituted congeners.
Dermal Exposure    
Commercial Mixtures.  Skin appearance and histology was normal in three hairless mice dermally treated
with Aroclor 1254 in estimated doses of up to 136 mg/kg/day on 4 days/week for 6 weeks (Puhvel et al.
1982).  Aroclor 1254 was applied in either pure acetone or in acetone-mineral oil emulsion; few
experimental details were provided in this study.  Dermal effects were produced by application of
Aroclor 1260 in an isopropanol vehicle to the shaved back skin of female New Zealand rabbits
5 days/week for 28 or 38 days at estimated doses of 42–44 mg/kg/day (Vos and Beems 1971; Vos and
Notenboom-Ram 1972).  Effects included thickening of the skin and acneform lesions resulting from
hyperplasia and hyperkeratosis of the epidermal and follicular epithelium. 
3.2.2.9.4  Evaluation of Animal Studies
PCB-related cutaneous effects are well characterized in monkeys after long-term oral exposure to
commercial PCB mixtures and are generally similar to those observed in humans.  Infant monkeys
exposed in utero and via breast milk also developed similar dermal lesions.  Chronic-duration oral
exposure studies in monkeys showed that adverse dermal effects can occur at dose levels lower than had
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been previously observed (Arnold et al. 1993a, 1993b, 1995, 1997).  It should be pointed out that dermal
effects in monkeys appeared with doses that resulted in tissue (5 ppm) and blood levels (10 ppb) of PCBs
near background concentrations found in the general human population.  In general, adverse cutaneous
effects in rodents followed exposure to relatively high oral doses of PCBs.  The series of studies with
single congeners by Chu and coworkers found no significant dermal effects at the dose levels tested, and
no conclusions regarding a potential ranking for dermatotoxicity of congeners can be drawn based on
these studies (Chu et al. 1994, 1995, 1996a, 1996b, 1998a, 1998b; Lecavalier et al. 1997). 
3.2.2.10  Ocular Effects
3.2.2.10.1  Summary
Along with dermal alterations, adverse ocular effects are markers of exposure to PCBs and structurally-
related halogenated aromatic hydrocarbons.  Ocular effects consisting primarily of hypersecretion of the
Meibomian glands and abnormal pigmentation of the conjunctiva have been reported in subjects
occupationally exposed to PCBs and in individuals exposed by accidental ingestion of rice oil
contaminated with high concentrations of PCBs, CDFs, and related chemicals (Yusho and Yu-Cheng).  In
general, these effects appear in individuals with serum PCB levels 10–20 times higher than those of the
general population, but there is great variability among individuals.  Long-term oral administration of
relatively low doses of PCBs to monkeys resulted in ocular alterations similar to those observed in
humans exposed to high concentrations of PCBs.  The ocular effects were observed in the monkeys at
serum PCB levels not much higher than serum PCB levels in humans with no known high exposure to
PCBs.  Offspring from monkeys exposed during gestation and nursed by exposed mothers developed
similar ocular alterations after a few weeks of suckling.  
3.2.2.10.2  Human Studies
3.2.2.10.2.1  Occupational Exposure  
The primary ocular effects reported by workers exposed to airborne PCBs were eye irritation, tearing, and
burning (Emmett et al. 1988a; Ouw et al. 1976; Smith et al. 1982).  The workers had been exposed to a
variety of Aroclors at concentrations between 0 and 2.2 mg/m3 for >3 years.  A significant relationship
between the incidence of irritated, burning eyes and plasma levels of higher and lower chlorinated PCB
congeners has been found (Smith et al. 1982).  Emmett et al. (1988a) suggested that because PCBs have
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low volatility and are relatively nonirritating, 1,1,1-trichloroethane used to clean up spills or
trichlorobenzene in Askarel may have been responsible for the complaints.
An ocular examination of 181 workers at a capacitor manufacturing plant revealed a 13% prevalence of
edema of the upper eyelid, congestion or hyperemia of conjunctiva, eye discharge, and enlargement of
Meibomian glands following exposure to 0.007–11 mg/m3 mean concentrations of various Aroclors for
>5 years (Fischbein et al. 1985).  The median blood value of lower homologues of PCBs was
approximately 60 ppb and of the higher homologues, 18 ppb.  There was no significant association
between ocular abnormalities and blood concentrations of PCBs (Fischbein et al. 1985).  
3.2.2.10.2.2  Accidental Exposure
In addition to dermal effects, ocular effects were the most obvious manifestations of Yusho and Yu-Cheng
exposure  (Fu 1984; Kuratsune 1989; Lu and Wu 1985; Rogan 1989).  As previously mentioned, victims
of these poisoning episodes also were exposed to CDFs and other chlorinated chemicals (ATSDR 1994). 
Hypersecretion of the Meibomian glands and abnormal pigmentation of the conjunctiva were commonly
observed (Masuda 1994).  Typical cases showed swollen Meibomian glands filled with yellow infarct-
like contents.  Abnormal changes in the Meibomian glands as well as eye discharge were still seen
10 years after the poisoning incident (Kono and Yamana 1979).  The incidence of ocular signs was
closely related to PCB concentrations and patterns in blood.  Babies born to Yusho mothers also had
increased eye discharge.  Similar findings were seen in children born to Yu-Cheng mothers who also
showed high incidence of conjunctivitis, swelling of the eyelid, and eye discharge (Rogan et al. 1988).
3.2.2.10.2.3  Evaluation of Human Studies
There is sufficient evidence that exposure to high concentrations of PCBs (and other chlorinated
hydrocarbons) induce adverse ocular effects in humans.  Typical responses include hypersecretion of the
Meibomian glands and abnormal pigmentation of the conjunctiva.  This has been observed among
capacitor workers (Fischbein et al. 1985) and in Yusho and Yu-Cheng victims (Hsu et al. 1994; Kono and
Yamana 1979; Kuratsune 1989; Masuda 1994; Rogan et al. 1988).  The contribution of PCBs to this
effect in Yusho and Yu-Cheng is unknown since the victims also were exposed to CDFs and other
structurally-related chemicals.  In the occupationally-exposed subjects described by Fischbein et al.
(1985), PCBs seemed to have been responsible for the high incidence of ocular effects since there was no
apparent exposure to CDFs or similar chemicals, although such possibility could not be completely ruled
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out.  No adverse ocular effects have been reported in subjects with high consumption of Great Lakes fish
contaminated with PCBs and other environmentally persistent chemicals or in other cohorts from the
general population, although it is unknown if this outcome was systematically studied in these cohorts.
3.2.2.10.3  Animal Studies
The highest NOAEL values and all reliable LOAEL values for ocular effects for each study are recorded
in Table 3-2 and plotted in Figure 3-2.
Oral Exposure    
Commercial Mixtures.  Ocular effects were commonly observed in Rhesus monkeys fed diets containing
Aroclors for intermediate durations (Allen and Norback 1973, 1976; Allen et al. 1973, 1974a; Barsotti
et al. 1976; Becker et al. 1979; Ohnishi and Kohno 1979; Thomas and Hinsdill 1978).  The effects
consisted of swelling and reddening of the eyelid and eyelid discharge.  Females appear to be more
sensitive than males.  The effects appear to be reversible and have been produced by estimated doses as
low as 0.1 mg/kg/day Aroclor 1248 for 2 months (Barsotti et al. 1976) and 0.12 mg/kg/day Aroclor 1242
for 2 months (Becker et al. 1979).  NOAELs for these effects in monkeys were not identified in the
available studies.  Monkeys exposed to 0.005–0.08 mg/kg/day Aroclor 1254 for 37 months showed
characteristic dose-related ocular and dermal effects, including eye exudate, inflammation and/or
prominence of the tarsal (Meibomian) glands, and various finger and toe nail changes (Arnold et al.
1993a).  Eye inflammation is a result of metaplastic changes in the Meibomian glands, which cause the
glands to be come keratinaceous.  Conjunctivitis was observed in Rhesus monkeys treated in the diet with
0.2 mg/kg/day Aroclor 1254 for 12 months (Tryphonas et al. 1986a).  Exophthalmia was observed in rats
treated in the diet with 2.5 mg/kg/day Aroclor 1254 for 104–105 weeks (NCI 1978); a dietary level of
1.25 mg/kg/day Aroclor 1254 was a NOAEL.  No histopathologic changes were observed in the eye of
male or female rats that were fed Aroclor 1016, 1242, 1254, or 1260 for 24 months at dose levels of
8.0–11.2, 4.0–5.7, 4.3–6.1, or 4.1–5.8 mg/kg/day, respectively (Mayes et al. 1998).  
Single Congeners.  Treatment of female and male weanling Sprague-Dawley rats for 90 days with several
PCB congeners in the diet, both dioxin-like and nondioxin-like (PCBs 28, 77, 105, 118, 126, 128, 153),
did not result in any treatment-related histological alterations in the eye or optic nerve (Chu et al. 1994,
1995, 1996a, 1996b, 1998b; Lecavalier et al. 1997).  Doses ranged from 0.009 mg/kg/day for the dioxin-
like PCB 126 to approximately 4 mg/kg/day for some mono- and di-ortho-substituted congeners.
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3.2.2.10.4  Evaluation of Animal Studies
PCB-induced ocular effects are well characterized in monkeys after long-term oral exposure to
commercial PCB mixtures and are generally similar to those observed in humans.  Infant monkeys
exposed in utero and via breast milk also developed similar ocular lesions (Arnold et al. 1995).  Chronic-
duration oral exposure studies in monkeys showed that adverse ocular and dermal effects occurred at
doses of 0.005 mg/kg/day (Arnold et al. 1993a, 1993b, 1995, 1997).  Because these effects occurred at the
lowest tested dose of any PCB mixture in any species, they are used as part of the basis for the chronic-
duration MRL for oral exposure as discussed in Chapter 2 and Appendix A.  It is worth mentioning that
ocular effects appeared in monkeys given PCB doses that resulted in tissue (5 ppm) and blood levels
(10 ppb) of PCBs near background concentrations found in the general human population.  The series of
studies with single congeners by Chu and coworkers found no significant effects in the eye and optic
nerve at the dose levels tested and no conclusions regarding a potential ranking for oculotoxicity of
congeners can be drawn based on these studies (Chu et al. 1994, 1995, 1996a, 1996b, 1998; Lecavalier et
al. 1997). 
3.2.2.11  Body Weight Effects
3.2.2.11.1  Human Studies
No studies were located regarding body weight effects in humans after exposure to PCBs.
3.2.2.11.2  Animal Studies
A number of animal studies have shown that inhalation, oral, or dermal exposure to PCBs results in
decreases in body weight gain.  Body weight gain was decreased in guinea pigs and mice that were
intermittently exposed to 5.4 mg/m3 Aroclor 1254 over 121 days or in guinea pigs exposed to 1.5 mg/m3
Aroclor 1254 over 213 days (Treon et al. 1956).  Exposure-related changes in body weight were not
observed in rats or rabbits that were similarly exposed to 1.5 or 5.4 mg/m3 Aroclor 1254 or to 8.6 mg/m3
Aroclor 1242 over 24 days.  The concentrations of PCBs are uncertain due to an invalid analytical
technique and differential evaporation of the most volatile PCB congeners.  A decrease in body weight
gain was also observed in rats exposed to 0.009 mg/m3 Aroclor 1242 for 30 days (Casey et al. 1999); the
rate of body weight gain was 33% as compared to 39% in controls.
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Reduced body weight (or reduced weight gain) is a characteristic effect of oral exposure to PCBs in
animals.  Acute-duration studies have shown moderate to severe weight decreases in rats following a
single gavage dose of $4,000 mg/kg Aroclor 1242 or dietary administration of 50 mg/kg/day
Aroclor 1254 for 14 days (Bruckner et al. 1973; Kling et al. 1978).  No significant effect on weight gain
was reported in rats administered up to 25 mg/kg/day Aroclor 1254 in several acute-duration studies
(Brown and Lamartiniere 1995; Carter 1984, 1985; Carter and Koo 1984) or in rats administered four
daily doses of 25 mg/kg of Aroclor 1221 (Brown and Lamartiniere 1995).  The weight loss following
single high doses appears to be due to dehydration (Bruckner et al. 1973).  Effects on animal body weight
are often pronounced following intermediate- and chronic-duration dietary administration, constituting a
wasting syndrome.  Decreases in body weight or body weight gain relative of different toxic doses have
been observed with various species and Aroclor mixtures, including rats and minks fed Aroclor 1254
(Andrews 1989; Bleavins et al. 1980; Gray et al. 1993; Hornshaw et al. 1986; Kimbrough et al. 1972;
Kling et al. 1978; Mayes et al. 1998; NCI 1978; Phillips et al. 1972), rats fed Aroclor 1260 (Kimbrough et
al. 1972), pigs fed Aroclor 1254 or 1242 (Hansen et al. 1976), and monkeys fed Aroclor 1242 or
1248 (Allen 1975; Allen and Norback 1976; Allen et al. 1973; Becker et al. 1979), but not Aroclor 1254
(Arnold et al. 1993a, 1993b, 1997; Tryphonas et al. 1986b).  The body weight from guinea pigs treated
with 4 mg/kg/day Aroclor 1260 for 187 days was not altered by treatment (Vos and de Roij 1972).  In
general, Aroclors administered to rats in doses of #5 mg/kg/day for intermediate durations did not
significantly affect body weight (Bruckner et al. 1974, 1977; Byrne et al. 1987; Goldstein et al. 1974;
Huang et al. 1998a, 1998b).  Rats that were fed Aroclor 1254 for 24 months at dose levels of
1.4–6.1 mg/kg/day had final body weights that were 12–28% lower than unexposed animals (Mayes et al.
1998).  Decreased body weight was also observed following similar exposure to Aroclor 1242 (10%
reduction at 5.7 mg/kg/day), but not to Aroclor 1016 (2.0–11.2 mg/kg/day) or Aroclor 1260
(1.0–5.8 mg/kg/day).  The existing data indicate that monkeys and minks may be particularly susceptible
species, as effect levels were higher in rats and adverse effects on body weight were not observed in
rabbits and mice fed Aroclor 1254 (Kimbrough and Linder 1974; Street and Sharma 1975).  Food and
water consumption were not measured in most of these studies, but in general decreases in food and water
intake were not sufficient to account for the decreases in body weight.  In swine and sheep fed
Aroclors 1242 and 1254 at 20 ppm in the diet, feed efficiency (unit gain/unit feed) were decreased about
the same degree as by diet variations (Hansen et al. 1976).
Body weight gain was not adversely affected in rats fed diets containing #4.1 mg/kg/day of
PCB 153 (Chu et al. 1996a), #4.2 mg/kg/day of PCB 128 (Lecavalier et al. 1997), #4.0 mg/kg/day of
PCB 105 (Chu et al. 1998b), #3.7 mg/kg/day of PCB 28 (Chu et al. 1996b), #0.77 mg/kg/day of
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PCB 77 (Chu et al. 1995), or #0.17 mg/kg/day of PCB 118 (Chu et al. 1995).  A significant decrease in
body weight gain was observed in rats fed diets containing 7.4 mg/kg/day of PCB 126 (Chu et al. 1994)
for 13 weeks.
A significant reduction in body weight gain was observed in rabbits that received estimated doses of
42–44 mg/kg of Aroclor 1260 in isopropanol 5 days/week for 28 or 38 days applied to the shaved back
skin (Vos and Beems 1971; Vos and Notenboom-Ram 1972).  These studies tested small numbers of
rabbits (four) and used Aroclor 1260 that had undetectable levels (<1 ppm) of CDFs.
The highest NOAEL values and all reliable LOAEL values for body weight effects for each study are
recorded in Tables 3-1, 3-2, and 3-3, and plotted in Figures 3-1 and 3-2.
3.2.2.12  Other Systemic Effects
Inhalation and oral exposure to Aroclor 1242 resulted in epithelial hyperplasia in the urinary bladders of
rats near continuously (23 hours/day) exposed to 0.009 mg/m3 or 0.033 mg/kg/day in the diet for 30 days
(Casey et al. 1999).  In contrast, no effects on the urinary bladder were reported in a study by Mayes et al.
(1998) involving chronic oral exposure to approximately #6 mg/kg/day Aroclor 1242, 1254, and 1260 or
#11 mg/kg/day Aroclor 1016.  Additionally, no urinary bladder effects were noted in a series of dietary
exposure studies on single PCB congeners in which rats were exposed to #4.1 mg/kg/day of
PCB 153 (Chu et al. 1996a), #4.2 mg/kg/day of PCB 128 (Lecavalier et al. 1997), #4.0 mg/kg/day of
PCB 105 (Chu et al. 1998b), #3.7 mg/kg/day of PCB 28 (Chu et al. 1996b), #0.77 mg/kg/day of
PCB 77 (Chu et al. 1995), #0.17 mg/kg/day of PCB 118 (Chu et al. 1995) or #7.4 mg/kg/day of
PCB 126 (Chu et al. 1994) for 13 weeks.
3.2.3 Immunological and Lymphoreticular Effects
3.2.3.1 Summary
Immunologic changes have been observed in human populations exposed to mixtures of PCBs and other
persistent toxic substances.  Alterations have been associated with consumption of contaminated fish and
other marine foods, consumption of contaminated rice oil in the Yusho and Yu-Cheng poisoning incidents,
and general environmental exposures.  Findings include increased susceptibility to respiratory tract
infections in adults and their children, increased prevalence of ear infections in infants, decreased total
3.  HEALTH EFFECTS - Immunological
PCBs 147
serum IgA and IgM antibody levels, and/or changes in T lymphocyte subsets.  Overall, there is a
consistency of effects among the human studies suggesting sensitivity of the immune system to PCBs,
particularly in infants exposed in utero and/or via breast feeding.  However, due to the mixed chemical
nature of the exposures and generally insufficient information on exposure-response relationships, the
human studies provide only limited evidence of PCB immunotoxicity.  In contrast to the human data,
immunotoxicity of PCBs has been documented in animals that were exposed via commercial mixtures,
mixtures of congeners analogous to human breast milk, Great Lakes fish, or single congeners.  Effects of
commercial PCBs in rats, mice, guinea pigs, and rabbits included morphological and functional changes,
such as thymic and splenic atrophy, reduced antibody production against foreign antigens, such as tetanus
toxoid and sheep red blood cells (SRBC), and increased susceptibility to microbial infection.  Oral studies
of commercial mixtures in monkeys confirm the observations in other species and further indicate that the
immune system of nonhuman primates is particularly sensitive to PCBs.  Suppressed antibody responses
to SRBCs is the parameter most consistently affected by PCBs in monkeys and have been observed in
adult animals, infants exposed during gestation and lactation, and infants exposed postnatally to a PCB
congener mixture simulating the congener content of human milk.  Immunological assessments of rodents
that were fed Great Lakes fish containing PCBs and other chemicals were generally limited although
some alterations were observed that are similar to those in animals exposed to commercial PCB mixtures.  
3.2.3.2  Human Studies
Occupational Exposures.  A limited amount of information is available on immunological end points in
PCB-exposed workers because assessments in most occupational studies were limited to routine clinical
measurements of white blood cell (WBC) counts and serum proteins and did not include assessment of
immunocompetence.  Total and differential WBC counts were determined in 194 capacitor plant workers
(152 males, 42 females) who were exposed to Aroclors 1254, 1242, and/or 1016 for an average duration
of 17 years (Lawton et al. 1985a).  Mean area air concentrations of PCBs were 0.69 mg/m3 in 1975 and
0.16 mg/m3 in 1983, and average personal time-weighted average (TWA) levels in 1977 were
0.17 mg/m3; all PCB use was discontinued in 1977.  Clinical examinations in 1976 showed some
elevations in total WBCs associated with decreased PMN cells and increased lymphocytes, monocytes,
and eosinophils.  In 1979, the WBC and lymphocyte counts were near normal and the increases in
monocytes and eosinophils were marginal, although there was a strong association between serum PCB
levels and monocyte counts.
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Other studies of PCB-exposed workers did not report any effects on total and differential WBC counts or
changes in serum albumin, globulin, and/or total proteins (Chase et al. 1982; Maroni et al. 1981b; Smith
et al. 1982).  These included studies of 86 men exposed to unreported levels of unspecified PCBs via
transformer fluids for an average of 17 years (Chase et al. 1982), 40 men and 40 women exposed mainly
to Pyralene 3010 or Apirolio (Italian PCB formulations containing 42% chlorine) at concentrations
ranging from 0.048 to 0.275 mg/m3 for an average duration of 12 years (Maroni et al. 1981b),
228 electrical equipment manufacturing workers exposed to Aroclor 1242 and 1016 (sex and exposure
duration not reported) at a median personal TWA air concentration of 0.081 mg/m3 (Smith et al. 1982),
and 14 and 25 electrical utility workers exposed to Askarel (Aroclor 1254 or 1260 either alone or in
combination with tri- or tetrachlorobenzenes) at personal TWA levels of 0.037–0.215 mg/m3 and
0.0031–0.0823 mg/m3, respectively (Smith et al. 1982).  Exposure durations and worker gender were not
reported in the Smith et al. (1982) study.
Delayed-type hypersensitivity was not affected in 55 transformer repairmen compared to 56 unexposed
workers who were matched for age, race, and marital status (Emmett et al. 1988a, 1988b).  The mean
length of employment of the exposed workers was 3.75 years, most (38) of the workers were currently
exposed to PCBs, and the predominant exposure was from Aroclor 1260.  Measurements of air PCB
levels at four work areas showed 8-hour TWA concentrations of 0.0167–0.024, 0.0032–0.007,
0.00001–0.0004, and 0.0007–0.0124 mg/m3.  The percentages of exposed and control workers with
positive skin responses to mumps antigen (92 vs. 89%) and trichophyton antigen (17 vs. 8%) were not
significantly different, and the mean diameters of the skin reactions were identical in the two groups. 
Other immunologic end points were not evaluated in the study, and none of the workers had clinical
manifestations typical of PCB poisoning.
Contaminated Fish Consumption.  Immunological parameters were compared in a group of 23 Swedish
men with high consumption of fatty fish species from the Baltic Sea and 20 men with virtually no fish
consumption (Svensson et al. 1994).  Evaluation of white cell counts, numbers of total lymphocytes and
their subsets, and serum immunoglobulin levels showed indications of reduced natural killer (NK) cell
activity.  The proportions and numbers of NK cells were marginally lower in the fisheaters than in the
nonconsumers, although the differences were not statistically significant (p>0.05), and the weekly intake
of fatty fish was negatively correlated with NK cell activity (r= -0.32, p<0.04).  Concurrent measurements
of blood PCBs were not performed.  Data from some of the subjects obtained 3 years prior to the study
showed weak negative correlations between numbers of NK cells and blood levels of PCB 126 and
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PCB 118, but a similar correlation was also found for p,pN-DDT.  Information on the presence and
incidence of infections was not reported.
Lymphocyte subsets were also evaluated in 68 Latvian fisherman who consumed fatty fish from the
Baltic Sea (Hagmar et al. 1995).  The study group was divided into groups of 19, 24, and 25 subjects with
low, intermediate, or high fish consumption (average 0.3, 3.3, and 12 meals/month, respectively).  PCBs
were not measured in the subjects or fish.  High fish consumption was correlated positively with B cell
numbers (r=0.41, p=0.0008) and CD4+/CD8+ ratios (r=0.40, p=0.001), but negatively with levels of
cytotoxic (CD8+) T cells (r= -0.38, p=0.002).
Information has been reported on infectious illnesses in breast-fed infants whose mothers consumed
contaminated Great Lakes fish (Smith 1984).  Seventy-three mother/infant pairs from Sheboygan,
Wisconsin were divided into three groups:  women who breast-fed and ate Lake Michigan or Sheboygan
River fish at least twice a month for $3 years (Group 1, 23 pairs); women who breast-fed and ate Lake
Michigan or Sheboygan River fish not more than twice a year for #3 years (Group 2, 39 pairs); and
women who bottle-fed and ate Lake Michigan or Sheboygan River fish at least twice a month for
$3 years (Group 3, 11 pairs).  Mean PCB concentrations in maternal serum (5.48–5.76 ppb) and breast
milk fat (1.13–1.14 ppm) were similar among the three exposure groups and at two postnatal sampling
times (during the second month and at 4 months of age); PCB levels in maternal serum during pregnancy
or in umbilical cord blood were not determined.  There were no significant group differences in the mean
number of infectious illnesses (colds, earaches, and flu symptoms) during the first 4 months of life.  The
number of infectious illnesses in the infants (r=0.33, p=0.03) was positively and significantly associated
with maternal serum PCB level, although infant illnesses had a weak but significantly negative
association with breast milk PCBs.  Possible associations between infectious illnesses and other chemicals
in the fish were not investigated.
Susceptibility to infections and immune status was studied in 98 breast-fed and 73 bottle-fed Inuit
(Eskimo) infants from Arctic Quebec, Canada (Dewailly et al. 2000).  The Inuits have high body burdens
of various organochlorine compounds (2–10 times higher than those of southern Quebec populations) due
to high consumption of marine foods, particularly sea mammal fat.  Concentrations of PCBs and other
chlorinated pesticides or metabolites were measured in early breast milk fat and used as an index of
prenatal exposure to these substances;  p,p’-DDE showed the highest mean concentration (962 ppb),
followed by PCBs (621 ppb; sum of congeners 138, 153, and 180), hexachlorobenzene (107 ppb),
dieldrin (30 ppb), and mirex (14 ppb) (Dewailly et al. 1993).  Prenatal organochlorine exposure was not
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determined in the bottle-fed infants.  The number of infectious disease episodes and status of
immunologic parameters  (WBCs, total lymphocytes and lymphocyte subsets, serum immunoglobulins)
were evaluated during the first year of life.  Acute otitis media was the most frequent health problem
during the first year of life, with 80.0% of ever breast-fed and 81.3% of bottle-fed infants experiencing at
least one episode.  Relative risk (RR) analysis by follow-up period and number of episodes showed
associations between increasing prenatal exposure to organochlorine compounds and otitis media that
were more consistent for hexachlorobenzene and p,p’-DDE than PCBs.  For example, although RRs of
experiencing at least one episode of otitis media during the first year of life were similar for
hexachlorobenzene (RR, 1.49; 95% CI, 1.10–2.03), p,p’-DDE (RR, 1.52; CI, 1.05–2.22), and PCBs (RR
1.28; CI, 0.92–1.77) for the highest tertile of prenatal exposure compared to the lowest tertile, the RR of
recurrent otitis media ($3 episodes) was 1.49 (95% CI, 1.10–12.56), 3.48 (CI, 0.86–14.11), and 1.65 (CI,
0.49–5.57), respectively.  However, because these and other detected organochlorine compounds
originated from the same few food items and have concentrations in breast milk that are correlated with
each other due to similar properties such as lipid solubility and persistence, the results precluded
identification of which compounds could be responsible for the increased susceptibility to otitis media. 
Immunologic parameters that were significantly lower in the breast-fed babies compared to the bottle-fed
group included numbers of WBCs and lymphocytes (CD4 subtype) at 3 months of age, and serum IgA
concentrations at 7 and 12 months of age; CD4/CD8 lymphocyte ratios (helper T-cells/cytotoxic T-cells)
were also reduced in the breast-fed infants at 7 and 12 months of age, although the change did not reach
statistical significance.  None of the immune parameters were associated with prenatal organochlorine
exposure.
Yusho and Yu-Cheng Exposures.  Clinical observations strongly suggest that Yusho and Yu-Cheng
patients experienced frequent or more severe skin and respiratory infections and lowered resistance to
illness (Kuratsune 1989; Nakanishi et al. 1985; Rogan 1989; Shigematsu et al. 1971).  Children born to
mothers who had Yu-Cheng disease had higher prevalence of bronchitis or pneumonia at 6 months of age,
respiratory tract infections at 6 years of age, and middle ear infections at 6–14 years of age (Chao et al.
1997; Yu et al. 1998).  Total serum levels of IgA and IgM, but not IgG, were reduced in Yusho and
Yu-Cheng patients (Chang et al. 1981; Shigematsu et al. 1971).  Other assessments of Yu-Cheng patients
found various other immunologic changes, including lower percentages of monocytes and PMN
leukocytes with immunoglobulin and complement receptors, reduced T lymphocytes apparently due to
reduced T-helper/inducer cells, and suppressed dermal delayed-type hypersensitivity responses to
streptokinase/streptodornase antigen mixtures tested 1 year after exposure and tuberculin antigen tested
4 years after exposure (Chang et al. 1981, 1982a, 1982b; Lu and Wu 1985).  Lymphoproliferative
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responses of peripheral lymphocytes to T-cell mitogens (PHA, pokeweed mitogen [PWM], and
tuberculin) were significantly enhanced in Yu-Cheng patients (Lu and Wu 1985).  
General Population Exposures.  Immunologic effects of pre- and postnatal environmental exposure to
PCBs and dioxins were assessed in a subgroup of 55 infants (Weisglas-Kuperus et al. 1995) from the
Dutch Mother-Child study summarized in Section 3.2.4.2.1.2 (Neurological Effects).  Prenatal
PCB/dioxin exposure was estimated by the sum of PCB congeners 118, 138, 153, and 180 in maternal
blood during the last month of pregnancy and the total TEQ level in maternal milk (17 dioxin and
8 dioxin-like PCB congeners), and postnatal exposure was calculated as a product of the total TEQ level
in human milk multiplied by the weeks of breast-feeding.  No correlation was found between pre- or
postnatal exposure and the number of episodes of rhinitis, bronchitis, tonsillitis, and otitis during the first
18 months of life, or with humoral immunity as evaluated by antibody levels to mumps, measles, and
rubella at 18 months of age (infants were immunized at 14 months of age).  Determination of monocyte,
granulocyte, and lymphocyte counts in cord and venous blood at 3 and 18 months of age showed that a
higher prenatal as well as postnatal PCB/dioxin exposure was associated with lower monocyte and
granulocyte counts at 3 months of age, and that a higher prenatal exposure was associated with increased
total numbers of T-lymphocytes and several T-cell subpopulations (CD8+, TcRαβ+, and TcRγδ+) at
18 months of age.  There were no significant associations between postnatal PCB/dioxin exposure and
T cell markers at 18 months of age.  Although there were differences in the leukocyte subpopulation
between high and low PCB/dioxin-exposed infants, all values were within the normal range (Weisglas-
Kuperus et al. 1995).  Follow-up evaluations at 42 months of age, reported as a study abstract, found that
prenatal PCB exposure was associated with increased T cell numbers and lower antibody levels to
mumps, measles, and rubella (Weisglas-Kuperus 2000).  Additionally, a higher prevalence of recurrent
middle ear infections and chicken pox and a lower prevalence of allergic reactions was reported to be
associated with PCB body burden at 42 months of age.  
Evaluation of Human Studies.  Limited information on immunological effects of PCBs in humans is
available from studies of people exposed in the workplace, by consumption of contaminated fish and
other marine foods, by consumption of contaminated rice oil in the Yusho and Yu-Cheng poisoning
incidents, and via general environmental exposures.  A comparison of PCB levels in blood and breast
milk in some of these studies is included in Appendix A.
One study of PCB-exposed workers found no effects on delayed-type hypersensitivity skin reactions to
the mumps and trichophyton antigens (Emmett et al. 1988a, 1988b).  Other occupational studies reported
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no changes in serum albumin, globulin, and/or total proteins, although a transient effect on total and
differential WBC counts has been observed (Chase et al. 1982; Lawton et al. 1985a; Maroni et al. 1981b;
Smith et al. 1982).  Functional and other immunologic end points were not evaluated in any of the worker
studies, precluding an assessment of the potential for adverse immune effects following occupational
exposure.
The number of infant infectious illnesses (colds, earaches, and/or flu symptoms) during the first 4 months
of life were positively correlated with maternal serum PCB levels in a study of women who consumed
contaminated Great Lakes fish (Smith 1984), although other immunological end points and possible
associations with other chemicals in the fish were not investigated.  Susceptibility to infections was also
studied in infants of Inuit women who had elevated body burdens of PCBs and other organochlorine
chemicals due to high consumption of sea mammal fat (Dewailly et al. 2000).  Associations between risk
of acute otitis media and increasing organochlorine exposure (levels in breast milk) during the first year
of life were found, although the data are insufficient for identifying whether the effect may be due to
PCBs, hexachlorobenzene, p,p’-DDE, or other chemicals.  No statistically significant changes in
immunological indices were observed, although there were indications of reduced total serum IgA levels
and altered T-lymphocyte subpopulations in breast-fed Inuit infants at 7 and 12 months of age.
Immunotoxic effects have been documented in the Yusho and Yu-Cheng populations and include changes
consistent with those reported in the Inuit and Great Lakes populations, particularly increased middle ear
and respiratory tract infections in children of exposed mothers and changes in T lymphocytes and their
subsets (Chang et al. 1981, 1982a, 1982b; Chao et al. 1997; Kuratsune 1989; Lu and Wu 1985; Nakanishi
et al. 1985; Rogan 1989; Shigematsu et al. 1971; Yu et al. 1998).  The Dutch environmental exposure
study (Weisglas-Kuperus et al. 1995) also found some changes in lymphocyte T cell subpopulations in
infants (although all values were within the normal range), but the clinical significance of these alterations
is unclear because there was no significant correlation between the incidence of infection (otitis, rhinitis,
bronchitis, or tonsillitis) or antibody levels to common childhood vaccines (mumps, measles, or rubella)
during the first 18 months of life and pre- or postnatal exposure to PCBs and dioxins.  The human
populations that have been studied differ greatly with respect to sources of PCB exposure and
consequently are likely to vary with respect to both organochlorine contaminants and nutrient contents
which may affect susceptibility to infections.  Although the studies are insufficient for determining which
specific chemical(s) may be responsible for the observed alterations, the available data support a possible
association between PCBs and immune effects in humans that may be manifested as compromised ability
to overcome infections, particularly in infants exposed in utero and/or by breast-feeding.
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3.2.3.3  Animal Studies
The highest NOAEL values and all reliable LOAEL values for immunological and lymphoreticular
effects for each study are recorded in Tables 3-2 and 3-3, and plotted in Figure 3-2.
3.2.3.3.1  Inhalation Exposure
No studies were located regarding immunological or lymphoreticular effects in animals following
inhalation exposure to PCBs.
3.2.3.3.2  Oral Exposure
Commercial PCB Mixtures.  Information on the immunotoxicity of commercial PCBs in orally-exposed
animals is available from intermediate- and chronic-duration studies in various species.  Findings in
nonhuman primates are emphasized in the following summary because monkeys appear to be more
sensitive than other species and provide a better animal model due to phylogenetic and biologic
similarities to humans (Tryphonas 1994, 1995).
Aroclor 1260 and Similar Mixtures.  Immunological effects of 60% chlorinated PCB mixtures were
investigated in several guinea pig studies.  Dietary exposure to Aroclor 1260 for 8 weeks caused
decreases in gamma globulin-containing cells in popliteal lymph nodes following foot pad stimulation
with tetanus toxoid at estimated doses of 0.8 and 4 mg/kg/day (lower doses not tested), although the
magnitude of response was not dose-related.  Increased mesenteric lymph node weights were also
observed at $0.8 mg/kg/day, but there were no consistent changes in cervical lymph node weights or
serum levels of albumin or globulins.  Leukocyte counts and histology of the lymph nodes, thymus, and
spleen were unaffected (Vos and de Roij 1972).   Effects in guinea pigs that were fed 4 mg/kg/day
Clopen A-60 or Aroclor 1260 for 6 weeks included decreases in antibody titers (IgM and IgG) to tetanus
toxoid, skin (footpad) reactivity to tuberculin, leukocyte, and lymphocyte counts, and relative thymus
weight, with no effects occurring at 0.8 mg/kg/day of Clopen A-60 (low dose of Aroclor 1260 not tested)
(Vos and Van Driel-Grootenhuis 1972).
No changes in total or differential WBC counts or histology of the thymus, spleen, or lymph nodes were
found in male and female rats that were exposed to Aroclor 1260 at dietary doses as high as 4.1 and
5.8 mg/kg/day, respectively, for 24 months (Mayes et al. 1998).    
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Aroclor 1254 and Similar Mixtures.  Information on immunotoxicity of Aroclor 1254 is available from
oral studies in rats, mice, rabbits, and monkeys.  A number of significant effects on humoral and cell-
mediated parameters were found in rats.  Dietary exposure to Aroclor 1254 at estimated doses of 4.3 or
43 mg/kg/day for 10 weeks caused decreased serum total immunoglobulin G (IgG) antibody response to
keyhole limpet hemocyanin (KLH) antigen, decreased NK cell activity, and increased interleukin 2 (IL-2)
production by concanavalin A (ConA)-stimulated splenocytes in Sprague-Dawley male rats (Exon et al.
1985; Talcott et al. 1985).  Male F344 rats treated with Aroclor 1254 by gavage for 5–15 weeks had
reduced thymus weight and NK cell activity at 10 and 25 mg/kg/day, and increased PHA mitogen-
induced lymphocyte proliferation at 25 mg/kg/day; no significant effects were seen at #1 mg/kg/day.
(Smialowicz et al. 1989).  Enhanced responses to ConA, PWM, or Salmonella typhimurium mitogen
(STM) were not observed.  Decreased thymus weight and enhanced lymphoproliferative activity in
response to stimulation by PHA, but not PWM, were also observed in male Sprague-Dawley rats that
were fed Aroclor 1254 at an estimated dose of 21.5 mg/kg/day for 7 days (Bonnyns and Bastomsky
1976).  Thymus weight, WBC, and neutrophil counts were reduced in Sprague-Dawley rats fed an
estimated dose of 50 mg/kg/day Aroclor 1254 for 6 weeks (Allen and Abrahamson 1973); immune
function was not evaluated.  No changes in total or differential WBC counts or histology of the lymph
nodes, spleen, or thymus were found in male and female rats that were exposed to Aroclor 1254 at dietary
doses as high as 4.3 and 6.0 mg/kg/day, respectively, for 24 months (Mayes et al. 1998). 
Susceptibility to Moloney leukemia virus (MLV) was increased in male BALB/c mice that ingested
$4.9 mg/kg/day estimated dietary doses of Aroclor 1254 for 6 months; no effect was found at
0.5 mg/kg/day (lowest tested dose) (Koller 1977).  Similarly, susceptibility to mortality from herpes
simplex virus was increased in male ICR mice that ingested Kanechlor 500 in the diet for 21 days at
$33 mg/kg/day, but not at the lowest tested dose of 18 mg/kg/day (Imanishi et al. 1980).  Swiss-Webster
mice were fed Aroclor 1254 at doses of 1.2, 11.7, or 29.2 mg/kg/day for 12 weeks prior to mating with
exposure continuing throughout gestation and lactation  (Talcott and Koller 1983).  Immunologic
evaluation of the offspring at 8 weeks of age showed no significant effects on antibody titers to bovine
serum albumin (BSA), phagocytosis of SRBC (measured by ingestion by peritoneal macrophages in
vitro), or delayed-type hypersensitivity to oxazolone, although relative spleen weights were reduced at
29.2 mg/kg/day.  
Male New Zealand rabbits that were exposed to 0.18–6.44 mg/kg/day dietary doses of Aroclor 1254 for
8 weeks had no effects on several immunological end points, including hemolysin and hemagglutination
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titers against SRBC, gamma-globulin/transferrin ratio, and skin sensitivity to tuberculin, although
significant atrophy of the thymus occurred at all doses (Street and Sharma 1975).
Immunological effects of Aroclor 1254 in monkeys were first indicated in pilot studies of general toxicity
(Truelove et al. 1982; Tryphonas et al. 1986a).  Dietary ingestion of Aroclor 1254 in apple
juice-gelatin-corn oil emulsion at doses of 0.1 mg/kg/day (2 Cynomolgus monkeys) or 0.4 mg/kg/day
(1 monkey) for 238–267 days, beginning at approximately day 60 of gestation, caused a decreased
antibody response to SRBC in all treated animals compared to one control monkey (Truelove et al. 1982). 
No effect on antibody titers to tetanus toxoid was observed.  Both monkeys exposed to 0.1 mg/kg/day
delivered stillborn infants, and the 0.4 mg/kg/day monkey delivered a live infant which was nursed, but
failed to respond to SRBC and died at 139 days postpartum with acute confluent bronchopneumonia.
Groups of four Cynomolgus and four Rhesus monkeys ingested 0 or 280 µg/kg/day Aroclor 1254 in apple
juice-gelatin-corn oil emulsion on 5 days/week for 12–13 months and 27–28 months, respectively
(Tryphonas et al. 1986a).  Immunologic parameters that were evaluated included serum protein levels,
total serum IgG, IgA, and IgM, and antibody titers to SRBC.  Total serum IgM levels and anti-SRBC
(IgM) titers were reduced in both species. 
A subsequent series of tests on Aroclor 1254 was conducted in Rhesus monkeys because they appeared to
be more sensitive than Cynomolgus monkeys based on relatively greater severity of clinical signs and
higher blood and adipose PCB levels (Tryphonas et al. 1986a).  Groups of 16 female Rhesus monkeys
were orally administered Aroclor 1254 in capsules at doses of 0, 5, 20, 40, or 80 µg/kg/day, with
immunological assessments performed after 23 months (Tryphonas et al. 1989) when blood PCB steady-
state was established, and at 55 months (Tryphonas et al. 1991a, 1991b).  Average concentrations of
PCBs in the 0, 5, 20, 40, and 80 µg/kg/day dose groups around the time of immunologic testing were 0.1,
10.2, 34.0, 74.9, and 112 ppb, respectively, in blood and 0.4, 2.7, 9.0, 15.7, and 31.2 ppm, respectively, in
adipose tissue (Tryphonas et al. 1989).  Significant dose-related decreases in IgM (all doses except
0.02 mg/kg/day) and IgG (all doses) antibody titers to SRBC were found after 23 months.  Secondary
challenge with SRBC after 55 months showed decreasing dose-related trends in the IgM and IgG
anamnestic responses, although only IgM was significantly lower than controls at all dose levels.  Other
effects included alterations in lymphocyte T-cell subsets characterized by a significant decrease in the
ratio of T-helper/inducer (CD4) cells to T-suppressor/cytotoxic (CD8) cells, due to reduced CD4 and
increased CD8 cells, after 23 months at 80 µg/kg/day (not tested at lower doses).  No effects on total
lymphocytes or B-cells were found, indicating that T-cells were preferentially affected by the PCBs,
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although there were no exposure-related changes in T-cell subsets after 55 months suggesting that
adaptation had occurred.  Statistically significant dose-related trends, but no significant differences
between exposed and control groups, were observed after 55 months for decreasing lymphocyte
proliferation in response to mitogens (PHA and ConA, but not PWM), increasing NK cell activity,
increasing levels of serum thymosin alpha-1, decreasing phagocytic activity of peripheral blood
monocytes following activation with phorbol myristate acetate (PMA), and increasing total serum
complement activity.  End points that were not affected by PCB exposure included IgG antibody response
to pneumococcal antigens, total serum immunoglobulins (IgG, IgM, and IgA) levels, and other serum
proteins as well as serum hydrocortisone levels.
Offspring from the Rhesus monkeys studied by Tryphonas et al. (1989, 1991a, 1991b) were also
evaluated for immunological changes (Arnold et al. 1995).  Females were mated after 37 months of
exposure to 0, 5, 20, 40, or 80 µg/kg/day of Aroclor 1254.  The maternal dosing was continued
throughout pregnancy and into lactation until nursing infants were approximately 7 weeks old, and
treatment was restarted in the infants at weaning (22 weeks).  Immunological testing was initiated at
20 weeks of age although statistical evaluation was limited by small numbers of animals due to fetal and
postpartum deaths (see Section 3.2.5.3).  IgM and IgG antibody levels were determined 1–3 weeks
following immunization with SRBC at 20 and 60 weeks of age.  Significant reductions in IgM titers were
found at 5 and 40 µg/kg/day at weeks 22 and 23, and 5 µg/kg/day at weeks 61–63; IgM levels were
insignificantly reduced in the 40 µg/kg/day group at weeks 61–63.  IgG titers were significantly reduced
only in the 40 µg/kg/day group at week 22.  Other immunological tests were performed at 20, 28, and
60 weeks of age and included assays for lymphocyte proliferation (in response to stimulation by PHA,
ConA, or PWM mitogens or leucocyte stimulator cells) and NK cell activity; the only significant finding
was a decreased lymphocyte proliferation response at 40 µg/kg/day at weeks 28 and 60.
Aroclor 1248.  Immune responses to Aroclor 1248 were investigated in oral studies with mice, rabbits,
and monkeys.  Female mice (Albino outbred) that were fed Aroclor 1248 for 5 weeks had increased
endotoxin sensitivity at estimated doses of 13 and 130 mg/kg/day and decreased resistance to challenge
by S. typhimurium at 130 mg/kg/day (not tested at lower dose), but no effects on spleen and thymus
weight or histology at #130 mg/kg/day (Thomas and Hindill 1978).  In a study with New Zealand rabbits,
females were exposed to 3.6, 28, or 91 mg/kg/day dietary doses of Aroclor 1248 from 4 weeks before
mating until offspring were weaned at 4 weeks of age (Thomas and Hinsdill 1980).  Testing at 7 weeks of
age showed that skin contact sensitivity response to dinitrofluorobenzene was reduced in the offspring of
the 91 mg/kg/day rabbits.  This effect was accompanied by reduced body weight, making it unclear
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whether the effect was directly due to PCBs or secondary to some other form of toxicity.  No exposure-
related changes in spleen and thymus weights, plaque forming cell (PFC) response and antibody titers to
SRBC, or mitogenic response of peripheral blood lymphocytes to PHA or ConA were observed in the
rabbits at any dose level.  Thymus weight and WBC and neutrophil counts were reduced in Sprague-
Dawley rats fed Aroclor 1248 at an estimated dose of 50 mg/kg/day for 6 weeks (Allen and Abrahamson
1973); these effects were similar in severity to those induced by Aroclor 1254.
Increased susceptibility to bacterial infections was reported in two monkeys after dietary exposure to
approximately 0.1–0.2 mg/kg/day Aroclor 1248 (Barsotti et al. 1976).  The monkeys, which died after
173 and 310 days of treatment, had clinical signs of PCB toxicity and developed, terminally, a severe
enteritis from which Shigella flexneri type IV was isolated.
Immunologic changes were investigated in groups of eight Rhesus monkeys that were immunized with
SRBC and tetanus toxoid following dietary exposure to 0.1 or 0.2 mg/kg/day Aroclor 1248 for 11 months
(Thomas and Hinsdill 1978).  Comparison with a control group of five monkeys showed effects at
0.2 mg/kg/day that included reduced anti-SRBC antibody titers at weeks 1 and 12 after primary
immunization (i.e., at 2 of 6 postimmunization times), and decreased percent gamma-globulin after
20 weeks.  Antibody responses to SRBC were not significantly affected at 0.1 mg/kg/day.  The response
to tetanus toxoid was not significantly modified at either dose level.
Pathological changes in lymphoid tissues occurred in offspring of Rhesus monkeys that were fed 0.1 or
0.2 mg/kg/day estimated dietary doses of Aroclor 1248 for a 15-month period that included breeding,
gestation, and lactation (Allen and Barsotti 1976).  The offspring were exposed for approximately
46 weeks from beginning of gestation until they were weaned.  The doses were both fetotoxic (early
abortions occurred in 5 of 8 low-dose and 4 of 6 high-dose animals) and postnatally lethal (3 of 6 infants
died of PCB intoxication between days 44 and 329).  Gross and microscopic changes in the deceased
infants included reduced cortical and medullary areas in the thymus, reduced lymph nodes and absence of
germinal centers in the spleen, and hypocellularity of the bone marrow.  The females from the Allen and
Barsotti (1976) study were bred again after 1 year on the control diet (Allen et al. 1980).  Early infant
mortality was observed (2 of 4 in the former 0.1 mg/kg/day group and 2 of 7 in the former 0.2 mg/kg/day
group), and histological examinations showed thymus, spleen, and bone marrow effects similar to those
described above, as well as findings of hypocellular lymph nodes devoid of germinal centers.  Regression
of the cortical areas of the thymus and hypoplastic bone marrow were similarly observed in 5 infant
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(1-month-old) Rhesus monkeys that were intubated with 35 mg/kg/day Aroclor 1248 for 30 days
(Abrahamson and Allen 1973).
Aroclors 1242, 1221, and 1016.  Effects of Aroclors 1242, 1221, and 1016 on immune function have
been studied in male BALB/c mice.  Mice that were exposed to an estimated dietary dose of
22 mg/kg/day Aroclor 1242 for 3 or 6 weeks caused decreased  primary and secondary PFC responses to
SRBC antigens with concurrent reductions in total serum IgG1, IgM, and IgA levels (Loose et al. 1977,
1978a, 1978b, 1979).  There were no effects on thymus and spleen weights or histological alterations in
the thymus, spleen, or mesenteric lymph nodes, and morphometric analysis of the spleens did not show
changes in the number, size, or cellular composition of the germinal follicles.  Mice that were exposed to
22 mg/kg/day Aroclor 1242 for 3 or 6 weeks also had increased susceptibility to challenge by Salmonella
typhosa endotoxin or the malarial parasite Plasmodium berghei which resulted in increased mortality
(Loose et al. 1978a, 1979), although exposure to the same dose for up to 18 weeks did not affect
macrophage function (in vitro phagocytic capacity and activity or microbiocidal activity) or resistance to
challenge by EL-4 lymphoma or kidney ascites tumor cells (Loose et al. 1981).  Susceptibility to
Moloney leukemia virus was increased in male BALB/c mice that ingested dietary Aroclor 1242 for
6 months at estimated doses of $4.9 mg/kg/day, but not in mice that were similarly exposed to
Aroclor 1221 at doses as high as 48.8 mg/kg/day (Koller 1977).
Male C57BL/6 mice that were exposed to Aroclor 1016 in the diet at an estimated dose of 22 mg/kg/day
for up to 40 weeks had no consistent effects on thymus and spleen weights, lymphocyte counts, or
lymphocyte function as evaluated by the splenic graft-versus-host (GVH) response, mixed lymphocyte
response, mitogenic response to stimulation by PHA or LPS, or cytotoxic activity of sensitized
lymphocytes to target tumor cells (Silkworth and Loose 1978).
No changes in total or differential WBC counts or histology of the lymph nodes, spleen, or thymus were
found in male and female rats following 24 months of dietary exposure to Aroclor 1242 at doses as high
as 4.0 and 5.7 mg/kg/day, respectively, or Aroclor 1016 at doses as high as 8.0 and 11.2 mg/kg/day,
respectively (Mayes et al. 1998).
Defined Experimental Mixtures.   The toxicity of a mixture of PCB congeners analogous to that in
human breast milk (Canadian women) was studied in monkeys (Arnold et al. 1999).  Groups of infant
Cynomolgus monkeys (6 control males, 10 treated males) and Rhesus monkeys (2 control and 3 treated
males, 1 control and 3 treated females) were administered the congener mixture in a total daily dose of
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0 or 7.5 µg PCBs/kg/day from birth until 20 weeks old (i.e., without in utero exposure), and were
observed until they were at least 66 weeks old.  The dose was divided into thirds and administered prior
to the first three daily feedings via syringe to the back of the mouth.  The dose represented the
approximate daily intake of a nursing human infant whose mother’s milk contained 50 ppb PCBs (the
Health Canada guideline for maximum concentration in breast milk).  Immunological assessment of the
infants was started at 22 weeks of age and included IgM and IgG antibody production following
immunization with SRBC, lymphoproliferative activity of peripheral leucocytes in response to mitogens
(PHA, ConA, and PWM), numbers of peripheral leucocytes and their subsets, and NK cell activity.  Few
statistically significant changes were observed.  Anti-SRBC titers were reduced in the treated Rhesus and
Cynomolgus monkeys, but were not significantly different from controls, although antibodies were
significantly reduced over postimmunization time (p#0.025 for IgM and IgG in Cynomolgus monkeys,
p=0.002 for IgM in Rhesus monkeys).  Other changes included reduced absolute mean numbers of
B lymphocytes in the treated Cynomolgus monkeys (no change in mean percent); the effect was not
observed when re-evaluated in the monkeys at 1 year of age.  The investigators concluded that, overall,
the effects on the infant immune system were mild and of unclear biological significance due to large
inter-animal variability and the small numbers of animals.   
Single Congeners.  A series of toxicity studies was performed in which groups of 10 male and 10 female
Sprague-Dawley rats were exposed to diets containing four dose levels of various single congeners for
13 weeks (Chu et al. 1994, 1995, 1996a, 1996b, 1998; Lecavalier et al. 1997).  End points relevant to the
immune system included total and differential WBC counts, spleen weight, and histology of the spleen,
thymus, mesenteric lymph nodes, and bone marrow.  Data on these end points were reported for seven
congeners: PCB 28, 77, 105, 118, 126, 128, and 153.  Effects were essentially limited to thymic changes,
generally reductions in cortical and medullary volume and atrophy, which were observed following
exposure to PCB 126 ($0.74 µg/kg/day), PCB 153 ($3,534 µg/kg/day), PCB 28 ($3,783 µg/kg/day), and
PCB 105 ($3,960 µg/kg/day).  No changes in the immunologic end points were induced by PCB 77
(#892 µg/kg/day), PCB 118 (#170 µg/kg/day), or PCB 128 (#4,125 µg/kg/day).
Contaminated Fish Consumption.  Effects on the immune system were investigated as part of a two-
generation reproduction study of Sprague-Dawley rats that were fed diets containing 0, 5, or 20% (w/w)
of lyophilized protein from chinook salmon from Lake Huron or Lake Ontario (Arnold et al. 1998; Feely
and Jordan 1998; Feeley et al. 1998; Tryphonas et al. 1998a, 1998b).  Daily intakes of total PCBs in the
female F1 rats fed diet containing 0, 5, or 20% lyophilized Lake Ontario salmon flesh were calculated to
be 0.22, 23.20, and 82.37 µg/kg/day, respectively (Feely and Jordan 1998).  PCB intakes were
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qualitatively similar, but generally were somewhat smaller, for males compared with females and for F0
rats compared with F1 rats, although intakes from the Lake Huron diet were about 35–40% lower than
from the Lake Ontario diet.  The DDT complex (p,p’-DDT,  p,p’-DDE, and  p,p’-DDD) accounted for
75 and 60% of organochlorine pesticide residues in the Lake Huron and Lake Ontario fish, respectively,
and other major contaminants included CDDs and CDFs, mirex, chlordane, cadmium, lead, mercury, and
arsenic.  No consistent exposure-related effects were found across generations on various immunological
end points, including numbers of splenic leukocytes and T-lymphocyte subsets, PFC response to SRBC
antigen, NK cell activity, lymphocyte transformation in response to mitogens (ConA, PHA, and LPS),
phagocytic activity of peritoneal exudate cells, and resistance to infection by Listeria monocytogenes
(Tryphonas et al. 1998b).  The most notable finding was an increase in absolute leukocyte and
lymphocyte levels in the spleen of the F2 male rats fed the Lake Huron fish compared to controls and to
F2 males fed Lake Ontario fish, with higher cell numbers in the 20% group compared to the 5% group in
each fish source.  Additional data suggested that the increases in splenic leukocyte and lymphocyte levels
were due to changes in T-lymphocyte subsets, particularly the T-helper/inducer cells.  The changes in
spleen cellularity paralleled changes in peripheral WBC and lymphocyte levels (Tryphonas et al. 1998a).  
Another study assessed immunological effects in juvenile C57Bl/6 mice that were fed diets containing no
fish or 33% coho salmon from Lake Ontario or the Pacific Ocean for 2–4 months (Cleland et al. 1989). 
Intakes of persistent toxic substances were not reported although the halogenated aromatic hydrocarbons
with the highest concentrations in the control chow, Pacific salmon diet, and Lake Ontario salmon diet
were total PCBs (0.4, 20, and 2,900 ppb, respectively) and p,p-DDE (0.1, 10, and 670 ppb, respectively). 
Levels of PCDDs and PCDFs, mercury, tin compounds, and other metals were not examined. 
Evaluations included IgM, IgG, and IgA PFC responses to SRBC and numbers of spleen total
lymphocytes, total T-lymphocytes, and T-lymphocyte subsets following 2 months of exposure.  Cellular
immunity was assessed after 4 months of exposure by the cytotoxic T-lymphocyte response to allogeneic
tumor target cells.  The only significant finding was a reduced PFC response to SRBC for all three
immunoglobulin classes in the mice that consumed the Lake Ontario diet compared to responses in the
mice fed the Pacific Ocean salmon or control diets.
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3.2.3.3.3  Dermal Exposure
Limited data are available on immunological effects in animals after dermal exposure to PCBs.  Dermal
application of an estimated 44 mg/kg/day Aroclor 1260, 5 days/week for 4 weeks resulted in moderate
atrophy of the thymus in rabbits (Vos and Notenboom-Ram 1972).  No treatment-related histological
effects were observed in the spleen and lymph nodes.  Application of an estimated 42 mg/kg/day of the
same Aroclor for 38 days to rabbits produced histological atrophy of the thymus cortex and a reduction in
the number of germinal centers in the spleen and lymph nodes (Vos and Beems 1971).  No treatment-
related effects were observed in control rabbits in either study.  These studies tested small numbers of
animals and used Aroclor 1260 that had undetectable levels (<1 ppm) of CDFs.
3.2.3.3.4  Other Routes of Exposure
The relative potencies of five Aroclor mixtures and an experimental congener mixture resembling an
extract from human milk were evaluated using the splenic plaque-forming cell response to SRBC in
C57BL/6 mice treated by single intraperitoneal injection (Davis and Safe 1989).  Comparison of ED50
values showed that the higher chlorinated Aroclors 1260, 1254, and 1248 (ED50 of 104, 118, and
190 mg/kg, respectively) were more potent than the lower chlorinated Aroclors 1242, 1016, and
1232 (ED50 of 391, 408, and 464 mg/kg, respectively).  The experimental milk mixture contained an
average chlorine percentage resembling Aroclor 1254, but did not significantly decrease the number of
plaque-forming cells to SRBC, although the tested doses (5–50 mg/kg) were less than the ED50 values for
Aroclor 1254 and the other mixtures.
A large number of acute intraperitoneal and in vitro studies have investigated congeneric structure-
activity relationships for the purpose of elucidating mechanisms of immunotoxicity and relative potencies
of individual congeners and their potential interactive effects.  As summarized in Section 3.4.2
(Mechanisms of Toxicity), there is evidence from various test systems that noncoplanar as well as
coplanar and mono-ortho-coplanar congeners are immunologically active, indicating that both Ah
receptor-dependent and receptor-independent mechanisms are involved in the immunotoxicity of PCB
mixtures (e.g., Brown and Ganey 1995; Brown et al. 1998; Davis and Safe 1989, 1990; Ganey et al. 1993;
Harper et al. 1993a, 1993b, 1995; Schulze-Stack et al. 1999; Tithof et al. 1995).
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3.2.3.3.5  Evaluation of Animal Studies
The immunotoxicity of PCBs has been evaluated in various species of animals that were exposed to
commercial mixtures, mixtures of congeners analogous to human breast milk, Great Lakes fish, or single
congeners.  Studies in rats, mice, guinea pigs, and rabbits have conclusively shown that intermediate-
duration oral exposure to $4 mg/kg/day doses of commercial PCB mixtures can induce both
morphological and functional alterations in the immune system.  Effects in lymphoid tissues were
commonly observed, although no generalizations can be made across species.  Decreases in thymus
weight occurred in rats exposed to Aroclors 1254 or 1248 and rabbits exposed to Aroclor 1254 (Allen and
Abrahamson 1973; Smialowicz et al. 1989; Street and Sharma 1975), but not in guinea pigs exposed to
Aroclor 1260, mice exposed to Aroclors 1248, 1242, or 1016, or rabbits exposed to Aroclor 1248 (Loose
et al. 1978b; Silkworth and Loose 1978; Thomas and Hinsdill 1978; Vos and de Roij 1972).  Spleen
weight was reduced in mice exposed to Aroclor 1254, but not in mice exposed to Aroclors 1248, 1242, or
1016, rabbits exposed to Aroclor 1248, or guinea pigs exposed to Aroclor 1260 (Allen and Abrahamson
1973; Loose et al. 1978b; Silkworth and Loose 1978; Talcott and Koller 1983; Thomas and Hinsdill
1980; Vos and de Roij 1972).  Histological examinations showed no PCB-related changes in the thymus,
spleen, and lymph nodes of guinea pigs exposed to Aroclor 1260 or mice exposed to Aroclors 1242, but
histopathology data are not available for other orally-exposed species and mixtures (Loose et al. 1978b;
Vos and de Roij 1972).  Repeated dermal applications of Aroclor 1260 (42–44 mg/kg/day for 4–5 weeks),
however, caused histopathologic changes in the thymus (cortical atrophy) and spleen and lymph nodes
(reduced germinal centers) in rabbits (Vos and Beems 1971; Vos and Notenboom-Ram 1972).   
Effects on immune function, as indicated by altered responses in humoral and cell-mediated immunity
assays and host resistance tests, were also induced by intermediate-duration oral exposure to commercial
mixtures.  Studies in nonprimate species showed reduced antibody responses to tetanus toxoid in guinea
pigs exposed to Clopen A-60 (4 mg/kg/day for 3–5 weeks), keyhole limpet hemocyanin in rats exposed to
Aroclor 1254 (4.3 mg/kg/day for 10 weeks), and SRBC in mice exposed to Aroclor 1242 (22 mg/kg/day
for 3–6 weeks) (Exon et al. 1985; Loose et al. 1977, 1978a, 1978b, 1979; Vos and Van Driel-Grootenhuis
1972).  Commercial PCBs also increased susceptibility to infection by foreign antigens, including
Moloney leukemia virus in mice exposed to Aroclor 1254 or Aroclor 1242 ($4.9 mg/kg/day for
6 months), herpes simplex virus in mice exposed to Kanechlor 500 ($33 mg/kg/day for 21 days), and
S. typhosa endotoxin and the malarial parasite Plasmodium berghei in mice exposed to Aroclor 1242
(22 mg/kg/day for 3–6 weeks) (Imanishi et al. 1980; Koller 1977; Loose et al. 1979).  Proliferative
responses of splenic mononuclear leukocytes to PHA, but not to other mitogens (ConA, STM, or PWM),
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was enhanced in rats exposed to Aroclor 1254, although no effects on mitogen-induced proliferation of
lymphocytes were observed in rabbits exposed to Aroclor 1248 or mice exposed to Aroclor 1016
(Bonnyns and Bastomsky 1976; Silkworth and Loose 1978; Smialowicz et al. 1989; Thomas and Hinsdill
1980).  Skin reactivity to tuberculin was reduced in guinea pigs exposed to Clopen A-60, but not in
rabbits exposed to Aroclor 1254, and there was no effect on delayed-type hypersensitivity to the skin
sensitizer oxazolone in mice exposed to Aroclor 1254 (Street and Sharma 1975; Talcott and Koller 1983;
Vos and Van Driel-Grootenhuis 1972).  NK cell activity was reduced in rats following intermediate oral
exposure to Aroclor 1254 (Smialowicz et al. 1989; Talcott et al. 1985).
Immunological assessments of rodents fed Great Lakes fish that contained PCBs and other chemicals
produced some changes that are similar to those observed in the studies of commercial PCB mixtures. 
Although no consistent exposure-related effects were found on several immunological variables (thymus
weights, PFC response to SRBC, mitogen-induced lymphocyte proliferation, NK cell activity, and
susceptibility to challenge with Listeria monocytogenes) in a multigenerational study of rats fed Lake
Huron or Lake Ontario salmon, increases in splenic leukocyte and lymphocyte levels were increased in
F2 male rats due to changes in T-lymphocyte subsets (Tryphonas et al. 1998a, 1998b).  In addition,
juvenile mice that consumed salmon from Lake Ontario for 2–4 months had reduced antibody responses
to SRBC compared to mice fed Pacific Ocean salmon or control diets, but no changes in T-lymphocytes
or their subsets were observed (Cleland et al. 1989). 
Intermediate-duration oral studies of Aroclors in monkeys confirm the observations of PCB
immunotoxicity in rats, mice, guinea pigs, and rabbits and further indicate that nonhuman primates are
more sensitive than the other species.  Early studies found decreased antibody responses to SRBC,
increased susceptibility to bacterial infections, and/or histopathological changes in the thymus, spleen,
and lymph nodes in adult monkeys and their offspring at 0.1–0.2 mg/kg/day doses of Aroclor 1254 and
1248, although these findings are limited by small numbers of animals and dose levels (Abrahamson and
Allen 1973; Allen and Barsotti 1976; Allen et al. 1980; Barsotti et al. 1976; Thomas and Hinsdill 1978;
Truelove et al. 1982; Tryphonas et al. 1986a).  The most extensive characterization of immunological
effects in nonhuman primates involved assessments on groups of 16 monkeys performed after 23 and
55 months of oral exposure to 5 dose levels of Aroclor 1254 ranging from 5 to 80 µg/kg/day (Tryphonas
et al. 1989, 1991a, 1991b).  The immune parameters that were most consistently affected in the monkeys
were IgM and IgG antibody responses to SRBC, which showed significant dose-related decreases at
levels as low as 5 µg/kg/day (lowest tested dose).  Other effects were either transient (e.g., alterations in
T-cell subsets occurring after 23 but not 55 months of exposure) or showed dose-related trends after
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55 months without significant differences between exposed and control groups (e.g., decreasing
lymphoproliferative responses to mitogens, increasing NK cell activity, increasing levels of serum
thymosin alpha-1, decreasing phagocytic activity of peripheral blood monocytes following activation with
PMA, and increasing total serum complement activity).
Results of studies in infant Rhesus monkeys are consistent with the data in adults showing
immunosuppressive effects of PCBs at doses as low as 5 µg/kg/day.  Evaluation of in utero and
lactationally-exposed offspring from the monkeys in the Tryphonas et al. (1989, 1991a, 1991b) studies
indicated exposure-related reductions in antibody levels to SRBC and mitogen-induced lymphocyte
transformation that paralleled the findings in the maternal animals (Arnold et al. 1995).  Although
assessment of the data is limited by small numbers of infants in the exposed groups, statistical
significance was achieved for some end points and evaluation times, including reduced IgM titers at
22–23 and 61–63 weeks of age (following gestational/lactational and/or postweaning dietary exposure) in
the infants exposed to 5 µg/kg/day.  Infant Rhesus and Cynomolgus monkeys that were orally
administered a PCB congener mixture simulating the congener content of human milk at a dose level of
7.5 µg/kg/day for the first 20 weeks of life (i.e., from parturition without in utero exposure) had minimal
immunological changes (Arnold et al. 1999).  More specifically, anti-SRBC titers (IgM and IgG) were
uniformly reduced in the treated compared to control monkeys, although group differences were not
statistically significant due to small numbers of animals.  In addition, B lymphocyte numbers in the
exposed Cynomolgus monkeys were decreased compared to controls, although the levels were similar
when evaluated again at 1 year of age.  These results provide further evidence that monkeys are sensitive
to low doses of PCBs administered either as commercial mixtures or as a mixture of congeners
representative of those commonly found in breast milk.
As summarized above, oral immunotoxicity studies have shown that suppressed antibody response to
SRBC is the parameter most consistently affected by PCBs in adult and infant monkeys and that effects
on antibody responses have also been demonstrated in other species.  Reductions in antibody responses to
SRBC were also observed in juvenile mice that ingested diet containing fish from Lake Ontario.  The
immunologic response to SRBC antigens, as measured using the PFC assay, is a validated sensitive
indicator for detecting potentially immunotoxic chemicals (Luster et al. 1992).  Because antibody
responses to SRBC antigens were suppressed in monkeys at dose levels of Aroclor 1254 as low as
0.005 mg/kg/day, the lowest tested dose of any PCB mixture in any species, this effect is used as the main
basis for deriving the chronic MRL for oral exposure as indicated in the footnote to Table 3-2 and
discussed in Chapter 2 and Appendix A.




The neurological effects of PCBs have been extensively investigated in humans and in animals.  The main
focus in humans studies has been on the effects in neonates and young children, although studies of adults
have also been conducted.  A great deal of concern exists that even low levels of PCBs transferred to the
fetus across the placenta may induce long-lasting neurological damage.  Because PCBs are lipophilic
substances, there is also concern that significant amounts might be transferred to nursing infants via breast
milk.  Studies in humans who consumed high amounts of Great Lakes fish contaminated with
environmentally persistent chemicals, including PCBs, have provided evidence that PCBs are important
contributors to subtle neurobehavioral alterations observed in newborn children and that some of these
alterations persist during childhood.  Some consistent observations at birth have been motor immaturity
and  hyporeflexia and lower psychomotor scores between 6 months and 2 years old.  There is preliminary
evidence that highly chlorinated PCB congeners, which accumulate in certain fish, are associated with
neurobehavioral alterations seen in some newborn children.  Subtle neurobehavioral alterations have also
been observed in children born to mothers in the general population with the highest PCB body burdens. 
Due to the limitations of epidemiological studies, these effects cannot be attributed entirely to PCB
exposure.  In one general population study, there was strong evidence that dioxins as well as PCBs were
contributors to the neurobehavioral effects seen in exposed children.  Children born to women who
accidentally consumed rice oil contaminated with relatively high amounts of PCBs and CDFs during
pregnancy also had neurodevelopmental changes.  Studies in animals support the human data. 
Neurobehavioral alterations have been also observed in rats and monkeys following pre- and/or  postnatal
exposure to commercial Aroclor mixtures, defined experimental congener mixtures, single PCB
congeners, and Great Lakes contaminated fish.  In addition, monkeys exposed postnatally to PCB
mixtures of congeneric composition and concentration similar to that found in human breast milk showed
learning deficits long after exposure had ceased.  A few other generalizations can be made from the data
in animals.  It appears that ortho-substituted PCB congeners are more active than coplanar PCBs in
modifying cognitive processes.  In addition, one effect observed in both rats and monkeys—deficits on
delayed spatial alternation—has been known to be induced by exposure to ortho-substituted PCBs,
defined experimental mixtures, and commercial Aroclors.  Both dioxin-like and non-dioxin-like PCB
congeners have been shown to induce neurobehavioral alterations in animals.  Changes in levels of
neurotransmitters in various brain areas have also been observed in monkeys, rats, and mice.  Of all the
observed changes, the most consistent has been a decrease in dopamine content in basal ganglia and
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prefrontal cortex, but further research is needed before specific neurobehavioral deficits can be correlated
with PCB-induced changes in specific neurotransmitters in specific brain areas.
3.2.4.2 Human Studies
3.2.4.2.1  Neurobehavioral Effects
3.2.4.2.1.1  Contaminated Fish Consumption
The Michigan Cohort.  Indices of neurological development were evaluated in 313 newborn infants (Fein
et al. 1984a, 1984b).  Of these infants, 242 were born to mothers who had consumed moderate to large
quantities of Lake Michigan fish sometime during their lives, and 71 were born to mothers who did not
consume Lake Michigan fish.  In the exposed group, mean fish consumption, estimated by recall and
duration of consumption, was 6.7 kg/year and 15.9 years, respectively; this rate is equivalent to 2 or
3 salmon or lake trout/month (Fein et al. 1984a, 1984b).  Consumption during pregnancy was 4.1 kg/year. 
The mean PCB level in maternal serum among those eating Lake Michigan fish was 6.1 ppb (SD=3.7),
while the mean among those reporting no fish consumption was 4.1 ppb (SD=2.7).  The mean PCB
residues also were significantly higher in breast milk samples from the fisheaters as compared to the
nonfisheaters, 865.6 ppb (fat basis) versus 622.2 ppb (Fein et al. 1984a).  No relationship was found
between cord serum PCB levels and maternal fish consumption possibly because of detection problems in
cord serum analysis.  A list of 68 potential confounders was collected from the maternal interview and
medical record.  The list contained data pertaining to demographic background, reproductive health
history including pregnancy and delivery, anesthesia during delivery, and exposure to other substances
such as caffeine, nicotine, and alcohol (Fein et al. 1984a, 1984b).  Because many of these mothers had
been exposed to polybrominated biphenyls (PBBs), cord serum PBB level also was used as a control
variable.  Potential confounders were included only if the frequency in each category exceeded 15%. 
Consequently, data on approximately 37 potential confounders were available for inclusion in the study
analyses (Fein et al. 1984a, 1984b).
Gestational age was evaluated by both the Ballard Examination for Fetal Maturity and the mother's report
of her last menstrual period.  The Ballard Examination was administered at 30 to 42 hours after birth to
209 of 313 (67%) infants with maternal permission granted during the limited time frame available for
assessment.  The Ballard estimate is based on an assessment of the newborn's neuromuscular and physical
maturity.  The Neonatal Behavioral Assessment Scale (NBAS) was administered to 284 of 313 (91%)
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newborns on day 3 after birth.  Three other infants also were tested sometime after their third day of life. 
In order to enhance the reliability of measures, the 44 NBAS items were reduced to seven summary
clusters; response decrement, orientation, tonicity, range of state, regulation of state, autonomic maturity,
and reflexes.  These reduced clusters were derived by synthesizing the results of factor analyses from
studies of six independent samples  (Fein et al. 1984a; Jacobson et al. 1984a). 
The results of the tests conducted on the newborns showed that decreased neuromuscular maturity, as
measured on the Ballard Scale was significantly associated with consumption of contaminated fish (Fein
et al. 1984b).  However, when the non-fisheater and fisheater populations were divided according to cord
serum level (<3 and $3 ppb, respectively), there was no significant difference in neuromuscular maturity
outcome.  The relationship between seven clusters from the NBAS and contaminated fish consumption
was evaluated using linear regression with control for caffeine and alcohol consumption both before and
during pregnancy.  The potential confounders were chosen based on their statistical significance in prior
correlation analyses.  Infants of mothers eating contaminated fish were more likely to exhibit hypoactive
reflexes, more motor immaturity, poorer lability of states, and a greater amount of startle (Jacobson et al.
1984a).
A follow-up of 39% (92 fisheating mothers, 31 controls) of the children in the Michigan Mother-Child
study occurred at 7 months of age (Jacobson et al. 1985).  Infants were administered Fagan's test of visual
recognition to assess the effect of pre- or postnatal PCB exposure on fixation to familiar and novel
stimuli.  Cord serum PCB level was a better, but only moderate, predictor of poorer mean visual
recognition memory than overall contaminated fish consumption.  Recognition memory performance was
not related to postnatal exposure from breast-feeding.  According to the investigators (Jacobson et al.
1985), there was an inverse relationship between preference for novelty and PCB levels in cord serum
(Fein et al. 1984a, 1984b).  The investigators further indicated that visual recognition was unrelated to
neonatal variables such as birth size, gestational age, and neurobehavioral performance.
Approximately 75% of the children were re-examined at age 4 (Jacobson et al. 1990a, 1990b). 
Neurobehavioral testing showed that prenatal exposure (maternal exposure before and during pregnancy),
assessed by cord serum PCB levels was associated with poorer performance on both the Verbal and the
Memory scales of the McCarthy Scales of Children’s Abilities.  There was no indication of perceptual
motor deficits or alterations of long-term memory.  Activity level was inversely related to 4-year serum
PCB level in a dose-dependent manner and also to maternal milk PCB level.  Multivariate analysis of
variance indicated that the effect of maternal milk was strongest in children of women with higher-than-
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average milk PCB levels ($780 ppb) who breast-fed for at least 12 months.  Correlations with fish
consumption were not examined.  Cognitive performance was unrelated to exposure from breast-feeding,
which, according to the investigators (Jacobson et al. 1990a), suggested that the neurobehavioral deficits
were due to fetal exposure.  Jacobson et al. (1990a) indicated that the deficits found in these studies were
not attributable to exposure to PBBs, lead, or seven other organochloride pesticides since these variables
were controlled for. 
A second evaluation of 226/313 children, 3 months after the McCarthy Scales assessment, was
undertaken using adaptions of the Sternberg visual search and recognition memory test, the Kagan's
Matching Familiar Figures Test, and the Streissguth vigilance paradigm  (Jacobson et al. 1992). 
Regression analyses were performed with control for statistically selected potential confounders.  The
exposure variables employed were cord serum and maternal milk PCB levels as well as the duration of
breast feeding.  Less efficient visual discrimination processing and increased errors in short term memory
scanning were associated with prenatal exposure to PCBs, but sustained attention was not.  Cognitive
performance was unrelated to postnatal exposure via breast milk (Jacobson et al. 1992).
A reanalysis of the assessment at 4 years of age was undertaken using the average of the standardized
scores for cord serum, maternal serum, and milk PCB values.  All values below the detection level (66.9%
of cord and 22.5% maternal serum values) were discarded (Jacobson and Jacobson 1997).  Results using
this composite score as the exposure and the McCarthy Scales, height, and weight as outcomes were
similar to those reported by Jacobson et al. (1990a, 1990b,1992).  Potential confounders in these analyses
were not delineated.  Additional findings were reported using the composite score which indicated that
the McCarthy Memory Scale and the General Cognitive Index declines were associated with prenatal
PCB exposure only in the most highly exposed children.
 
An 11-year follow-up was undertaken to assess the relationship between prenatal exposure to PCBs and
intellectual impairment.  The outcomes studied were the Wechsler Intelligence Scales, the Wide Range
Achievement tests, and the Woodcock Reading Mastery tests (Jacobson and Jacobson 1996a).  The
exposure variable consisted of a standardized average of the cord serum, maternal serum, and breast milk
PCB values.  These values were available for approximately 178/313 (57%) of the original group of
children in the study.  Linear regression modeling with confounder control, indicated that prenatal
exposure to PCBs was significantly associated with lower full-scale and verbal IQ scores.  On the
academic achievement tests, prenatal exposure to PCBs was associated with poorer word comprehension
and overall reading comprehension.  Covariates included in all the models were SES, maternal education
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and vocabulary, and the Home Observation for Measurement of the Environment (HOME) inventory. 
Additional confounders selected on the basis of their statistical relationship to the particular outcome were
also included in several models.  Mercury was included in two of the Woodcock Reading Mastery test
models, while lead was not included in any of the multivariate analyses assessing PCBs and intellectual
performance (Jacobson and Jacobson 1996a).
The associations of intellectual performance to lead and mercury were evaluated in separate multivariate
linear regression models lacking terms for PCB exposure.  Lower verbal IQ scores, lower verbal-
comprehension scores, and poorer word, passage, and reading comprehension were significantly
associated with higher lead levels at 4 years of age.  Poorer spelling was significantly associated with a
higher mercury concentration at 11 years of age (Jacobson and  Jacobson 1996a).
The Oswego Cohort.  A study similar to the one conducted in Michigan was initiated in Oswego County
(New York) based on babies born between 1991 and 1994 (Lonky et al. 1996).  Pregnant women were
recruited from the office of one obstetric practice and, following interviews, were divided into three
groups based on their estimated fish consumption.  The high fish consumption group was composed of
women who reported having eaten $40 PCB-equivalent pounds of Lake Ontario fish in their lifetime
(n=152) (the same as Michigan’s high fish consumption group).  The low consumption group reported
eating <40 PCB-equivalent pounds (n=243), while the no fish consumption group had never eaten Lake
Ontario fish (n=164).  The mean PCB-equivalent pounds consumed in the high fish consumption group
was 388.47 (SD=859.0), while the mean among those in the low fish group was 10.14 (SD=17.8).  The
exposure in the high fish consumption group corresponds to a mean of 2.3 salmon or trout meals per
month (belly fat trimmed and skin fat removed).  The three groups did not differ with regard to
demographic, health and nutritional data, maternal substance use, and infant birth characteristics.  The
high fish consuming group had a significantly heavier pre-pregnancy weight than the nonfisheating
group.
The end points evaluated in the study were based on the NBAS.  The NBAS behavioral and reflex items
were reduced to seven clusters nearly identical to the clusters used in the Michigan Mother-Child pairs
study (Jacobson et al. 1984a).  The NBAS was administered twice to each infant, once at 12–24 hours and
again at 25–48 hours after birth.  A total of 58 potential confounding variables were submitted to
principal components analysis.  Three sets of analyses were performed;  the first set contained
demographic, nutrition, and stress variables while the second was composed of substances consumed
during pregnancy, chronic medical conditions, and other toxic exposures including the type of plumbing
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in the woman's home (lead).  The third group of variables included labor and delivery complications as
well as birth characteristics.  A total of 24 components were derived from these three sets of variables.
Statistical analyses were performed using the change scores from the NBAS evaluation (Time 2–Time 1). 
Multivariate analysis of covariance (MANCOVA) was performed for each of the NBAS clusters with
group membership (high, low, and no fish consumption) as the independent variable and the
24 components representing potential confounders as covariates.  Approximately 75% of each fish
consumption group was included in the analysis (n=416).  The loss of subjects occurred because only
subjects with data for all variables were included.  Multiple regression was also performed for each of the
NBAS clusters with inclusion of component covariates for confounder control. 
The results of the MANCOVA analyses indicated that newborns exposed to high concentrations of fish
demonstrated a greater number of abnormal reflexes and less mature autonomic responses than newborns
in the other two exposure groups.  Change scores for the Habituation cluster were analyzed in a separate
analysis of covariance due to the large number of subjects with missing data (n=285 in the analysis).  For
that cluster, infants in the high fish group showed a worsening performance from Time 1 to Time 2.  The
regression analyses showed that infants in the high fish group had a significantly smaller decrease in the
number of abnormal reflex scores from Time 1 to Time 2 than the low and no fish groups.  In the
Autonomic cluster, the high fish group demonstrated a significant worsening in performance between the
first and second testing.  Performance for the remaining clusters was not significantly associated with fish
consumption in the regression analyses.  In this study, birth weight, head circumference, and gestational
age were unrelated to fish consumption.  The differences in the birth weight and head circumference
findings of the Michigan and Oswego studies could be due to the differences in PCB exposure levels.
In a later publication, the Oswego group of investigators examined the validity of using fish consumption
as a surrogate for PCB exposure (Stewart et al. 1999).  The study included 279 women with complete fish
consumption histories, PCB cord blood levels, and demographic and covariate information.  The sample
included 145 women who reported never having consumed Lake Ontario fish (controls) and 134 who
reported consuming at least 40 PCB-equivalent pounds over their lifetime (high fish consumption as
defined earlier).
Total PCB levels were divided into three PCB homologue clusters representing the lower, middle, and
upper tail of the distribution of all PCB homologues.  The lower tail corresponded to lightly chlorinated
PCB homologues with one to three chlorines per biphenyl (C1 1–3); the middle, to moderately
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chlorinated PCBs with four to six chlorines per biphenyl (C1 4–6); and the upper tail, to heavily
chlorinated PCB homologues with seven to nine chlorines per biphenyl (C1 7–9).  In a previously
conducted study in rats fed Lake Ontario salmon, the highly chlorinated PCB homologues accounted for a
greater proportion of the PCBs detected (mole percent) when the fish was fed longer or the absolute
concentration of PCBs was higher (Stewart et al. 2000a).  The authors predicted the same type of results
from the validity study using human cord blood.  The average concentration of total PCBs in human cord
blood was extremely low, 0.8 ppb among high fisheaters and 1.03 ppb among nonfisheaters (controls)
(p=0.36).  The relative percent (mole percent) of low- and medium-chlorinated congener PCB clusters
from cord blood were similar for fisheaters and controls across each level of total PCB.  The mole percent
of highly chlorinated congeners was significantly greater in the cord blood of women who ate Lake
Ontario fish as compared to the controls who reported no fish consumption (p=0.006).  The difference
between fisheaters and controls increased significantly (p=0.02) as the total PCB concentration increased.  
Eighty-three women in the study also provided breast milk samples within 6 months of the birth of their
child.  The C17–C19 homologues in breast milk and cord blood were moderately correlated (Pearson’s
r=0.29; p<0.05), while no correlation was found for the light- and moderately-chlorinated homologues. 
Actual values of PCBs in milk were not provided.
Based on their findings, the authors concluded that maternal consumption of Great Lakes fish increases
the risk of prenatal exposure to the most heavily chlorinated PCB homologues.
A subset of women from the Lonky et al. (1996) study also had cord blood samples collected for total
PCB and congener distribution pattern analysis (Stewart et al. 1999).  The study group was comprised of
mothers who had consumed Lake Ontario fish (n=141) and those who had not (n=152).  Each cord blood
sample was analyzed for the presence of 69 PCB congeners and several coeluters (e.g., hexachloro-
benzene [HCB], mirex, DDE).  Exposure was divided into four groups based upon the distribution of
heavily chlorinated PCBs (Cl 7–9) in each sample.  The exposure variable was an ordinal level measure
with the following categories: nondetectable (n=173); bottom 33rd percentile of detectable (n=39);
middle 33rd percentile (n=40); and upper 33rd percentile (n=40). The actual lipid-adjusted PCB levels
represented by these tertiles among those with detectable PCB levels were: >0–23.2 ng/g fat;
23.3–132.7 ng/g fat; and $132.7 ng/g fat.  The heavily chlorinated PCB congeners were used as the
measure of PCB exposure since the validity study results support the position that these congeners are the
most valid index of fish-borne PCB exposure from Lake Ontario (Stewart et al. 1999, 2000a).
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The end points evaluated were based on the seven clusters of the modified NBAS as evaluated by Lonky
et al. (1996).  The modified NBAS was also used in the Michigan Mother-Child Study (Fein et al. 1984b;
Jacobson et al. 1984a).  Potential confounders included in the models were selected if preliminary
analyses using one-way analysis of variance or linear regression of each covariate in relation to exposure
resulted in a p value of <0.20.  Those meeting the p<0.20 criterion included: education, SES score,
HOME score, maternal prepregnancy weight and weight gain, child gender, birth weight and head
circumference, cigarettes/day, and caffeine consumption.  Unlike the analyses employing fish
consumption as the exposure, the outcomes (i.e., NBAS performance clusters at Time 1 [12–24 hours]
and Time 2 [25–48 hours after birth]) were analyzed separately rather than as a change score
(Time 2–Time 1) (Stewart et al. 2000b).  No associations were noted between PCB cord levels and the
NBAS clusters at Time 1.  These findings are similar to those described using fish consumption as the
exposure variable (Lonky et al. 1996).  In looking at Time 2 NBAS cluster indices, significant linear
trends were observed between poorer Habituation and poorer Autonomic scores and exposure to heavily
chlorinated PCBs.  The suggestion of a trend for abnormal reflexes with PCB exposure was observed, but
the p value was 0.10 (Stewart et al. 2000b).  Linear trend analysis also revealed a significant association
between the proportion of poor NBAS clusters and heavily chlorinated PCBs.  None of the NBAS
performance scores were associated with non-PCB contaminants (i.e., HCB, DDE, lead, mercury, mirex)
in linear regression modeling (Stewart et al. 2000b).
Lake Michigan Aging Population Study.  This study was designed to assess the neuropsychological
functioning of a group of 50–90-year-old fisheaters exposed to PCBs through Great Lakes fish
consumption compared to a group of age- and sex-matched nonfisheaters (Schantz et al. 1996a, 1999). 
Fisheaters were defined as those who regularly consumed one or more meals of Lake Michigan
sportsfish/week (>24 pounds/year); nonfisheaters consumed <6 pounds/year.  Four classes of control
variables were evaluated: a comprehensive list of demographic, life-style, psychological, and health-
related variables.  Fisheaters and nonfisheaters had very similar demographic characteristics, reported
similar patterns of smoking and alcohol consumption, and had comparable scores on measures of
intellectual functioning and affect (Schantz et al. 1996a).  
The final analysis was conducted on 101 fisheaters and 78 nonfisheaters.  Blood samples of the
participants were analyzed for PCBs and 10 other contaminants included PBBs, DDE, HCB,
oxychlordane, dieldrin, mirex, mercury, and lead.  Serum levels of PCBs and DDE were significantly
elevated in the fisheaters (PCBs=16.0 ppb) relative to the age- and sex-matched nonfisheaters
(PCBs=6.2 ppb), and also relative to the population at large.  Lead and mercury were low in both groups,
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but were slightly higher in the fisheaters.  Because of the high correlation between serum PCBs and DDE,
the effects of PCBs and DDE were assessed jointly using a single derived exposure variable categorized
as low, intermediate, or high (Schantz et al. 1999).  A great majority of the high exposure group were
fisheaters and a large majority of the low exposure group were nonfisheaters.  However, 15% of
nonfisheaters had elevated PCB/DDE exposure and 15% of fisheaters had low PCB/DDE exposure. 
Based on this, Schantz et al. (1999) stressed the importance of quantitating contaminant levels rather than
relying on fisheating status as a surrogate measure for exposure. 
Each subject was tested on two fine-motor tasks, the Grooved Pegboard Test (GPT), which assesses
visual-motor coordination, and the Static Motor Steadiness Test (SMST), which assesses hand steadiness. 
Each subject performed the task first with the dominant hand and then with the nondominant hand.  The
final multivariate model for GPT included age, gender, income, diabetes and use of angiotensin-
converting enzyme (ACE) inhibitors, sympatholytic agents, and cardiac glycosides.  PCB/DDE exposure
was not a significant factor affecting the GPT score; age and gender were the strongest predictors of
performance followed by sympatholytics and income.  Performance on the SMST was not related to
PCB/DDE exposure in initial unadjusted analyses and in the final model, scores on the SMST improved
slightly as PCB/DDE exposure increased.
3.2.4.2.1.2  General Population Exposure
The North Carolina Breast Milk and Formula Project.  The North Carolina Breast Milk and Formula
Project (NCBMFP) is a cohort study designed to assess the relationship between exposure to prenatal and
postnatal PCBs and growth and development in infants and children.  The NCBMFP was initiated in 1978
and included a cohort of 931 children born between 1978 and 1982.  Mothers planning to deliver at one
of three participating institutions were recruited from hospital familiarization tours, Lamaze classes, and
from both private and public prenatal clinics.  No attempt was made to assemble a random sample of
women (Rogan et al. 1986a, 1986b, 1987).  The participants were administered a questionnaire while in
the hospital following delivery.  Maternal serum, cord blood, and placenta samples were collected as well
as colostrum, breast milk, or formula.  The first follow-up visit occurred at 6 weeks with subsequent
evaluations at 3 and 6 months postpartum.  Breast milk or formula was collected at each of these visits.  A
second maternal serum specimen also was collected at the 6-week assessment.  Subsequent follow-up
evaluations occurred at 12, 18, and 24 months, with yearly visits until the age of 5.  The children were
examined and a health history was taken at each exam.  The mothers also were queried about weaning. 
Breast milk was collected until the mother ceased lactation (Rogan et al. 1987).  All biological samples
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and a 10% sample of formula specimens were analyzed for PCBs.  Because most of the PCB levels from
the cord blood and placenta were below the quantitation limits, these two samples were not used as
measures of exposure.  The median PCB maternal serum level at birth was 9.06 ppb.  PCB levels in milk
at birth averaged around 1.8 ppm (fat basis).  In lactating women, the levels of PCBs in breast milk
declined about 20% over six months and about 40% over 18 months (Rogan et al. 1986a).
The participating mothers were not a representative sample of the North Carolina population.  Ninety
percent of the participants were white, with an age range of 16–41 (median=27).  The women were well
educated with 53% having a college education.  Occupations among the participants were listed as
housewife for 16%, while 41% were professionals.  Eighteen percent smoked and 40% drank alcohol at
least once a week.  Twenty-one percent reported eating sportfish at least once during pregnancy.  Forty-
three percent of the women were primiparous and most (88%) breast-fed their study child to some extent
(Rogan et al. 1986a).
The assessment at birth comprised 912 children with at least partial neonatal information.  The outcomes
evaluated in the neonatal period included birth weight, head circumference, and the presence of jaundice
as recorded in the medical record.  The NBAS was also administered to the newborns by a trained staff
member in the presence of the parents.  Fifty-nine percent of the NBAS exams were conducted during the
first week of life, 20% in the second, and 16% in the third.  The seven cluster scores used in the Michigan
Mother-Child Study (Jacobson et al. 1984a) were also employed in this project (Rogan et al. 1986b).  The
relationships of birth weight, head circumference, and the NBAS clusters to PCB levels were assessed by
multiple regression.  The covariates (potential confounders) included in the analyses of birth weight and
head circumference were infant race, sex, mother's age, education, occupation, smoking, alcohol
consumption, prior pregnancies, maternal weight, and center enrolling the participant.  The analysis of
head circumference also included the birth weight variable (Rogan et al. 1986b).  The covariates included
in the analyses of the NBAS clusters included mother's age, education, occupation, smoking, alcohol
consumption, sportfish consumption, general anesthesia during delivery, infant race and sex, birth weight,
presence of jaundice, number of hours since eating, one term for the center, and one for the examiner
(Rogan et al. 1986b).  
The multiple regression analyses found no associations between birth weight or head circumference and
PCB level.  For the NBAS assessment, only the cluster scores for tonicity and reflexes were significantly
associated with PCB levels.  The authors looked at the four scales that make up the tonicity cluster score
and found that exposure to PCBs affected the general tone and activity scales; less muscle tone and
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activity were associated with higher PCB levels, but only at the highest levels of PCBs.  The reflex cluster
score was also significantly affected by PCB exposure.  When the abnormal reflex scores were separated
into high and low, it became apparent that only hypo-reflexia, (not hyper-reflexia), was associated with
PCB levels.  Since the NBAS were carried out over the first 3 weeks of life rather than during the first
3 days of life (considered to be the best time for this exam according to several investigators), the authors
also repeated the same analysis with the population restricted to those whose exams were conducted on
day 3 or earlier.  The effect of PCB levels on hyporeflexia remained significant while the effect on
tonicity was unchanged in size but no longer statistically significant.  The authors interpreted the lack of
significance to the decrease in sample size rather than confounding due to the age the exam was
administered (data were not shown, Rogan et al. 1986b).
The follow-up evaluations at both 6 and 12 months included the administration of the Bayley Scales of
Infant Development (Gladen et al. 1988).  This exam yields a mental development index (MDI) score and
a psychomotor development index (PDI) score, both of which are scaled like a standard IQ test.  There
were 858 infants (92%) from the original cohort who participated in the study past the neonatal period. 
Of these, 788 had Bayley scores available at 6 months while 720 had 12-month scores (706 children had
scores at each time period).  The exposure variable representing prenatal exposure used in the analyses at
6 and 12 months was the estimated PCB levels in milk at birth.  The exposure variable representing
postnatal exposure used in these follow-up assessments was a combination of the concentration of PCB in
breast milk fat and the duration of breast feeding.  In addition, milk was assumed to average 2.5% fat over
the entire lactation.  The authors also assumed that children consumed 700 grams of milk daily, if mostly
breast fed, and half of that amount until breast-feeding stopped (Rogan et al. 1987).  Children who were
not breast fed were counted as having no postnatal exposure (Gladen et al. 1988).  Potential confounders
included maternal age, race, education, occupation, smoking, alcohol consumption and the infant's sex,
gestational age, birth weight, head circumference, jaundice, duration of breast feeding, number of older
siblings, number of abnormal reflexes from the NBAS exam, age Bayley administered, and center or
examiner.  
Linear regression analyses indicated that the psychomotor index scores declined with increasing prenatal
PCB exposure at both 6 and 12 months.  At 6 months, the PDI was estimated to decrease 0.96 points for
every increase of 1 ppm in PCBs.  This would mean a drop of 2.6 points if a child moved from the 5th to
the 95th percentile of PCB exposure.  At 12 months, the drop was estimated at 1.34 points/ppm.  Neither
the 6-month nor the 12-month mental index scores were related to transplacental PCB exposure (Gladen
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et al. 1988).  Similar analyses were run to examine postnatal exposure in breast-fed children.  Postnatal
exposure to PCBs was not associated with the PDI or MDI scores at either time period.
The children also were evaluated by the Bayley Scales of Infant Development at 18 and 24 months. 
Scores were available for 676 (73%) children at 18 months and for 670 (72%) children at 24 months
(Rogan and Gladen 1991).  Linear regression modeling was used to assess the relationship between
prenatal the Bayley scores and exposure to PCBs.  Covariate adjustment included sex, race, age of exam,
number of older siblings, maternal age, education, and occupational grouping.  Maternal smoking, alcohol
consumption, and a term for the examiner were also included.  The effects of prenatal PCB exposure on
the PDI score at 18 and 24 months were similar to those seen at 6 and 12 months; however, neither were
significant.  Scores at the age of 18 months, declined 0.38 for every increase of 1 ppm in PCBs.  The
decline at 24 months of age was 1.16 points for every 1 ppm increase in transplacental PCB exposure.  As
the score pattern was not linear, the authors also conducted an analysis of variance in which the
transplacental exposures were broken into categories.  Each category of PCB exposure was then
compared to the lowest with adjustment for covariates.  At 18 and 24 months, adjusted scores on the
psychomotor scales were 4–9 points lower among children in the two highest exposure groups (top 5th
percentile of prenatal PCB exposure), significantly so at 24 months (p <0.05).  There was no evidence of
an effect through postnatal PCB exposure in breast milk.  An additional report in this series found that the
deficits observed in children through 2 years of age were no longer apparent at ages 3, 4, and 5 years as
determined by evaluation with the McCarthy Scales of Children’s Abilities (Gladen and Rogan 1991). 
Finally, evaluation of third and higher grade children showed no significant relationship between the
child’s work habit or conduct grades and PCB exposure either prenatally or through breast milk, or
between hyperactivity reported by parents and exposure (Rogan and Gladen 1992).
The Dutch Mother-Child Study.   The Dutch Mother-Child Study was designed as a prospective study to
assess the possible adverse health effects of prenatal and postnatal PCB and dioxin exposure.  The initial
study group consisted of 489 healthy mother-infant pairs recruited between June 1990 and June 1992
during the last month of pregnancy by their obstetrician or midwife (Koopman-Esseboom et al. 1994b). 
The entry criteria included first or second-born term infants (37–42 weeks gestation) without serious
illnesses or complications during pregnancy and delivery.  All participants were caucasian (Huisman et al.
1995a).  Among the volunteers, 50% of the mothers were planning to breast feed for at least 6 weeks (for
postnatal exposure assessment), while the other 50% were planning to use formula from a well
characterized batch.  This was part of the study design in order to compare breast-fed infants with bottle-
fed infants.  Seventy-one mother-infant pairs were lost because of the inability to breast feed for 6 weeks
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leaving 418 pairs in the study population.  Two hundred seven pairs (105 breast-fed and 102 formula-fed)
were from Rotterdam, a highly industrialized area, while 211 pairs (104 breast-fed and 107 formula-fed)
were from Groningen, a semi-urban area in northern Holland (Koopman-Esseboom et al. 1994b).  
  
The exposure variables used in this study were maternal serum and milk samples as well as cord blood
specimens.  Maternal serum was collected during the last month (weeks 36–40) of pregnancy while milk
samples were collected at 2 and 6 weeks post delivery.  Data on the duration of breast feeding in weeks
were also collected (Koopman-Esseboom et al. 1996).  PCB levels in maternal serum and cord blood were
assumed to be a direct measure of prenatal PCB exposure while the breast milk values in the second week
after delivery were assumed to reflect the extent of intrauterine and neonatal exposure during the first
2 weeks after birth (Huisman et al. 1995a).
  
The focus of the authors was to investigate if one of the more easily measurable PCB congener levels
could predict the PCB and dioxin exposure of the developing fetus and breast-fed infant. In order to
express the potency of the mixture of dioxins and dioxin-like PCBs in breast milk, the authors used the
toxic equivalency factor (TEF) approach (Huisman et al. 1995a; Koopman-Esseboom et al. 1994b;
Patandin et al. 1999).  As discussed in Section 3.5.2, the TEF approach compares the relative potency of
individual congeners with that of 2,3,7,8-TCDD, such that the TEF for 2,3,7,8-TCDD is 1.  TEQs were
calculated by multiplying the concentration of each congener by it’s TEF.  These values were then
multiplied by the number of weeks of breast feeding reported by the mother to obtain a measure of
postnatal PCB exposure (Patandin et al. 1998).  In breast milk, of the total TEQ value, dioxins contributed
46%, coplanar PCBs 24%, mono ortho-substituted PCBs 23%, and di-ortho-substituted PCBs 7%.
Because dioxin measurements are time-consuming, expensive, and require large volumes of blood, the
authors chose four nonplanar PCB congeners (PCB 118, 138, 153, and 180) as indicators of PCB and
dioxin exposure of the developing fetus and breast–fed infant (Koopman-Esseboom et al. 1994b). 
Although the correlation coefficients between these congeners and congener levels in maternal plasma
and PCB levels in cord plasma or PCB and dioxin levels in human milk were highly significant, the 95%
predictive interval was too wide to accurately predict the PCB and dioxin levels to which an individual
infant is exposed in utero or postnatally by breast feeding, from the PCB levels in maternal plasma
(Koopman-Esseboom et al. 1994b).  The sum of these four congeners in maternal plasma and cord plasma
amounted to 2.21 and 0.45 ppb, respectively.  A total of 26 PCB congeners, including the four mentioned
above, were measured in breast milk and the total PCB concentration in milk was approximately 620 ppb
(fat basis).  The sum of PCB 118, 138, 153, and 180 in milk totalled 430 ppb.
3.  HEALTH EFFECTS - Neurological
PCBs 178
Data from the obstetrical optimality list were collected in this study as potential confounders and
covariates of interest.  The list included 72 items that measure SES (demographic, educational, and
occupational variables) and pre-, intra-, and immediate postpartum conditions (Huisman et al. 1995a). 
Other potential confounders were maternal smoking and alcohol consumption (Koopman-Esseboom et al.
1996).  The obstetrical optimality score was calculated by counting the number of items that fulfilled
preset criteria for optimality.  Data on the 5th, 50th, and 95th percentiles of the PCB distributions have
been presented in these reports for the biological samples.  The PCB levels were logarithmically
transformed (natural logarithm).  Comparisons of participant levels from Groningen to Rotterdam were
made using the chi-square and Wilcoxen rank sum test.  Both univariate and logistic regression analyses
were conducted to evaluate the relationship between exposure variables and outcomes while controlling
for covariates. 
Several outcomes were evaluated in the newborn period.  The neonatal neurological examination was
administered to evaluate age appropriate neurological behavior.  Sixty-three percent of the newborns were
examined in the second week of life, 31% in the third week, and 6% in the fourth week of life.  The
examination used in this study included performance on a 10 item reflex cluster and an 11 item postural
tone cluster.  The scores for each item (0=low, 1=intermediate, and 2=high) were summed for each
cluster.  A score of #9 was considered to reflect low muscle tone on the postural cluster and a score of
#10 was classified as low responsiveness on the reflex score.  A neurological optimality score (NOS) was
also calculated using a 60 item scale.  The NOS score was dichotomized at the median of the pooled
population scores (<57=not optimal, $57=optimal) (Huisman et al. 1995a). 
Logistic regression analyses with NOS as the dependent variable and maternal serum or cord blood as the
measure of prenatal exposure, were conducted with adjustment for maternal age, study center, alcohol,
and the interaction of age and alcohol.  Models for each of the four nonplanar PCB congeners (118, 138,
153, 180) alone and the sum of the four resulted in odds ratios (ORs) around 1.0 (no association).  An OR
of greater than 1.0 indicates an increased risk in the exposed group (see Chapter 10, Glossary).  The
prenatal exposure variables (PCB levels in maternal and cord plasma) were not associated with either the
reflex or postural cluster scores.  Another logistic regression analysis, with the postural tone cluster as the
dependent variable, and adjusting for study center, showed a significantly higher percentage of hypotonia
with an increase in planar PCB TEQ in milk.  No effect on the reflex cluster was found.  
At 18 months of age, the neurological condition of the infants was assessed using an age-specific
neurological examination which focuses on the observation of motor functions (grasping, sitting,
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crawling, standing, and walking) in a standardized free field situation (Huisman et al. 1995b).  Based on
this examination, each infant was classified as normal, mildly abnormal, or abnormal.  The neurological
findings were also evaluated in terms of optimality.  Huisman et al. (1995b) also state that special
attention was given to the quality of movements in terms of fluency since fluency of motility has been
shown to be an indicator for the integrity of brain function in fetuses and prematures.  The effect of PCB
and dioxin exposure was investigated by a multiple linear regression analysis in which the dependent
variables were the neurological optimality score and the fluency cluster score at 18 months.  After
adjusting for covariates, the results showed that prenatal PCB exposure had a small negative effect on the
neurological condition of 18-month-old infants whose fathers did not smoke; no such effect was observed
in children of fathers who smoked.  Neurological condition was unrelated to exposure to PCBs and
dioxins via breast milk. 
To assess the mental and psychomotor development of infants exposed to PCBs both pre- and postnatally,
the Dutch standardized version of the Bayley Scales of Infant Development were administered at 3, 7, and
18 months of age.  Both the MDI and the PDI were included in the assessments.  The tests were
performed at the infant's home in the presence of the parent(s) (Koopman-Esseboom et al. 1996).  The
evaluations of the infants using the Bayley Scales of Infant Development were undertaken only for the
207 children from Rotterdam.  Rotterdam is an urban area thought to have higher exposures to PCBs than
Groningen, a semi-urban area in northern Holland.
Multiple regression analysis assessing the effects of prenatal PCB exposure on the psychomotor scale
revealed that prenatal exposure to PCBs was significantly associated with a decrease in the PDI score at
3 months of age.  A doubling of the PCB-plasma-sum resulted in a decrease in the psychomotor score of
three points.  The covariates included in the model were gestational age, parity, the HOME inventory
score, education of the mother, and duration of breast feeding.  At both 7 and 18 months of age, there was
no significant effect of prenatal PCB exposure on the PDI scores (Koopman-Esseboom et al. 1996). 
Decreased PDI scores at 7 months among infants who were breast fed for longer periods and had higher
TEQ scores were associated with postnatal total TEQ (PCB plus dioxin) exposure.  The PDI score at
18 months was not associated with postnatal PCB-dioxin exposure.  The MDI scores were not
significantly associated with either prenatal or postnatal PCB exposure.  Higher MDI scores at 7 months
of age was positively associated with breast feeding per se.  Finally, neither the psychomotor nor the
mental development scales (at any age) were associated with an exposure variable created with the PCB-
milk-sum multiplied by the duration of breast feeding.
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At the age of 42 months, follow-up evaluations included both neurological and cognitive outcomes
(Lanting et al. 1998c; Patandin et al. 1999).  The neurological evaluation was comprised of an age-
appropriate clinical exam, which focused on the observation of motor functions (i.e., prehension, sitting,
crawling, standing, and walking) as well as the calculation of age appropriate NOS.  A movement fluency
score also was tabulated (not described).
A preliminary analysis summarizing the plasma PCB levels among children in the Rotterdam group at
42 months (n=173), found that median plasma levels were 3.6 times higher in breast-fed children
(0.75 µg/L) than in their formula-fed peers (0.21 µg/L).  Breast feeding period and breast milk PCB levels
were important predictors of plasma levels in breast-fed children at 42 months, while plasma levels in
formula-fed children were significantly related to maternal serum levels during the last month of
pregnancy (Patandin et al. 1997).  These results were obtained using multivariate linear modeling.  The
neurological assessment included 394 mother-infant pairs (94% of total participants) from both Rotterdam
and Groningen.  The clinical exam yielded a diagnosis of “neurologically normal” in 97% of the children.
 
Linear regression analyses using the NOS as the dependent variable and either maternal PCB-cord sum,
maternal PCB-serum sum, or the child’s PCB level at 42 months as the exposure found no associations
between this outcome and any of these exposure variables.  (Each exposure variable was modeled
separately).  Potential confounders in each model included the study center, the type of feeding during
early life, the duration of breast feeding, and several items from the obstetrical optimality score (i.e., SES,
obstetrical and perinatal conditions) (Lanting et al. 1998c).  A similar model with PCB breast milk levels
(TEQ method) as a measure of postnatal PCB exposure with NOS as the outcome, also found no
association between the dependent and independent variables.  In the last set of four models, fluency
score, the dependent variable, was not found to be significantly associated with any of the four exposure
variables.
Cognitive abilities also were evaluated at 42 months using the Kaufman Assessment Battery for Children
(KABC), an 11 sub-test exam standardized for a large sample of preschool children in the 2.5–4.5 year
old range (Patandin et al. 1999).  The KABC is constructed to assess two types of mental functioning,
sequential problem solving, and simultaneous problem solving.  Both the Rotterdam and the Groningen
children were administered this test battery.  The Rotterdam children also were evaluated for verbal
comprehension using  the Dutch version of the Reynell Developmental Language Scales (RDLS). 
Logistical difficulties was stated as the reason for the omission of the Groningen children from this 
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evaluation.  The exposure variables included the two measures of prenatal exposure (maternal serum and
cord blood congener sums), postnatal exposure via breast milk (TEQ method), and current PCB body
burden based on the serum sample levels in the children at 42 months of age. 
The effects of prenatal, postnatal, and current body burden of PCBs on the cognitive outcomes were
studied using multivariate linear regression.  Potential confounders were chosen based on previous
research, clinical expertise relative to the developmental outcomes, and beta coefficient changes observed
when adding new variables to the linear regression model.  Covariates included in the final regression
models were: maternal age at the child’s birth; parity; gender; feeding type; duration of breast feeding;
HOME score; paternal and maternal educational levels; parental verbal IQ scores; smoking and alcohol
use during pregnancy; and study center.  Analyses were conducted for the entire group, for breast-fed
children, and for formula-fed children.
In the group as a whole, a significant decline (p<0.05) in scores on the KABC for the overall scale, the
sequential processing scale and the simultaneous processing scale were observed in adjusted regression
models with maternal serum PCB levels as the independent variable.  When the groups were divided into
breast-fed and formula-fed, only formula-fed children showed a significant association between declines
in the scores for the same three KABC scales, as well as the RDLS verbal comprehension scale, and
maternal serum PCB levels.
Adjusted regression analyses conducted with a categorized version of maternal plasma PCB levels found
the mean overall score on the KABC to be four points lower in the group with the highest PCB exposure
($3 ppb) as compared to children in the lowest (#1.5 ppb).  Four point deficits in both the simultaneous
and sequential scales also were calculated for the highest exposure group as compared to the lowest.  Six
to eight point deficits were observed for the formula-fed group on the KABC scales while a
nonsignificant decline of two points was observed in the breast-fed group.  Cognitive performance at
42 months was not related to either lactational exposure or current exposure to PCBs and dioxins.
European Background PCB Study - German Sample.  This multicenter European study was designed as
a prospective study to assess developmental outcomes associated with prenatal exposure to PCBs in
Germany, the Netherlands, and Denmark (Winneke et al. 1998b).  This study is very similar in design to
the Dutch Mother-Child Study.  The German cohort included 171 mother-infant pairs consecutively
recruited from the obstetrical wards of three hospitals in Dusseldorf.  All infants were term, from German
speaking families, with an Apgar score of $7, first or second children, with no serious illnesses or
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complications during pregnancy and delivery.  Exposure to PCBs was based on the sum of PCB
congeners 138, 153, and 180 in cord blood (0.55 ppb).  A second measure of PCB exposure in milk was
obtained from samples collected at 2 and 4 weeks of age and analyzed for these same three PCB
congeners (427 ppb, fat basis).  From 171 mother-infant pairs, 169 cord blood and 131 breast milk
samples were obtained.
Outcomes measured at 7 months of age included the Bayley Scales of Infant Development (BSID) and the
Fagan Test of Infant Intelligence (FTII).  The Bayley Scales are comprised of the MDI, the PDI, and the
Behavior Rating Scale; only the MDI and the PDI were used in this study.  The MDI and PDI were used
in the North Carolina Breast Milk and Formula Project (Gladen et al. 1988) and in the Dutch Mother-
Child Study (Koopman-Esseboom et al. 1996).  A test by Fagan also was used in the Lake Michigan
Mother-Child Study (Jacobson et al. 1985).  A test of the reliability of the mobile test version of the FTII
in the Dusseldorf cohort for 2 observers and 10 children was close to zero (lack of reliability). 
Confounder selection procedures included a combination of a priori selection and statistical significance
with the outcome.  Linear regression modeling was used to assess the effects of PCB exposure on
outcome with adjustment for other covariates.
After adjusting for confounders, there was a significant inverse association between MDI scores and
PCBs in milk.  There was no association between MDI, PDI, or FTII scores and blood PCBs.
3.2.4.2.1.3  Occupational Exposure
Reports of neurological effects in workers exposed to PCBs are limited.  Approximately 49% of workers
(64 males, 94 females) exposed to 0.07–11 mg/m3 mean area concentrations of various Aroclors (early
exposure to Aroclors 1242 and 1254; recent exposure to Aroclors 1016 and 1221) at a capacitor
manufacturing plant for more than 5 years complained of headache, dizziness, depression, fatigue,
memory loss, sleeplessness, somnolence, and nervousness (Fischbein et al. 1979).  The prevalence of
these symptoms was not compared to a control group.  Routine neurological examination did not reveal
any remarkable prevalence of abnormalities; extensor weakness was observed in six individuals (1.8%),
whereas only one worker presented tremor at physical examination.  No further relevant information was
provided in this study.  In a study by Smith et al. (1982) of three groups of workers occupationally
exposed to Aroclors 1242, 1016, 1254, and/or 1260 significant positive correlations of symptoms
suggestive of altered peripheral sensation were noted with increasing concentration of serum PCBs. 
However, there was no overt clinical dysfunction identifiable on physical examinations.  Geometric mean
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serum levels of up to 500 ppb of low-chlorinated PCBs (#4 chlorines/molecule) and up to 44 ppb of high-
chlorinated PCBs were reported for workers in some jobs.  Frequent headaches, sleeping difficulties, and
memory problems were reported in switchgear workers exposed to Aroclors 1260 and 1242
(0.00001–0.012 mg/m3) compared to unexposed workers (Emmett et al. 1988a).  The geometric mean
serum PCBs in the exposed group was 9.7 ppb, and was significantly higher than in the comparison
group, 4.6 ppb.  Emmett et al. (1988a) stated that the reported symptoms were probably not related to
PCBs because they were not consistent with toxic effects ascribed to PCBs in the published literature.
3.2.4.2.1.4  Accidental Exposure
Children from Chinese women accidentally exposed to PCBs and other related chemicals through
consumption of contaminated rice (Yu-Cheng incident) have been evaluated for cognitive development.
Evaluations were conducted when the children were 4–7 years old (Stanford-Binet test and Wechsler
Intelligence Scale) and were compared to controls matched for neighborhood, age, sex, mother’s age,
parent’s combined educational level, and parent’s occupation.  The results showed that at each age, and
for each scale other than the WISC-R at the age of 6 years, there was a consistent 5-point difference
between the Yu-Cheng children and the control children (Chen et al. 1992).  Results of the evaluation of
the behavior and activity level of these children were published by Chen et al. (1994).  Emotional or
behavioral disorders were evaluated with the Rutter’s Child Behavior Scale A and activity level with a
modified Werry-Weiss-Peters Activity Scale.  At each year, Yu-Cheng children scored 7–43% worse
(more disorders) than control children in the Rutter scale.  At any fixed age, Yu-Cheng children scored
11–63% worse than control children.  Furthermore, there was no consistent trend toward decreased
differences in scores of Yu-Cheng and control children as the interval between the exposure and year of
birth increased.  Similar results were observed for the activity scores, although the differences between
Yu-Cheng children and controls were less marked (Yu-Cheng children had increased activity levels).  The
authors also found that children with physical signs had a higher mean score in the Rutter’s and activity
scores at some age and a lower score at others.  There were no consistent relationships between either
Rutter or activity scores and cognitive scores of PCB detectability, maternal serum PCB levels, or breast-
feeding mode.  Yu-Cheng children also scored significantly lower than controls in MDI and PDI tests
between the ages of 6 months and 2 years (Lai et al. 1994) and in Raven’s Colored Progressive Matrices
and at ages 6, 7, or 9, and in Standardized Progressive Matrices at age 9 (Guo et al. 1995). 
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3.2.4.2.2  Neurophysiological Effects
Various neurological symptoms, including numbness, weakness and neuralgia of limbs, hypesthesia, and
headaches, are common in Yusho and Yu-Cheng victims (Chia and Chu 1984, 1985; Kuratsune 1989;
Rogan 1989).  It is important to mention, however, that the findings from the studies of these groups
cannot be attributed solely to exposure to PCBs since the victims also were exposed to CDFs and other
chlorinated chemicals (ATSDR 1994).  Conduction velocities were reduced in sensory nerves (radial
and/or sural) in 9 of 23 Yusho patients examined soon after poisoning (Kuroiwa et al. 1969).  Sensory
fibers may have been preferentially affected as conduction velocities in motor nerves (ulnar and tibial)
were reduced in only two cases and motor functions were normal.  Follow-up studies were not performed
on the Yusho patients, but disappearance of related symptoms and signs indicated that the effects on nerve
conduction did not persist.  Reduced sensory and motor nerve conduction velocities also occurred in
Yu-Cheng patients (Chen et al. 1985; Chia and Chu 1984, 1985).  Evaluation of 110 patients within 1 year
of Yu-Cheng exposure showed significantly reduced sensory nerve (median and ulnar) and motor nerve
(tibial and peroneal) conduction velocities in .44 and 22% of the patients, respectively (Chen et al. 1985). 
All of the subjects had developed eye and skin manifestations of toxicity, but there were no significant
correlations between nerve conduction values and blood levels of PCBs, CDFs, or PCQs. 
Electroencephalographic examination of Yu-Cheng patients did not show any abnormalities potentially
indicative of central nervous system damage (Chia and Chu 1984, 1985).  Additional information on the
Yusho and Yu-Cheng poisoning episodes can be found in the toxicological profile for chlorodibenzofurans
(ATSDR 1994).
3.2.4.2.3  Evaluation of Human Studies
Several studies are available that evaluated the relationship between prenatal PCB exposure (and
postnatal exposure in some instances) and neurobehavioral parameters in infants and children.  These
studies are the Michigan Mother-Child Study (Fein et al. 1984a, 1984b; Jacobson and Jacobson 1996a,
1997; Jacobson et al. 1984a, 1985, 1990a, 1990b, 1992), the Oswego Newborn and Infant Development
Project (Lonky et al. 1996, Stewart et al. 1999, 2000a), the North Carolina Breast Milk and Formula
Project (Gladen et al. 1988; Rogan and Gladen 1991, 1992; Rogan et al. 1986a, 1986b, 1987), the Dutch
Mother-Child study (Huisman et al. 1995a, 1995b; Koopman-Esseboom et al. 1994b, 1996; Lanting et al.
1998c; Patandin et al. 1999; Weisglas-Kuperus et al. 1995), and the German Study (Winneke et al.
1998b).  A comparison of PCB levels in blood and breast milk in some of these studies is included in
Appendix A.  Related information is also available from the Yu-Cheng accidental poisoning incident in
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Taiwan (Chen et al. 1992, 1994; Guo et al. 1995; Lai et al. 1994).  Data from adults exposed to PCBs are
available from studies by Schantz et al. (1996a, 1996b, 1999) and from evaluations of victims from the
Taiwan poisoning episode (Chen et al. 1985; Chia and Chu 1984, 1985).
The association between consumption of Great Lakes contaminated sportfish (i.e., PCB exposure) and
neurodevelopmental alterations in children has been examined in the Michigan series of studies and in the
Oswego series.  Despite concerns about the design and analysis of the data from the Michigan Mother-
Child Study (Expert Panel 1994; Paneth 1991; Schantz 1996; Seegal 1996a, 1996b), many of the findings
of Jacobson and colleagues in the Michigan cohort have been replicated in studies of other cohorts. 
Jacobson et al. (1984a) found that newborn children exposed to PCBs from mothers who ate PCB-
contaminated sportfish were more likely to exhibit hypoactive reflexes, more motor immaturity, poorer
lability of states, and greater amount of startle.  In the Oswego study, the high PCB exposure group was
defined as those who consumed a mean of 2.3 salmon or lake trout meals/month, as done in the Michigan
study, and children born to mothers from this group demonstrated a greater number of abnormal reflexes
and less mature autonomic responses than those born to low PCB-exposed or non-exposed mothers
(low-fisheaters or nonfisheaters) (Lonky et al. 1996).  However, Lonky et al. (1996) found no significant
association between fish consumption and birth weight, head circumference, and gestational length, as
Fein et al. (1984a) had found in the Michigan cohort.  Taking advantage of improved analytical
techniques available at the time of the study, researchers from the Oswego study observed a significant
linear trend between poorer Habituation and Autonomic scores and heavily chlorinated PCBs (Stewart et
al. 2000b).  The suggestion of a trend for abnormal reflexes with PCB exposure was observed, but the
finding was not statistically significant.  Linear trend analysis also revealed a significant association
between the proportion of poor NBAS clusters and heavily chlorinated PCBs.  No significant association
was seen for the lightly and moderately chlorinated PCBs, DDE, lead, HCB, and mercury.  It is worth
noting that in the Oswego cohort, the average concentration of total PCBs in cord blood was 0.8 ppb
among high fisheaters and 1.03 among nonfisheaters, such that no association could have been found had
total PCBs in cord blood been used as surrogate for exposure.  
Neonatal evaluations also were conducted in the North Carolina study (Rogan et al. 1986b).  This is a
study of women from the general population with no known high exposure to PCBs.  PCBs in milk at the
time of birth (approximately 1.8 ppm, but may have been overestimated by a factor of 2) was used as
indicator of prenatal exposure; the median PCBs in maternal serum at birth was 9.06 ppb.  In the
Michigan cohort, the mean concentration of PCBs in maternal milk and serum in high fisheaters were
approximately 0.9 ppm and 6.1 ppb, respectively.  The NCBMFP also found that less muscle tone and
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activity were associated with higher PCB levels.  The reflex cluster score was also significantly affected
by PCB exposure.  When the abnormal reflexes were separated into high and low, it became apparent that
hypo-reflexia, not hyper-reflexia, was associated with PCB levels.  
Evaluations of various cohorts at later ages provide the opportunity to compare results of similar tests
conducted at similar ages.  For example, the BSID has been administered to infants in the North Carolina
cohort, the Dutch children, and the German study.  This group of tests yields a MDI and a PDI score, both
of which are scales like a standard IQ test.  In the North Carolina cohort, a significant decrease in PDI
scores at the ages of 6 and 12 months was associated with prenatal exposure to PCBs (assessed by PCBs
in maternal milk at birth, 1.8 ppm) (Gladen et al. 1988), although the association lost statistical
significance at the ages of 18 and 24 months (Rogan and Gladen 1991).  No significant association was
observed between PDI scores at 6–24 months of age and postnatal exposure to PCBs (PCBs in milk
factored by duration of breast feeding).  There was no significant association between MDI scores and
either prenatal or postnatal exposure to PCBs.  The latter is consistent with a lack of significant
association between MDI scores at 7 or 18 months of age and prenatal or postnatal exposure, also
observed in the Dutch children (Koopman-Esseboom et al. 1996).  Yu-Cheng children also had lower PDI
and MDI scores when tested between the ages of 6 months and 2 years old (Lai et al. 1994). 
Both the Dutch and the German studies assessed prenatal and postnatal exposure by measuring the
concentration of a limited number of PCB congeners in cord blood and in breast milk.  In the Dutch
study, the researchers measured PCBs 118, 138, 153, and 180 in cord blood and the sum of the mean
concentration of these congeners was 0.45 ppb (Koopman-Esseboom et al. 1994b).  The German study
measured PCBs 138, 153, and 180 in cord blood and the sum amounted to 0.55 ppb (Winneke et al.
1998b).  The added concentration of these four PCB congeners in breast milk in the Dutch study was
430 ppb, whereas in the German study, the concentration of PCBs 138, 153, and 180 in breast milk was
essentially the same at 427 ppb.  Both studies evaluated MDI and PDI scores at 7 months of age.  In the
Dutch study, at this age, neither PDI nor MDI scores were significantly associated with prenatal exposure
to PCBs; however, lower PDI scores, but not MDI scores were significantly associated with postnatal
exposure.  In the German study, also no significant association was found between MDI or PDI scores
and prenatal exposure to PCBs, but in contrast with findings from the Dutch children, lower MDI scores,
but not PDI scores, was significantly associated with postnatal exposure to PCBs.  Thus, it would appear
that practically the same exposure assessments in the two studies (including the concentration of marker
PCBs) and tests conducted at the same age provided apparently opposite results.  This may indicate that
more thorough analyses are necessary especially given the importance of ‘minor’ congeners in animal
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studies.  Also, the results from the German cohort on background PCB exposure in Europeans appear
preliminary with few details described.  
Evaluations at the age of 4 years have been done on the Michigan (Jacobson and Jacobson 1997;
Jacobson et al. 1990a; 1992) and Dutch children (Lanting et al. 1998c; Patandin et al. 1999).  Jacobson et
al. (1990a) showed that poorer performance on both the Verbal and the Memory scales of the McCarthy
Scales of Children’s Abilities was associated with prenatal exposure to PCBs.  Jacobson et al. (1992) also
found that less efficient visual discrimination processing and more errors in short-term memory scanning,
but not sustained attention, were associated with prenatal exposure to PCBs.  Dutch children evaluated at
42 months of age on neurological optimality scores showed no decrement on performance as a result of
exposure to PCBs either prenatally or postnatally (Lanting et al. 1998c).  Cognitive abilities evaluated in
these children using the KABC showed a significant decreased performance associated with prenatal
exposure to PCBs (Patanding et al. 1999).  Since the tests from the Patandin et al. (1999) and Jacobson et
al. (1990a) are both designed to provide a measure of general intelligence, the data are comparable and
the effects observed in the two studies on these end points are consistent. 
Evaluation of the children from the Michigan cohort at 11 years of age showed that lower full-scale and
verbal IQ scores and poorer reading word comprehension were significantly associated with prenatal
exposure to PCBs (Jacobson and Jacobson 1996a).  The mean maternal serum PCB concentration among
fisheaters in the Michigan study was 6.1 ppb (Fein et al. 1984a).  Decreased IQ was also observed among
Yu-Cheng children (Chen et al. 1992), but exposure levels in this group were significantly higher than in
the Michigan cohort and there was also significant exposure to CDFs, dioxins, and other related
chemicals. 
Evaluation of an adult population (50–90-years old) on a visual-motor coordination test and a hand
steadiness test revealed no significant effect from exposure to PCB/DDE through long-term consumption
of Lake Michigan fish (>24 pounds/year) (Schantz et al. 1999).  Results from cognitive assessment of this
cohort have not yet become available.  Workers exposed to PCBs have reported adverse neurological
symptoms, but routine examination of these workers did not reveal any clinical dysfunction (Emmett et
al. 1988a; Fischbein et al. 1979; Smith et al. 1982).  There is no indication that cognitive function or fine
motor behavior was evaluated in any way in the workers.  Neurological examination of Yusho and
Yu-Cheng victims showed reduced both motor and sensory nerve conduction velocities (Chen et al. 1985;
Chia and Chu 1984, 1985; Kuroiwa et al. 1969), but due to the mixed chemical nature of the rice oil
exposure, the results cannot be attributed specifically to PCBs.
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In summary, there is mounting evidence that PCBs can be important contributors to subtle
neurodevelopmental alterations in neonates and infants of women who consume high-amounts of sport-
caught fish from the Great Lakes and also of women in the general population with the highest PCB body
burdens.  Most of the studies summarized above have quantitative exposure estimates, associations
between the outcome and exposure which are likely free from confounding, and minimal biases, making
their findings more convincing.  Data from Yu-Cheng can only be considered supportive due to the
known exposure to other chlorinated aromatic hydrocarbons.  Data from the Dutch Mother-Child Study
strongly suggest that exposure to dioxins in general, not solely PCBs, may be related to altered
developmental effects in neonates and children.  The Oswego validity study to assess fish consumption as
a measure of PCBs, as well as the reanalysis of the Oswego neurodevelopmental outcomes using cord
blood C17–C19 PCB homologue levels as measure of exposure makes this series of studies important in
establishing biomarkers of exposure for quantitative risk assessment.  Unlike the North Carolina study,
the outcomes of the Oswego study are limited to NBAS within the first 2 days of life, although it is
expected that these children will be the subject of follow-up evaluations for years to come.
3.2.4.3 Animal Studies
The highest NOAEL values and all reliable LOAEL values for neurological effects for each study are
recorded in Table 3-2 and plotted in Figure 3-2.
3.2.4.3.1  Neurobehavioral Effects
Oral Exposure    
Neurobehavioral effects of PCBs have been examined in several species exposed for various durations. 
Experiments have been conducted with commercial mixtures, defined experimental mixtures,
contaminated fish, and single congeners.
Commercial PCB Mixtures.  Spontaneous motor activity was significantly decreased in male CD1 mice
(unspecified age) 15 minutes to 3 hours following a single gavage dose of 500 mg Aroclor 1254/kg
(Rosin and Martin 1981).  However, dosing with 30 or 100 mg/kg for 14 days had no significant effect on
this end point.  Assessment or motor coordination with two tests (screen test and rotor rod) did not reveal
any significant effect 15–120 minutes after treatment with a single dose of 500 mg Aroclor 1254/kg. 
Similar results regarding a decrease in spontaneous motor activity were reported in adult male Long-
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Evans rats following single gavage doses of $300 mg Aroclor 1254/kg; no significant effect was seen
with 100 mg/kg (Nishida et al. 1997).  Incomplete recovery to pretreatment levels of activity occurred
over a 9-week period.  Repeated administration of Aroclor 1254 resulted in dose-related decreases in
activity at doses $30 mg/kg/day, the NOEL was 10 mg/kg/day.  In this case, complete recovery of
activity occurred 3 weeks after exposure.  Kodavanti et al. (1998) also reported decreased motor activity
in adult male rats treated with 30 mg Aroclor 1254/kg/day for 4 weeks.  Nishida et al. (1997) also
conducted flavor aversion conditioning tests and reported that the acute and repeated NOELs for this
behavioral test were 15 and 7.5 mg/kg, respectively.  
Freeman et al. (2000; General Electric Co. 1995a, 1995b) conducted a 52-week feeding study in rats with
various Aroclor mixtures (1016, 1242, 1254, 1260) and found no significant treatment-related effects on a
comprehensive number of neurological end points.  PCB intakes ranged from 1.3 to 14.1 mg/kg/day
depending on the Aroclor mixture.  The functional observational battery assessed autonomic function,
muscle tone and equilibrium, sensorimotor function, and central nervous system function.  Motor activity
tests and histopathological examination of the central and peripheral nervous system were also performed. 
Open field activity on PND 14 was significantly suppressed in offspring from rats treated by gavage with
2 mg/kg/day Fenclor 42 (a non-Aroclor PCB, similar in composition to Aroclor 1242) on PND days 1–21,
but not in offspring from rats treated with 2–4 mg/kg/day on gestation days 6–15 (Pantaleoni et al. 1988). 
Neurobehavioral alterations including impaired swimming behavior and acquisition of one-way
avoidance response were also observed in the pups exposed in utero and also following postnatal
exposure.  
Neurobehavioral alterations were also reported in the offspring of rats treated with 2.4 mg/kg/day
Clophen A30 (technical mixture with 42% chlorine) premating and during gestation (Lilienthal et al.
1990).  Offspring, which continued on the PCB diet after weaning, were tested for open field activity on
PND 22 and 120, active avoidance learning on PND 65–75, and operant conditioning on a fixed interval
on PND 380.  Spontaneous activity was increased on PND 22, but not on PND 120.  Avoidance responses
and intertrial responses were increased, as were the responses in the operant conditioning test.  No
significant behavioral alterations were seen in rats treated with about 0.4 mg Clophen 42/kg/day.  In a
subsequent cross-fostering experiment, Lilienthal and Winneke (1991) reported that exposure in utero
resulted in alterations in active avoidance learning and retention of a visual discrimination task similar to
those seen in rats exposed in utero plus through mother’s milk, whereas postnatal-only exposure caused
no detectable behavioral changes.  Lilienthal and Winneke (1991) also observed that brain levels of
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higher chlorinated congeners peaked at weaning in groups with postnatal or postnatal plus prenatal
exposure, whereas the concentration of a low-chlorinated congeners was lower at weaning than at birth or
at later ages.  This suggests that transfer of low-chlorinated congeners may be more pronounced during
gestation, while preferential transfer of high-chlorinated PCBs occurs via the milk.  
Overmann et al. (1987) reported that pups from rats exposed in the diet to approximately 1.3 mg
Aroclor 1254/kg/day during gestation and lactation were significantly slower than controls in the negative
geotaxis test when tested on PND 7 and 8, but not on PND 5 or 6.  Also, the appearance of auditory
startle was slightly delayed on PND 12, but not PND 11, 13, or 14, in pups from dams treated with
0.13 and 1.3 mg/kg/day.  The development of air righting ability also was slightly delayed at  the
1.3 mg/kg/day dose  level on PND 18, but not PND 16, 17, or 19. 
Suggested evidence of memory impairment in a radial arm maze in rats resulting from perinatal exposure
to Aroclor 1254 was presented by Corey et al. (1996).  The pups, tested at age 42–54 days, were exposed
in utero and via mothers’ milk.  The dams received 8 or 17.8 mg Aroclor 1254/kg/day during gestation
and exposure continued until postpartum day 28.  Rats exposed to PCBs made significantly more maze
errors than control rats regardless of whether exposure of the pups ceased at weaning or had continued by
direct feeding.  In a more recent study, the same group of investigators reported that offspring from rats
fed approximately 1 mg Aroclor 1254/kg/day during gestation and lactation and tested between 25 and
29 days of age performed significantly worse than controls in a Morris water maze during trials 8, 9, and
10 (Provost et al. 1999).  No differences were seen in earlier trials, and interestingly, during the first four
trials, control rats performed much worse than treated rats.
Neurobehavioral studies also have been conducted in monkeys born to exposed mothers.  In a study by
Bowman et al. (1978), the assessment was conducted in three offspring of mothers fed a diet providing
approximately 0.1 mg/kg/day Aroclor 1248 for 16–21 months; PCB feeding terminated at the end of
3 months of nursing.  All monkeys were tested on a sequence of 11 tasks between the age of 6 and
24 months; four untreated monkeys served as controls.  Relative to controls, exposed monkeys showed
hyperlocomotor activity at 6 and 12 months of age, which correlated with peak PCB body burdens; they
also showed decreased performance in five out of nine discriminating learning tasks.  According to the
investigators (Bowman et al. 1978), the learning deficits appeared to represent residual toxicity, since
they could be observed after almost total clearance of PCBs from the body.  The same monkeys tested at
44 months of age appeared to exhibit hypoactive behavior relative to controls (Bowman and Heironimus
1981).  
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Neurobehavioral deficits reflected as impaired performance on a spatial learning and memory task were
seen in the progeny of monkeys fed 0.08 mg/kg/day Aroclor 1248 for 18 months and allowed to breed
32 months postexposure (Levin et al. 1988).  The deficit did not appear to be due to memory impairment,
but rather to impairment in associational or attentional processes.  Aroclor 1016, tested at a dose level of
0.008 mg/kg/day, did not significantly alter performance on that task (Levin et al. 1988), but impaired the
monkeys' ability to learn a simple spatial discrimination problem at 0.03 mg/kg/day (Schantz et al. 1989). 
These long-term studies in monkeys showed that doses of $0.03 mg/kg/day of some PCBs can alter
performance in neurobehavioral tests. 
Defined Experimental Mixtures.   Rice and Hayward (1997) studied the effects on learning in monkeys
of postnatal exposure to a PCB mixture representative of the PCBs typically found in human breast milk. 
Eight male monkeys were dosed from birth to 20 weeks of age with 0.0075 mg/kg/day of PCBs.  Five
monkeys served as controls.  At 20 weeks of age, the levels of PCBs in fat and blood in treated monkeys
were 1.7–3.6 ppm and 2–3 ppb, respectively; corresponding values for controls were 0.05–0.2 ppm and
0.30–0.37 ppb.  Beginning at 3 years of age, the monkeys were tested on a series of nonspatial
discrimination reversal problems followed by a spatial delayed alternation task.  Treated monkeys showed
decreased median response latencies and variable increases in mean response latencies across three tasks
of nonspatial discrimination reversal.  There was no difference in overall accuracy of the tests.  There was
no correlation between performance and tissue levels of PCBs.  Treated monkeys also displayed retarded
acquisition of a delayed alternation task and increased errors at short delay task responses. These finding
were interpreted as a learning/performance decrement rather than an effect on memory per se.  In a
separate portion of this study (Rice 1997), treated monkeys displayed shorter mean interresponse times
when compared with controls.  The increase in pause time for fixed-interval performance emerged more
slowly across the 48 sessions in treated monkeys.  For fixed-ratio performance tasks, the control monkeys
decreased their mean pause time across 10 sessions, whereas the treated monkeys did not.  Rice (1997)
interpreted these results as suggesting learning deficit, perseveration, and/or inability to inhibit
inappropriate responding as a result of postnatal PCB exposure.  Testing of these monkeys at 4.5–5 years
of age showed that treated animals performed in a less efficient manner than controls under a differential
reinforcement of low rate (DRL) schedule of reinforcement (Rice 1998).  There were no differences
between groups on the accuracy of performance on a series of spatial discrimination reversal tasks,
although some treated monkeys made more errors than others on certain parts of the experiment.  Further
tests conducted at about 5 years of age did not find treatment-related effects on a series of concurrent
RI-RI (random interval) schedules of reinforcement (Rice and Hayward 1999a).  This schedule was
designed to study behavior in transition (learning) as well as at steady state.  However, there was a
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difference between treated and control monkeys on performance on a progressive ratio (PR) schedule. 
Rice and Hayward (1999a) stated that the interpretation of this finding is not straightforward, but may be
indicative of retarded acquisition of the steady-state PR performance in treated monkeys. 
Contaminated Fish Consumption.  The neurobehavioral effects of exposure of rats to feed adulterated
with 5 or 20% lyophilized salmon fillets from Lake Huron (LH) or Lake Ontario (LO) were examined by
Pappas et al. (1998).  The study was conducted in F1- and F2-generation 88-day-old male and female rats
that had been exposed in utero, during lactation, and postnatally until they were tested.  Exposure to the
contaminated diet caused no observable effects on many behavioral parameters including activity,
exploration, sensorimotor function, and stereotypy.  Also, there was no diet-induced impairment of spatial
learning or long-term memory, and no evidence of an exaggerated response to food reward reduction. 
The only significant effect found was decreased performance of the F1 LO-20 and F2 LH-20 rats in the
reference/working memory version of the radial arm maze.  Stewart et al. (2000a) examined the effects of
feeding adult male rats a 30% diet of salmon from Lake Ontario, Pacific Ocean salmon, or a laboratory
chow on performance on a multiple FR-PR reinforcement schedule.  Rats were fed for 65 days.  Lake
Ontario diet contained 739 ppb PCBs, whereas the Pacific Ocean diet and the lab diet contained 45 and
64 ppb PCBs, respectively.  Also, the average chlorines per biphenyl for the Lake, Ocean, and lab diets
were 5.65, 4.58, and 4.54, respectively.  Analysis of PCB homologues in the brain of rats showed that rats
fed Lake fish had significantly higher concentrations of homologues with 6, 7, 8, or 9 chlorines per
biphenyl than the other groups.  These rats’ brains also contained DDE and mirex, which were not
detected in the Ocean or lab diet groups.  Behavioral test results showed that Lake rats responded
normally during FR schedules, but quit significantly sooner than control rats on a PR-5 schedule, when
response costs were demanding.  None of the response rates were significantly related to contaminants.
Single Congeners.  Administration of 32 mg 3,3',4,4'-tetraCB/kg (PCB 77) to pregnant CD-1 mice on
gestation days 10–16 resulted in motor and behavioral alterations in the offspring tested at 35 and/or
65 days of age (Tilson et al. 1979).  Some, but not all, exposed mice exhibited a neurobehavioral
syndrome consisting of intermittent stereotypic circling activity (PCB-spinners).  Relative to controls and
to PCB-nonspinners, PCB-spinners were hyperactive during the dark phase of the diurnal phase, showed
decreased muscular strength and impaired ability to traverse a wire rod, altered visual placement
responding, and impaired acquisition of one-way avoidance.  However, reflex activity and orientation to
environmental stimuli were not affected by exposure to PCB 77.  No PCB-derived radioactivity could be
detected in $28-day-old mice born to dams administered radioactive PCB 77 on gestation days 10–16. 
Microscopical examination of tissues from PCB-spinners (up to 8 months old) showed cylindrical
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peninsulas of central nervous system parenchyma in the cranial and spinal nerve roots as well as
alterations in synapses of the nucleus accumbens (Chou et al. 1979).  Increased motor activity in PCB-
spinners was still evident at 1 year of age (Agrawal et al. 1981).  Altered spontaneous motor activity was
seen in 4-month-old male NMRI mice given a single gavage dose of 0.41 mg PCB 77/kg at 10 days of
age (Eriksson et al. 1991).  When tested during three 20-minute blocks, treated mice were hypoactive
during the first block, but hyperactive during the third block relative to controls.  Similar results were
obtained with PCBs 28, 52, and 126, but no such effect was seen with PCBs 118, 156, or 105 (Eriksson
and Fredricksson 1996a, 1996b, 1998).  There was also a marginal effect of PCB 52 (4.1 mg/kg) on
learning and memory assessed by performance on a swim-maze and a radial-arm maze and of PCB 126
(0.46 mg/kg) also on the swim-maze.
Several PCB congeners have been evaluated for neurobehavioral alterations in rats.  The most widely
studied appears to be PCB 126, a dioxin-like congener, with an estimated dioxin-like toxicity potency
1/10 that of 2,3,7,8-TCDD.  Barnhoft (1994) found reduced onset of spontaneous movements and delayed
neuromuscular maturation in pups from Lewis rats administered six gavage doses of 10 or 20 µg
PCB 126/kg on gestation days 9–19; evaluations were conducted during the first 4 weeks of life. 
Spontaneous activity level was not affected by treatment.  Tests for visual discrimination learning (age
5–18 weeks) did not reveal any significant differences in performance between PCB-treated rats and
controls.  However, in a later paper, the same group of investigators reported that administration of six
doses of 2 µg PCB 126/kg on gestation days 10–20 resulted in both poorer visual discrimination and
hyperactivity in treated rats relative to controls; similar, but less marked effects were seen with
2,3',4,4',5-pentaCB (PCB 118) (Holene et al. 1995).  In two more recent studies, it was reported that male
pups from dams treated with PCB 153 from day 3 to 13 after delivery were hyperactive and had impaired
performance in a visual discrimination test (Holene et al. 1998), but female pups showed no significant
differences compared with controls (Holene et al. 1999).
Rice and coworkers conducted a series of behavioral studies in offspring from Long-Evans rats dosed
with 0, 0.25, or 1 µg PCB 126/kg/day beginning 5 weeks before and continuing through gestation and
lactation (Bushnell and Rice 1999; Rice 1999a; Rice and Hayward 1998, 1999b).  Exposure to PCB 126
did not significantly alter performance of male or female pups on a multiple fixed interval fixed-ratio
schedule of reinforcement or on a DRL schedule at about 200 days of age (Rice and Hayward 1998). 
Exposure to PCB 126 did produce developmental toxicity as evidenced by reduced birth weight, reduced
serum thyroxine, and changes in hematology and serum biochemistry parameters.  Assessment of
performance on a spatial delayed alternation task also revealed no significant differences between treated
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and control rats (Rice 1999a, 1999b); no PCB was detected in pups brain at age 60 days.  Further tests
conducted in males to assess visuospatial attention and sustained attention showed no significant
treatment-related deficits (Bushnell and Rice 1999).  Finally, male and female pups were tested under a
series of three concurrent RI-RI schedules of reinforcement at about 400 days of age followed by
assessment under a PR schedule (Rice and Hayward 1999b).  Although there was some indication of less
accurate performance in high-dose rats in the RI-RI schedule, there was no difference between treated and
control rats in the PR performance.
Schantz and colleagues assessed learning and memory in an 8-arm radial maze and in a T-maze in male
and female offspring from Sprague-Dawley rats treated with PCB congeners on gestation
days 10–16 (Schantz et al. 1995, 1996b, 1997).  Testing started at 60 days of age.  The first study tested
the ortho-substituted congeners PCBs 28, 118, and 153 (Schantz et al. 1995).  No treatment-related
effects were seen on a memory task on a radial maze test, but female offspring were less accurate than
controls on a T-maze spatial delayed alternation task; PCB 118 caused the smallest deficit of the three
congeners.  Subsequent studies examined 2,3,7,8-TCDD, the dioxin-like congeners PCB 77 and PCB 126,
and PCB 95 and found that performance on the radial arm maze task was facilitated by treatment with
each of the four compounds, but mostly by 2,3,7,8-TCDD (Schantz et al. 1996b, 1997).  No significant
group differences were seen on the T-maze test.  An additional observation was that exposure to PCB 95
did not alter spontaneous activity in rats tested as juveniles (35 days old), but induced hypoactivity in
tests conducted  in adulthood (100 days old).  In these rats exposed to PCB 95, Schantz et al. (1997) also
observed decreased density of ryanodine receptor binding proteins in the hippocampus, increased binding
in the cerebral cortex, and a biphasic response in the cerebellum.
Other Routes of Exposure.    Altmann et al. (1995) examined the effect of 3,3',4,4'-tetraCB (PCB 77)
on long-term potentiation (LTP), a measure of neuronal functional plasticity, in rats.  Pregnant Wistar rats
were treated with daily subcutaneous injections of 1 mg/kg of PCB 77 on gestation days 7–18.  At the age
of 180–220 days, offspring were sacrificed and slices were prepared from the visual cortex and
hippocampus.  Treatment with PCB 77 resulted in inhibition of LTP in visual cortex slices, but not in the
hippocampus.  A follow-up study reported the same result in slices from 11–19-day-old pups (Altmann et
al. 1998).  In the latter study, PCB 47 was also tested and was much less effective than PCB 77.  Using
the same exposure protocol, the effects of these two congeners also were assessed on locomotor activity
in the open field, spatial learning in the radial arm maze, catalepsy induced by the dopamine receptor
blocker haloperidol, and passive avoidance learning at PND 25, 95, 180, and 220, respectively (Weinand-
Harer et al. 1997).  Of all of these end points, exposure to PCB 77 altered the haloperidol-induced
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catalepsy and impaired performance in passive avoidance behavior; PCB 47 produced changes in the
same direction, but the differences relative to controls did not achieve statistical significance.
3.2.4.3.2  Neurochemical Effects
Neurochemical effects of PCBs have been examined in rats, mice, and monkeys exposed to commercial
PCB mixtures and to individual PCB congeners.  Some studies have assessed both neurochemical and
neurobehavioral effects of PCBs in an attempt to link a biochemical alteration to a particular
neurobehavioral deficit.
Oral Exposure    
Commercial PCB Mixtures.  Administration of single, high doses (500 and 1,000 mg/kg) of a mixture of
Aroclor 1254 and 1260 to adult male rats reduced serotonin levels in the frontal cortex and hippocampus,
increased serotonin in the lateral olfactory tract, and had no effect in the hypothalamus and brainstem
(Seegal et al. 1986a).  A correlation between the direction of the changes (increase or decrease) and
changes in PCB levels in the different areas could not be made.  In a similar study, there was a dose-
dependent decrease in the levels of dopamine in the caudate nucleus, but not in the lateral olfactory tract,
of adult rats treated with 500 or 1,000 mg/kg of a mixture of Aroclor 1254 and 1260 (Seegal et al. 1986b). 
In a subsequent study, a dose of 1,000 mg/kg of Aroclor 1016 increased dopamine turnover in peripheral
neurons of rats, whereas the same dose of an Aroclor 1254/1260 mixture increased dopamine turnover in
central neurons (Seegal et al. 1988), suggesting that PCBs with different degrees of chlorination can alter
dopaminergic functions in different locations of the nervous system.  Treatment of adult male rats with a
diet that provided approximately 0, 39, or 79 mg Aroclor 1254/kg/day for 30 days resulted in significant
decreases in dopamine concentrations and metabolism in the striatum and the lateral olfactory tract, but
not in other brain areas (Seegal et al. 1991a).  Analysis of PCB congeners in striatum, lateral olfactory
tract, and hippocampus showed that the hippocampus contained the highest PCB concentration and that
the major PCB congeners were penta and hexabiphenyls mono- or di-ortho-substituted.  In contrast to the
finding of decreased dopamine concentration by Seegal et al. (1991a), Kodavanti et al. (1998) found no
alterations in the concentrations of dopamine, norepinephrine, or serotonin in the striatum or cortex of
adult male rats treated with up to 30 mg Aroclor 1254/kg/day for 4 weeks; in addition, tyrosine
hydroxylase activity in striatal minces was not significantly altered by PCB treatment.  However,
treatment with Aroclor 1254 significantly reduced the Ca buffering capacity of microsomes and
mitochondria in the cerebellum and of microsomes in the frontal cortex and striatum.  Aroclor 1254 also
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decreased total protein kinase C (PKC) activity and increased membrane-bound PKC activity in the
cerebellum, but not in other brain areas.  In this study, treated rats were hypoactive compared to controls.
Doses between 0.8 and 3.2 mg/kg/day Aroclor 1016 in the diet for 20 weeks did not alter the
concentrations of noradrenaline, adrenaline, or serotonin in several areas of the brains of monkeys (Seegal
et al. 1990).  A similar exposure protocol with Aroclor 1016 or 1260 resulted in dose-dependent decreases
in dopamine contents in several areas of the brain (Seegal et al. 1991b).  Dopamine continued to be
depressed 24 weeks after the exposure period ceased (Seegal et al. 1992, 1994); at this time, the
concentration of PCBs had greatly decreased.  After the 20-week exposure, only PCBs 28, 47,
and 52 congeners were detected in the brains of the monkeys treated with Aroclor 1016, and mainly hexa-
and hepta-chlorinated di-ortho-substituted congeners were detected in the brains of monkeys treated with
Aroclor 1260.  Seegal et al. (1991b) concluded that the neurochemical changes were caused by a
mechanism different than that involved in other toxic responses to PCBs.  Because the concentration of
total PCBs was higher in the brains of monkeys treated with Aroclor 1260 than in those treated with
Aroclor 1016, Seegal et al. (1991b) concluded that lightly-chlorinated congeners were more effective in
reducing central dopamine levels than highly-chlorinated ones.  
Exposure of rats in utero to 0, 5, or 25 mg Aroclor 1254/kg (gestation days [Gd] 10–16) resulted in a
significant increase in levels of  5-hydroxyindole acetic acid (5-HIAA), and in the ratio of
5-HIAA/5-hydroxytryptamine in the lateral olfactory tract, prefrontal cortex, and hippocampus from
90-day-old offspring (Morse et al. 1996a).  Dopamine, 3,4-dihydroxyphenylacetate, norepinephrine, and
homovanillic acid were not affected.  In a study of similar design, Morse et al. (1996b) observed
significant increases in the glial cell marker GFAP in the lateral olfactory tract and the cerebellum and
significant decreases in the brain stem of offspring at 21 and 90 days old.  The neuronal marker
synaptophysin was significantly decreased in the lateral olfatory tract, prefrontal cortex, and striatum of
90-day-old offspring.  These changes were interpreted as reactive gliosis following direct damage to the
neurones or glia, or alteration in the regulation of the proliferation or protein expression of specific
subpopulations of neural cells.  
Choline acetyltransferase (ChAT) activity was significantly decreased in the basal forebrain, but not in
the hippocampus, from 15-day-old rats exposed to Aroclor 1254 (125 or 250 ppm in diet) during
gestation and via mother’s milk (Corey et al. 1996).  However, ChAT activity returned toward control
levels by 60 days of age.  These rats made significantly more maze errors than control rats regardless of
whether exposure to PCBs ceased at weaning or had continued by direct feeding.  In a follow-up paper,
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the authors reported that treatment with much smaller amounts of Aroclor 1254 (1.25 or 12.5 ppm in the
diet) resulted in a significant increase in ChAT activity relative to controls in the hippocampus and
forebrain from 15-day-old low-dose pups, but not high-dose pups (Provost et al. 1999).  In 30-day-old
pups, ChAT activity was significantly decreased in both the hippocampus and basal forebrain with the
two dietary PCB levels.  At this age, high-dose pups performed significantly worse than controls on a
Morris water maze. 
Contaminated Fish Consumption.   The neurochemical effects of exposure of rats to feed adulterated
with 5 or 20% lyophilized salmon fillets from Lake Huron (LH) or Lake Ontario (LO) were examined by
Seegal et al. (1998).  The study was conducted in 88-day-old male and female rats that had been exposed
in utero, during lactation, and postnatally until they were tested.  Dopamine, serotonin, norepinephrine,
and their metabolites, as well as ChAT activity were assayed in the frontal cortex, nucleus accumbens,
caudate nucleus, hippocampus, and substantia nigra.  Significant treatment-related effects included
(1) decreased dopamine in the frontal cortex of the high-dose rats, (2) decreased dopamine in the caudate
nucleus from all groups, (3) decreased dopamine in the substantia nigra from the high-dose LO rats,
(4) reduced epinephrine in all groups except for low-dose LO rats, and (5) no significant effect on ChAT
concentration in any experimental group.  No specific contaminants were assayed in the fish in this
report.
Single Congeners.  Mice exposed to 3,3',4,4'-tetraCB (PCB 77) in utero (maternal dose 32 mg/kg/day),
which exhibited spinning behavior and hyperactivity at 1 year of age, had decreased dopamine levels and
dopamine receptor binding sites in the corpus striatum (Agrawal et al. 1981).  However, Seegal et al.
(1997) reported that in utero and lactational exposure of rats to PCB 77 (0.1 or 1 mg/kg/day) resulted in
significant and persistent elevations in dopamine concentrations in the frontal cortex and the substantia
nigra, but not in the caudate nucleus.  In contrast, similar treatment with PCB 47 (1–20 mg/kg/day)
significantly decreased dopamine concentrations in the frontal cortex and caudate nucleus (Seegal et al.
1997).  Administration of a single dose of 0.41 or 41 mg PCB 77/kg to 10-day-old NMRI mice resulted in
a significant decrease (not dose-related) in density of muscarinic cholinergic receptors in the
hippocampus 7 days after dosing, but not 24 hours after dosing relative to controls; there was no
significant effect on receptor density in the cerebral cortex (Eriksson 1988).  In mice similarly exposed
but tested at the age of 4 months, muscarinic cholinergic receptor density was slightly but significantly
increased (high-dose only) in the hippocampus; no significant changes were detected in the cortex,
striatum, or midbrain and thalamus (Eriksson et al. 1991).  As previously mentioned, these mice had
abnormal spontaneous motor activity at that age.  Treatment with PCB 28 and PCB 52 did not alter
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muscarinic receptor density in the hippocampus, but PCB 52 increased the density of nicotinic cholinergic
receptors in the cortex (Eriksson and Fredriksson 1996a, 1996b).  Neither dopamine, serotonin, or
metabolites were significantly altered in the striatum by treatment with PCB 28 or PCB 52.  At this age
(6 months old), the mice showed altered spontaneous activity.  Neonatal exposure to 3,3',4,4',5-PentaCB
(PCB 126) resulted in increased density of nicotinic cholinergic receptors in the hippocampus at 5 month
of age and in impaired learning on a swim maze; no neurochemical or behavioral alterations were seen in
mice treated with 2,3,3',4,4'-pentaCB (PCB 105) (Eriksson and Fredriksson 1998).
Treatment of female and male weanling Sprague-Dawley rats for 90 days with PCB 28 in the diet
($0.04 mg/kg/day) resulted in a significant decrease in dopamine concentration in the substantia nigra in
females, but not in other brain areas (Chu et al. 1996a); neither norepinephrine, serotonin, or their
metabolites were altered in any brain area.  Other significant effects in similarly conducted experiments
included decreased dopamine in the caudate nucleus and substantia nigra and decreased serotonin in the
substantia nigra with PCB 118, $0.2 mg/kg/day in females, decreased dopamine in the caudate nucleus in
males and increased serotonin in the substantia nigra in females with PCB 105, $4 mg/kg/day, decreased
dopamine and serotonin in the frontal cortex with PCB 153, $0.01 mg/kg/day in males, and decreased
dopamine in the frontal cortex with $0.005 mg/kg/day PCB 128 and in the hippocampus with
4.4 mg/kg/day PCB 128 in females; no significant changes were seen with PCB 126 (up to
0.009 mg/kg/day) (Chu et al. 1994, 1995, 1996b, 1998a, 1998b; Lecavalier et al. 1997).
3.2.4.3.3  Other Neurological Effects
Oral Exposure    
Commercial PCB Mixtures.  The effects of perinatal exposure to PCBs on auditory function has been
studied in rats.  Goldey et al. (1995) tested the hypothesis that hypothyroidism induced by developmental
exposure to PCBs may cause permanent auditory dysfunction.  Long-Evans rats were given 0, 1, 4, or
8 mg Aroclor 1254 from gestation day 6 through PND 21 and pups were evaluated at various ages up to
1 year old.  Exposure to Aroclor significantly reduced circulating thyroxine concentrations up to PND 45. 
At PND 24, the high-dose pups showed reduced auditory startle amplitudes, but this was not seen when
tested as adults.  However, Aroclor induced permanent auditory deficits (20–30 dB threshold shift) at the
frequency of 1 kHz in the mid- and high-dose rats.  In a subsequent study, by monitoring brain stem
auditory evoked responses, the authors concluded that the auditory alterations are consistent with
peripheral auditory dysfunction (Herr et al. 1996).  In a more recent study, Goldey et al. (1998) reported
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that thyroxine replacement therapy significantly attenuated the effect of Aroclor 1254.  It is important to
note that high mortality occurred among the pups in the mid- and high-dose groups.  By PND 12 and 21,
25 and 50% of the pups in the 8 mg/kg/day group had died, respectively.  In the control and 4 mg/kg/day
groups, 3 and 15% of the pups had died by PND 21, respectively.
Single Congeners.  Offspring (76–90 days old) from rats that received 1 µg/kg/day of  PCB 126 for
35 days prior to breeding and throughout gestation and lactation had elevated auditory thresholds for
0.5 and 1 kHz tones (Crofton and Rice 1999).  There were no treatment-related effects in postnatal
mortality or litter size.
Other Routes of Exposure      
Single Congeners.  Subcutaneous administration of 1.5 mg/kg of PCB 77 to pregnant Long-Evans rats on
gestational days 7–18 resulted in altered electroretinogram (ERG) in female offspring recorded at about
200 days of age (Kremer et al. 1999).  Specific alterations consisted of decreases in the scotopic b-wave
as well as on the a-wave and maximum potential, the first two wavelets of the oscillatory potentials, and
the flicker response at the beginning of light adaptation.  No significant alterations were observed in male
offspring or in male or female offspring from rats injected subcutaneously 1.5 mg/kg of PCB 47.
Numerous in vitro studies have been conducted with both commercial PCB mixtures and single congeners
in efforts to elucidate the mechanisms of neurotoxicity of these compounds, to possibly discern patterns
among structurally similar types of congeners, and to establish toxic potency rankings.  These studies are
discussed in Section 3.5.2 Mechanisms of Toxicity. 
3.2.4.3.4  Evaluation of Animal Studies
Neurobehavioral Effects.  For the purpose of this appraisal, the neurobehavioral effects of PCBs in
animals are divided into (1) effects on motor activity and (2) effects on higher functions (e.g., learning
and memory).  Motor activity (spontaneous or open field) has been evaluated in mice, rats, and monkeys
exposed to commercial mixtures and single PCB congeners in a variety of experimental designs leading,
not unexpectedly, to a wide range of results from which few generalizations can be made.  Single or
repeated administration of relatively high doses of Aroclor 1254 to adult mice or rats generally decreased
spontaneous motor activity (Kodavanti et al. 1998; Nishida et al. 1997; Rosin and Martin 1981). 
Postnatal (via breast milk) exposure to Fenclor 42 decreased open field activity in pups on PND 14, but
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exposure in utero did not (Pantaleoni et al. 1988).  Exposure to similar doses of Clophen A30 (congener
composition similar to Fenclor 42) during gestation and lactation increased open field activity on PND 22
but not on PND 120 (Lilienthal et al. 1990).  Exposure of monkeys to Aroclor 1248 during pregnancy and
for 3 months after giving birth resulted in hyperlocomotor activity in the offspring at 6 and 12 months of
age (Bowman et al. 1978), but these monkeys exhibited hypoactive behavior at the age of 44 months
(Bowman and Heironimus 1981).  A somewhat similar finding was reported by Schantz et al. (1997) in
rats; in this case, offspring from Sprague-Dawley rats treated with the di-ortho-substituted PCB 95 on
gestation days 10–16 had control levels of spontaneous activity at 35 days of age (juveniles), but were
hypoactive as adults (100 days old).  A series of studies by Eriksson and coworkers (Eriksson and
Fredricksson 1996a, 1996b, 1998; Eriksson et al. 1991) observed altered spontaneous activity (increased
followed by decrease in trials separated by 20 minutes) in 4–5-month-old mice administered a single
gavage dose of a variety of PCB congeners at the age of 10 days.  These effects were observed with both
coplanar congeners (dioxin-like) PCB 77, PCB 126, and with the mono ortho-substituted congener
PCB 28 and the di-ortho-substituted PCB 52.  No effects were observed with three mono-ortho-
substituted congeners (PCB 105, 118, or 156).  No pattern is apparent from these findings.
The effects of PCBs on higher cognitive functions (i.e., learning, memory, attention) have been examined
in rats and monkeys exposed mostly perinatally, but in some cases, testing was done long after exposure
occurred.  Exposure of rats to Fenclor 42 during gestation or via mother’s milk impaired acquisition of
one-way active avoidance (Pantaleoni et al. 1988).  A different study reported decreased active avoidance
learning and retention of a visual discrimination task in rats exposed during gestation to Clophen A30, but
not in rats exposed postnatally (Lilienthal and Winnecke 1991).  Rats exposed during gestation and
lactation made more errors than controls in a radial arm maze (Corey et al. 1996) and performed worse
than controls in a Morris water maze (Provost et al. 1999).  Studies in monkeys exposed to Aroclors
during gestation and lactation, and tested after exposure ceased, showed decreased performance in
discriminating learning tasks (Bowman et al. 1978), impaired associational or attentional processes and
ability to learn a simple discrimination problem, and failure to learn the irrelevancy of a shape cue (Levin
et al. 1988; Schantz et al. 1989).  Monkeys that were treated from birth to 20 weeks of age with a defined
PCB mixture analogous to the congener composition of human breast milk (comprised mostly of mono-
and di-ortho-substituted congeners), and tested beginning at age 3 years, had impaired performance in
both nonspatial and spatial discrimination reversal tasks and exhibited inability to inhibit inappropriate
responding (Rice 1997, 1998, 1999b; Rice and Hayward 1997, 1999a).  Because these effects occurred at
a level of 0.0075 mg/kg/day, the lowest tested intermediate-duration dose of any PCB mixture in any
species, they are used as the basis for deriving the intermediate MRL for oral exposure as indicated in the
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footnote to Table 3-2 and discussed in Chapter 2 and Appendix A.  Perinatal exposure of rats to the
dioxin-like PCB congener PCB 126 during gestation and lactation provided little evidence that it altered
behavior (Bushnell and Rice 1999; Rice 1999a, 1999b; Rice and Hayward 1998, 1999a, 1999b).  Of five
tasks designed to assess a range of cognitive processes, only one provided any suggestive evidence of an
effect.  Other coplanar PCBs, as well as 2,3,7,8-TCDD, failed to alter the response of rats exposed in
utero on a T maze test, but facilitated the response on a radial arm maze (Schantz et al. 1995, 1996b).  In
contrast, ortho-substituted congeners had no effect on performance on the radial maze test, but impaired
performance of females on the T-maze test.  From the data summarized above, few generalizations can be
attempted.  It appears that ortho-substituted PCB congeners are more active than coplanar PCBs in
modifying cognitive processes.  In addition, an effect observed in both rats and monkeys was a deficit on
delayed spatial alternation, and was induced by exposure to ortho-substituted PCBs (Schantz et al. 1995),
defined experimental mixtures (Rice and Hayward 1997), and commercial Aroclors (Levin et al. 1988).
Neurochemical Effects.  The most consistent result from studies that examined the neurochemical effects
of PCBs is a decrease in dopamine concentrations in different areas of the brain.  This was seen in adult
rats and monkeys administered relatively high doses of Aroclor mixtures (Seegal et al. 1986b, 1991a,
1991b) and in 90-day dietary studies that used relatively low doses of single PCB congeners (Chu et al.
1994, 1995, 1996a, 1996b, 1998a, 1998b).  Less studies reported alterations in serotonin levels, and for
the most part, levels of norepinephrine were unaffected.  No single brain region appeared to be a preferred
target.  Studies with single congeners in rats reported decreases in dopamine levels in the frontal cortex,
caudate nucleus, substantia nigra, and striatum.  Studies with Aroclors in rats and monkeys observed
decreases in dopamine in the caudate, striatum, substantia nigra, putamen, hypothalamus, and olfactory
tract.  The lowest effective doses in the 90-day single congeners studies were 0.01 and 0.005 mg/kg/day
for PCB 153 and PCB 128, respectively, two di-ortho-substituted hexachlorobiphenyls.  The dioxin-like
PCB 126 was ineffective at the highest dose tested, 0.009 mg/kg/day.  In contrast with the majority of the
findings in adult animals, Seegal et al. (1997) reported an increase in dopamine concentration in the
frontal cortex and substantia nigra from rats exposed to the coplanar PCB 77 in utero and via mother’s
milk.  In the series of studies by Eriksson and colleagues (Eriksson and Fredricksson 1996a, 1996b, 1998;
Eriksson et al. 1991), no significant alterations in biogenic amine levels were seen in brains from adult
mice exposed to PCB 28 or PCB 52 at 10 days of age; these mice had altered spontaneous motor activity
and those exposed to PCB 52 had impaired learning and memory functions.  These investigators also
described increases in density of cholinergic muscarinic and nicotinic receptors in certain brain areas in
mice exposed to PCB 77, PCB 52, or PCB 126, but no such assays were conducted for PCB 118,
PCB 105, or PCB 156.  More information is necessary to speculate on patterns of effects among general
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classes of PCB congeners or to try to associate specific behavioral alterations with neurochemical
changes. 
Other Neurological Effects.  The findings of Crofton and Rice (1999) of auditory deficits in offspring
from rats administered PCB 126 during gestation and lactation without evidence of general toxicity give
credence to those of Goldey and coworkers (Goldey and Crofton 1998; Goldey et al. 1995; Herr et al.
1996).  In the latter series, high mortality was observed among the exposed pups during the first 3 weeks
of life suggesting that survivors may have been in less than optimal health conditions.  Whether the effect
seen with PCB 126 represents an Ah receptor-mediated effect remains unknown until additional both
dioxin- and nondioxin-like PCB congeners are tested.  
3.2.5 Reproductive Effects
3.2.5.1 Summary
Information is available on reproductive effects of PCBs in humans.  Studies that examined reproductive
end points found indications that exposure to PCBs is associated with menstrual disturbances in women
and effects on male fertility.  Increasing PCB levels have also been observed in women with late
miscarriages.  In addition, a reduction in the months of lifetime lactation was associated with increasing
levels of PCBs in maternal breast milk.  The reproductive toxicity of PCBs in animals has been well
established.  Effects in females have been observed in various species, including rats (prolonged estrus,
decreased sexual receptivity, and reduced implantation rate in adults and/or their offpsring exposed via
gestation and lactation), mice (decreased conception), minks (partial or total reproductive inhibition), and
monkeys (prolonged menstruation, decreased fertility).  Female minks and monkeys are particularly
sensitive to reproductive effects of PCBs.  There is limited evidence for reproductive effects in male adult
animals, although it is well documented that gestational and lactational exposure to PCBs can adversely
affect morphology and production of sperm and fertility in the male offspring of rats and mice.
3.2.5.2 Human Studies
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3.2.5.2.1 Female Reproductive Effects
Occupational Exposure.  There were no apparent effects on gravidity (number of pregnancies) in women
capacitor manufacturing workers who were exposed to Aroclors 1254, 1242, and/or 1016 for a minimum
of 3 months between 1946 and 1975 (Taylor et al. 1989).  High-exposure workers were directly exposed
to Aroclors during the manufacturing process for at least 1 year prior to birth of an infant, and workers
with low exposure were employed in areas where Aroclors were not used directly.  Area air samples
collected in 1977 showed geometric mean air concentrations of 310 and 27 µg/m3 in the high and low
exposure groups, respectively.  Evaluation of birth data on 172 high-exposure and 184 low-exposure
workers showed no significant difference in the mean number of pregnancies (3.2±1.7 and 3.5±2)..  As
discussed in the Developmental Toxicity section (Section 3.2.6.2), decreased birth weights and
gestational ages in the exposed women were associated with increased serum PCB levels.  Other
reproductive outcomes and well-designed reproductive epidemiologic studies have not been conducted in
this highly exposed female occupational cohort.
Contaminated Fish Consumption.  
The New York State Angler Cohort.  The New York State (NYS) Angler Cohort is a population-based
group of New York State anglers who were between 18 and 40 years of age and held fishing licenses for
the 1990–1991 season.  The cohort was compiled for the study of a variety of reproductive and other
health end points (Mendola et al. 1995a, 1995b).  Data from the entire cohort were collected from self-
administered questionnaires mailed to anglers living in 16 counties in close proximity to Lake Ontario. 
Responses were received from 10,782 male anglers, 934 female anglers, and 6,579 wives/partners of male
anglers for a total response rate, among the anglers, of about 40%.  This cross-sectional survey included
questions on sportfish consumption patterns (to estimate exposure to PCBs) and reproductive outcomes
and associated data focusing on children born between June 1986 and June 1991.  A telephone interview
with 100 randomly selected nonrespondents revealed that nonresponders did not differ from respondents
with respect to fishing habits, knowledge of fishing advisories, and fish consumption patterns, but had
sociodemographic differences (were less likely to be married and had lower levels of education and
income).  Findings for reproductive or developmental end points from this study have been reported in
several reports (Buck et al. 1997, 1999, 2000; Kostyniak et al. 1999; Mendola et al. 1995a, 1997).  
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Shorter menstrual cycles were associated with consumption of sportfish was associated with in women
from the NYS Angler Cohort (Mendola et al. 1997).  Menstrual cycle data were collected from
2,223 women (mean age 31.2 years) who stated in 1991 that they were considering becoming pregnant in
the following 3 years.  Lake Ontario fish consumption was measured in terms of exposure duration (total
number of years eating fish) and monthly frequency of fish meals in 1991, and an index was developed to
estimate cumulative lifetime PCB exposure through fish consumption (subjects were placed in no, low,
and combined moderate/high exposure classes).  Multiple regression analyses showed that consumption
of more than one Lake Ontario fish meal/month was associated with statistically significant reductions in
mean menstrual cycle length of >1 day in all 2,223 women (-1.11 days, 95% CI  -1.87 to -0.35), and of
about half a day for a subgroup of 2,080 women who reported having regular menstrual cycles (-0.51 day,
95% CI  -0.92 to -0.10).  Similar reductions were found in women in the highest cumulative exposure
category (moderate/high); mean cycle length was about 1 day shorter for the main group (-1.03 days, 95%
CI  -1.88 to -0.19), and about half that reduction in the regular menstrual cycle group (-0.56 day, 95% CI 
-1.01 to -0.09).  No significant differences in mean menstrual cycle length were found when the subjects
were classified into groups based on the number of years during which fish were consumed.  The
strengths of the study include the use of trained nurses to obtain menstrual cycle information.  Limitations
include the reliance on self-reported exposure data (biological samples were not collected and analyzed
for PCBs and other expected contaminants) and outcome data, and the lack of information on potential
confounders such as current smoking status, stress, and the use of contraceptives.  Mendola et al. (1997)
noted that although the small decreases in menstrual cycle length are not likely to be clinically significant
or of major public health concern, they may indicate potential endocrine effects on a population level.   
No statistically significant association was found between time-to-pregnancy (TTP), a measure of
fecundity and conception delay, and consumption of Lake Ontario sportfish in a preliminary analysis of
874 women from the NYS Angler Cohort who were pregnant between 1991 and 1993 (Buck et al. 1997). 
Exposure was estimated as the total number of years from 1955 to 1991 in which fish caught in Lake
Ontario were consumed.  The mean duration of fish consumption was 2.2 years (SD 4.5) for all women
and 5.2 years (SD 5.6 years) for women who reported any fish consumption.  No differences were
observed in fish consumption between women who did and did not become pregnant, fish consumption
between women with known and unknown TTP, or age distributions for women with and without a
pregnancy.  Multiple regression analysis was used to assess the linear relation between log-TTP and log-
years eating fish (duration of exposure).  Analyses were stratified by fish consumption (fish consumers/all
women) and parity status (nulliparous/parous), and controlled for maternal age, smoking, gynecologic
pathology (e.g., endometriosis), and history of sexually transmitted diseases.  R2 coefficients showed that
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duration of fish consumption and maternal age accounted for only a small percentage of the explained
variance in TTP (0.5%), even after the analysis was restricted to women who reported eating fish (0.6%). 
Beta coefficients, calculated to reflect the unit change in log-TTP for every unit change in log-years
eating fish, were positive but not statistically significant.  A larger beta coefficient was observed for log-
years eating fish among nulliparous women (0.1030) in comparison to parous women (0.0095),
suggesting that the effect of duration of fish consumption on TTP may have been greater among
nulliparous women.  Strengths of the study included the use of trained nurse interviews to obtain TTP
information.  As with other NYS Angler Cohort studies, limitations include the reliance on self-reported
exposure data and outcome data, and the lack of information on potential confounding factors such as
occupational exposures, alcohol and caffeine consumption, and current smoking status.  In addition,
women with unplanned pregnancies were necessarily ruled out from the analysis; Buck et al. (1997) noted
that this may be a potential bias inherent in the study.
In further analysis of the Buck et al. (1997) study summarized above and the Buck et al. (1999) study
summarized in Section 3.2.5.2.2 (Male Reproductive Effects), Buck et al. (2000) combined maternal and
paternal fish consumption into one model looking at fecundability ratios as the outcome, rather than TTP
(continuous variable used in 1997 paper) or conception delay (>12 months unprotected intercourse used
in 1999 paper).  The sample included 606 women with known and unknown TTP who discontinued birth
control in order to become pregnant during 1991–1993 and for whom the partners' fish consumption data
also were available.  The exposure measures included the duration, frequency, and lifetime PCB index
used in the previous studies.  Separate analyses were run for each exposure measure as both paternal and
maternal consumption measures were correlated.  Statistical analyses included the use of a discrete-time
analog of the Cox proportional hazards model to predict the probability of conception (i.e., fecundability-
biological capacity for reproduction) at the jth cycle given the absence of conception at an earlier cycle.
The natural logarithm of this conditional probability was modeled as a linear function of the covariates
and potential confounders (i.e., maternal smoking, gynecologic history [e.g., endometriosis; pelvic
inflammatory disease], parental ages, gravidity [number of pregnancies], and history of fertility drugs). 
The outcome measure used was the conditional fecundability ratio (CFR), the probability of conception
during a given menstrual cycle for the exposed fisheaters divided by that for unexposed nonfisheaters.
The 95% CI for the CFR was also calculated; exclusion of the value 1.0 from the CI indicates statistical
significance at the p=0.05 level.  This ratio is conditional upon becoming pregnant; a value <1 indicates
reduced fecundability.  Fish consumption was generally higher for men than women (68 and 42%,
respectively) as was the mean number of years of fish consumption (5.9 and 2.1 for the entire sample
whether they consumed fish or not).  Men also had higher mean PCB indices than women in the study,
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although partners' consumption patterns were related (e.g., both might be in the same category of fish
consumption).  The adjusted fecundability ratios for parental Lake Ontario fish consumption indicated
that maternal consumption of 3–6 years was associated with significantly reduced fecundability
(CFR=0.75, 95% CI 0.59–0.91), as was eating more than one monthly fish meal in 1991 (CFR = 0.73,
95% CI 0.54–0.98).  Paternal consumption was associated with slightly elevated, but non-significant,
CFRs for all three measures of fish consumption, suggesting that maternal but not paternal consumption
of contaminated fish may reduce fecundability among couples attempting pregnancy.  The investigators
considered the findings preliminary, given the retrospective data collection on TTP and fish consumption,
limited information on potential confounders, and potential sources of bias.  In addition to the limitations
indicated for the previous studies, Buck et al. (2000) commented on several biases associated with TTP,
particularly pregnancy recognition bias (when or how women became aware of pregnancy).  Another
possible bias is the fact that the analytic strategy is dependent on a woman achieving a pregnancy; if fish
consumption exerts a deleterious effect on fecundability, no pregnancy will be achieved and the women
will not be in the sample in the first place.  Hence, it is possible that women with the highest exposures
were excluded from the study since they did not achieve a pregnancy.  Due to the preliminary nature of
the findings, the investigators could not speculate as to whether the effect on fecundability could be
strong enough to reduce fertility, as measured by a reduction or absence of livebirths, or to impair
fecundity, as measured by pregnancy loss.
No statistically significant associations between increased risk for spontaneous fetal death and dietary
exposure to Lake Ontario fish were found among 1,820 multigravid, fertile women from the NYS Angler
Cohort (Mendola et al. 1995a).  Spontaneous fetal death histories (ever having a pregnancy end in
miscarriage, spontaneous abortion, or stillbirth) were obtained from New York State live-birth
certificates.  Fish consumption histories were used to construct four measures of PCB exposure for each
subject: (1) lifetime PCB exposure based on species-specific PCB levels (subjects were placed in no, low,
moderate, or high exposure classes); (2) number of years of sportfish consumption from 1955 to 1991; (3)
kilograms of sportfish consumed in the 1990–1991 season; and (4) lifetime kilograms of sportfish eaten
(no, low, moderate, or high exposure classes).  Women who never ate Lake Ontario sportfish comprised
the referent group.  Odds ratios and 95% CI were calculated in bivariate analyses to identify potential
confounders including smoking and alcohol consumption, and parental ages, paternal sportfish
consumption (none were statistically significant).  Unconditional logistic regression models were used to
calculate ORs and 95% CI for multivariate analyses.  Analyses were stratified by number of prior
pregnancies to better describe the relationship between maternal age and spontaneous death at different
levels of prior gravidity, and controlled for smoking and maternal age.  No consistent relationship was
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seen between a history of spontaneous fetal death and any of the four measures of exposure.  The ORs in
the logistic regression models evaluating lifetime PCB level and lifetime sportfish consumption relative to
spontaneous fetal death tended to be slightly above 1.0 (the null value) for the low exposure categories
and below 1.0 for the moderate and high exposure categories.  Odds ratios of approximately 1.0 also were
observed in the models assessing the number of years of consumption and the mass (kg) of sportfish
consumed in 1990–1991 (Mendola et al. 1995a).  Strengths of the study included sufficient statistical
power to detect fairly small increases in ORs and the reliability of reproductive history data on birth
certificates.  Limitations included the focus on clinically recognized fetal deaths which may not detect
early pregnancy loss, the self-reported nature of both exposure and outcome data, and the lack of
biomarker monitoring to validate the self-reported exposure data.  Because the findings suggested that
early fetal loss may be important, a prospective pregnancy study is currently underway (ongoing study by
J. Vena, see Section 3.12.3).
Decreasing number of months of lifetime lactation were significantly associated with increasing levels of
PCBs or DDE in breast milk (normalized for lipid content) in a group of 98 lactating women from the
NYS Angler Cohort (Kostyniak et al. 1999).  In this sample, PCB levels in breast milk were significantly
associated with self-reported measures of fish consumption, but DDE levels were not.  The observed
association is likely to be important in estimating dose rates for these chemicals in nursing neonatal
populations, but the relevance of the association to reproductive performance is not clear.
The Michigan Anglers Cohort.   An association between conception delay and sportfish consumption
was found in a survey of 626 married couples conducted between 1993 and 1995 (Courval et al. 1999). 
At least one person in each couple was a licensed angler residing in 1 of 10 Michigan counties bordering
a Great Lake (Lake Erie, Lake Huron, or Lake Michigan).  Subjects were categorized into four sex-
specific exposure classes (none, low, medium, high) based on an index of lifetime fish consumption
(estimated number of sportfish meals consumed in the past 12 months multiplied by the number of years
since 1970 in which fish were caught and consumed):  0, 1–114, 115–270, and 271–1,127 for men, and 0,
1–54, 55–138, and 139–1,127 for women.  Conception delay, defined as ever having failed to conceive a
child after 12 months of trying, was essentially the same in both sexes (reported by 12.9% of the men and
13.3% of the women).  Unadjusted logistic regression analysis showed that ORs for conception delay
increased in women with increasing exposure class, although results of a trends test were not statistically
significant (p=0.35); the OR in the high exposure category for women was 1.4 (95% CI 0.7–2.7).  
Adjustment for age, race, region of Michigan, household income, smoking, and alcohol consumption did
not strengthen the associations in women.  The OR in the high exposure category declined in the female
3.  HEALTH EFFECTS - Reproductive
PCBs 208
models after the addition of husbands’ fish consumption, indicating no risk associated with female
consumption after accounting for male partner consumption.  In contrast to the findings in women,
analysis of the male data provide suggestive evidence that frequent consumption of Great Lakes sportfish
may be associated with an increased risk of conception delay for men (see Section 3.2.5.2.2).  Although
data analysis controlled for several potential confounders, no information was collected regarding the
subjects’ frequency or timing of sexual intercourse during the period of attempting to conceive, whether
the partner providing fish consumption data also was the partner with whom the conception delay had
occurred, or levels of PCBs and other persistent toxic chemicals in biological samples from the subjects. 
The researchers will be addressing many of these limitations in a prospective reproductive health study. 
Additionally, the participation rate (29%) was extremely low in this study, which could have resulted in
nonresponse bias, a bias similar to selection bias.
General Population Exposures.  A case-control study was conducted that compared mean plasma
concentrations of 14 PCB congeners and 11 chlorinated pesticides in women with endometriosis and
women without endometriotic lesions (Lebel et al. 1998).  Cases (86) and controls (70) were selected
among premenopausal women with no previous diagnosis of endometriosis who underwent laparoscopy
for either pelvic pain, infertility, or tubal fulguration, and were matched according to the indication for
laparoscopy.  Cases and controls did not differ with respect to age, body mass index, history of breast
feeding, use of organochlorines, smoking, mean number of fish meals/week, income, and education,
although the proportion of women who had never been pregnant was higher in cases than controls. 
Analysis of covariance was used to adjust means for confounding variables, and ORs were estimated by
logistic regression.  Crude or adjusted mean concentrations of individual or summed congeners did not
differ between the groups.  Additionally, there was no significant linear trend in the adjusted ORs for
endometriosis as PCB concentrations increased.
In a study of 89 women (87% German) with repeated ($2) miscarriages, Gerhard et al. (1998) found that
blood concentrations of PCBs were higher than the reference level in 22% of the cases.  The sum of
congeners 101–180 was used for evaluation because they were the only congeners detected in significant
concentrations.  Blood levels of other organochlorine compounds (pentachlorophenol, DDE, β- and
γ-hexachlorocyclohexanes, HCB) were higher than reference ranges in 7–15% of the cases.  No
significant differences in PCB levels were found between women with early or late miscarriages (after
#12 or >12 weeks of gestation) and primary or secondary miscarriages (had never delivered or delivered
at least one baby).  Women with a history of at least four miscarriages (n=25) had significantly elevated
blood levels of PCBs, although other organochlorine compounds (γ-hexachlorocyclohexane and HCB)
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were also increased.  Hormonal disorders were identified as the cause of repeated miscarriages in 31% of
the women, including hyperprolactinemia in 9%, hyperandrogenemia in 7%, and luteal insufficiency in
14% of the cases.  Correlations were found between increasing PCB concentrations and some hormonal
parameters (e.g., increasing FSH and LH, decreasing TSH) and immunological parameters (e.g.,
increasing IgM, monocytes, and NK cells, decreasing interleukin 2 receptor-positive cells), but none of
the associations were specific for PCBs.  There were no significant associations between PCB
concentrations and further conceptions or the outcome of further pregnancies.
Yusho and Yu-Cheng Exposures.  Irregular menstrual cycles (60% of 81 patients) and abnormal basal
body temperature patterns (85% of 81 patients) were observed female Yusho patients in 1970 (Kusuda
1971).  Menstrual irregularities included changes in cycle intervals, duration, and flow that showed no
consistent pattern and were unrelated to severity of Yusho poisoning as indicated by degree of dermal
signs.  These alterations were accompanied by decreased urinary excretion of estrogens, pregnanediol,
and pregnanetriol.  Fertility, fecundity, and rates of spontaneous abortion have not been studied in Yusho
and Yu-Cheng patients (Hsu et al. 1994; Kuratsune 1989; Masuda 1994; Rogan 1989).  Sex ratio was not
altered in children born to 74 Yu-Cheng women during or after the poisoning began (Rogan et al. 1999). 
Of 137 live births occurring between 1978 and 1985, 69 were girls and 68 were boys.
3.2.5.2.2  Male Reproductive Effects
Occupational Exposure.  Sperm counts, fertility history, and testicular abnormalities as determined by
physical examination were normal in 55 transformer repairmen compared to 56 unexposed workers who
were similar in age, race, and marital status (Emmett et al. 1988a, 1988b).  The mean length of
employment of the exposed workers was 3.75 years, most (38) of the workers were currently exposed to
PCBs, and the predominant exposure was from Aroclor 1260 with lesser exposure to Aroclor 1242. 
Measurements of air PCB levels at four work areas showed 8-hour TWA concentrations of 0.0167–0.024,
0.0032–0.007, 0.00001–0.0004, and 0.0007–0.0124 mg/m3.  Geometric mean PCB concentrations in the
current-exposed, past-exposed, and comparison workers were 2.08, 0.83, and 0.60 ppm, respectively, in
adipose tissue and 12.2, 5.9, and 4.6 ppb, respectively, in serum.  Interpretation of the negative results of
this study is complicated by the similar PCB body burdens in the past-exposed and control groups. 
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Contaminated Fish Consumption.  
The New York State Angler Cohort.  Paternal exposure to Lake Ontario fish was not associated with an
increased risk of conception delay, as indicated by TTP, in women from the NYS Angler Cohort (Buck et
al. 1999).  The study sample included 785 spouses of male anglers reporting one or more pregnancies
between 1991 and 1993, known TTP, and complete paternal fish consumption histories.  Female anglers
were excluded from the study, as fish consumption data from their spouses and partners were not
collected.  Three measures of paternal fish consumption were used: (1) frequency of consumption
(number of Lake Ontario fish meals consumed in 1991), (2) duration of consumption (number of years),
and (3) an index of lifetime cumulative PCB exposure from fish consumption (categorized as low,
moderate, and high).  Conception delay was defined as requiring $12 menstrual cycles with unprotected
intercourse to achieve pregnancy.  Statistical analyses included descriptive methods and unconditional
logistic regression modeling to calculate ORs and 95% CIs.  Potential and known confounders included
maternal age, age at menarche, menstrual regularity, education, income, cigarette smoking; history of
prior pregnancy; and history of previous pregnancy loss.  Adjusted ORs for paternal fish consumption and
risk of conception delay were <1.0 for all categories of meal frequency and duration.  For the PCB index
measure, the ORs were <1.0 in all categories except moderate consumption.  The confidence intervals
included one in all analyses.  The ORs of <1.0 and inclusion of the value 1.0 in the confidence intervals
indicate that paternal fish consumption did not significantly increase the risk of conception delay among
the women.  When the analyses were restricted to spouses or partners with no Lake Ontario fish
consumption (n=445), similar results were obtained for each of the three paternal fish consumption
exposure variables.  Selection bias is a potential study concern as the study did not include women who
may have become pregnant accidentally, although there is no evidence to suggest that fish consumption is
systematically related to pregnancy intentions (Buck et al. 1999).  Other study limitations include possible
underestimation of paternal fish consumption because data did not include the 2 years prior to the TTP
assessment, and possible residual confounding as several potential confounders of female fecundity were
not collected.  
In further analysis of the Buck et al. (1999) study summarized above and the Buck et al. (1997) study
summarized in Section 3.2.5.2.1 (Female Reproductive Effects), Buck et al. (2000) combined maternal
and paternal fish consumption into one model looking at fecundability ratios as the outcome, rather than
TTP (continuous variable used in 1997 paper) or conception delay (>12 months unprotected intercourse
used in 1999 paper).  The sample included 606 women with known and unknown TTP who discontinued
birth control in order to become pregnant during 1991–1993 and for whom the partners' fish consumption
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data also were available.  The exposure measures included the duration, frequency, and lifetime PCB
index used in the previous studies.  As described in Section 3.2.5.2.1, Buck et al. (2000) used a discrete
time analogue of Cox proportional hazards analysis to estimate conditional fecundability ratios and
95% CI for fish consumption among couples with complete exposure data who discontinued birth control
to become pregnant.  Fish consumption was generally higher for men than women (68 and 42%,
respectively) as was the mean number of years of fish consumption (5.9 and 2.1 for the entire sample
whether they consumed fish or not).  Men also had higher mean PCB indices than women in the study,
although partners' consumption patterns were related.  The adjusted fecundability ratios for parental Lake
Ontario fish consumption indicated that maternal consumption of 3–6 years was associated with
significantly reduced fecundability, as was eating more than one monthly fish meal in 1991 (see
Section 3.2.5.2.1).  Paternal consumption was associated with slightly elevated, but nonsignificant, CFRs
for all three measures of fish consumption (only duration of 1–2 years had a CFR below 1.0).  The
findings suggest that maternal but not paternal consumption of contaminated fish may reduce
fecundability among couples attempting pregnancy. 
The Michigan Anglers Cohort.  An association between conception delay and sportfish consumption was
found in a survey of 626 married couples conducted between 1993 and 1995 (Courval et al. 1999).  At
least one person in each couple was a licensed angler residing in 1 of 10 Michigan counties bordering a
Great Lake (Lake Erie, Lake Huron, or Lake Michigan).  Subjects were categorized into four sex-specific
exposure classes (none, low, medium, high) based on an index of lifetime fish consumption (estimated
number of sportfish meals consumed in the past 12 months multiplied by the number of years since 1970
in which fish were caught and consumed):  0, 1–114, 115–270, and 271–1,127 for men, and 0, 1–54,
55–138, and 139–1,127 for women.  Conception delay, defined as ever having failed to conceive a child
after 12 months or more of trying, was essentially the same in both sexes (reported by 12.9% of the men
and 13.3% of the women).  Unadjusted logistic regression analysis showed that ORs for conception delay
increased in men with increasing exposure class: 1.2 (95% CI 0.5–2.9), 1.3 (0.6–3.1), and 2.0 (0.9–4.5);
results of a trends test were marginally statistically significant (p=0.06).  Adjustment for age, race, region
of Michigan, household income, smoking, and alcohol consumption minimally increased the odds ratios
for men.  The addition of the partners’ fish consumption in the adjustment further increased the odds
ratios associated with fish consumption in the model for men; the high fish consumption category OR was
2.8 (1.0–8.0), indicating that men with the highest fish consumption were at nearly 3 times the risk of
conception delay as nonconsumers.  The findings provide suggestive evidence that frequent consumption
of Great Lakes sportfish may be associated with an increased risk of conception delay for men.  As
discussed in Section 3.2.5.2.1, there was no evidence of increased risk of conception delay in the exposed
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women.  Although analysis of the data controlled for several potential confounders, no information was
collected regarding the subjects’ frequency or timing of sexual intercourse during the period of attempting
to conceive, whether the partner providing fish consumption data also was the partner with whom the
conception delay had occurred, or levels of PCBs and other persistent toxic chemicals in biological
samples from the subjects.  Additionally, the participation rate (29%) was extremely low in this study,
which could have resulted in nonresponse bias, a bias similar to selection bias.
General Population Exposures.  Semen samples from fertile men and those with low sperm counts
(idiopathic oligospermia or azoospermia) were analyzed for 74 PCB congeners (Bush et al. 1986). 
Multiple linear regression analysis of combined sample data showed no association between
concentration of any individual congener or total PCBs (summed congeners) and either sperm count,
motility, or percentage of normal forms.  Analysis of the data by fertility status (fertile, subfertile,
infertile) indicated that in the infertile men (sperm count <20 million cells/mL), decreasing sperm motility
was associated with increasing concentrations of three congeners (2,3',4,4',5-pentaCB [PCB 118],
2,2',3,4,4',5-hexaCB PCB 137], and 2,2',4,4',5,5'-hexaCB [PCB 153]).  The proportion of total variance
attributable to the regression (R2) was 9–16% for these congeners.  Another study found that blood
concentrations of tetra-CBs and penta-CBs, but not hexa-CBs and total PCBs, were significantly higher in
infertile males than in normal individuals (Pines et al. 1987).  Levels of p,p’-DDT and other
organochlorine compounds were also increased in the semen and blood of the men in these studies.
Yusho and Yu-Cheng Exposures.  Sexual maturation was not delayed, and testicular and scrotal
development was not altered in boys born to Yu-Cheng women, although the exposed boys had
significantly shorter penises (Guo et al. 1993).  Sex ratio was not altered in children born to 74 Yu-Cheng
women during or after the poisoning began (Rogan et al. 1999).  Of 137 live births occurring between
1978 and 1985, 69 were girls and 68 were boys.
3.2.5.2.3  Evaluation of Human Studies.  
Information is available on reproductive effects of PCBs in humans from studies of people exposed by the
general environment, consumption of contaminated rice oil in the Yusho and Yu-Cheng poisoning
incidents, consumption of contaminated fish, and occupational exposures.  A comparison of PCB levels in
blood and breast milk in some of these studies is included in Appendix A.
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Females.  Gerhard et al. (1998) examined a number of university hospital female patients (n=89) with a
history of miscarriages.  Although other substances were also detected (e.g., hexachlorobenzene), PCB
levels were found to be higher in the blood of patients with a history of three or more miscarriages. 
Another study of the general population found no association between endometriosis and concentrations
of PCBs in the blood (Lebel et al. 1998).  
Menstrual irregularities (i.e., altered intervals, duration, and flow) were observed in women exposed
during the Yusho poisoning incident (Kusuda 1971).  Heating of the PCB-contaminated rice oil also
resulted in the formation of other contaminants of concern (i.e., dibenzofurans and ter-, and
quarterphenyls) (Rogan 1989). 
In a study of Native Americans, fish consumption has been shown to be a major risk factor for elevated
PCB body burdens (Fitzgerald et al. 1996).  The studies that examined reproductive end points in women
whose diets contained Great Lakes fish found evidence that consumption of the fish may be associated
with a slightly shorter length of menstrual cycle (Mendola et al. 1997), but not with increased risk of
conception delay in females (Buck et al. 1997; Courval et al. 1999) or increased risk for spontaneous fetal
death (Mendola et al. 1995a).  Buck et al. (1997) examined time-to-pregnancy (i.e., after stopping birth
control, the number of menstrual cycles before pregnancy) as the outcome measure of conception. 
However, in a more recent study (Buck et al. 2000), their outcome measure was a fecundability ratio (i.e.,
probability of conception during a given menstrual cycle for the exposed, divided by the same probability
for the unexposed).  Utilizing this outcome, the researchers found that maternal consumption of fish for
3–6 years was associated with a reduction in fecundability (i.e., biological capacity for reproduction). 
Significantly higher levels of several PCB congeners (e.g., 153 and 138) were also detected in the breast
milk of fisheaters (Kostyniak et al. 1999).  The number of months of lifetime lactation declined in these
females with a rise in PCB concentration in breast milk.  
Mendola et al. (1997) note that the effect on menstrual cycle length in the women fisheaters is a
preliminary finding that needs to be interpreted cautiously because of certain limitations (e.g., lack of
information on confounders such as stress, use of contraceptives, body mass index, and physical
exercise).  The decreases in menstrual length were small and were considered not likely to be clinically
relevant.  However, they may be indicative of potential endocrine effects to the population.  At the
highest exposure levels, the decrease was approximately 0.5 days for women who reported regular cycles
and 1 day for all women who reported cycle length information.  The effect did not appear to be mediated
through irregular cycles since the fish consumption-based exposure levels were similar for women who
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reported regular or irregular cycles.  The human populations in which menstrual changes have been
observed differ with respect to the sources of PCBs and exposures to other chemicals that may affect
susceptibility to menstrual disturbances.  Although the studies are insufficient for determining which
specific chemical(s) may be responsible for the observed alterations, the available data support a possible
association between PCBs and menstrual disturbances. 
There was no apparent effect on mean number of pregnancies in women who were occupationally
exposed to Aroclors 1254, 1242, and/or 1016 (Taylor et al. 1989).  This study had limitations due to small
numbers of subjects and the availability of only estimates of exposure based upon job descriptions,
manufacturing process, and industrial hygiene data.  Additionally, the mean number of pregnancies
represented data not adjusted for potential confounders.  
The human studies of reproductive effects in females have not always resulted in consistent findings.  For
example, two studies of fish consumption and conception demonstrated no effect (Buck et al. 1997;
Courval et al. 1999).  However, a more recent study by Buck et al. (2000) demonstrated that fish
consumption of a 3–6 year duration was associated with a reduction in fecundity in females.  Despite the
variation in results between studies, an association can be observed between the documented reproductive
effects (e.g., menstrual irregularities and conception failure), making these findings biologically
persuasive.
Males.  Analysis of semen for 74 PCB congeners showed that increasing concentrations of three
congeners (PCBs 118, 137, and 153), but not total PCBs, were associated with decreasing sperm motility
in infertile men (Bush et al. 1986).  Another study found that blood concentrations of tetra-CBs and
penta-CBs, but not hexa-CBs and total PCBs, were significantly higher in infertile males than in normal
individuals (Pines et al. 1987).  These results do not necessarily indicate a causative relationship between
PCBs and infertility in men for a number of reasons, particularly because levels of p,p’-DDT and other
persistent toxic chemicals were also increased in semen and blood.  Bush et al. (1986) found that the PCB
congeners only accounted for a small proportion of the total variance attributable to the linear regression
analysis, and hypothesized that the increased levels of PCBs in the low sperm count samples could be due
to other factors, such as biological malfunction in the sperm generation system causing lipid leakage. 
Associations between conception delay and consumption of PCB-contaminated Great Lakes sportfish
were reported in exposed men, but not their wives, in the study of the Michigan Anglers Cohort (Courval
et al. 1999).  Although analysis of the data controlled for several potential confounders, no information
was collected regarding the subjects’ frequency or timing of sexual intercourse during the period of
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attempting to conceive, or levels of PCBs and other persistent toxic chemicals in biological samples from
the subjects.  Additionally, there was no clear association between paternal exposure to consumption of
contaminated fish and conception delay or reduced fecundability in the NYS Angler Cohort, another
cohort of Great Lakes Anglers (Buck et al. 1999, 2000).  Occupational studies of reproductive effects in
men provide no clear indications of PCB-related effects.  Sperm counts, fertility history, and testicular
examinations were normal in a study of transformer repairmen who were occupationally exposed to
Aroclors 1260 and 1242 for a mean duration of 3.75 years (Emmett et al. 1988a, 1988b).  Although the
overall evidence for associations between PCBs and effects on sperm and conception delay in males has
not always been consistent, there are indications of possible reproductive effects in males which are
supported by the findings for female study subjects with similar exposure patterns.  
3.2.5.3  Animal Studies
The highest NOAEL values and all reliable LOAEL values for reproductive effects for each study are
recorded in Table 3-2 and plotted in Figure 3-2.
3.2.5.3.1  Female Reproductive Effects
Commercial Mixtures.  Information on reproductive toxicity of commercial PCB mixtures in female
animals is available from studies in rats, mice, rabbits, minks, and monkeys.  As discussed below, effects
on fertility and/or reproductive function have been observed in most of these species with minks and
monkeys showing particular sensitivity.
Wistar rats that were administered 10 mg/kg/day Aroclor 1254 by gavage for 4–6 weeks had prolonged
estrus cycle, decreased sexual receptivity, and a transient decrease in body weight gain, but no significant
effect on the number of ovulations compared to unexposed controls (Brezner et al. 1984).  Animals that
were subsequently bred (duration of exposure at time of mating not specified) experienced treatment-
related vaginal bleeding during gestation, delayed parturition, and decreased litter size.  Evaluation of
pups following gestational and lactational exposure showed decreased body weight gain, decreased
preweaning survival, premature vaginal opening, and delayed first estrus, but there were no effects on
sexual differentation, estrous cycle, mating, or pregnancy.  There were no significant changes in number
of implantation sites, litter size, or offspring sex ratio in Long-Evans rats that were exposed to
4 mg/kg/day Aroclor 1254 in the diet from 50 days prior to mating until birth (Hany et al. 1999b).  There
were no overt signs of maternal toxicity, and other dose levels were not tested.  Body weight (average of
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both sexes) was significantly reduced in the pups at birth and PND 7–21, and relative testes weights and
serum testosterone levels were reduced in adult male offspring at PND 170.
Two-generation studies were performed in which groups of 20 female Sherman rats were exposed by diet
to Aroclor 1254 in doses of 0, 0.06, 0.32, 1.5, or 7.6 mg/kg/day or Aroclor 1260 in doses of  0, 0.39, 1.5,
or 7.4 mg/kg/day (Linder et al. 1974).  Exposure to Aroclor 1254 caused significantly reduced litter sizes
at 7.6 mg/kg/day in the F1a generation (14% smaller than controls) and $1.5 mg/kg/day in the F1b, F2a,
and F2b generations (15–72% smaller than controls).  No effects on litter size were found in either
generation of rats fed 0.06 mg/kg/day of Aroclor 1254 or $0.39 mg/kg/day of Aroclor 1260.  Insufficient
information is available to determine whether the effect on litter size is due to reproductive or
developmental toxicity because fertility and other reproductive end points were not evaluated in the
study.
Reproductive effects were evaluated in female offspring of Holtzman rats following maternal exposure to
0, 8, 32, or 64 mg/kg/day of Aroclor 1254 by gavage on lactation days 1, 3, 5, 7, and 9 (Sager and Girard
1994).  Young, mature, and older adult offspring were examined at 2–4.5, 5–8, and 8.5–13 months of age,
respectively, and mated to untreated males at 112, 200, and 350 days of age, respectively.  Effects
included a dose-related reduction in preweaning weight gain that was statistically significant at
$32 mg/kg/day, delayed puberty as indicated by late vaginal opening and first estrus at $32 mg/kg/day;
reduced mating rate (sperm-positive females) in mature offspring at $8 mg/kg/day; reduced implantation
rate and mean number of embryos in young and mature offspring at 64 mg/kg/day; reduced uterine
weight during proestrus in young, mature, and older offspring at $8 mg/kg/day; and reduced uterine
response to exogenous 17-beta estradiol in ovariectomized mature offspring at $8 mg/kg/day.  Average
estrus cycle length was not significantly different in any of the groups, although cycle patterns were
altered in low- and high-dose young offspring and in mid-dose mature rats.  Pregnancy and ovulation
rates, reproductive aging, and ovarian weights were not affected by exposure Aroclor 1254.
Estrogenic effects of PCBs were also evaluated in in utero and lactationally exposed female offspring of
Sprague-Dawley rats that were administered 0 or 30 mg/kg/day doses of Aroclor 1221, 1242, or 1260 by
gavage on days 12–20 of gestation (Gellert and Wilson 1979).  Evaluation of the offspring at
approximately 6 months of age showed no exposure-related changes in ovarian weight, ovulatory status,
or vaginal estrus cyclicity.
Female ICR Swiss mice that were exposed to Aroclor 1254 in the diet at a dose of 12.5 mg/kg/day for
90 days before mating had a conception rate that was reduced approximately 30% compared to lower
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dose groups (#1.25 mg/kg/day) and controls (Welsch 1985).  There were no exposure-related effects on
fertilization rate or pre- and postimplantation embryonic losses in New Zealand rabbits that were
administered 4 mg/kg of Aroclor 1260 (only treatment level) by gavage on 3 days/week for 12–15 weeks
before artificial insemination and throughout gestation (Seiler et al. 1994).  No other reproductive
parameters were examined in these studies.
It is well established that oral exposure to low doses of PCBs causes reproductive failure in minks.  For
example, in minks that were exposed to Aroclor 1254 at an estimated dietary dose of 0.4 mg/kg/day for a
39-week period that began approximately 6 months before mating and ended when the kits were 4 weeks
of age, only two of seven mated females produced offspring with a total of two kits (one alive and one
dead) (Aulerich and Ringer 1977).  No effects on numbers of females producing offspring or kits born
were induced by similar exposure to Aroclor 1242, 1221, or 1016, although 0.4 mg/kg/day was the only
dose level tested.  Dietary exposure to 0.2 mg/kg/day Aroclor 1254 for a 21-week period that began
approximately 4 months before breeding and ceased at the end of gestation had no effect on numbers of
females producing offspring or kits born, although marked reductions occurred at 0.9 mg/kg/day, and
there were no births at 2.8 mg/kg/day (Aulerich and Ringer 1977).  Female minks that were exposed to
1.3 mg/kg/day Aroclor 1254 in the diet from approximately 5 weeks before breeding until 5 days after
parturition had an increased frequency of interrupted pregnancies and 48% reduced litter size with no live
births (Kihlstrom et al. 1992).  Similar effects on reproduction were observed in female minks that were
exposed to 0.5–1.7 mg/kg/day Aroclor 1254 or 1.8 mg/kg/day Clophen A50 from before mating until
5 days after parturition for total durations of approximately 3 months (Backlin and Bergman 1995;
Backlin et al. 1997, 1998a, 1998b; Jones et al. 1997).  No indications of PCB-induced impaired ovulation
or implantation have been observed in minks, although histopathological studies of mid- to late-gestation
placentae indicate that fetal death is mediated by degenerative changes in maternal (endothelial
detachment and thrombosis in maternal vessels) and fetal (trophoblastic disintegration and loss of fetal
capillary integrity) tissues (Backlin and Bergman 1995; Backlin et al. 1997, 1998a, 1998b; Jones et al.
1997; Kihlstrom et al. 1992).
Reproductive effects of low doses of commercial PCB mixtures have also been demonstrated in
intermediate-duration studies in female monkeys.  Exposure to 0.8 mg/kg/day Aroclor 1248 for 2 months
caused a reduction in conception rate in monkeys (Allen et al. 1974a).  Conception did not occur in two
of five monkeys that were bred 3 months posttreatment, resorption and/or abortion occurred in two of the
three pregnant monkeys, and the two nonpregnant monkeys were bred twice again during the subsequent
5 months without success.  Groups of eight female Rhesus monkeys were exposed to 0.1 or 
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0.2 mg/kg/day Aroclor 1248 in the diet from 7 months prior to breeding and throughout pregnancy
(Barsotti et al. 1976).  Increased menstrual duration (5–7 days) and bleeding occurred at $0.1 mg/kg/day,
and conception rate was decreased at 0.2 mg/kg/day.  Resorptions or abortions occurred in 3/8 and 4/6 of
low- and high-dose impregnated monkeys, compared with 0/12 in controls, and the remaining two high-
dose animals were bred 5 times without success.  Similar effects occurred in four Rhesus monkeys that
were mated after 38 weeks of dietary exposure to 0.2 mg/kg/day Aroclor 1248 (Arnold et al. 1990). 
Following extended post-implant bleeding, all of the treated monkeys aborted within 30–60 days of
gestation.  Following recovery from the abortions, the monkeys were bred again up to a maximum of
7 times but none appeared to conceive, and the menstrual cycle lengths and durations became erratic and
longer during and subsequent to the breeding period.
Information on reproductive effects of chronic exposure to PCBs is available from a study in which groups
of 16 female Rhesus monkeys ingested capsules providing 0, 0.005, 0.02, 0.04, or 0.08 mg/kg/day doses of
Aroclor 1254 for up to 72 months (Arnold et al. 1993a, 1993b, 1995, 1997).  Evaluation during the
premating phase of the study (first 37 months) found no exposure-related changes in serum levels of
estrogen and progesterone (assessed during one menstrual cycle), menstrual duration (number of days of
menstrual flow), or menstrual cycle length (number of days from first day of menses until the day
preceding the next menses) (Arnold et al. 1993a, 1993b).  The average cycle duration was slightly
increased in the 0.04 and 0.08 mg/kg/day groups compared to controls and the average cycle length was
slightly shortened in treated groups compared to controls, but none of the differences were statistically
significant.  There also were no apparent treatment-related effects on incidences of anovulatory cycles or
temporal relationships between estrogen peak and menses onset, menses end, or progesterone peak.  After
37 months of exposure, the females were mated with untreated males and dosing was continued throughout
mating and gestation until the breeding phase of the study (29 months) was completed (Arnold et al. 1995). 
Incidences for impregnation success were 11/16, 10/16, 4/15, 6/14, and 5/15 in the control to high-dose
groups.  Statistical analysis of these conception rates, adjusted for either total number of matings or
number of matings with positive sires, showed that there was a significant (p=0.017) decreasing trend in
the rate of impregnation with increasing dose from 0 to 0.08 mg/kg/day.  There was no evidence of such a
trend when conception rates among only the treated groups were compared.  Comparisons between the
treated and control groups showed that the conception rates were significantly (p<0.05) reduced at doses
$0.02 mg/kg/day.  Age of the females did not appear to be a confounding factor.  A significantly
increasing dose-related trend in fetal mortality incidence rates (p=0.040) was also found in this study. 
Comparisons between the treated and control groups showed that fetal mortality was significantly (p<0.05)
increased at 0.08 mg/kg/day and marginally (p=0.077) increased at 0.02 mg/kg/day, indicating that 
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0.02 mg/kg/day is the LOAEL for both reduced conception and fetal survival.  Although the increased
fetal mortality in the 0.02 mg/kg/day group was marginally nonsignificant, the number of animals was
small; this group had three fetal deaths in four impregnated animals, and the infant that was born died
within 2 weeks postpartum.  Maternal treatment was discontinued after approximately 7 weeks of lactation
to preclude infants from self-ingesting the mother’s dosing capsule, and restarted in the adult monkeys
when infants were weaned at 22 weeks of age and continued for the following 8 months (Arnold et al.
1997).  Necropsies performed at the end of the postweaning exposure period showed no exposure-related
histopathological changes in the uterus and other parts of the reproductive system or increased incidences
or severity of endometriosis.
Defined Experimental Mixtures.  There were no significant effects on number of implantation sites, litter
size, or offspring sex ratio in Long-Evans rats that were exposed to 4 mg/kg/day of a PCB congener
mixture simulating the congener content of human milk from 50 days prior to mating until birth (Hany et
al. 1999b).  Overt signs of maternal toxicity were not observed, and other dose levels were not tested. 
Body weight in the pups (average of both sexes) was significantly reduced at birth and PND 7–21, relative
uterine weight was significantly increased in the female offspring on PND 21, and relative testes weights
and serum testosterone levels were significantly reduced in adult male offspring at PND 170.
Contaminated Fish.  No adverse reproductive effects were found in a 2-generation study in which
Sprague-Dawley rats were fed diets containing 0, 5, or 20% (w/w) of lyophilized protein from chinook
salmon from Lake Huron or Lake Ontario (Arnold et al. 1998; Feely and Jordan 1998; Feeley et al. 1998). 
The F0 rats (30 males and 30 females/group) were mated after 70 days on the test diet and the F1 rats
(1 male and 1 female from 24 litters) were mated 70 days postweaning.  Daily intakes of total PCBs in the
female F1 rats fed diet containing 0, 5, or 20% lyophilized Lake Ontario salmon flesh were calculated to
be 0.22, 23.20, and 82.37 µg/kg/day, respectively (Feely and Jordan 1998).  PCB intakes were
qualitatively similar, but generally somewhat lower, for males compared with females and for F0 rats
compared with F1 rats, and intakes from the Lake Huron diet were about 35–40% lower than from the
Lake Ontario diet.  The DDT complex (p,p’-DDT,  p,p’-DDE, and  p,p’-DDD) accounted for 75 and 60%
of organochlorine pesticide residues in the Lake Huron and Lake Ontario fish, respectively, and other
major contaminants included CDDs and CDFs, mirex, chlordane, cadmium, lead, mercury, and arsenic. 
Comprehensive reproductive assessment, which included evaluation of conception rate and mating,
fertility, viability, and lactation indices, showed no significant exposure-related adverse effects in either
generation.
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A 2-generation reproduction study of Lake Huron fish was conducted in minks (Restum et al. 1998). 
Although numerous chlorinated pesticides and other persistent toxic substances were present in the fish,
the dietary treatments were expressed as targeted concentrations of total PCBs.  Diets were formulated to
provide 0, 0.25, 0.5, or 1.0 ppm PCBs by substituting carp from Lake Huron for ocean fish in the control
diet.  To determine whether the effects of exposure were permanent, half of the parental (P1) animals
were switched from the treatment diets to the control diet after whelping the first of two F1 generations. 
Total exposure time for the P1 minks that were switched to the control diet after weaning was about
6 months, and the P1 minks that were continued on the treatment diets until termination of the study were
exposed for approximately 16–18 months.  Effects of gestational and lactational exposure on reproductive
performance of the first F1 generation were examined by switching half of the F1 offspring to the control
diet at weaning (offspring were exposed for about 3 months), and continuing the remaining offspring on
their parental diet throughout their lifetime (continuous exposure for 12–15 months).  The second F1
generation included kits born to the P1 dams that were exposed for 6 months followed by 10–12 months
of consumption of control diet prior to whelping, as well as kits born to the P1 dams that were
continuously exposed over an 18-month period.  F2 generation minks consisted of kits born to the first F1
generation and exposed to PCBs either during gestation and lactation only, or from gestation throughout
their lifetime.  Effects included delayed onset of estrus, as determined by vulvar swelling and time of
mating, in P1 and F1 females that were continuously exposed to the mid and high doses of PCBs.  There
were no significant differences in breeding performance (numbers of confirmed bred) and reproductive
performance (number whelped/number mated) in the P1 and F1 females.  Survivability of F1 and F2
offspring was markedly decreased in the mid- and high-dose groups.  The reduced survivability of the F1
kits predominately occurred after birth during the lactation period.  For example, the first F1 litter
produced by the F0 generation showed a 70.5% survivability at birth (compared with 94.6% in controls),
but by the end of lactation, 6 weeks after birth, the average survivability was 23% (compared with about
73% in controls).  In several exposure groups, there were decreased percentages of mated females that
gave birth, but the decreases were not statistically significant.  The failure to demonstrate statistical
significance may have been due to small sample sizes for several of these groups.  For example, in a high-
dose F1 group, 2/4 mated females gave birth (50%), compared with 11/14 (79%) in the F1 control group.  
  
Single Congeners.  A series of toxicity studies was performed in which groups of 10 male and 10 female
Sprague-Dawley rats were exposed to diets containing four dose levels of various single congeners for
13 weeks (Chu et al. 1994, 1995, 1996a, 1996b, 1998b; Lecavalier et al. 1997).  Histological
examinations of the female reproductive organs and mammary glands showed mild changes in the ovaries
in 7/10 rats exposed to PCB 126 at 8.7 µg/kg/day, but not #0.83 µg/kg/day (Chu et al. 1994).  The 
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ovarian changes were characterized by loss of oogonia in the primary follicles with degeneration of the
inner layer of the corona.  No effects in reproductive tissues were found in females following exposure to
PCB 28 at #3,956 µg/kg/day; PCB 77 at 892 µg/kg/day; PCB 105 at #3,960 µg/kg/day; PCB 118 at
#170 µg/kg/day; PCB 128 at #4,125 mg/kg/day; or PCB 153 at #4,397 µg/kg/day.  Measurements of
serum leutinizing hormone and follicle-stimulating hormone concentrations, performed only in the female
rats exposed to PCB 28 and PCB 77, showed no exposure-related changes (Desaulniers et al. 1997).
Promotion of surgically-induced endometriosis was studied in B6C3F1 mice that were treated with
PCB 126 or PCB 153 by gavage every 3 weeks for a total of 5 doses (Johnson et al. 1997).  Dose levels
were 0, 100, 300, or 1,000 µg/kg/day for PCB 126 and 0, 3, or 30 mg/kg for PCB 153.  No significant
changes in the size, weight, or histology of endometriotic lesions were induced by either congener.  There
also were no significant effects on ovarian or uterine weights, although histological examination of the
ovaries (uterus not examined) from a small number of animals (three per group) suggested possible
induction of ovarian atrophy by PCB 126. 
A reproduction study of PCB 169 was conducted in which offspring of exposed female Wistar rats were
mated (Smits-van Prooije et al. 1993).  The maternal rats were treated with a single 0, 0.2, 0.6, or
1.8 mg/kg dose of PCB 169 by gavage on day 1 of gestation.  Mating of male and female offspring as
young adults (age not specified) resulted in significantly reduced mating success (females mated) and
pregnancy rate at 1.8 mg/kg.  Mating of female offspring with unexposed males as 1-year-old adults
caused nearly a completely reduced number of mated females and zero pregnancy rate at 1.8 mg/kg.
Female C57BL/6J mice were fed PCB 77 in estimated dietary doses of 0, 0.6, or 7 mg/kg/day for 2 weeks
before mating with unexposed males and subsequently throughout gestation and lactation (Huang et al.
1998b).  Female offspring were fed the same diets as the dams from weaning until 7 weeks of age, at
which time they were mated with unexposed males.  Fecundity (percentage of mated females that gave
birth) and pup survival at ages 4 and 21 days were reduced in the F0 females at 7 mg/kg/day.  There were
no effects on fecundity or litter size in the F1 females, although all of their offspring died before 4 days of
age at $0.6 mg/kg/day.  Other effects included reduced in vitro fertilizing ability of the eggs and
increased degenerated eggs in the F1 females at $0.6 mg/kg/day; these end points were not evaluated in
F0 females. 
Other Relevant Information.  Results from in vitro studies with oocytes obtained from superovulated
B6D2F1 mice showed that and 3,3',4,4'-tetraCB and Aroclors 1221, 1254, and 1268 significantly reduced
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fertilization rates and increased the incidence of degenerative ova and abnormal 2-cell embryos (Kholkute
et al. 1994a).  Of the four PCBs tested, Aroclor 1254 was the most effective.  
3.2.5.3.2  Male Reproductive Effects
Commercial Mixtures.  High oral doses of commercial PCBs induced testicular effects in weanling rats,
but not adult rats or mice.  Adult mice that were exposed to 130 mg/kg/day Aroclor 1254 in the diet for
14 days had no treatment-related changes in relative weights of the testes or preputial and vesicular
accessory glands (Sanders et al. 1974).  Similarly, no effects on testis weight, epididymis weight, or
testicular histology or cytogenicity were found in adult rats that were treated with 50 mg/kg/day
Aroclor 1254 by gavage for 7 days (Dikshith et al. 1975).  Weanling F344 rats that were administered
25 mg/kg/day Aroclor 1254 by gavage for 15 weeks, however, had significant reductions in seminal
vesicle and cauda epididymal weights, caudal epididymal sperm counts, and body weight gain (Gray et al.
1993).  These effects were not observed at lower doses of 0.1–10 mg/kg/day, and there were no changes
in testicular sperm count and motility, testicular weight, serum levels of testosterone, weight of the
testicular interstitial fluid, testosterone concentration in the interstitial fluid, or total testosterone in the
interstitial fluid compartment of the testis.  None of these mouse and rat studies evaluated reproductive
capability.   
Fertility was markedly reduced in male offspring of Holtzman rats that were lactationally exposed to
Aroclor 1254 (Sager 1983; Sager et al. 1987, 1991).  The maternal rats were treated with 8, 16, 32, or
64 mg/kg doses by gavage on lactation days 1, 3, 5, 7, and 9, and male offspring were mated with
untreated females 130–150 days postweaning (Sager 1983; Sager et al. 1987).  Significant decreases in
numbers of implants and embryos were observed at 8 mg/kg/day (21 and 29% lower than controls,
respectively) and higher doses, and there was either a significant decrease or a decline in number and
percent of normal fertilized eggs and eggs at the two- to four-cell blastocyte stages at $16 mg/kg/day. 
The reduction in male fertility appears to be due to impaired ability of sperm to fertilize eggs because
sperm production, morphology, and motility were not affected and plasma FSH and testosterone
concentrations were not reduced (Sager et al. 1987, 1991).  Seminal vesicle and ventral prostate weights
were decreased at $16 mg/kg/day.
In contrast to the effects of Aroclor 1254 summarized above, fertility was not impaired in male offspring
of Sprague-Dawley rats that were administered 0 or 30 mg/kg/day doses of Aroclor 1221, 1242, or
1260 by gavage on days 12–20 of gestation (Gellert and Wilson 1979).  There were no exposure-related
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changes in the percentage of male offspring (F1) siring progeny when they were mated with unexposed
females at approximately 6 months of age, or in the sex ratio of the F2 offspring from this mating. 
Measurements of absolute testes and ventral prostate weights in the F1 males (relative weights not
determined) showed no changes except for increased testes weight in the Aroclor 1260 group.
Limited information is available on reproductive effects of commercial PCB mixtures in male minks and
monkeys.  Mating performance and testicular histology were normal in four male minks that were fed
0.1 mg/kg/day Aroclor 1254 in the diet for approximately 6 months (Wren et al. 1987b).  Aulerich and
Ringer (1977) noted that long-term dietary exposure to Aroclor 1254 did not exert any apparent adverse
effects on spermatogenesis in minks.  Matings between unexposed females and PCB-treated males
reportedly resulted in acceptable reproduction, but no additional study information was provided.   
One of four male Rhesus monkeys that were fed 0.1 mg/kg/day Aroclor 1248 for 17 months developed
decreased libido and dermal and ocular signs of PCB toxicity after the first year of exposure (Allen and
Norback 1976).  A testicular biopsy on the affected animal showed marked hypoactivity of the
seminiferous tubules characterized by an absence of mature spermatozoa and a predominance of Sertoli
cells.  The remaining three males remained healthy and sexually active.  Evaluation of sperm morphology
and viability and the ability to fertilize unexposed females, performed during the first year of exposure,
showed no effects in any of the four males.  
Contaminated Fish.  There were no effects on breeding performance in male minks in the 2-generation
reproduction study of Lake Huron fish summarized in Section 3.2.5.3.1 (Restum et al. 1998).  No
differences in the number of attempted or confirmed matings, or testicular volumes, were observed among
the P1 and F1 generation males.
Single Congeners.  Reproductive effects were evaluated in offspring of female Wistar rats that were
treated with a single 0, 0.2, 0.6, or 1.8 mg/kg dose of PCB 169 by gavage on day 1 of gestation (Smits-
van Prooije et al. 1993).  Mating of exposed male and female offspring as young adults (age not
specified) resulted in significantly reduced mating success (females mated) and pregnancy rate at
1.8 mg/kg.  Mating of exposed male offspring with unexposed females as 1-year-old adults resulted in a
zero pregnancy rate at 1.8 mg/kg.
Female C57BL/6J mice were fed PCB 77 in estimated dietary doses of 0, 0.6, or 7 mg/kg/day for 2 weeks
before mating with unexposed males and subsequently throughout gestation and lactation (Huang et al.
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1998a).  Male F1 offspring were fed the same diets as the dams from weaning through 7 and 17 weeks of
age, at which time, they were mated with unexposed females.  Evaluation of reproductive ability of the F1
males showed no effects es as indicated by changes in fecundity (percentage of mated females that gave
birth), litter size, sex ratio, or pup survival.  Testes weights were increased in 7 mg/kg/day F1 males at
3 weeks, but not at 9 or 19 weeks of age.  Additionally, although there were no effects on breeding, in
vitro sperm-fertilizing ability was reduced in 7 mg/kg/day F1 males at 19 weeks, but not at 9 weeks of
age.     
A series of toxicity studies was performed in which groups of 10 male and 10 female Sprague-Dawley
rats were exposed to diets containing four dose levels of various single congeners for 13 weeks (Chu et al.
1994, 1995, 1996a, 1996b, 1998; Lecavalier et al. 1997).  Histological examinations showed no effects in
male reproductive tissues following exposure to PCB 28 at #3,783 µg/kg/day; PCB 77 at
#768 µg/kg/day; PCB 105 at #4,327 µg/kg/day; PCB 118 at #683 µg/kg/day; PCB 126 at
#7.4 µg/kg/day; PCB 128 at #3,534 µg/kg/day; or PCB 153 at #4,210 µg/kg/day.  Measurements of
serum testosterone concentrations, performed only in the male rats exposed to PCB 28 and PCB 77,
showed no exposure-related changes (Desaulniers et al. 1997).
Other Relevant Data.  Daily sperm production was reduced and percentages of abnormal sperm were
increased in adult male rats 1–8 weeks following administration of a single subcutaneous dose of 18 or
60 mg/kg of 3,3',4,4'-tetraCB (PCB 77) (Faqi et al. 1998).  No effects on testis histology or serum
testosterone concentration were observed, and reproductive capability was not evaluated.
Effects on the testis were evaluated in adult male rats that were neonatally exposed to either
Aroclor 1242 (.10, 40, or 80 mg/kg/day) or Aroclor 1254 (.10 or 40 mg/kg/day) by daily subcutaneous
injection from birth to PND 25 (Cooke et al. 1996).  Examinations at 135 days of age showed
significantly increased testis weight at $40 mg/kg/day Aroclor 1242 and $10 mg/kg/day Aroclor 1254,
and increased daily sperm production at 10 mg/kg/day Aroclor 1242 and $10 mg/kg/day Aroclor 1254. 
Sertoli cell proliferation was also increased in exposed rats (only examined in 15-day-old pups treated
with 40 mg/kg/day Aroclor 1242).  Both Aroclor 1242 and 1254 also suppressed serum thyroxine (T4)
concentrations and T4 replacement decreased or eliminated the testicular effects.  As discussed in
Section 3.2.2.8 (Endocrine Effects), other studies also indicate that hypothyroidism is involved in PCB-
induced testicular effects in neonatal rats.  Fertility tests showed that all Aroclor 1242-treated rats
successfully impregnated unexposed females (Aroclor 1254 was not tested).   
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3.2.5.3.3  Evaluation of Animal Studies
Reproductive toxicity in female animals has been established in a number of oral studies with commercial
PCB mixtures.  Effects have been observed in various species, including rats (e.g., prolonged estrus,
decreased sexual receptivity, and reduced implantation rate in adults and/or their offpsring exposed via
gestation and lactation), mice (decreased conception), minks (partial or total reproductive inhibition), and
monkeys (prolonged menstruation, decreased fertility) (Allen et al. 1974a; Arnold et al. 1990, 1993a,
1993b, 1995; Aulerich and Ringer 1977; Backlin and Bergman 1995; Backlin et al. 1997, 1998a, 1998b;
Barsotti et al. 1976; Brezner et al. 1984; Jones et al. 1997; Kihlstrom et al. 1992; Sager and Girard 1994;
Welsch 1985).  Minks and monkeys are particularly sensitive, with effects occurring in these species at
doses in the range of 0.1–1 mg/kg/day in intermediate-duration studies, and as low as 0.02 mg/kg/day in
monkeys following chronic exposure.
In minks, repeated exposure to 0.4–1.8 mg/kg/day doses of Aroclor 1254 or Clophen A50 caused
reproductive failure that has been associated with fetal death following embryo implantation (Aulerich
and Ringer 1977; Backlin and Bergman 1995; Backlin et al. 1997, Kihlstrom et al. 1992).  No indications
of PCB-induced impaired ovulation or implantation have been observed in minks, although
histopathological studies indicate that fetal death is mediated by changes in the placental vasculature
which cause degenerative changes in the maternal and fetal vessels during gestation (Backlin and
Bergman 1995; Backlin et al. 1997, 1998a, 1998b; Jones et al. 1997; Kihlstrom et al. 1992).  As discussed
in Section 3.5.2, multiple mechanisms are likely to be involved in PCB-induced reproductive impairment
in minks.  Although these studies provide important information on the mechanism and sensitivity of
reproductive toxicity in female minks, it is unclear if this species is an appropriate surrogate for human
toxicity.  Impaired ability to conceive and decreased fetal survival are well-documented in female
monkeys following repeated oral exposures to Aroclors 1254 and 1248 (Allen et al. 1974a; Arnold et al.
1990, 1993a, 1993b, 1995; Barsotti et al. 1976).  For example, reduced conception rates, as well as
increased incidences of abortions, resorptions, or stillbirths, were observed in groups of 16 female Rhesus
monkeys that were fed encapsulated Aroclor 1254 at dose levels of 0.02–0.08 mg/kg/day for 37 months
before breeding and subsequently throughout mating and gestation (Arnold et al. 1995).  There were no
clear effects on reproduction at 0.005 mg/kg/day, the lowest tested dose in this study and in any species. 
This dose is the LOAEL for immunological effects in the maternal monkeys and developmental toxicity
in their offspring (see Sections 3.2.3 and 3.2.6).  Mechanisms for the reproductive effects in monkeys
have not been elucidated, although Arnold et al. (1995) found no evidence that they were associated with
endometriosis.
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There is some evidence suggesting that noncommercial mixtures of PCBs may have the potential to
induce estrogenic and anti-estrogenic effects in the offspring of exposed animals.  There were no
significant effects on number of implantation sites or litter size in rats that were exposed to 4 mg/kg/day
of a PCB congener mixture simulating the congener content of human milk from 50 days prior to mating
until birth (Hany et al. 1999b).  Evaluation of the offspring, however, showed significantly increased
relative uterine weight in immature females (PND 21) and reduced testes weights and serum testosterone
levels in adult males (PND 170).  No significant exposure-related adverse effects on reproductive
parameters (mating, fertility, viability, lactation indices, litter size) were found in a 2-generation study of
rats fed contaminated fish from Lake Huron or Lake Ontario (Feeley et al. 1998).  A 2-generation
reproduction study of Lake Huron-fed minks similarly found no effects on breeding or reproductive
performance, although onset of estrus was delayed in P1 and F1 females and survivability was decreased
in F1 and F2 offspring (Restum et al. 1998).  From the available information, it is not possible to
determine whether the different results from the minks and rat studies are due to physiological or
biochemical differences between minks and rats, qualitative or quantitative differences in chemical
composition of the fish flesh, or some other cause.  Additional information on the estrogenic and
antiandrogenic effects of PCBs is discussed in Mechanisms of Toxicity (Section 3.5.2). 
A limited amount of information is available on reproductive effects of PCBs in male animals.  Short-
term exposure to high oral doses of Aroclor 1254 induced no changes in the weight or histology of the
testes or accessory glands in adult rats exposed to 50 mg/kg/day for 7 days or mice exposed to
130 mg/kg/day for 14 days (Dikshith et al. 1975; Sanders et al. 1974).  Weanling F344 rats that were
treated with 25 mg/kg/day Aroclor 1254 by gavage for 15 weeks, however, had significant reductions in
seminal vesicle and cauda epididymal weights, caudal epididymal sperm counts, and body weight gain
(Gray et al. 1993).  These effects were not observed at lower doses of 0.1–10 mg/kg/day, and there were
no changes in other testicular end points including sperm count and motility, testicular weight, and serum
levels of testosterone.  The results of the Gray et al. (1993) study may be related to the age of the rats at
the start of dosing (day 31), which is after the development of Sertoli cells is complete, and therefore may
have missed the vulnerable period in the postnatal development of the testes (see discussion in
Section 3.2.2.8.3).  None of these mouse and rat studies evaluated reproductive capability.  Observations
on small numbers of animals indicated that mating performance and testicular histology were normal in
male minks that were fed 0.1–0.9 mg/kg/day doses of Aroclor 1254 for 4–6 months (Aulerich and Ringer
1977; Wren et al. 1987b).  One of four monkeys that were fed 0.1 mg/kg/day Aroclor 1248 for 17 months
developed clinical signs of toxicity, decreased libido, and marked hypoactivity of the seminiferous
tubules, including an absence of mature spermatozoa, after the first year of exposure (Allen and Norback
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1976).  The remaining three males remained healthy and sexually active, and none of the animals had
effects on sperm morphology and viability and the ability to fertilize unexposed females, although the
latter end points were only evaluated during the first year of exposure.  
In contrast to the limited evidence for reproductive effects in exposed male adult animals, fertility was
markedly reduced in male offspring of rats that were lactationally exposed to $8 mg/kg/day
Aroclor 1254 (Sager 1983; Sager et al. 1987, 1991).  The reduction in male fertility appears to be due to
impaired ability of sperm to fertilize eggs because sperm production, morphology, and motility were not
affected and plasma FSH and testosterone concentrations were not reduced (Sager et al. 1987, 1991). 
Fertility was not impaired in the male offspring of rats that were administered 30 mg/kg/day of
Aroclor 1221, 1242, or 1260 by gavage during gestation (Gellert and Wilson 1979), but this study did not
include postnatal exposure.  Results of oral and subcutaneous studies with single congeners have shown
that gestational, lactational, or adult exposures can adversely affect morphology and production of sperm
and fertility in male rats and mice (Faqi et al. 1998; Huang et al. 1998a; Smits-van Prooije et al. 1993),
although congeneric structure-activity relationships are unclear.  
3.2.6 Developmental Effects
This section describes effects of exposure to PCBs on anthropometric measures at birth in humans as well
as on physical growth during infancy.  For consistency, the discussion of animal data is restricted mostly
to these same end points.  Effects of perinatal exposure to PCBs on other end points in the offspring,
including changes in the thyroid gland and thyroid hormones, neurobehavior, and the immune and
reproductive systems, are discussed in the respective sections in Chapter 3.
3.2.6.1 Summary
Anthropometric measures have been evaluated in newborn from women (1) exposed to PCBs through
consumption of Great Lakes and ocean fish contaminated with PCBs and other environmentally persistent
chemicals, (2) from the general population with no known high exposure to PCBs, (3) occupationally
exposed to commercial PCB mixtures, and (4) accidentally exposed to PCBs and structurally-related
chemicals.  Some studies found significant negative associations between anthropometric measures at
birth (and at early ages) and exposure to PCBs, whereas others found significant positive associations,
and yet a third group reported no significant associations.  The wide range of results may reflect the
different degree of controlling for confounders and/or the different exposure measures.  Of the studies of
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women who consumed contaminated fish from the Great Lakes, only the Michigan study reported an
association between reduced birth weight, head circumference, and gestational age in newborns and with
body weight at 4 years with prenatal exposure to PCBs (PCBs in cord blood).  A study of Lake Ontario
fisheaters, which used similar measures of exposure as the Michigan study, found no significant
association between birth weight, head circumference, or gestational age and prenatal exposure to PCBs. 
In two additional studies of Lake Michigan women, fish consumption had a positive effect on birth
weight.  A study of Swedish wives of Baltic Sea fishermen found an increased risk of low birth weight
with increasing maternal blood concentrations of the PCB congener PCB 153 used as surrogate of PCB
exposure during the year of childbirth.  In a study of the general population in the Netherlands, prenatal
exposure to PCBs (PCBs in cord blood) was associated with reduced birth weight, but not with head
circumference or height at 10 days of age.  Prenatal exposure in formula-fed children was associated with
reduced growth between birth and 3 months, but no such association was seen in breast-fed children,
suggesting that any detrimental effect observed in newborns due to prenatal exposure to PCBs may have
been counteracted by the benefits of breast feeding.  No significant association was seen between growth
during the ages of 3–7, 7–18, or 18–42 months and any measure of exposure to PCBs.  A study of the
general population in Finland found no significant association between birth weight and the concentration
of PCBs in breast milk.  No firm conclusions can be made regarding growth and development of children
and environmental exposures to PCBs, although perinatal exposure to high concentrations of PCBs and
structurally-related chemicals, as occurred in Yusho and Yu-Cheng, affects birth weight and growth during
early life.
Studies have been conducted in animals exposed to commercial PCB mixtures, single PCB congeners,
and a reconstituted PCB mixture with a composition of congeners similar to the pattern found in human
breast milk.  The results of these studies suggest that primates are much more sensitive to the effects of
perinatal exposure to PCBs than rodents.  It also appears that unless very high doses are used, PCBs are
not teratogenic.  In general, studies in rodents have used relatively high doses of PCBs.  Data in rodents
treated with commercial PCB mixtures showed that developmental toxicity can occur in the absence of
overt signs of maternal toxicity.  Limited data from a study in rats exposed during gestation showed that
Aroclor 1254 was more potent than Aroclor 1260 in reducing survival of the pups to weaning.  These two
Aroclors differ primarily in that Aroclor 1254 lacks congeners with 7–9 chlorines.  Reduced birth weight
was reported in offspring from Rhesus monkeys treated before mating and during gestation with low
doses of commercial PCB mixtures.  These monkeys also showed characteristic signs of PCB intoxication
such as hyperpigmentation.  In all of the monkey studies, signs of PCB intoxication were also evident in
the mothers.
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3.2.6.2 Human Studies
3.2.6.2.1  Growth and Development
3.2.6.2.1.1  Contaminated Fish Consumption
The Michigan Cohort.  Birth weight, length, and gestational age were evaluated in 313 newborn infants
in the Michigan study (Fein et al. 1984a, 1984b).  A detailed description of the study design is presented
in Section 3.2.4 Neurological Effects.  Briefly, of the 313 infants, 242 were born to mothers who had
consumed moderate to large quantities of Lake Michigan fish sometime during their lives, and 71 were
born to mothers who did not consume Lake Michigan fish.  In the exposed group, mean fish consumption,
estimated by recall and duration of consumption, was 6.7 kg/year and 15.9 years, respectively; this rate is
equivalent to two or three salmon or lake trout/month (Fein et al. 1984a, 1984b).  Consumption during
pregnancy was 4.1 kg/year.  The mean PCB level in maternal serum among those eating Lake Michigan
fish was 6.1 ppb (SD=3.7), while the mean among those reporting no fish consumption was 4.1 ppb
(SD=2.7).  The mean PCB residues also were significantly higher in breast milk samples from the
fisheaters as compared to the nonfisheaters, 865.6 ppb (fat basis) versus 622.2 ppb (Fein et al. 1984a). 
Data on approximately 37 potential confounders, including smoking during pregnancy, were considered
in the study analyses (Fein et al. 1984a, 1984b). 
Overall, lower birth weight, smaller head circumference, and shorter gestational age were positively
correlated with consumption of fish and levels of total PCBs in cord serum; however, when the two
populations were divided according to the cord serum levels, the great majority in the low-level group
were fisheaters, suggesting that fish consumption rates were poor indicators of PCB exposure.  Fish
consumption only during pregnancy did not predict either birth size or gestational age (Fein et al. 1984b). 
Approximately 75% of the children were re-examined at age 4 (Jacobson et al. 1990a, 1990b).  Levels of
total PCBs in maternal milk or cord serum, or total duration of breast-feeding, were not related to height
or head circumference at 4 years, but prenatal PCB exposure was associated with lower weight at age 4.
The Oswego Cohort.  A study similar to the one conducted in Michigan was initiated in Oswego County
(New York) based on babies born between 1991 and 1994 (Lonky et al. 1996) (see also
Section 3.2.4.2.1.1, Neurological Effects).  Pregnant women were recruited from the office of one
obstetric practice and, following interviews, were divided into three groups based on their estimated fish
consumption.  The high fish consumption group was composed of women who reported having eaten
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$40 PCB-equivalent pounds of Lake Ontario fish in their lifetime (n=152) (the same as the Michigan high
fish consumption group).  The low consumption group reported eating <40 PCB-equivalent pounds
(n=243), and the no-fish-consumption group had never eaten Lake Ontario fish (n=164).  The mean PCB-
equivalent pounds consumed in the high fish group was 388.47 (SD=859.0), while the mean among those
in the low-fish-consumption group was 10.14 (SD=17.8).  The three groups did not differ with regard to
demographic, health, and nutritional data, maternal substance use, infant birth characteristics.  The high-
fish consuming group had a significantly heavier pre-pregnancy weight than the nonfisheating group.  In
contrast to findings from the Michigan study, which had higher levels of exposure, birth weight, head
circumference, and gestational age were unrelated to fish consumption.  In subsequent studies, the
investigators analyzed the association between specific groups of PCB congeners (according to degree of
chlorination) and neurobehavioral outcomes in the newborn, but they provided no information regarding
such analyses being done for birth weight, head circumference, and gestational age.
 
The Green Bay Wisconsin Study.  This study was designed to evaluate the reproductive effects
associated with maternal consumption of contaminated Great Lakes fish (Dar et al. 1992).  All women
between the ages of 18 and 35 with positive pregnancy tests at two Green Bay Wisconsin obstetrical
clinics were invited to participate in this study.  The recruitment occurred between January 1, 1987 and
January 1, 1988.  Participants were asked to complete a self-administered questionnaire at the first
prenatal visit including questions on fish consumption, socioeconomic status, medical, reproductive,
family, and occupational histories as well as a section on maternal behaviors.  Of the 1341 eligible
women, 1,115 agreed to participate for an overall participation rate of 82.9%.  Nonparticipants (n=226)
completed a brief questionnaire and were found to have lower education, lower income, and were more
likely to be nonwhite.  Exposure to PCBs was estimated from fish consumption scores determined from
the questionnaire responses and corroborated by serum analyses.  Fish consumption scores were
calculated for each participant based on the amount and species of fish consumed in the preceding year. 
Levels of PCBs in the 18 species of fish that participants reported consuming were based on Wisconsin
Department of Natural Resources surveys.  Estimated PCB mean intake scores were used to establish the
exposure variable categories.  The low fisheating group (n=522) included women who consumed no
locally caught fish, while the medium group (n=401) contained participants whose PCB scores were
greater than 0 but less than the 90th percentile.  The high exposure group was composed of women whose
PCB intake scores were above the 90th percentile (n=104).  Neither the actual fish consumption scores
nor the means of the PCB scores for each exposure group were reported (Dar et al. 1992).
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Due to the high cost of serum PCB analyses, maternal serum specimens were drawn from a random
sample of participants (n=100) to assess the validity of the fish consumption variables.  Correlation
analysis between the fish consumption variables and serum PCB levels yielded a correlation coefficient of
0.666.  The sum of the individual congener levels of PCBs in serum ranged from 0.6 to 5.0 ppb.  The
mean for each exposure group was not provided.  The birth size outcomes evaluated in this study included
birth weight, birth length, head circumference, ponderal index, and birth weight percentiles for gestational
age (method not specified).  These data were abstracted from hospital and clinic reports.  Only data on
birth weight were presented in this publication due to the similarity of results obtained from the other
parameters.  Multiple regression analyses were performed to assess the relationship between fish
consumption and the outcomes of interest.  Effect modification was assessed through the inclusion of
interaction terms in the models.  Factors known to influence birth outcomes were included as potential
confounders (sex of child, birth order, smoking, caffeine and alcohol consumption during pregnancy,
gestational age, pregnancy weight gain, usual maternal weight, and demographic variables).  
Birth weight was found to increase with increasing PCB exposure, based on the fish consumption scores. 
Maternal weight gain modified the effect of fish consumption (PCB exposure) on birth weight; birth
weight increased with fish consumption in women gaining <34 pounds during pregnancy while there was
little difference in mean birth weights for the three fish consumption categories in women gaining more
than 34 pounds during pregnancy (Dar et al. 1992).  Smoking and caffeine consumption were negatively
related to birth weight while male infants were found to be slightly heavier than female infants.  
The Sheboygan Wisconsin Study.  A study of Sheboygan, Wisconsin residents was conducted in 1980
and 1981 to assess the relationship between maternal serum and breast milk PCB levels and infant health,
behavior, and development (Smith 1984).  Routine testing for PCBs in 1978 along the Sheboygan River
in Wisconsin revealed that game fish had PCB levels far in excess of the standard set for fish by the FDA
(5 ppm at the time of the study, currently 2 ppm).  To ascertain the potential health risks associated with
the elevated PCB levels, a study of mother-infant pairs was undertaken in 1980 and 1981.  A total of
73 of the mothers were included in the study.  The participants were divided into three groups based on
their screening survey responses (it is unclear if these groups were meant to be exposure variable
categories or simply a description of the study population).  Group 1 (n=23 pairs) included women who
were breast feeding and ate Lake Michigan or Sheboygan River fish at least twice a month for $3 years. 
Group 2 (n=39 pairs) included women who were breast feeding and ate Lake Michigan or Sheboygan
River fish not more than twice a year (and had not done this for more than 3 years). Group 3 (n=11 pairs)
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included women who were not breast feeding and ate Lake Michigan or Sheboygan River fish at least
twice a month for 3 or more years.
Maternal serum and a breast milk sample were also taken during each of the mother-infant evaluations. 
The first evaluation took place during the second month of postnatal life while the second occurred at
4 months of age.  Prenatal maternal serum samples were not taken for any of the participants.  The
maternal survey instrument included questions on demographic variables, work history, medical history
including reproductive history and the most recent pregnancy, smoking and alcohol consumption, and
general diet.  Information on fish consumption also was collected from this questionnaire and included
data on species, amount, and frequency of fish meals.  The data collected on the infants included a health
history, dietary history, and growth and development assessment (Smith 1984).  Statistical analyses
included preliminary descriptive analyses using t-tests and chi-square tests.  Multiple regression and
logistic regression were used for the final models.
The mean level of PCBs in the first maternal serum was 5.76 ppb (range=1.29–14.9 ppb) while the mean
for the second was 5.48 ppb (range=1.15–14.1 ppb).  These levels indicated a low exposure level (Smith
1984).  The means were very similar between the three groups of mother-child pairs.  The mean breast
milk PCB levels (fat basis) in the first sample of Sheboygan women was 1.13 ppm
(range=0.29–4.02 ppm) while the mean for the second sample was 1.14 ppm (range=0.34–3.79 ppm).
Several variables were significant predictors of serum PCB levels (first sample) in linear regression
modeling.  These included the mother's education, a fish diet after birth, occupation, total bilirubin,
cholesterol, and phosphorus (negatively associated).  Regression analyses indicated that serum PCB level
and cholesterol were significant predictors of the first breast milk sample PCB level.  Regression analyses
examining the relationship between birth weight and serum PCB levels (first sample) found that maternal
serum PCB level was positively associated with birth weight after controlling for gestational age,
smoking, and mother's weight.  Fish consumption was not included as a variable in this analysis.  In this
investigation, the first breast milk sample was collected 2 months postnatal, and breast feeding would
decrease serum concentrations.  Therefore, a major confounder not adjusted for was breast feeding
duration.
The Wives of Swedish Fishermen Cohort Study.  A study of the wives of fishermen from two established
cohorts was conducted to investigate whether east coast wives with a presumably higher intake of fatty
fish (and PCBs) were more likely to have adverse reproductive outcomes than those living on the west
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coast and elsewhere in Sweden (Rylander et al. 1995).  Cohorts of fisherman from the east and west
coasts of Sweden were established based on membership in fishermen organizations from 1930 forward. 
Through linkage to the national Swedish population register and to registers at the local parish offices,
1,568 women from the east coast and 4,027 from the west coast who were, or had been, married to these
fishermen were identified.  From 1973 to 1991, 757 women from the east coast cohort gave birth to
1,501 infants while 1,834 women from the west coast cohort gave birth to 3,553 infants.  
Exposure to PCBs was represented by a variable called "east coast affiliation."  The east coast of Sweden
borders the Baltic Sea, a source of fatty fish (salmon and herring) thought to be contaminated with
persistent organochlorine compounds.  The west coast of Sweden is thought to have less contamination
than the east.  The study was designed as a retrospective cohort investigation comparing children born to
east coast women (exposed) and west coast women (unexposed) who were, or had been, married to
fishermen.  The majority of the data in this study was collected from the Swedish Medical Birth Registry,
which includes information on maternal demographics, smoking during pregnancy, prenatal care,
delivery, and pediatric assessments of the newborns.  The principal end points evaluated in this study
were birth weight, birth length, and head circumference.  Two cutpoints were used as an indicator of low
birth weight, 2,500 and 3,000 g.
Smoking was less frequent among west coast women during early pregnancy than among east coast
women (22.7 versus 38%).  In addition, there was a higher proportion of short women (<165 cm) among
the east coast cohort as compared to the west (48.6 versus 39.2%).  Weight distributions during early
pregnancy were similar for both cohorts.
In order to assess the dietary habits of both the east and west coast fishermen's wives, interviews were
conducted with a 5% random sample (n=38) of east coast cohort members and 2% random sample (n=31)
of west coast cohort members.  Equal numbers of female residents from the general population were also
interviewed; these "control" women were matched to the east and west coast wives by age and county of
residence.  Both the east and west coast women, who were married to fishermen, ate locally caught fish,
both lean and fatty species, twice as often as their referents.  The fishermen's wives also consumed about
3 times the amount of fatty fish species/month as their referents.
Among the fishermen's wives, west coast cohort members ate significantly more lean fish species than the
east coast cohort members.  There were no statistically significant differences between the east and west
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coast fishermen's wives in the total number of fatty fish meals eaten/month or in the amount of fatty fish
consumed on a monthly basis.
  
Comparison between the cohorts showed that birth weight and head circumference, but not length at birth,
were slightly reduced (p<0.001) in the east coast group.  The effect on head circumference was observed
even when multiple births and infants with major malformations were excluded.  Odds ratios were
calculated to evaluate the effect of cohort affiliation on low birth weight using a stratified analysis to
control for confounders.  East coast affiliation was significantly associated with low birth weight
(<3,000 g) even after adjustment for gender of the child, maternal age, parity, marital status, and smoking. 
Stratified analyses for head circumference and birth length were not presented in this report.
In a more recent publication from this group, the authors examined the association between the
concentration of 2,2',4,4',5,5'-hexaCB (PCB 153) in maternal serum during the year of childbirth and birth
weight of 57 east coast low birth weight cases and 135 controls matched on gender, parity, and calendar
year of birth (Rylander et al. 1998b).  In 1995, blood samples were collected from the wives and ex-wives
of fisherman from the east cost who had given birth during the period of 1973–1991.  PCB 153 in
maternal blood was used as biomarker of exposure to PCBs and the concentration during the year of
childbirth was estimated using kinetic models.  The median concentration in serum (fresh weight) in 1995
was 1.0 ppb for the case mothers compared to 0.92 ppb for control mothers.  Rylander et al. (1998b)
found an increase in the risk of a low birth weight at maternal blood PCB 153 concentrations of 300 and
400 ng/g (ppb, lipid basis). 
3.2.6.2.1.2  General Population Exposure
The North Carolina Breast Milk and Formula Project.  The North Carolina Breast Milk and Formula
Project (NCBMFP) is a cohort study designed to assess the relationship between exposure to prenatal and
postnatal PCBs and DDE and growth and development in infants and children (Rogan et al. 1986a,
1986b).  A detailed description of this cohort study in presented in Section 3.2.4.2.1.2 (Neurological
Effects).  Briefly, the participants were administered a questionnaire while in the hospital following
delivery.  Maternal serum, cord blood, and placenta samples were collected at birth as well as colostrum,
breast milk, or formula.  The first follow-up visit occurred at 6 weeks with subsequent evaluations at
3 and 6 months postpartum.  Breast milk or formula was collected at each of these visits.  PCB levels in
milk at birth averaged around 1.8 ppm (fat basis).  A total of 912 children were available with at least
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partial neonatal information (Rogan et al. 1986a).  The outcomes evaluated in the neonatal period
included birth weight and head circumference.  
The relationships of birth weight and head circumference to PCB levels were assessed by multiple
regression.  The covariates (potential confounders) included in the analyses were infant race, sex,
mother's age, education, occupation, smoking, alcohol consumption, prior pregnancies, maternal weight,
center enrolling the participant, and jaundice.  The analysis of head circumference also included the birth
weight variable (Rogan et al. 1986a).  The multiple regression analyses found no associations between
birth weight or head circumference and PCB level.  The birth weight decrement was noted for smokers as
was the male-female difference.  Larger mothers also had significantly larger babies.  Head circumference
was associated with the infant's birth weight and sex, and the mother's education and occupation (Rogan
et al. 1986a).
The Dutch Mother-Child Study.  The Dutch Mother-Child Study was designed as a prospective study to
assess the possible adverse effects of prenatal and postnatal PCB and dioxin exposure.  Details of this
study are presented in Section 3.2.4 (Neurological Effects).  Briefly, 207 pairs (105 breast-fed and
102 formula-fed) were from Rotterdam, a highly industrialized area, while 211 pairs (104 breast-fed and
107 formula-fed) were from Groningen, a semi-urban area in northern Holland (Koopman-Esseboom et
al. 1994b).  The exposure variables used in this study were maternal serum and milk samples as well as
cord blood specimens.  
The effect of prenatal cord blood PCB exposure on birth size at 10 days of age was evaluated using a
series of linear regression models (one for each outcome) in 207 mother-infant pairs from Rotterdam. 
Covariates included in the models were parity, gestational age, smoking, alcohol use during pregnancy,
and a factor representing parental height.  Gender, an important determinant of size, was not included
among the covariables for some reason even though there were significantly more boys in the breast-fed
(59%) than in the formula-fed group (46%).  This may have resulted in confounded effect measures.  A
significant decrease in birth weight at 10 days of age was observed with cord blood PCB exposure; birth
weight declined by a mean of 86 g at the 50th percentile of exposure relative to the 10th percentile
exposure levels while a mean 165 g decrease was observed for those in the 90th percentile of exposure
relative to the 10th percentile.  Head circumference and height at 10 days of age were not significantly
associated with cord blood PCB levels.  Similar effects were observed when using maternal plasma PCB
levels as the exposure variable with weight, height, and head circumference as outcomes at 10 days of age
(Patandin et al. 1998).
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The effect of prenatal PCB exposure on growth rate was assessed in the formula-fed group (n=102) using
linear regression modeling.  Covariates were identical to those described in the previous paragraph, with
the addition of the relevant variable value at 10 days of age in each model (e.g., change in birth weight
between 0 and 3 months included birth weight at 10 days of age).  Gender was not included in these
models.  Cord blood PCB levels showed a significant inverse association with growth rate at 0–3 months
of age for each index (i.e., birth weight, height, and head circumference).  Similar findings were observed
when maternal plasma PCB levels were used as the exposure.  Prenatal PCB levels in formula-fed
children were not significantly associated with growth rate for any of the indices from 3–7, 7–18, or
18–42 months (Patandin et al. 1998).
The associations between growth rates and prenatal and postnatal PCB/dioxin levels also were evaluated
in 107 children from Rotterdam who were breast-fed.  Both cord blood levels and postnatal breast milk
levels were included in these models as were the covariates described above.  PCB levels (prenatal or
postnatal) were not associated with growth rates at 0–3 months of age.  Postnatal PCB/dioxin levels were
negatively associated with a change in height between 3 and 7 months (p=0.04), but not with weight or
head circumference growth rates.  Pre- and postnatal PCB levels were not associated with changes in
growth rate between 7–18 and 18–42 months of age in the breast-fed children (Patandin et al. 1998).
Finnish General Population Study.  This study was part of follow-up studies into levels of dioxins,
dibenzofurans, and PCBs in human milk coordinated by WHO/EURO.  The objectives of the study were
to correlate the birth weight and sex of a child to dioxins/dibenzofurans and PCB concentrations of its
mother’s milk and to evaluate personal and environmental determinants that correlated with the levels of
these chemicals in human milk in two areas in Finland, an urban area and a rural area (Vartiainen et al.
1998).  One hundred sixty-seven random human milk samples were collected 4 weeks after delivery for
2 weeks.  Information on each mother and child was gathered by a questionnaire that included questions
on all relevant covariates.
The concentration of PCBs in breast milk from urban and rural mothers was approximately 500 and
400 ppb (fat basis), respectively.  The average weight for all children was 3,630 g and the median was
3,625 g.  The mean weight of the urban children was not significantly different from rural children,
although dioxin international TEQs were significantly higher in milk from urban mothers.  No correlation
was found between the weight of children and total PCBs in all of the children, in boys, in girls, among
all primiparae, or in primiparae girls or boys.  The birth weight, especially of boys, slightly decreased
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with increasing concentrations of TEQs, 2,3,4,7,8-penta CDF, 1,2,3,7,8-pentaCDD, and 2,3,7,8-TCDD,
but when the analysis was restricted to primiparae, the correlation lost statistical significance.  
3.2.6.2.1.3  Occupational Exposure
Upstate New York Capacitor Manufacturers Study.  This study comprised women workers of two
facilities of the same company located in adjacent communities in upstate New York that manufactured
capacitors using PCBs with Aroclors 1254, 1242, and 1016 as their primary dielectric fluid (Taylor et al.
1984).  Birth certificates for pregnancies between 1958 and 1975 were used to obtain information on birth
weight, maternal age, parity, year of birth, race, sex, and date of the last menses.  The high-exposure
workers were directly exposed to Aroclors during the manufacturing process for at least 1 year prior to
birth of the infant; the workers with low exposure were employed in areas where Aroclors were not used
directly.  
Fifty-one infants born to 39 women with high exposure to PCBs had lower mean birth weights and
shorter mean gestational ages than those of 337 infants born to 280 women with low exposure to PCBs. 
After adjusting for gestational age, however, the difference in birth weight was markedly reduced,
suggesting that the difference in weight may have resulted partially from a shortened gestation period. 
Furthermore, while the infants born to the high-exposure women were, on the average, lighter than
matched community controls, those born to low-exposure women were heavier than matched community
controls; thus, a dose-response relationship was not established.  While relatively little detail was given
regarding the statistical analysis of the results, Taylor et al. (1984) state that they had no information on
tobacco use, underlying medical conditions, maternal height, and history of low birthweight, all factors
known to influence birthweight.  In a follow-up study of the same population in which most of these
confounders were accounted for, a significant effect of high-homolog exposure was seen for birth weight
and gestational age (Taylor et al. 1989).  The difference in birth weight between the two groups was 60 g. 
However, when gestational age was accounted for in addition to the other variables related to birth
weight, estimated serum PCB was no longer a significant predictor of birth weight.  Taylor et al. (1989)
concluded that the data suggested a significant relation between increased estimated PCB level and
decreased birth weight and gestational age, and that the decrease in birth weight is partially related to
shortened gestational age.
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3.2.6.2.1.4  Accidental Exposure
Yusho and Yu-Cheng.  Decreased birth weight was a commonly reported effect of Yusho and Yu-Cheng
exposure (Funatsu et al. 1971; Lan et al. 1987; Rogan 1989; Taki et al. 1969; Yamaguchi et al. 1971).  A
survey of 128 children known to have been in utero during or after Yu-Cheng exposure found that mean
birth weight was decreased by approximately 15% compared to a group of 115 unexposed controls
(Rogan et al 1988).  Exposed children also were shorter than controls; these children were a few months
to 6 years old.  Lan et al. (1987) documented the decreased birthweight of 49 Yu-Cheng children exposed
transplacentally and born between 1979 and 1986, and showed that the deficit continued through the
second child born after the outbreak, but was not detectable in the third.  In a review of the Yusho
poisoning incident, Masuda (1994) stated that most babies were small-for-date and their postnatal growth
curves were similar in shape to the national standard curves, but lower for some of the babies.  Relative to
unexposed controls, height and weight gains of school children with Yusho significantly decreased after
the poisoning, and the same tendencies were observed in some of the girls (Masuda 1994).  These
tendencies to reduced growth were later found to be reversed, as subsequent increaments tended to be
close to the average value in the control group (Yoshimura and Ikeda 1978).   It should be kept in mind
that in both the Yusho and Yu-Cheng poisoning episodes, there was exposure to relatively high
concentrations of CDF and PCQ impurities.  Further information on Yusho and Yu-Cheng incidents can
be found in ATSDR (1994).
3.2.6.2.2  Evaluation of Human Studies
Anthropometric measures have been evaluated in children from women (1) who consumed Great Lakes
fish contaminated with PCBs and other chemicals (Dar et al. 1992; Fein et al. 1984b; Jacobson et al.
1990a, 1990b; Lonky et al. 1996; Smith 1984), (2) who consumed Baltic Sea fish contaminated with
organochlorines (Rylander et al. 1995, 1998b), (3) from the general U.S. (Rogan et al. 1986a, 1986b),
Dutch (Patandin et al. 1998), and Finnish populations (Vartiainen et al. 1998), (4) who were
occupationally exposed to commercial PCB mixtures (Taylor et al. 1984, 1989), and (5) who were
accidentally exposed to PCBs and other structurally related chemicals in the Yusho and Yu-Cheng
poisoning incidents (Funatsu et al. 1971; Lan et al. 1987; Rogan 1989; Yamaguchi et al. 1971).  A
comparison of PCB levels in blood and breast milk in some of these studies is included in Appendix A.
The results have been varied, with some studies finding significant inverse associations between exposure
to PCBs and anthropometric measures at birth (and at early ages), some studies reporting significant
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positive associations, and yet a third group reporting no significant associations.  The wide range of
results may reflect the different degree of controlling for confounders and/or the different exposure
measures, levels, and substances.  Also, in some cases, the difference in serum PCB levels between case
studies and controls may have been too small to allow detection of differences between the variables
measured.  Of the studies of women who consumed contaminated fish from the Great Lakes, the
Michigan study (Fein et al. 1984b; Jacobson et al. 1990a, 1990b) reported an association between reduced
birth weight, head circumference, and gestational age in newborns and with body weight at 4 years with
prenatal exposure to PCBs (PCBs in placental cord blood).  
A study of wives of Swedish fishermen found that newborn infants born to mothers from the east coast
(Baltic Sea) gave birth to infants with significantly lower birth weight and head circumference compared
to infants born to mothers from the west coast (Rylander et al. 1995).  East coast mothers were reported to
consume more contaminated fatty fish (and PCBs) than women from the west coast where fish
contamination was much less.  In a subsequent study of east coast/Baltic Sea mothers (Rylander et al.
1998b), their low birth weight infants (1,500–2,750 g weight) were compared with control infants from
this same cohort (3,250–4,500 g weight).  Blood samples from the mothers were analyzed for PCB
congener 153, which was used as a surrogate of total PCB exposure during the year of childbirth.  The
mothers of the low birth weight infants were reported to have a higher median PCB blood level
(1,000 pg/g) compared to the control mothers (920 pg/g).  These researchers also found an increased risk
of low birth weight with increasing maternal blood concentrations of PCB 153 (at 300 or 400 ng/g, lipid
basis).
In the Dutch general population cohort, prenatal exposure to PCBs (PCBs in cord blood) was associated
with a reduced birth weight, but not with head circumference or height at 10 days of age (Patandin et al.
1998).  Prenatal exposure (as measured by cord and maternal blood PCB levels) in formula-fed children
was associated with reduced growth (weight, length, and head circumference) between birth and
3 months.  No such association was seen in breast-fed children, suggesting to the investigators that any
detrimental effect observed in newborns due to prenatal exposure to PCBs may have been counteracted
by the benefits of breast feeding.  Additionally, there were no significant associations between growth
during the ages of 3–7, 7–18, or 18–42 months and any measure of exposure to PCBs.  In an occupational
study, Taylor et al. (1989) studied high PCB exposed females employed in capacitor manufacturing
facilities and compared them with female workers in low PCB exposure jobs.  A significant association
was observed between the increased estimated PCB exposure level and decreased birth weight and
gestational age.  In addition, effects on birth weight and growth during early life have been demonstrated
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following perinatal exposure to high concentrations of PCBs and structurally-related chemicals during the
Yusho and Yu-Cheng poisoning incidents.
Consumption of PCB-contaminated fish had a positive effect on birth weight in two studies of Lake
Michigan women (Dar et al. 1992; Smith 1984).  This finding could be related to the beneficial effects of
certain fatty acids in fish (Olsen et al. 1990).  In one of these studies (Smith 1984), the concentration of
PCBs in breast milk was higher than in breast milk from women from the Michigan cohort (1.13 vs
0.87 ppm) in the Jacobson study discussed above.  In the other study (Dar et al. 1992), fish consumption
levels were less than in the Jacobson study.
In the Oswego cohort of Lake Ontario fish consumers (Lonky et al. 1996) there was no significant
association between prenatal exposure to PCBs, assessed by the same fish consumption measures as in the
higher exposure Michigan study, and birth weight, head circumference, or gestational age.  In addition, a
study of the general population in Finland found no significant association between birth weight and the
concentration of PCBs in breast milk (Vartiainen et al. 1998).  In this study, the mean concentration of
PCBs in milk (0.4–0.5 ppm) was slightly lower than in the Dutch general population study (0.62 ppm)
(Koopman-Esseboom et al. 1994b; Patandin et al. 1998).
For those studies with effects, there is consistency in the outcome of lower birth weight for infants
exposed in utero to maternal body burdens of PCBs.  This association remains constant regardless of the
method by which PCB exposure is measured (e.g., estimate by fish consumption or actual body burdens
in maternal blood).  Jacobson et al. (1990b) have demonstrated that, even at the age of 4 years, the
children most highly exposed to PCBs weighed less on the average than those with the least exposure. 
This tendency can also be seen in the Dutch study (Patandin et al. 1998), which reported a significant
association between lower infant growth rate in 0–3 month olds and mothers’ body burden as
demonstrated by cord and maternal PCB levels.  The consistency with which this finding has been
demonstrated strengthens the position that PCBs (and related substances) are developmental toxicants.  In
addition, birth weight is a sound indicator of newborn development and health.
3.  HEALTH EFFECTS - Developmental
PCBs 241
3.2.6.3 Animal Studies
Developmental effects discussed in this section are restricted mainly to effects on fetal development, birth
weight and weight gain in early life, and teratogenicity.  Information regarding effects on the thyroid,
immune system, and reproduction in offspring following perinatal exposure to PCBs is presented in
Sections 3.2.3, 3.2.4, and 3.2.5, respectively.
The highest NOAEL values and all reliable LOAEL values for developmental effects for each study are
recorded in Table 3-2 and plotted in Figure 3-2.
3.2.6.3.1  Birth Weight and Early Development
Oral Exposure    
Commercial PCB Mixtures.  Doses of #100 mg/kg/day Aroclor 1254 administered on Gd 6–15 by
gavage did not affect maternal weight gain nor induce developmental toxicity in Wistar rats, as evidenced
by number of litters, litter size and weight, and number of resorption sites (Villeneuve et al. 1971).  Morse
et al. (1996b) also reported that treatment of Wistar rats on Gd 10–16 with up to 25 mg
Aroclor 1254/kg/day by gavage did not affect maternal body weight, fetal body weight, number of live
fetuses, late gestational death, number of resorptions, number of live pups born, sex ratio, and postnatal
death.  However, a study with Aroclor 1254 in Holzman rats reported a significant reduction in fetal
weight at 5 mg/kg/day and reduced fetal survival at 15 mg/kg/day after dosing also on Gd 6–15; both
effects were dose-related (Spencer 1982).  A dose of 2.5 mg/kg/day was without effect.  Maternal body
weight loss occurred at 30 mg/kg/day.  Decreased survival of pups to weaning was found in Sherman rats
administered nine doses of 100 mg Aroclor 1254/kg by gavage on Gd 7–15 (Linder et al. 1974), but that
treatment did not affect the number of litters or the litter size at birth.  Doses of #50 mg/kg/day did not
affect survival at weaning.  No effect on the number of litters, litter size, survival to weaning, or body
weight at weaning were observed in the offspring of rats treated with doses of 100 mg/kg/day
Aroclor 1260 on Gd 7–15 (Linder et al. 1974).  Offspring from Long-Evans rats exposed to 4 mg
Aroclor 1254/kg/day via the diet starting 50 days prior to mating until birth had significantly reduced
weight at birth, and on PND 7, 14, and 21 (Hany et al. 1999b).  This was observed in the absence of any
overt sign of maternal toxicity.  There were no significant treatment-related effects on number of
pups/litter, number of implantation sites, or sex ratio.
3.  HEALTH EFFECTS - Developmental
PCBs 242
Litter size was significantly reduced in Osborne-Mendel rats fed a diet that provided approximately
25 mg Aroclor 1254/kg/day during gestation and lactation (Collins and Capen 1980c).  Body weight of
pups at 21 days was significantly reduced with dietary PCB levels of 2.5 and 25 mg/kg/day, but was not
affected at birth or at 7 and 14 days.  Doses of approximately 13.5 mg Aroclor 1254/kg/day administered
during gestation and lactation induced high early mortality in the pups (Overmann et al. 1987).  Doses of
approximately 1.3 mg/kg/day significantly decreased pups’ weight on PND 21 and 14, and doses of
0.13 mg/kg/day decreased pups’ weight on PND 14 (Overmann et al. 1987).  Doses of 1.3 mg/kg/day had
no significant effect on maternal weigh or food consumption.  High early mortality was also observed in
pups from Long-Evans rats treated with 4 or 8 mg Aroclor 1254/kg/day from Gd 6 through PND 21
(Goldey et al. 1995).  Wistar rats that were treated with 10 mg/kg/day Aroclor 1254 by gavage during
gestation had delayed parturition and decreased litter size (Brezner et al. 1984).  This dose level resulted
in no weight gain in the dams.  Offspring of these rats that were exposed throughout lactation experienced
decreased pre- and postweaning survival, premature vaginal opening, and delayed first estrus, but no
effects on sexual differentiation, estrus cycle, mating, or pregnancy.  
Offspring of mice exposed to doses up to 12.5 mg Aroclor 1254/kg/day on Gd 6–18 did not show adverse
developmental effects, as judged by number of litters, number of dead and reabsorbed fetuses, fetal
weight, incidence of gross malformations, and skeletal development (Welsch 1985).  A single, but much
higher dose (244 mg/kg) of Aroclor 1254 given on Gd 9 to pregnant mice significantly increased the
percentage of fetuses with hydronephrosis, did not induce cleft palate, and did not affect the number of
resorptions and number of dead and live fetuses (Haake et al. 1987).  Maternal weight gain was not
influenced by PCB treatment (Haake et al. 1987).
Doses up to 10 mg Aroclor 1254/kg/day administered to rabbits on Gd 1–28 did not induce
developmental toxicity, as monitored by total number of fetuses, number of viable fetuses or resorption
sites, fetal weight, fetal liver weight, and placental weight (Villeneuve et al. 1971).  Doses of
12.5 mg/kg/day or higher, however, significantly increased the number of dead fetuses, resorption sites,
and fetuses aborted.  Aroclor 1248 did not affect litter size, appearance, or postnatal mortality in New
Zealand rabbits administered doses of #91 mg/kg/day in the diet for 11 weeks, but a dose of
28 mg/kg/day induced focal liver necrosis in the offspring (Thomas and Hinsdill 1980).  
Administration of 2.2 mg of Clophen A50/kg/day by gavage to pregnant guinea pigs during Gd 16–60
caused high incidence of fetal mortality, but did not cause maternal lethality or any other overt sign of
maternal toxicity (Brunstrom et al. 1982).  Also, administration of 2.5 mg/kg/day Clophen A50 (50%
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chlorine by weight) to guinea pigs on Gd 18–60 significantly increased the frequency of dead fetuses and
stillbirth (27.4 versus 9.4% in controls), decreased litter size, and decreased maternal weight gain during
gestation and birth weight (Lundkvist 1990).  First vaginal opening was abnormal in the surviving
offspring, occurring at an older age and with a shorter duration, but there was no significant effect on age
at first ovulation. 
A dose of 0.1 mg/kg/day Aroclor 1254 administered in a juice-oil emulsion to two Cynomolgus monkeys
starting at Gd 60 resulted in delivery of dead, term infants after approximately 105 days of dosing
(Truelove et al. 1982).  The infant of one monkey that was similarly treated with 0.4 mg/kg/day had
reduced birth weight and weight gain, and later died of bronchopneumonia at 139 days of age.  The only
sign of maternal toxicity was loss of fingernails.  Resorption and/or abortion occurred in monkeys that
were bred 3 months following dietary treatment with 0.8 mg/kg/day Aroclor 1248 for 2 months (Allen et
al. 1974a).  Chronic developmental data are limited to studies in monkeys.  In these studies, the exposure
period ranged from 12 to 37 months.  Pregnant Rhesus monkeys that were fed a diet that provided
approximately 0.007 or 0.03 mg/kg/day Aroclor 1016 for a total of 12 months (before mating and during
gestation) experienced uncomplicated pregnancies, carried their infants to term, and delivered viable
offspring (Barsotti and Van Miller 1984).  Information regarding maternal body weight and age was not
provided.  Head circumference and crown-to-rump length were not affected by treatment with
Aroclor 1016, but mean birth weight in the high-dose group was significantly lower than in controls. 
Both groups of neonates showed hyperpigmentation.  At weaning, body weight in the high-dose group
was still lower than in controls, but the difference was not statistically significant.  Dose-related early
abortions were reported in female monkeys fed a diet that provided 0.1 or 0.2 mg/kg/day Aroclor 1248 for
15 months (five of eight in the low-dose group and four of six in the high-dose group); this period
included breeding, gestation, and lactation (Allen and Barsotti 1976).  Mean birth weight in both groups
was significantly lower than in controls and remained low for the next 12 weeks.  Skeletal development
was not affected by PCB treatment.  At 2 months of age, the infants had signs of PCB intoxication such as
facial acne, swollen eyelids, loss of eyelashes, and hyperpigmentation of the skin, and three of the six
infants died of PCB intoxication between days 44 and 329.  Gross and microscopic examination of the
major organs revealed a rudimentary thymus, extremely small spleen lymph nodes, hypocellularity of the
bone marrow, and degenerative changes in the liver.  Maternal toxicity, evidenced as facial acne, swollen
eyelids, and lack of facial hair, was observed at weaning.  One year after receiving a control diet, the
same females from the Allen and Barsotti (1976) study were bred again (Allen et al. 1980).  Mean birth
weights of the infants of the former high-dose mothers were significantly lower than those of controls,
and signs of PCB intoxication (hyperpigmentation about the hairline) developed during suckling.  Early
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infant mortality was also observed (two of four in the former low-dose group and two of seven in the
former high-dose group).  Histological examination of infant tissues showed hypocellularity of the
thymus and of lymph nodes in the spleen and hyperplastic gastritis.
Arnold et al. (1995, 1997) treated female monkeys with Aroclor 1254 for 37 months (0.005, 0.02, 0.04, or
0.08 mg/kg/day) after which time they were mated with untreated males; dosing continued through
mating and gestation.  Treatment ceased when the infants were 7 weeks old.  The young monkeys were
sacrificed at the age of 122 weeks.  Statistical analysis of the results showed a significant increasing dose-
related trend in fetal mortality incidence rates (combined fetal and postpartum deaths).  However, when
only the treated groups were compared, there was no evidence of such a trend.  Results of the Fisher’s
exact test showed a significant increase rate for only the highest dose group with the 0.02 mg/kg/day dose
approaching significance.  Mean birth weight was not significantly affected by maternal treatment with
Aroclor 1254.  The major clinical findings in the offspring from treated females were the presence of
inflammation and/or enlargement of the tarsal (Meibomian) gland, nail lesions, and gum recession.
Single Congeners.  No effect on maternal body weight or on gestational length, litter size, percent live
births, birth weight, or pup weight at weaning was observed following administration of 0.001 mg/kg/day
PCB 126 or 8 mg/kg/day PCB 77 to pregnant Sprague-Dawley rats on Gd 10–16 (Seo et al. 1995). 
Administration of 0.001 mg/kg/day of PCB 126 to Long-Evans rats beginning 5 weeks before and
continuing through gestation and lactation did not result in any significant effect on neonatal mortality,
birth weight, litter size, or on weight gain monitored up to PND 60 (Rice 1999a)
Pregnant C57BL/6J mice given up to 21 mg PCB 77/kg/day by gavage on 5 consecutive days beginning
on days 1, 6, or 11 of pregnancy showed no adverse effect on maternal body weight or on pup weight,
crown-rump length, litter size, sex ratio, day of eye opening, or upper incisor eruption (Rodriguez et al.
1997).  Administration of a single gavage dose of approximately 0.8 or 1 mg PCB 126/kg to pregnant
C57B46 mice on Gd 10 significantly increased the percentage of fetuses with cleft palate (Zhao et al.
1997b).  However, no fetuses with cleft palate were seen after administration of up to 271 mg PCB 153. 
Combined administration of PCB 126 and PCB 153 significantly reduced the incidence of cleft palate
compared to that produced by PCB 126 alone.
Defined Experimental Mixtures.  Offspring from Long-Evans rats exposed via the diet to 4 mg/kg of a
reconstituted PCB mixture composed according to the congener pattern in human breast milk starting
50 days prior to mating until birth had significantly reduced weight at birth, and PND 7, 14, and 21 (Hany
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et al. 1999b).  This was observed in the absence of any overt signs of maternal toxicity.  There were no
significant treatment-related effects on number of pups/litter, number of implantation sites, or sex ratio. 
Arnold et al. (1999) administered a PCB mixture of congeneric composition similar to that found in
Canadian breast milk to Rhesus and Cynomolgus monkeys during the first 20 weeks of life; each infant
received 0.0075 mg PCBs/kg/day.  There was no statistically significant difference between the control
and treated groups for body weight gains throughout the study.
3.2.6.3.2  Evaluation of Animal Studies
Studies in animals suggest that primates are much more sensitive to the effects of perinatal exposure to
PCBs than rodents.  It also appears that unless very high doses are used, PCBs are not teratogenic in
animals.  Hydronephrosis was reported in mice treated with a single dose of 244 mg Aroclor 1254/kg on
Gd 9 (Haake et al. 1987) and increased incidence of fetuses with cleft palate was reported by Zhao et al.
(1997b) following treatment of mice with a single dose of 0.8 mg of PCB 126/kg, a dioxin-like congener. 
Treatment with up to 271 mg/kg of the di-ortho-substituted congener PCB 153 did not induce cleft palate
(Zhao et al. 1997b).  Susceptibility to both hydronephrosis and cleft palate formation by dioxin-like
congeners is a trait that segregates with the Ah locus (Hassoun et al. 1984) and Zhao’s findings are
consistent with this fact. 
Data in rats treated with commercial PCB mixtures showed that developmental toxicity can occur in the
absence of overt signs of maternal toxicity as evidenced by reduced fetal weight and viability in a study
by Spencer (1982) and reduced birth weight and postnatal growth in a study by Hany et al. (1999).  It
should be noted that Villaneuve et al. (1971) and Morse et al. (1996b) reported adverse developmental
effects at Aroclor 1254 doses much higher than those used by Spencer (1982) in similarly designed
experiments.  It is possible that the Holzman strain of rats, which Spencer (1982) used, is more
susceptible than the Wistar rat, which the other two studies used.  Hany et al. (1999b), in addition to
testing Aroclor 1254, also treated rats with a reconstituted PCB mixture of congeneric composition
similar to the pattern found in human breast milk and both mixtures induced similar reductions in birth
weight and in weight gain during lactation. 
Linder et al. (1974) administered Aroclor 1254 or Aroclor 1260 at the same dose levels on Gd 7–15 to
Sherman rats and found that Aroclor 1254 significantly reduced survival to weaning, whereas
Aroclor 1260 did not.  These two Aroclors differ primarily in that Aroclor 1254 lacks congeners with
7–9 chlorines (Albro et al. 1981), but further information is needed before speculating as to which PCB
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congeners might or might not be responsible for neonatal lethality.  Studies in rats which included in
utero and lactational exposure to Aroclors suggest that transfer of PCBs via milk may be considerable, as
decreased body weight was seen in the pups after weeks of nursing even though body weight at birth was
not significantly different than unexposed rats (Collins and Capen 1980c; Goldey et al. 1995; Overmann
et al. 1987).  It should be kept in mind that, in general, studies in rats used fairly high doses of Aroclors to
the dams such that it is reasonable to assume that breast milk had the potential to accumulate high
concentrations of PCBs. 
As previously mentioned, monkeys seem to be much more sensitive to developmental effects of PCBs
than rodents.  Reduced birth weight was reported in offspring from Rhesus monkeys treated before
mating and during gestation with 0.03 mg Aroclor 1016/kg/day (Barsotti and Van Miller 1984).  These
monkeys also showed characteristic signs of PCB intoxication such as hyperpigmentation.  Reduced mean
birth weight also was reported in monkeys exposed to Aroclor 1248 (Allen and Barsotti 1976; Allen et al.
1980).  Doses even smaller of Aroclor 1254 (0.005 mg/kg/day), while not significantly affecting birth
weight or growth, produced clear signs of PCB intoxication manifested as skin, nail, and gum lesions
(Arnold et al. 1995, 1997).  In all of these studies in monkeys, maternal toxicity was also evident.  
3.2.7 Genotoxic Effects
3.2.7.1  Summary
The genotoxicity of PCBs has been tested in in vivo and in vitro studies with generally negative results. 
End points that have been examined in these studies include gene mutations in bacteria and Chinese
hamster V79 cells, chromosomal aberrations in human lymphocytes and rat and mouse bone marrow cells
and spermatogonia, micronuclei in mouse bone marrow cells, and dominant lethal mutations in rat sperm
cells. 
3.2.7.2  In Vivo Studies
Available information on in vivo genotoxic effects of PCBs in humans is limited by confounding
exposures that involved mixtures of chemicals.  Chromosomal aberrations and sister chromatid exchanges
in peripheral lymphocytes were increased in 32 workers involved in the manufacturing of
DELOR 103 and DELOR 106 (Czechoslovakia-made PCBs with three and six chlorine atoms in the
biphenyl ring, respectively) for 2–25 years (Kalina et al. 1991).  These increases over control values
3.  HEALTH EFFECTS - Genotoxic
PCBs 247
achieved statistical significance in workers exposed for >10 years.  Although control and exposed groups
were matched regarding smoking and alcohol drinking habits, the exposed workers were also exposed to
benzene and formaldehyde.  Another occupational study found a moderately increased incidence of
chromatid exchanges in peripheral lymphocytes from a group of 12 workers who were exposed to PCBs
following a fire in an electric station (Melino et al. 1992).  The authors also observed that the number of
chromosome breaks per cell was often higher in the exposed subjects than in unexposed controls. 
Additionally, lymphocytes from the exposed workers appeared to be more fragile than those from
unexposed individuals.  However, exposure to toxic chlorinated dioxins and/or furans generated during
the fire may have occurred.
Six of 16 workers engaged in cleaning oil from old transformers showed abnormal banding pattern for fes
oncogene-related proteins; all of the 6 were smokers (Brandt-Rauf and Niman 1988).  Since none of the
nonsmoking workers (six) showed this pattern, the role of PCBs, if any, in the induction of genetic
abnormalities described in this study cannot be ascertained.  A control unexposed group was not included
in this study.
PCBs gave generally negative results in in vivo assays in animals (see Table 3-4).  Several studies
investigated genotoxic effects in rats following acute oral exposure to PCBs.  Single doses #5,000 mg/kg
of Aroclor 1242 administered by gavage did not induce chromosome abnormalities in bone marrow cells
or spermatogonial cells of rats (Green et al. 1975a).  In the same study, doses #750 mg/kg/day
Aroclor 1254 administered for a 5-day period did not increase the incidence of chromosomal
abnormalities in rat bone marrow cells.  Dominant lethal mutations were not induced in male Osborne-
Mendel rats following gavage treatment with a single dose of 625–2,500 mg/kg Aroclor 1242, or with
five daily doses of 125 or 250 mg/kg Aroclor 1242 or 75–300 mg/kg Aroclor 1254 (Green et al. 1975b). 
Rats treated with a single dose of 1,295 mg/kg Aroclor 1254 showed evidence of DNA damage in
hepatocytes 4–12 hours after treatment (Robbiano and Pino 1981).  However, this damage was no longer
detectable 48 hours after treatment due to DNA repair.  Whysner et al. (1998) administered
Aroclor 1260 as a single dose of 50 mg/kg or as a concentration of 200 ppm in the diet for 14 days. 
Neither the single dose nor the exposure in the diet produced detectable DNA adducts in the liver.
Two studies that examined genotoxic effects of intermediate-duration oral exposure to PCBs were
identified.  Rats administered 0.25–25 mg/kg/day Aroclor 1254 in their diets for #35 days had no
evidence of chromosomal damage in bone marrow and spermatogonial cells (Garthoff et al. 1977). 









Table 3-4.  Genotoxicity of Polychlorinated Biphenyls In Vivo




Rat spermatogonia Chromosomal abnormalities – Dikshith et al. 1975 Aroclor 1254
Rat spermatogonia Chromosomal abnormalities – Dikshith et al. 1975 Aroclor 1254
Rat hepatocytes DNA fragmentation + Robbiano and Pino 1981 Aroclor 1254
Rat spermatogonia Chromosomal abnormalities – Green et al. 1975a Aroclor 1242
Rat bone marrow cells Chromosomal abnormalities – Green et al. 1975a Aroclor 1242
Rat bone marrow cells Chromosomal abnormalities – Green et al. 1975a Aroclor 1242
Rat sperm cells Dominant lethal mutation – Green et al. 1975b Aroclor 1242
Rat sperm cells Dominant lethal mutation – Green et al. 1975b Aroclor 1254
Mouse bone marrow cells Micronuclei – Bruce and Heddle 1979 Aroclor 1254
Mouse sperm cells Chromosomal abnormalities – Bruce and Heddle 1979 Aroclor 1254
Nonmammalian cells:
Chicken embryos Chromosomal abnormalities – Blazak and Marcus 1975 Aroclor 1242
Ring dove Chromosomal abnormalities + Peakall et al. 1972 Aroclor 1254
Drosophila melanogaster Chromosomal abnormalities – Nilsson and Ramel 1974 Clophen 30
D. melanogaster Chromosomal abnormalities – Nilsson and Ramel 1974 Clophen 50
DNA = deoxyribonucleic acid; – = negative result; + = positive result
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mutations in male rats (Green et al. 1975b).  Lack of dominant lethality was indicated by no consistent
changes in numbers of implantations and dead implantations per pregnant untreated female.  The 70-day
duration of the feeding study covered the spermatogenic cycle of the rat.
PCBs did not induce chromosomal aberrations when tested in Drosophila melanogaster (Nilsson and
Ramel 1974) and chicken embryos (Blazak and Marcum 1975), although slight effects were reported in
ring dove embryos (Peakall et al. 1972).
3.2.7.3  In Vitro Studies
PCBs are generally nongenotoxic in in vitro assay systems (see Table 3-5).  Aroclor 1254 was not
mutagenic in the bacteria S. typhimurium with or without exogenous metabolic activation (Bruce and
Heddle 1979; Heddle and Bruce 1977; Schoeny et al. 1979).  Gene mutations also were not induced by
Aroclor 1242 or Clophen A60 in Chinese hamster V79 cells (Hattula 1985).  Varying results were found
in two assays for Aroclor 1254-induced chromosomal damage in cultured human lymphocytes, but the
different findings may be the consequence of a higher test concentration in the positive study
(Hoopingarner et al. 1972; Sargent et al. 1989).  Aroclor 1254 induced DNA damage in rat liver cells in
vitro as indicated by an increase in unscheduled DNA synthesis (Althaus et al. 1982), but it was not
reported whether the genotoxic doses were also cytotoxic.
Chromosome breakage and micronuclei were not induced in human lymphocytes in whole blood or
isolated cultures following in vitro exposure to the single congener 3,3'4,4'-hexaCB (PCB 77) (Belpaeme
et al. 1996).  In another study, PCB 77, but not Aroclor 1254, induced DNA adducts in the Hep G2
human cell line and in primary fetal rat and quail hepatocytes (Dubois et al. 1995). 
3.2.7.4  Evaluation of Genotoxicity Studies 
The generally negative results of in vitro and in vivo genotoxicity studies indicate that commercial PCB
mixtures are not potent genotoxicants.  Although PCBs have been found to be generally inactive as
mutagens in S. typhimurium strains and in several other tests of genotoxicity that may be predictive of
tumor initiation activity, in vitro studies with rat microsomes have indicated that metabolism of lower
chlorinated congeners can lead to covalently modified macromolecules including proteins and DNA









Table 3-5.  Genotoxicity of Polychlorinated Biphenyls In Vitro
Results










Gene mutation – – Schoeny et al. 1979 Aroclor 1254
S. typhimurium
(plate incorporation)
Gene mutation – – Heddle and Bruce 1977 Aroclor 1254
S. typhimurium
(plate incorporation)




Gene mutation No data – Hattula 1985 Aroclor 1242
Chinese hamster V79
cells (tissue culture)





No data – Hoopingarner et al. 1972 Aroclor 1254
Rat hepatocytes (tissue
culture)





No data + Sargent et al. 1989 Aroclor 1254
DNA = deoxyribonucleic acid; – = negative result; + = positive result
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indicate that PCBs are not potent genotoxicants, there is some experimental support for the possible
involvement of genotoxic mechanisms in the development of PCB-induced cancer.
3.2.8 Cancer
3.2.8.1 Summary
The carcinogenicity of PCBs in humans has been investigated in retrospective cohort mortality studies
that investigated cancer in exposed workers, and in case-control studies of environmental exposure that
examined associations between serum or adipose tissue levels of PCBs and occurrence of cancer.  Some
of the mortality studies suggest that occupational exposures to PCBs were associated with cancer at
several sites, particularly the liver, biliary tract, intestines, and skin (melanoma).  A report of liver cancer
in Yusho victims appears to support the occupational hepatocarcinogenicity data.  There is no clear
association between occupational exposures to PCBs and cancer in other tissues, including the brain,
hematopoietic, and lymphatic systems.  Case-control studies of the general population are inconclusive
with respect to associations between environmental exposures to PCBs and risk of breast cancer or
non-Hodgkin’s lymphoma, although there are preliminary indications that particular subgroups of women
may be at increased risk for breast cancer.  Overall, the human studies provide some evidence that PCBs
are carcinogenic.  In contrast to the studies in humans, there is conclusive evidence that commercial PCB
mixtures are carcinogenic in animals based on induction of tumors in the liver and thyroid.
3.2.8.2 Human Studies
Most of the information on the carcinogenicity of PCBs in humans is available from cohort mortality
studies of workers exposed during the manufacture and use of capacitors and case-control studies of
breast cancer in women exposed to background levels in the environment.
3.2.8.2.1  Liver, Biliary Tract, and Gall Bladder
Occupational Exposure.  A small excess risk of liver-related cancer was found in studies of workers from
two capacitor manufacturing plants in New York and Massachusetts (Brown 1987b; Brown and Jones
1981).  The workers had completed at least 3 months of employment between 1940 and 1976 in areas of
the plants considered to represent the potential for the highest exposure to PCBs.  Aroclor 1254 was used
at first, but usage was later changed to Aroclor 1242, and finally to Aroclor 1016.  Historical exposure
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data were not available, but personal time-weighted average concentrations of Aroclor 1016 in 1977
ranged from 0.024 to 0.393 mg/m3 at Plant 1 and 0.170 to 1.26 mg/m3 at Plant 2.  These data were
collected shortly after changes in work practices and engineering controls were effected, and the use of
PCBs was reduced to 25% of the 1976 level.  The workers were also exposed to additional chemicals,
including trichloroethylene, toluene, and methyl isobutyl ketone.  The first study (Brown and Jones 1981)
included 2,567 total subjects comprised of 968 workers (583 males, 385 females) in Plant 1 and
1,599 workers (675 males and 924 females) in Plant 2.  Of these workers, 25.5 and 8.2% in Plant 1 and
19.4 and 8.9% in Plant 2 were exposed for 3–10 years and $10 years, respectively.  The second study
(Brown 1987b) was conducted after 7 additional years of observation on 2,588 total subjects, comprised
of 981 workers (593 males, 388 females) in Plant 1 and 1,607 workers (677 males and 930 females) in
Plant 2.  Expected numbers of deaths were based on U.S. white male and white female cause-specific
mortality rates.  A slight increase in mortality due to cancer of the liver, biliary tract, or gall bladder
(3 observed/1.07 expected, SMR=280, 95% CI 58–820) that was not statistically significant (p>0.05) was
found in the first study (Brown and Jones 1981).  The follow-up study (Brown 1987b) identified two
additional cases of liver/biliary tract/gall bladder cancer, which made the excess statistically significant
(5 observed/1.9 expected, SMR=263, CI not reported, p<0.05).  Four of the five cancer cases occurred in
women who worked in Plant 2 (4 observed/0.9 expected, SMR=444, CI not reported, p<0.05).  Although
the four cases in women occurred in the plant with the higher exposure range, there was no clear increase
in the risk of liver/biliary tract/gall bladder cancer with increasing latency (time from start of exposure to
end of observation) or length of employment; however, the confidence in this analysis is low due to the
small numbers of deaths.  Reclassification of the data showed that only two of the five deaths were from
liver cancer and the remaining three were in the biliary tract (two cases) or gall bladder (one case) (Brown
1987b).  Additionally, one of the two liver cancers was not a primary carcinoma as it metastasized from
another site (unknown).  If the metastatic liver cancer is not included in the analysis, the SMR for liver
and biliary tract cancer in the whole cohort loses statistical significance (SMR=210, p$0.05) (Nicholson
and Landrigan 1994).  Other findings included a slight increase in rectal cancer in the first study, but not
in the follow-up (see Section 3.2.8.2.3).  Limitations of these studies include small number of deaths,
relatively short periods of observation, and possible misclassification of the cause of death because it is
not clear in every case if death was due to primary cancer of the liver, biliary tract, or gall bladder.
Liver cancer was not statistically significantly increased in a retrospective cohort mortality study of
7,075 workers from two capacitor manufacturing/repairing plants in New York (Kimbrough et al. 1999a). 
An unspecified number of the male workers in this study were included in the cohort studied by Brown
(1987b) and Brown and Jones (1981) summarized above.  The Kimbrough et al. (1999a) cohort was
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comprised of hourly workers (2,984 male, 2,544 female) and salaried workers (1,078 male, 469 female)
employed for at least 90 days between January 1, 1946 and June 15, 1977, and followed to death or
January 31, 1993, whichever came first.  Follow-up was essentially complete (98.7%), and the mean age
at end of employment ranged from 31 to 35 years in the four subgroups, mean follow-up time was
31 years, mean age of all cohort members alive at the end of follow-up was 57 years, and mean age at
death was 62 years.  PCB exposures were predominantly to Aroclor 1254 from 1946 to 1954,
Aroclor 1242 from 1954 to 1971, and Aroclor 1016 from 1971 to 1977.  Exposures were qualitatively
classified as high, low, or undefinable based on types and locations of jobs and some area measurements. 
No personal exposure monitoring was performed, although previously reported data on 290 self-selected
workers from one of the plants had serum PCB levels in ranges of 6–2,530 and 1–546 ppb (ng/mL) for
lower and higher chlorinated homologs, respectively (Wolff et al. 1982a).  Workers with high exposure
jobs had direct PCB contact (dermal and/or inhalation), workers with low exposure jobs primarily had
inhalation exposure to background levels of PCBs in the plant, and workers with undefinable exposures
had exposures that varied depending on where tasks were performed.  Exposure-specific analysis was
limited to workers with the greatest potential for exposure, (i.e., hourly workers who ever worked in a
high-exposure job, worked for at least 6 months in a high-exposure job, or worked for at least 1 year in a
high-exposure job).  Workers who exclusively worked in high-exposure jobs could not be analyzed as a
separate group due to small numbers (112 males, 12 females).  SMRs were calculated for hourly and
salaried workers by gender, length of employment (6 or 12 months), and latency categories (<20 or
$20 years), using age-, sex-, race-, and time-specific U.S. general population rates for comparison.  No
statistically significant elevations in mortality from cancer of the liver and biliary passages were found in
any of the groups, including in the most highly exposed workers, and SMRs for liver/biliary cancer did
not statistically significantly increase with length of cumulative employment and latency.  SMRs for
cancer of the liver and biliary passages were <100 in the male hourly workers (2 observed/2.5 expected,
SMR=80, 95% CI 10–289), female hourly workers (2 observed/2.2 expected, SMR=89, CI 11–321), and
male salaried workers (1 observed/1.2 expected, SMR=79, CI 2–439), and could not be calculated in the
female salaried workers due to no observed cases (0.3 expected).  Other findings in this study included a
suggestive increase in mortality from intestinal cancer as discussed in Section 3.2.9.2.2.  A healthy
worker effect was demonstrated by SMRs that were less than expected for mortality from all causes and
from all cancers.
Interpretation of the Kimbrough et al. (1999a) findings is complicated by a few study limitations and
biases, including some exposure misclassifications related to use of length of employment alone as a
surrogate of exposure, potentially insufficient dosage differences between exposed and comparison
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groups, a degree of selection bias due to the healthy worker effect that may have resulted in an
underestimate of SMRs, concern for low statistical power due to small numbers of deaths from site-
specific cancers in some of the groups (e.g., female hourly workers with high exposure and $20 years
latency), relatively young age at follow-up, and use of the general population for comparison rather than
an internal control group or a group of workers from another company.  These issues are discussed by
Bove et al. (1999), Frumkin and Orris (1999), and Kimbrough et al.  (1999b).  Some of the limitations are
typical of occupational cohort mortality studies, and strengths of the study include its size (the largest
cohort of PCB workers ever studied) and essentially complete follow-up of long duration.  Unresolved are
the puzzling Kimbrough et al. (1999a) findings of significantly lower than expected mortality from all
cancers among males and the lower number of observed cases of liver and biliary tract cancers among
females compared to the smaller cohort studied by Brown et al. (1997b), a subset of the same study
population.  These unresolved findings suggest that ascertainment of cancer mortality was not complete in
this study.  Overall, the study limitations are sufficient to cast doubt on the negative findings for liver and
biliary tract cancer and other site-specific cancers.  Increases in mortality from intestinal cancer, rectal
cancer, and melanoma are summarized in Sections 3.2.8.2.2, 3.2.8.2.3, and 3.2.8.2.4, respectively.
Mortality from liver and bile duct cancer was increased (2 observed cases/0.78 expected, SIR=256, 95%
CI 31–926) in a small group of workers at a Swedish capacitor manufacturing facility (Gustavsson and
Hogstedt 1997; Gustavsson et al. 1986).  The subjects were exposed to PCBs of 42% chlorine content for
an average of 6.5 years between 1965 and 1978.  Airborne PCB levels measured on one occasion in 1973
were 0.1 mg/m3, and dermal exposure was common.  The first study of these workers included 142 males
and had a median latency time of 13 years (Gustavsson et al. 1986).  The second study added 9 years of
follow-up and included 242 males (Gustavsson and Hogstedt 1997).  Although only two cases were
observed in the category for liver and bile duct cancers, both cases were relatively rare bile duct types (a
cholangiocarcinoma of the primary bile duct in one high-exposure worker employed for 3 years, and an
adenocarcinoma of the Papilla Vaterii in one low-exposure worker employed for 9 years).
Mortality from cancers of the digestive system, which included the liver and biliary tract, was increased in
a study of 544 male and 1,556 female workers involved in the manufacture of PCB-impregnated
capacitors in a plant in Italy (Bertazzi et al. 1987).  The workers were employed for a minimum of 1 week
between 1946 and 1978 and were examined during 1946–1982.  PCB mixtures containing 54% chlorine
(Aroclor 1254 and Pyralene 1476) were used until 1964; these were progressively replaced by mixtures
containing 42% chlorine (Pyralene 3010 and 3011) until 1970, when only Pyralene 3010 and 3011 were
used.  The maximum quantities of PCBs were used in 1967–1968, and the use of PCBs was abandoned
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completely since 1980.  Area samples taken in 1954 and 1977 showed air PCB concentrations ranging
from 5.2 to 6.8 mg/m3 (Aroclor 1254) and 0.048 to 0.275 mg/m3 (Pyralene 3010), respectively. 
Concentrations of total PCBs on workers' hands in 1977 and 1982 ranged from 0.3 to 9.2 and 0.09 to
1.5 µg/cm2, respectively.  Deaths from digestive system cancers were statistically significantly increased
in males when compared with national rates (6 observed/1.7 expected, SMR=346, 95% CI 141–721) and
local rates (6 observed/2.2 expected, SMR=274, 95% CI 112–572).  The digestive system category was
not defined, but is not specific for the stomach and intestines as the six cases included cancers of the liver
(one case), biliary tract (one case), and pancreas (two cases), as well as stomach (two cases).  Follow-up
evaluation of the cohort by Tironi et al. (1996) after an additional 9 years of latency found that mortality
from digestive system cancers was still increased in comparison to local rates (10 observed/5.1 expected,
SMR=195, CI 94–359), although the excess was not as high as found previously.  Other findings included
increased mortality from hematological neoplasms as discussed in Section 3.2.8.2.6.  Limitations of the
Bertazzi et al. (1978) and Tironi et al.  (1996) studies include questionable grouping of digestive system
cancers; small number of cases; short minimum exposure period; lack of pattern or trend when data were
analyzed by duration of exposure, latency, and year of first exposure; and some cancer deaths in males
with low potential for direct PCB exposure.  
Mortality from cancer of the liver, biliary passages, and gall bladder was not increased in the Sinks et al.
(1992) study of capacitor manufacturing workers or Loomis et al. (1997) study of electric utility workers
summarized in Section 3.2.8.2.4.
Contaminated Fish Consumption.  Mortality from liver cancer was not increased in the Svensson et al.
(1995a) study of Swedish east coast (Baltic Sea) and west coast fisherman summarized in
Section 3.2.8.2.2.
Yusho and Yu-Cheng Exposures.  A retrospective study of 887 male and 874 female patients that were
observed for an average of 11 years following registration as Yusho victims found statistically
significantly (p<0.01) increased mortality from liver cancer in the males compared to national death rates
(9 observed/1.61 expected, SMR=559, 95% CI not reported) (Kuratsune et al. 1987).  Elevated mortality
from liver cancer was also seen in the females, but the increase was not statistically significant
(2 observed/0.66 expected, SMR=304, p>0.05).  Comparisons based on local death rates also showed a
statistically significantly increased mortality from liver cancer in the males (9 observed/2.34 expected,
SMR=385, p<0.01) but not in females (2 observed/0.79 expected, SMR=253, p>0.05), as well as in males
when early liver cancer cases (those occurring <9 years after poisoning) were excluded
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(4 observed/1.04 expected, SMR=385, p<0.05).  However, because the geographic distribution of liver
cancer deaths was markedly uneven (there was no significant increase in one of two locations), the cancer
could not be conclusively associated with Yusho exposure.
A retrospective mortality study of 1940 Yu-Cheng cases summarized in Section 3.2.8.2.6 found no
statistically significantly increased mortality from cancer of the liver and intrahepatic bile ducts (Hsieh et
al. 1996).
3.2.8.2.2  Gastrointestinal Tract
Occupational Exposure.   Mortality from cancer of the stomach or intestines was not statistically
significantly increased in the Kimbrough et al. (1999a) study of capacitor workers summarized in
Section 3.2.8.2.1, although the rate for intestinal cancer (large and small intestine) was elevated and
approached statistical significance (20 observed/12.7 expected, SMR=157, 95% CI 96–242) in the hourly
female subgroup of workers.  Most of these cancers occurred in women with $20 years of latency and the
increase in this subgroup was statistically significant (SMR=189, 95% CI not reported, p<0.05).  There
was no increasing trend with length of employment and the SMR was 100 for women employed for
$10 years with a latency period of $20 years (Kimbrough et al. 1999b).  Comparison with the regional
population resulted in a SMR which is still elevated (SMR=120, 95% CI 74–186) and similar to the SMR
of 157 based on the national rates (Kimbrough et al. 1999b).  Due to the small number of cases, healthy
worker effect bias, and exposure misclassification bias, it is remarkable that an elevation of intestinal
cancer was found among hourly women workers.  However, this finding must be viewed as suggestive
given the limitations of the study.
Deaths from cancers of the digestive system were statistically significantly increased in the Bertazzi et al.
(1987) study of capacitor workers summarized in Section 3.2.8.2.1.  This category was not specific for the
stomach and intestines as it included other parts of the digestive system, including the liver and biliary
tract.  Of six observed deaths from digestive system cancers, one was due to hepatocellular carcinoma and
another from a cancer of the biliary tract.
Mortality from cancer of the stomach or intestine was not statistically significantly increased in other
studies of capacitor manufacturing workers (Brown 1987b; Brown and Jones 1981) summarized in
Section 3.2.8.2.1, or in the Loomis et al. (1997) study of electric utility workers summarized in
Section 3.2.8.2.4.  Mortality from cancer of the digestive organs (not otherwise specified) was not
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increased in the Sinks et al. (1992) study of capacitor manufacturing workers summarized in
Section 3.2.8.2.4.
Contaminated Fish Consumption.  Cancer incidences were studied in cohorts of fisherman from the
Swedish east coast (on the Baltic Sea) (2,896 subjects) and Swedish west coast (8,477 subjects)
(Svensson et al. 1995a).  Both cohorts ate almost twice as much fish as the general regional populations,
although intake of fatty fish was higher in the east coast fisherman (Svensson et al. 1995b).  Plasma levels
of PCB congeners, particularly non-ortho PCBs, were also higher in the east coast fisherman compared
west coast fisherman and referents from both coasts; the sum of non-ortho, mono-ortho, di-ortho, and
other congeners expressed as the TEQ was about 2 times higher in the east coast fisherman than in those
from the west coast.  The incidence of stomach cancer was increased in the east coast fisherman when
compared with both the regional general population (Incidence Rate Ratio [IRR]=1.6, 95% CI 1.0–2.4)
and the west coast fisherman (IRR=2.2, CI 1.3–3.5).  Stomach cancer was not increased in the west coast
fisherman when compared to the regional general population.  Although the east and west coast fisherman
ate almost twice as much fish as controls, and intake of fatty fish and PCBs was higher in the east coast
fisherman compared to the west coast fisherman and referents from both coasts, the east coast fisherman
also consumed smoked fish (a risk factor for stomach cancer) twice as often as the west coast fisherman
(Svensson et al. 1995a).
Yusho and Yu-Cheng Exposures.  The retrospective study Yusho victims summarized in
Section 3.2.8.2.1 found no statistically significant (p<0.05) increased mortality from cancer of the
stomach or esophagus (Kuratsune et al. 1987).  The retrospective study of Yu-Cheng victims summarized
in Section 3.2.8.2.6 found no statistically significantly increased mortality from cancer of the stomach or
small intestine (Hsieh et al. 1996).
3.2.8.2.3  Rectum
Occupational Exposure.  An elevation in rectal cancer was found in the first of two studies of two
capacitor manufacturing plants in New York and Massachusetts (Brown 1987b; Brown and Jones 1981). 
Background information on these studies is provided in Section 3.2.8.2.  Brown and Jones (1981) found
that rectal cancer mortality was statistically significantly (p<0.05) increased in 1,309 females (3 observed/
0.5 expected, SMR=600, 95% CI not reported) from Plant 2, but not among 675 males from Plant 2
(0 observed/0.20 expected), 924 males from Plant 1 (1 observed/0.31 expected, SMR=323, 95% CI not
reported), 385 females from Plant 1 (0 observed/0.18 expected), or 2,567 total males and females from
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both plants (4 observed/1.19 expected, SMR=336, 95% CI 92–860).  Follow-up evaluation (Brown
1987b) of 2,588 total workers from both plants after a further 7 years of observation found no additional
deaths from rectal cancer (4 observed/1.9 expected, SMR=211), and the excess in the females from
Plant 2 was no longer statistically significant because of the small numbers of observed and expected
cases (3 observed/0.8 expected, SMR=375, p>0.05).
There was a non-statistically significant (p>0.05) increase in rectal cancer mortality (4 observed/
2.3 expected, SMR=169, 95% CI 46–434) in the female hourly worker subgroup of the capacitor manu-
facturing workers studied by Kimbrough et al. (1999a) (Section 3.2.8.2.1).  Mortality from rectal cancer
was not increased in the Sinks et al. (1992) study of capacitor manufacturing workers or Loomis et al.
(1997) study of electric utility workers summarized in Section 3.2.8.2.4.
Contaminated Fish Consumption.  Mortality from cancer of the rectum or colon was not statistically
significantly increased in the Svensson et al. (1995a) study of Swedish east coast (Baltic Sea) and west
coast fisherman summarized in Section 3.2.8.2.2.
Yusho and Yu-Cheng Exposures.  The retrospective study Yusho victims summarized in
Section 3.2.8.2.1 found no statistically significantly increased mortality from cancer of the rectum,
sigmoid colon, and anus (Kuratsune et al. 1987).  
3.2.8.2.4  Skin
Occupational Exposure.  Mortality analysis of 3,588 workers (2,742 male, 846 female) employed at an
Indiana capacitor manufacturing facility when PCBs were used (1957–1977) provided evidence of
exposure-related malignant melanoma (NIOSH 1991; Sinks et al. 1992).  The mean latency was
19.2 years (range, 0.04–32.5 years), mean duration of employment was 4.1 years (range,
1 day–20.2 years), and mean age at hire was 27 years (range, 16.8–62.6 years).  Aroclor 1242 was used
until 1970, and Aroclor 1016 was used subsequently.  Area monitoring for PCBs in 1977 showed mean
concentrations ranging from 0.016 to 0.076 mg/m3.  The workers were also exposed to various solvents
(toluene, xylene, methyl ethyl ketone, trichloroethylene, and 1,1,1-trichloroethane) and unspecified
metals from brazing and soldering operations.  Mortality from all causes and all cancers was lower than
expected, indicating a healthy worker effect.  More deaths were observed than expected for malignant
melanoma (8 observed/2 expected, SMR=4.1, 95% CI 1.8–8.0, p<0.01).  The excess mortality from
melanoma affected both men and women.  All eight melanoma deaths occurred $5 years after first
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employment, and three occurred in individuals who had worked for >10 years.  One of the eight cases of
malignant melanoma was diagnosed 2 months before starting employment and should not have been
included in the analysis; the excess mortality remained when this case was excluded from analysis
(SMR=3.5, 95% CI 1.4–7.3).  Two other melanoma cases possibly should have been excluded from
analysis due to low risk from short-term exposure of <6 months; however, PCBs are bioaccumulative and
exposure may have been high.  A ninth worker died with malignant melanoma listed as a contributory
cause of death; this person had worked at the plant for 1 month and died 20 years after exposure.  There
was no clear relationship between malignant melanoma and latency or duration of employment.  Analysis
performed to determine if a dose-response relationship existed between average estimated cumulative
PCB exposure (duration of employment multiplied by a primarily qualitative exposure intensity rating)
and mortality showed no statistically significant differences in estimated exposures between the workers
that died from malignant melanoma and other workers at the same plant.  Other findings in this study
included a non-statistically significant increase in brain cancer as discussed in Section 3.2.8.2.5. 
Limitations of this study include possible insensitivity of mortality as an index of risk for malignant
melanoma; inability to evaluate risk of cancers with long latency periods (<10% of the person-years at
risk were accumulated with $20 years of latency); insufficient monitoring data, which precluded detailed
exposure weighting; and exposure intensity ratings, which may have resulted in exposure
misclassification and obscured a dose-response relationship.  Screening of the affected workers for
malignant melanoma was recommended based on the conclusion that the workers were at excess risk
(NIOSH 1990).
There were non-statistically significant (p>0.05) increases in mortality from skin melanomas in the hourly
male workers (5 observed/3.8 expected, SMR=130, 95% CI 42–303), hourly female workers
(3 observed/2.0 expected, SMR=144, 95% CI 30–421), and salaried male workers
(4 observed/1.9 expected, SMR=210, 95% CI 57–538 in the Kimbrough et al. (1999a) study of capacitor
manufacturing workers summarized in Section 3.2.8.2.1.
Mortality from malignant melanoma was not statistically significantly different than expected in the
Gustavsson and Hogstedt (1997) study of capacitor manufacturing workers summarized in
Section 3.2.8.2.1.
Preliminary data, reported in letters to the editor of the journal, indicated that the incidence of malignant
melanoma was increased in a small group New Jersey petrochemical refinery workers who were involved
in processes that used Aroclor 1254 (Bahn et al. 1976, 1977; Lawrence 1977; NIOSH 1977).  Two cases
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of malignant melanoma were observed in 31 men believed to have been heavily exposed to PCBs; when
compared to 0.04 expected cases based on national rates, the increase was statistically significant
(p=0.001).  An additional malignant melanoma was observed in another group of 41 workers believed to
have had less exposure.  Aroclor 1254 had been used over a 9-year period ending in the late 1950s, but
PCB exposure was not quantified and concurrent exposure to other potential and known carcinogens was
not evaluated.  Other limitations of this study include the small number of cases and cohort size, and the
use of expected cancer rates based on U.S. population data rather than on local New Jersey rates.
Loomis et al. (1997) analyzed cancer mortality among 138,905 men employed as electric utility workers
for at least 6 months between 1950 and 1986 at five power plants.  No increases in total-cancer mortality
were found when data were analyzed by total cohort, duration of employment, job category, or estimated
cumulative exposure to PCBs in insulating fluids.  Mortality from malignant neoplasms of the skin was
not increased in the total cohort (116 observed/111.9 expected, SMR=1.04, 95% CI 0.86–1.24), although
relative risk of malignant melanoma by duration of employment appeared to increase in the job category
with the greatest potential for dermal exposure to PCBs (i.e., in mechanics, but not in electricians,
lineman and cable splicers, or laborers and material handlers).  The mortality RR for malignant melanoma
in mechanics employed for >0–5 years and >5–10 years were 2.57 (95% CI 1.06–6.20, based on eight
deaths) and 3.16 (95% CI 0.92–10.85, based on three deaths), respectively; analysis for >10 years
duration was precluded by small number of deaths.  Analysis of mortality by cumulative exposure was
only performed for the total cohort (all job categories combined).  Mortality from malignant melanoma in
the total cohort increased with increasing cumulative exposure; the RRs relative to unexposed men were
1.23 (95% CI 0.56–2.52), 1.71 (95% CI 0.68–4.28), and 1.93 (95% CI 0.52–7.14) for men with <2000,
>2000–10,000, and >10,000 hours of cumulative exposure, respectively, without consideration of latency. 
A latency interval of 20 years yielded RRs of 1.29 (95% CI 0.76–2.18), 2.56 (95% CI 1.09–5.97), and
4.81 (95% CI 1.49–15.50) for the same cumulative exposure levels, although the RR for the highest
exposure category is based on only one death.  Although mortality from melanoma was highest among
workers in the job category with the greatest potential for dermal exposures, this study is limited by small
numbers of subjects in the higher exposure and longer latency groups, as well as possible incomplete
control of confounding due to exposure to sunlight.
Of 55 transformer workers who were exposed to Askarel PCBs (0.00001–0.012 mg/m3) for a mean
duration of 3.75 years, 2 gave a history of removal of a melanoma (type not reported) (Emmett et al.
1988a).  No melanomas were reported by 56 age-matched nonexposed subjects, and the difference
between the groups was not statistically significant.
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Contaminated Fish Consumption.  Cancer incidences were studied in the Svensson et al. (1995a) study
of Swedish east coast (Baltic Sea) and west coast fisherman summarized in Section 3.2.8.2.2.  When
compared to the regional general populations, incidences of lip cancer were significantly increased in
both the east and west coast fisherman (SIR=2.6, 95% CI 1.1–5.4 and SIR=1.9, CI 1.3–2.8, respectively),
and incidences of squamous cell skin cancer were increased in the east and west coast fisherman
(SIR=2.3, CI 1.5–3.5 and SIR=1.1, CI=0.9–1.4, respectively).  The incidence of skin cancer in the east
coast fisherman was also higher than in the west coast fisherman (SIR=1.9, CI 1.2–3.1).  Mortality from
skin cancer was increased in the fisherman from the west coast (SMR=3.05, CI=0.99–7.13), but not east
coast (SMR=0, CI=0.00–15.4).  Mortality from melanoma was not increased in either the east coast
fisherman (SMR=0, CI=0.00–1.73) or west coast fisherman (SMR=0.67, CI=0.25–1.46).  The
investigators noted that exposure to ultraviolet (UV) radiation in sunlight is too small to explain the
observed difference in skin cancer sunlight and that UV light is not a risk factor for lip cancer.
General Population Exposures.  An increased annual occurrence of ocular melanoma was discerned in
Ohio residents during 1967–1977 (1.09 cases/100,000 persons/year versus 0.6 in other reports), with no
statistically significant difference in the number of cases reported from year to year (Davidorf and Knupp
1979).  No relationship between PCB exposure and the occurrence of ocular melanoma was suggested by
a crude state-wide geographic comparison, which showed that distribution of the cancer was similar in
counties with and without presumed elevated exposures, as indicated by high PCB levels in fish or
presence of industries that might use PCBs.
3.2.8.2.5  Brain and Central Nervous System 
Occupational Exposure.  Suggestive increases in mortality from brain cancer were reported in the Sinks
et al. (1992) study of capacitor manufacturing workers and Loomis et al. (1997) study of electric utility
workers summarized in Section 3.2.8.2.4.  Sinks et al. (1992) found a non-statistically significant increase
in brain cancer mortality in 3,588 male and female workers based on five cases in both sexes compared to
2.8 expected (SMR=1.8, 95% CI 0.6–4.2, p>0.05).  There was no clear relationship between brain cancer
and latency or duration of employment, although there was an indication that brain cancer deaths were
more common among those with a longer duration of employment (three deaths occurred after
$10 years).  Additional analysis was performed to determine if a dose-response relationship existed
between average estimated cumulative PCB exposure and mortality from brain cancer.  This analysis
showed no statistically significant differences in estimated exposures between the workers that died from
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brain cancer and other workers at the same plant, although the estimated exposure of the brain cancer
fatalities was approximately twice as high as that of the other workers.
Loomis et al. (1997) found that mortality from brain cancer was increased among mechanics who were
dermally exposed to PCBs in capacitor fluids for 0–10 years (RR=1.84, 95% CI 0.90–3.78).  There were
no deaths from brain cancer in mechanics employed for >10 years.  Mortality from brain cancer was also
increased in the total cohort of electric utility workers with cumulative exposures of <2,000 hours
(RR=1.61, 95% CI 0.86–3.01) and 2,000–10,000 hours (RR=1.79, 95% CI 0.81–3.95) and no latency
period.  The RRs of 1.6–1.8 rose to about 2.0 when a latency period of 5 years was used, but latencies of
10 and 20 years diminished or eliminated the effect.  There were no deaths from brain cancer in workers
in the highest cumulative exposure category (>10,000 hours).  The lack of either strong or consistent
associations of brain cancer with exposure, as well as the tendency for brain cancer mortality rates to
decline with longer employment and greater exposure, weakens support for a causal relation.
Mortality from cancer of the brain and nervous system was not statistically significantly different than
expected in Kimbrough et al. (1999a) and Gustavsson and Hogstedt (1997) retrospective studies of
capacitor manufacturing workers summarized in Section 3.2.8.2.1.
3.2.8.2.6  Hematological
Occupational Exposure.  Hematological cancers were increased in the Bertazzi et al. (1987) study of
544 male and 1,556 female Italian capacitor manufacturing workers summarized in Section 3.2.8.2.2. 
Mortality from hematological neoplasms was statistically significantly (p<0.05) higher than expected in
the females based on local rates (4 observed/1.1 expected, SMR=377, 95% CI 115–877).  All four of the
hematologic neoplasms in females were associated with lymphatic tissue (three deaths from Hodgkin’s
disease and one death from lymphosarcoma).  Mortality from hematological neoplasms was also
increased in females compared to national rates (4 observed/1.5 expected, SMR=266, CI not reported),
and males compared to both national rates (3 observed/0.8 expected, SMR=375, CI not reported) and
local rates (3 observed/1.1 expected, SMR=263, CI not reported), but these increases were not statistically
significant.  Follow-up evaluation of the cohort after an additional 9 years of latency found an additional
death from a hematologic neoplasm (lymphatic leukemia) in the females (no change in males), although
the increase in the women was no longer statistically significant based on local rates
(5 observed/3.5 expected, SMR=141, 95% CI 46–330) (Tironi et al. 1996).    
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Mortality from cancers of the lymphatic and hematopoietic tissues was not increased in other studies of
capacitor manufacturing workers summarized in Sections 3.2.8.2.1 and 3.2.8.2.4 (Brown 1987b; Brown
and Jones 1981; Gustavsson and Hogstedt 1997; Gustavsson et al. 1986; Kimbrough et al. 1999a; Sinks et
al. 1992), or in the Loomis et al. (1997) study of electric utility workers summarized in Section 3.2.8.2.4.
Contaminated fish Consumption.  There was no increased mortality from Hodgkin’s lymphoma or non-
Hodgkin’s lymphoma in the Svensson et al. (1995a) study of Swedish east coast (Baltic Sea) and west
coast fisherman summarized in Section 3.2.8.2.2.  Mortality from multiple myeloma was increased in the
fisherman from the east coast (SMR=3.08, 95% CI=1.24–6.35) and west coast (SMR=2.08,
CI=0.76–4.53), as was mortality from leukemia was increased in the east coast fisherman (SMR=1.38,
CI=0.45–3.22).
General Population Exposures.  Two studies reported an association between risk of non-Hodgkin’s
lymphoma and exposure to PCBs (Hardell et al. 1996; Rothman et al. 1997).  Adipose tissue
concentrations of total PCBs and 34 non-coplanar congeners were compared in 27 Swedish hospital
patients with non-Hodgkin’s lymphoma (NHL) (B-cell type) and 17 surgical controls without malignancy
(Hardell et al. 1996).  Analysis of three coplanar congeners (PCB 77, 126, and 169) was performed in
20 of the cases and all 17 controls.  The mean total PCB concentration, calculated as the sum of the non-
coplanar congeners, was about 33% higher (p=0.06) in the cases than controls.  Mean levels of
11 individual non-coplanar congeners were statistically significantly (p<0.05) increased compared to
controls; the difference was most significant (p#0.01) for PCB 156 and PCB 208.  Mean concentrations
of the three coplanar congeners were not statistically significantly different in the cases and controls.  An
increased risk of NHL (OR=2.7, 95% CI 0.8–9.4]) was calculated for cases with total PCB concentrations
higher than the median concentration (1,300 ng/g lipid) of the total group.
An association between serum PCBs and increased risk of NHL was found in a nested prospective case-
control study of Maryland residents (Rothman et al. 1997).  Serum levels of total PCBs were compared in
74 cases of NHL and 147 matched controls identified in a cohort established in 1974.  The mean time to
diagnosis after enrollment into the cohort was 12.1 years.  The mean PCB concentration was statistically
significantly higher in the cases than controls (10% increase, p=0.0014).  Conditional logistic regression
analysis showed that the risk of NHL increased significantly with increasing PCB serum concentrations (p
for trend=0.0008); the ORs in the two highest concentration quartiles were 2.8 (95% CI 1.1–7.6) and
4.5 (95% CI 1.7–12.0).  Additional analysis indicated that the effect of PCBs on risk of NHL was
increased among participants who were seropositive for Epstein-Barr virus early antigen.
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Yusho and Yu-Cheng Exposures.  A retrospective cohort mortality study followed, 1940 Yu-Cheng cases
(929 males, 1,011 females, >95% of all registered cases) for 12 years following exposure in 1979 (Hsieh
et al. 1996).  The average age of the subjects was 27 years at the beginning of the study.  Mortality from
Hodgkin’s disease was increased in comparison to Taiwan national or local rates in the males
(SMR=61.17, 95% CI 1.55–340.72 or SMR=86.45, 95% CI 2.19–481.52, respectively).  There was no
statistically significantly increased mortality from leukemia.  The retrospective study Yusho victims
summarized in Section 3.2.8.2.1 found no statistically significantly increased mortality from leukemia
(Kuratsune et al. 1987).  
3.2.8.2.7  Breast
Occupational Exposure.  Mortality from breast cancer was not increased in the Brown and Jones (1981),
Brown (1987b), and Kimbrough et al. (1999a) studies of capacitor manufacturing workers summarized in
Section 3.2.8.2.1.
General Population Exposures.  Eight case-control studies compared breast tissue concentrations of
PCBs in women with breast cancer and women with benign breast disease or who died in accidents.  Four
of these studies found higher average levels of total PCBs or individual congeners in breast fat among the
cases than in controls (Dewailly et al. 1994; Falck et al. 1992; Guttes et al. 1998; Wasserman et al. 1976). 
Wasserman et al. (1976) reported that the mean concentration of total PCBs in malignant breast tissue of
nine Brazilian women collected after diagnosis (date not reported) was about 3 times higher (p<0.01) than
that found in adjacent breast glandular or adipose tissue from the same women, or in normal breast tissue
from five controls.  Total PCB levels in breast fat were 40% higher (p<0.02) in 20 Connecticut patients
with breast cancer compared to 20 age-matched controls who had benign breast disease (Falck et al.
1992); adipose samples were obtained near the time of diagnosis in 1987.
Dewailly et al. (1994) measured breast adipose levels of total PCBs and 10 individual congeners in
Canadian women with benign breast disease (n=17), breast cancer with estrogen receptor (ER)-positive
breast cancer cells (n=9), and breast cancer with ER-negative cells (n=9).  Analysis near the time of
diagnosis during 1991–1992 showed no statistically significant group differences in total PCBs.  Mean
congener concentrations in ER-negative cases were generally lower than those in control subjects,
although the difference was statistically significant (p=0.02) only for PCB 118.  ER-positive case patients,
however, showed congener levels that were generally higher than controls, with the difference reaching 
statistical significance (p=0.05) for PCB 99.  Guttes et al. (1998) measured concentrations of total PCBs 
3.  HEALTH EFFECTS - Cancer
PCBs 265
and 12 congeners in breast fat samples from 45 German women with breast cancer and 20 controls with
benign breast disease; samples were obtained at the time of diagnosis in 1993–1994.  Geometric mean
levels of total PCBs were not statistically significantly different in the cases and controls after statistical
adjustment for age differences.  Mean concentrations of PCB 126 and PCB 153 were 25% (p=0.04) and
24% (p=0.08) higher, respectively, in the cases compared to controls.
In contrast to the findings summarized above, the four other case-control breast tissue studies found no
increased levels of total PCBs or individual congeners in patients with breast cancer (Aronson et al. 2000;
Liljegren et al. 1998; Mussalo-Rauhamaa et al. 1990; Unger et al. 1984).  There was no statistically
significant difference in mean PCB levels in breast fat from 14 newly diagnosed Danish breast cancer
patients and 21 noncancer patients, or in samples taken at autopsy from groups of 18 deceased women with
breast cancer and 35 deceased women without breast cancer (Unger et al. 1984).  Mussalo-Rauhamaa et al.
(1990) similarly found no statistically significant difference in mean concentrations of PCBs in breast fat
of 44 breast cancer cases from Finland and 33 controls without cancer.
Breast adipose tissue concentrations of PCB congeners were assessed in a case-control study of
43 Swedish women with invasive breast cancer and 35 controls with benign breast disease (Liljegren et al.
1998).  Total or individual levels of 36 non-coplanar congeners, or individual levels of coplanar congeners
3,3',4,4'-tetraCB (PCB 77), 3,3',4,4',5-pentaCB (PCB 126), and 3,3',4,4',5,5'-hexaCB (PCB 169), did not
statistically significantly differ between cases and controls in the entire group or in subgroups of pre- and
postmenopausal women.  Analysis of coplanar congeners was limited to PCB 77, PCB 126, and PCB 169
in 19 cases and 19 controls.  Logistic regression analysis was used to estimate risk associated with
exposure to elevated tissue levels of total non-coplanar congeners, and each of the three coplanar
congeners in all women, as well as subgroups who were postmenopausal, had ER-positive tumors, or were
postmenopausal with ER-positive tumors.  Based on age- and parity-adjusted data, increased risks of breast
cancer were associated with PCB 77 (tissue concentration >4.5 ng/g lipid) in postmenopausal women
(OR=5.8, 95% CI 0.8–42), women with ER-positive tumors (OR=5.0, CI 0.8–28) and postmenopausal
women with ER-positive tumors (OR= 33, CI 1.8–588), and PCB 126 (>145 ng/g lipid) in women with
ER-positive tumors (OR=5.1, CI 0.8–30).  An OR for PCB 126 in postmenopausal ER-positive women
was not calculated due to insufficient data.
Aronson et al. (2000) investigated the association between risk of breast cancer and breast adipose tissue
concentrations of total PCBs or 14 individual congeners.  Analyses were performed on biopsy tissue from
217 Canadian women diagnosed with breast cancer and 213 matched controls with benign breast lesions.  
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Mean breast fat concentrations of total PCBs and individual congeners were not statistically significantly
higher in the cancer cases than in controls.  Multiple logistic regression was used to calculate ORs for
increasing tissue concentrations of total PCBs and individual congeners.  When the whole group was
adjusted for age, menopausal status, and other confounders, risk was increased for 2,3,3',4,4'-pentaCB
(PCB 105) and 2,3,4,4',5-pentaCB (PCB 118).  The ORs for these congeners increased linearly with tissue
concentrations (p values for trend #0.01), reaching 3.17 (95% CI 1.51–6.68) for PCB 105 and
2.31 (CI 1.11–4.78) for PCB 118 in the highest concentration categories ($13 and $50 µg/kg,
respectively).  Risks for breast cancer were even higher among premenopausal women for PCB 105
(OR=3.91, CI 1.73–8.86) and PCB 118 (OR=2.85, CI 1.24–6.52).  Risks among postmenopausal women
were elevated for PCB 170 and PCB 180, but these were not clearly tissue concentration-related.
 
Four case-control studies used serum PCB concentrations as the marker of exposure with measurements
performed after the diagnosis of breast cancer (Moysich et al. 1998, 1999b; Wolff et al. 1993; Zheng et al.
2000).  Studies by Moysich et al. (1998, 1999b) were based on 154 cases of postmenopausal breast cancer
and 192 matched postmenopausal controls from western New York.  Based on serum congener analysis
performed within 3 months of diagnosis in 1986–1991, exposure was characterized as total PCBs, total
number of detected peaks, and three congener groups (less chlorinated, moderately chlorinated, and more
highly chlorinated PCBs).  No statistically significant differences in mean PCB concentrations were found
between cases and controls in the total sample, or in subgroups of who breast-fed (85 cases, 106 controls)
or never lactated (46 cases, 61 controls), using any of the measures of exposure (Moysich et al. 1998). 
Additionally, analyses using unconditional logistic regression showed that higher serum levels of total
PCBs, moderately chlorinated congeners, more highly chlorinated congeners, or greater number of
detected peaks, were not associated with increased risk of breast cancer.  There was an indication of a
small increase in risk for women with detectable levels of less chlorinated congeners (OR=1.66, 95%
CI 1.07–2.88), and in parous women who had never lactated having higher serum levels of total PCBs
(OR=2.87, CI 1.01–7.29), moderately chlorinated congeners (OR=3.57, CI 1.10–8.60), and detected
congener peaks (OR=3.31, CI 1.04–11.3).  Further study of the 154 cases and 192 controls investigated the
association between cytochrome P-4501A1 genotype and breast cancer risk in the postmenopausal women
(Moysich et al. 1999b).  An increased risk of breast cancer was associated with elevated serum PCB
concentrations ($3.73 ng/g of serum) among women with CYP1A1 polymorphism, as indicated by an OR
of 2.96 (95% CI 1.18–7.45) in women carrying at least one CYP1A1 valine for isoleucine substitution
allele (Ile:Val or Val:Val), compared with women with lower serum PCB levels and who were
homozygous for the isoleucine allele (Ile:Ile).  No effect of CYP1A1 was found among women with lower
serum levels of PCBs or women homozygous for the isoleucine allele.  
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Zheng et al. (2000) investigated the relationship between serum PCBs and breast cancer risk in a case-
control study of 475 Connecticut patients with confirmed cancer and 502 age-matched controls with
benign breast diseases.  Blood samples were collected at the time of recruitment in 1995–1997 and
analyzed for 9 PCB congeners.  There were no statistically significant differences in mean serum level of
total PCBs between the cases and controls in all subjects or subgroups of cases based on stage of cancer at
time of diagnosis, type of cancer treatment, type of cancer or benign breast disease, or ER status.  Logistic
regression analysis showed no statistically significant association between breast cancer risk (OR) and
serum total PCB levels for all subjects or subgroups based on parity, lactation, or menopausal status. 
Additionally, mean serum levels for each of three structure-activity congener groups (potentially
estrogenic, potentially antiestrogenic and immunotoxic (dioxin-like), and phenobarbital-type cytochrome
P-450 (CYP1A and CYP2B) enzyme inducers) were comparable between the cases and controls, and there
was no statistically significant increasing trend for risk of breast cancer with increasing serum levels of
these congener groups.
Wolff et al. (1993) found that mean concentrations of total PCBs were 19% higher in the sera of 58 New
York City women with breast cancer than in 171 matched cancer-free controls, but the difference only
approached statistical significance (p=0.058).  The blood samples were collected between 1985 and 1991
and analyzed within 6 months of cancer diagnosis.  Conditional logistic regression analysis showed that
the relative risk of breast cancer increased less than 2-fold for a change in serum PCB levels from
3.9 ng/mL (10th percentile) to 10.6 ng/mL (90th percentile; OR=1.70, 95% CI 0.79–3.68), and that there
was no statistically significant positive trend (p=0.16) with increasing concentrations of PCBs. 
Wolff et al. (2000) found a more conclusive lack of association between serum total PCBs and breast
cancer in a prospective investigation nested within the same cohort from which the women in their 1993
study were selected.  Cases (n=148) and individually matched controls (n=295) were identified among
women whose blood had been collected at least 6 months before diagnosis in October 1994.  In addition,
among 84 cases and 196 controls, two or more consecutive annual blood samples were available to
estimate elimination half-lives of total PCBs.  Cases and controls had similar mean serum levels of PCBs,
and this difference remained statistically nonsignificant when ER status of the tumors was considered. 
Additionally, PCB half-lives did not differ between cases and controls.  Conditional logistic regression
analysis showed no positive association between serum PCB levels and risk of breast cancer; although ORs
were elevated in the three upper concentration quartiles relative to the lowest one, none of the ORs were
statistically significant and there was no evidence of a trend (p=0.23).  The risk of breast cancer was not
influenced by menstrual status, lactation history, or PCB half-life. 
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Five other prospective studies similarly found no association between serum levels of PCBs and breast
cancer incidence using blood samples collected prior to diagnosis (Dorgan et al. 1999; Helzlsouer et al.
1999; Høyer et al. 1998; Hunter et al. 1997; Krieger et al. 1994).  Total plasma PCBs were determined in
blood samples collected during 1989–1990 in a prospective study of the health of nurses in the United
States (Hunter et al. 1997).  Mean plasma levels of PCBs did not statistically significantly differ between
230 women who developed breast cancer before June 1992 and pair-matched controls who did not
subsequently develop breast cancer.  There was no association between plasma levels of PCBs and
established or suspected risk factors for breast cancer (e.g., menopausal status, age, age at menarche, age at
birth of first child, number of children, and history of lactation), nor any increase in relative risk of breast
cancer with increasing concentrations of PCBs.  It should be noted that the short follow-up period (not
more than 3 years) could have contributed to the negative findings.
A prospective nested case-control study of blood samples collected in 1964–1971 compared serum levels
of total PCBs in 150 California women (50 white, 50 black, 50 Asian) who were later diagnosed with
breast cancer with levels in matched controls who did not develop breast cancer in the interval at least
6 months after the blood was drawn through the end of 1990 (Krieger et al. 1994).  Serum samples were
collected an average of 14 years prior to cancer diagnosis.  Mean concentrations of PCBs were not
statistically significantly different in cases or controls in the total group or racial/ethnic subgroups,
regardless of menopausal and estrogen-receptor status.  Conditional logistic regression analyses showed no
statistically significant trends for increased breast cancer risk with increasing serum PCB levels or by year
of diagnosis or length of follow-up. 
A case-control study of 240 breast cancer patients and 477 matched controls (two controls for each case)
was nested within a prospective study conducted in Denmark (Høyer et al. 1998).  Blood samples were
collected in 1976 and breast cancer was diagnosed during the following 17 years.  Conditional logistic
regression analysis indicated no increased risk of breast cancer with increasing serum levels of total PCBs. 
Exclusion of women who developed breast cancer within 5 years of serum sampling did not alter the
results.  The average amount of time between the collection of the serum sample and the diagnosis of
breast cancer is unclear.
Serum PCBs were measured in blood samples collected in 1974 or 1989 in a breast cancer case-control
study nested within a prospective cohort study of Washington County, Maryland residents (Helzlsouer et
al. 1999).  A group of 346 women who were diagnosed with breast cancer by June, 1994 (i.e., after a
follow-up period of up to 20 years) were matched to 346 cancer-free controls by age, race, menopausal 
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status, and date of blood donation.  Mean and median concentrations of total PCBs in 1974 or 1989 were
not statistically significantly different in women who subsequently developed breast cancer than in
controls.  Logistic regression analysis showed that the risk of breast cancer did not statistically
significantly increase with increasing serum levels of total PCBs measured in 1974 or 1989.  Additionally,
there was no statistically significantly increased risk of breast cancer associated with increasing
concentrations of 26 individual congeners, or three groupings of congeners based on structure-activity
considerations (potentially estrogenic, potentially antiestrogenic and immunotoxic (dioxin-like), and
phenobarbital-type cytochrome P-450 (CYP1A and CYP2B) enzyme inducers).  Length of follow-up,
menopausal and estrogen-receptor status, lactation and birth history, and putative high-risk genotypes for
detoxification enzymes such as glutathione transferase (GSTM1, GSTT1, GSTP1, or COMT) did not
contribute to an increased risk of breast cancer.     
The association between breast cancer and PCB exposure was evaluated in 105 cases and 208 matched
controls in a prospective nested case-control study using the Columbia, Missouri breast cancer serum bank
(Dorgan et al. 1999).  Breast cancer was diagnosed up to 9.5 years after blood samples were obtained
between 1977 and 1987.  Exposure was estimated using lipid-adjusted serum levels of total PCBs and
27 individual congeners.  The percent of participants with total PCBs or individual congeners above the
assay detection limit was not statistically significantly higher in cases compared to controls.  Conditional
logistic regression analysis of the entire group showed no indication of increased relative risk of breast
cancer among women with elevated serum levels of total PCBs or individual congeners.  A positive
association between serum PCB 138 concentration and breast cancer was suggested (p=0.07) when blood
was collected close to the time of diagnosis (#2.7 years, 53 cases, 104 controls), based on RRs of 1.7 (95%
CI 0.7–4.2) and 1.9 (CI 0.8–4.8) in the middle and highest concentration tertiles, respectively.
3.2.8.2.8  Other Sites
Occupational Exposure.  Pancreatic cancer was increased in 1,939 males employed between 1947 and
1975 at a transformer manufacturing plant in Canada (Yassi et al. 1994).  Only a very small number of
transformers contained PCBs, and there was considerably more exposure to mineral oil refined
predominantly from naphthenic base crudes.  Therefore, unlike the typical studies of capacitor
manufacturing workers who were mainly exposed to PCBs, the transformer plant workers in the Yassi et
al. (1994) study were predominantly exposed to mineral oil not containing PCBs.  Mortality from
pancreatic cancer was statistically significantly increased.  Based on 11 observed deaths, SMRs for 
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pancreatic cancer ranged from 2.92 (95% CI 1.17–6.01) to 12.9 (95% CI 2.59–37.7), depending on cohort
definition and acceptability criteria used.  The authors also reported that those who entered the cohort prior
to 1960 had a higher mortality risk than those who entered later.  Additionally, SMRs for pancreatic
cancers were higher in the departments in which transformers were assembled than in departments in
which the exposures were thought to be lower.  The role of PCBs is unclear due to the exposure to other
transformer chemicals and study limitations such as the fact that no medical history of the workers was
provided.  Wong (1995) raises serious concerns about the Yassi et al. (1994) pancreatic cancer findings. 
For instance, in the group with the highest SMR, three cancers were reported.  One of these had worked for
<1 year and had died within 1 year of leaving the plant.  Another case that was "possibly" linked to
employment at the plant had worked at the plant for 1 year.  Thus, two of the three cases in the group with
the highest SMR had neither sufficient duration of exposure nor latency for their cancers to be considered
occupationally related to PCB exposure at the plant.
Kidney adenocarcinoma was found in three male public utility workers (aged 34–56) exposed to
unspecified PCBs while servicing and repairing transformers for 5–14 years (Shalat et al. 1989).  The
workers were employed by the same company during the same period, but the total exposed population
was not reported.  Although kidney cancer is relatively rare in young men (range,
1.3–29.7 cases/100,000 in the age group of the subjects), an association between PCB exposure and kidney
cancer cannot be demonstrated due to limitations of the study, particularly exposure to other chemicals
including unspecified organic solvents and herbicides.
Mortality from pancreatic, kidney, or urinary cancer was not statistically significantly increased in other
studies of capacitor manufacturing workers summarized in Sections 3.2.8.2.1 and 3.2.8.2.4 (Brown 1987b;
Kimbrough et al. 1999a; Sinks et al. 1992), or in the Loomis et al. (1997) mortality study of electric utility
workers summarized in Section 3.2.8.2.4.
Contaminated Fish Consumption.  Mortality from pancreatic cancer was not increased in the Svensson et
al. (1995a) study of Swedish east coast (Baltic Sea) and west coast fishermen summarized in
Section 3.2.8.2.2. 
Yusho and Yu-Cheng Exposures.  The retrospective study of Yusho victims summarized in
Section 3.2.8.2.1 found no statistically significant (p<0.05) increased mortality from cancer of the pancreas
(Kuratsune et al. 1987.).
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3.2.8.2.9  Evaluation of Human Studies
The carcinogenicity of PCBs in humans has been investigated in retrospective occupational studies that
investigated cancer mortality in exposed workers, and in case-control studies of environmental exposure
that examined associations between serum or adipose tissue levels of PCBs and occurrence of cancer.  As
discussed below and summarized in Appendix A, some of these studies provide meaningful evidence that
PCBs are carcinogenic in humans.
Occupational mortality data indicate that exposures to PCBs during capacitor manufacturing and repairing
were associated with cancer of the liver, biliary tract and/or gall bladder, intestinal cancer, and skin
melanoma.  A slight but statistically significant increase in cancer of the liver, biliary tract, and gall
bladder category was found by Brown (1987b) based on a small number of deaths (five cases) in a cohort
of 2,588 workers (SMR=263, p<0.05).  Of the five deaths, four occurred in women from one plant, and
two deaths were from liver, two from biliary tract, and one from gall bladder cancer.  One of the two liver
cancers was not a primary carcinoma as it metastasized from another site, and the SMR loses statistical
significance if the metastatic liver cancer is not included in the analysis.  No analysis was performed to
assess risk from biliary cancer alone.  Mortality from cancer of the liver/biliary tract/gall bladder was not
statistically significantly increased in any of the other occupational studies of PCB workers (Bertazzi et al.
1987; Gustavsson and Hogstedt 1997; Gustavsson et al. 1986; Kimbrough et al. 1999a; Loomis et al. 1997;
Sinks et al. 1992), although Bertazzi et al. (1987) did observe one death from biliary tract cancer and
another from a primary liver cancer in six cases classified as digestive system cancers, and there were two
deaths from relatively rare types of bile duct cancers in the small cohort of 242 workers evaluated by
Gustavsson and Hogstedt (1997).  Because no individual study indicated a statistically significantly
increased risk of primary liver/biliary tract/gall bladder cancer, Nicholson and Landrigan (1994) combined
the results from the various studies available at the time by summing observed and expected cases.  Based
on a total of 8 observed and 2.8 expected cases from studies of capacitor manufacturing workers from
three cohorts (Bertazzi et al. 1987; Brown 1987b; Brown and Jones 1981; Gustavsson et al. 1986),
statistically significant increases were found for liver/biliary tract/gall bladder (SMR=285, p=0.008) and
for biliary tract/gall bladder separately (p<0.05, SMR not reported).  Although the Nicholson and
Landrigan (1994) analysis is based on combined results from cohorts having different durations and levels
of exposure, latencies, and follow-up, and did not include data from the most recent studies (Gustavsson
and Hogstedt 1997; Kimbrough et al. 1999a), it provides an indication that PCBs are associated with
cancer of the liver, biliary tract, and/or gall bladder in humans.  The finding for biliary cancer is
particularly meaningful considering its relatively rare nature and the fact that data on liver and 
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biliary cancers were not reported separately in most studies.  Additionally, support for the
hepatocarcinogenicity of PCBs in humans is provided by data indicating that mortality from liver cancer
was increased following Yusho exposure (Kuratsune et al. 1987).
Data suggestive of PCB-related intestinal cancer were reported in the Kimbrough et al. (1999a) mortality
study of capacitor workers.  Mortality from cancer of the intestines (large and small) was not statistically
significantly increased in any of the groups of male or female workers in this study; however, the mortality
rate for intestinal cancer in the hourly female subgroup was elevated and approached statistical
significance (SMR=157, 95% CI 96–242).  Additionally, most of the intestinal cancer cases (18 of 20) in
this subgroup occurred in women with $20 years of latency, who had a rate that was significantly elevated
(SMR=189, p<0.05).  There was no trend for increased risk with cumulative exposure; however, there is
low precision in this analysis due to a particularly small number of deaths in each exposure duration
category.  There was no indication of increased mortality from stomach cancer in this study, or from
cancer of the intestines or stomach in other studies of PCB workers.  Bertazzi et al. (1978) did report a
statistically significantly increased mortality from digestive system cancers in male workers (SMR=274,
p<0.05), but this classification included cancers of the liver, biliary tract, and pancreas as well as stomach,
and no deaths from intestinal cancer were reported.  Additionally, follow-up evaluation of the same cohort
after an additional 9 years of latency showed that mortality from digestive system cancer was no longer
statistically significantly increased.  The incidence of stomach cancer was significantly elevated in
Swedish fisherman that had high intake of PCBs in fish (Svensson et al. 1995a), but the effect cannot be
definitely attributed to PCBs because consumption included smoked fish and PCBs were not the only
contaminants in the fish.
Mortality from malignant melanoma was statistically significantly increased in one study of capacitor
workers (Sinks et al. 1992).  The excess mortality affected both men and women (SMR=350, p<0.01). 
Because the number of deaths was relatively small and a dose-response relationship or increase with
latency could not be established, the results of this study are not conclusive.  Two other studies support the
skin cancer finding of Sinks et al. (1992).  Bahn et al. (1976, 1977) observed two cases of malignant
melanoma in 31 refinery workers believed to have been heavily exposed to PCBs (Bahn et al. 1976, 1977). 
Although the increase was statistically significant (p#0.001), it cannot definitely be attributed to PCBs
because the workers were exposed to other chemicals in the refinery.  Mortality from malignant melanoma
appeared to increase with cumulative exposure and latency among electric utility power plant mechanics
who were dermally exposed to PCBs in capacitor fluids (Loomis et al. 1997).  Although SMRs were
elevated at 2.57 (95% CI 1.06–6.20) and 3.16 (95% CI 0.92–10.85) in mechanics employed for 
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>0–5 years and >5–10 years, respectively, the association between malignant melanoma and exposure is
unclear due to a small number of deaths, which precluded assessment of employment durations longer than
10 years and analysis by cumulative exposure and latency.  Considering the limitations of the Bahn et al.
(1976, 1977) and Loomis et al. (1997) studies, the apparent relationships to PCB exposure are more
uncertain than in the Sinks et al. (1992) study, although the data from the three studies collectively suggest
an association.
Other findings in the Sinks et al. (1992) study of capacitor manufacturing workers and Loomis et al.
(1997) study of electric utility workers included slightly increased mortality from brain cancer in some
subgroups.  Because confidence intervals on risk ratios were broad with lower 95% limits <1.0, and there
was no clear relationship between brain cancer and exposure duration, level, or latency, the association
between PCBs and brain cancer is uncertain.
There is also no clear association between PCBs and hematopoietic or lymphatic cancers.  Investigations
of a cohort of Italian capacitor workers found statistically significantly increased mortality from
hematological neoplasms in females in the first study (SMR=377, CI 115–877, p<0.05) (Bertazzi et al.
1987), but not upon follow-up after an additional 9 years of latency (SMR=141, CI 46–330) (Tironi et al.
1996).  All of the cases of hematological neoplasms (five observed) were associated with lymphatic
tissues, including three deaths from Hodgkin’s disease (Hodgkin’s lymphoma).  Although mortality from
lymphatic or hematopoietic cancers was not increased in any of the other studies of capacitor
manufacturing workers, the cases of Hodgkin’s disease observed by Bertazzi et al. (1987) may be
consistent with the significantly increased mortality from Hodgkin’s disease found in Yu-Cheng victims
(Hsieh et al. 1996).  Two background environmental exposure studies found that mean concentrations of
PCBs in adipose tissue (Hardell et al. 1996) and serum (Rothman et al. 1997) were statistically
significantly higher in patients with NHL than in controls without NHL.  Although these studies also
showed that the risk of NHL increased significantly with increasing levels of PCBs in adipose and serum,
additional information is needed to conclude that the NHL is specifically due to PCBs.  The absence of
consistent evidence for lymphatic cancers might result from the rarity of these cancers, and not from a lack
of an association between PCBs and the cancers.
Associations between exposure to PCBs and breast cancer were investigated in a few of the occupational
retrospective cohort mortality studies and in a number of case-control studies of women with background
environmental exposures.  The occupational studies found no indications of increased mortality from
breast cancer in female capacitor manufacturing workers who were mainly exposed to PCBs by the 
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inhalation and/or dermal routes (Brown 1987b; Brown and Jones 1981; Kimbrough et al. 1999a).  The
environmental exposure studies assessed relationships between breast cancer and levels of PCBs in breast
fat or blood in the general population.  These studies were generally conducted to investigate a
hypothetical role of organochlorine compounds, including PCBs, in the development of breast cancer.  In
environmental case-control studies that compared breast tissue PCB concentrations in women with and
without breast cancer, some reported higher levels of total PCBs and/or congeners in breast fat among
cases than in controls (Dewailly et al. 1994; Falck et al. 1992; Guttes et al. 1998; Wasserman et al. 1976),
whereas others found no elevated breast adipose PCB levels in breast cancer cases (Aronson et al. 2000;
Liljegren et al. 1998; Mussalo-Rauhamaa et al. 1990; Unger et al. 1984).  Risk analyses, performed in two
of the tissue studies, suggest increased risks of breast cancer associated with increased tissue levels of
some congeners in subgroups of women that were postmenopausal or had estrogen receptor-positive
tumors (Aronson et al. 2000; Liljegren et al. 1998).  Other case-control studies used serum PCB
concentrations as the marker of exposure with blood samples taken after the diagnosis of breast cancer
(Moysich et al. 1998, 1999b; Wolff et al. 1993; Zheng et al. 2000), or prospectively collected prior to
diagnosis (Dorgan et al. 1999; Helzlsouer et al. 1999; Høyer et al. 1998; Hunter et al. 1997; Krieger et al.
1994; Wolff et al.  2000).  None of the serum studies found significantly different mean blood levels of
PCBs in breast cancer cases and controls.  Additionally, logistic regression analyses showed no statistically
significant associations between breast cancer risk and serum PCBs in most of the serum studies.  The
negative findings in the serum studies were generally not influenced by menopausal or estrogen receptor
status, birth or breast-feeding history, types of congeners, and/or other contributing or confounding factors. 
Increased risks were associated with serum PCBs in postmenopausal women who were parous and had
never breast-fed or in postmenopausal women with a putative high-risk CYP1A1 variant genotype
(Moysich et al. 1998, 1999b), but these findings are only suggestive due to small number of subjects and
variance with another study (Zheng et al.  2000).  
As discussed above, associations between PCBs and breast cancer have been reported in only a few of the
many case-control studies.  Inconsistencies in the results could be related to methodological differences in
the studies.  For example, most of the breast tissue studies are limited by small numbers of subjects and/or
inadequate control for known breast cancer risk factors, not all of the blood studies adjusted for serum
lipids or factors such as menstrual status, parity, and duration of lactation, and only some studies used
congener-based exposure assessment or considered timing of exposure assessment relative to the etiology
of cancer.  Many of the better designed studies have been prospective, using blood samples obtained a
number of years prior to the diagnosis of cancer (Dorgan et al. 1999; Helzlsouer et al. 1999; Høyer et al.
1998; Hunter et al. 1997; Krieger et al. 1994; Wolff et al. 2000), but none of the prospective studies found
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a relationship between serum PCBs and breast cancer.  Interpretations, however, are hampered by
differences in target analytes since some studies have found associations with congeners that were not
considered in larger studies due to expense of analysis.  Although the overall epidemiologic evidence for
an association between breast cancer and PCBs is inconclusive, there are meaningful preliminary
indications that specific subgroups may be at risk.
The human studies examining the cancer causing effect of PCBs often have methodological limitations. 
However, the evidence, taken in totality, indicates a potential cancer causing effect for PCBs.  EPA
determined that the human data are inadequate, but suggestive, of carcinogenicity (IRIS 2000), and IARC
(1987) concluded that the evidence for carcinogenicity to humans is limited.  
3.2.8.3  Animal Studies
Reliable cancer effect levels (CELs) are recorded in Table 3-2 and plotted in Figure 3-2.
3.2.8.3.1  Inhalation Exposure
No studies were located regarding carcinogenicity of PCBs in animals following inhalation exposure.
3.2.8.3.2  Oral Exposure
Chronic Oral Bioassays.  A number of oral cancer studies of commercial PCB mixtures have been
performed in animals.  As summarized below, these studies demonstrate the hepatocarcinogenicity of
PCBs as well indicate that the thyroid is a site of tumorigenesis.
Hepatocellular carcinomas developed in female Sherman rats fed an estimated dose of 5 mg/kg/day
Aroclor 1260 (purity not reported) for .21 months (Kimbrough et al. 1975).  Almost all treated rats
(170 of 184) exhibited a few to multiple tan nodules on the surface of the liver and more upon sectioning. 
Only one control rat had gross abnormalities of the liver.  Hepatocellular carcinomas were diagnosed in
14.1% (26 of 184) of the treated rats and 0.6% (1 of 173) of the controls.  Neoplastic nodules were found
in 84.7% (144 of 170) of the treated rats with surface nodules and in none of the controls (0 of 173).  The
total reported incidence of neoplastic liver lesions was 92.4% (170 of 184) in treated rats and 0.6% (1 of
173) in controls.  Incidences of neoplastic lesions were not increased in tissues other than liver (all major
tissues and organs were examined). 
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Liver tumors also developed in Sprague-Dawley rats fed an estimated average dose of 4.2 mg/kg/day
Aroclor 1260 (purity not reported) for 24 months (Norback and Weltman 1985).  In treated rats that
survived 18 months or longer, 95.7% (45 of 47) of the females and 15.2% (7 of 46) of the males had
hepatocellular carcinomas or neoplastic nodules, indicating a sex-related effect.  Of the 47 treated females,
43 had trabecular carcinomas and/or adenocarcinomas, and another 2 had neoplastic nodules only.  Of the
46 treated males, 2 had trabecular carcinomas and another 5 had neoplastic nodules.  Incidences of
hepatocellular neoplasms in control rats were 0% (0 of 32) in males and 2% (1 of 49) in females; the
1 female had a single neoplastic nodule.  Hepatocellular lesions progressed as follows:  centrilobular cell
hypertrophy at 1 month; foci of altered cells at 3 months and areas at 6 months; neoplastic nodules at
12 months; trabecular carcinoma at 15 months; and adenocarcinoma at 24 months.  The authors observed
that, while the tumors met morphologic criteria for malignancy, they were relatively nonaggressive
because they did not metastasize to distant organs or invade blood vessels.  Mortality was not affected,
probably because of the late appearance and slow growth of the tumors.  Preneoplastic lesions in the
biliary tract (simple cholangiomas, also referred to as bile duct hyperplasia) occurred at a higher incidence
in treated males and females (14 and 21%, respectively) than in control males and females (2 and 2%,
respectively).  
Liver neoplastic nodules and hepatocellular carcinomas developed in 50% (63 of 126) and 48.4% (61 of
126) of male Wistar rats, respectively, that were fed Clophen A60 (60% chlorine by weight) at an
estimated dosage of 5 mg/kg/day for up to 832 days (Schaeffer et al. 1984).  The incidences of these
lesions were significantly (p<0.05) higher than control values of 3.8% (5 of 131) and 0.8% (1 of 131),
respectively.  Combined incidences of neoplastic nodules and hepatocellular carcinomas were 98.4%
(124 of 126) and 4.5% (6 of 131) in the treated and control groups, respectively.  Time-dependent
progression from altered foci to neoplastic nodules to hepatocellular carcinoma was observed.  The
Clophen A60 mixture was reported to be free of CDFs, but it is not certain whether these contaminants
were absent from the mixture because no information was provided on detection limit or analytical
technique, nor is it known whether and how the mixture may have been treated to remove CDFs.
In a study conducted by NCI (1978), male and female Fischer 344 rats were fed Aroclor 1254 (purity not
determined) in estimated doses of 1.25, 2.5, or 5.0 mg/kg/day for 104–105 weeks.  Low incidences of
hepatocellular carcinomas and unspecified adenomas occurred in the middle- and high-dose groups, but in
none of the control or low-dose groups, which contained 24 rats each.  The incidences of combined tumors
were 4.2% (1 of 24) and 12.5% (3 of 24) in the middle- and high-dose males, respectively, and 4.5% (1 of
22) and 8.3% (2 of 24) in the middle- and high-dose females, respectively.  Analysis of these 
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results revealed no statistically significant difference between treated groups and matched controls.  Re-
examination and reclassification of the NCI (1978) liver data by Ward (1985) found that total tumor
incidence (hepatocellular adenomas and carcinomas) was significantly increased (p<0.05) in the high-dose
males.  Tumor incidences for males in the control, low-, middle-, and high-dose groups were 0% (0 of 24),
4.2% (1 of 24), 8.3% (2 of 24), and 29.2% (7 of 24), respectively, and the response showed a significant
(p<0.01) dose-related trend.
There were no nonhepatic tumors clearly related to Aroclor 1254 treatment in the NCI (1978) study,
although adenocarcinomas in the stomach, jejunum, or cecum of two treated males (mid-dose group) and
two treated females (low- and mid-dose groups), and a stomach carcinoma in one treated male (high-dose
group) were found.  Although their incidences were not statistically significant, the low historical
incidences of these lesions suggested that they were treatment-related.  Morgan et al. (1981) re-examined
the NCI (1978) gastrointestinal data and found increased incidences of stomach metaplasia that were dose-
related and stomach adenocarcinomas in six treated rats.  When compared with incidences of stomach
adenocarcinomas in historical controls (1 of 3,548), the total incidence (6 of 144) was statistically
significant.  This comparison may not be appropriate, however, because the Aroclor 1254-treated animals
were specially examined.  The investigators commented that the stomach adenocarcinoma and intestinal
metaplasia appeared to be related and might have the same initiating mechanism.  They concluded that
Aroclor 1254 led to induction of intestinal metaplasia and probably to induction of adenocarcinoma in the
glandular stomachs of Fischer 344 rats.  No correlation between rats having stomach and liver lesions was
found.  Ward (1985), who also re-examined the NCI (1978) gastrointestinal data, noted that the metaplastic
lesions were similar to those seen in monkeys, but differed in being focal and singular, while monkey
lesions were diffuse.  The appearance of the few metaplastic lesions in the stomachs of controls differed
from those in treated rats, which resembled precancerous lesions induced by gastric carcinogens.  A
significant dose-related trend in combined incidences of lymphomas and leukemias in male rats also was
found by NCI (1978), but incidences in each dose group were not statistically significantly different from
matched controls. 
In another study of Aroclor 1254 (purity not reported), no neoplastic nodules or hepatocellular carcinomas
developed in small groups of Sherman rats (10 per sex) treated with estimated dietary doses as high as
72.4 mg/kg/day for 8 months (Kimbrough et al. 1972).  Increased incidences of adenofibrosis of the liver
were observed, but this lesion was not considered precancerous by the investigators.  Sensitivity of this
study is limited by the small number of animals, and the short duration may be insufficient to express
possible carcinogenicity and to draw any negative conclusions.
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The carcinogenicity of a lower chlorinated PCB mixture was evaluated in male Wistar rats that were fed
Clophen A30 (42% chlorine by weight) in estimated dosages of 5 mg/kg/day for up to 832 days (Schaeffer
et al. 1984).  Liver neoplastic nodules and hepatocellular carcinomas were diagnosed in 29.2% (38 of 130)
and 3.1% (4 of 130), respectively, in the treated rats compared to 4% (2 of 53) and 2% (1 of 53),
respectively, in controls.  The increased incidence of neoplastic nodules is statistically significant (p<0.05),
but this pathology classification could have included nonneoplastic hyperplasia as well as benign
adenomas.  Combined incidences of neoplastic nodules and hepatocellular carcinomas were 7.7% (10 of
130) and 4.5% (6 of 131) in the treated and control groups, respectively.
A panel of pathologists re-evaluated seven of the PCB cancer studies in rats for the purpose of minimizing
differences among studies that may have been due to the diagnostic criteria used or individual variability
among pathologists (Moore et al. 1994).  Also, under a new diagnostic criteria and nomenclature, lesions
that had been previously diagnosed as neoplastic nodules were now classified as either hepatocellular
hyperplasia or hepatocellular adenoma.  A study was defined as “a protocol that examined the pathological
effects associated with the chronic dietary exposure to a PCB mixture in one sex of rat.”  The studies re-
examined were: Kimbrough et al. (1975) (Aroclor 1260), Norback and Weltman (1985) (Aroclor 1260),
NCI (1978) (Aroclor 1254), and Schaeffer et al. (1984) (Clophen A30).  In general, the results showed
consistency in diagnoses between the original reports and the re-evaluation.  One key difference was a
change in some diagnoses from neoplastic nodule to focus of cellular alteration, which downgraded the
finding to a nonneoplastic lesion.  The results led the authors to conclude that PCBs with a 60% chlorine
content consistently induce a high yield of liver tumors in rats, which supported the original findings.  In
addition, the reassessed results now showed that the studies in which rats were fed mixtures with 54 or
42% chlorination showed no statistically significant increases in liver tumors, and that there was no clear
sensitivity differences in tumor response between males and females.  
A more recent carcinogenicity study provides comparative data on the four most widely used commercial
Aroclor mixtures (1016, 1242, 1254, and 1260) in rats (General Electric Co. 1997a, 1997b; Mayes et al.
1998).  This is a comprehensive investigation designed to clarify carcinogenic differences in the mixtures
by allowing direct comparisons of Aroclors using current tumor diagnostic criteria, and thereby address
some of the limitations in previous studies and problems associated with inter-study comparisons.  Groups
of 50 male and 50 female Sprague-Dawley rats were fed Aroclor 1016, 1242, 1254, or 1260 in the diet for
24 months at three dose levels per compound (two for Aroclor 1242) in ranges of 2.0–11.2, 2.0–5.7,
1.0–6.1, or 1.0–5.8 mg/kg/day, respectively.  One control group of 100 males and 100 females was used
for the entire study (i.e., for all Aroclors).  The base feed contained <0.15 ppm of PCBs 
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(estimated dose <0.01 mg/kg/day).  The Aroclor 1016, 1242, 1254, and 1260 test mixtures contained
PCDD concentrations of 0.6, 0, 20, and 0 ppb, respectively, and PCDF levels of 0.035, 2.9, 23, and
4.9 ppm, respectively.  The Aroclor 1254 was treated for PCDF removal because the level was considered
higher than the acceptable range.  The cleanup procedure removed >99% of the PCDFs, and additionally
reduced the concentration of congener 3,3',4,4',5-pentaCB (PCB 126) by approximately 35%, which was
still about 2 times greater than that of “ordinary” Aroclor 1254.  It was subsequently found that the tested
lot of Aroclor 1254 had been made by a modified procedure that was used only in the final years of
manufacture, and accounted for <1% of the total Aroclor 1254 production for the years 1958–1977 (Frame
1999).
Comprehensive histological examinations were performed on all rats in the high-dose and control groups
at the end of the study (24 months), as well on animals in all groups that died prior to 24 months (Mayes et
al. 1998).  Evaluations of all remaining animals included the liver, brain, mammary gland, thyroid (males
only), and gross lesions.  Statistically significantly increased tumor incidences were found in the liver and
thyroid, while significant decreases occurred in the mammary gland.  The response in the liver was both
Aroclor- and sex-dependent (much greater in females than males), consisted primarily of benign
hepatocellular adenomas and, for females, increased with dose and followed the general incidence pattern
of Aroclor 1254 > Aroclor 1260 . Aroclor 1242 > Aroclor 1016.  For females exposed to Aroclor 1254,
percentages with liver tumors were statistically significantly (p#0.05 or p#0.01) increased as follows: 
hepatocellular adenomas in all dose groups at 1.4, 2.9, and 6.1 mg/kg/day (36, 52, and 54%, respectively,
vs. 1% in controls), hepatocellular carcinomas in the middle- and high-dose groups (8 and 12%,
respectively, vs. 0%), and hepatocholangiomas in the middle-dose group (12 vs. 4%).  For females
exposed to Aroclor 1260, hepatocellular adenomas were significantly increased in all dose groups at 1.4,
2.8, and 5.8 mg/kg/day (18, 20, and 42%, respectively, vs. 1% in controls), and hepatocellular carcinomas
and hepatocholangiomas were increased at the high dose (10 and 6%, respectively, vs. 0% in controls). 
For females exposed to Aroclor 1242, hepatocellular adenomas were increased in both dose groups at
2.8 and 5.7 mg/kg/day (20 and 24%, respectively, vs. 1% in controls).  For females exposed to
Aroclor 1016, hepatocellular adenomas were increased in the middle- and high-dose groups at 5.4 and
11.2 mg/kg/day (10 and 10%, respectively, vs. 0% in controls).  In males, liver tumor responses were
nonsignificant (p>0.05) in all groups except for increased hepatocellular adenomas at the highest dose
(4.1 mg/kg/day) of Aroclor 1260 (14 vs. 4% in controls).  The liver neoplasms did not adversely affect
survival rates in any of the Aroclor-exposed groups.
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Thyroid follicular cell adenomas were significantly (p#0.05 or p#0.01) increased in male rats in a non-
dose-related and non-Aroclor-related manner (Mayes et al. 1998).  Increased percentages of males with
follicular cell adenomas were induced by Aroclor 1242 in both dose groups at 2.0 and 4.0 mg/kg/day
(10 and 10%, respectively, vs. 1% in controls), Aroclor 1254 in all dose groups at 1.0, 2.0, and
4.3 mg/kg/day (12, 8, and 10%, respectively, vs. 1%), and Aroclor 1260 in the low and middle-dose
groups at 1.0 and 2.0 mg/kg/day (12 and 8%, respectively, vs. 1%).  The morphologic appearance of the
thyroid tumors were reported to be characteristic of those that developed as a secondary response to
chronic overstimulation by thyroid-stimulating hormone.  The incidence of spontaneous mammary gland
tumors (fibroadenoma, adenoma, and/or adenocarcinoma) in females was statistically significantly
decreased by Aroclor 1254 at the high dose of 6.1 mg/kg/day (27 vs. 45% in controls), and Aroclor 1260
in the low and middle-dose groups of 1.4 and 2.8 mg/kg/day (35 and 36%, respectively, vs. 45% in
controls).  Additionally, statistically significant negative trends (p#0.05) for total mammary tumors
occurred for Aroclors 1242, 1254, and 1260.
Oral carcinogenicity evaluations of commercial PCB mixtures in mice are limited to two less-than-lifetime
studies that did not examine tissues other than liver (Ito et al. 1973; Kimbrough and Linder 1974). 
Incidences of benign hepatomas were statistically significantly increased in male Balb/cJ mice fed an
estimated dose of 49.8 mg/kg/day Aroclor 1254 (purity not reported) for 11 months, but not in mice
similarly treated for 6 months followed by a 5-month recovery period (Kimbrough and Linder 1974).  The
hepatoma incidences were 0% in two control groups (0 of 34 and 0 of 24), 45.5% (10 of 22) in the
11-month exposure group, and 4.2% (1 of 24) in the 6-month exposure group.  No malignant tumors were
observed, but the investigators noted that the tested mouse strain only rarely develops hepatomas
spontaneously and considered the hepatomas to be potentially malignant.  Additionally, adenofibrosis
occurred in all of the 22 mice treated for 11 months.  
Liver nodular hyperplasia and hepatocellular carcinomas were found in 58.3% (7 of 12) and 41.7% (5 of
12) of dd strain mice, respectively, that were fed an estimated dose of 65 mg/kg/day Kanechlor 500
(52–54% chlorine by weight, purity not reported) for 32 weeks (Ito et al. 1973).  Neither of these
incidences was significantly increased compared to control values of 0% (0 of 6), but the statistical power
of this study is low due to the small number of animals, relatively short treatment duration, and no
posttreatment observation period.  Proliferative liver lesions were not observed in mice fed lower doses
(32.5 or 13 mg/kg/day) of Kanechlor 500, or in mice similarly exposed to the lower chlorinated mixtures
Kanechlor 400 (48% chlorine by weight) or Kanechlor 300 (40–42% chlorine by weight) at estimated
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dietary doses of #65 mg/kg/day for 32 weeks.  Limitations of this study include small numbers of animals,
relatively short treatment period, and no observation period following treatment.
The EPA has derived cancer potency estimates for oral exposure to PCBs (Cogliano 1998; EPA 1996c,
2000a).  Based on rat liver tumor incidence data for Aroclors 1260, 1254, 1242, and 1016 from the Mayes
et al. (1998)/General Electric Co. (1997a, 1997b) study and Aroclor 1260 from the Norback and Weltman
(1985) study, a range of upper-bound slope factors were calculated to represent the potency of
representative classes of environmental PCB mixtures.  A three-category approach is used that considers
how environmental processes (partitioning, chemical transformation, and bioaccumulation) affect each
exposure pathway or situation by altering the composition and cancer potential of the original PCB
mixtures.  The highest slope factor (2.0 per [mg/kg]/day) is for the high risk and persistent category, which
is used for pathways in which environmental processes are likely to increase risk, such as food chain
exposure, sediment or soil ingestion, dust or aerosol inhalation, and exposure to dioxin-like, tumor-
promoting, or persistent congeners.  Due to the potential for higher sensitivity in early life, the highest
slope factor is also used for all early-life exposures.  An intermediate slope factor (0.4 per [mg/kg]/day) is
used for the low risk and persistence category, which is appropriate for exposure pathways in which
environmental processes tend to decrease risk, such as drinking water ingestion of water soluble
congeners, inhalation of evaporated congeners, and dermal exposure (because PCBs are incompletely
absorbed through the skin).  The lowest slope factor (0.07 per [mg/kg]/day) applies to the lowest risk and
persistence category, and is used when congener or homologue analyses of an environmental mixture
verify that congeners with more than four chlorines comprise <0.5% of total PCBs, as well as the absence
of dioxin-like, tumor-promoting, and persistent congeners.  For the upper slope factor of
2 per (mg/kg)/day, doses corresponding to risk levels ranging from 10-4 to 10-7 are 5x10-5 to
5x10-8 mg/kg/day, respectively, as indicated in Figure 3-2.
Tumor Promotion Studies.  It is well documented that orally administered commercial PCB mixtures
can promote tumors in the liver (hepatocellular carcinomas, adenomas, and neoplastic nodules) and lung
(alveologenic adenomas) of rats and mice following initiation with carcinogens such as
N,N’-dimethylnitrosamine (DMNA), N,N’-diethylnitrosamine, N-ethyl-N’-hydroxyethylnitrosoamine,
hexachlorocyclohexanes, 2-acetylaminofluorene, and 3'-methyl-4-dimethylaminoazobenzene (Anderson
et al. 1986, 1991, 1994; Beebe et al. 1993; Buchmann et al. 1991; Hirose et al. 1981; Ito et al. 1973;
Kimura et al. 1976; Nishizumi 1976; Preston et al. 1981; Silberhorn et al. 1990; Tatematsu et al. 1979 ). 
These studies typically administered the tumor initiator with a proliferative stimulus (e.g., hepatotoxic
3.  HEALTH EFFECTS - Cancer
PCBs 282
dose, partial hepatectomy, or neonatal administration) and showed effects using higher chlorinated PCB
mixtures (>50% chlorine by weight, particularly Aroclors 1254 and Kanechlor 500) as the promoter.
The promoting activity of PCBs is also indicated by short-term assays in which orally administered
commercial mixtures or single congeners promoted development of putative preneoplastic lesions in rat
liver following induction by various initiators (Anderson et al. 1991; Buchmann et al. 1991; Deml and
Oesterle 1982, 1987; Deml et al. 1983; Hemming et al. 1993; Laib et al. 1991; Oesterle and Deml 1983,
1984; Pereira et al. 1982; Preston et al. 1985; Rose et al. 1985; Sargent et al. 1991; Silberhorn et al.
1990).  Enzyme-altered hepatic foci, identified by alterations in adenosine triphosphatase (ATPase),
GGT, or placental glutathione S-transferase (PGST) activity, were used as markers of promoting
activity.  The commercial PCBs showing promotion in these studies were usually the higher-chlorinated
mixtures Aroclor 1254 or Clophen A50.  The congener studies have shown promoting activity with non-
ortho PCBs such as PCB 77 and PCB 126; mono-ortho-substituted PCBs such as PCB 105 and
PCB 114, and di-ortho PCBs such as PCBs 47, 49, and 153.  Although structurally diverse congeners
show promoting activity, the co-planar PCBs appear to be most effective.  Additional information on
tumor promotion by PCBs is discussed in Section 3.5.2 (Mechanisms of Toxicity).
3.2.8.3.3  Dermal Exposure
Dermal carcinogenicity studies of PCBs consist of skin tumor initiation and promotion assays.  A single
dose of 0.1 mg of Aroclor 1254 (purity not reported) showed no conclusive initiator activity when
applied to the shaved skin of female CD-1 mice followed by promotion with the phorbol ester
12-O-tetradecanoylphorbol-13-acetate (TPA) twice weekly for 32 weeks (DiGiovanni et al. 1977).  The
finding is inconclusive due to low skin papilloma incidence and lack of control mice treated with TPA
alone.  Aroclor 1254 (purity not reported) was not a skin tumor promoter when applied to the shaved
skin of female CD-1 mice (0.1 mg/mouse, twice weekly for 30 weeks) that were initiated with dimethyl-
benzanthracene (DMBA) (Berry et al. 1978, 1979), or to female HRS/J hairless mice (1 mg/mouse, twice
weekly for 20 weeks) that were initiated with N-methyl-NN-nitro-N-nitrosoguanidine (MNNG) (Poland
et al. 1983).  These results must be interpreted with caution since only one dose level of Aroclor 1254
was tested, and the doses may have been too low, as indicated by slight, although not statistically
significant, promotion in the Poland et al. (1983) study.  The initiation and promotion studies tested
sufficient numbers of animals and, except as noted above, included positive and negative control groups. 
Pretreatment with a single topical dose of 0.1 mg of Aroclor 1254 inhibited skin tumor initiation by
DMBA in female CD-1 mice by as much as 45% (Berry et al. 1979).
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3.2.8.3.4  Evaluation of Animal Studies
The carcinogenicity of several commercial PCB mixtures has been evaluated in a number of chronic oral
bioassays in rats.  The most comprehensive and adequately performed study compared Aroclors 1016,
1242, 1254, and 1260 and found that all four mixtures induced liver tumors when fed to female Sprague-
Dawley rats (General Electric Co. 1997a, 1997b; Mayes et al. 1998).  Aroclor 1260 also induced liver
tumors in male rats.  The liver response was both Aroclor- and sex-dependent (much greater in females
than males), consisted primarily of benign hepatocellular adenomas and, in females, increased with dose
in the general potency pattern of Aroclor 1254 > Aroclor 1260 . Aroclor 1242 > Aroclor 1016. 
Previous lifetime dietary exposure studies found that commercial mixtures with 60% chlorine content
(Aroclor 1260 and Clophen A60) induced liver tumors in three strains of rats (Kimbrough et al. 1975;
Moore et al. 1994; Norback and Weltman 1985; Schaeffer et al. 1984), with indications of a sex-
dependent  response (stronger in females) in one of these studies (Norback and Weltman 1985).  Many
of the rat liver tumors were benign, although sequential morphologic analyses demonstrated the eventual
progression of the benign liver lesions to malignant carcinomas (Norback and Weltman 1985).  Lifetime
carcinogenicity tests of commercial PCB mixtures containing <60% chlorine were performed in only a
few studies prior to the Mayes et al. (1998) bioassay.  Liver tumors were reportedly induced by
Aroclor 1254 in Fischer 344 rats (NCI 1978; Ward 1985) and a 42% chlorine mixture (Clophen A30) in
Wistar rats (Schaeffer et al. 1984), but re-evaluation of these studies using current diagnostic criteria
showed no statistically significant increases in tumor incidences or clear sensitivity differences in tumor
responses between males and females.  The chronic rat studies provide a limited amount of evidence for
neoplastic or preneoplastic changes in tissues other than the liver.  Incidences of preneoplastic lesions in
the biliary tract were increased in both sexes by exposure to Aroclor 1260 (Norback and Weltman 1985),
although the response was greater in females.  There was a suggestive indication of Aroclor 1254-
induced precancerous intestinal metaplasia and adenocarcinomas in the stomach of rats in one study
(Morgan et al. 1981; NCI 1978; Ward 1985).  The preneoplastic lesions in the biliary tract and stomach
have not been reported in other studies, particularly Mayes et al. (1998).  Statistically significant
increases in thyroid gland follicular cell adenomas were induced by Aroclors 1242, 1254, and 1260 in
males, but not females (Mayes et al. 1998).   
The oral carcinogenicity of commercial PCB mixtures has also been tested in mice, but these studies are
limited by intermediate-duration exposures, lack of postexposure observation, and histological
examinations that were limited to the liver.  These studies generally indicate that less-than-lifetime dietary 
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exposure to commercial mixtures with 42–60% chlorine induced precancerous liver lesions (Ito et al.
1973; Kimbrough and Linder 1974; Kimbrough et al. 1972).   
It is well documented that oral exposure to commercial PCBs and single congeners can promote
preneoplastic lesions and tumors in the liver and lung of rats and mice following initiation with other
carcinogens (Anderson et al. 1986, 1991, 1994; Beebe et al. 1993; Buchmann et al. 1991; Deml and
Oesterle 1982, 1987; Deml et al. 1983; Hemming et al. 1993; Hirose et al. 1981; Ito et al. 1973; Kimura et
al. 1976; Laib et al. 1991; Nishizumi 1976; Oesterle and Deml 1983, 1984; Pereira et al. 1982;  Preston et
al. 1981, 1985; Rose et al. 1985; Sargent et al. 1991; Silberhorn et al. 1990; Tatematsu et al. 1979).  The
commercial PCBs showing promotion in these studies were usually the higher-chlorinated mixtures such
as Aroclor 1254.  Congeners showing promoting activity are structurally diverse, although the co-planar
PCBs appear to be most effective.
Several studies in which relatively low doses (0.1 mg/mouse) of Aroclor 1254 were applied to the skin of
mice showed no conclusive initiation or promotion activity (Berry et al. 1978, 1979; DiGiovanni et al.
1977; Poland et al. 1983).  Studies corroborating these findings on skin tumor initiation, promotion, and
inhibition or evaluating the carcinogenicity of PCBs applied to the skin without initiators or promoters
have not been performed.
Before the comprehensive four-Aroclor comparative carcinogenicity study was conducted by Mayes et al.
(1998), only commercial PCBs mixtures with 60% chlorine had been adequately tested, and there was
controversy about whether mixtures with lower chlorine content were carcinogenic.  The liver and thyroid
tumor results of the Mayes et al. (1998) rat study, in addition to confirming the carcinogenicity of higher
chlorinated PCBs, provide compelling evidence that all commercial PCB mixtures can cause cancer in
animals.  The sufficiency of the evidence of carcinogenicity of PCBs in animals is recognized by both
EPA (Cogliano 1998; IRIS 2000) and IARC (1987).
3.3 HEALTH EFFECTS IN WILDLIFE POTENTIALLY RELEVANT TO HUMAN HEALTH 
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3.3.1 Overview
The EPA’s final rule strictly limiting the manufacture, processing, distribution, and use of PCBs under
Section 6(e) of the Toxic Substances Control Act was promulgated in 1979 (EPA 1979a).  A technical
support document for the EPA rule was comprised primarily of a draft environmental impact statement
that outlined the significance of the release of PCBs into the environment from both human and wildlife
health perspectives (EPA 1978c).  Health effects in wildlife that were cited in the support document
included the following: mortality in piscivorous birds; reproductive impairment in monkeys, minks, ring
doves, and American kestrels; immunotoxicity in monkeys and birds; and endocrine and neurobehavioral
effects in birds.  A variety of other health effects have since been evaluated in wildlife, some of which
may be relevant to human health.  Environmental monitoring studies have shown that PCBs are highly
persistent in the environment (see Section 6.3, Environmental Fate), and therefore continue to present a
potential health hazard to humans.  
Wildlife may be regarded as sentinels for human health.  Wildlife sentinel species data may be used for
several purposes related to exposure and hazard assessment (NRC 1991; van der Schalie et al. 1999),
including the following: (1) provide additional weight of evidence in a human health risk assessment;
(2) act as an early warning for potential effects in humans (e.g., by identifying new locations of potential
concern for human health, or identifying new end points of potential human concern not previously
observed in experimental animal studies); (3) suggest potential cause-and-effect relationships for further
study; (4) investigate the bioavailability of contaminants from environmental media; and (5) monitor
contamination in the food web, such as during the course of remedial actions.  Reviews of public health
considerations regarding toxic substances (including PCBs) in the Great Lakes region have incorporated
effects in wildlife in a weight-of-evidence analysis of the potential for detrimental effects in humans in
the region, particularly in human populations that rely heavily on Great Lakes fish for their dietary
protein (Johnson et al. 1998b, 1999).
The purpose of this section is to provide a qualitative synopsis of health effects in wildlife to address the
potential concern that effects observed in wildlife that are attributable to PCB exposure may also occur in
humans, and to highlight information in the wildlife database that contributes to the weight of evidence
supporting the critical effects that form the basis for the chronic- and intermediate-duration oral MRLs.
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A hazard identification table (Table 3-6) is provided to quickly scan the wildlife database for taxa or
categories of toxicological end points that are of particular interest.  Since Table 3-6 is intended for
hazard identification, data concerning effects from parenteral exposures were included, as well as oral,
inhalation, and dermal routes that are more directly relevant to human environmental exposures. 
Table 3-6 distinguishes between correlational evidence from field observations and experimental
evidence.  Correlational evidence from field studies inherently has multiple sources of uncertainty, many
of which are controlled in experimental studies.  Observations that indicate a positive relation between
environmental PCB exposure (sometimes represented by PCB concentration in tissue) and an adverse
health effect in free-ranging wildlife are represented in Table 3-6 as correlational field observations. 
Effects that were observed in experimental studies under controlled or closely monitored exposure
conditions were included in the table as experimental observations.  However, no entry was made in
Table 3-6 for responses that were reported in an experimental study to be equivocal, ambiguous, or not
statistically significant.
Several reviews of the PCB ecotoxicological literature (e.g., DOI 1986, 1996; Hansen 1987b; Safe 1994;
WHO 1993) provided much of the information included in this section.  Information contained in the
reviews was supplemented by individual studies that were not otherwise represented, such as more recent
studies.  The number of sources identified for an individual Table 3-6 entry does not necessarily reflect
the number of studies showing that effect for the following reasons: (1) several reviews may have
reported the same results from a single study, or (2) a single source document may report effects in
multiple studies, but the source is represented only once for a given entry.  Information included in
Table 3-6 was limited to effects in fish and birds, and in mammals that had not been bred to reduce
genetic variability (e.g., Table 3-6 includes data on monkeys and minks, but excludes data on laboratory-
bred strains of rats, mice, rabbits, etc.).  No data concerning effects in fungi, invertebrates, microbes, or
terrestrial or aquatic plants were included.  Among the classes of organisms represented in Table 3-6,
mustelids (primarily minks and ferrets), galliform birds (primarily domestic fowl and quail), and
freshwater fish were the most frequently studied (see Table 3-6).  End points that received the most
attention in the wildlife toxicology literature on PCBs were mortality, reproductive, developmental, and
endocrine effects, and enzyme induction.  Additional categories of end points that were relatively
frequently addressed were immunological, neurological/behavioral, and hepatic effects.  Most of the
toxicological information represented in Table 3-6 was derived from experimental studies, but the focus
of some experiments was influenced by observations in earlier field studies of correlations between levels









Table 3-6.  PCB Hazard Identification in Wildlife
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Table 3-6.  PCB Hazard Identification in Wildlife (continued)

































































Egg shell Not relevant for wild mammals OC44 OE332 OE35
OC44
Not relevant for amphibians or fish
Genotoxic OE34
Cancer No cancer data
Entry: Effect Code 
O = effect was observed, as reported in the source document.
Blank = effect was either not evaluated, or evaluated but not observed (including equivocal, ambiguous, or not statistically significant responses)
Subscript:  Observation Type
E = experimental observation
C = correlational field observation
PCB Exposure
1 = dioxin-like PCB congener (AhR binder; planar; chlorine para-substituted and non- or mono-ortho-substituted)
2 = non-dioxin-like PCB congener (poorly binds to AhR; non-planar; chlorine di-, tri-, or quatro-ortho-substituted)
3 = commercial PCB mixture (e.g., Aroclor 1016)
4 = “weathered” (i.e., environmentally degraded and/or metabolized) PCB mixture, usually in combination with other chemicals (e.g., PCBs in wild-caught fish)
5 = unspecified PCB
Superscript: Source Documents (including reviews of PCB toxicity in wildlife and experimental studies not otherwise represented)
1 = Backlin et al. 1998b
2 = Bergman and Olsson 1985
3 = Crisp et al. 1998
4 = DOI 1986
5 = DOI 1996
6 = EPA 1980f
7 = Giesy and Kannon 1998
8 = Geisy et al. 1994
9 = Gutleb et al. 1999
10 = Hansen 1987b
11 = Harding et al. 1999
12 = Heaton et al. 1995a
13 = Heaton et al. 1995b
14 = Hornung et al. 1998
15 = Jarman et al. 1996
16 = Johnson et al. 1998
17 = Johnson et al. 1999
18 = Jones et al. 1979
19 = Käkelä et al. 1999
20 = Kannan et al. 1993
21 = Murk et al. 1996
22 = Nisbet et al. 1996
23 = Olsson et al. 1994
24 = Restum et al. 1998
25 = Ringer et al. 1991
26 = Risebrough 1999
27 = Rosenshield et al. 1999
28 = Safe 1994
29 = Shipp et al. 1998a
30 = Shipp et al. 1998b
31 = van der Schalie et al. 1999
32 = WHO 1993
33 = Wren et al. 1987a
34 = Wren et al. 1987b
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There is some question as to the relevance of experimental studies in wildlife using single congeners or
well-described commercial mixtures to situations involving environmental exposures of free-ranging
wildlife to weathered PCBs (i.e., PCB mixtures in environmental media, such as the water column or
animal tissues, that have undergone selective environmental degradation, bioaccumulation, and/or
metabolism of component PCB congeners).  Reviews (Giesy et al. 1994; WHO 1993) identified the
following difficulties in extrapolating from toxicity observed in wildlife experimental studies to effects
expected in wildlife in the environment: (1) most of the experimental studies in fish and wildlife tested
the effects of commercial mixtures of PCBs, so the identity of the particular components (or interactive
sets of components) that caused the effects is not generally known; (2) tests were generally conducted in
environmentally unrealistic conditions; (3) because of differences between congeners in environmental
fate, bioaccumulative potential, and species-specific degree of metabolism, weathered mixtures of PCBs
in various environmental compartments (e.g., the water column and animal tissues) frequently bear little
resemblance to the original commercial mixture that was released into the environment; (4) PCB exposure
in the environment invariably involves co-exposure to other pollutants that may interact to produce
effects that were not observed under experimental conditions.  For example, among mink studies,
weathered total PCBs in fish were found to be more potent than commercial PCB mixtures, possibly
because the weathering process selectively removed the less toxic congeners or possibly because of
interactions with other contaminants (Giesy and Kannan 1998; Giesy et al. 1994).
3.3.2 Health Effects in Wildlife
Biological responses in wildlife to exposures to individual PCB congeners and commercial PCB mixtures
varied widely, possibly reflecting not only variability in susceptibility among species, but also differences
in mechanism of action or selective metabolism of individual congeners (DOI 1986, 1996; WHO 1993). 
More highly chlorinated congeners tend to bioaccumulate most readily, and PCBs tend to biomagnify in
the food chain, reaching relatively high, toxic concentrations at higher trophic levels, such as in
piscivorous birds (e.g., gulls, terns, and cormorants) and mammals (e.g., minks, otters, seals, and sea
lions) (EPA 1978c; WHO 1993).  It is generally accepted that dioxin-like PCB congeners (i.e., those that
can assume a planar configuration and exhibit high affinity for the Ah receptor) are more potent toxicants
than other congeners (i.e., those with multiple chlorine substitution in ring positions 2 and 6) (DOI 1996;
Giesy and Kannon 1998; Giesy et al. 1994).  Of interest is the observation that the patterns of toxicities in
seals may be changing with apparent decreasing global burdens; certain pathological changes are now
more closely associated with methyl sulfonyl metabolites of DDE and PCBs than with parent coplanar
PCBs (Olsson et al. 1994).  Reproductive effects in birds and piscivorous mammals appear to be Ah
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receptor-mediated, since planar, dioxin-like PCB congeners are more effective in inducing these effects
than non-dioxin-like congeners (Giesy and Kannan 1998).  In a comprehensive review of the literature
concerning the ecotoxicology of planar PCBs, DOI (1996) concluded that the chinook salmon, domestic
chicken, mink, and Rhesus macaque were among the most sensitive species to effects from planar PCB
exposure. 
In aquatic organisms including fish, PCB toxicity was enhanced by flow-through experimental conditions
as compared to static exposure conditions, and commercial Aroclor mixtures with moderate chlorine
content were generally more toxic than commercial mixtures with low or high percentage chlorination
(WHO 1993).  Fish in early life stages were more vulnerable than adults to PCB toxicity (WHO 1993).  In
birds, acute toxicity in experiments was generally positively related to degree of chlorination of the
commercial mixture (WHO 1993).  Avian reproduction was impaired primarily due to decreased egg
hatchability and increased embryotoxicity (WHO 1993).  Available evidence indicates that PCBs do not
directly affect egg shell thickness in birds, but may indirectly affect egg shells by decreasing food
consumption and thereby reducing body weight (WHO 1993).  PCBs are ubiquitous and continuously
circulating in the global environment, and appear to be gradually redistributing toward the marine
environment (WHO 1993).  For this reason, and because marine mammals are near the top of the food
chain, piscivorous marine mammals are regarded as potentially the most sensitive wildlife receptors to
PCB exposure (DOI 1996; WHO 1993).  Field studies suggested, and subsequent experimental studies
confirmed, that accumulated PCBs impair pinniped (e.g., seals and sea lions) reproduction by preventing
implantation of the embryo; whether this effect is caused by endocrine disruption remains unresolved
(WHO 1993).  The endocrine disruptive potential of PCBs and other persistent and bioaccumulative
pollutants has been critically reviewed in the literature (e.g., Crisp et al. 1998; DeRosa et al. 1998;
Risebrough 1999); the wildlife toxicology database summarized in Table 3-6 indicates that PCBs have
induced endocrine-related effects in a variety of taxa.
Of particular interest are PCB-induced effects in wildlife that contribute to the weight of evidence
supporting the oral MRL derivations, including neurological/behavioral, immunological, and dermal
effects.  The intermediate-duration MRL is based on neurodevelopmental alterations in infant Rhesus
monkeys that were postnatally fed a constituted mixture of PCB congeners analogous to those found in
human breast milk.  The chronic-duration MRL is based on immunological and dermal/ocular effects in
Rhesus monkeys resulting from long-term oral exposure to Aroclor 1254 (see Section 2.3, Relevance to
Public Health and Appendix A for further details concerning MRL rationale and derivations).  Effects that
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occurred in monkeys at doses proximate to the LOAELs used to derive the MRLs included decreased
conception and fetal mortality. 
Effects in wildlife that are potentially related to neurological impairment included alterations in central
nervous system neurotransmitter levels, retarded learning, increased activity, and behavioral changes. 
Significantly reduced dopamine levels were observed in certain regions of the brain in adult pigtailed
macaques provided Aroclor 1016 or Aroclor 1260 orally at 0.8, 1.6, or 3.2 mg/kg/day for 20 weeks;
reduced dopamine levels persisted after termination of exposure (Geisy and Kannon 1998; Safe 1994). 
Offspring of Rhesus monkeys provided Aroclor 1248 in the diet at 0.5–2.5 mg/kg before and during
gestation showed hyperactivity and other behavioral deficits (Geisy and Kannon 1998; Hansen 1987). 
“Long-term neurobehavioral changes” were seen in monkeys provided an unspecified PCB mixture (DOI
1996).  Two-and-a-half and 5-year-old monkeys exhibited retarded learning and inefficient response
behavior following a 20-week oral exposure to a PCB mixture immediately after birth (Johnson et al.
1998).  Similarly, retarded learning, increased locomotor activity, impaired discrimination reversal
learning, and increased hyperactivity were observed in monkeys provided Aroclor 1248 for an
unspecified duration (Safe 1994).  Brain catecholamine levels were altered in minks exposed (by an
unreported route and duration) to PCB 136 (Hansen 1987).  Minks provided diets of carp containing
weathered PCBs for up to 182 days showed listlessness and nervousness, as well as anorexia, hindlimb
paralysis, and sporadic seizures prior to death (Heaton et al. 1995b).  Brain weight was significantly
reduced in F1 adult female minks exposed to weathered PCBs (in carp) in utero, during lactation, and
through the diet until 1.5–14 months postpartum (Restum et al. 1998).  Significantly reduced sleeping
times were observed in white-footed mice and raccoons provided diets containing 25–100 ppm
Aroclor 1254 for up to 3 weeks (DOI 1986). 
Suppressed avoidance response was observed in Japanese quail fed a diet containing 200 µg
Aroclor 1254/g diet for 8 days (Geisy and Kannon 1998).  Doves provided an unspecified Aroclor
mixture showed altered brain catecholamine levels (Hansen 1987).  Altered courtship, reproductive, and
nesting behavior were seen in mourning doves at 14–44 days after termination of a 6-week dietary
exposure to up to 40 ppm Aroclor 1254 (DOI 1986; WHO 1993).  Decreased parental attentiveness was
seen in ring doves provided Aroclor 1254 at 10 mg/kg diet (WHO 1993).  Nest-building activity was
reduced in pigeons orally dosed with 15 mg Aroclor 1254/day by gelatin capsule throughout a courtship
cycle (WHO 1993).  Avoidance response was significantly reduced in Japanese quail following dietary
exposure to 200 ppm Aroclor 1254 (unspecified duration), compared to pre-exposure response levels, and
persisted for 6 days after exposure (WHO 1993).  Increased migratory restlessness was observed in
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European robins and redstarts provided diets of mealworms containing Clophen A50 for 11–13 days
(WHO 1993).
Guppies appeared sluggish and uncoordinated after consuming diets containing up to 150 mg PCB 133 or
PCB 197/kg diet for up to 247 days, or 550–1,400 mg/kg diet for 65 days (DOI 1996).  Poor muscle
coordination, tetany, and lateral or ventral caudal flexion were observed in salmon and trout after 1 week
of dietary exposure to unspecified PCB mixtures (DOI 1986).  Whole-brain noradrenalin amd dopamine
levels were significantly reduced and swimming activity was increased in Gulf killifish exposed to 4 mg
Aroclor 1242/L for 24 hours; increased swimming activity persisted for 2 days after exposure (WHO
1993).  
Positive findings in wild mammals, birds, or fish that contribute to the weight of evidence for
immunological effects included morphological changes in organs related to the immune system, as well as
functional impairment of humoral- and cell-mediated immune responses.  Reduced antibody production
in response to SRBC erythrocyte challenge was observed in monkeys exposed to Aroclor 1254 and
Kanechlor 400 (Safe 1994).  Absolute and relative spleen weights were increased in female minks fed
diets containing 1 ppm total weathered PCBs (in carp) for approximately 6 months compared to a control
group; no such changes were observed in males (Restum et al. 1998).  Increased disease susceptibility in
California sea lions has been positively associated with tissue PCB residue (Hansen 1987b).  Impaired
natural killer cell activity and T-lymphocyte function were observed in harbor seals fed diets of Baltic Sea
herring containing relatively high levels of organochlorine-compounds, including PCBs, compared to
seals fed diets of fish with lower levels of contamination (Johnson et al. 1998).  High blubber PCB levels
(94 to 670 µg/g) were observed in a population of western Mediterranean striped dolphins affected by a
mobillivirus epizootic (Kannan et al. 1993).
In a survey of herring gulls and Caspian terns (piscivorous birds) in the Great Lakes region, suppression
of T-cell-mediated immunity was associated with level of prenatal exposure to unspecified PCBs (van der
Schalie et al. 1999).  Splenic atrophy was observed in groups of cockerels fed diets containing 400 mg/kg
Phenochlor DP6, Clophen A60, or Aroclor 1260 for 60 days (WHO 1993).  PCB-induced atrophy of
lymphoid tissues in chickens and pheasants and increased susceptibility of ducklings to hepatitis virus
have been associated with the immunosuppressive effect of PCBs (WHO 1993).  Thymic involution and
edema were observed in 1-day-old domestic chickens fed diets containing 400 mg/kg PCB 169 for
21 days (DOI 1996).  A lymphoid depletion of the spleen was observed in nestling American kestrels
administered daily oral doses of 50 µg/kg PCB 126 for 10 days (DOI 1996).
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In channel catfish, 100% mortality was observed in an immunized group that was intraperitoneally
injected with 70 mg/kg Aroclor 1232 and then challenged with the virulent bacterium Aeromonas
hydrophila, while an immunized control group had no mortality.  The PCB-treated group also showed
significantly decreased serum β-globulin levels, slightly elevated serum α-globulin levels, and decreased
peritoneal macrophage activity compared to the control group (Jones et al. 1979).  Rainbow trout showed
a reduction in the lymphatic elements of the spleen after dietary exposure to 10 or 100 mg/kg
Aroclor 1254 for 330 days (WHO 1993).  Increased disease susceptibility was observed in pinfish and
spot fish (marine/estuarine species) exposed to Aroclor 1254 at concentrations as low as 0.005 ppm
(Hansen 1987b).
Wildlife findings that contribute to the weight of evidence for dermal/ocular effects include dermal
changes in several taxa.  Dose- and time-dependent increases in chloracne and histological changes in the
sebaceous glands were observed in Rhesus macaques fed diets containing 0.3 to 3.0 ppm PCB 77 for 1 to
6 months (DOI 1996).  Scaly skin, hair loss, and abnormal nail growth were observed in cotton top
marmoset monkeys orally administered 0.1 to 3.0 mg PCB 77/kg body weight twice/week for
18–28 weeks (DOI 1996).  Enlarged, thickened, and deformed toe nails, hyperkeratosis at the junction of
the skin and sponchium, and dysplasia of the root and matrix of the nail were observed in ferrets fed a diet
containing 20 ppm Aroclor 1242 for 8 months; Aroclor 1016 similarly administered did not cause these
effects (WHO 1993).  Bilateral epidermal thinning, hyperkeratosis, cystic dilations of hair follicles, and
deformations and fractures of the claws were observed in grey seals of the Baltic Sea suspected of having
significant exposure to weathered PCBs (Bergman and Olsson 1985).  Flagfish (Jordanella floridae)
exposed to water concentrations of 5.1 and 18 µg Aroclor 1248/L “almost completely lost their fins and
tails”, while sheepshead minnow fry exposed to 0.1–10 µg/L showed increased fin rot (WHO 1993).
Regarding the weight of evidence for reproductive and developmental toxicity, embryo/fetal loss is one
effect among a suite of developmental effects observed repeatedly in Great Lakes wildlife that have been
characterized as the Great Lakes embryo mortality, edema, and deformity syndrome (GLEMEDs
syndrome) (Giesy et al. 1994; Hansen 1987b).  The wildlife database outlined in Table 3-6 includes
observations of increased postimplantation embryo/fetal loss in several taxa (e.g., nonhuman primates and
mustelids), as well as additional effects that may be indicative of PCB-induced embryo/fetal death (e.g.,
reduced egg hatchability in bird and fish eggs, and reduced numbers of live births in mammals).
In summary, the wildlife toxicity database for PCBs summarized in Table 3-6 contributes to the weight of
evidence supporting the critical health effects used in the MRL derivations (i.e., neurological/behavioral,
3.  HEALTH EFFECTS - Toxicokinetics
PCBs 295
immunological, and dermal/ocular effects), as well as other PCB-induced effects that are particularly
relevant to human health (e.g., reproductive and developmental toxicity).
3.4 TOXICOKINETICS
Although most toxicological data reviewed in this profile have been obtained from studies in which PCB
mixtures were used, Section 3.4.3 (Metabolism) in particular, contains descriptions of studies in which
individual PCB congeners were used.  This supplemental information is considered necessary since most
of the current knowledge regarding biotransformation of chlorinated biphenyls in experimental animals
has been derived from such studies.  Table 4-2 lists the IUPAC number of the congeners and the
corresponding chlorine substitution.
Data regarding toxicokinetics of PCBs in humans are limited to information derived from cases of
ingestion of food contaminated with PCBs and cases of occupational exposure by the inhalation and
dermal routes.  Humans can absorb PCBs by the inhalation, oral, and dermal routes of exposure.  PCBs,
when administered orally, are well absorbed by experimental animals, but they are absorbed less
efficiently when administered by the dermal route.  Inhalation absorption data are insufficient for
estimating absorption rates.  In the gastrointestinal tract, PCBs are absorbed on a congener specific basis
by passive diffusion.  A high diffusion gradient and nearly complete absorption occurs when the PCB
level in the gut contents (lipid basis) is much greater than the concentration in serum lipids.  The
predominant PCB carriers in human plasma are in the lipoprotein fraction.  Due to their lipophilic nature,
PCBs, especially the highly chlorinated congeners, tend to accumulate in lipid-rich tissues.  Greater
relative amounts of PCBs are usually found in the liver, adipose, skin, and breast milk.  PCBs are
metabolized by the microsomal monooxygenase system catalyzed by cytochrome P-450 to polar
metabolites that can undergo conjugation with glutathione and glucuronic acid.  State of the art PCB
exposure assessment utilizing human serum, milk, and/or tissues should not only include congener
specific PCB analysis, but also analyze persistent PCB metabolites.  Since certain hydroxylated and
methylsulfonyl (MeSO2) PCB metabolites are present in some cases at levels higher than their respective
parent compounds, it is necessary to further investigate the potential biological and/or toxicological
activities of these persistent metabolites.  The major routes of excretion of PCBs are fecal and, especially
for metabolites, urinary.  Mainly metabolites are found in urine and bile, although small amounts of
parent compound may appear in the feces.  Some PCB congeners are relatively poorly metabolized and
thus can remain in the body for long periods of time (months to years).  A flow-limited pharmacokinetic
model was constructed to describe disposition of some PCB congeners in adults of various animal
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species.  In general, the model predicted the experimental data well, although some deviations were
apparent.  Knowledge of the metabolic rates for PCBs is crucial for meaningful interpretation of data. 
Enzyme induction over long-term occupational and/or environmental exposure can render some PCBs
less persistent in exposed humans than in the general population. 
3.4.1 Absorption
3.4.1.1 Inhalation Exposure
Inhalation exposure is considered to be a major route of occupational exposure to PCBs (Wolff 1985). 
Indirect evidence of absorption of PCBs by this route in humans is based on the fact that individual
congeners have been detected in tissues and body fluids of subjects exposed in occupational settings
where air concentrations have also been measured.  From data summarized by Wolff (1985), a maximum
of 80% of the levels commonly seen in adipose tissue of exposed capacitor workers may have been
absorbed by the inhalation route.  A maximum of 20% would have been derived from dermal or oral
exposure.  Exposure to PCBs in air was positively related to mean serum PCB levels in subjects involved
in clean-up operations following a PCB transformer fire (Fitzgerald et al. 1986); the relative contribution
of the dermal route was not determined.  Duarte-Davidson and Jones (1994) estimated that the average
total background PCB exposure for the contemporary UK population was 0.53 µg/person/day, with food
consumption accounting for 97% of the total PCB exposure, air contributing 3.4%, and water only 0.04%. 
2,4,4'-TriCB (PCB 28) was the most abundant congener detected in air samples and accounted for 3.7%
of the total exposure to this congener.  More highly chlorinated congeners, such as PCB 180 were
detected at lower levels in air, with air borne exposure accounting for only 1.7% of the total daily
exposure to this congener.  Further information regarding tissue levels in occupationally-exposed subjects
can be found in Section 3.4.2.
Information regarding absorption of PCBs in animals following inhalation exposure is limited.  Male rats
were exposed (whole body) to an aerosol of a PCB mixture, Pydraul A200 (42% chlorine), at a
concentration of 30 g/m3 (0.5–3 µm particle diameter) for #2 hours (Benthe et al. 1972).  After a
15-minute exposure, the PCB concentration in the liver was .40 µg/g tissue, and reached a maximum of
70 µg/g after 2 hours of exposure.  These results provide qualitative information regarding absorption of
this specific PCB mixture, but the data were not sufficient for estimating the amount or rate of absorption. 
It must be also mentioned that since exposure was not nose-only, the dermal route may have contributed
to absorption.
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A recent study in ferrets by Apfelbach et al. (1998) reported for the first time that the olfactory system
may be a potentially significant portal for the entry of airborne PCBs.  Ferrets were exposed for 5 years to
low levels of PCBs (total PCBs, 260 ng/m3 air) in the ambient air of an animal care room which had PCB
containing sealants.  Tetra-chlorinated PCBs dominated the congener profile of ambient air, with PCB 52
being found at the highest concentration.  The PCB congener pattern in the olfactory bulbs resembled that
found in the ambient air, with the less chlorinated, more volatile PCBs (52) being retained at the higher
levels.  In contrast, the congener profile in adipose tissue resembles that of most exposed or unexposed
animals, with hexa- and hepta-substituted congeners being the major congeners present.  The olfactory
bulbs of the exposed animals had the highest total PCB concentration (642 ng/g lipids), while the liver,
adipose tissue, and brain had levels of 202, 303, and 170 ng/g lipids, respectively.  The data suggest that
inhaled PCBs pass into the dentrites of olfactory sensory neurons and are transported via olfactory axons
directly to the bulbs where they accumulate.  While the olfactory system appears to be a significant site
for the disposition of airborne PCBs, further studies are needed to confirm this observation and assess
whether greater disposition in the brain is associated with inhalation exposure.
3.4.1.2 Oral Exposure
Oral exposure through consumption of contaminated food is presumed to be the major route of exposure
to PCB mixtures for the general population (Duarte-Davidson and Jones 1994; Hansen 1999).   
Furthermore, oral exposure through ingestion of contaminated water or soil represents a possible
additional source of exposure for populations in the vicinity of hazardous waste sites.  Duarte-Davidson
and Jones (1994) estimated that the average total PCB exposure for the contemporary UK population was
0.53 µg/person/day, with food consumption accounting for 97% of the total PCB exposure, air
contributing 3.4%, and water only 0.04%.  PCB contaminated fish, milk and dairy products, vegetables,
and meat and animal fat were estimated to account for 32, 26, 18, and 16% of the respective exposure. 
The congener pattern for different food products varied, with vegetables accounting for a major part of
the intake of lower chlorinated PCB congeners, while fatty foods, such as fish, dairy products, and meat,
played a greater role with exposure to higher chlorinated congeners.  For example, vegetables accounted
for 78% of the total dietary exposure to PCB 28 and only 0.2% of the exposure to PCB 180.  In contrast,
freshwater fish account for 1.2 and 27% of the total dietary exposure to PCBs 28 and 180, respectively.
Direct evidence of absorption of PCBs in humans after oral exposure was provided in a study in which a
volunteer ingested 329 µg of a 13C-PCB mixture/kg body weight in a single dose dissolved in edible oil
(Buhler et al. 1988).  The PCB mixture, which was prepared by the investigators, contained 54% chlorine
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(mainly penta-, hexa-, and heptachlorobiphenyls).  Use of 13C-PCBs allowed the investigators to
distinguish between the administered PCBs and 12C-PCBs already present in the body from diet or other
exposure.  Blood samples obtained during a period of 260 days after dosing revealed the presence of
mostly penta- and hexachlorobiphenyls and smaller amounts of heptachlorobiphenyls.  From data
presented in the report, it appears that the maximum concentration in blood was reached within 2 days of
dosing (the first time point examined).  Concentrations of PCBs in whole blood declined rapidly, but
strong fluctuations were apparent.  This was attributed to changes in blood lipids, which depended on
factors such as diet, physical activity, and time of day.  Also, additional exposure is also possible since
diet was unrestricted and 12C-PCB was more than the administered 13C-PCB.  The investigators estimated
that an intake of 26 µg/kg of PCB 153 would lead to a total concentration in whole blood of 0.5 ppb
1 month later.
A more recent study in a 19-week-old nursing infant provided quantitative data on absorption
(McLachlan 1993).  Absorption was estimated as the difference between ingestion and the amount of
PCBs found in the feces over a period of 12 days.  The mother was 32 years old and nursing for the first
time.  Several PCB congeners were determined in the milk: 2,2N,4,4N,5-pentaCB (PCB 99),
2,2N,4,4N,5,5N-hexaCB (PCB 153), 2,2N,3,4,4N,5N-hexaCB (PCB 138), and 2,2N,3,4,4N,5,5N-heptaCB
(PCB 180).  The percentage of dose absorbed was estimated at 96–98% after corrections were made for
background levels in the diapers.  Similar results were observed in a group of four nursing infants where
absorption of 56 PCB congeners in milk was measured over two 48-hour periods, 1–3 months apart (Dahl
et al. 1995).  Absorption of the coplanar congeners 126 and 169 was estimated to be from 93 to 100%,
while the absorption of PCB 77 ranged from 71 to 98%.  Absorption of non-coplanar tetra- and higher
chlorinated congeners was from 90–100%, while absorption of trichlorinated congeners was 60–98%.
However, the authors noted that it was difficult to draw conclusions on the absorption of trichlorinated
PCBs due to their low levels and the analytical methodology.  The primipara mother’s milk had the
highest levels of generally all PCBs, and the level in milk generally decreased with months of nursing. 
Absorption of PCBs was unaffected by the age of the infant (1–6 months).
Indirect evidence of absorption results from studies regarding ingestion of contaminated food by the
general population.  Elevated levels of PCBs were found in the serum and breast milk of women who ate
PCB-contaminated fish from Lake Michigan (Schwartz et al. 1983).  Blood levels of PCBs were
positively correlated with the amount of fish consumed.  Two volunteers who consumed a total of
0.181 and 0.128 mg, respectively, of PCBs (mixture of 42, 48, 54, and 60% chlorine content) in
contaminated fish showed a maximum 52–60% increase (2.5–4.0 and 2.3–3.5 ppb) in blood levels of total
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PCBs .5 hours after ingesting the meal (Kuwabara et al. 1979).  The concentration of PCBs in blood
returned to premeal levels 17 hours later.  Levels of PCBs in adipose tissues were not determined.
Schlummer et al. (1998), used a mass balance approach to assess the gastrointestinal absorption of PCBs
from food in seven individuals, 24–81 years of age, with different contaminant body burdens (Table 3-7).  
The net absorption is calculated as the difference between contaminant input with food and contaminant
output with feces, normalized to the contaminant intake.  Positive values in Table 3-7 indicate net
absorption and negative values indicate net excretion, with absorption or excretion expressed as a
percentage of daily intake.  Nearly complete net absorption was observed for PCBs 28, 52, 77, 101, and
126.  Incomplete net absorption and/or net excretion (in older subjects) was observed for PCBs 105, 138,
153, 180, and 202.   In the case of the coplanar PCBs, 77 and 126, the congener specific levels in blood
lipids of the subjects (given in parentheses) were very low and absorption was nearly complete (90% or
greater for PCB 126 in all but two subjects).  In the 76- and 81-year-old subjects, PCB 126 was found at
higher levels in the blood lipids and the estimated net absorption of this congener was 77 and 53%,
respectively.  Net excretion or limited absorption was observed for PCBs 138, 153, and 180 in the three
older subjects which had the highest levels of these congeners in their blood lipids.  Thus, the
gastrointestinal absorption or excretion of PCBs from food in humans is not only congener dependent, but
is directly related to the concentration of a given PCB in blood, or the congener specific body burden.  In
most cases of background dietary exposures to PCBs, the PCB blood level or body burden increases with
the age of the individual.
Table 3-7 illustrates that compounds showing nearly complete net absorption had low levels in the serum
lipids, and for other congeners, there was a trend for decreasing net absorption/increasing net excretion
with increasing congener concentration in serum lipids.  Together, the data support the passive diffusion
model for gastrointestinal absorption, where the concentration of the contaminant in the blood is the
major factor determining absorption.   In addition, the results suggest that the ingestion of highly
contaminated food should result in nearly complete absorption due to the high diffusion gradient
associated with high levels of PCBs in the gut contents.  This may also be the case for the ingestion of
PCB contaminated soil and water near hazardous waste sites.  It should not be assumed that PCB
absorption involves intestinal transfer to the hepatic portal system.  As with fats and other fat-soluble
chemicals, PCBs are most likely absorbed from the gut via lymphatic circulation and consequently avoid








Table 3-7.  Net Gastrointestinal Absorption or Excretion of PCBs in Humans
and Dependence on Congener-Specific Blood Lipid Levelsa,b
Gender (age in years)c F(24) M (25) M (28) M (36) M (53) F (76) F (81)
PCB 28d 65 84 85 87 64 89 84
(5.0) (2.8) (1.9) (1.9) (4.5) (7.8) (6.6)
PCB 52 73 82 90 89 69 93 92
(1.52) (1.09) (0.89) (<0.46) (0.75) (1.84) (<0.69)
PCB 77 >91e 83 >90 >90 >82 >93 92
(n.d.)f (n.d.) (n.d.) (n.d.) (0.007) (0.064) (<0.02)
PCB 101 56 81 91 90 48 92 82
(1.50) (1.11) (1.22) (0.78) (1.38) (2.3) (1.43)
PCB 105 78 87 99 90 63 3 61
(2.2) (1.21) (1.65) (0.86) (2.9) (3.2) (5.7)
PCB 126 90 93 95 96 92 77 53
(0.066) (0.068) (0.042) (0.029) (0.082) (0.174) (0.39)
PCB 138 80 72 70 87 6 33 6
(55) (63) (131) (50) (174) (133) (270)
PCB 153 74 60 65 85 -54 31 -42
(89) (135) (230) (84) (410) (250) (600)
PCB 180 83 70 59 82 -41 34 -75
(51) (115) (171) (67) (330) (175) (380)
PCB 202 51 36 2 19 -324 -63 -123
(0.69) (0.97) (2.3) (1.59) (3.4) (1.53) (3.3)
aFrom Schlummer et al. 1998
bNet absorption is calculated as the difference between contaminant input with food and contaminant output with feces, normalized to the contaminant intake
and is expressed as a percentage of the daily intake.  Positive values indicate net absorption and negative values indicate net excretion with absorption or
excretion expressed as a percentage of daily intake.  Congener-specific levels in blood lipids are given in parentheses.  
cM or F = sex of volunteer with age in parentheses
dPCB blood levels: nanograms per gram of blood lipids, shown in parentheses.
e< = values did not exceed three times blank values.
fn.d. = not determined due to detection problems.
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In a related, but much older study, Price et al. (1972) estimated the gastrointestinal absorption efficiency
by monitoring the daily PCB intake through food, and the excretion through feces and urine in 7–9 year
old girls.  They found that 88% of the ingested PCBs were not excreted, and were therefore assumed to be
retained in the body.  This estimate of PCB absorption in young girls is supported by the more
comprehensive, congener specific mass balance study of Schlummer et al. (1998) discussed above.
In experimental animals, the absorption of PCBs by the gastrointestinal tract is well documented;
however, few studies provided quantitative estimates.  In rats, individual congeners (mono- to hexa-
chlorobiphenyls) were readily absorbed when administered by gavage (vehicle not reported) in doses
between 5 and 100 mg/kg (Albro and Fishbein 1972).  Retention was >90% of the administered dose over
a 4-day period, and was apparently dose independent.  No relationship between substitution pattern and
degree of absorption could be established due to the low levels of excretion, although a later study
reported that absorption efficiency decreased in rats as the number of chlorine atoms increased such that
dichlorobiphenyls were absorbed with a 95% efficiency, whereas octachlorobiphenyls had an absorption
efficiency of only 75% (Tanabe et al. 1981).  Results similar to those obtained in rats were reported in
monkeys administered a single dose of 1.5 or 3.0 g Aroclor 1248/kg by gavage (Allen et al. 1974b) and in
ferrets given 0.05 mg 14C-labeled Aroclor 1254 in the food on days 14 and 35 of gestation (Bleavins et al.
1984).  Retention was estimated to be >90% and 85.4% of the administered dose in the monkeys and
ferrets, respectively.  Over 90% of a single dose of 10 mg PCB 105 was absorbed by minks (Klasson-
Wehler et al. 1993).  In mice, absorption of a gavage dose of 8 mg/kg of PCB 52 or 100 mg/kg of PCB 77
was rapid, with serum concentrations increasing 4–7-fold in 30–60 minutes; peak serum concentrations
were achieved .2 hours after dosing (Clevenger et al. 1989).  
Following a single oral dose of 15 mg/kg Aroclor 1254 to 55-kg growing swine, total PCBs reached
maximum blood concentrations (9.8% of dose) in 5 hours (Borchard et al. 1975).  The 11 packed-column
peaks containing multiple congeners were also calculated individually, reaching maximum levels of
8–20% of the dose in 4–8 hours.  In mature ewes receiving 30 mg/kg of the same Aroclor in a single oral
dose, absorption was slower and maximum blood levels of 2.2% of the total PCB dose were achieved in
12 hours (Borchard et al. 1975).  The absorption half-life for total PCBs was 1.13 hours in swine and
3.83 hours in the ruminants.  Maximum blood levels of individual peaks were 3–6 times higher in swine
than in sheep; however, sheep readily eliminated the peak containing mainly 2,3,3N,4N,6-pentaCB so that
maximum blood levels were 11-fold lower in sheep than in swine for this peak (Borchard et al. 1975). 
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In weanling swine administered 15 mg/kg Aroclor 1254 in 7 daily oral doses of 2.14 mg/kg, whole blood
concentrations peaked near 0.3 ppm between 7 and 28 days (Hansen and Welborn 1977).  The
concentration in dissectable backfat was about 15 ppm on day 7 and 10 ppm on day 14; however, the
body composition was determined by noninvasive means so that the actual amount in body fat was
estimated at 70 mg on day 7 and 60 mg on day 14.  The slower decline in amount than in concentration
was due to disproportionate expansion of the fat compartment in these rapidly growing animals (Hansen
and Welborn 1977).  The initial decline of total PCBs in fat was due to rapid clearance of lower
chlorinated peaks and slower distribution of higher chlorinated peaks from centralized fat to the more
peripheral backfat.  Simultaneous studies with individual PCBs demonstrated greater amounts of PCB 52
on days 7 and 14 than of PCB 153 if fat PCB content was calculated on the basis of backfat PCB
concentration.  The total amount of tetrachlorobiphenyl declined linearly through 118 days, but the
amount of hexachlorobiphenyl estimated in total fat based on backfat concentration increased gradually
so that the 118-day amount was only slightly lower than the 7-day amount (Hansen and Welborn 1977). 
Further evidence, although indirect, regarding absorption of PCBs after oral exposure in several species
can be found in studies on tissue distribution of these chemicals, which are presented in Section 3.4.2.2.
3.4.1.3 Dermal Exposure
The dermal route of exposure has been recognized as a significant contributor to the accumulation of
PCBs in adipose tissue of workers in the capacitor manufacturing industry (Maroni et al. 1981a, 1981b;
Smith et al. 1982; Wolff 1985).  For example, it was reported that the concentration of PCBs in wipe
samples from the face and hands of two employees at a private utility company varied from 0.05 to
5 µg/cm2 (Smith et al. 1982).  Assuming 100% dermal absorption into the main body reservoir (10 kg
adipose), Wolff  (1985) estimated that the figure of 5 µg/cm2 would represent 0.2–20% of a 50-µg/g
adipose level, which is commonly seen among capacitor workers.  
In addition to contributing to exposure in occupational settings, the dermal route, through skin contact
with contaminated water or soil, represents a potential route of exposure to PCB mixtures for populations
in the vicinity of hazardous waste sites.
Experimental data on the percutaneous absorption of PCBs in humans is limited to in vitro studies
thatused human cadaver skin (Wester et al. 1990, 1993).  These studies utilized 14C-labeled Aroclor 1242
and 1254 (mixtures containing 42 or 54% chlorine by mass) in soil, mineral oil, and water.  Over a
24-hour period, 2.6, 10, and 43% of the dose was retained in human skin when the Aroclor 1242 was
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formulated in soil, mineral oil, or water, respectively.  Similar results were observed with Aroclor 1254,
with 1.6, 6.4, and 44.3% of the dose retained in human skin, following PCB exposure in a soil, mineral
oil, or water vehicle, respectively.  The in vitro data indicate that PCBs readily enter human skin and are
available for systemic absorption, and that the dosing vehicle has a major role in regulating the relative
retention of PCBs in human skin. 
In a related study, Wester et al. (1990, 1993) assessed the in vivo percutaneous absorption of PCBs in
adult female Rhesus monkeys.  14C-Labeled Aroclor 1242 and 1254 were separately administered iv and
topically to Rhesus monkeys and urinary and fecal excretion of radioactivity was measured for the next
30 days.  Following iv administration, the 30-day cumulative excretion was 55% of the administered dose
(39% urine, 16% feces) for Aroclor 1242 and 27% (7% urine, 20% feces) for Aroclor 1254.  The
percentage of the dose absorbed following topical administration to abdominal skin (after light clipping of
hair) was estimated from the ratio of the total urinary and fecal excretion following topical and iv
administration. Topical administration of Aroclor 1242 in soil, mineral oil, trichlorobenzene, or acetone
resulted in 14, 20, 18, and 21% absorption of the administered dose, respectively.   In contrast to the
above in vitro results with human skin, the vehicle had little effect on the systemic absorption of the PCBs
applied to the skin of monkeys.  This may be due to the uncertain viability of the human skin used in the
in vitro studies and the fact that the in vitro study primarily assessed retention of PCBs in human skin and
could not estimate systemic absorption.
The effectiveness of methods for decontaminating or removing Aroclor 1242 from Rhesus monkey skin
was also investigated by Wester et al. (1990).  Use of soap and water was similar in effectiveness to
washing with trichlorobenzene, mineral oil, or ethanol.  At 15 minutes following dermal exposure, 93%
of the applied dose was removed from skin by washing with soap and water.  At 24 hours following
dermal exposure, only 26% of the dose was removed from skin by washing with soap and water,
suggesting that with time, most of the PCB dose undergoes systemic absorption and/or retention in the
skin.  Thus, washing with soap and water is an effective method for removing PCBs from skin,
particularly when washing immediately following a known dermal exposure.   
Dermal absorption of PCBs has been measured in monkeys and guinea pigs by comparing excretion
following topical administration to excretion following parenteral administration.  Single doses of
14C-labeled PCBs (42% chlorine content) in benzene/hexane were applied to the abdominal skin of four
Rhesus monkeys and to the lightly clipped skin behind the ear of three guinea pigs (Wester et al. 1983). 
To an additional group of three guinea pigs, PCB with 54% chlorine content was applied.  The
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application amount ranged between 4.1 and 19.3 µg/cm2 skin.  The application sites were washed with
water and acetone after 24 hours, and radioactivity was monitored in the urine for several weeks
postdosing.  Absorption efficiency ranged from .15 to 34% of the applied radioactivity in the monkeys
and averaged .33% (42% chlorine) and 56% (54% chlorine) of the applied radioactivity in the guinea
pigs.  Washing the skin immediately after PCB application removed 59% of the applied dose.  However,
only 1% of the applied label from the PCB containing 42% chlorine and 20% of the label from the PCB
containing 54% chlorine could be recovered from the application site when the skin was washed 24 hours
after dosing.  Dermal absorption of PCBs (48% chlorine) has also been demonstrated in rats (Nishizumi
1976); however, quantitative data were not provided.
Dermal penetration rate constants have been measured in male Fischer 344 rats after single 0.4 mg/kg
dermal doses of 14C mono-, di-, tetra-, and hexachlorobiphenyls applied for 48 hours to shaved back skin
(Garner and Matthews 1998).  Congeners used were 4-chlorobiphenyl (PCB 3), 4,4’-dichlorobiphenyl
(PCB 15), 2,2’,4,4’-tetraCB (PCB 47), and 2,2’,4,4’,6,6’-hexaCB (PCB 155).  Penetration rate and degree
of penetration (defined as penetration through the stratum corneum into the viable epidermis) were
inversely related to degree of chlorination.  Rate constants for penetration were 0.14, 0.074, 0.028, and
0.0058 hour-1 for the mono-, di-, tetra-, and hexachlorinated forms, respectively.  Rate constants
correlated strongly with the logarithm of the octanol-water partition coefficient.  Jackson et al. (1993) also
reported a strong inverse correlation between octanol-water partition coefficient estimates and the dermal
absorption of several halogenated aromatic hydrocarbons, including 3,3',4,4'-tetraCB (PCB 77). 
Cumulative penetration at 48 hours was near 100% for the mono-, 95% for the di-, 75% for the tetra-, and
30% for the hexachlorinated forms.  Absorption of the tetra- and hexachlorinated forms continued after
washing the site with acetone at 48 hours, indicating that the viable epidermis served as a reservoir for
these higher chlorinated forms.  The rate of systemic absorption of radioactivity was kinetically complex
and not a first-order process like penetration into the skin.  This may be due to metabolism and
partitioning within the skin. 
The dermal absorption of 14C-3,3',4,4'-tetraCB (PCB 77) and 2,2',4,4',5,5'-tetraCB (PCB 153) in female
F344 rats was assessed under conditions where the PCB was applied as either a solid, aqueous paste,
aqueous suspension, or dissolved in ethanol (Hughes et al. 1992).  The chemicals were applied to the
clipped mid-dorsal region of the rat.  The treatment area was then occluded, and urine and feces were
collected and analyzed for radioactivity.  At 24-hours postexposure, the treatment area was washed with
soap and water, recovering 61–91% of PCB 77 and 81–92% of PCB 153.  The percentage of the dose
absorbed ranged from 6 to 8% for PCB 77 and from 5 to 8% for PCB 153, while the treated skin retained
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from 3 to 31% of the PCB 77 and from 3 to 12% of the PCB 153.  Although significantly greater
absorption of PCB 153 was observed when administered as a solid, compared to using the ethanol
vehicle, the remainder of the results indicate that the dermal absorption of PCBs 77 and 153 was similar
even when the PCBs were applied in four different physical forms.   
3.4.2 Distribution
Quantitative data regarding distribution of PCBs to specific organs or tissues of humans after route-
specific exposure were not located.  However, relevant information regarding the distribution of PCBs in
humans following environmental, dietary, and/or occupational exposures are presented below. 
Data regarding distribution of PCBs in human tissues and body fluids are derived mainly from the study
of populations exposed in occupational settings or from those who have consumed contaminated food.  It
is generally agreed that the inhalation and dermal routes are the main exposure routes to PCBs in
occupational settings (Wolff 1985).  For the general population, the oral route is the major route for PCB
exposure (Humphrey 1983).
In humans, PCBs are found in highest concentration in adipose tissue.  Due to its high fat content, human
milk can accumulate a large amount of PCBs, which can then transferred to children through breast-
feeding (Ando et al. 1985; Jacobson et al. 1984b; McLachlan 1993).  The PCB congener composition in
milk differs from that of the commercially produced PCB formulations (Safe et al. 1985b) (see
Section 3.8.1).  Offspring can be also exposed to PCBs through transplacental transfer.  In a sample of
313 women and their newborn infants, placental passage of PCBs was evidenced by a significant maternal
to cord serum correlation (Jacobson et al. 1984b).  Additional information on the prenatal and postnatal
exposure to PCBs are included in Section 3.7.
Average measured concentrations of 0.5–4 ppm total PCBs have been reported for human milk fat,
<5 ppb for blood plasma, and 0.5–10 ppm for adipose tissue (Jensen 1987).  However, as pointed out by
Jensen (1987), due to the heterogeneity of the study populations, the differences in sampling, and the
analytical techniques used, the PCB levels reported by different studies may not be comparable.  The
levels of several di-ortho-substituted congeners in human milk (on a lipid basis) ranged from not detected
to >300 ppb (Schecter et al. 1994).  For comparable exposure levels, PCB levels in plasma and adipose
tissue are generally higher in males than in females (Jensen 1987; Wolff et al. 1982a).  PCBs have also
been detected in ovarian follicular fluid in concentrations ranging from 0.5 to 24.2 µg/kg, in sperm fluid
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ranging from 1.8 to 58.6 µg/kg (Schlebusch et al. 1989), and in bone marrow ranging from 2 to 4 mg/kg
based on dry lipid weight (Scheele et al. 1994).  Analytical techniques for determining PCBs in biological
materials are presented in Chapter 7.
The major components in plasma and adipose tissue (subcutaneous) of occupationally exposed
individuals were PCB congeners with chlorine atoms in the 4 and 4N positions (Wolff et al. 1982b, 1992),
whereas PCBs with unsubstituted 3,4 positions on at least one ring were observed at lower concentrations. 
On a wet weight basis, the adipose/plasma partition ratio for Aroclor 1248 residues was 185/1; the
partition ratio for Aroclor 1254 residues was 190/1.  In a study of 173 workers of the same population,
adipose/plasma partition ratios of 210/1, 190/1, and 200/1 were determined for residues of Aroclors 1242,
1254, and 1260, respectively (Brown and Lawton 1984).  The partition ratios were significantly
dependent on the levels of lipids in the serum, but not on albumin content.  A 1989 study determined the
concentration of individual PCB congeners in both serum and adipose tissue of 35 currently exposed
workers, 17 former workers, and 56 control individuals who were never occupationally exposed to PCB
mixtures (Fait et al. 1989).  Among all exposure categories, the homolog groups present in the highest
concentrations were the hexa- and heptachlorobiphenyls, both in sera and adipose tissue, as expected
from the highly chlorinated Aroclor 1260.  Mono-, di-, tri-, and nonachlorobiphenyls were found at very
low levels in adipose tissue, as expected, and no differences were observed among the exposure
categories.  Currently exposed workers had significantly higher levels of penta-, hepta-, and
octachlorobiphenyls than those in both formerly exposed and control groups.  The concentration of
tetrachlorobiphenyls was significantly higher among currently exposed individuals than among the other
groups.  No significant differences were seen in serum for tetra- and nonachlorobiphenyls.  Mono-, tri-,
penta-, hexa-, hepta-, and octachlorobiphenyls were found at significantly higher concentrations
(p<0.0167) in currently exposed workers than in comparison groups.  Hepta- and octa-concentrations
were significantly higher (p<0.0167) in serum of formerly exposed subjects than in the serum of the other
comparison groups.  The relative distribution of individual congeners was similar in the three groups, but
the amounts varied.  The seven major peaks in serum and adipose tissue were mainly penta-, hexa-,
hepta-, and octachlorobiphenyls.  More standards became available after the study was published and
some congener (but not homolog) identifications were corrected (see Hansen 1999).
Mean PCB concentrations of 5.1, 3.2, and 0.76 mg/kg of extractable fat were determined in samples of
abdominal fat, liver, and brain, respectively, obtained from autopsies performed in Denmark (Kraul and
Karlog 1976).  None of the 82 subjects were occupationally exposed to PCBs.  The PCB values in liver
could be best correlated with those in adipose tissue.  A more recent study described 14 different PCB
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isomers in tissues and organs obtained at autopsy of three individuals in North America (Schecter et al.
1989).  The large differences observed in isomer distribution within a given tissue and between the
various tissues of the donors do not allow generalizations to be made on general population isomer
distribution.  When expressed as the sum of the 14 isomers on a lipid basis, PCB concentrations ranged
from 101–573 ng/g (ppb) of fat in adipose, 89–517 ppb in liver, 30–409 ppb in kidney, 83–354 ppb in
muscle, 80–42 ppb in adrenal (two patients), 131–193 (ppb) in lung (two patients), 102–341 ppb in spleen
(two patients), 103 ppb in bone marrow (one patient), and 102 ppb in testis (one patient).
The existing information regarding distribution of PCBs in humans is limited.  Nevertheless, based on
experimental data obtained in animals (see Section 3.4.2.2) and the known physicochemical properties of
PCBs, it is reasonable to assume that the lipid soluble PCBs, once cleared from the bloodstream, will
accumulate in highest concentration in fatty tissues.  Initially, however, PCBs could accumulate in the
liver due to its high blood perfusion rate.  The availability of PCBs for retention in fatty tissues is
intimately linked to metabolism (see Section 3.4.3); therefore, it would be expected that the higher
chlorinated PCBs would persist for longer periods of time solubilized in fatty tissues.
As with other organisms, PCB residue levels in humans reflects multiple exposure pathways, and
congener-specific elimination.  PCB profiles in human serum immediately following exposures reflect the
profiles in the exposure sources, however, selective metabolism, excretion, and deposition begin to alter
the congener profile within 4–24 hours (Hansen 1999).  Thus, in most cases, the PCB profile in adults
represents a steady state body burden which does not match the profile of commercial PCB formulations
(Aroclors, etc.).  For example, neither the PCB profile of human adipose nor of a composite human milk
sample resemble the pattern of any commercial PCB formulation (Jensen and Sundstrom 1974; Safe et al.
1985).  Abbreviated PCB residue analysis indicates that humans, aquatic mammals, birds, fish and other
biota retain a similar profiles of the 4–6 more dominant PCBs, but more complete analyses demonstrate
unique patterns among the remaining congeners.
Consumption of PCB contaminated freshwater fish is an example of an excess dietary exposure, which
can elevate and/or modify serum PCB profiles.  Non-coplanar, ortho-substituted, PCB congeners were
measured in the serum (collected in 1993–1995) from a group of Lake Michigan residents over 50 years
of age who eat fish (fisheaters) and an age- and region-matched comparison group that did not eat fish
(nonfisheater) (Humphrey et al. 2000).   The same general PCB profile was observed in both groups, with
the fisheaters having a mean total PCB level in serum of 14.26 ng/g (n=101), and the nonfisheaters having
a mean serum level of 4.56 ng/g (n=78).  Four congeners, 138/163 (2,2',3,4,4',5/2,3,3',4',5,6),
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180 (2,2',3,4,4',5,5') and 153 (2,2',4,4',5,5'), accounted for 55–64% of the total PCB load.  Although
90 congener peaks were quantitated, the analysis found that 22 peaks representing 25 PCB congeners
comprised 99% of the total PCBs in both the fisheater and nonfisheater groups.  
Anderson et al. (1998) assessed serum levels of coplanar and noncoplanar  PCBs in 32 anglers that
consumed an average of 49 Great Lakes sportfish meals per year for a mean of 33 years.  Highly
persistent coplanar PCB 126 (3,3',4,4',5) and PCB 169 (3,3'4,4',5,5') were elevated 8- and 5-fold above
the respective levels of these congeners in the control unexposed comparison group from Jacksonville,
Arkansas.  The less persistent coplanar PCB 77 (3,3',4,4') was found at similar levels in the Great Lakes
fish consumer and control groups.  The highly persistent, most abundant  noncoplanar PCB 138 and
PCB 153 were 2- and 3-fold higher in the fish consumers, relative to the respective control group.  Thus,
the long-term consumption of Great Lakes fish results in an increase in the serum levels of persistent
PCBs, and particularly the coplanar PCBs 126 and 169.  In subsequent studies from these investigators,
Falk et al. (1999) found that consumption of lake trout and salmon significantly predicted serum log (total
coplanar PCB) levels, and Hanrahan et al. (1999) found that PCB levels were significantly correlated to
age, body mass index, and sportfish and Great Lakes sportfish consumption histories.  Regression
analysis identified years of consuming sport caught fish as the most robust predictor of serum PCB levels. 
The above PCB residue data in humans and other animals suggests that tissue or body burdens of PCBs
should be based on individual congeners or groups of congeners and not based on profiles of commercial
PCB formulations.  The simplest approach involves using one congener as a marker of total PCBs in a
biological specimen.  Levels of PCB 153 (2,2',4,4',5,5'), a very stable and often the most abundant
congener, have been shown to correlate with the total amount of PCBs in human breast milk (Johansen et
al. 1994) and human plasma, with a correlation coefficient of r=0.99 (Grimvall et al. 1997).  PCB 153 was
highly correlated (r=0.95) with total PCBs in 460 serum samples from Swedish men and women (Atuma
and Aune 1999).  PCB 153 was also highly correlated with total PCBs in serum (r=0.99) and follicular
fluid (r=0.99) (Pauwels et al. 1999).  In addition, PCB 153 levels correlated (r=0.91) with the total PCB-
TEQs in human plasma (Grimvall et al. 1997).  However, if a more complete profile of congeners is
considered, the correlations are lower (Bachour et al. 1998; Hansen 1998, 1999).  Total PCBs or PCB 153
as a marker of the total could be a misleading indicator of the differential exposure to other individual or
groups of congeners of toxicological significance.  
Another important issue related to exposure assessment is whether analysis of PCBs in serum and adipose
tissue provide comparable information on body burden.  Stellman et al. (1998) measured 14 PCB
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congeners in adipose tissue and serum from 293 women with nonoccupational exposure.  The relative
patterns of the 14 PCB congeners were similar to those reported in other human studies.  Significant
positive serum to adipose correlation coefficients were obtained for PCBs 74, 99, 118, 138, 146, 153,
156, 167, 170, 180, 183, and 187, while PCBs 172 and 178 did not reach statistical significance.  Thus,
this study supports the conclusion that either serum or adipose tissue PCB levels may serve as useful
biomarkers of body burden and/or exposure.
Recently, Dewailly et al. (1999) measured the concentration of 14 PCB congeners in subcutaneous fat,
omental fat, brain, and liver from autopsy tissue samples collected from Greenlanders between 1992 and
1994 (Table 3-8).  The PCB body burden of the Inuit population of Greenland is presently among the
highest resulting from environmental exposure.  The levels of PCB 138, 153, and 180 were 19, 21, and
16-fold higher than the respective congeners measured by the same analytical method in Canadians from
Quebec City.  The sum of the three most abundant PCB congeners (138, 153, 180) represents 63–68% of
the total PCBs in the Greenlander tissue samples.  Since PCBs primarily distribute with the tissue lipids,
the tissue PCB concentrations were expressed relative to the lipid content (ng/g lipid) of each tissue. 
Mean lipid contents were 62% in subcutaneous fat, 59.6% in omental fat, 8.3% in brain, and 4.5% in
liver.  Table 3-8 summarizes the mean concentration (µg/kg lipid) for the 14 PCBs in the four tissues. 
PCB concentrations (lipid basis) were similar in omental fat and subcutaneous abdominal fat, while the
hepatic concentrations were generally about 20% lower than fat.  PCB levels in brain (lipid basis) were
about 10–20% of the levels found in subcutaneous fat.  The lower concentration in brain cannot be
explained by the presence of the blood-brain barrier because PCBs are highly lipophilic and are therefore
expected to freely diffuse across this barrier.  The difference in accumulation may be due to the nature of
more polar brain lipids, which are mainly phospholipids.  PCBs may partition to a greater extent into the
triglycerides found in adipose tissue.
In support of the above observations, Weistrand and Noren (1998) found that the concentration of PCB
congeners (ng/g lipid basis) were similar in paired human intra-abdominal adipose tissue and liver 
autopsy samples from seven Swedish subjects.  The ratio of the sum of PCBs in liver to that in adipose
tissue ranged from 0.8 to 1.0 (median 0.8), which was very similar to that reported in more highly
exposed human samples from Greenland (Dewailly et al. 1999).
The concentration of PCBs (ng/g lipid) was measured in brain, liver, muscle, and lung tissue from








Table 3-8.  Mean PCB Concentrations (Microgram Per Kilogram Lipid Basis) 














28 10 (0.2–185) 100 8 (2.3–156) 96 2.4 (0.5–33) 41 4 (0.5–79) 57
52 10 (2–150) 100 13 (1.9–200) 100 1.8 (0.3–19) 29 8c (0.5–92) 65
99 238 (32–857) 100 215 (33–620) 100 31 (15–74) 100 154 (21–486) 100
101 26 (7–100) 100 18 (4–90) 100 8 (2–24) 94 19 (3–92) 92
105 47 (10–152) 100 50 (7–140) 100 3 (0.5–29) 53 18 (0.9–124) 77
118 257 (41–811) 100 267 (46–764) 100 38 (8–127) 100 209 (32–478) 100
128 9 (0.8–70) 85 3 (0.1–27) 100 1.0 (0.5–2.4) 6 2.1 (0.6–15) 15
138 1,103 (273–3,870) 100 1,098 (190–2,450) 100 134 (34–296) 100 855 (161–2,120) 100
153 1,689 (531–5,580) 100 1,582 (280–3,800) 100 198 (53–397) 100 1,177 (242–3,770) 100
156 173 (57–625) 100 195 (27–497) 100 30 (5–88) 100 143 (51–270) 100
170 385 (112–1,550) 100 422 (61–1,100) 100 46 (7–154) 100 327 (105–886) 100
180 1,147 (239–4,420) 100 1,136 (170–3,000) 100 145 (27–378) 100 791 (234–2,310) 100
183 92 (14–413) 100 93 (19–318) 100 10 (0.5–29) 88 69 (11–241) 100
187 499 (113–2,200) 100 507 (99–1,330) 100 82 (14–175) 100 445 (110–1,030) 100
Source: Dewailly et al. 1999
aGeometric mean; in calculating mean values, results not detected were attributed a value equal to half of the detection limit.  
bPercentage of analyzed samples in which the substance was detected.
cMean lipid content of tissues were 62.0% in subcutaneous fat, 59.6% in omental fate, 8.3% in brain, and 4.5% in liver.
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Liver and muscle lipids generally contained similar levels of each of the PCB congeners, while the brain
contained consistently lower levels.  The lung generally had the highest concentration of the lower
chlorinated congeners, including PCBs 28, 31, 49, 52, and 101.  The levels in the lung were greater than
brain and less than muscle or liver for PCBs 138, 153, 156, 170, 180, and 183.  The higher levels of the
lower chlorinated congeners in the lung may be related to the greater volatility and greater direct
pulmonary exposure to these congeners.  It is also possible that PCB binding proteins in the lung
contribute to the enhanced pulmonary disposition of these congeners (Brandt et al. 1981).       
3.4.2.1 Inhalation Exposure
No studies were located regarding distribution in humans following controlled inhalation exposure to
PCBs.  Occupational data are presented in the preceding section.
Information regarding PCB distribution in animals after inhalation exposure is limited.  Rats exposed to
30 g/m3 of an aerosol of a PCB mixture (Pydraul A 200, 42% chlorine) had 52, 14, and 9 µg PCB/g tissue
in the liver, adipose, and brain, respectively, after 30 minutes of exposure (Benthe et al. 1972).  The
concentration of total PCBs attained in the liver after 2 hours of exposure was 70 µg/g.  PCB levels in the
liver reached a maximum 2 hours after exposure and slowly declined to less than half of the maximum
12 hours after exposure.  Analysis of retroperitoneal adipose tissue revealed only trace amounts of PCBs
immediately after exposure; only a slight increase in concentration was detected after 12 hours. 
Maximum concentration in adipose tissue was attained 36 hours after exposure.  In contrast to adipose
tissue, PCBs were detected in the brain immediately after exposure, reached a maximum 24 hours after
exposure, and slowly declined thereafter.
A recent study in ferrets by Apfelbach et al. (1998) reported for the first time that the olfactory system
may be a potentially significant portal for the entry of airborne PCBs.  Ferrets were exposed for 5 years to
low levels of PCBs (total PCBs, 260 ng/m3 air) in the ambient air of an animal care room that had PCB-
containing sealants.  Tetra-chlorinated PCBs dominated the congener profile of ambient air, with PCB 52
being found at the highest concentration.  The PCB congener pattern in the olfactory bulbs resembled that
found in the ambient air, with the less chlorinated, more volatile PCBs (52) being retained at the higher
levels.  In contrast, the congener profile in adipose tissue resembles that of most exposed or unexposed
animals, with PCBs 153, 138, and 180 being the major congeners present.  The olfactory bulbs of the
exposed animals had the highest total PCB concentration (642 ng/g lipids), while the liver, adipose tissue,
and brain had levels of 202, 303, and 170 ng/g lipids, respectively.  The data suggest that inhaled PCBs
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pass into the dentrites of olfactory sensory neurons and are transported via olfactory axons directly to the
bulbs where they accumulate.  While the olfactory system appears to be a significant site for the
disposition of airborne PCBs, further studies are needed to confirm this observation and assess whether
greater disposition in the brain is associated with inhalation exposure.
3.4.2.2 Oral Exposure
Retention of individual PCB components from commercial mixtures depends upon species and organ,
degree of chlorination, and substitution pattern (Hansen 1979, 1987b).  The metabolism of specific PCB
congeners by different species is influenced by existing residues and can result in considerable variations
in metabolite distribution (Hansen 1987b; Safe 1989a) (see Section 3.4.3, Metabolism).  Representative
examples in various animal species are described below.
In adult mice, repeated administration of 100 mg/kg 2,2N,5,5N-tetraCB or 8 mg/kg 3,3N,4,4N-tetraCB
achieved apparent steady-state levels in 8–10 days (Clevenger et al. 1989).  Steady-state concentrations in
adipose tissue were much higher than in liver and thymus.  Liver concentrations increased from steady-
state levels for 2 hours after the final dose before beginning to decline.  The distribution ratio of the
3,3N,4,4N-isomer for adipose tissue was 2-fold higher than that of the 2,2N,5,5N-isomer, and the ratios for
thymus and liver were 3- and 10-fold higher, respectively.  The decline in concentration of both isomers
in the three tissues followed first-order kinetics.  Tissue elimination half-lives for adipose tissue, thymus,
and liver ranged from 1.07 to 2.9 days.  Similar values were reported in mice for six other tetra-
substituted PCBs (Mizutani et al. 1977).  No apparent relationship between a substitution pattern and
biological half-life could be observed.  Preferential accumulation in mice of 3,3N,4,4N-tetraCB in liver and
adipose tissue relative to kidney and lung was also observed (Klasson-Wehler et al. 1989a).  Results from
whole-body autoradiography experiments showed high concentration of radioactivity in adipose tissue of
mice administered 14C-2,3,3N,4,4N-pentaCB (Klasson-Wehler et al. 1993); lower, but significant amounts
were detected in the liver.  No selective tissue retention was observed over a 30-day period that followed
dosing.  Physical exercise has been shown to increase the PCB levels by a factor of 10 in mice livers due
to mobilization of fat deposits from adipose tissue (Kurachi and Mio 1983a).
In monkeys, a single dose of 1.5 or 3.0 g/kg Aroclor 1248 resulted in a dose-dependent liver
concentration of Aroclor 1248 (25 or 53 µg/g) 2 times higher than that found in the kidney (12 or
27 µg/g) and brain (17 or 28 µg/g) 4 days after dosing (Allen et al. 1974b).  This difference was greatly
increased 14 days after treatment due to both a reduction in kidney and brain concentration and an
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increase in liver concentration.  The blood levels of Aroclor 1254 increased rapidly in monkeys during
10 months of treatment (from approximately 1.2 µg/g at time zero to about 100 µg/g in the high-dose
group) with doses between 20 and 80 µg/kg/day (Mes et al. 1989), but this increase leveled off during the
remaining 27 months of treatment.  A dose of 5 µg/kg/day induced only a slight increase in blood PCB
levels during the total treatment period of 37 months.  When the data were expressed as relative
concentration, it appeared that absorption and bioaccumulation were dose-dependent.  However, the
concentration/dose levels were, to some extent, affected by background PCB levels of the control group,
which would have a greater impact on the relative concentrations of the lowest dose groups rather than on
the higher dose groups.
Information regarding distribution of PCB residues in monkeys after long-term feeding of Aroclor 1254 is
available.  In that study (Mes et al. 1995b), female monkeys were dosed with Aroclor 1254 (0.005, 0.02,
0.04, or 0.08 mg/kg/day) for over 6 years.  Throughout the treatment period the monkeys were bred to
untreated males and the resulting offspring were nursed by their mother.  In dams, PCB residues in blood
and tissues (on a lipid basis) increased with dose.  On a wet tissue basis and at all dose levels, adipose
tissue contained the most PCBs (10 times that found in the liver).  At the highest dose, blood had
274 µg/g, followed by the liver (190 µg/g), adipose (171 µg/g), kidney (156 µg/g), and brain (22 µg/g)
based on the lipid content in each tissue.  Monkeys that were sacrificed before termination of treatment
because of poor health had higher PCB levels in their tissues than monkeys killed at termination. 
Following a 7-day total dose of 15 mg/kg Aroclor 1254 to growing pigs, lower chlorinated congeners
reached peripheral fat (dissectable backfat) more rapidly than did higher chlorinated congeners; however,
redistribution (from more central fat) between 35 and 80 days resulted in total estimated amounts of
higher chlorinated congeners (Hansen and Welborn 1977).  Total PCBs in noninvasively determined total
fat were estimated by multiplying body weight times percent body fat times the concentration of PCBs in
backfat.  Long-term declines in fat concentrations for higher chlorinated PCBs were due mainly to
dilution by growth and expansion of the fat compartment. 
Administration of a total dose of .7 mg/kg of PCBs (tetra- and hexachlorobiphenyls) to rats over
#50 weeks resulted in the highest PCB concentration being detected in adipose tissue regardless of the
treatment duration (Hashimoto et al. 1976).  Intermediate concentrations were detected in the skin,
adrenal gland, aorta, and sciatic nerve; all other major organs and tissues had lower PCB concentrations. 
In each tissue, PCBs were preferentially distributed to the lipid fraction.  Similar results were observed in
rats following administration of a single dose of hexachlorobiphenyl followed by a long-term observation
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period (Mühlebach and Bickel 1981).  The highest concentration of chlorinated hydrocarbon residues
24 hours following administration by gavage of a single dose of 1,600 mg/kg Aroclor 1254 or
3,200 mg/kg Aroclor 1260 to female Sherman rats was found in fat tissue, followed by kidney, liver, and
brain; plasma and muscle contained the least (Curley et al. 1971).  Despite the difference in administered
doses, the concentration of residues in tissues, derived from both Aroclors, were comparable.  When male
and female rats were given an oral dose of 73 mg/kg/day Aroclor 1254 for 98 days, fat tissue again had
the highest concentration, followed by muscle and liver (Curley et al. 1971).  No significant differences
were observed between adult male and female rats.
A number of animal studies have demonstrated that PCB mixtures and specific congeners and isomers can
cross the placental barrier and enter the fetus.  High levels of lipid soluble PCBs accumulate in the fat
portion of the milk, also resulting in high exposure of suckling animals.  Significantly increased PCB
residues were detected in blastocytes (day 6 postcoitum) from female rabbits administered Aroclor 1260
before insemination (Seiler et al. 1994), but no residues could be detected in cleavage stage embryos
(day 1 postcoitum).  In pregnant mice fed PCBs through the first 18 days of gestation, the highest levels
of serum PCBs were found in 1–2-week-old offspring compared with 18-day fetuses or with older
offspring (Masuda et al. 1979).  In studies that exposed monkeys prior to and during gestation, signs of
PCB-induced intoxication were observed in suckling offspring, but not in neonates (Allen and Barsotti
1976; Iatropoulus et al. 1978).  PCB blood levels in the offspring continuously increased during lactation,
but decreased just before or immediately upon weaning (Mes et al. 1994, 1995c).  In rats administered
PCBs before gestation, 0.003% of the PCBs accumulated in the dams was transferred to the fetus through
the placenta; however, the amount transferred to sucklings increased to 5% of the maternal PCB (Takagi
et al. 1986).  Similar results have been reported in ferrets administered single doses of PCBs early or late
during gestation (Bleavins et al. 1984).  Results such as these have led to the conclusion that suckling
may account for higher exposure of young offspring than does placental transfer; the fetus, however, may
be more sensitive.
Experiments in monkeys have suggested that fetal tissue may be unable to metabolize and excrete certain
PCB congeners that are more readily metabolized and eliminated by adults and older infants (Barsotti and
Van Miller 1984; Mes et al. 1995b, 1995c). 
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3.4.2.3 Dermal Exposure
No studies were located regarding distribution in humans following dermal exposure to PCBs.  However,
there is no evidence suggesting that distribution is route-dependent.  Because of the lipophilic nature of
these compounds, it would be reasonable to assume that once they are absorbed, PCBs will distribute to
various tissues in proportion to their lipid contents.  However, data from humans at autopsy suggest that
the disposition of PCBs is congener and tissue specific and not based exclusively on the lipid content of
tissues  (Bachour et al. 1998; Dewailly et al. 1999; Schecter et al. 1994).  Data regarding occupational
exposure are discussed in Section 3.4.2.
Total tissue radioactivity has been measured in male Fischer 344 rats after single 0.4 mg/kg dermal doses
of 14C mono-, di-, tetra-, and hexachlorobiphenyls applied for 48 hours to shaved back skin (Garner and
Matthews 1998).  Congeners used were 4-CB, 4,4’-diCB, 2,2’,4,4’-tetraCB, and 2,2’,4,4’,6,6’-hexaCB. 
Peak total radioactivity in the tissues (excised dose site, samples of blood, adipose tissue, muscle, skin
[ears], and the entire liver and kidney) occurred at progressively later times depending on the degree of
chlorination.  For example, the monochlorinated form reached maximal concentrations (37% of the
absorbed dose) in blood and other tissues at 4 hours postadministration and was almost absent (0.2%) at
2 weeks.  In contrast, peak tissue concentrations of the tetrachlorinated form (80% of the absorbed dose)
occurred at 72 hours and approximately 45% remained in the tissues after 2 weeks.  Absorption of the
tetra- and hexachlorinated forms continued after washing the site with acetone at 48 hours, indicating that
the viable epidermis retained these forms and served as a reservoir.  This may be due to partitioning into
lipophilic sites in the skin or adsorption to epithelial proteins.
3.4.2.4 Other Routes of Exposure
In general, the results reported by studies in which PCBs were administered to experimental animals by
parenteral routes are consistent with those derived from oral administration.
In adult rats with a constant adipose tissue mass, 2,2N,4,4N,5,5N-hexaCB (PCB 153) administered
intravenously distributed preferentially to adipose tissue (about 5 µg/g), followed by the skin, lung, and
liver (all about 0.3 µg/g) (Wyss et al. 1986).  Four days after dosing, only adipose tissue, skin, and muscle
contained significant amounts of the PCBs (.75% of the dose).  Between 2 and 4 weeks later, PCB levels
in adipose tissue and skin reached a maximum, corresponding to 68 and 15% of the administered dose,
respectively, which indicates a slow redistribution process of the chemical.  In rats given 3,3N,5,5N-tetra-
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CB intravenously, 20–40% of the administered dose was found in adipose tissue over 42 days; the blood,
liver, muscle, and skin had <20% (Tuey and Matthews 1977).  
In pregnant mice injected intravenously with 14C-labeled 3,3N,4,4N-tetraCB (PCB 77), most of the
radioactivity was localized in the fetus and consisted mainly of a hydroxylated metabolite (Klasson-
Wehler et al. 1989b).  However, after a dose of 3,3N,4,4N,5-pentaCB (PCB 126), no radioactivity was
found in the fetus, except for traces in the liver.  This differential distribution is probably due to
differences in maternal metabolism for the tetra- and pentachlorobiphenyls (see Section 3.4.3,
Metabolism).  
3.4.3 Metabolism
The metabolism of PCBs has been extensively reviewed (Hansen 1999; Hu and Bunce 1999; Safe 1989a,
1993).  Differential accumulation and retention of PCBs is related to exposure and the relative biological
stability (rate of biotransformation) of each congener.  Limited excretion of parent PCBs does occur (see
Table 3-7), but biotransformation is necessary for the majority of PCB excretion.    
The initial step in the biotransformation of PCBs involves CYP enzyme (cytochrome P-450) (CYP1A1,
1A2, and CYP2B1/2B2) mediated oxidation of arene oxides, which readily undergo further metabolism
(Matthews 1982; Preston et al. 1984).  CYPs of the 3A family are also very likely to participate and,
perhaps, are more important than CYPs of the 2B family (see Hansen 1998, 1999).  Coplanar (nonortho)
PCBs are dioxin-like inducers of CYP1A and PCB 77 is preferentially oxidized by these isozymes.  Many
ortho-substituted, nonplanar, PCBs are inducers of CYP 2B isozymes and are also metabolized by these
enzymes (Brown 1994).  Mono-ortho PCBs are often mixed inducers of CYP1A and CYP2B isozymes
(Safe et al. 1985a).  Some congeners induce P-450s from the 3A and 4A families, but the structure-
activity relationships are incomplete (Huang and Gibson 1992; Schuetz et al. 1986).  Arene oxides are
mainly transformed to hydroxylated aromatic compounds but also to sulfur-containing metabolites via the
mercapturic acid pathway (Haraguchi et al. 1999b; Matthews 1982).  Depending on the number and
position of the chlorine-substitutions, one or more arene oxide intermediate may be formed from a given
PCB.  Unsubstituted meta and para carbon atoms are the preferred site for oxidation (Borlakoglu and
Wilkins 1993b).  Hydroxylation of coplanar PCBs usually predominates at the para position in the least
chlorinated phenyl ring, and the rate of metabolism generally decreases with increasing chlorine
substitution (Hu and Bunce 1999).  Nonplanar PCBs are generally hydroxylated at an open meta position. 
The presence of vicinyl hydrogens (adjacent unchlorinated carbons) favors the metabolism of higher
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chlorinated PCBs.  Comparison of the molecular structures of the biologically persistent congeners
reveals different molecular weights, substitution patterns, feasibility to rotate on the phenyl-phenyl bond,
and intramolecular distances determined by nonelectrostatic forces (Borlakoglu and Walker 1989). 
Despite these physicochemical differences, it appears that higher chlorinated PCBs and congeners that
lack unsubstituted meta-para-vicinal positions are better candidates for bioaccumulation.
Information regarding the metabolism of PCBs in humans is limited.  Chromatographic analysis of
adipose tissue samples of volunteers revealed almost 60 individual PCB components (Jensen and
Sundström 1974).  Examination of these results showed that <12 congeners accounted for .80% of the
total PCBs.  For example, 2,2N,4,4N,5,5N-hexaCB (PCB 153) was the congener found in the highest
concentration, whereas 2,2N,4,4N,6,6N-hexaCB (PCB 155) was not detected.  PCB 155 is neither in
commercial PCB mixtures nor in the environment at appreciable levels (Table 4-5).  As PCB 153 is found
in commercial PCB mixtures and in the environment, the presence of this congener in adipose tissue
appears to be related to biologic persistence and/or to metabolism.  The results of in vitro metabolism
with human liver microsomes entirely support the conclusions drawn above.  Human liver microsomes
did not metabolize PCB 153 under various conditions, but did metabolize PCB 136 (Schnellmann et al.
1983).  The major metabolites identified, 2,2N,3,3N,6,6N-hexachloro-4-biphenylol, and
2,2N,3,3N,6,6N-hexachloro-5-biphenylol, suggest that this congener is metabolized through an arene oxide. 
PCB 153 is often the most prevalent PCB detected in humans, due to exposure and the slow rate of
biotransformation of this congener.  More recently, 3-hydroxy-2,4,5,2',4',5'-hexaCB was identified as the
major metabolite of PCB 153 formed by human CYP2B6 (Ariyoshi et al. 1995).  CYP2B6 is
constitutively expressed in humans, but only accounts for a maximum of 1–2% of the total CYPs in
human liver.  Approximately 75% of the subjects examined had no detectable level of CYP2B6 protein
by immunoblotting (Mimura et al. 1993).  This may be the reason why no metabolite of PCB 153 was
detected in an earlier in vitro study using human liver microsomes (Schnellmann et al. 1983).  The in vitro
metabolism of 4,4N-diCB by human liver microsomes produced six metabolites, with 4,4N-dichloro-2-bi-
phenylol being the most abundant (Schnellmann et al. 1984).  These data also suggested that 4,4N-diCB is
metabolized through an arene oxide and that migration of substituents from the site of hydroxylation to
the adjacent carbon atom (NIH shift) occurs (Gardner et al. 1973; Safe et al. 1975).  The major
hydroxylated PCB metabolite in human plasma from unexposed people is 4-hydroxy-
2,2N,3,4N,5,5N,6-heptaCB, originating from either 2,2N,3,4N,5,5N,6-hepta- and/or 2,2N,3,4,4N,5N,6-heptaCB
(Bergman et al. 1994).  All major 1-ortho-PCBs are transformed to 4-hydroxy-chlorobiphenyl
metabolites, retained in plasma or blood.  Changes in residue patterns, including actual increases over
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time, indicating possible dechlorination products were observed by Wolff et al. (1992).  Brown (1994)
further suggested that humans were capable of very slow PCB dechlorination.
Most hydroxylated PCB metabolites are excreted in feces and/or in urine, or are conjugated to glucuronic
acid or sulfate.  However, several hydroxylated PCB metabolites are retained in the body, either due to
their high lipophilicity or reversible binding to proteins.  Although several of the OH-PCBs are present in
rat plasma and seal blood, the spectrum of OH-PCBs is different in human plasma, compared to that in
rats or seals (Bergman et al. 1994).  For example, 4-OH-2,3,5,6,2',4',5'-hepta PCB, the major OH-PCB in
human plasma (Bergman et al. 1994; Sandau et al. 1998), was found in seal blood but was not detected in
rat plasma.  This major metabolite may originate from 2,3,5,6,2',4',5'-heptaCB (PCB 187) and/or
2,3,4,6,2',4',5'-heptaCB (PCB 183), which are present in human milk.  The 4-OH-2,3,5,3',4'-pentachloro-
biphenylol, the major hydroxy PCB metabolite detected in rat plasma, is also a major contributor to
hydroxy-PCBs in seal blood and in human plasma (Bergman et al. 1994).  This metabolite is formed after
a 1,2-shift of a chlorine in the para position in the 2,3,4-trichlorinated phenyl ring of PCB 105.  In
addition to PCB 105 and 118, this metabolite could arise from the PCB 156 3,4- or 4,5-arene oxide with
the loss of a chlorine.  A similar rearrangement is also observed to occur in the 3,4-dichloro-substituted
phenyl rings of PCBs 77, 105, 118, and 156 (Klasson-Wehler et al. 1993).  Thus, all of the major 1-ortho-
PCBs can be biotransformed to 4-OH PCB metabolites that are retained in plasma or blood. 
Hydroxylated PCBs are retained in lung, liver and kidney tissue, which may be explained by the blood
residues in these tissues.  It is important to note that the concentration of the 4-OH metabolite of PCB 105
in rat liver or lung is similar to that of PCB 153, one of the most persistent and abundant PCB congeners.
Persistent 3-OH PCB metabolites have also been identified at lower levels.  In general, the persistent OH-
PCBs have chlorine atoms on the adjacent carbons to the OH-group and contain five or more chlorine
atoms. 
Methylsulfonyl (MeSO2) metabolites of PCBs have been widely detected in the tissues of marine
mammals (Bergman et al. 1994; Letcher et al. 1995) and of humans (Haraguchi et al. 1986; Noren et al.
1996; Weistrand and Noren 1997).  The MeSO2-PCBs are formed via P-450 dependent epoxidation (Safe
1989a, 1989b) and subsequently via the mercapturic acid pathway (Preston et al. 1984).  The most
abundant MeSO2 metabolites in wildlife and humans are originated from 2,2',4,5,5'-pentaCB (PCB 101)
or 2,2',3,4',5',6-hexa (PCB 149) (Bergman et al. 1994; Haraguchi et al. 1992; Noren et al. 1996).  Human
milk in Sweden was analyzed for methylsulfonyl metabolites of PCBs, which decreased from
approximately 9 to 2 ng/g milk lipid from 1972 to 1992 (Noren et al. 1996).  The levels of these
metabolites also correlated with the levels of total PCBs.  The major MeSO2-PCBs in the milk were
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4-MeSO2-2,5,2',3',4'-PCB (87) and 4-MeSO2-2,3,6,2',4',5'-PCB (149).  Methylsulfonyl metabolites of
PCBs were also analyzed in autopsy tissues from seven Swedish individuals (Weistrand and Noren 1997). 
Twenty MeSO2-PCBs were detected in liver and adipose tissues, with 4-MeSO2-2,5,2',3',4'-PCB (87) and
4-MeSO2-2,3,6,2',4',5'- PCB (149) also being found at the highest levels in these tissues.  3-MeSO2
metabolites were detected in adipose tissue, but at lower levels.  However, in the liver, the 3-MeSO2
metabolites were most abundant, with 3-MeSO2-2,2',3',4',5,6-PCB (132) contributing 61–82% of the sum
of all  MeSO2-PCBs in the liver.   The methylsulfonyl metabolite profile in one lung sample was similar
to that observed in adipose tissue, with 4-MeSO2 metabolites dominating the profile.  The ratios of the
sum of all methylsulfonyl metabolites to total PCB levels were 1/250 and 1/28 in adipose tissue and liver,
respectively, calculated for the median values.  Thus, methylsulfonyl metabolites of PCBs are selectively
retained in different human tissues and therefore require further study regarding their biological and/or
toxicological activity.
The metabolism of PCBs in experimental animals has been extensively reviewed (Safe 1980, 1989a;
Sipes and Schnellmann 1987; Sundstrum et al. 1976a, 1976b).  Many substrates have been tested, and the
PCBs were usually administered by the oral or parenteral routes.  In general, these studies showed that the
metabolism rate of PCBs depends on the number and position of chlorine atoms on the phenyl ring and on
the animal species.  In rats, the elimination half-lives of four PCBs with one, two, five, or six chlorines
increased as the number of chlorines increased (Matthews and Anderson 1975).  The decreased excretion
rate with increasing chlorination was directly related to the decreased rate of metabolism of the more
highly chlorinated congeners.  Sheep liver microsomes converted 2,2N,5-triCB to at least 5 more polar
metabolites within 1 minute and at least 10 metabolites by 15 minutes; however, within the homologous
series, 2,2N,5,5N-tetraCB and 2,2N,4,5,5N-pentaCB were oxidized to only 3 metabolites at rates 7- and
14-fold slower, respectively (Hansen 1987b; Hansen et al. 1977).  Not only does the number of chlorines
affect the rate of biotransformation, but the position of the chlorines on the phenyl rings is also critical. 
This was demonstrated in rats, which excreted four symmetrical hexachlorobiphenyls at different rates
depending on the chlorine positions (Kato et al. 1980).  As the number of unsubstituted meta positions or
adjacent unsubstituted carbon atoms increases, the percentage of the dose excreted increases.  The major
hydroxylated PCB metabolite in rat plasma after administration of 25 mg/kg Aroclor 1254 in peanut oil
by gavage is 4-hydroxy-2,3,3N,4N,5-pentaCB.  From days 1 to 14 after exposure, this metabolite is found
at concentrations 7–10 times the concentration of the major PCB 153 (Bergman et al. 1994).
The following generalizations based mostly on data obtained from experimental animals can be made
(Safe 1980):
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1. Hydroxylation is favored at the para position in the least chlorinated phenyl ring unless this site
is sterically hindered (i.e., 3,5-dichloro substitution).
2. In the lower chlorinated biphenyls, the para position of both biphenyl rings and carbon atoms
that are para to the chloro substituent are all readily hydroxylated.
3. The availability of two vicinal (adjacent) unsubstituted carbons atoms (particularly C5 and C4)
also facilitates oxidative metabolism of the PCB substrate, but it is not a necessary requirement
for metabolism.
4. As the degree of chlorination increases on both phenyl rings, the rate of metabolism decreases.
5. The metabolism of specific PCB isomers by different species can result in considerable
variations in metabolite distribution.
The major PCB metabolites are phenolic products; however, sulphur-containing metabolites (Klasson-
Wehler et al. 1987), trans-dihydrodiols (Norback et al. 1976), polyhydroxylated congeners, and methyl
ether derivatives (Koga et al. 1989) have also been identified.  The occurrence of trans-dihydrodiol
metabolites suggests that the metabolism of PCB congeners proceeds through formation of arene oxide
intermediates (Gardner et al. 1973).  Due to their high reactivity, arene oxide intermediates are difficult to
detect.  They hydrate to give trans-dihydrodiols and spontaneously rearrange to phenols with the
concomitant 1,2-migration of substituents from the site of hydroxylation to the adjacent carbon atom
(NIH shift) (Daly et al. 1972).  Arene oxides are potential electrophiles, and have been implicated in
cellular necrosis, mutagenicity, and carcinogenicity (Safe 1989b).  Experimental evidence using P32-
postlabeling supports the hypothesis that lower chlorinated biphenyls are metabolically activated to
electrophilic species which bind to DNA (McLean et al. 1996; Oakley et al. 1996).  The incubation of
2-chloro-, 4-chloro-, 3-chloro-, 3,4-dichloro-, and 3,4,5-trichlorobiphenyl with calf thymus DNA and rat
liver microsomes followed by oxidation with a peroxidase, produced 1–3 major DNA adducts.  The
reactive metabolites may result for arene oxides and/or catechol and p-hydroquinone species, which are
oxidized to semiquinones and/or quinones.  The results raise the possibility that lower chlorinated
biphenyls may be genotoxic and may explain the fact that commercial PCB mixtures are complete rodent
carcinogens.  
The formation of 3-hydroxy-2,2N5,5N-tetraCB as a metabolic product of 2,2N,5,5N-tetraCB suggested that a
nonarene oxide direct hydroxylation mechanism is an alternative metabolic route for some chlorinated
biphenyl congeners (Billings and McMahon 1978; Preston et al. 1983).  Sipes and Schnellmann (1987)
review and confirm additional routes for PCB oxidative metabolism.
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Methylsulphonyl metabolites of PCBs have received considerable attention since these compounds are
possibly etiologically connected to the respiratory toxicity described in Yusho victims (Brandt and
Bergman 1987; Haraguchi et al. 1986).  PCB methyl sulfones are formed as follows:  products of the
reaction between arene oxides and glutathione are degraded and excreted in the bile into the large
intestine where they undergo cleavage by a microbial C-S lyase.  The thiols formed are methylated,
reabsorbed, and further oxidized on the sulfur to the corresponding methyl sulfones, which are distributed
by the blood (Brandt et al. 1985).  The methylsulphonyl-PCBs are initially bound to a uteroglobin-like
protein found in high concentrations in rat and mouse lung cytosol (Lund et al. 1985) of the Clara and
goblet cells.  This protein-sulfone complex is subsequently secreted into the airway lumen and spread
over the surface lining.  It has also been suggested that this complex is transported by the mucociliary
system to the pharynx and swallowed (Brandt and Bergman 1987).  In the gastrointestinal tract, the
complex may be released, reabsorbed, and recirculated to the lung, which could contribute to the long
retention times for methylsulphonyl-PCBs in rodents (Brandt and Bergman 1987).  Methylsulphonyl-
PCBs have also been localized in rodent kidney cortex (Brandt et al. 1985), but the mechanism of
accumulation in the proximal tubules appears to be different than that operating in respiratory airways
since only trace amounts of the lung binding protein are present in rodent kidney (Lund et al. 1985). 
Methylsulphonyl metabolites of PCBs are also retained in the fat of seals (Jensen et al. 1979) and in liver
and muscle of minks (Bergman et al. 1992).
It has also been shown that the 3-MeSO2 metabolites from PCBs with 2,5-chlorine substitution were
selectively retained in the liver of marine mammals (Bergman et al. 1994), whereas the isomeric 4-MeSO2
metabolites were localized in the lung of mice (Bergman et al. 1979; Klasson-Wehler et al. 1996). 
Although the binding mechanism for 3-MeSO2 metabolites is not clear, the binding protein for 4-MeSO2
metabolites has been identified as a uteroglobulin-like protein present in the nonciliated bronchiolar
(Clara) cells of the lung, also referred to as Clara cell secretary protein (CCSP) (Hard et al. 1995; Stripp et
al. 1996).  Exposure to 4-MeSO2-2,2',4',5,5'-PCB demonstrated that CCSP-deficient mice no longer
accumulate this metabolite within lung or kidney tissue (Stripp et al. 1996).  These data demonstrate that
CCSP is the 4-MeSO2-PCB binding protein in mice and suggests that 4-MeSO2-PCBs will accumulate at
sites of CCSP localization, such as the respiratory and reproductive tracts of humans. 
Haraguchi et al. (1999a) recently investigated the tissue distribution of methylsulfonyl metabolites
derived from PCB 101 and 149 in male Wistar rats.  Both congeners are metabolized primarily by
hydroxylation at the 3-position and methylthiolation at the 4-position.  The 3-/4-MeSO2 metabolite ratios
in liver and adipose tissue for both congeners were 0.41–0.61 at day 4, increasing to 0.85–1.00 for up to
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42 days.  In contrast, the ratios in lung were 0.03–0.04, and then decreased to 0.01 at 42 days.  The ratio
of metabolite to parent compound in tissues provides an estimate of the relative persistence or abundance
of the methylsulfonyl metabolites.  In the liver, the ratio of 3-MeSO2 to PCB 101 was 0.46 and the ratio
of 3-MeSO2 to PCB 149 was 0.21.  4-MeSO2 metabolites were highly retained in the lung, with
metabolite to parent compound ratios of 9.5 and 4.0 for PCBs 101 and 149, respectively.   
Persistent MeSO2-PCBs also have been reported to induce hepatic P-450s in rats.  3-MeSO2-PCBs
identified in mammals were strong phenobarbital type inducers of CYP2B protiens, while the 4-MeSO2
metabolites were inactive (Kato et al. 1995, 1997).  Specifically, the inducing ability of 3-MeSO2-
PCB 101 was more than 500 times greater than the parent PCB101.
A summary of the structures of PCB metabolites that have been identified using various substrates and
biosystems is presented in Figure 3-3.
3.4.4 Elimination and Excretion
3.4.4.1 Inhalation Exposure
No studies were located regarding excretion in humans or animals following controlled inhalation
exposure to PCBs.  However, there is no reason to believe that once absorbed by inhalation, the excretion
pattern of PCBs will differ from that observed after oral absorption.  Much greater amounts of PCBs are
excreted in the feces than in the urine following oral absorption.
3.4.4.2 Oral Exposure
Human Studies.  Estimates for the half-lives for elimination of PCBs from humans have been based on
body burden measurements at two or more time points form the same individual.  A simple mass balance
approach is commonly employed to characterize the elimination of PCBs from humans.  In general, a
simplified single compartment model is used where only intake and first order elimination are assumed to
occur.  In most cases, the intake is assumed to be negligible and the following equation is used to estimate
k, the first order loss or rate constant (day -1), where Co and Ct are the initial and final tissue
concentrations, respectively, and t is the time between sampling.
         (1)Ct ' C0@e
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Figure 3-3.  Metabolic Pathways for Polychlorinated Biphenyls 
Source: Safe 1984
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This relationship assumes that the mass of the adipose tissue compartment and daily intake remaining
constant over the observed time period and that daily intake is negligible.  If these conditions are not met
or are unknown, the k in the above equation represents an apparent rate constant (k’).  The apparent half-
life from the above equation can then be expressed as follows:





Equation (2) was used to calculate apparent half-lives when human body burden data, such as blood,
serum, plasma, or adipose tissue concentrations of PCBs are available at two or more time points.
It is often useful for the purposes of risk assessment to estimate the daily intake of PCBs needed to
maintain a steady state body burden or tissue level of PCBs.  The daily intake, I, required to produce a
steady state body burden of C@Mfat is as follows:
       (3a)I ' k @ (C@M)fat
      (3b)I ' ln2
t1/2
@ (C@M)fat
Tables 3-9 and 3-10 summarize data from multiple studies on the apparent half-lives (years) of PCB
congeners and PCB mixtures in humans.  Although analysis of human blood, serum, plasma, adipose
tissue, or other tissues does not match the specific profile of commercially produced PCB mixtures
(Aroclors, etc.), the studies in Table 3-10 did not use congener specific analysis and estimated apparent
half lives for PCB profiles with varying degrees of chlorination.  Most of the studies cited in Table 3-9
utilized congener specific analysis; however, this was not the case for several studies.  The studies report
apparent half-life estimates as low as 0.02 years and as long as infinity, with no apparent loss in body
burden despite removal of a known source of exposure.  Thus, it is important to evaluate the variability
between studies and use caution in interpreting results from a given study.  Absolute values for PCB
congeners and mixtures must also be interpreted with caution, since methods for analysis have improved
in recent years.  However, even with high resolution gas chromatography and electron capture detection
(congener specific analysis), a given peak may represent more than one chemical (see Table 3-9). 
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Extensive sample preparation followed by gas chromatography/mass spectrometry (GC/MS) analysis is
necessary to validate that a given peak is a PCB.  This is the method of choice for the quantitation of very
low levels of coplanar PCBs.  However, for comparison of half-life estimates, it is not necessary to
compare absolute PCB concentrations in different studies.  Half-life estimates for a given study do depend
on a consistent analytical method used to quantify PCB levels in biological samples obtained at two or
more time points.  The studies cited in Tables 3-9 and 3-10 are often limited by small sample size, short
sampling intervals, and low initial body burdens.
Half-life estimates of less than one year have been reported by several studies in Tables 3-9 and 3-10. 
Buhler (1989) reported elimination in a single volunteer that ingested a single dose of a uniformly
13C-labeled PCB mixture similar to Aroclor 1254 (329 µg/kg).  Blood samples were taken during a
260 day period and analyzed for the concentration of 13C- and 12C-PCB using GC/electron capture
detection (ECD) and GC/MS.  Elimination of congeners followed first order kinetics and resulted in half
lives of <1 year in this individual.  These short apparent half-life estimates may be measuring a 
redistribution of the PCBs among body compartments during this relatively short sampling time rather
than actual elimination from the body.  Luotamo et al. (1991) estimated very short apparent PCB half-
lives of 0.02–0.13 years in 12 individuals involved in a capacitor accident at a pulp mill.  Apparent half-
life estimates were based on blood and adipose tissue taken 1 and 30 days following the accident.  Since
the first sample was taken only 1 day following the accident, it is likely that equilibrium had not yet been
reached and that absorption and/or distribution of the PCB exposure/dose was still occurring at that early
time point.  The sampling interval (29 days) was also very short in this study, particularly for highly
persistent PCB congeners.  These limitations must be considered in interpreting the half-life data from
this study, which is much shorter than other studies.  
Wolff and Schecter (1991) investigated an accident where four children (2–6 years of age) were exposed
to PCBs while playing with parts of a capacitor.  The excess exposure resulted in a serum PCB
concentration of lower chlorinated congeners, similar to Aroclor 1242, that was about 4-fold above the
reference group.  Half-life estimates in Table 3-9 were based on serum samples obtained on 1–4 children
at 5 and/or 11 months following the accident.  Packed column GC of the serum samples resulted in
detected peaks that often contained more than one PCB congener.  Infinite half-lives were reported for
seven congeners in Table 3-9, based on the fact that the levels of these congeners did not decline over
time.  One explanation for this observation was that the accidental exposure did not markedly increase the
levels of these congeners, which appear to be at steady state.  Furthermore, there was no correction for the

















































28 1.4 0.05 0.12 0.5i 4.8 3.0
33 0.02 0.02
52 0.3j 5.5k
47 0.2 0.3j 5.5k
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118 5.8 0.3–0.8p 0.83 0.77 1.2 9.6

































153 12.4 0.93 47 26 4 3.8 4q 27.5
105 3.9 0.58 0.51 4q
138 6–7 0.88 32 20 3.4 16.7 16.3
163 >20
183 0.13 7.9r
128 5.2 5.4 7.9r
171 0.08 24
156 4 4 4.0
180 0.34 4 4 4.3 9.9
169 10.4
170 47 71 3.9
n 39 1 17s 7s 12 12 1, 3 1–4 18–165 8
Datat Geomean nr Median Median Mean Mean Median Mean Geomean Mean
Source: Modified from Shirai and Kissel (1996)
aRecalculated using median concentration ratios
bFirst and second samples
cFirst and third samples
dSerum
eAdipose
fHalf-life of congener 169 was not recalculated
due to inadequate data.
gDoes not include adjustment for growth











sFor congener 105, the
n's were 14 and 6
tMean = arithmetic mean;
geomean = geometric






































300/500 >15 0.67 7.1, 2.8d
Aroclors
1242 2.6 2.0 1.8 0.9, 4e
1248 8.6
1254 4.8 3.3 65
1260 27.6 4.1 1.2, 0.5e
n 12 20, 14 58 5 148, 148, 121 4–5 18–165 1 8, 18
Dataf nr Mean Median Median Geomean Mean Geomean Mean Mean
Source: Modified from Shirai and Kissel (1996)
aRecalculated using median concentration ratio
bNot adjusted for growth rate
cBased on a 46- month interval
dMothers and children, respectively
eDirect and indirect exposure groups, respectively
fMean = arithmetic mean; geomean = geometric mean; nr = not reported
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reported congeners had apparent half-lives of 0.3–0.5 years, and due to lack of chromatographic
resolution, represent at least eight PCB congeners.  Thus, there are serious limitations of the apparent
half-life estimates from the congener data of Wolff and Schecter (1991) (Table 3-9).  Apparent half-life
estimates for PCB mixtures (Aroclor 1242 and 1260) are presented in Table 3-10 for these four children
and five adults and teenagers that had an opportunity for indirect exposure, since they lived in the same
households as the children (Wolff and Schecter 1991).  Half-lives of 0.9 and 1.2 years were reported in
the children for lower and higher chlorinated congeners, respectively.  The PCB levels in the five
teenagers and adults were not different from unexposed individuals, and were likely to be at steady state. 
Thus, although apparent half-lives were reported for the five teenagers and adults, the lack of excess
exposure in this group makes half-life estimates of limited value. 
Chen et al. (1982) measured blood PCB levels in 17 subjects from Taiwan that consumed PCB
contaminated rice-bran oil in March and April of 1979 (Yu-Cheng episode).  Blood was sampled for PCB
analysis in 1980 and 1981.   The authors estimated apparent half-lives of 0.83 and 0.58 years for PCB 118
and 105, respectively.  The authors stated that half-lives of other congeners in blood were not calculated
because they were either too long or too short to calculate or because the concentrations of these PCBs in
blood were too small to accurately measure.  Shirai and Kissel (1996) estimated the apparent half-lives
for the other congeners reported by Chen et al. (1982), which ranged from 5.2 years to infinity.  PCB
exposures in this study were relatively low (0.7–4.7 ppb initially) and thus, the long half-lives may reflect
near steady state conditions over this relatively short sampling period and, should be interpreted
cautiously.
Wolff et al. (1992) estimated the apparent half-lives of PCBs in up to 165 capacitor manufacturing
workers with initial serum total PCB levels of 1.2–24 ppb.  Blood samples were taken in March of 1976
and in December of 1979 and the serum PCB levels were measured by packed column GC, which often
results in two or more PCBs co-eluting in the same peak.  Apparent half-lives in Table 3-9 range from
1.2 years to infinity.  One explanation for the longer half-lives of certain congeners is that excess
exposure to PCBs occurred in some individuals during the interval between 1976 and 1979.  Excess
occupational exposure could have occurred from 1976 to 1977, when all PCB use stopped.  Although
PCBs may not have been in use in the manufacturing facilities from 1977 to 1979, residual contamination
at and around the work site could have contributed to additional occupational exposure.  Secondary
exposures from nonoccupational sources such as high fish consumption rates, and/or exposure in homes
may also impact on loss rates.  The  apparent half-life estimates in Table 3-9 do not consider excess
exposure to PCBs during the sampling interval and thus may be an over estimate of the relative
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persistence of particularly the congeners with half-lives in excess of 10 years.  The above factors also
contribute to the long apparent half-lives reported by Wolff et al. (1992) for the low and particularly the
highly chlorinated PCBs (Table 3-10).
Brown et al. (1989) investigated a subgroup of 39 individuals, originally from the study of Lawton et al.
(1985a, 1985b), who had occupational exposure to PCBs from two capacitor plants. Inhalation and
dermal contact were considered the main routes of occupational exposure.  PCBs were measured in serum
from blood samples obtained in 1976 and 1983.  Apparent half-lives ranged from 1.4 years for PCB 28 to
>20 years for PCB 163.  Once again, excess occupational exposure to PCBs was possible over the
sampling period, particularly from 1976 to 1977, which would increase the apparent half-life estimates. 
However, strengths of the study include the 7-year sampling period and the 39 subjects.  Brown et al.
(1989) made an interesting comparison between this population and that reported for a Taiwan population
(Yu-Cheng) which was accidentally exposed via ingestion of contaminated rice oil (Chen et al. 1982).  It
was found that the mono-ortho congeners (PCBs 74, 118, 105) were cleared 3–7 times faster in the
Yu-Cheng population than the capacitor workers, while the di-ortho congeners (PCBs 99, 153, 138) were
eliminated 3–7 times more slowly in the Yu-Cheng population.  Brown et al. (1989) speculated that these
differences may have been related to alterations in the cytochrome P-450 mediated metabolism of PCBs
in the Yu-Cheng population that was exposed to PCBs and PCDFs.  Specifically, they speculated that
PCDF exposure in the Yu-Cheng population may have produced an increase in CYP1A and depression of
CYP2 forms.
Ryan et al. (1993) estimated the apparent half-lives of the seven most abundant PCBs in three individuals
who ingested PCB contaminated rice oil in Taiwan (Yu-Cheng) in 1979.  Blood samples were obtained
171, 425, 1,049, 2,025, and 3,502 days following the first sampling in May of 1980.  Total PCBs levels in
1980 ranged from 150 to 400 ppb and 9 years later, decreased to about 30–35 ppb.  PCB 180 was the
most persistent, with apparent half-lives ranging from 3.7 to 5.7 years (median of 4.3 years).  PCB 118
was the least persistent of the measured congeners, with apparent half-lives ranging from 1.1 to 1.3 years
(median of 1.2 years).  The apparent half-life for total PCBs ranged from 3.2 to 4.6 years (median of
3.5 years).   This study was not limited by short sampling intervals, low initial body burdens, or the
method for PCB analysis.  Although the results were obtained from only three subjects, this study
provides a good estimate of the apparent half-lives of the most abundant PCB congeners in humans
(Table 3-9).  Half-lives may still have been extended from ambient exposures, though.
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Yakushiji et al. (1984) studied PCB elimination over a 3-year period in eight Japanese women
occupationally exposed to Kanechlor 300 (similar to Aroclor 1242).  Apparent half-lives for this mixture
of 7.1 and 2.8 years were reported for these eight women and their children (1–13 years of age),
respectively (Table 3-10).  Initial whole blood mean PCB concentrations were 42 and 30 ppb for the
women and children, respectively.  The shorter half-life in children may be related to growth over the
3-year sampling period and subsequent dilution of PCB blood levels with increasing mass.  Apparent
half-lives for four PCB congeners in the eight occupationally-exposed women were also reported in
Table 3-9. 
In 1977 and 1985, serum PCB concentrations were determined for 58 workers in a factory that used PCBs
in capacitor manufacturing until 1977 (Phillips et al. 1989a).  This study expanded upon the earlier
investigation in five members of this cohort (Steele et al. 1986).  Less chlorinated PCBs were quantitated
as Aroclor 1242, and more highly chlorinated congeners were quantitated as Aroclor 1254.  The workers
had excess occupational exposure, as documented by serum PCB levels of 2–3,300 and 5–250 ppb in
1977 for Aroclors 1242 and 1254, respectively.  Median apparent half-lives of 2.6 and 4.8 years for
Aroclors 1242 and 1254, respectively (Table 3-10).  The half-lives of the respective mixtures in each
individual varied inversely with the initial (1977) serum concentrations, with more rapid elimination
occurring at higher PCB levels.  This relationship may be a result of continued low level PCB exposure,
variations in the time of exposure, and/or cytochrome P-450 induction, with the resulting increase in PCB
metabolism and elimination at high initial PCB body burdens.  Strengths of the study by Phillips et al.
(1989a) are the population size (n=58) and the 8-year sampling interval.  The study was limited by not
providing congener specific analysis.
Taylor and Lawrence (1992) reported apparent half-lives in another occupational cohort, where serum
PCB levels were available from 1979 and 1983 on 148 workers for Aroclors 1242 and 1254, and
121 workers for Aroclor 1260.  The range of concentrations in serum in 1979 were 0–3,133, 4–639, and
4–377 ppb for Aroclors 1242, 1254, and 1260, respectively.  The apparent half-lives in this study
(Table 3-10) were similar to those reported by Phillips et al. (1989a) for another occupationally exposed
group.   As in the earlier report by Phillips et al. (1989), this study observed more rapid elimination of
PCBs in individuals with higher initial (Phillips et al. 1979) serum PCB levels.  Again, this relationship
may be a result of continued low level PCB exposure, variations in the time of exposure, and/or
cytochrome P-450 induction, with the resulting increase in PCB metabolism and elimination at high
initial PCB body burdens.  
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In summary, the studies by Phillips et al. (1989a) and Taylor and Lawrence (1992) on apparent half-lives
of PCB mixtures (Table 3-10) are in general agreement.  These are well designed studies in two different
occupational cohorts that are not limited by small sample size, short sampling intervals, or low initial
body burdens.  The main limitation of these studies was that congener specific PCB analysis was not
conducted.  Nevertheless, these studies provide the best estimates of the apparent half-lives of PCB
mixtures following occupational exposure.  
Animal Studies.  In experimental animals, the major PCB excretion pathways were the fecal and urinary
routes (Lutz and Dedrick 1987; Sipes and Schnellmann 1987), although trace amounts were reported in
expired air of rats 24 hours after gavage administration of hexa- and tetrachlorobiphenyl (Hashimoto et al.
1976).  Biliary excretion represents a major source of the PCB compounds found in the feces (Allen et al.
1974b; Norback et al. 1976).  Significant amounts of PCBs can also be eliminated through lactation (see
Section 3.7, Children’s Susceptibility).  At equilibrium, chlorobiphenyl congeners are eliminated from
tissues according to individual kinetic parameters.  For example, rats that received six weekly doses of
PCBs showed three general patterns of elimination (Tanabe et al. 1981).  One group of compounds,
primarily di- and trichlorobiphenyls, had elimination half-lives of 1–2 days; a second group, primarily
tetrachlorobiphenyls, had two elimination constants:  one between 2 and 10 days and a second one of
#90 days.  A third group, composed mostly of penta- and hexachlorobiphenyls, had single elimination
half-lives of >90 days.  Thus, highly chlorinated PCBs are preferentially retained, probably because of a
lower metabolism rate.
A 2-phase elimination process was also described in monkeys fed 2,4N,5-triCB for 84 days.  When dosing
was discontinued, the initial rapid phase had a whole body elimination half-life of 30–32 hours and was
followed by a slower process, with a combined urinary and fecal excretion half-life of 4.5–4.8 days (Felt
et al. 1977).
Elimination half-lives from blood between 0.3 and 7.6 years were estimated for a group of mono-ortho-
chlorine-substituted PCB congeners in monkeys dosed with Aroclor 1254 for over 6 years (Mes et al.
1995a).  In these monkeys, steady-state in adipose tissue had apparently been achieved after 37 months of
dosing.  Half-lives were estimated from blood measurements every 2 weeks after treatment ceased and
monthly during the subsequent 2 years.  The half-lives did not seem to be dose-dependent over the dose
range tested (0.005, 0.02, 0.04, or 0.08 mg/kg/day).  The wide range estimates were probably due to the
small sample size (n=3) and the great degree of variation among the individual monkeys.
3.  HEALTH EFFECTS - Toxicokinetics
PCBs 333
The very long half-lives of some PCBs introduces a dilution-by-growth variable that must be considered
in making comparisons.  Weanling pigs were given seven daily oral doses of one of three single-congener
PCBs, or Aroclor 1254 for a total of 15 mg/kg (Hansen and Welborn 1977).  Blood and biopsied backfat
were monitored for up to 118 days, and the increase in total body fat was determined.  If elimination was
based on concentration in the backfat, half-lives of 24, 24, 63, and 42 days were determined for the three
single congeners and Aroclor 1254, respectively.  Half-lives based on estimated total body PCBs
increased to 108, 268, >300, and 284 days, respectively.  Body weights increased 370–560% in these
rapidly growing animals and percent fat increased disproportionally from about 21% body weight to near
28% body weight during the duration of the study.  The long total body half-lives in swine compared to
rats (Anderson et al. 1993; Mühlebach and Bickel 1981) reflect sequestering in a larger and expanding
compartment, making less PCB available for metabolism as well as elimination.  This may be more
relevant to some humans with fluctuating body weight and composition, contributing to the long half-
lives reported by Wolff et al. (1992a, 1992b).
An important factor in the elimination process of PCBs is the location of the chlorine atoms in the phenyl
rings.  This was studied in mice administered a series of PCBs with different molecular configurations
(Gage and Holm 1976).  For the series of PCB congeners tested, the results show that differential
biotransformation results in compounds having at least one pair of unsubstituted ortho-meta vicinal
carbon atoms (positions two and three) being excreted much faster than those with other configurations,
but this was greatly diminished by chlorines in the 2,2'- or 2',2'-positions.
The chemical identity of the PCB metabolites excreted by different species greatly depends on the
structure of the parent compound.  This has been studied by numerous investigators.  In rats, 85% of the
fecal excretion of metabolites derived from a hexachlorobiphenyl was hexane-extractable, indicating the
presence of nonpolar compounds as opposed to urinary metabolites, which are usually polar derivatives
(Mühlebach and Bickel 1981).  Analysis of the feces of rats dosed with 3,3N,4,4N-tetraCB revealed parent
compound (indicative of incomplete absorption), 5-hydroxy-tetraCB, 6-hydroxy-tetraCB, and 4-hydroxy-
3,3N,4N,5-tetraCB, whereas the urine contained mainly conjugated hydroxylated metabolites (Klasson-
Wehler et al. 1989a, 1989b).  Rats treated with 2,3-diCB and 2,4,6,-triCB excreted compounds
hydroxylated in the 4-position in the feces; a dihydroxy metabolite in position 3- and 4- was also
identified (Goto et al. 1974).  The major metabolites found in the urine of monkeys treated with
2,5,4N-triCB were free and conjugated monohydroxy derivatives; the feces were not examined (Felt et al.
1977).  The urine of rabbits administered 2,2N,5,5N-tetraCB revealed 3-hydroxy-2,2N,5,5N-tetraCB,
4-hydroxy-2,2N,5,5N-tetraCB, and a trans 3,4-dihydro-3,4-dihydroxy-2,2N,5,5N-tetraCB (Gardner et al.
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1973).  Excretion of radioactive material in the urine of ferrets treated with 14C-labeled Aroclor 1254
accounted for <10% of the amount excreted in the feces (Bleavins et al. 1984).  During the first week
after dosing, 22.1 and 1.8% of the dose was excreted in the feces and urine, respectively.  Total excretion
diminished considerably during subsequent weeks.
3.4.4.3 Dermal Exposure
Limited data were found regarding the excretion of PCBs in experimental animals following dermal
exposure.  The urinary excretion half-life of an undefined PCB containing 42% chlorine applied to the
abdominal skin was 6.9 days in monkeys (Wester et al. 1983).  In guinea pigs in which the same mixture
was applied to the back of the ear, a 2-phase urinary excretion process was observed.  The first phase was
rapid, with an elimination half-life of 1.9 days, and was followed by a slower phase, with an elimination
half-life of 12.6 days.  However, the elimination half-life of a PCB containing 54% chlorine was 2.9 days
and was linear for the duration (16 days) of the urine collection (Wester et al. 1983).  Wester et al. (1990)
reported that following percutaneous application of 4 µg 14C-labeled Aroclor 1242/cm2 to the abdominal
skin of monkeys (four per group), a maximum of 11% of the dose (as 14C-derived radioactivity) was
excreted over a 30-day period when the solvent was mineral oil, while 10% was excreted when the
solvent was trichlorobenzene (unspecified isomer).  Excretion was virtually complete after the first
10 days.  Urinary excretion of 14C-derived radioactivity was approximately 2 times fecal excretion. 
Following application of 4.8 µg 14C-labeled Aroclor 1254/cm2 in mineral oil or trichlorobenzene, 5.5 and
3.9% of the dose, respectively, was excreted over a 30-day period.  The probability that the authors
measured only excretion for the most readily metabolized components is increased because in the most
recent study, which specified Aroclor mixtures, urinary excretion was 2 times fecal excretion and urinary
excretion was virtually complete after 10 days.
3.4.4.4 Other Routes of Exposure
Excretion of PCBs and metabolites after parenteral administration follows the same general pattern as
after oral administration:  much greater amounts are excreted in the feces than in the urine.  Furthermore,
nonpolar derivatives are found in the feces, whereas polar metabolites are preferentially found in the
urine.
In rats, 80% of an intravenous dose of 14C-labeled 3,3N,5,5N-tetraCB was excreted in the feces over a
42-day period, whereas only 6.1% was excreted in the urine (Tuey and Matthews 1977).  Less than 10%
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of the radioactivity in bile, feces, and urine was parent compound.  The terminal half-life for whole-body
elimination was 9.8 days.  In contrast to the tetrachlorobiphenyl, excretion of 14C-labeled
2,2N,4,4N,5,5N-hexaCB was minimal after intravenous injection in rats.  Only 16% of the dose was
excreted in the feces over 40 weeks, while urinary excretion accounted for 0.8% of the dose (Mühlebach
and Bickel 1981).  It has been suggested that the hexachlorobiphenyl, which is minimally metabolized,
was stored after redistribution (Hansen and Welborn 1977; Mühlebach and Bickel 1981).  The higher
lipid solubility of the hexachlorobiphenyl may have also contributed to the greater retention of this
congener.  The significance of the chlorine substitution in the phenyl rings was examined by Kato et al.
(1980), who injected four symmetrical hexachlorobiphenyls intravenously in rats.  Most of the
administered doses underwent predominantly fecal elimination.  The 2,2N,3,3N,6,6N-hexaCB congener,
which has unsubstituted vicinal carbon atoms, was rapidly and extensively (90%) excreted over a 7-day
period.  For the other isomers, <15% was excreted over the 7-day period.
Following intravenous injection of 32.7 µg Aroclor 1242 to Rhesus monkeys, 39.4% of the administered
dose was excreted in the urine, and 16.1% was excreted in the feces over a 34-day period (Wester et al.
1990); the bulk of the dose (>90%) was excreted within the first 10 days.  For Aroclor 1254, 7% of the
administered dose (47.4 µg) was excreted in the urine and 19.7% in the feces over a 30-day period.  The
duration of the study probably accounted for only the most rapidly metabolized components of the
mixtures (Kato et al. 1980; Lutz and Dedrick 1987).
In rats with ligated bile ducts, unchanged 2,3N,4,4N-tetraCB appeared in the small intestine 1 hour after
intravenous injection suggesting that the wall of the small intestine is an important site of PCB excretion
(Yoshimura and Yamamoto 1975).  Lactation was also shown to be a major route of excretion of PCBs
from postpartum mice administered the compounds before pregnancy (Gallenberg and Vodicnik 1987).
The time-course of elimination of several PCB congeners (mono and di-ortho-substituted penta-, hexa-,
and heptachlorobiphenyls) was examined in the liver, lungs, and carcass of mice over a period of several
weeks after a single intraperitoneal dose of 500 mg Aroclor 1254/kg at 8 days of age (Anderson et al.
1993).  The concentration of total PCBs decreased in the three compartments as a function of time. 
Analyses of elimination half-times for total PCBs from carcass and liver, and of changes in body weight
indicated excretion as well as dilution.  All congeners were efficiently retained in the lung and decreased
only as a function of dilution due to growth.  In general, congeners with pairs of unsubstituted carbons
were eliminated faster than those without unsubstituted carbon pairs.  The changes in liver over time were
complex: there was retention of all congeners during the prepubertal growth phase, with specific
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enrichment of 2,3,3N,4,4N-pentaCB.  This was followed by more rapid elimination of certain congeners at
a later time.  The investigators suggested that changes in the liver may have reflected differences or
changes in amounts or types of lipids, in binding proteins, and/or in metabolizing enzymes.
3.4.5 Physiologically Based Pharmacokinetic (PBPK)/Pharmacodynamic (PD) Models
Physiologically based pharmacokinetic (PBPK) models use mathematical descriptions of the uptake and
disposition of chemical substances to quantitatively describe the relationships among critical biological
processes (Krishnan et al. 1994).  PBPK models are also called biologically based tissue dosimetry
models.  PBPK models are increasingly used in risk assessments, primarily to predict the concentration of
potentially toxic moieties of a chemical that will be delivered to any given target tissue following various
combinations of route, dose level, and test species (Clewell and Andersen 1985).  Physiologically based
pharmacodynamic (PBPD) models use mathematical descriptions of the dose-response function to
quantitatively describe the relationship between target tissue dose and toxic end points.  
PBPK/PD models refine our understanding of complex quantitative dose behaviors by helping to
delineate and characterize the relationships between: (1) the external/exposure concentration and target
tissue dose of the toxic moiety, and (2) the target tissue dose and observed responses (Andersen et al.
1987; Andersen and Krishnan 1994).  These models are biologically and mechanistically based and can
be used to extrapolate the pharmacokinetic behavior of chemical substances from high to low dose, from
route to route, between species, and between subpopulations within a species.  The biological basis of
PBPK models results in more meaningful extrapolations than those generated with the more conventional
use of uncertainty factors.  
The PBPK model for a chemical substance is developed in four interconnected steps: (1) model
representation, (2) model parametrization, (3) model simulation, and (4) model validation (Krishnan and
Andersen 1994).  In the early 1990s, validated PBPK models were developed for a number of
toxicologically important chemical substances, both volatile and nonvolatile (Krishnan and Andersen
1994; Leung 1993).  PBPK models for a particular substance require estimates of the chemical substance-
specific physicochemical parameters, and species-specific physiological and biological parameters.  The
numerical estimates of these model parameters are incorporated within a set of differential and algebraic
equations that describe the pharmacokinetic processes.  Solving these differential and algebraic equations
provides the predictions of tissue dose.  Computers then provide process simulations based on these
solutions.  
3.  HEALTH EFFECTS - Toxicokinetics
PCBs 337
The structure and mathematical expressions used in PBPK models significantly simplify the true
complexities of biological systems.  If the uptake and disposition of the chemical substance(s) is
adequately described, however, this simplification is desirable because data are often unavailable for
many biological processes.  A simplified scheme reduces the magnitude of cumulative uncertainty.  The
adequacy of the model is, therefore, of great importance, and model validation is essential to the use of
PBPK models in risk assessment.
PBPK models improve the pharmacokinetic extrapolations used in risk assessments that identify the
maximal (i.e., the safe) levels for human exposure to chemical substances (Andersen and Krishnan 1994). 
PBPK models provide a scientifically sound means to predict the target tissue dose of chemicals in
humans who are exposed to environmental levels (for example, levels that might occur at hazardous waste
sites) based on the results of studies where doses were higher or were administered in different species. 
Figure 3-4 shows a conceptualized representation of a PBPK model.
3.4.5.1 Summary of the PBPK Model
A flow-limited physiologic pharmacokinetic model was formulated to describe the individual kinetics of
the tissue distribution, metabolism, and excretion of several PCB congeners in the rat, mouse, dog, and
monkey.  In general, the model predicted well the experimental data, but some deviations were apparent. 
Rates of metabolism were species specific, and there was no apparent scaling factor, such as body weight
or surface area, for predicting metabolic rates from species to species.  Meaningful extrapolation of data
among species is dependent on accurate estimates of the rates of PCB congener metabolism. 
The information presented below has been extracted from studies by Lutz et al. (1977), Tuey and
Matthews (1980), and Lutz et al. (1984), and from reviews of those studies by Matthews and Dedrick
(1984) and Lutz and Dedrick (1987).  Models for the prediction of congener-specific PBPK parameters
(tissue:blood partition coefficients, rates of metabolism) from structural information are discussed at the
end of this section.






















































Figure 3-4.  Conceptual Representation of a Physiologically Based
 Pharmacokinetic (PBPK) Model for a Hypothetical Chemical Substance
Source: adapted from Krishnan et al. (1994) and Hansen (1999)
Note: This is a conceptual representation of a physiologically based pharmacokinetic (PBPK) model for a hypothetical
chemical substance.  The chemical substance is shown to be absorbed by inhalation, by ingestion, or via the skin;
metabolized in the liver; and excreted in the urine, bile, feces, sweat, or by exhalation.  Lymphatic absorption from the
gastrointestinal tract avoids the first-pass effect of liver metabolism and is very important for lipophilic chemicals (e.g.,
PCBs).  Important first-order rate constants are Ke (elimination) and Km (metabolism).
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3.4.5.2 Description of the Model
The PBPK model for PCBs includes several compartments (Figure 3-4) thought to represent regions of
substantial chemical uptake, regions involved in the clearance process, or regions of interest due to their
toxic response to PCBs.  Transport of the PCBs occurs by the inflow and outflow of blood through the
compartment, by transcapillary transport, and by transport across cell membranes.  The concept of blood
flow-limited uptake was used because experimental data appeared to indicate that PCBs leave the blood
and enter tissues very rapidly.  Therefore, the assumption was made that the uptake is flowlimited.  In
Figure 3-4, dashed lines within compartments represent rapid equilibrium partitioning between blood and
tissue space.  In order to simplify the model, metabolism of PCBs was assumed to occur in the liver
compartment as a single step leading to the formation of one metabolite that is excreted in the urine and
bile as the glucuronide conjugate.  The mathematical model consists of a set of differential equations
describing mass balances on each PCB congener in each compartment.  For example, for a tissue in which
metabolism may occur, such as the liver, the mass balance takes the form
d(VLCL)/dt = QL(CB - CL/RL) - (km x CL/RL)
where t = time, V = tissue volume or mass, C = concentration, Q = blood flow rate, km = metabolic rate
constant, and R = tissue/blood distribution coefficient.  The subscripts L and B refer to liver and blood,
respectively. 
The PCB model was initially constructed to describe the distribution of 4-monoCB, 4,4N-diCB,
2,2N,4,5,5N-pentaCB and 2,2N,4,4N,5,5N-hexaCB in Sprague-Dawley rats following a single intravenous
dose (0.6 mg/kg) of the PCB congeners (Lutz et al. 1977).  The same model was subsequently applied to
these congeners in CD-1 mice administered a single 0.6 mg/kg intravenous dose of the same PCB
congeners (Tuey and Matthews 1980).  In the dog (beagle) and monkey (Cynomolgus), 4,4N-diCB,
2,2N,4,4N,5,5N-hexaCB, and 2,2N,3,3N,6,6N-hexaCB were modeled, also after a single intravenous dose of
0.6 mg/kg (Lutz et al. 1984).  The latter two congeners were chosen since they have the same number of
chlorines, but 2,2N,3,3N,6,6N-hexaCB has two adjacent unsubstituted carbons, which has been shown to
enhance metabolism.  
Many of the parameters used in the model, in particular anatomical parameters and blood flow rates, were
available from the literature.  The skin flow rate used in the model had to be reduced by 10-fold in order
to simulate the behavior of PCBs in the skin.  Use of measured values or literature values resulted in
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overprediction of the skin PCB concentration at early times by a considerable amount.  This may have
reflected a deviation from a flow-limited transport mechanism in the skin.  Distribution coefficients (R)
for both parent and metabolite were estimated for each compartment by taking the respective ratios of the
specific tissue concentration to the blood concentrations at times when the compartments (tissues) were
assumed to be in equilibrium with effluent venous blood.  This implies that elimination is sufficiently
slow so that the venous blood is a fair representation of the effluent venous blood from each tissue. 
Metabolic rate constants (km) for rapidly metabolized PCB congeners were estimated by dividing the
amount of PCB appearing in the urine, feces, and tissue, by area under the blood concentration-time curve
for a given time interval.  For slowly metabolized PCB congeners, km was estimated by dividing the
average rate of excretion of metabolite by the average blood concentration of metabolite.  The rate of
urinary excretion was assumed to be proportional to the blood metabolite concentration.  Urinary
clearance (kK) was estimated by dividing the amount of PCB metabolite collected in the urine by the area
under the metabolite blood curve.  Biliary excretion (kB) was estimated from direct cannulation of the bile
duct or calculated from fecal excretion rates.  Liver equations for the dog and monkeys carried an
additional term that allowed for preferential and rapid removal of a specified fraction (F) of the PCB from
the liver blood pool; this fraction was rapidly and irreversibly transferred to the bile fluid.  Some
metabolism parameters (metabolism rate, kidney clearance rate, biliary clearance rate) for the mouse were
scaled from values reported for the rat. 
3.4.5.3 Discussion of the Model
Anatomical parameters used in the model are listed in Table 3-11.  Metabolism and clearance parameters
are listed in Tables 3-12, 3-13, and 3-14.  Table 3-12 shows that in the animal species examined km
decrease as chlorination increases, but the chlorine position also determines the rate of metabolism.  This
is suggested by the difference in km values between 2,2N,3,3N,6,6N-hexaCB and 2,2N,4,4N,5,5N-hexaCB in
the rat, dog, and monkey.  It appears that the meta and para positions are preferred sites for arene oxide
formation, which would explain why the km for 2,2N,3,3N,6,6N-hexaCB is even larger than for 4,4N-diCB. 
Table 3-12 also shows no apparent interspecies correlation of km with body weight or surface area.  As
body size increased, km increased, but when the parameters are normalized by either body weight or body
surface area, no consistent pattern of km is evident.  On any basis, km values for the dog are greater than
those for the mouse, rat, or monkey.  Based on these data alone, it cannot be ascertained which species, if
any, would predict PCB metabolism in humans; however, the collective data integrated with human
residue data have been developed into what appears to be a reliable model (Brown 1994).
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Table 3-11.  Volumes and Flow Rates in Several Tissues of Four Speciesa

















Blood 2.89 22.5 300 1000 – – – –
Muscle 17.1 125 2068 5530 1.42 7.5 103 275
Liver 2.24 10 118 480 3.1 16 125 342
Skin 5.51 40 470 1680 0.12 0.5 2.7 11.7
Fat 3.72 17.5 389 777 0.1 0.4 10.7 17.9
aValues were used in physiologic pharmacokinetic model.
Source:  Lutz and Dedrick 1987
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Table 3-12.  Metabolism Rate Constant (k) from the Physiologic Modela,b
4-MCB 4,4'-DCB 2,2',4,5,5'-PCB 2,4,5-HCB 2,3,6-HCB
km mL/min
Mouse (30 g) 2.4 0.37 0.095 0.01 –
Rat (250 g) 10 2 0.39 0.045 5
Monkey (5 kg) – 7 – 0.67 15
Dog (12 kg) – 470 – 16 183
km mL/min/kg
Mouse 68.5 9.7 2.5 0.25 –
Rat 40 8 1.56 0.18 20
Monkey – 1.4 – 0.13 3
Dog – 39 – 1.33 15.2
km mL/min/kg0.7
Mouse 25 3.7 0.94 0.1 –
Rat 26.4 5.2 1.02 0.12 13
Monkey – 2.3 – 0.22 5
Dog – 82 – 2.8 32
aSource:  Lutz and Dedrick 1987
bMiddle set of numbers is per-unit animal body weight, mL/min/kg.  Bottom set is mL/min/kg0.7, since body surface
area is approximately proportional to body weight to the 0.7 power.








Table 3-13.  Tissue-to-blood Distribution Coefficients for Parent Polychlorinated Biphenyls (R) 
and Metabolites (R’)
4-Monochlorobiphenyl 4,4N-Dichlorobiphenyl 2,2N4,5,5N-Pentachlorobiphenyl
Mouse Rat Monkey Dog Mouse Rat Monkey Dog Mouse Rat Monkey Dog
Parent, R
Muscle 1 1 – – 2 2 5 4 5 1 – –
Skin 10 10 – – 10 10 50 12 20 7 – –
Fat 30 30 – – 70 70 300 40 200 70 – –
Liver 1 1 – – 5 3 20 6 14 12 – –
Metabolite, RN
Muscle 0.14 0.14 – – 0.4 0.4 0.1 0.1 – –
Skin 0.25 0.25 – – 0.8 0.3 0.1 0.1 – –
Fat 0.4 0.4 – – 1 0.6 0.4 0.4 – –
Liver 2 2 – – 4 5 2 2 – –
2,4,5-Hexachlorobiphenyl 2,3,6-Hexachlorobiphenyl
Mouse Rat Monkey Dog Mouse Rat Monkey Dog
Parent, R
Muscle 5 4 7 6 – – 4 4
Skin 35 30 70 30 – – 40 8
Fat 300 400 500 300 – – 250 30
Liver 10 12 30 10 – – 20 2
Metabolite, RN
Muscle 3 0.3 1 0.2 – – 0.1 0.1
Skin 5 2 3 0.7 – – 0.5 0.2
Fat 1 2 9 2 – – 1 0.25
Liver 10 4 5 10 – – 5 10








Table 3-14.  Kidney Clearance (kk) and Biliary Clearance (kg) for Selected Polychlorinated Biphenyls 
in Several Speciesa,b
4-MCB 4,4N-DCB 2,2N,4,5,5N-PCB 2,4,5-HCB 2,3,6-HCB
kg kk kg kk kg kk kg kk kg kk
Mouse
  (30 g)
0.05 0.05 0.15 0.069 0.10 0.009 0.074 0.018 – –
Rat
  (250 g)
0.2 0.2 0.35 0.133 0.3 0.033 0.30 0.03 1.0 0.03
Monkey
  (5 kg)
– – 0.083 1.5 – – 0.70 0.041 0.5 0.4
Dog
  (12 kg)
– – 10.2 2.7 – – 1.8 0.15 7.0 2.0
 
aSource:  Lutz and Dedrick 1987
bClearance values are in mL/minute.
DCB = dichlorobiphenyl; HCB = hexachlorobiphenyl; MCB = monochlorobiphenyl; PCB = pentachlorobiphenyl 
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Table 3-13 lists tissue/blood distribution coefficients (R) for parent compounds and metabolites.  In the
four species tested, and for all the PCB congeners modeled, the rank order for R is fat >skin >liver
>muscle >blood.  The large R for parent PCBs in adipose tissue is not unexpected considering the
lipophilic nature of the compounds.  Also, as expected, Rs for metabolites were considerably lower than
those for the parent compounds.  This is likely because glucuronide conjugates of the parent compound
are less lipophilic and more water soluble.  The largest R for metabolites were found in the liver,
reflecting the fact that metabolism of PCBs occurs primarily in the liver.  Clearance parameters for biliary
and urinary elimination listed in Table 3-14 do not show any apparent interspecies scaling correlations.  
3.4.5.4 Validation of the Model
The model used to simulate the data described well the kinetics of distribution, metabolism, and excretion
of the PCB congeners studied in adult animals.  However, some deviations were apparent.  For example,
in the rat the model predicted a faster rate of clearance from blood and tissues for lower chlorinated
biphenyls beyond 48 hours.  This was tentatively attributed to the formation of minor metabolites, which
have different pharmacokinetic behavior than the major metabolites.  Formation of metabolites covalently
bound to tissue macromolecules also was a possibility.  The model overpredicted the concentration of
PCBs in the skin at early times, suggesting that the use of measured or literature values of skin-flow rate
in the flow-limited skin compartment may not have been appropriate.  Among the possibilities offered to
explain this phenomenon were: the existence of an additional barrier in the skin that reduced uptake,
inaccurate measurement of skin blood-flow rates because of shunt flow, and presence of subcutaneous
skin fat serving as reservoir for the diffusion of PCBs from the skin tissue.  Also, in order to obtain a good
simulation of the behavior of the poorly metabolized 2,2N,4,4N,5,5N-hexaCB in rats, a term describing
changes in fat volume of the growing rats had to be incorporated into the model.  Without this term, the
simulations overpredicted the long-term data.  Apparent elimination of the PCB congener from blood or
adipose tissue was in reality a dilution effect due to the increased fat volume.  When the physiological
compartment model for the rat was scaled to the mouse, the disposition of PCBs in the latter was in
reasonable agreement with the experimental data.  An exception was the finding that greater biliary
clearance rates than the corresponding rate scaled from the rat for the di-, penta-, and hexachlorobiphenyl
were observed.  Model simulations of tissue disposition of parent compounds in the monkey were in
reasonably good agreement with the experimental data.  This was not the case for the dog, a species in
which, except for 2,2N,4,4N,5,5N-hexaCB, the simulations underpredicted the experimental data at longer
time points.  The data showed that the dog metabolized the three PCB congeners tested considerably
faster than the monkey.  As with the rat, simulations of blood-flow rate to 
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the skin in the dog and monkey had to be reduced to one-tenth its physiologic value in order to fit the
experimental data.  
The results of these studies show that pharmacokinetic modeling is a valuable tool for predicting PCB
disposition in one animal species by extrapolation of data from other animal species.  However, while
many similarities exist from species to species, some important differences were also apparent.  The most
important parameter in the model appeared to be the km.  Knowledge of this parameter in a species of
interest is crucial if reliable predictions of PCB disposition are to be made.  Lutz et al. (1984) recognized
that “without additional information about metabolism, extrapolation of the present model to simulation
of human disposition would be suspect."  The model constructed by Lutz and co-workers provides kinetic
and metabolic information regarding a very small number of PCB congeners, but not toxicity information
that could eventually be used for developing risk assessment approaches for PCBs.  The most extensively
studied PCB congeners from the point of view of their toxic properties are the dioxin-like congeners. 
These congeners lack chlorine substitution in the ortho position and are isostereomers of 2,3,7,8-TCDD
(dioxin).  The mechanism of toxicity for these congeners is related to the enhancement of gene expression
triggered by initial binding to a cytosol receptor (Ah receptor) (see Section 2.5.2 for further details). 
Although no PBPK model has been constructed for the dioxin-like congeners, information exists for
2,3,7,8-TCDD.  PBPK models for 2,3,7,8-TCDD account not only for determinants of disposition, such
as tissue partitioning, biotransformation rates, and protein-binding constants, but also describe
pharmacodynamic events related to the induction of specific dioxin-binding proteins in the liver (Leung et
al. 1988).  Recent refinements of the model incorporate information on the interactions of the dioxin-Ah
receptor complex with regulatory regions of specific genes (Andersen et al. 1993).  This level of
information is expected to provide a basis for investigating the scaling across species of the PBPK model
for dioxin and chemicals with common-mediated mechanisms of toxicity.
3.4.5.5 Prediction of Congener Specific PBPK Model Parameters.
Since the toxicity of a given PCB mixture is related to its congener composition, congener-specific
information on kinetic parameters is necessary if PBPK models are to be used as part of risk assessment. 
Methods to predict the tissue:blood partition coefficient (Parham et al. 1997) and metabolic rate constants
(Parham and Portier 1998) for all 209 congeners based on structural information are discussed below.
Data from a study of occupationally exposed humans allowed the authors to calculate the adipose:plasma
partition coefficient for 24 PCB congeners (Wolff et al. 1982b).  In an effort to predict these results by 
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modeling (Parham et al. 1997), a total of 27 structural descriptors were identified for PCBs (e.g., total
number of chlorines, number of ortho-chlorines, number of chlorines on most-substituted ring, etc.).  A
stepwise regression method was used to identify a small set of descriptors that would adequately predict
the observed adipose:plasma partition coefficients for each congener.  It was found that the three most
important structural descriptors for the prediction of the adipose:plasma coefficient were (1) whether the
congener had a ring with unsubstituted adjacent meta and para carbons, (2) the congeners nonplanarity,
and (3) the polarity of the congener.  The adipose:blood partition coefficient can be derived from the
adipose:plasma partition coefficient if the ratio between plasma and whole blood is known for the
congener.  Stepwise regression was similarly used to predict a data set for the distribution between plasma
and the cellular component of blood of eight PCB congeners and biphenyl in the rat (Matthews et al.
1984).  In this case, a good fit with the experimental data was obtained with the use of only one structural
descriptor, the number of adjacent unsubstituted meta and para carbons.  Conversion from rat blood to
human blood was accomplished by adjusting for the higher proportionate volume of the cellular
component in rat blood and assuming that all PCBs in plasma are bound to protein in both species.  A
factor was derived for conversion of the predicted adipose:plasma partition coefficient to the
adipose:blood partition in humans; this factor depends on the number of unsubstituted meta-para carbon
pairs (0-4) in the specific congener.  Adjustment factors for partition coefficients for other tissues (liver,
muscle, and skin) were developed based on lipid fraction in the tissue, percent nonneutral lipid, and
percent neutral lipid.
A similar stepwise regression process has been applied to the prediction of metabolic rate constants for
specific PCB congeners from structural descriptors (Parham and Portier 1998).  The metabolic rates used
as the input for the stepwise regression were derived from in vitro rates of formation of metabolites for
25 congeners in rat liver microsomes (Borlakoglu and Wilkins 1993a, 1993b) and from a modification of
the Lutz et al. (1977) PBPK model using data from four intravenous injection studies in rats employing
nine congeners (Abdel-Hamid et al. 1977; Matthews and Anderson 1975; Tuey and Matthews 1977,
1980).  The in vitro data included 14 congeners tested with microsomes from Aroclor 1254-induced rats
and 11 congeners from noninduced rats.  The stepwise regression resulted in seven descriptors included in
the model.  Five were structural descriptors (degree of chlorination, noncoplanarity, and three that
described the presence of adjacent unsubstituted carbon atoms) and two were nonstructural (whether the
data was from [1] induced or noninduced rats and [2] in vitro or in vivo experiments).  The final model
was used to predict the blood radioactivity data from intravenous injection studies and appeared to fit the
experimental data well.  Some individual misfits could be attributed to the fact that Borlakoglu and
Wilkins (1993a, 1993b) measured only primary metabolites but used prolonged incubation times.
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3.5 MECHANISMS OF ACTION
PCBs are lipophilic compounds that are readily absorbed from the gastrointestinal tract.  While PCBs in
many cases entered the environment as commercial formulations containing a relatively defined mixture
of specific PCB congeners, the accumulation and retention of specific PCB congeners in various
environmental matrices, wildlife, and humans does not directly reflect the PCB profile of the commercial
mixtures.  Therefore, it is important to consider the biological fate and activity of individual PCB
congeners when assessing the risk that PCBs pose to human health.  Although PCBs are found in all
tissues analyzed to date, they are stored in high concentration in adipose tissue since they are lipophilic. 
PCB congeners are metabolized in the liver by microsomal cytochromes P-450 to less lipophilic
metabolites that can undergo conjugation with glutathione or glucuronic acid.  The rate of congener
metabolism is highly dependent on the chlorine substitution pattern in the biphenyl ring.  Strong evidence
suggests that the mechanism of toxicity for dioxin-like congeners is related to the enhancement of gene
expression triggered by initial binding to the same cytosol receptor (Ah) involved in 2,3,7,8-TCDD
toxicity.  The mechanism(s) of toxicities for other groups of PCB congeners, such as those showing
estrogenic or neurotoxic activity, and the mechanism of PCB carcinogenicity, has not been elucidated. 
Similarly, disruption of neutrophil function and calcium homeostasis appear to be mediated by
mechanisms other than the Ah receptor.  Disruption in thyroid hormone homeostasis occurs through
mechanisms that transcend all congener groups of PCBs.
3.5.1 Pharmacokinetic Mechanisms
The mechanism of absorption of PCBs by the inhalation and dermal routes of exposure is not known. 
PCBs are well absorbed from the gastrointestinal tract.  Diet is the main source of background human
exposures to persistent lipophilic organic pollutants, such as PCBs (Duarte-Davidson and Jones 1994;
Hansen 1999).  Because PCBs are lipid soluble, transfer from the aqueous environment of the intestine
across cell membranes is a passive process (Albro and Fischbein 1972; Gage and Holm 1976; Matthews
and Anderson 1975).  The concentration gradient favors partitioning across the cells into blood serum or
lymph.  As with other fat-soluble chemicals, PCBs are most likely absorbed from the gut via lymphatic
circulation rather than by transfer to the hepatic portal system (Hansen 1999).  Absorption efficiency
appears to increase with the degree of ring chlorination up to a certain point.  Schlummer et al. (1998)
calculated the net gastrointestinal absorption of PCBs in humans as the difference between contaminant
input with food and contaminant output with feces, normalized to the contaminant intake.  PCB congeners
showing nearly complete net absorption had very low or nondetectable levels in the serum lipids, while 
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for other congeners, there was a trend for decreasing net absorption and /or increasing net excretion with
increasing congener concentration in serum lipids.  Together, the data support the passive diffusion model
for gastrointestinal absorption, where the concentration of the contaminant in the blood is the major factor
determining absorption.  This suggests that the ingestion of more highly contaminated food should result
in nearly complete absorption due to the high diffusion gradient associated with high levels of PCBs in
the gut contents.  In blood, PCBs are associated with red blood cells, albumin, and lipoproteins (Matthews
et al. 1984).  Distribution in plasma is determined primarily by partition among the various proteins
according to lipid solubility and concentration (Matthews and Dedrick 1984).  As the degree of
halogenation increased, the binding to lipoproteins also increased (Matthews et al. 1984).  Partition of
PCBs between blood and tissues also seems determined primarily by lipid content and concentration
gradient.  The fraction associated with red blood cells is more rapidly removed from the blood by the
tissues than fractions associated with plasma proteins (Matthews et al. 1984).  
Borlakoglu et al. (1990) proposed a model for the transport and cellular uptake of PCBs following oral
exposure.  Following the ingestion of PCBs, the absorbed congeners are secreted into the bloodstream in
association with chylomicrons and then are associated with the VLDLs synthesized in the liver.  As the
congeners come in contact with the lipoprotein lipase located on the surface of the capillary endothelial
cells of adipose tissue, the PCB congeners are transferred into the adipocytes.  Mobilization of PCBs from
adipose tissue will release PCBs into the bloodstream, where they will associate with HDL and plasma
proteins, such as albumin, by non-covalent binding.  Noren et al. (1999) found PCBs mainly associated
with the lipoprotein depleted (LPDP) fractions (containing primarily albumin).  On average, 44% of the
PCBs and 61% of the methylsulfonyl metabolites of PCBs (MeSO2-CBs) were distributed in the LPDP
fraction.  This may be expected due to the more polar character of the  MeSO2-CBs.  Among the
lipoprotein fractions, LDL was the main carrier of PCBs, while MeSO2-CBs were distributed equally
between the LDL and HDL fractions.  When the concentrations of PCBs were calculated in relation to
apolipoprotein B, the levels were about 10 times higher in VLDL than LDL.  
As with other organisms, PCB residue levels in humans reflects multiple exposure pathways, and
congener-specific elimination.  PCB profiles in human serum immediately following exposures reflect the
profiles in the exposure sources; however, selective metabolism and excretion begin to alter the congener
profile within 4–24 hours (Hansen 1999).  Thus, in most cases, the PCB profile in adults represents a
steady state body burden which does not match the profile of commercial PCB formulations (Aroclors,
etc.).  For example, neither the PCB profile of human adipose nor of a composite human milk sample
resemble the pattern of any commercial PCB formulation (Jensen and Sundstrom 1974; Safe et al. 1985).  
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Humans, aquatic mammals, birds, fish, and other biota retain unique profiles of PCB congeners consistent
with exposures and toxicokinetic principles.  Borlakoglu and Walker (1989) reported that fish-eating sea
birds, human fat, American breast milk, and German breast milk have similar PCB congener profiles,
reflecting fish residues, which differ from Aroclor 1260 or Clophen A60.  Hansen (1999) cites several
studies reporting diet-dependent PCB profiles in various birds, and a larger breast milk study shows
regional differences in congener profiles in Canadian breast milk (Newsome et al. 1995).  
PCBs are rapidly (minutes to hours) cleared from the blood of adult animals and accumulated in the liver
and muscle (Matthews and Dedrick 1984; Safe 1980, 1989a).  This appears to be due to the high
perfusion in the liver and the relatively large muscle volume.  Due to their high affinity for lipophilic
tissues, PCBs are subsequently translocated to adipose tissue and skin for storage.  Subcutaneous fat
accumulates PCBs more slowly than central fat stores (Hansen and Welborn 1977).  Stored residues are
less available for elimination or metabolism by the liver.  A dynamic equilibrium of PCB concentrations
is established among all tissues for each PCB homolog (Matthews and Dedrick 1984).  As previously
discussed, mathematical models that incorporate anatomical as well as pharmacokinetic parameters have
been developed to describe distribution and body burden of PCBs in adults of species such as mice, rats,
dogs, and monkeys (Lutz and Dedrick 1987).  Pharmacokinetic modeling of PCB disposition predicts
that, at equilibrium, changes in the PCB concentration or changes in tissue volume of any tissue will lead
to a corresponding change in all tissues (Matthews and Dedrick 1984).  For instance, if the concentration
of a PCB congener in the liver is reduced by metabolism or excretion, then the concentration of that PCB
congener in all tissues will be reduced proportionally.  Congeners that cannot be metabolized or excreted
will concentrate in adipose tissue, but will still circulate to other tissues.  Exposure to other tissues will be
proportional to the respective tissue/blood ratios and the concentration in the main storage tissues.  This
dynamic distribution results in accumulation of persistent congeners in all tissues and depletion from all
tissues of those congeners that can be cleared (Matthews and Dedrick 1984).  Metabolites, however, may
accumulate in specific tissues due to solubility differences as well as tissue binding (Section 3.4.3). 
Relatively little is known regarding the  biological and toxicological activity of these persistent PCB
metabolites.  
A possible explanation for the highly selective retention of the OH-PCBs in blood may be their structural
resemblance with thyroxin.  Both rats and mice metabolize PCB 77 by CYP1A to the 1,2-shift metabolite,
4-OH-3,5,3',4'-PCB, 5-OH 3,3',4,4'-PCB, and 6-OH-3,3',4,4'-PCB (McKinley et al. 1993; Morse et al.
1995).  Only the 4-OH metabolite was selectively retained, with blood containing 4-OH-3,5,3',4'-PCB at a
concentration 15 times higher than the parent compound, 5 days after oral exposure to PCB 77 in mice 
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(Bergman et al. 1994).  This metabolite was found to be bound to a thyroxin-transporting protein
(transthyretin) in the blood (Brouwer et al. 1986).  Competitive binding studies of OH-PCBs relative to T4
and computer modeling showed that OH-PCBs with the substituents in meta or para positions were much
more effective competitors for T4 than if the substituents were bound in an ortho position (Rickenbacher
et al. 1986).
Methylsulfonyl (MeSO2) metabolites of PCBs have been widely detected in the tissues of marine
mammals (Bergman et al. 1994; Letcher et al. 1995) and of humans (Haraguchi et al. 1986; Noren et al.
1996; Weistrand and Noren 1997).  Although the binding mechanism for 3-MeSO2 metabolites is not
clear, the binding protein for 4-MeSO2 metabolites has been identified as a uteroglobulin-like protein
present in the nonciliated bronchiolar (Clara) cells of the lung, also referred to as Clara cell secretary
protein (CCSP) (Hard et al. 1995; Stripp et al. 1996).  Exposure to 4-MeSO2-2,2',4',5,5'-PCB
demonstrated that CCSP-deficient mice no longer accumulate this metabolite within lung or kidney tissue
(Stripp et al. 1996).  These data demonstrate that CCSP is the 4-MeSO2-PCB binding protein in mice and
suggests that 4-MeSO2-PCBs will accumulate at sites of CCSP localization, such as the respiratory and
reproductive tracts of humans. 
Experimental evidence using P32-postlabeling supports the hypothesis that lower chlorinated biphenyls are
metabolically activated to electrophilic species which bind to DNA (McLean et al. 1996; Oakley et al.
1996).  The incubation of 2-chloro-, 4-chloro-, 3-chloro-, 3,4-dichloro-, and 3,4,5-trichlorobiphenyl with
calf thymus DNA and rat liver microsomes followed by oxidation with a peroxidase, produced 1–3 major
DNA adducts.  The reactive metabolites may result for arene oxides and/or catechol and p-hydroquinone
species, which are oxidized to semiquinones and/or quinones.  The results raise the possibility that lower
chlorinated biphenyls may be genotoxic and may explain the fact that commercial PCB mixtures are
complete rodent carcinogens.
The major routes of excretion of PCBs are fecal and urinary.  For higher chlorinated congeners such as
penta- and hexachlorobiphenyls, the predominant route of excretion is via the feces (up to 60% of total
excretion); for lower chlorinated congeners, the situation seems to reverse (Lutz and Dedrick 1987). 
Mainly metabolites are found in urine and bile, although small amounts of parent compound may appear
in the feces, in particular congeners that are poorly metabolized such as 2,2N,4,4N,5,5N-hexaCB. 
Elimination kinetics tend to follow first-order processes with elimination rates directly related to their
metabolic rates (Gage and Holm 1976).  An important route of PCB elimination is milk.  This varies
considerably with the species due to volume and lipid content of the milk, but the basic mechanisms are
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the same for all species.  Because PCBs are in dynamic equilibrium with all tissues, they move passively
from blood to milk at the beginning of lactation to maintain their respective tissue/blood ratios.  
PCBs are metabolized by microsomal cytochrome P-450 to polar metabolites that can undergo
conjugation with glutathione and/or glucuronic acid.  The rate of metabolism of some PCB congeners
depends on (1) the degree of ring chlorination, (2) the chlorine ring substitution pattern, and (3) the
pattern and levels of P-450 isozymes and other enzymes in the target tissue.  PCB congeners of low
chlorine content are transformed into hydroxylated derivatives that are predominately eliminated in the
urine.  Highly chlorinated congeners with nonsusceptible substitution patterns are either retained or
excreted unchanged in the feces.  Extensive information regarding the mechanism of metabolism of PCBs
is provided in Section 3.4.3.
Because of the many factors that may determine the toxic response associated with exposure to PCBs,
caution should be exercised when extrapolating high-dose response to low-dose responses, and/or single-
dose exposures to chronic exposures.  Caution is warranted for two main reasons.  First, the dynamic
mechanism involved in the distribution of PCB congeners, in which lipophilicity plays a crucial role, will
influence the amount of circulating PCBs.  For example, one can predict that because lean individuals
have a smaller fat compartment, all of their body tissues will have higher concentrations of PCBs than
those in fatter individuals of the same exposure.  Also, the dosing schedule (single compared to repeated)
will determine whether steady-state is achieved.  Secondly, because PCBs can induce their own
metabolism, data obtained with exposure levels associated with a significant induction of CYP1A1 and
CYP1A2 may not necessarily reflect toxicokinetic behavior at low exposure levels.  This has been
illustrated in the model proposed by Brown (1994) in comparing high-exposed humans to low-exposed
humans.  In addition, serum residues of 2,2N,4,4N,5,5N-hexaCB are lower in prepubertal rats when the total
of two doses is high enough to induce P-450 2B (Li et al. 1994).  Toxicokinetic data for PCBs do not
suggest route-dependent toxicity.
3.5.2 Mechanisms of Toxicity
Mechanisms by which the broad array of toxic effects observed in animals orally exposed to PCB
mixtures develop are incompletely understood, but there is evidence to suggest that PCB congeners differ
qualitatively and quantitatively in biological activities and that multiple and diverse mechanisms are
involved in responses to PCB mixtures.  Research in the 1970s and 1980s focused on mechanistic
similarities between PCBs and CDDs involving initial mediation of effects by the Ah receptor (Poland 
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and Knutson 1982; Safe 1990, 1994), but research through the 1990s has found increasing evidence for
the involvement of alternative mechanisms for several PCB-induced effects (Chauhan et al. 2000; Cheek
et al. 1999; Fischer et al. 1998; Hansen 1998; Harper et al. 1993a, 1993b; Safe 1994; Tilson and
Kodavanti 1998).  An in-depth and all-inclusive review of the many recent and ongoing research efforts
regarding PCB mechanisms of action is outside of the scope of this profile; rather, an overview of this
large body of research is presented with the intent of providing information relevant to public health
issues.
 
PCB Effects Involving Ah-receptor Dependent Mechanisms    
Induction of Hepatic CYP1A Oxygenases and Phase II Enzymes.  PCBs induce hepatic Phase I enzymes
(CYP oxygenases) and Phase II enzymes (e.g., UDP glucuronyltransferases, epoxide hydrolase, or
glutathione transferase) to varying degrees and specificities (Connor et al. 1995; Hansen 1998; Safe
1994).  The demonstration of relationships between PCB molecular structure and induction of CYP
isozymes has provided a framework within which much mechanistic research has been conducted.  In
general, commercial mixtures of PCBs induce both 3-methylcholanthrene-type (CYP1A1 and 1A2) and
phenobarbital-type (CYP2B1, 2B2, and 3A) CYPs.  Strong structure-activity relationships have been
demonstrated between CYP1A1/1A2 induction in rodents and non-ortho and mono-ortho PCBs, which
can assume a coplanar molecular configuration and bind to the Ah receptor  (Connor et al. 1995; Hansen 
1998; Safe 1994).  In structure-activity studies of CYP1A induction in hepatocytes from Cynomolgus
monkeys by 20 PCBs varying in degree and pattern of chlorine substitution (4–7 chlorines), the most
potent inducers were without ortho chlorines (van der Burght et al. 1999).  Many PCBs with ortho
chlorines (mono-, di-, tri-, and tetra-ortho congeners) displayed no CYP1A induction activity, but a few
mono-ortho and multiple-ortho congeners displayed activities that were about 1,000- and 10,000-fold less
than the most potent non-ortho congeners, respectively (van der Burght et al. 1999).  A working
mechanistic hypothesis involves initial binding of coplanar PCBs to the Ah receptor in the cytosol of
target cells, transport of the ligand-receptor complex to the nucleus, and subsequent changes in gene
expression (e.g., induction of CYP1A1/1A2) leading to toxic responses via subsequent and/or parallel
molecular mechanisms that are largely unexplored.  Support for this hypothesis comes from the similarity
in the array of PCB effects compared with the array produced by 2,3,7,8-TCDD and related halogenated
aromatic hydrocarbons via initial Ah-receptor mediation, results from in vitro binding studies, and results
from congener-specific in vivo studies of specific end points (e.g., enzyme induction and down regulation,
body weight, and immunological responses to SRBC) in mouse strains and rat genders differing in
responsiveness to Ah-receptor mediation (Hori et al. 1997; Safe 1990, 1994).  
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The complexity of Ah-receptor mediated effects on hepatic enzyme levels is illustrated by results from a
study with mouse strains differing in Ah-receptor responsiveness and three PCB congeners (Hori et al.
1997).  Ah responsive (C57BL/6) and Ah nonresponsive (DBA/2) mice were given single intraperitoneal
doses of 3,3',4,4',5-pentaCB (a congener with high Ah receptor affinity), 3,3',4,4'-tetraCB (a congener
with lesser affinity), and 2,2',5,5'-tetraCB (a low-affinity ligand).  Only the high-affinity
3,3',4,4',5-congener produced body weight wasting in the dose range tested (up to 50 mg/kg) in
Ah-responsive C57BL/6 mice, and this effect was accompanied by a decrease in selenium-dependent
glutathione peroxidase and an increase in θ glutathione S-transferase.  The effect on levels of these Phase
II enzymes was not produced by the other congeners in C57BL/6 mice, and did not occur in DBA/2 mice
exposed to any of the congeners, indicating the involvement of Ah-receptor mediation.  These Phase II
enzymes both play protective roles in scavenging intracellularly generated peroxides and the balance of
their activities is likely to influence a cell’s ability to withstand damage from peroxides. 
Body Weight Wasting, Thymic Atrophy, and Porphyria.  In addition to induction of hepatic levels of
CYP1A1/1A2/1B1 and induction or repression of some Phase II enzymes, PCB-induced effects that
appear to predominately involve Ah-receptor initiated mechanisms include body weight wasting and
thymic atrophy from acute exposure (Hori et al. 1997; Safe 1994) and porphyria and porphyria cutanea
tardea (Franklin et al. 1997; Smith et al. 1990a, 1990b).  For example, single intraperitioneal doses of
5 mg/kg 3,3',4,4',5-pentaCB, a potent inducer of CYP1A1 and a high-affinity Ah-receptor agonist
(relative to other PCBs), produced marked body weight wasting in Ah-responsive C57BL/6 mice, but not
in DBA/2 mice that have a low-affinity Ah-receptor (Hori et al. 1997).  Showing a link between
Ah-receptor responsiveness and development of uroporphyria, female F344 rats had significantly higher
hepatic levels of porphyrins and ethoxyresorufin deethylase activity (an indicator of CYP1A1) in
response to exposure to 0.005% Aroclor 1254 in the diet for 15 weeks than did male rats (Smith et al.
1990b).  A similar gender-specific correlation between porphyrinogenic response and CYP1A induction
was observed in iron-loaded F344 rats exposed to single intraperitoneal doses of 63 mg Aroclor 1254/kg
(Franklin et al. 1997).  In mice of the Ah-responsive C57BL/6 strain, a single dose of iron-dextran
(600 mg Fe/kg), followed by feeding of a diet containing 0.01% Aroclor 1254 for up to 12 months,
produced markedly increased hepatic levels of porphyrins and liver enlargement, but this response to iron
and Aroclor 1254 was not observed in similarly treated DBA/2 mice (Smith et al. 1990a).  Exposure to
iron-dextran alone caused a moderate porphyria in C57BL/6 mice, but not in DBA/2 mice, lending
support to a postulate that there are constitutive genetic differences between these strains that influence
porphyria development and do not involve Ah-receptor mediation (Smith et al. 1990a).  One mechanistic
hypothesis proposes that induction of CYP1A2 by the Ah-receptor-PCB complex leads to generation of a
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competitive inhibitor of uroporphyrinogen decarboxylase in the liver and subsequent accumulation of
porphyrins (see Franklin et al. 1997).
Ah Receptor TEF Approach to Health Hazard Assessment.  A TEF approach to evaluating health
hazards from exposure to complex environmental mixtures containing PCBs, CDDs, and CDFs has been
developed and used to some extent to guide public health decisions because humans are exposed to
complex and varying mixtures of these halogenated aromatic hydrocarbons and there are limited
toxicological data for these complex mixtures and many of their components (ATSDR 1998; Safe 1990,
1994; van den Berg et al. 1998).  PCBs were included in this component-based approach because (1) the
spectrum of effects in animals exposed to some PCB mixtures and congeners is similar to the spectrum
produced by 2,3,7,8-TCDD (via Ah receptor initial mediation) and (2) coplanar PCBs display Ah receptor
binding affinities that were related to their potency in producing health effects in rodents such as body
weight wasting and inhibition of immunological responses to SRBC (Safe 1990, 1994).  The TEF
approach compares the relative potency of individual congeners, based on in vitro or acute in vivo data,
with that of 2,3,7,8-TCDD, the best-studied member of this chemical class, so that the TEF for
2,3,7,8-TCDD is 1.  The concentration or dose of each active component in a mixture of concern is
multiplied by its TEF to arrive at a TEQ, and the TEQs are added to give the total toxic equivalency of
the mixture which is compared with reference exposure levels for 2,3,7,8-TCDD expected to be without
significant risk for producing health hazards.  TEFs have recently been recommended by the World
Health Organization for 7 CDD, 10 CDF, and 12 PCB congeners (Van den Berg et al. 1998).  
Limitations in using the TEF approach for assessing health hazards from PCB-containing environmental
media revolve around the inherent assumptions that the components jointly act in an additive manner
through a common Ah-receptor initial mechanism and the evidence that Ah-receptor-binding congeners in
PCB-containing environmental mixtures are minor components (Hansen 1998; Safe 1998a, 1998b) 
Several studies have provided evidence of nonadditive interactions between specific PCB congeners and
between some PCB congeners and 2,3,7,8-TCDD (Safe 1998a, 1998b), and there is evidence, discussed
below, that several Ah-receptor-independent mechanisms may make contributions to toxic effects from
PCB mixtures.
PCB Effects Involving Ah-receptor Independent Mechanisms    
Induction of Hepatic CYP2B Oxygenases.  In contrast to the distinct relationships between
CYP1A1/1A2 induction, PCB molecular structures, and Ah-receptor initiation of toxic effects, 
3.  HEALTH EFFECTS - Mechanisms
PCBs 356
relationships between potency in inducing CYPs 2B1/2B2/3A, PCB structural properties, and toxic
effects are less clear (Connor et al. 1995).  For example, some PCBs with two ortho chlorines and lateral
chlorines induce both types of CYPs and display a very small affinity for the Ah receptor, whereas other
di-ortho PCBs with one or two para chlorines predominately induce CYP2B1/2B2/3A and have no
measurable affinity for the Ah receptor (Connor et al. 1995; Hansen 1998).  Some noncoplanar
congeners, such as 2,2',4,4'-tetraCB, also induce CYP3A through the glucocorticoid-sensitive pregnane X
receptor (PXR) (Schuetz et al. 1986, 1998).  It is clear that PCB induction of phenobarbital-type CYPs is
independent of the Ah receptor and that the most potent inducers of CYP have at least two ortho chlorines
and one or two para chlorines.
Other PCB-induced effects involving Ah-receptor independent mechanisms include neurological and
neurodevelopmental effects involving changes in brain dopamine levels (Seegal 1996b, 1998; Seegal et
al. 1989, 1990; Shain et al. 1991); inhibition of dopamine vesicular uptake (Mariussen et al. 1999) and/or
changes in brain cell intracellular calcium homeostasis and related signal transduction processes
(Kodavanti and Tilson 1997; Tilson and Kodavanti 1997, 1998; Tilson et al. 1998; Wong and Pessah
1996, 1997; Wong et al. 1997); tissue injury related to activation of neutrophils (Brown and Ganey 1995;
Ganey et al. 1993; Tithof et al. 1995); thyroid disruptions not involving UDP-GT induction (Chauhan et
al. 2000; Cheek et al. 1999; Darnerud et al.1996a; Li and Hansen 1996; Ness et al. 1993; Van Birgelen
1992); and PXR and ryanodine receptor (RyR) mediated mechanisms (Schuetz et al. 1986, 1998).  
Brain Dopamine Levels and Neurological Effects.  Aroclor 1254 decreased cellular levels of dopamine
in cultured pheochromocytoma cells, which synthesize, store, release, and metabolize dopamine in a
manner similar to the intact mammalian central nervous system (Seegal et al. 1989).  Daily oral exposure
of adult nonhuman primates (Macaca nemestrina) to Aroclor 1016, a commercial mixture of lightly
chlorinated PCB congeners, for 20 weeks, likewise, produced decreased dopamine concentrations in brain
regions including the caudate, putamen, substantia nigra, and hypothalamus (Seegal et al. 1990).  In these
brain regions, only three PCB congeners were detected (2,4,4'-triCB and 2,2',4,4'- and 2,2',5,5'-tetraCB),
suggesting that nonplanar PCBs, which are poor Ah receptor agonists, may have been responsible for the
effect.  Structure-activity studies of 50 PCB congeners in the pheochromocytoma in vitro system found
that the most active congeners had at least two ortho chlorines (e.g., 2,2',4,6-, 2,2',5,5'-, and
2,2',4,5-tetraCB) and that congeners that were relatively strong Ah receptor agonists (e.g.,
3,3',4,4'-tetraCB and 3,3',4,4',5-pentaCB) were inactive or had minimal effects on dopamine levels (Shain
et al. 1991).  However, ortho substitution was not the sole determinant of activity in this system; for
example, a congener with four ortho chlorines (2,2',6,6'-tetraCB) had no effect on dopamine levels in 
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pheochromocytoma cells (Shain et al. 1991).  The effect on dopamine levels has been postulated to
involve decreased dopamine synthesis via direct or indirect PCB inhibition of tyrosine hydroxylase
(Choksi et al. 1997; Seegal et al. 1996b) or L-aromatic amino acid decarboxylase (Angus et al. 1997)
and/or decreased uptake of dopamine into vesicles (Mariussen et al. 1999).  For example, several
congeners that were inactive in causing dopamine level changes in pheochromocytoma cells (e.g.,
2,2',6,6'- and 3,3',4,4'-tetraCB) were much less active in inhibiting vesicular uptake of dopamine than
other more active congeners (e.g., 2,2',4,6- and 2,2',4,5'-tetraCB) (Mariussen et al. 1999). 
Disruption of Ca+2 Homeostasis and Neurological Effects.  Neurological and/or neurodevelopmental
effects from exposure to PCBs also have been hypothesized to involve interference with calcium
homeostatic mechanisms and intracellular second messenger systems by PCB congeners that are not
effective Ah receptor agonists (see reviews by Kodavanti and Tilson 1997; Tilson and Kodavanti 1998;
Tilson et al. 1998).  In agreement with structure-activity relationships observed for PCB effects on
dopamine levels in pheochromocytoma cells (Shain et al. 1991), 2,2'-diCB altered intracellular calcium
homeostasis in cultured rat cerebellar granule cells (increased free calcium levels and inhibited calcium
buffering systems) at noncytotoxic exposure concentrations (higher concentrations were cytotoxic)
(Kodavanti et al. 1993).  In contrast, 3,3',4,4',5'-pentaCB, one of the most effective Ah receptor agonists
among tested PCBs (Safe 1994), was not cytotoxic in the tested concentration range and did not alter
calcium homeostasis to as great an extent as 2,2'-diCB (Kodavanti et al. 1993).  Using phorbol ester
binding in rat cerebellar granule cells as a measure of protein kinase C translocation (which is thought to
play key roles in cellular signal transduction in neurons and be regulated by several intracellular factors
including intracellular levels of free calcium), commercial mixtures of PCBs (Aroclors 1016, 1254, and
1260) were shown to increase protein kinase C translocation in a concentration-dependent manner with
varying potencies  (Kodavanti et al. 1995).  Aroclors 1016 and 1254 were more potent than Aroclor 1260. 
Examination of 24 PCB congeners showed that the most potent congeners (e.g., 2,2'-diCB,
2,2',5,5'-tetraCB, and 2,2',4,6,6'-pentaCB) had multiple ortho chlorines, whereas congeners without ortho
chlorines tended to have either no or lower activities (Kodavanti et al. 1995).  Similar results were found
in structure-activity studies of 24 PCB congeners and their effects on in vitro Ca+2 sequestration by
microsomes and mitochondria from freshly isolated rat cerebellar cells (Kodavanti et al. 1996a). 
Structure activity relationships for PCB congeners and protein kinase C translocation in rat cerebellar
granule cells and Ca+2 sequestration were similar to relationships for PCB congener-induced changes in
dopamine levels in pheochromocytoma cells.  For example, 2,2',5,5'- and 2,2',4,6-tetraCB were among the
most potent congeners and 2,2',6,6'- and 3,3',4,4'-tetraCB were inactive in all three systems (Kodavanti et
al. 1995, 1996a; Shain et al. 1991). 
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One proposed molecular target for PCB disruption of calcium homeostasis that may be involved in
neurological and neurodevelopmental effects is ryanodine-sensitive Ca+2 channels.  Commercial PCB
mixtures with intermediate to high degrees of chlorination (Aroclors 1248, 1254, and 1260) enhanced
ryanodine binding to calcium release channels in sarcoplasmic reticulum membranes from skeletal or
cardiac rabbit muscles, and mixtures with lower (Aroclors 1221, 1232) or higher (Aroclor 1268)
chlorination showed little enhancement (Wong and Pessah 1996).  Examination of selected
pentachlorobiphenyls indicated that ortho substitution favored activity; 2,2',3,5',6-pentaCB induced the
greatest enhancement of ryanodine binding, whereas the 3,3',4,4',5-isomer did not enhance binding
(Wong and Pessah 1996).  The 2,2',4,6,6'-isomer with full substitution at the ortho positions produced
less enhancement than the 2,2',3,5',6-isomer, indicating that some degree of rotation about the biphenyl
bond may be important for full activity.  Results from studies with hippocampal slices from freshly
dissected rat brains indicated that perfusion with a tri-ortho congener (2,2',3,5',6-pentaCB) enhanced
ryanodine binding and inhibited electrophysiological responses to electrical pulse stimulations, but a
mono-ortho congener (2,3',4,4'-tetraCB) showed no enhancement of ryanodine binding and no inhibition
of electrophysiological responses to stimulation (Wong et al. 1997).  Offspring of rats exposed to gavage
doses of 8 or 32 mg/kg/day 2,2',3,5',6-pentaCB on gestation days 10–16 displayed neurobehavioral
changes as adults (depressed open field locomotor activity, faster acquisition on a working memory task,
and no changes in a delayed spatial alternation task) and changes in ryanodine binding to calcium
channels in specific regions of the brain (e.g., decreased in hippocampus and increased in cerebral cortex)
(Schantz et al. 1997).  Although it is not understood how these changes in ryanodine binding are
specifically related to the observed neurobehavioral changes, the results from this series of studies
emphasize the potential importance of Ah receptor independent mechanisms in PCB-induced neurological
and neurodevelopmental effects.
Neutrophil Function and Immunological Effects and Tissue Damage.  PCB-induced functional changes
in neutrophils may be involved in impaired immune defenses against pathogens or enhanced
inflammatory responses (e.g., production of reactive oxygen species and cytolytic enzymes) leading to
tissue injury.  Incubation of quiescent cultured rat peritoneal neutrophils with Aroclor 1242 stimulated
neutrophil production of superoxide anion and induced degranulation in a concentration-dependent
manner without producing cytotoxicity (Ganey et al. 1993).  In neutrophils that were activated for these
functions, Aroclor 1242 produced further increases in superoxide anion production, but inhibited the
activated degranulation process.  Similar effects were observed when neutrophils were incubated with
2,2',4,4'-tetraCB, a congener that has little affinity for the Ah receptor and induces phenobarbital-type
CYPs, but 3,3',4,4'-tetraCB, an Ah receptor agonist and inducer of 3-methylcholanthrene-type CYPs, did 
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not affect neutrophil function (Ganey et al. 1993).  The effects of 2,2',4,4'-tetrachlorbiphenyl on in vitro
production of superoxide anion by neutrophils were inhibited when neutrophils were incubated in the
absence of extracellular calcium or in the presence of TMB-8, an antagonist of the intracellular
mobilization of calcium (Brown and Ganey 1995).  In addition, neutrophil degranulation induced by
2,2',4,4'-tetraCB was enhanced by coexposure with the calcium ionophore A23187 (Brown and Ganey
1995).  A mono-ortho congener, 2,3,4,5-tetraCB, displayed somewhat different effects on neutrophil
functions than those from the 2,2',4,4'-congener: it stimulated degranulation in quiescent and activated
neutrophils, but only increased superoxide anion production in activated neutrophils, not in quiescent
cells.  The results from the neutrophil studies suggest the involvement of an Ah-receptor independent
mechanism that involves PCB-induced increases in intracellular calcium or PCB effects on a signal
transduction pathway that is dependent on calcium availability (Brown and Ganey 1995).  Recent work
suggests activation of phospholipase A2, release of arachidonic acid from triglycerides, and production of
prostaglandins as a probable mechanism (Tithof et al. 1996; Olivero and Ganey 2000).  This mechanism
could also contribute to other pathologies.
PCB Effects Involving Ah-receptor Dependent and Independent Mechanisms    
PCB-induced effects that may involve both Ah-receptor dependent and independent mechanisms include
liver hypertrophy (Hori et al. 1997); neurodevelopmental effects or reproduction effects involving
changes in steroid hormone homeostasis (Arcaro et al. 1999; Connor et al. 1997; Gierthy et al. 1997;
Fischer et al. 1998; Li and Hansen 1997; Nesaretnam and Dabre 1997; Nesaretnam et al. 1996; Seegal et
al. 1997) and/or thyroid hormone disruption (Brouwer et al. 1998b; Hansen 1998; Li and Hansen 1996a,
1996b, 1997); immunological effects (Harper et al. 1993a, 1993b; Silkworth and Grabstein 1982; Stack et
al. 1999); and cancer through nongenotoxic mechanisms involving promotion of oncogenic cells
(Cogliano 1998; Safe 1994) and/or genotoxic mechanisms (Robertson and Gupta 2000).
Liver Hypertrophy.  Liver hypertrophy in animals is produced by oral exposure to commercial PCB
mixtures and appears to involve both Ah-receptor dependent and independent mechanisms.  An
illustration of this phenomenon is the observation that single intraperitoneal doses of any one of three
PCB congeners varying in affinity for the Ah receptor produced liver hypertrophy in Ah responsive
(C57BL/6) and Ah nonresponsive (DBA/2 mice (Hori et al. 1997).  The studied congeners were
3,3',4,4',5-pentaCB, a congener with high Ah receptor affinity, 3,3',4,4'-tetraCB, a congener with lesser
affinity, and 2,2',5,5'-tetraCB, a low-affinity Ah-receptor ligand. 
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Reproductive Effects.  There are several studies examining female reproductive function variables in rats
(Brezner et al. 1984; Hany et al. 1999b; Linder et al. 1974; Sager and Girard 1994), mice (Welsch 1985),
rabbits (Seiler et al. 1994), minks (Aulerich and Ringer 1977; Backlin and Bergman 1995; Kihlstrom et
al. 1992), and monkeys (Arnold et al.1995, 1996; Barsotti et al. 1976) repeatedly exposed orally to
commercial PCB mixtures, predominately Aroclor 1254.  In general, results from these studies identify
minks and monkeys as sensitive species. 
In minks, repeated exposure to low doses of Aroclor 1254 or Clophen A50 (0.4–1.8 mg/kg/day) caused
reproductive failure that has been associated with fetal death following embryo implantation (Aulerich
and Ringer 1977; Backlin and Bergman 1995; Backlin et al. 1997; Kihlstrom et al. 1992).  This effect
may predominately involve Ah-receptor mediation, as evidenced by observations that only 1/10 minks
exposed to 2.5 ppm Aroclor 1254 in the diet from 1 month prior to breeding through parturition produced
offspring, whereas exposure by a similar protocol to 2,2',4,4',5,5'-hexaCB or 2,2',3,3',6,6'-hexaCB at
concentrations up to 5 ppm did not influence reproductive performance (Aulerich et al. 1985).  In
contrast, exposure to dietary concentrations as low as 0.1 ppm 3,3',4,4',5,5'-hexaCB in this study
(Auerlich et al. 1985), and 0.05 ppm in another study (Aulerich et al. 1987), caused mortality and
prevented the minks for reproducing.  Dietary exposure of minks to a fraction of Aroclor 1254, containing
only congeners with no ortho-chlorines or a single ortho-chlorine and representing <20% of the total
weight of Aroclor 1254, reduced litter size and fetal survival, and increased incidence of interrupted
pregnancies to a similar degree as doses of the complete Aroclor 1254 mixture (1.3 mg/kg/day)
containing the same amount of these congeners (Kihlstrom et al. 1992).  These results suggest the
importance of Ah-receptor mediation of PCB-induced reproductive impairment in minks.  
Another mink study comparing reproductive effects from intraperitoneal doses of 2,2',4,4',5,5'- and
3,3',4,4',5,5'-hexaCB reinforces the idea that congeners with high Ah-receptor affinity are more potent
than congeners with low Ah-receptor affinity, but also provides evidence that Ah-receptor independent
mechanisms may be involved (Patnode and Curtis 1994).  Administration of single 20-mg/kg doses of the
2,2',4,4',5,5'-isomer (a poor Ah-receptor agonist that has been detected in wild mink tissues at
concentrations 50-fold greater than the 3,3',4,4',5,5'-isomer) to pregnant minks on the approximate date of
implantation did not affect the number of implantation sites (assayed 14 days after dose administration),
but significantly decreased the number of embryos and embryonic weight, crown-to-rump length, and
head length.  The 3,3',4,4',5,5'-isomer (at lower dose levels of 0.4 or 0.8 mg/kg) also did not affect the
number of implantation sites, but produced more severe effects on embryo survival and the weight,
crown-to-rump length, and head length of surviving embryos (Patnode and Curtis 1994).
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The mechanisms involved in PCB-induced reproductive impairment in minks are unknown, but
examination of mid- to late-gestation placentae from minks exposed to Clophen A50 by light and electron
microscopy revealed degenerative lesions in maternal (endothelial detachment and thrombosis in maternal
vessels) and fetal (trophoblastic disintegration and loss of fetal capillary integrity) tissues (Backlin et al.
1998b).  Jones et al. (1997) postulated that the mechanisms are likely to be multifactorial given the
possibility of direct and/or indirect tissue damaging actions of PCBs and the wide range of reported
effects of PCBs on steroid hormone synthesis and functions including PCB regulation of CYP oxygenases
that activate or deactivate different endogenous steroid hormones, estrogenic and antiestrogenic effects of
PCBs, and PCB regulation of estrogen and progesterone receptor levels (see Battershill 1994; Li and
Hansen 1997; Patnode and Curtis 1994).
Impaired ability to conceive and decreased fetal survival have been observed following repeated exposure
of female Rhesus monkeys to commercial PCB mixtures.  Exposure to dietary levels of 2.5 or 5 ppm
Aroclor 1248 (approximately 0.1 or 0.2 mg/kg/day) for 16–19 months (including a 7-month period before
breeding with nonexposed males) produced resorptions or abortions in 3/8 and 4/6 impregnated female
Rhesus monkeys, compared with 0/12 in a control group (Barsotti et al. 1976).  In this study, 12/12, 8/8,
and 6/8 females became impregnated in the 0-, 2.5-, and 5-ppm groups, respectively.  Another study fed
encapsulated Aroclor 1254 at dose levels of 0, 0.005, 0.02, 0.04, or 0.08 mg/kg/day to female Rhesus
monkeys for 37 months before breeding with nonexposed males and continued dosing through mating
and gestation (Arnold et al. 1995).  Incidences of abortions, resorptions, or stillbirths were 2/11, 5/10, 3/4,
2/6, and 4/5 in impregnated monkeys in the control through high-dose groups, respectively; respective
incidences for impregnation success were 11/16, 10/16, 4/15, 6/14, and 5/15 (Arnold et al. 1995). 
Mechanisms for these effects in monkeys are unknown, but microscopic examination of tissues from
control and exposed monkeys in the second monkey study found no evidence for an association with
endometriosis (Arnold et al. 1996).
The plausibility that PCB effects on reproductive function (and other functions such as neurobehavior and
immunological competence) may involve PCB effects on endocrine functions has led to investigations of
the estrogenic and anti-estrogenic activities of PCB mixtures and individual congeners, and the effects of
PCBs or related halogenated aromatic compounds on steroid hormone metabolism via induction of
Phase I or Phase II enzymes.  How these PCB effects are specifically related to PCB effects on
reproductive function is unknown, but the results of these investigations provide further evidence that
reproductive effects from PCB mixtures may not be restricted to Ah-receptor mediation alone and are 
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likely to involve multiple mechanisms that have yet to be elucidated.  Related information on endocrine
disruption is discussed in Section 3.6.   
The estrogenic and anti-estrogenic activities of some commercial PCB mixtures, PCB congeners, and
hydroxylated derivatives of PCB congeners have been assayed by examining uterine variables in
immature or ovariectomized female rodents, cell proliferation or gene expression variables in cultured
cells including human breast cancer or HeLa cells, and in vitro binding to estrogen receptor preparations
(see Andersson et al. 1999; Arcaro et al. 1999; Battershill 1994; Connor et al. 1997; Gierthy et al. 1997;
Hansen 1998; Kramer et al. 1997; Krishnan and Safe 1993; Li and Hansen 1997; Moore et al. 1997; Safe
1999; Safe et al. 1998b for reviews).  In general, (1) PCB-induced estrogenic activities have been
characterized as weak compared to the endogenous hormone, 17β-estradiol, (2) a wide variability of
responses has been observed across types of PCBs and assays indicating the involvement of multiple
mechanisms (e.g., direct binding to the estrogen receptor is not the only way that estrogenic or anti-
estrogenic physiological effects may be mediated), (3) anti-estrogenic activities have been most strongly
associated with PCBs that are Ah-receptor agonists, and (4) hydroxylated metabolites of PCBs are
postulated to be at least partly responsible for physiological responses to PCBs that may involve changes
in estrogen receptor-dependent physiological processes.  Recent demonstrations that hydroxy PCBs
inhibit hydroxy steroid sulfotransferase suggest that PCB metabolites indirectly exert estrogenic activity
via inhibition of estradiol metabolism (Kester et al. 2000).
Early studies showed that subcutaneous administration of 8 mg of Aroclors 1221, 1232, 1242, or
1248 increased uterine weight and glycogen content in rats, but similar exposure to Aroclors 1254, 1260,
1262, or 1268 did not produce this estrogenic effect (Bitman and Cecil 1970).  More recent studies have
provided further evidence that PCB mixtures can produce estrogenic responses (albeit weak) and that
PCB congeners with multiple ortho chlorines (or their hydroxylated metabolites) may be at least partly
responsible for these responses.  Intraperitoneal doses of Aroclor 1242 (8 mg/rat on day 20 or 0.08 or
0.32 mg/rat on days 20 and 21) significantly increased uterine wet weight in immature female rats to
about 40% of the increase produced by 0.001 mg 17β-estradiol (Jansen et al. 1993).  Similar increases in
uterine wet weight were produced by exposure to di-ortho congeners or hydroxylated derivatives
(0.640 mg 2,2',5,5'-tetraCB or 0.250 mg 2,4,6-trichloro-4'-hydroxy-biphenyl on days 20 and 21), but not
by exposure to a coplanar congener without ortho chlorines (0.160 mg 3,3',4,4'-tetrachlorobiphenyl).  In
another study, the tetra-ortho congener, 2,2',6,6'-tetraCB, displayed similarly weak estrogenic responses
in an in vitro human breast cancer cell assay and an in vivo immature female rat assay (Arcaro et al.
1999).  This congener did not competitively bind in vitro to recombinant human estrogen receptors α and 
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β, but a hydroxylated metabolite, 2,2',6,6'-tetrachloro-4'-hydroxy-biphenyl, competitively bound to
estrogen receptor α and produced proliferative responses in the breast cancer assay at concentrations
about 10-fold lower than effective concentrations of the parent molecule (Arcaro et al. 1999). 
Combined exposure of immature rats to 0.32 mg Aroclor 1242 and 0.001 mg 17β-estradiol produced a
response similar to estradiol alone, indicating no obvious anti-estrogenic activity, but combined exposure
to 0.001 mg estradiol and 0.160 mg 3,3',4,4'-tetraCB markedly diminished the estradiol-induced increase
in uterine wet weight (Jansen et al. 1993).  Anti-estrogenic effects similar to those from 3,3',4,4'-tetraCB
were also observed in rodent uterine tissue (Astroff and Safe 1990) and human breast cancer cells
(Krishnan and Safe 1993) by other congeners with no or single ortho chlorines (e.g., 3,3',4,4',5-pentaCB,
2',3,3',4,4',5-hexaCB), but commercial PCB mixtures were not anti-estrogenic in the breast cancer cell
assay.  Whereas the data collected by Krishnan and Safe (1993) suggest that anti-estrogenic activities of
PCBs may be related to Ah receptor binding affinity of nonmetabolized PCBs, anti-estrogenic activities
of hydroxylated metabolites of PCBs with no ortho chlorines, with single ortho chlorines, or with
multiple ortho chlorines have been observed in in several assay systems (Connor et al. 1997; Moore et al.
1997; Nesaretnam et al. 1996; Safe et al. 1998b).  Thus, whether or not a specific PCB mixture will be
anti-estrogenic appears to be at least partly dependent on the chlorine substitution pattern of the parent
PCBs and on the degree of formation of hydroxylated metabolites.
Structure-activity relationships for estrogenic activities of PCB congeners or their metabolites are less
clear.  Some hydroxylated PCBs (2,4,6-trichloro-4'-hydroxy-biphenyl and 2,3,4,5-tetrachloro-4'-hydroxy-
biphenyl) have been demonstrated to competitively bind to mouse estrogen receptor preparations and to
increase uterine weight and glycogen in immature mice (Korach et al. 1988).  In other estrogenic assays,
2,2',4,4',6-tetraCB, 2,4,4',6-tetrachloro-4-hydroxy-biphenyl, and 2,4,6-trichloro-4'-hydroxy-biphenyl were
equally effective in stimulating proliferation of human breast cancer cells, but only 2,4,6-trichloro-
4'-hydroxy-biphenyl caused significant induction of vitellogenin in cultured brown trout hepatocytes
(Andersson et al. 1999).  A structure-activity study of eight hydroxylated PCBs in a series of in vivo and
in vitro estrogenic assays found that structure activity relationships were complex and differed from one
assay to the next (Connor et al. 1997; Safe et al. 1998b).  For example, all but one of the compounds
displayed competitive binding to rat and mouse cytosolic estrogen receptors (affinities ranged from about
10-3 to 10-5 of 17β-estradiol’s affinity), but no estrogenic activities (wet weight, peroxidase activity,
progesterone receptor level) were produced in the uteri of immature rats and mice exposed to three
consecutive daily doses of the individual hydroxylated PCB congeners at levels of  25, 50, or 100 mg/kg.  
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In contrast, four of the hydroxylated congeners produced estrogenic effects in cultured human breast cells
and HeLa cells (Connor et al. 1997; Safe et al. 1998). 
Complex effects on male reproductive organs and functions have been observed in animals exposed to
commercial PCB mixtures including reduced testes weight in adult male offspring of guinea pigs exposed
during gestation to Clophen A50 (Lundkvist 1990), reduced testes weight in adult male offspring of
female rats exposed from 50 days prior to mating through birth of offspring to 4 mg/kg/day
Aroclor 1254 or a mixture of PCBs reflective of the composition of human milk samples (Hany et al.
1999b), reduced fertility (without changes in reproductive organ weights, sperm production, or sperm
morphology) in adult male offspring of female rats exposed to doses of 8 mg/kg Aroclor 1254 and higher
on lactation days 1, 3, 5, 7, and 9 (Sager et al. 1987, 1991), and elevated testes weight and increased
sperm production in adult rats exposed to subcutaneous doses of Aroclor 1242 or 1254
(10–80 mg/kg/day) on postnatal days 0–25 (Cooke et al. 1996).  Mechanisms involved in these effects on
male reproductive organ development are unknown, but have been postulated to involve developmentally
specific periods of responsiveness such as long-lasting elevation of testosterone-metabolizing enzymes
from in utero exposure leading to reduced testes weight (Hany et al. 1999b) and continued depression of
thyroid hormone levels during the neonatal period leading to Sertoli cell proliferation and increased testes
weight (Cooke et al. 1996).
Disruption of Thyroid Hormone Homeostasis.  Concern that the thyroid hormone system may be
important in PCBs mechanisms of toxicity stems from mainly two important types of observations
(Brouwer et al. 1998b; Porterfield and Hendry 1998): (1)  extensively corroborated findings in
experimental animals that exposure to PCBs in utero and/or during early development (e.g., through
breast milk) can deplete levels of circulating thyroid hormone in the fetus or neonate, which may give rise
to effectively a hyopothyroid state during development (Collins and Capen 1980c; Cooke et al. 1996;
Corey et al. 1996; Darnerud et al. 1996a; Goldey et al. 1995; Juarez de Ku et al. 1994; Li et al. 1998;
Morse et al. 1996c; Rice 1999a; Provost et al. 1999; Schuur et al. 1998a; Seo and Meserve 1995; Zoeller
et al. 2000); and (2) the recognition of the importance of thyroid hormones in normal development of the
brain, as evident from neurodevelopmental disorders and deficits associated with hypothyroidism
(Boyages 2000).  The latter are typified by iodine deficiency (e.g., endemic cretinism), which can produce
a wide range of neurodevelopmental deficits, including auditory, motor, and intellectual deficits.  These
outcomes suggest an importance of thyroid hormones in the normal development of the fetal cochlea,
basal ganglia, and cerebral cortex, which begin to develop in humans during the second trimester of
gestation.  This is also the time in which the fetal thyroid gland becomes functional.
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Evidence for a potential thyroid hormone involvement in PCB toxicity rests largely on observations made
in experimental animals, including rodents and nonhuman primates (see Section 3.2.2.8.3).  Although the
studies differ in design and, in particular, the emerging picture from these studies is that, depending on
dose and duration, PCBs can disrupt the production and disposition of thyroid hormones at a variety of
levels.  The major findings include (1) histological changes in the thyroid gland indicative of both
stimulation of the gland (e.g., similar to that induced by TSH or a hypothyroid state) and a disruption of
the processing of follicular colloid needed for normal production and secretion thyroid hormone (Chu et
al. 1994, 1995, 1996a, 1996b, 1998b; Collins and Capen 1980a; Collins et al. 1977; Hansen et al. 1995;
Tryphonas et al. 1986b); (2) depression of serum T4 and T3 levels, which may effectively create a
hypothyroid state (Byrne et al. 1987; Collins and Capen 1980c; Cooke et al. 1996; Corey et al. 1996;
Darnerud et al. 1996a; Desauliniers et al. 1997; Goldey et al. 1995; Gray et al. 1993; Hansen et al. 1995;
Hood et al. 1999; Juarez de Ku et al. 1994; Kasza et al. 1978; Li et al. 1998; Morse et al. 1996c; Price et
al. 1988; Provost et al. 1999; Rice 1999a; Schuur et al. 1998a; Seo and Meserve 1995; Van Birgelen et al.
1995; Zoeller et al. 2000); (3) increased rates of elimination of T4 and T3 from serum (Goldey and Crofton
1998); (4) increased activities of T4-UDP-GT in liver (Chu et al. 1995; Desauliniers et al. 1997; Morse et
al. 1996c; Schuur et al. 1998a; Van Birgelen et al. 1995), which is an important metabolic elimination
pathway for T4 and T3; (5) decreased activity of iodothyronine sulfotransferases in liver which are also
important in the metabolic elimination of iodothyronines (Schuur et al. 1998a, 1998b, 1999);
(6) decreased activity of iodothyronine deiodinases  including brain Type-2 deiodinase, which provide the
major pathways for the production of the active thyroid hormone, T3 (Morse et al. 1996c; Schuur et al.
1998a); and (7) decreased binding of T4 to transthyretin an important transport protein for both T4 and T3
(Cheek et al. 1999; Darnerud et al.1996a).  
The above observations suggest that PCBs can disrupt the production of thyroid hormones, both in the
thyroid and in peripheral tissues, can interfere with their transport to peripheral tissues, and can accelerate
the metabolic clearance of thyroid hormones.  The most convincing evidence that PCBs can exert toxicity
by disrupting thyroid hormone system derives from two studies in rats.  In one study, neurobehavioral
deficits in pups that experienced exposures to Aroclor 1254 in utero and during nursing, were
significantly attenuated by subcutaneous injections of T4 that increased serum T4 and T3 concentrations
that were otherwise depressed in the PCB-exposed animals (Goldey and Crofton 1998).  While this study
examined relatively high doses of Aroclor 1254 ($1 mg/kg/day), it nevertheless demonstrated
neurodevelopmental effects that are directly relevant to observations made in epidemiological studies and
to neurological sequelae of fetal hypothyroidism, including motor disturbances and hearing.  
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In the second study, increased testes weight and sperm production in rats that were administered
Aroclor 1254 on postnatal days 1–25 were attenuated by injections of T4 on postnatal days 1–25, which
also prevented the depression in serum T4 concentrations (Cooke et al. 1996).  Here again, although
produced by relatively large doses of Aroclor 1254 ($40 mg/kg/day, subcutaneous), similar effects can be
produced by other hypothyroid-inducing agents, including PTU.  Furthermore, the effects observed may
reflect a disruption of the normal sexual maturation process, which is known to be associated with
neonatal hypothyroidism in humans (Longcope 2000).
The effects PCBs on thyroid hormone status appear to involve Ah-receptor mediated or modulated actions
as well as actions that appear to be independent of the Ah receptor.  Depressed levels of serum T4 have
been observed in rats given oral doses of coplanar PCB congeners (Desauliniers et al. 1997; Price et al.
1999; Van Birgelen et al. 1994b) or di-ortho-substituted congeners that have relatively low affinity for the
Ah receptor (Ness et al. 1993; Van Birgelen 1992).  At least one potential Ah-receptor mediated
mechanism for this effect is the induction of UDP-GT, which catalyzes the metabolic elimination of T4 to
the T4-glucuronide conjugate (Desauliniers et al. 1997; Van Birgelen et al. 1995).  However, the UDP-GT
mechanism does not appear to be important in the depression of T4 levels produced by non-coplanar
PCBs.  Li and Hansen (1996) observed depressed serum T4 levels in rats administered a PCB mixture
extracted from soil.  Treatment of the mixture with activated charcoal greatly reduced the content of co-
planar PCBs in the mixture, substantially decreased the potency of the mixture for inducing UDG-GT and
EROD, but had little effect on the potency for depressing T4 levels.  This suggests that an Ah-independent
mechanism may exist that is not related to UDP-GT induction. 
PCBs, including poly-ortho-substituted PCBs, which have a very low affinity for the Ah receptor, inhibit
the binding of T4 to transthyretin, an important transport protein for both T4 and T3 (Chauhan et al. 2000;
Cheek et al. 1999; Darnerud et al. 1996a).  Inhibition of binding of thyroid hormones to transthryetin
could alter hormone delivery to target tissues, including the brain, and could also result in depressed
levels of serum total TT4 or TT3 (Brouwer et al. 1998).
Immunological Effects.  Studies with inbred mice strains differing in Ah-receptor responsiveness
indicate that immunosuppression from PCB mixtures involves Ah-receptor mediation (e.g., Silkworth and
Grabstein 1982; Harper et al. 1993a), but there is evidence that other mechanisms also may contribute to
PCB-induced immunological effects (Harper et al. 1993a, 1993b; Stack et al. 1999).  Illustrating the
importance of Ah-receptor mediation for some PCB congeners, Ah-responsive C57BL/6 mice given
single intraperitoneal doses of 100 mg/kg 3,3',4,4'-tetraCB showed marked decreases in the number of 
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splenic PFCs formed in response to immunization with SRBCs (which are T-cell dependent antigens)
compared with similarly treated Ah-nonresponsive DBA/2 mice (Silkworth and Grabstein 1982).  In
addition, ED50 values for 2,3,7,8-TCDD, three CDFs, and two PCBs without ortho substitution
(3,3',4,4',5-pentaCB and 3,3',4,4',5,5'-hexaCB) in this immunotoxicity assay were lower in C57BL/6 mice
than in DBA/2 mice, and the order of immunotoxic potency of these six compounds was the same as that
for potency in inducing CYP1A1 (Harper et al. 1993a).  In another study, a series of four hexachlorinated
biphenyls with differing chlorine substitution patterns displayed varying ED50 values in the same
immunotoxicity assay as follows: 2, >1,000, 120, and >1,000 µmol/kg for a mono-ortho- (2,3,3',4,4',5'-),
di-ortho- (2,2',4,4',5,5'-), tri-ortho- (2,2',4,4',5',6-), and tetra-ortho (2,2',4,4',6,6'-)-isomer, respectively
(Harper et al. 1993b).  Harper et al. (1993b) concluded that immunotoxic potency decreases (i.e., ED50s
increase) with increasing ortho-chlorine substitution of PCBs, but, as shown above, the decrease was not
monotonic with increasing degree of ortho chlorination.  Furthermore, this relationship did not apply to
more highly chlorinated PCBs with three or four ortho chlorines that are inactive as Ah-receptor agonists
and only minimally induce CYP1A1 (Harper et al. 1993b).  Three nonachlorobiphenyls
(2,2',3,3',4,4',5,5',6-, 2,2’,3,3',4,4',5,6,6'-, and 2,2',3,3',4,5,5',6,6'-nonaCB) and decachlorobiphenyl
displayed ED50s for inhibition of the splenic PFC response to SRBC in C57BL/6 mice that were less than
those for hexachlorobiphenyl isomers with multiple ortho chlorines reported above: 15, 7, 17, and
35 µmol/kg, respectively.  These results are consistent with the hypothesis that some PCBs induce
immunotoxicity via Ah-receptor independent mechanisms.  In an in vitro assay of cell proliferation in
response to lipopolysaccharide (a T-cell independent antigen), Aroclors 1221, 1242, 1254, or
1260 inhibited the proliferative response similarly in splenocytes from either C57BL/6 or DBA/2 mice
(Stack et al. 1999).  Two non-ortho and two mono-ortho PCBs that have been demonstrated to be
effective Ah-receptor agonists and CYP1A1 inducers did not inhibit the in vitro proliferative response to
lipopolysaccharide, but two di-ortho congeners (2,2',3,4,4',5- and 2,2',4,4',5,5'-hexaCB) significantly
inhibited the response.  These in vitro results provide supporting evidence for the existence of
mechanisms of PCB immunotoxic actions that are independent of the Ah receptor.  
Cancer.  Lifetime oral exposure to any one of four commercial PCB mixtures (Aroclors 1016, 1242,
1254, and 1260) has been demonstrated to produce liver tumors in female rats; Aroclor 1260 also induced
liver tumors in male rats (Mayes et al. 1998).  Mixtures with high chlorination content (e.g.,
Aroclor 1254) were generally more potent than mixtures with low chlorine content (e.g., Aroclor 1016)
(Mayes et al. 1998).  Tumor promotion by commercial PCB mixtures following initiation by a variety of
chemical agents also has been investigated in a number of animal systems including rat liver, rat kidney,
mouse skin, and newborn mouse liver and lung (see Silberhorn et al. 1990 for review).  The tumor 
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promoting effect of extended exposure to PCB mixtures was demonstrated principally in the liver of rats;
there is some evidence that PCB mixtures also can promote tumors in mouse lung and mouse skin, but not
in rat kidneys.  The mechanism of PCB-induced cancer is poorly understood, but there is evidence to
suggest that both Ah-receptor dependent and independent mechanisms may be involved.
PCB promotion of tumors does not appear to be solely an Ah-receptor mediated process, since individual
congeners that are not Ah receptor agonists have tumor promotion capabilities in animal systems.  For
example, 2,2',5,5'-tetraCB, 2,2',4,4'-tetraCB, and 2,2',4,4',5,5'-hexaCB were shown to promote liver
tumors in female Sprague-Dawley rats (Hemming et al. 1993; Preston et al. 1985).  In addition,
2,2',5,5'-tetraCB, 2,2',3,3',4,4'-hexaCB, and 2,2',4,4',5,5'-hexaCB were potent inhibitors of in vitro gap
junctional cellular communication, an assay that is indicative of tumor promotion capacity (Bager et al.
1997; De Haan et al. 1996).  A general working mechanistic hypothesis for PCB promotion of liver
tumors involves indirect stimulation of cell proliferation following cell or tissue injury by reactive
metabolites of PCBs (Silberhorn et al. 1990).  Alternatively, the cell injury could be caused by increased
intracellular concentrations of other reactive species (e.g., superoxide anion or other reactive oxygen
species) caused by an overall imbalance from PCB-induced perturbations of cellular biochemical
processes, including induction of CYP oxygenases and glutathione S-transferases, repression of selenium-
dependent glutathione peroxidases, and/or disruption of calcium homeostatic processes and signal
transduction pathways (Silberhorn et al. 1990).
PCB mixtures have not shown consistent tumor initiating activity in animal initiation-promotion protocols
(Silberhorn et al. 1990), but demonstration that chronic oral exposure to commercial PCB mixtures
induced liver tumors in female rats (Mayes et al. 1998) suggests that PCBs may have both tumor initiating
and promoting activities.  Although PCB mixtures generally have been found to be inactive as mutagens
in S. typhimurium strains and in several other tests of genotoxicity that may be predictive of tumor
initiation capability (see Silberhorn et al. 1990 for review), in vitro studies with rat microsomes have
indicated that metabolism of lower chlorinated PCBs (e.g., 4-CB, 3,4-diCB, and 3,4,5-triCB) can lead to
covalently modified macromolecules including proteins and DNA (see Robertson and Gupta 2000 for
review).  Studies demonstrating the Ah-receptor dependence or independence of this potential genotoxic
effect from PCBs were not located.  The available data indicate that PCBs are not potent genotoxicants,
but the possible involvement of genotoxic mechanisms (involving covalent modification of proteins
and/or DNA) in the development of PCB-induced cancer is not without some experimental support.
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The relative contribution that Ah-receptor dependent and independent mechanisms may make to
carcinogenic responses to PCB mixtures is unknown.  Safe (1994) compared carcinogenic responses of
female rats to 2,3,7,8-TCDD in the diet with responses of female rats of the same strain to
Aroclor 1260 in the diet using the TEF approach.  TCDD at a TEQ feed concentration of 2,100 ppt
induced hepatic adenocarcinomas in 11/50 (22%) rats, whereas a TEQ of only 1,040 ppt from
Aroclor 1260 induced adenocarcinomas in 24/47 (51%) rats.  For this situation, the TEF approach
markedly underestimated the carcinogenic response to Aroclor 1260.  A possible explanation is that PCB
congeners that are not Ah receptor agonists and are abundant in Aroclor 1260 make significant
contributions to the mixture’s carcinogenicity.  Although this comparison suggests that the TEF approach
may underestimate cancer responses to complex PCB mixtures, another study of the tumor promotion
activity of a simpler mixture of two CDDs, one CDF, and three PCBs in female rats found that the TEF
approach overestimated the observed response by a factor of about 2 (van der Plas et al. 1999).  The
mixture contained 2,3,7,8-TCDD, 1,2,3,7,8-pentachlorodibenzo-p-dioxin, 2,3,4,7,8-pentachloro-
dibenzofuran, 3,3',4,4',5- and 2,3',4,4',4-pentaCB, and 2,3,3',4,4',5-hexaCB at relative levels found in
Baltic Sea herring.  The rats were initiated with an injection of diethylnitrosoamine, 24 hours after a
partial hepatectomy and were administered weekly subcutaneous injections of the mixture for 20 weeks
starting 6 weeks after initiation.  The volume and volume fraction of glutathione S-transferase-positive
altered hepatic foci were taken as indicators of tumor promotion activity in this study (van der Plas et al.
1999).  Although the composition of this mixture reflected relative concentrations and accounted for
>90% of total TEQs in Baltic Sea herring, it did not contain PCBs with multiple ortho chlorines, which
comprise the predominant bulk of PCB weight in most commercial and environmental mixtures.  For
example, non-, mono-, and di-ortho congeners accounted for <1, 18, and 82% of PCB weight per gram of
fat in human milk samples from Italy (Larsen et al. 1994).  Another group of rats was similarly treated
with the same synthetic mixture plus a di-ortho PCB congener (2,2',4,4',5,5'-hexaCB), which is one of the
predominant PCB congeners in environmental mixtures and has minimal Ah receptor agonist activity
(van der Plas et al. 1999).  Mean foci volume and foci volume fraction were increased in rats treated with
the supplemented mixture compared with the mixture without the di-ortho congener, but the observed
responses were still less than that predicted by the TEF approach.  Better understanding of the relative
contributions of Ah receptor dependent and independent mechanisms to the carcinogenicity of PCB
mixtures awaits further research.
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3.5.3 Animal-to-Human Extrapolations
As with other organisms, PCB residue levels in humans reflects multiple exposure pathways, and
congener-specific elimination.  PCB profiles in human serum immediately following exposures reflect the
profiles in the exposure sources, however, selective metabolism and excretion begin to alter the congener
profile within 4–24 hours (Hansen 1999).  Thus, in most cases, the PCB profile in adults represents a
steady state body burden which does not match the profile of commercial PCB formulations (Aroclors,
etc.).  For example, the PCB profile of a composite human milk sample does not resemble the pattern of
any commercial PCB formulation (Safe et al. 1985).  Furthermore, PCB residue analysis indicates that
humans, aquatic mammals, birds, fish, and other biota retain a similar profile of PCB congeners. 
Borlakoglu and Walker (1989) reported that fisheating sea birds, human fat, American breast milk, and
German breast milk have similar PCB congener profiles, which are different from that of Aroclor 1260 or
Clophen A60.  The hexachlorinated PCBs, 138 (2,2',3,4,4',5') and 153 (2,2',4,4',5,5'), were major
congeners present in all samples from this study, while PCB 149 (2,2',3',4',5',6) was only found as a major
component of Aroclor 1260 and Clophen A60.  PCB 118 (2,3',4,4',5) was a major congener in biological
samples and only a minor component of the commercial PCB formulations.  McFarland and Clarke
(1989) reported that  PCBs 118, 138, 153, 156, 170, 180, and 187 were PCBs retained at a high relative
abundance in porpoise, carp, duck, oligochaete, seston, shrimp, and human fat and milk.  PCB 153 was
the most abundant congener present in porpoise, carp, duck, oligochaete, and human fat and milk.  In
contrast to PCB residues present in the above populations with normal background exposures, humans
retained PCB 74 as the most abundant PCB in human fat and serum following a case of occupational
exposure (Stellman et al. 1998; Wolff et al. 1982a, 1982b).  Thus, selective high level exposures, such as
an occupational exposure, may result in an altered profile of retained PCB congeners, relative to that
observed in cases of normal background exposure.  However, the above studies generally find similar
PCB congener profiles in different tissues and species, indicating that the biological fate of PCB
congeners is qualitatively similar in various animal species.
Significant interspecies differences in the quantitative metabolism of PCBs contributes directly to the
species differences in the relative persistence (biological half-life) of PCB congeners.  For example,
PCB 153 is often the most prevalent PCB detected in humans, due to exposure and the slow rate of
biotransformation of this congener.  3-Hydroxy-2,4,5,2',4',5'-hexaCB was identified as the major
metabolite of PCB 153 formed by human CYP2B6 (Ariyoshi et al. 1995).  CYP2B6 is constitutively
expressed in humans, but only accounts for a maximum of 1–2% of the total CYPs in human liver. 
Approximately 75% of the subjects examined had no detectable level of CYP2B6 protein by 
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immunoblotting (Mimura et al. 1993).  This may be the reason why no metabolite of PCB 153 was
detected in an earlier in vitro study using human liver microsomes (Schnellmann et al. 1983). 
3-Hydroxy-PCB 153 is also the major metabolite in the feces and bile of monkeys treated with PCB 153
(Norback et al. 1981).  The CYP2B isoform represents about 5% of the total P-450 in monkey liver, and
this may account for the approximately 5-fold more rapid elimination of PCB 153 from monkeys and the
resulting shorter half-life in monkeys, relative to humans (Mes et al. 1995a, 1995b, 1995c; Ohmori et al.
1992).  The dog has a unique ability to more rapidly metabolize and eliminate PCB 153 through the
CYP2B11- mediated 3-hydroxylation of PCB 153 via a 2,3-arene oxide intermediate (Ariyoshi et al.
1992; Duignan et al. 1987; Sipes et al. 1982).  Thus, the high potential for accumulation and persistence
of PCB 153 in humans is due to the very low levels of CYP2B6 and low catalytic activity for
3-hydroxylation of this congener.
PCB congeners that are structurally similar to 2,3,7,8-TCDD exhibit Ah receptor-mediated responses. 
These congeners appear to be the most potent for some PCB-induced effects.  Therefore, it would seem
reasonable to assume that, at least for these specific toxic effects, differences in susceptibility among
animal species could be explained by differences in receptor levels in target tissues or by differences in
the affinity of binding of the specific congeners.  Information on this subject is mainly derived from
studies with 2,3,7,8-TCDD.  Data summarized by Okey et al. (1994) indicate that differences in receptor
level or receptor affinity cannot explain marked differences in susceptibility to halogenated aromatic
hydrocarbon toxicity across species.  It is possible that differences in sensitivity among species may be
determined by some event or events occurring after the initial binding of the ligand to the receptor.  
The Ah receptor has been identified in many human tissues and human cell lines (Okey et al. 1994). 
Several differences between human and animal Ah receptor protein have been described.  Perhaps the
most important difference is that the human Ah receptor has a lower affinity for 2,3,7,8-TCDD than the
Ah receptor from rats or from responsive strains of mice.  This information, although limited, leads to the
conclusion that the biochemical and toxicological responses (those that exhibit a threshold) to dioxin-like
aromatic hydrocarbons in humans would require higher doses or exposures than in animal species
possessing a receptor of higher affinity (Okey et al. 1994).
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3.6 ENDOCRINE DISRUPTION
Recently, attention has focused on the potential hazardous effects of certain chemicals on the endocrine
system because of the ability of these chemicals to mimic or block endogenous hormones, or otherwise
interfere with the normal function of the endocrine system.  Chemicals with this type of activity are most
commonly referred to as endocrine disruptors.  Some scientists believe that chemicals with the ability to
disrupt the endocrine system are a potential threat to the health of humans, aquatic animals, and wildlife. 
Others believe that endocrine disrupting chemicals do not pose a significant health risk, particularly in
light of the fact that hormone mimics exist in the natural environment.  Examples of natural hormone
mimics are the isoflavinoid phytoestrogens (Adlercreutz 1995; Livingston 1978; Mayr et al. 1992).  These
compounds are derived from plants and are similar in structure and action as endogenous estrogen.  While
there is some concern over the public health significance of endocrine disrupting chemicals, it is agreed
that the potential exists for these compounds to affect the synthesis, secretion, transport, binding, action,
or elimination of natural hormones in the body that are responsible for the  maintenance of homeostasis,
reproduction, development, and/or behavior (EPA 1997).  As a result, endocrine disruptors may play a
role in the disruption of sexual function, immune suppression, and neurobehavioral function.  Endocrine
disruption is also thought to be involved in the induction of breast, testicular, and prostate cancers, as well
as endometriosis (Berger 1994; Giwercman et al. 1993; Hoel et al. 1992).
In recent years, concern has been raised that many industrial chemicals, PCBs among them, are
endocrine-active compounds capable of having widespread effects on humans and wildlife (Crisp et al.
1998; Daston et al. 1997; Safe et al. 1997).  (Effects on wildlife are summarized in Section 3.3.2). 
Particular attention has been paid to the possibility of these compounds mimicking or antagonizing the
action of estrogen.  Estrogen influences the growth, differentiation, and functioning of many target
tissues, including female and male reproductive systems, such as mammary gland, uterus, vagina, ovary,
testes, epididymis, and prostate.  In addition, there is evidence that some of these environmentally-
persistent chemicals alter the thyroid hormone system, which is very a important system in normal
structural and functional development of sexual organs and the brain.  
Several studies in humans have examined possible associations between body burdens of PCBs and other
organochlorines and the incidence of alterations in tissues and systems.  Evaluations of blood samples
from women who aborted, miscarried, or delivered prematurely showed positive associations between
these effects and concentrations of PCBs (Bercovici et al. 1983; Leoni et al. 1989; Wassermann et al.
1980, 1982).  However, other chlorinated chemicals were also increased, and the specific contribution of 
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PCBs, if any, could not be determined.  Similar findings were reported in a more recent study of the
general population (Gerhard et al. 1998).  Another general population study found no association between
endometriosis and concentrations of PCBs in the blood (Lebel et al. 1998).  
Breast Cancer.  The issue of breast cancer has received special attention following reports of high levels
of organochlorine compounds in breast cancer patients.  However, the hypothesis that environmental
exposure to PCBs can cause breast cancer in humans is controversial (Safe and Zacharewski 1997; Wolff
and Toniolo 1995).  Breast adipose levels of total PCBs or individual congeners were increased in women
with breast cancer in some (Dewailly et al. 1994; Falck et al. 1992; Guttes et al. 1998; Wasserman et al.
1976) but not all studies (Aronson et al. 2000; Liljegren et al. 1998; Mussalo-Rauhamaa et al. 1990;
Unger et al. 1984), but methodological limitations such as small numbers of subjects and/or inadequate
control for known breast cancer risk factors could have contributed to the inconsistent findings.  Two of
these studies included analyses that suggested increased risks of breast cancer associated with increased
tissue levels of some congeners in subgroups of women that were postmenopausal or had estrogen
receptor-positive tumors (Aronson et al. 2000; Liljegren et al. 1998).  Other environmental exposure
studies used serum PCB concentrations as the marker of exposure with blood samples taken after the
diagnosis of breast cancer (Moysich et al. 1998, 1999; Wolff et al. 1993; Zheng et al. 2000), or
prospectively collected prior to diagnosis (Dorgan et al. 1999; Helzlsouer et al. 1999; Høyer et al. 1998;
Hunter et al. 1997; Krieger et al. 1994; Wolff et al. 2000).  None of the serum studies found significantly
different mean blood levels of PCBs in breast cancer cases and controls.  Additionally, there were no
significant associations between risk of breast cancer and serum PCBs in most of these studies, although
some data suggest that risk may be increased in some subgroups of postmenopausal women (Moysich et
al. 1998, 1999).  Many of the better designed studies were prospective, and none found that PCBs were
associated with the occurrence of breast cancer (Dorgan et al. 1999; Helzlsouer et al. 1999; Høyer et al.
1998; Hunter et al. 1997; Krieger et al. 1994; Wolff et al. 2000).  However, the prospective studies are
limited by one biomarker of exposure in the distant past, which would not reflect differences over time in
exposure, absorption, enzyme induction, or other factors influencing body burden such as breast-feeding. 
It is still possible that the PCB measurements were too abridged to detect abnormally high proportions of
the more labile congeners, which appear to have greater estrogenic activities (Hansen 1998, 1999). 
Mortality from breast cancer was not increased in studies of workers who were occupationally exposed to
relatively high levels of PCBs (Brown 1987b; Brown and Jones 1981; Kimbrough et al. 1999a), providing
an additional indication that lower level environmental exposures to PCBs are unlikely to contribute
significantly to the disease.  Overall, the evidence for an association between breast cancer and PCBs
remains inconclusive and needs further study.  
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Estrogenic and Anti-Estrogenic Activity.  In early studies of experimental animals, research was focused
on the effects of chemicals administered orally or by parenteral routes.  In recent years, most of the
research has focused on elucidating the mechanisms of action involved using test systems in vitro which,
although not without limitations, are easier to manipulate and can be developed into biomarker assays for
(anti)estrogenic activity.  In general, results from in vivo and in vitro studies indicate that PCBs have
much lower estrogenic potency than the endogenous hormone, 17β-estradiol.  Subcutaneous
administration of 8 mg of Aroclors 1221, 1232, 1242, or 1248 increased uterine weight and glycogen
content in rats, but similar exposure to Aroclors 1254, 1260, 1262, or 1268 did not produce this
estrogenic effect (Bitman and Cecil 1970).  More recent studies have provided further evidence that PCB
mixtures can produce estrogenic responses (albeit weak) and that PCB congeners with multiple ortho
chlorines (or their hydroxylated metabolites) may be at least partly responsible for these responses. 
Intraperitoneal doses of Aroclor 1242 (8 mg/rat on day 20 or 0.08 or 0.32 mg/rat on days 20 and 21)
significantly increased uterine wet weight in immature female rats to about 40% of the increase produced
by 0.001 mg of 17β-estradiol (Jansen et al. 1993).  Similar increases in uterine wet weight were produced
by exposure to di-ortho congeners or hydroxylated derivatives (0.640 mg PCB 52 or 0.250 mg of
2,4,6–trichloro-4'-hydroxy-biphenyl on days 20 and 21), but not by exposure to 0.160 mg of the coplanar
congener PCB 77.  In another study, the tetra-ortho congener, PCB 47, displayed similarly weak
estrogenic responses in an in vitro human breast cancer cell assay and an in vivo immature female rat
assay (Arcaro et al. 1999).  This congener did not competitively bind in vitro to recombinant human
estrogen receptors α and β, but a hydroxylated metabolite, 2,2',6,6'-tetrachloro-4'-hydroxy-biphenyl,
competitively bound to estrogen receptor α and produced proliferative responses in the breast cancer
assay at concentrations about 10-fold lower than effective concentrations of the parent molecule (Arcaro
et al. 1999).  Evaluation of the offspring from rats given a PCB congener mixture simulating the congener
content of human milk from 50 days prior to mating until birth showed significantly increased relative
uterine weight in immature females on PND 21 (Hany et al. 1999b).
Anti-estrogenic properties of PCBs also have been examined in numerous studies.  Combined exposure of
immature rats to 0.32 mg Aroclor 1242 and 0.001 mg 17β-estradiol produced a response similar to
estradiol alone, indicating no obvious anti-estrogenic activity, but combined exposure to 0.001 mg
estradiol and 0.160 mg of PCB 77 markedly diminished the estradiol-induced increase in uterine wet
weight (Jansen et al. 1993).  Anti-estrogenic effects similar to those from PCB 77 were observed in rodent
uterine tissue (Astroff and Safe 1990) and human breast cancer cells (Krishnan and Safe 1993) by other
congeners with no or single ortho chlorines (e.g., 3,3',4,4',5-pentaCB, 2',3,3',4,4',5-hexaCB), but
commercial PCB mixtures were not anti-estrogenic in the breast cancer cell assay.  Whereas the data 
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collected by Krishnan and Safe (1993) suggest that anti-estrogenic activities of PCBs may be related to
Ah receptor binding affinity, anti-estrogenic activities of hydroxylated PCB congeners with multiple
ortho chlorines have been observed in several assay systems (Connor et al. 1997; Moore et al. 1997; Safe
et al. 1998b).   
Structure-activity relationships for estrogenic activities of PCB congeners or their metabolites are less
clear.  Some hydroxylated PCBs (2,4,6-trichloro-4'-hydroxy-biphenyl and 2,3,4,5-tetrachloro-4'-hydroxy-
biphenyl) have been demonstrated to competitively bind to mouse estrogen receptor preparations and to
increase uterine weight and glycogen in immature mice (Korach et al. 1988).  In other estrogenic assays,
PCB 104, 2,4,4',6-tetrachloro-4-hydroxy-biphenyl, and 2,4,6-trichloro-4'-hydroxy-biphenyl were equally
effective in stimulating proliferation of human breast cancer cells, but only 2,4,6-trichloro-4'-hydroxy-
biphenyl caused significant induction of vitellogenin in cultured brown trout hepatocytes (Andersson et
al. 1999).  A structure-activity study of eight hydroxylated PCBs in a series of in vivo and in vitro
estrogenic assays found that structure-activity relationships were complex and differed from one assay to
the next (Connor et al. 1997; Safe et al. 1998b).  For example, all but one of the compounds displayed
competitive binding to rat and mouse cytosolic estrogen receptors (affinities ranged from about 10-3 to
10-5 of 17β-estradiol’s affinity), but there was no evidence of estrogenic activities (wet weight, peroxidase
activity, progesterone receptor level) in the uteri of immature rats and mice exposed to three consecutive
daily doses of the individual hydroxylated PCB congeners at levels of  25, 50, or 100 mg/kg.  In contrast,
four of the hydroxylated congeners produced estrogenic effects in cultured human breast cells and HeLa
cells (Connor et al. 1997; Safe et al. 1998).  These results suggest that PCB-induced estrogenic activities
are weak compared to the endogenous hormone, 17β-estradiol.  Further, the wide variability of responses
observed across types of PCBs and assays indicates: (1) the involvement of multiple mechanisms,
(2) anti-estrogenic activities appear strongly associated with PCBs that are Ah receptor agonists, and
(3) hydroxylated metabolites of PCBs seem to be at least partly responsible for physiological responses to
PCBs that may involve changes in estrogen receptor-dependent physiological processes.
The results of some studies summarized above suggest that PCBs can produce estrogenic and anti-
estrogenic responses by interfering with the binding of natural ligands to their receptors.  The type of
response varied between assays and was dependent of the concentration of the test material.  Reviews of
published data suggest that the amount of naturally occurring estrogens ingested daily through a normal
diet is far greater than the daily intake of estrogenic organochlorine chemicals (Safe 1995).  Moreover,
results from many assays indicate that estrogenic organochlorines have a potency of 0.000001 times that
of 17β-estradiol, compared to 0.001–0.0001 times for naturally-occurring estrogenic substances.  In 
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addition, many naturally-occurring estrogenic substances, such as bioflavonoids, are also antiestrogenic at
some concentrations.  Dietary levels of anti-estrogen equivalents (industrial or natural) are significantly
higher than the estrogen equivalents of organochlorine chemicals (Safe 1995).
Reproductive Effects.  Sager and Girard (1994) have provided evidence of reproductive effects of PCBs
that may be related to PCB-induced endocrine disruption.  After giving birth, adult female rats were
exposed to 0, 8, 32, or 64 mg Aroclor 1254/kg/day by gavage on lactation days 1, 3, 5, 7, and 9.  Young,
mature, and older adult female offspring were examined at 2–4.5, 5–8, and 8.5–13 months of age,
respectively, and mated to untreated males at 112, 200, and 350 days of age, respectively.  Effects
included a dose-related reduction in preweaning weight gain that was statistically significant at
$32 mg/kg/day, delayed puberty as indicated by late vaginal opening and first estrus at $32 mg/kg/day;
reduced mating rate (sperm-positive females) in mature offspring at $8 mg/kg/day; reduced implantation
rate and mean number of embryos in young and mature offspring at 64 mg/kg/day; reduced uterine
weight during proestrus in young, mature, and older offspring at $8 mg/kg/day; and reduced uterine
response to exogenous 17β-estradiol in ovariectomized mature offspring at $8 mg/kg/day.  Average estrus
cycle length was not significantly different in any of the groups, although cycle patterns were altered in
low- and high-dose young offspring and in mid-dose mature rats.  Pregnancy and ovulation rates,
reproductive aging, and ovarian weights were not affected by exposure Aroclor 1254.
Fertility was markedly reduced in male offspring of Holtzman rats that were exposed via lactation to
Aroclor 1254 (Sager 1983; Sager et al. 1987, 1991).  The maternal rats were treated with 8, 16, 32, or
64 mg/kg doses by gavage on lactation days 1, 3, 5, 7, and 9, and male offspring were mated with
untreated females 130–150 days postweaning (Sager 1983; Sager et al. 1987).  Significant decreases in
numbers of implants and embryos were observed at $8 mg/kg/day (21 and 29% lower than controls,
respectively), and there was either a significant decrease or a decline in number and percent of normal
fertilized eggs and eggs at the two- to four-cell blastocyte stages at $16 mg/kg/day.  The reduction in
male fertility appears to be due to impaired ability of sperm to fertilize eggs because sperm production,
morphology, and motility were not affected and plasma FSH and testosterone concentrations were not
reduced (Sager et al. 1987, 1991).  Seminal vesicle and ventral prostate weights were decreased at
$16 mg/kg/day.
Fertility was not impaired in male offspring of Sprague-Dawley rats that were administered 0 or
30 mg/kg/day doses of Aroclor 1221, 1242, or 1260 by gavage on days 12–20 of gestation (Gellert and
Wilson 1979).  There were no exposure-related changes in the percentage of male offspring (F1) siring 
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progeny when they were mated with unexposed females at approximately 6 months of age, or in the sex
ratio of the F2 offspring from this mating.  Measurements of absolute testes and ventral prostate weights
in the F1 males (relative weights were not determined) showed no changes except for increased testes
weight in the Aroclor 1260 group.  Conflicting results regarding fertility in the aforementioned studies
may be related to the difference in exposure periods.  In the experiments by Sager and others, exposure
was postnatal via breast milk, whereas in the Gellert and Wilson (1979) study, the male rats were exposed
in utero.  
Studies that examined reproductive end points in women found indications that exposure to PCBs may be
associated with menstrual disturbances.  Mendola et al. (1997) reported that consumption of Lake Ontario
sportfish was associated with shorter menstrual cycles in women from the New York State Angler cohort. 
This is a preliminary finding that needs to be interpreted cautiously because of limitations in the data
analysis, particularly the lack of information on confounders such as stress, use of contraceptives, body
mass index, and physical exercise.  The decreases in menstrual length were small and were considered not
likely to be clinically relevant.  At the highest exposure levels, the decrease was approximately 0.5 days
for women who reported regular cycles and 1 day for all women who reported cycle length information. 
The effect did not appear to be mediated through irregular cycles since the fish consumption-based
exposure levels were similar for women who reported regular or irregular cycles.  Menstrual cycle
changes (altered intervals, duration, and flow) have also been observed in women exposed to higher doses
of PCBs during the Yusho poisoning incident (Kusuda 1971).  The human populations in which menstrual
changes have been observed differ with respect to the sources of PCBs and exposures to other chemicals
that may affect susceptibility to menstrual disturbances.  Although the studies are insufficient for
determining which specific chemical(s) may be responsible for the observed alterations, the available data
support a possible association between PCBs and menstrual disturbances.
In a study of 89 women (87% German) with repeated ($2) miscarriages, Gerhard et al. (1998) found that
blood concentrations of PCBs were higher than the reference level in 22% of the cases.  The effect cannot
be specifically attributed to PCBs because blood levels of other organochlorine compounds
(pentachlorophenol, DDE, β- and γ-hexachlorocyclohexanes, HCB) were higher than reference ranges in
7–15% of the cases.  No significant differences in PCB levels were found between women with early or
late miscarriages (after #12 or >12 weeks of gestation) and primary or secondary miscarriages (had never
delivered or had delivered at least one baby).  Women with a history of at least four miscarriages (n=25)
had significantly elevated blood levels of PCBs, although other organochlorine compounds
(γ-hexachlorocyclohexane and HCB) were also increased.  Hormonal disorders were identified as the 
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cause of repeated miscarriages in 31% of the women, including hyperprolactinemia in 9%,
hyperandrogenemia in 7%, and luteal insufficiency in 14% of the cases.  Correlations were found between
increasing PCB concentrations and some hormonal parameters (e.g., increasing FSH and LH, decreasing
TSH) and immunological parameters (e.g., increasing IgM, monocytes, and NK cells, decreasing
interleukin 2 receptor-positive cells), but none of the associations were specific for PCBs.  There were no
significant associations between PCB concentrations and further conceptions or the outcome of further
pregnancies.
Thyroid Effects.  Concern that the thyroid hormone system may be important in the mechanism of
toxicity of PCBs stems from mainly two important types of observations (Brouwer et al. 1998b;
Porterfield and Hendry 1998): (1) extensively corroborated findings in experimental animals that
exposure to PCBs in utero and/or during early development (e.g., through breast milk) can deplete levels
of circulating thyroid hormone in the fetus or neonate, which may give rise to effectively a hypothyroid
state during development (Collins and Capen 1980c; Cooke et al. 1996; Corey et al. 1996; Darnerud et al.
1996a; Goldey et al. 1995; Juarez de Ku et al. 1994; Li et al. 1998; Morse et al. 1996c; Rice 1999a;
Provost et al. 1999; Schuur et al. 1998a; Seo and Meserve 1995; Zoeller et al. 2000); and (2) the
recognition of the importance of thyroid hormones in normal development of the brain and sexual organs.
Studies in animals have shown that, depending of dose and duration of exposure, PCBs can disrupt the
production and disposition of thyroid hormones at a variety of levels.  The major findings include
(1) histological changes in the thyroid gland indicative of both stimulation of the gland (e.g., similar to
that induced by TSH or a hypothyroid state) and a disruption of the processing of follicular colloid
needed for normal production and secretion thyroid hormone (Chu et al. 1994, 1995, 1996a, 1996b,
1998b; Collins and Capen 1980a; Collins et al. 1977; Hansen et al. 1995; Tryphonas et al. 1986b);
(2) depression of serum T4 and T3 levels, which may effectively create a hypothyroid state (Byrne et al.
1987; Collins and Capen 1980c; Cooke et al. 1996; Corey et al. 1996; Darnerud et al. 1996a; Desaulniers
et al. 1997; Goldey et al. 1995; Gray et al. 1993; Hansen et al. 1995; Hood et al. 1999; Juarez de Ku et al.
1994; Kasza et al. 1978; Li et al. 1998; Morse et al. 1996c; Rice et al. 1988, 1999a; Provost et al. 1999;
Schuur et al. 1998a; Seo and Meserve 1995; Van Birgelen et al. 1995; Zoeller et al. 2000); (3) increased
rates of elimination of T4 and T3  from serum (Goldey and Crofton 1998); (4) increased activities of
T4-UDP-GT in liver (Chu et al. 1995; Desaulniers et al. 1997; Morse et al. 1996c; Schuur et al. 1998a;
Van Birgelen et al. 1995), which is an important metabolic elimination pathway for T4 and T3;
(5) decreased activity of iodothyronine sulfotransferases in liver which are also important in the metabolic
elimination of iodothyronines (Schuur et al. 1998a, 1998b, 1999); (6) decreased activity of iodothyronine 
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deiodinases including brain Type-2 deiodinase, which provide the major pathways for the production of
the active thyroid hormone, T3 (Morse et al. 1996; Schuur et al. 1998a); and (7) decreased binding of T4
to transthyretin, an important transport protein for both T4 and T3 (Cheek et al. 1999; Darnerud et al.
1996a).   
The above observations suggest that PCBs can disrupt the production of thyroid hormones (in the thyroid
and in peripheral tissues), can interfere with their transport to peripheral tissues, and can accelerate the
metabolic clearance of thyroid hormones.  The most convincing evidence that PCBs can exert toxicity by
disrupting thyroid hormone system derives from two studies in rats.  In one study, neurobehavioral
deficits in pups that experienced exposures to Aroclor 1254 in utero and during nursing were significantly
attenuated by subcutaneous injections of T4 that increased serum T4 and T3 concentrations which were
otherwise depressed in the PCB-exposed animals (Goldey and Crofton 1998).  While this study examined
relatively high doses of Aroclor 1254 ($1 mg/kg/day), it nevertheless demonstrated neurodevelopmental
effects that are directly relevant to observations made in epidemiological studies and to neurological
sequelae of fetal hypothyroidism, including motor disturbances and hearing.  
In the second study, increased testis weight and sperm production in rats that were administered
Aroclor 1254 on postnatal days 1–25 were attenuated by injections of T4 on postnatal days 1–25, which
also prevented the depression in serum T4 concentrations (Cooke et al. 1996).  Here again, although
produced by relatively large doses of Aroclor 1254 ($1.6 mg/kg/day, subcutaneous), similar effects can
be produced by other hypothyroid-inducing agents, including PTU.  Cooke and coworkers have proposed
that the increased testis weight and sperm production is the result of PCBs extending the proliferative
period of Sertoli cells, thus increasing their number.  A prolonged period of cell division in turn results in
a greater total number of germ cells per testis, creating an enlarged testis that produces more sperm than
normal (see Chapin et al. 1996 for review).  Neonatal hypothyroidism in humans also is known to be
associated with disruption of the normal sexual maturation process (Longcope 2000).
In summary, PCBs can affect a wide variety of endocrine systems by directly affecting the components of
the endocrine system such as hormones, metabolic enzymes, carrier proteins, receptors, endocrine glands,
and feedback regulation systems.  Effects on these components can lead to alterations in
neurodevelopment, reproduction, and in induction of endocrine-sensitive tumors.    
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3.7 CHILDREN’S SUSCEPTIBILITY
This section discusses potential health effects from exposures during the period from conception to
maturity at 18 years of age in humans, when all biological systems will have fully developed.  Potential
effects on offspring resulting from exposures of parental germ cells are considered, as well as any indirect
effects on the fetus and neonate resulting from maternal exposure during gestation and lactation. 
Relevant animal and in vitro models are also discussed.
Children are not small adults.  They differ from adults in their exposures and may differ in their
susceptibility to hazardous chemicals.  Children’s unique physiology and behavior can influence the
extent of their exposure.  Exposures of children are discussed in Section 6.6 Exposures of Children.
Children sometimes differ from adults in their susceptibility to hazardous chemicals, but whether there is
a difference depends on the chemical (Guzelian et al. 1992; NRC 1993).  Children may be more or less
susceptible than adults to health effects, and the relationship may change with developmental age
(Guzelian et al. 1992; NRC 1993).  Vulnerability often depends on developmental stage.  There are
critical periods of structural and functional development during both prenatal and postnatal life and a
particular structure or function will be most sensitive to disruption during its critical period(s).  Damage
may not be evident until a later stage of development.  There are often differences in pharmacokinetics
and metabolism between children and adults.  For example, absorption may be different in neonates
because of the immaturity of their gastrointestinal tract and their larger skin surface area in proportion to
body weight (Morselli et al. 1980; NRC 1993); the gastrointestinal absorption of lead is greatest in infants
and young children (Ziegler et al. 1978).  Distribution of xenobiotics may be different; for example,
infants have a larger proportion of their bodies as extracellular water and their brains and livers are
proportionately larger (Altman and Dittmer 1974; Fomon 1966; Fomon et al. 1982; Owen and Brozek
1966; Widdowson and Dickerson 1964).  The infant also has an immature blood-brain barrier (Adinolfi
1985; Johanson 1980) and probably an immature blood-testis barrier (Setchell and Waites 1975).  Many
xenobiotic metabolizing enzymes have distinctive developmental patterns.  At various stages of growth
and development, levels of particular enzymes may be higher or lower than those of adults, and
sometimes unique enzymes may exist at particular developmental stages (Komori et al. 1990; Leeder and
Kearns 1997; NRC 1993; Vieira et al. 1996).  Whether differences in xenobiotic metabolism make the
child more or less susceptible also depends on whether the relevant enzymes are involved in activation of
the parent compound to its toxic form or in detoxification.  There may also be differences in excretion,
particularly in newborns who all have a low glomerular filtration rate and have not developed efficient 
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tubular secretion and resorption capacities (Altman and Dittmer 1974; NRC 1993; West et al. 1948). 
Children and adults may differ in their capacity to repair damage from chemical insults.  Children also
have a longer remaining lifetime in which to express damage from chemicals; this potential is particularly
relevant to cancer.
Certain characteristics of the developing human may increase exposure or susceptibility, whereas others
may decrease susceptibility to the same chemical.  For example, although infants breathe more air per
kilogram of body weight than adults breathe, this difference might be somewhat counterbalanced by their
alveoli being less developed, which results in a disproportionately smaller surface area for alveolar
absorption (NRC 1993).
Children are exposed to PCBs in the same manner as the general population, primarily via consumption
of contaminated foods, particularly meat, fish, and poultry (Gunderson 1988).  Exposure also may occur
by transfer of PCBs that have accumulated in women’s bodies to the fetus across the placenta.  Because
PCBs are lipophilic substances, they can accumulate in breast milk and be transferred to nursing infants. 
Transfer across the placenta, although it may be limited in absolute amounts, is of great concern because
of the effects of PCBs on sensitive immature tissues, organs, and systems, with potentially serious long-
lasting consequences.  Transfer of PCBs via breast milk can be considerable and, like prenatal exposure,
has the potential to contribute to altered development.
Although embryos, fetuses, and nursing infants may be exposed to relatively high amounts of PCBs
during sensitive periods of development, it is not known if the susceptibility of children to the health
effects of PCBs differs from that of adults.  Younger children may be particularly vulnerable to PCBs
because, compared to adults, they are growing more rapidly and generally have lower and distinct profiles
of biotransforamtion enzymes, as well as much smaller fat depots for sequestering the lipophilic PCBs.
The best documented effect of exposure to high concentrations of PCBs in adults is the induction of skin
alterations, in particular, chloracne.  This has been observed in individuals occupationally exposed to
PCBs (Bertazzi et al. 1987; Fischbein et al. 1979, 1982; Maroni et al. 1981a, 1981b; Meigs et al. 1954)
and in Yusho and Yu-Cheng victims, who consumed rice oil contaminated with high concentrations of
PCBs and other dioxin-like chemicals (Hsu et al. 1994; Masuda 1994).  Children born to Yusho and
Yu-Cheng victims also exhibited acneform eruptions.  It is reasonable to assume that children exposed to
high amounts of PCBs, particularly dioxin-like congeners, also will develop dermal alterations as occurs
in adults.
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Numerous studies have investigated the effects of exposure to PCBs in newborn and young children.  The
main studies can be divided into those of women who consumed high amounts of contaminated fish,
primarily from the Great Lakes (Fein et al. 1984a, 1984b; Jacobson and Jacobson 1996a, 1996b, 1997;
Jacobson et al. 1984a, 1984b, 1985, 1990a, 1990b, 1992; Lonky et al. 1996, Stewart et al. 1999, 2000a), 
women from the general population with no known high exposure to PCBs (Gladen et al. 1988; Huisman
et al. 1995a, 1995b; Koopman-Esseboom et al. 1994b, 1996; Lanting et al. 1998c; Patandin et al. 1999;
Rogan and Gladen 1991, 1992; Rogan et al. 1986a, 1986b, 1987), and women who ingested rice oil
accidentally contaminated with high amounts of PCBs and structurally-related compounds (Chen et al.
1992, 1994; Guo et al. 1995; Hsu et al. 1994; Lai et al. 1994; Masuda 1994).  The main focus of these
studies has been the evaluation of neurobehavioral end points, but information on other end points such as
anthropometric measures at birth and growth rate  (Dar et al. 1992; Fein et al. 1984b, Jacobson et al.
1990a, 1990b; Lan et al. 1987; Lonky et al. 1996; Patandin et al. 1998; Rogan 1989; Rylander et al. 1995,
1998b; Smith 1984; Taylor et al. 1984, 1989; Vartiainen et al. 1998), immune status (Chao et al. 1997;
Dewailly et al. 2000; Weisglas-Kuperus et al. 1995; Yu et al. 1998), and thyroid status (Koopman-
Esseboom et al. 1994a) is also available.  
Surrogate measures of exposure that have been used in human studies include PCB measurements of
maternal blood, breast milk, and cord blood.  Cord blood is the most direct marker of fetal exposure, but
because of its relatively low fat content, it requires sensitive analytical methods for accurate PCB
analysis; analysis of breast milk does not present this difficulty.  Analytical techniques have improved
enormously in recent years, such that cord blood analysis of PCBs is now more accurate and reliable, but
still of concern due to the low concentration of fat in cord blood.
There is evidence that PCBs play a role in neurobehavioral alterations observed in newborn and young
children from women with PCB burdens near background levels, but the possibility cannot be ruled out
that other lipophilic compounds may contribute to the observed effects, particularly in the studies of
consumption of Great Lakes fish contaminated with other chemicals such as CDDs, DDE, and mercury. 
Newborns from women who ate high amounts of contaminated Lake Michigan fish had a greater number
of abnormal reflexes and more motor immaturity than low-fisheaters (Jacobson et al. 1984a).  Similar
observations were made by Rogan et al. (1986b) in the North Carolina study of children born to women
with no known high PCB exposure and in the Oswego study of children from women with high Lake
Ontario fish consumption (Lonky et al. 1996).  By measuring individual PCB congeners in cord blood of
Lake Ontario fisheaters, Stewart et al. (2000b) observed a significant association between highly
chlorinated PCBs and poorer Habituation and Autonomic scores of the NBAS for the newborns, but there 
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was no significant association with abnormal reflexes.  No significant association was seen for the lightly
and moderately chlorinated PCBs, DDE, lead, mercury, and hexachlorobenzene with any of the
neurological scores for newborns of the Lake Ontario fisheaters.  In the study of Dutch children, prenatal
exposure to four predominant PCBs (PCB levels in maternal or cord plasma) was not associated with
either reflex or postural cluster scores of a neurological examination (Huisman et al. 1995a), but there was
a significant association between increasing levels of planar PCB TEQ in breast milk and increases in
percentage with hypotonia but not percentage with abnormal reflexes.  There is limited support from
animal studies for the findings of hypotonia and hyporeflexia in newborn humans exposed to PCBs. 
Overmann et al. (1987) reported that newborn rats from dams exposed to 1.3 mg Aroclor 1254/kg/day
showed slower development of air righting ability (an index of neuromuscular maturation) on 1 of
4 testing days and also were slower than controls in a negative geotaxis test on 2 out 4 days of testing.  
Assessment of infants from the various cohorts with the Bayley Scales of Infant Development has
revealed some additional consistency among the studies.  This group of tests yields a mental development
index (MDI) and a PDI score, both of which are scaled like a standard IQ test.  In the North Carolina
cohort, prenatal exposure to PCBs (assessed by PCBs in maternal milk at birth, 1.8 ppm) was associated
with a significant decrease in PDI scores at the ages of 6 and 12 months (Gladen et al. 1988), but the
association lost statistical significance at the ages of 18 and 24 months (Rogan and Gladen 1991).  No
significant association was observed between postnatal exposure to PCBs (PCBs in milk factored by
duration of breast feeding) and PDI scores between 6 and 24 months of age.  Neither prenatal nor
postnatal exposure to PCBs showed a significant association with MDI scores.  The latter is consistent
with a lack of significant association between prenatal or postnatal exposure and MDI scores at 7 or
18 months of age also observed in the Dutch children (Koopman-Esseboom et al. 1996).  Yu-Cheng
children also had lower PDI and MDI scores when tested between the ages of 6 months and 2 years old
(Lai et al. 1994).  Alterations in memory functions were reported in children from the Michigan cohort at
7 months of age (Jacobson et al. 1985) and at 4 years of age (Jacobson et al. 1990a, 1990b, 1992), but not
in other cohorts studied.  In both instances, memory deficits were associated with prenatal exposure to
PCBs, as measured by PCBs in cord blood.  Decreased performance in memory tests has been reported
following perinatal exposure to commercial PCB mixtures in rats (Corey et al. 1996; Lilienthal and
Winneke 1991) and in monkeys (Levin et al. 1988; Schantz et al. 1989).  In addition, decreased
performance on a memory task was reported in 60-day-old rats exposed in utero to ortho-substituted PCB
congeners (Schantz et al. 1995). 
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A brain area of critical importance in the regulation of short-term or representational memory for spatial
information is the prefrontal cortex (Brozoski et al. 1979; Goldman et al. 1971).  Some studies in animals
have found changes in the concentration of neurotransmitters in the frontal cortex following exposure to
PCBs.  For example, Morse et al. (1996a) reported that rats exposed during gestation days 10–16 to 5 or
25 mg Aroclor 1254/kg/day had a significant increase in the levels of 5-HIAA and in the ratio
5-HIAA/5-hydroxytryptamine in the prefrontal cortex at 90 days of age.  These rats also showed a
significant decrease in the neuronal marker synaptophysin in the prefrontal cortex, which was interpreted
as reactive gliosis (Morse et al. 1996b).  A decrease in dopamine in the frontal cortex was also observed
in rats exposed to contaminated Great Lakes fish in utero, during lactation, and until 88 days of age
(Seegal et al. 1998).  Exposure of weanling rats to PCB 153 (0.01 mg/kg/day) or PCB 128
(0.005 mg/kg/day) for 90 days also resulted in decreased dopamine levels in the frontal cortex (Chu et al.
1996a; Lecavalier et al. 1997).  Changes in neurotransmitter levels have also been observed in other brain
areas, but further research is needed before specific neurobehavioral deficits can be correlated with
changes in specific neurotransmitters in specific brain areas.  
As previously mentioned, neurobehavioral alterations have been observed in rats and monkeys following
pre- and/or postnatal exposure to commercial Aroclor mixtures, defined experimental congener mixtures,
single PCB congeners, and Great Lakes contaminated fish.  Monkeys exposed from birth to age 20 weeks
to PCB mixtures of congeneric composition and concentration similar to that found in human breast milk
showed learning deficits long after exposure had ceased (Rice 1997, 1998, 1999b; Rice and Hayward
1997, 1999a).  This type of study appears to be the most relevant to evaluating risk of PCB exposure by
infants since they mimic the exposure scenario for a nursing human infant.
Results from evaluation of anthropometric measurements in newborn and young children have been
mixed.  Of the studies of women who consumed contaminated fish from the Great Lakes, only one out of
four, the Michigan study (Fein et al. 1984b; Jacobson et al. 1990a, 1990b), reported an association
between reduced birth weight, head circumference, and gestational age in newborns and with body weight
at 4 years with prenatal exposure to PCBs (PCBs in cord blood).  In the Oswego cohort (Lake Ontario
fish consumption), there was no significant association between prenatal exposure to PCBs, assessed by
the same fish consumption measures as in the Michigan study, and birth weight, head circumference, or
gestational age (Lonky et al. 1996).  In two additional studies of Lake Michigan women (Dar et al. 1992;
Smith 1984), fish consumption had a positive effect on birth weight.  This finding could be related to the
beneficial effects of certain fatty acids in fish (Olsen et al. 1990).  In one of these studies (Smith 1984),
the concentration of PCBs in breast milk was higher than in breast milk from women from the Michigan 
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cohort (1.13 vs 0.87 ppm).  A study of Swedish wives of Baltic Sea fishermen found an increased risk of
low birth weight with increasing maternal blood concentrations of the PCB congener PCB 153 used as a
surrogate of PCB exposure during the year of childbirth (Rylander et al. 1998b).  In the Dutch cohort,
prenatal exposure to PCBs (PCBs in cord blood) was associated with a reduced birth weight, but not with
head circumference or height at 10 days of age (Patandin et al. 1998).  Prenatal exposure in formula-fed
children was associated with reduced growth between birth and 3 months, but no such association was
seen in breast fed children, suggesting to the investigators that any detrimental effect observed in
newborns due to prenatal exposure to PCBs may have been counteracted by the benefits of breast feeding. 
No significant association was seen between any measure of exposure to PCBs and growth at the ages of
3–7 months, 7–18 months, or 18–42 months.  A study of the general population in Finland found no
significant association between birth weight and the concentration of PCBs in breast milk (Vartiainen et
al. 1998).  In this study, the mean concentration of PCBs in milk (0.4–0.5 ppm) was slightly lower than in
the Dutch study (0.62 ppm) (Koopman-Esseboom et al. 1994b).  Overall, it seems that if there is an
adverse effect of prenatal exposure to PCBs on growth, it is transient, as documented in children from the
Yusho poisoning episode (Yoshimura and Ikeda 1978).
Studies in rodents, generally with relatively high doses of PCB mixtures or congeners, have shown
decreased birth weight and reduced weight gain after birth.  This occurred in animals exposed in utero
and through breast milk, even though their weight at birth was not significantly different than in
unexposed controls (Collins and Capen 1980c; Overmann et al. 1987).  This suggests that a significant
transfer of PCBs occurred via breast feeding.  Long-term studies with much lower doses of Aroclors 1016
and 1248 in monkeys also reported decreased birth weight (Allen and Barsotti 1976; Barsotti and Van
Miller 1984).  Studies with low doses of Aroclor 1254 (0.005–0.08 mg/kg/day) found no significant
effects on anthropometric measures at birth or on growth thereafter (Arnold et al. 1995, 1997).
As indicated above, there is information regarding the effects of perinatal exposure to PCBs on
immunocompetence in children.  In a study of fisheating women from Sheboygan, Wisconsin (Lake
Michigan), maternal serum PCB level (mean 5.48–5.76 ppb) was positively and significantly associated
with the number of infectious illnesses in the infants (r=0.33, p=0.03), although breast milk PCB levels
(mean 1.13 ppm) had a weak but significantly negative association with infant illnesses (Smith 1984). 
Possible associations between infectious illnesses and other chemicals in the fish were not investigated.
Susceptibility to infections and immune status were studied in 98 breast-fed and 73 bottle-fed Inuit
(Eskimo) infants from Arctic Quebec, Canada (Dewailly et al. 2000).  The Inuits have high body burdens 
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of various organochlorine compounds due to high consumption of marine foods, particularly sea mammal
fat.  Concentrations of PCBs and other chlorinated pesticides or metabolites were measured in early breast
milk fat and used as an index of prenatal exposure to these substances;  p,p’-DDE showed the highest
mean concentration (962 ppb), followed by PCBs (621 ppb; sum of congeners 138, 153, and 180),
hexachlorobenzene (107 ppb), dieldrin (30 ppb), and mirex (14 ppb) (Dewailly et al. 1993).  The number
of infectious disease episodes and status of immunologic parameters  (WBCs, total lymphocytes and
lymphocyte subsets, serum immunoglobulins) were evaluated during the first year of life.  Acute otitis
media was the most frequent health problem during the first year of life, with 80.0% of ever breast-fed
and 81.3% of bottle-fed infants experiencing at least one episode.  Relative risk (RR) analysis by follow-
up period and number of episodes showed associations between increasing prenatal exposure to
organochlorine compounds and otitis media that were more consistent for hexachlorobenzene and
p,p’-DDE than PCBs.  Because these and other detected organochlorine compounds originated from the
same few food items and have concentrations in breast milk that are correlated with each other due to
similar properties such as lipid solubility and persistence, the results precluded identification of which
compounds could be responsible for the increased susceptibility to otitis media.  Immunologic parameters
that were significantly lower in the breast-fed babies compared to the bottle-fed group included numbers
of WBCs and lymphocytes (CD4 subtype) at 3 months of age, and serum IgA concentrations at 7 and
12 months of age; CD4/CD8 lymphocyte ratios (helper T-cells/cytotoxic T-cells) were also reduced in the
breast-fed infants at 7 and 12 months of age, although the change did not reach statistical significance. 
None of the immune parameters were associated with prenatal organochlorine exposure.
Immunologic effects of pre- and postnatal environmental exposure to PCBs and dioxins were assessed in
a subgroup of 55 infants from the Dutch Mother-Child study (Weisglas-Kuperus et al. 1995).  No
correlation was found between pre- or postnatal exposure to PCBs/dioxin and the number of episodes of
rhinitis, bronchitis, tonsillitis, and otitis during the first 18 months of life, or with humoral immunity as
evaluated by antibody levels to mumps, measles, and rubella at 18 months of age (infants were
immunized at 14 months of age).  Determination of monocyte, granulocyte, and lymphocyte counts in
cord and venous blood at 3 and 18 months of age showed that a higher prenatal as well as postnatal
PCB/dioxin exposure was associated with lower monocyte and granulocyte counts at 3 months of age,
and that a higher prenatal exposure was associated with increased total numbers of T-lymphocytes and
several T-cell subpopulations (CD8+, TcRαβ+, and TcRγδ+) at 18 months of age.  There were no
significant associations between postnatal PCB/dioxin exposure and T cell markers at 18 months of age. 
Although there were differences in the leukocyte subpopulation between high and low PCB/dioxin-
exposed infants, all values were within the normal range (Weisglas-Kuperus et al. 1995).  Follow-up 
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evaluations at 42 months of age, reported as a study abstract, found that prenatal PCB exposure was
associated with increased T cell numbers and lower antibody levels to mumps, measles and rubella
(Weisglas-Kuperus 2000).  Additionally, PCB body burden at 42 months of age was reported to be
associated with a higher prevalence of recurrent middle ear infections and chicken pox and a lower
prevalence of allergic reactions.  
Children born to mothers from the Yu-Cheng poisoning episode had higher prevalence of bronchitis or
pneumonia at 6 months of age, respiratory tract infections at 6 years of age, and middle ear infections at
6–14 years of age (Chao et al. 1997; Yu et al. 1998).  This group ingested rice oil accidentally
contaminated with high concentrations of PCBs and other dioxin-like chemicals.
Results of studies in infant Rhesus monkeys from dams exposed during gestation and lactation to as low
as 5 µg Aroclor 1254/kg/day indicated exposure-related reductions in antibody levels to SRBC and
mitogen-induced lymphocyte transformation that paralleled the findings in the maternal animals (Arnold
et al. 1995).  Although assessment of the data is limited by small numbers of infants in the exposed
groups, statistical significance was achieved for some end points and evaluation times, including reduced
IgM titers at 22–23 and 61–63 weeks of age (following gestational/lactational and/or postweaning dietary
exposure) in the infants from dams exposed to 5 µg/kg/day.  Infant Rhesus and Cynomolgus monkeys
that were orally administered a PCB congener mixture simulating the congener content of human milk at
a dose level of 7.5 µg/kg/day for the first 20 weeks of life (i.e., from parturition without in utero
exposure) had minimal immunological changes.  These included uniformly reduced anti-SRBC titers in
the treated monkeys compared to controls, although group differences were not statistically significant
due to small numbers of animals; and decreased B lymphocyte numbers in the exposed Cynomolgus
monkeys compared to controls, but this change was transient since levels returned to normal when
monkeys were retested at 1 year of age (Arnold et al. 1999).  Anti-SRBC titers were also uniformly
reduced in the treated compared to control monkeys, although group differences were not statistically
significant due to small numbers of animals.  The only other notable immunologic effect was a decrease
in B lymphocyte numbers in the exposed Cynomolgus monkeys compared to controls, but this change
was transient since levels were similar at 1 year of age.  The apparently weaker immunologic response in
the infant monkeys exposed to the breast milk congener mixture compared to those exposed in utero and
lactationally to Aroclor 1254 could be related to the lack of gestational exposure and different congener
composition of human and monkey breast milk.  These findings provide an indication that monkeys are
sensitive to low doses of PCBs whether they are administered as commercial mixtures or as a mixture of
congeners representative of those commonly found in breast milk.
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The recognition of the importance of thyroid hormones in normal development of the brain, as evident
from neurodevelopmental disorders and deficits associated with hypothyroidism, has triggered
considerable interest in the thyroid hormone system (Boyages 2000).  Hypothyroidism, typified by iodine
deficiency (e.g., endemic cretinism), can produce a wide range of neurodevelopmental deficits, including
auditory, motor, and intellectual deficits.  These outcomes suggest an importance of thyroid hormones in
the normal development of the fetal cochlea, basal ganglia, and cerebral cortex, which begin to develop in
humans during the second trimester of gestation.  This is also the time in which the fetal thyroid gland
becomes functional.  Key cell migration for brain development occurs prior to the time fetal thyroid
produces T3, and is therefore dependent on maternally produced thyroid hormone.
The results of several studies that examined relationships between indices of PCB exposure and thyroid
hormone status in children have been mixed, with negative, positive, or no correlations observed. 
Evaluation of thyroid status of 105 mother/infant pairs from the Dutch cohort during the first months of
life revealed that higher CDD, CDF, and PCB levels in breast milk, expressed as TEQs, correlated
significantly with lower plasma levels of maternal total T3 and total thyroxine, and with higher plasma
levels of TSH in the infants in the 2nd week and 3rd month after birth (Koopman-Esseboom et al. 1994a). 
Infants exposed to higher dioxin TEQ levels also had lower plasma free and total thyroxine in the 2nd
week after birth.  It should be noted, however, that plasma total T3, T4, free T4, and TSH levels of all
mother-infant pairs were in the normal range.  Longnecker et al. (2000) assayed umbilical cord sera from
160 children from the North Carolina cohort for total thyroxine, free thyroxine, and TSH.  The cord blood
had been stored frozen since its collection in 1978–1982.  The investigators found that background-level
exposure to PCBs had no effects on levels of thyroid-related hormones at birth.  Since the exposure levels
between the Dutch and the North Carolina cohorts appeared comparable, the difference in the results for
TSH across studies is unclear.  
A small (correlation coefficient, 0.15), but statistically significant positive correlation was found between
total serum PCB and TSH concentrations in cord blood of 170 infants from the general population in
Düsseldorf, Germany (Winneke et al. 1998a).  Nagayama et al. (1998a) examined the relationship
between serum TSH, total T4, and total T3 in 1-year-old infants and estimated intake of 2,3,7,8-TCDD
TEQ in breast milk during the first year of postnatal life.  The mothers had no known high exposure to
PCBs.  Small, but significant negative correlations were found for serum T4 and T3; no relationship was
apparent between TEQ intake and infant serum TSH or TBG.  The mean total dioxin TEQ intake was
34 ng/kg; however, the co-planar PCB contribution to the estimated TEQ intake, and intakes of other
PCBs were not reported.  Osius et al. (1999) examined the relationship between whole blood 
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concentrations of various PCB congeners and serum TSH, free T4, and free T3 in children who lived near
a hazardous waste incinerator.  All values were within expected ranges for children.  A significant
positive association was found between blood PCB 118 concentration and serum TSH concentration. 
Significant negative associations were found between serum T3 and PCBs 138, 153, 180, 183, and 187.
Most studies that examined effects of PCBs on thyroid function in young animals have been conducted in
rats that were administered commercial PCB mixtures or single PCB congeners during gestation and/or
lactation.  A common finding has been a decrease in circulating T4 in both the dams and the
fetus/offspring, whereas T3 levels may or may not change (Corey et al. 1996; Goldey and Crofton 1998;
Goldey et al. 1995; Juarez de Ku et al. 1994; Morse et al. 1996c; Provost et al. 1999; Schuur et al. 1998a;
Zoeller et al. 2000).  Goldey et al. (1995) reported neurobehavioral deficits in the pups, which were
attenuated by subcutaneous injections of T4 that increased serum T4 and T3 concentrations (Goldey and
Crofton 1998).  Rates of elimination of both hormones from serum were accelerated in the pups that had
been exposed to Aroclor 1254, relative to controls.  These observations suggest that the observed
neurobehavioral deficits may have been attributable to deficits in thyroid hormone.  The increased
elimination of T4 and T3 from serum is consistent with an induction of UDP-GT or other elimination
pathways for thyroid hormones (e.g., deiodination of T4 to T3).  Reduction in T4 levels in pups also have
been induced by maternal administration of the dioxin-like congeners 3,3',4.4',5-pentaPCB (PCB 126)
(Rice 1999a) and 3,3',4,4'-tetraPCB (PCB 77) (Darnerud et al. 1996a).
There is no evidence that PCBs are teratogenic in humans, and studies in rodents suggest that
teratogenicity may occur, but only at very high doses (Haake et al. 1987; Zhao et al. 1997b).  Adverse
reproductive effects have been observed in male animals following perinatal exposure to PCBs.  Fertility
was markedly reduced in male offspring of rats that were lactationally exposed to $8 mg/kg/day
Aroclor 1254 (Sager 1983; Sager et al. 1987, 1991).  The reduction in male fertility appears to be due to
impaired ability of sperm to fertilize eggs because sperm production, morphology, and motility were not
affected and plasma FSH and testosterone concentrations were not reduced (Sager et al. 1987, 1991). 
Fertility was not impaired in the male offspring of rats that were administered 30 mg/kg/day of
Aroclor 1221, 1242, or 1260 by gavage during gestation (Gellert and Wilson 1979), but this study did not
include postnatal exposure.  Results of oral and subcutaneous studies with single congeners have shown
that gestational, lactational, or adult exposures can adversely affect morphology and production of sperm
and fertility in male rats and mice (Faqi et al. 1998; Huang et al. 1998a; Smits-van Prooije et al. 1993),
although congeneric structure-activity relationships are unclear.  There were no significant effects on
number of implantation sites or litter size in rats that were exposed to 4 mg/kg/day of a PCB congener 
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mixture simulating the congener content of human milk from 50 days prior to mating until birth (Hany et
al. 1999b).  Evaluation of the offspring, however, showed significantly increased relative uterine weight
in immature females (PND 21) and reduced testes weights and serum testosterone levels in adult males
(PND 170).  There is increasing evidence that thyroid hormone serum concentrations play a crucial role in
testicular development by binding to thyroid hormone receptors expressed in Sertoli cells during a critical
window of time neonatally (Cooke et al. 1996).
PCBs have been shown to have both estrogenic and anti-estrogenic properties.  These properties of some
commercial PCB mixtures, PCB congeners, and hydroxylated derivatives of PCB congeners have been
assayed by examining uterine variables in immature or ovariectomized female rodents, cell proliferation
or gene expression variables in cultured cells including human breast cancer or HeLa cells, and in vitro
binding to estrogen receptor preparations (see Andersson et al. 1999; Arcaro et al. 1999; Battershill 1994;
Connor et al. 1997; Gierthy et al. 1997; Hansen 1998; Kramer et al. 1997; Krishnan and Safe 1993; Li
and Hansen 1997; Moore et al. 1997; Safe 1999; Safe et al. 1998 for reviews).  In general, PCB-induced
estrogenic activities have been characterized as weak compared to the endogenous hormone,
17β-estradiol, a wide variability of responses has been observed across types of PCBs and assays
indicating the involvement of multiple mechanisms, anti-estrogenic activities have been most strongly
associated with PCBs that are Ah receptor agonists, and hydroxylated metabolites of PCBs are postulated
to be at least partly responsible for physiological responses to PCBs that may involve changes in estrogen
receptor-dependent physiological processes.  Further details of some of these studies are presented in
Section 3.6, Endocrine Disruption.
There is no information regarding possible transgenerational effects of PCBs in humans and limited
information is available in animals.  Dominant lethal mutations were not induced in male Osborne-
Mendel rats following treatment by gavage with a single doses of 625–2500 mg/kg Aroclor 1242, by
gavage with five daily doses of 125 or 250 mg/kg Aroclor 1242 or 75–300 mg/kg Aroclor 1254, or in the
diet with estimated doses of 1.25 or 5 mg/kg/day Aroclor 1254 for 70 days (Green et al. 1975b).  Lack of
dominant lethality was indicated by no consistent changes in numbers of implantations and dead
implantations per pregnant untreated female.  The 70-day duration of the feeding study covered the
spermatogenic cycle of the rat.
There is no information regarding the pharmacokinetics of PCBs in children or the nutritional factors that
may influence the absorption of PCBs.  Both phase I and phase II metabolic enzymes participate in the
biotransformation and elimination of PCBs and metabolites.  Because the metabolism of PCB congeners 
3.  HEALTH EFFECTS - Children’s Susceptibility
PCBs 391
depends not only on the degree of chlorination, but also on the chlorine substitution pattern, many
different cytochromes P-450 (CYP enzymes) are involved.  Thus, metabolism of PCBs in fetuses,
neonates, and children may differ from adults depending on whether a particular cytochrome P-450
(CYP) subfamily is developmentally regulated or not.  Phase II enzymes such as glucuronosyltransferases
(UGT) and sulfotransferases also are involved in PCB metabolism and both are known to be
developmentally regulated (Leeder and Kearns 1997).  Because PCBs are lipophilic substances, they are
stored in the mother’s body and can be transferred to offspring through the placenta, as well as
accumulate in breast milk and be transferred to nursing infants.  This has been well documented by
measurements of PCBs in both umbilical cord blood and breast milk (Fein et al. 1984a; Greizerstein et al.
1999; Jacobson et al. 1984b; Koopman-Esseboom et al. 1994b; Kostyniak et al. 1999; Mes et al. 1993;
Rogan et al. 1987; Stewart et al. 1999).  Placenta passage of PCBs is further evidenced by findings of
significant correlations between maternal and cord serum PCB levels in groups of women and newborn
infants (e.g., Jacobson et al. 1984b).  Additionally, increased PCB residues were detected in blastocytes
(day 6 postcoitum) from female rabbits administered Aroclor 1260 before insemination, but not in
cleavage stage embryos (day 1 postcoitum) (Seiler et al. 1994).  In pregnant mice fed PCBs through the
first 18 days of gestation, the highest levels of serum PCBs were found in 1–2-week-old offspring
compared with 18-day fetuses or with older offspring (Masuda et al. 1979).  Results such as these have
led to the conclusion that suckling may account for higher exposure of young offspring than does
placental transfer, although the fetus may be more sensitive.  Both prenatal and breast milk exposures
have been associated with neurodevelopmental deficits in newborn and young children as discussed
above.  No PBPK models have been developed specifically for PCBs that could be used to quantitatively
predict transfer of PCBs across the placenta or via breast milk.
Since adverse health effects are of concern, particularly for prenatal exposure to PCBs, Lackmann et al.
(1999) investigated the influence of maternal age and duration of pregnancy on serum concentrations of
PCBs in full-term neonates.  Blood samples were taken from 80 full-term German neonates within the
first 12 hours of life, before the first oral feeding.  The median serum concentration of total PCBs was
0.96 µg/L (<0.30–3.14, range), with PCBs 138, 153, and 180 detected at median levels of
0.34 (<0.10–1.01), 0.42 (<0.10–1.42), and 0.17 (<0.10–0.78) µg/L, respectively.  All detectable PCB
congeners and total PCBs correlated significantly with the gestational age of the newborns, with
50–140% higher serum levels in children born at 42 weeks of gestation as compared with neonates born
in the 38th week.  Although the correlation between the PCB congeners and maternal age was not quite
statistically significant, higher PCB concentrations were observed with rising age.  PCB levels were not
correlated with birth weight.  As expected, the distribution pattern of the PCB congeners in newborns also 
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corresponds to that previously observed in adults.  Thus, the neonatal body burden of PCBs depends on
maternal age and duration of pregnancy, reflecting the increase in body burden with time as well as the
continuous transplacental transfer of PCBs from mother to fetus during pregnancy.  
Hagmar et al. (1998) measured PCB levels in whole blood, and cord blood from 30 Finnish women.  The
concentrations of PCBs 118, 138, 153, and 180 in cord blood were generally 2- to 3-fold lower than in the
whole blood from the mothers.  Positive correlations were observed between PCB concentrations in
whole blood and cord blood (r=0.67–0.80).  The correlation from this study was better than that reported
earlier between PCB levels in maternal and cord serum in the Lake Michigan study (r=0.42; Jacobson et
al. 1984b); however,  the correlation was consistent with the findings in the Dutch study on delivering
mothers (Koopman-Esseboom et al. 1994a, 1994b).  Although the concentration of PCB congeners in
cord blood is 2- to 4-fold lower than in maternal blood, cord blood represents a significant route for
prenatal exposure to PCBs as confirmed by the direct measurements made on the serum of new full-term
neonates (Lackmann et al. 1999).
Several human studies have investigated the levels of PCBs in human breast milk, not only because it
offers a means to assess body burden, but also because it represents a significant route for maternal
excretion and neonatal exposure. 
In women not known to have been exposed to high concentrations of PCBs, Masuda et al. (1978) reported
a significantly higher PCB level in infants' blood than in maternal blood; PCB levels in cord blood were
lower than in maternal blood.  These results suggested that larger amounts of PCBs are transferred
through milk compared with placental transfer.  Based on PCB levels in Canadian women's milk, it was
estimated that after the first 14 days of breast-feeding, infants would have ingested 144 µg of PCBs, and
their PCB body burden would be 0.32 ppm (Mes et al. 1984).  The average PCB concentration in
maternal whole blood was 2 ng/g (whole blood), whereas the average concentration in breast milk in 1982
was 26 ng/g (whole milk) (Mes et al. 1984).  In 1986, the average PCB concentration in breast milk had
declined to 6 ng/g (whole milk) (Mes 1994).  Data summarized by Kimbrough (1995) indicate that in
some industrialized countries an infant may accumulate 6.8% of its lifetime PCB body burden during a
nursing period of 6 months.
Lanting et al. (1998a) measured the levels of PCB congeners 118, 138, 153, and 180 in cord plasma,
breast milk, and plasma from 42-month-old children (n=126) living in the Groningen area, The
Netherlands.  In 42-month-old children who were fully breast-fed for at least 6 weeks, the median total 
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plasma PCB level was 0.81 µg/L (range: 0.23–2.2), compared to the formula-fed children that had levels
of 0.18 µg/L (range: 0.07–1.49).  The median total PCB concentration in breast milk was 11.9 µg/L
(range: 3.3–28.2), while the levels of PCBs 118, 138, 153, and 180 were below the limit of detection in
the formula milk samples.  While the plasma level of each of these congeners increased in the breast-fed
children between birth (cord blood) and 42-months of age, the formula-fed children exhibited a decrease
in the plasma level of each of these congeners over this same time period.  The relative abundance of PCB
congeners was similar within samples of cord plasma, breast milk, and plasma at 42-months of age, with
PCB 153>138>180>118.  Based on regression analysis of the above data, Lanting et al. (1998a) proposed
a model to estimate total PCBs in the plasma of 42-month-old children.  Using this model, each week of
additional breast-feeding is estimated to increase the 3PCB42mo by 0.28% (SE=0.05%) of the 3PCBmilk. 
For a mother with a median 3PCBmilk of 11.9 µg/L, as in this study, this results in an increase the 
3PCB42mo level of 0.033 µg/L per week of full breast-feeding. 
Similar results were observed in 93 formula-fed and 100 breast-fed children at 3.5 years of age in the
Rotterdam Area, The Netherlands (Patandin et al. 1997, 1999).  3PCBs 118, 138, 153, and 180 in plasma
of formula-fed children had a median level of 0.21 µg/L (range: 0.08–0.46), compared to the breast-fed
group which had a median level of 0.75 µg/L (range: 0.23–5.9).  PCB levels in maternal plasma
(2.04 µg/L, range: 0.59–7.35) and cord plasma (0.40 µg/L, range: 0.08–2.08) were significantly correlated
with the PCB levels at 3.5 years in the breast-fed and formula-fed groups.  In the breast-fed group, PCB
levels were significantly correlated with the period of breast feeding and milk PCB levels.  A higher body
weight of the child was significantly associated with lower plasma PCB levels at 3.5 years in both groups,
suggesting that growth in body mass is diluting the plasma PCB level.  With the assumptions that the
half-life for plasma PCBs is 2.8 years in children (Yakushiji et al. 1984), and that dietary intake of PCBs
after weaning is negligible, compared to prenatal and lactational exposure, it seems likely that plasma
levels of PCBs in infants during breast-feeding are similar to that of their mother’s. 
Dietary exposure to dioxin-like coplanar PCBs (77, 126, 169) and PCDDs and PCDFs from infancy until
adulthood was also estimated in this group of breast-fed and formula-fed children (Patandin et al. 1999). 
The 3PCB 77, 126, and 169 in breast milk had a median level of 14.8 pg TEQ/g milk fat (range:
4.4–45.7), while the TEQ due to PCDDs and PCDFs in breast milk was 30.6 pg TEQ/g milk fat (range:
11.1–76.4).  Thus, the coplanar PCBs contribute about one third of the total dioxin TEQs in human breast
milk.  The daily TEQ intake per kg body weight is about 50 times higher in breast-fed infants and 3 times
higher in toddlers than in adults.  Based on a model that included intake measures, food questionnaires,
and national food consumption and contamination data, breast-feeding for 6 months contributed about 
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12% (boys) or 14% (girls) of  the cumulative PCB/dioxin TEQ intake until 25 years of age.  In toddlers,
dairy products contribute 43% of the PCB-TEQ, meat and meat products contributed 14%, and processed
foods 23%.  Further information on exposures of children can be found in Section 6.6.
There are no biomarkers of exposure or effect for PCBs that have been validated in children or in adults
exposed as children.  There are no biomarkers in adults that identify previous childhood exposure.  No
studies were located regarding interactions of PCBs with other chemicals in children or adults.  No
information was located regarding pediatric-specific methods for reducing peak absorption following
exposure to PCBs, reducing body burden, or interfering with the mechanism of action for toxic effects.  In
addition, no data were located regarding whether methods for reducing toxic effects in adults might be
contraindicated in children.
3.8 BIOMARKERS OF EXPOSURE AND EFFECT
Biomarkers are broadly defined as indicators signaling events in biologic systems or samples.  They have
been classified as markers of exposure, markers of effect, and markers of susceptibility (NAS/NRC 1989).
Due to a nascent understanding of the use and interpretation of biomarkers, implementation of biomarkers
as tools of exposure in the general population is very limited.  A biomarker of exposure is a xenobiotic
substance or its metabolite(s) or the product of an interaction between a xenobiotic agent and some target
molecule(s) or cell(s) that is measured within a compartment of an organism (NAS/NRC 1989).  The
preferred biomarkers of exposure are generally the substance itself or substance-specific metabolites in
readily obtainable body fluid(s), or excreta.  However, several factors can confound the use and
interpretation of biomarkers of exposure.  The body burden of a substance may be the result of exposures
from more than one source.  The substance being measured may be a metabolite of another xenobiotic
substance (e.g., high urinary levels of phenol can result from exposure to several different aromatic
compounds).  Depending on the properties of the substance (e.g., biologic half-life) and environmental
conditions (e.g., duration and route of exposure), the substance and all of its metabolites may have left the
body by the time samples can be taken.  It may be difficult to identify individuals exposed to hazardous
substances that are commonly found in body tissues and fluids (e.g., essential mineral nutrients such as
copper, zinc, and selenium).  Biomarkers of exposure to [substance x] are discussed in Section 3.8.1.
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Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration within an
organism that, depending on magnitude, can be recognized as an established or potential health
impairment or disease (NAS/NRC 1989).  This definition encompasses biochemical or cellular signals of
tissue dysfunction (e.g., increased liver enzyme activity or pathologic changes in female genital epithelial
cells), as well as physiologic signs of dysfunction such as increased blood pressure or decreased lung
capacity.  Note that these markers are not often substance specific.  They also may not be directly
adverse, but can indicate potential health impairment (e.g., DNA adducts).  Biomarkers of effects caused
by polychlorinated biphenyls are discussed in Section 3.8.2.
A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism's ability
to respond to the challenge of exposure to a specific xenobiotic substance.  It can be an intrinsic genetic
or other characteristic or a preexisting disease that results in an increase in absorbed dose, a decrease in
the biologically effective dose, or a target tissue response.  If biomarkers of susceptibility exist, they are
discussed in Section 3.10 “Populations That Are Unusually Susceptible”.
3.8.1 Biomarkers Used to Identify or Quantify Exposure to Polychlorinated Biphenyls
PCBs are pervasive environmental contaminants that are found in body tissues and fluids of the general
population.  Because they are lipophilic and generally have half-lives longer than 1 week, PCBs are
preferentially stored in adipose tissue and are present in serum, blood plasma, and human milk.  Serum,
including umbilical cord serum, and adipose tissues are indicators of exposure, but serum or plasma PCB
concentrations can be significantly influenced by serum lipid content due to partitioning of PCBs between
adipose tissue and serum lipids (Brown and Lawton 1984).  Therefore, serum or plasma lipid PCB
concentrations are better indicators of body burden than PCB levels uncorrected by lipid content (Brown
and Lawton 1984).  This was clearly illustrated in a study by Phillips et al. (1989b).  These authors
showed that the concentration of PCBs in nonfasting serum samples from 20 healthy adult males was
29% higher than in fasting serum samples.  Total serum lipids (total cholesterol, free cholesterol,
triglycerides, and phospholipids) were 20% higher in the nonfasting group.  When the concentration of
PCBs was corrected by total serum lipids, the difference between fasting and nonfasting samples was no
longer statistically significant.  Differences in metabolic profiles among different congeners will also
influence the serum concentration at any given time.  Variations in procedures and methods of reporting
data can make interlaboratory comparison difficult (Jensen 1987).  It should also be mentioned that,
except for large exposures, blood should be collected quickly (days to weeks after exposure) if elevation 
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is to be found to document a given exposure.  The lack of obvious elevation months to years after
exposure does not, of itself, indicate lack of exposure.
Quantitative exposure to PCB mixtures can be estimated if the steady-state body burden and the
elimination half-life for the mixture are known.  In the simplest model, it is assumes that elimination of
PCBs from the body can be described as a first-order process.  Elimination half-lives of 6–7 months and
33–34 months were estimated for Aroclor 1242 and 1260, respectively, in two groups of capacitor
workers (Steele et al. 1986).  In a subsequent study, the same group of investigators (Phillips et al. 1989a)
indicate that recalculation of the half-life for Aroclor 1242 yielded a median value of 1.9 years.  This was
comparable to a half-life of 2.6 years estimated in a different group of workers over a period of 8 years
(Phillips et al. 1989a).  In individuals exposed to river water contaminated with PCBs, it was estimated
that the half-life elimination from blood for the PCB mixtures was .8–9 months, whereas skin lipid PCBs
had half-lives of 5 months (Jan and Tratnik 1988).
Short-term exposure to PCB mixtures that are rapidly eliminated may not result in the achievement of a
steady-state blood level, in which case, the elimination half-life determined will be misleading.  If a true
half-life is substantially longer than the calculated half-life, the steady-state burdens may actually be
higher than reported.  On the other hand, an underestimate of half-life, given adequate steady-state body
burden data, will result in an over-estimation of intake.
PCB congeners with a high degree of chlorination and congeners that lack unsubstituted meta-para
positions are better candidates for bioaccumulation (see Section 3.4.3, Metabolism).  This conclusion is
consistent with the finding that congeners with unsubstituted 3,4 positions on at least one of the phenyl
rings were found at a lower concentration in the blood and adipose tissue of capacitor manufacturing
workers than those with substitutions in the 2,4 or 3,4 positions on both rings (Wolff et al. 1982a).  This
means that fatty tissues will preferentially accumulate the retained congeners leading to a different
congeneric pattern compared with the original PCB source.
Eighty-nine PCB peaks were identified and confirmed in serum and adipose tissue of exposed workers
(past and/or present exposure) and nonexposed subjects (Fait et al. 1989).  Elimination of PCBs over time
was inferred from the fact that the total PCB levels in adipose tissue of previously exposed workers were
not significantly different than in nonexposed subjects.  Congeneric composition of adipose tissue did not
differ between previously exposed and nonexposed individuals indicating that single PCB congeners are
not good indicators of previous exposure.  However, the concentration of hepta- and octachlorobiphenyls 
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in the serum of previously exposed workers was significantly higher than in the comparison group and
equivalent to the currently exposed group.  Differences in serum levels of specific PCB congeners have
been observed in individuals exposed to PCB mixtures occupationally, accidentally, or environmentally
(Luotamo 1988).  Differences in the concentrations of trichlorinated and tetrachlorinated isomers were
found in the serum samples of the three groups.  Only one pentachlorinated isomer was found in
individuals environmentally exposed to PCBs, whereas five other pentachlorinated isomers were found in
accidentally exposed individuals.  The congeners that best indicated occupational exposure were
2,4,4N-triCB, 2,4,4N,5-tetraCB, 2,3,4,4N-tetraCB, and 2,3N,4,4N-tetraCB (Luotamo et al. 1993).  Those that
indicated accidental exposure were 2,4,4N-triCB, 2N,3,4-triCB, and 2,3N,4,4N-tetraCB (Luotamo et al.
1993).  Thus, it would appear that in some cases isomer-specific monitoring of serum levels of PCB
congeners in humans can determine likely exposure sources (Luotamo 1988).
PCB residue data in humans and other animals (see Section 3.4.2, Distribution) suggest that tissue or
body burdens of PCBs should be based on individual congeners or groups of congeners and not on
profiles of commercial PCB formulations.  The simplest approach involves using one congener as a
marker of total PCBs in a biological specimen.  Levels of 2,2',4,4',5,5'-hexaCB (PCB 153), a very stable
and often the most abundant congener, have been shown to correlate with the total amount of PCBs in
human breast milk (Johansen et al. 1994) and human plasma, with a correlation coefficient of
r=0.99 (Grimvall et al. 1997).  PCB 153 was highly correlated (r=0.95) with total PCBs in 460 serum
samples from Swedish men and women (Atuma and Aune 1999).  PCB 153 was also highly correlated
with total PCBs in serum (r=0.99) and follicular fluid (r=0.99) (Pauwels et al. 1999).  In addition,
PCB 153 levels correlated (r=0.91) with the total PCB-TEQs in human plasma (Grimvall et al. 1997). 
However, if a more complete profile of congeners is considered, the correlations are lower (Bachour et al.
1998; Hansen 1998, 1999).  Total PCBs or PCB 153 as a marker of the total therefore could be a
misleading indicator of the differential exposure to other individual or groups of congeners of
toxicological significance.  
Another important issue related to exposure biomarkers is whether analysis of PCBs in serum and adipose
tissue provide comparable information on body burden.  Stellman et al. (1998) measured 14 PCB
congeners in adipose tissue and serum from 293 women with nonoccupational exposure.  The relative
patterns of the 14 PCB congeners were similar to those reported in other human studies.  Significant
positive serum to adipose correlation coefficients were obtained for PCBs 74, 99, 118, 138, 146, 153,
156, 167, 170, 180, 183, and 187, while PCBs 172 and 178 did not reach statistical significance.  Thus, 
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this study supports the conclusion that either serum or adipose tissue PCB levels may serve as useful
biomarkers of body burden and/or exposure.
Due to its high fat content, human milk concentrates PCBs, which are then transferred to children through
lactation (EPA 1984d; Jacobson et al. 1984b).  For example, among 122 mothers’ milk samples in
Massachusetts screened for PCBs, 4 had total PCB levels ranging from 1,100 to 2,400 ng/g milk fat,
which were significantly higher than the group mean of 320 ng/g milk fat (Korrick and Altshul 1998). 
PCB levels in milk have been positively correlated with consumption of PCB-contaminated fish (EPA
1984d).  With the use of high resolution analytical techniques, it has been possible to compare the
congeneric composition of PCBs in milk with that of commercial PCB mixtures (Safe et al. 1985b).  Gas
chromatograms of human milk samples from Michigan did not resemble the pattern of any commercial
mixture; however, several PCB congeners possessing common structural features, which rendered them
metabolism resistant, were major components of both milk and Aroclor 1260 (Safe et al. 1985b). 
Conversely, other PCB congeners that are minor components of Aroclor 1260 were major components of
the human milk.  Yet, a different group of congeners, comprised only 28% of the PCBs present in
Aroclor 1260, only composed 0.81% of the human milk PCBs; this latter group was formed by congeners
having two adjacent unsubstituted carbons, which facilitates metabolic degradation (Safe 1989a).  Burse
et al. (1994) showed that PCB chromatograms of human serum matched the pattern of goats fed Aroclors
better than Aroclor standards.  This led the authors to suggest that some animal species could be useful in
delineating the source of the PCB exposure in humans.  In breast milk, most of the dioxin-like activity in
the milk was due to the high concentrations of (coplaner) PCB congeners (Dewailly et al. 1991).  Similar
findings were reported for milk from Norwegian mothers (Johansen et al. 1994).  In summary, highly
chlorinated PCB congeners and congeners that lack unsubstituted meta-para positions constitute the most
reliable biomarker of long-term exposure because they are metabolism resistant and, therefore, tend to
accumulate in tissues.  However, the specific PCB congeners or group of congeners to be used as
exposure biomarkers will be dependent on the outcomes under study (e.g., immunological effects,
reproductive end points, cancer).
Chloracne and other dermal alterations are well known markers of exposure to PCBs and structurally-
related halogenated aromatic hydrocarbons (Rice and Cohen 1996).  Chloracne and other dermal
alterations have been reported in subjects occupationally exposed to PCBs (Bertazzi et al. 1987; Fischbein
et al. 1979, 1982; Maroni et al. 1981a, 1981b; Meigs et al. 1954; Ouw et al. 1976, 1982; Smith et al.
1982) and in individuals exposed by accidental ingestion of rice oil contaminated with high
concentrations of PCBs, CDFs, and related chemicals during the Yusho or Yu-Cheng poisoning incidents 
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(Guo et al. 1999; Kuratsune 1989; Lu and Wu 1985; Rogan 1989).  Skin lesions consistent with those
observed in exposed adults were also commonly observed in children born to mothers with Yusho or
Yu-Cheng exposure (Funatsu et al. 1971; Gladen et al. 1990; Hsu et al. 1985; Rogan et al. 1988; Taki et
al. 1969; Yamaguchi et al. 1971; Yoshimura 1974).  No adverse dermal effects have been observed in
subjects with high consumption of Great Lakes fish contaminated with PCBs and other environmentally
persistent chemicals or in other cohorts from the general population.  In general, chloracne appears in
individuals with serum PCB levels 10–20 times higher than those of the general population, but there is
great variability among individuals.  Therefore, chloracne is not a sensitive (or specific) biomarker of
PCB exposure.
3.8.2 Biomarkers Used to Characterize Effects Caused by Polychlorinated Biphenyls
Several studies of PCB-exposed workers and general population subjects attempted to correlate serum
PCB levels with health indices.  Statistically significant correlations of serum PCB levels with serum
levels of liver-related enzymes (e.g., AST, ALT) and levels of serum lipids (cholesterol, triglycerides)
have been reported in workers occupationally exposed to PCBs (Baker et al. 1980; Emmett et al. 1988a,
1988b; Fischbein 1985; Fischbein et al. 1979; Lawton et al. 1985a, 1985b; Smith et al. 1982).  However,
associations between serum PCBs and these hepatic effects are inconclusive due to small and inconsistent
increases, lack of correction for confounding variables such as alcohol consumption, and other study
limitations.  Additionally, correlations between serum PCBs and lipids are influenced by partitioning of
PCBs between lipids in adipose tissue and serum.  This indicates that measurements of serum
triglycerides and cholesterol are more useful for correcting serum PCB levels to more accurately reflect
body burden than for detecting effects of PCBs.  It must also be pointed out that PCB mixtures display
different induction profiles, so that individual PCB congeners can be phenobarbital-type,
3-methylcholanthrene-type, or mixed-type mixed-function oxidase (MFO) inducers, or they may be
inactive as enzyme inducers.  Furthermore, the clinical significance of the alterations in liver-associated
enzymes is uncertain, as the increases may be nonspecific and are often in the normal range, and indices
of obstructive liver disorders have not been demonstrated even in occupationally exposed groups.  The
existing evidence in animals suggests that liver enzyme induction is perhaps the most sensitive biomarker
of PCB effects, but it is nonspecific (Nims et al. 1992).  MFO induction has been demonstrated indirectly
in PCB-exposed workers by increased metabolic clearance of antipyrine (Alvares et al. 1977).  The
caffeine breast test (CBT) appears to be a sensitive method for characterizing exposure/and or effects of
certain PCBs and related chemicals (Lambert et al. 1992).  In this test, 13C-methyl caffeine is ingested by
subjects, and hepatic cytochrome P-4501A2-dependent caffeine 3-N-demethylase activity is monitored by
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determining the amount of caffeine exhaled as radiolabeled CO2.  The CBT is not specific for PCBs since
PCDFs, PCDDs, and other polyaromatic hydrocarbons also induce cytochrome P-4501A. 
Results from a study with a feral mouse species showed that induction of hepatic EROD
(CYP1A1-mediated activity) was a sensitive biomarker of effect (and/or exposure) for Aroclor 1254
(Lubet et al. 1992).  Based on hepatic levels of the enzyme, the investigators could clearly distinguish
between a population of mice living in a PCB-contaminated area and a population of the same species
from a nonPCB reference site.  Furthermore, the relative levels of the enzyme correlated well with hepatic
PCB burdens.  When the results based on feral mice were compared to results obtained in female
Fischer 344/NCr rats exposed for acute or intermediate durations to Aroclor 1254 or in male B6C3F1
mice exposed acutely to Aroclor 1254 in the laboratory, the order of responsiveness was
Fischer 344/NCr > B6C3F1 > feral mice.  Results from a study by Nims et al. (1992) showed that
increased CYP1A1 activity could be detected directly or indirectly in rats treated with relatively low
doses of Aroclor 1254 (0.1 mg/kg/day for 7 days) in the diet.  CYP2B1 activity was a much less sensitive
indicator of effect (and/or exposure).  It should be noted that induction of CYP1A1-mediated activity may
also result from exposure to a variety of other environmental contaminants.  Recently, a human hepatoma
cell line, HepG2, was used to determine the dose response of various Aroclor mixtures as well as several
dioxin-like PCB congeners (Anderson et al. 1995).  In this assay, the human CYP1A1 gene was
engineered such that, when activated by an inducer, produces luciferase instead of P-450.  The reaction is
then monitored by measuring luminescence and protein content.  Of the seven Aroclor mixtures assayed,
Aroclor 1260 produced the greatest induction.  Aroclor 1016 and 1221 induced the lowest levels; for the
remaining Aroclor mixtures, 1232, 1242, 1248, and 1254, induction did not correlate with the percentage
of chlorination.  The order of inducing potential for the congeners was 3,3',4,4',5-pentaCB
>3,3',4,4',5,5'-hexaCB >2,3,4,4',5-pentaCB > 3,3',4,4'-tetraCB >2,3,3',4,4',5-hexaCB.  Based on the
results of the assays, the authors estimated that except for Aroclors 1016 and 1221, the approximate
detection limit in environmental samples for the other Aroclors would be in the 2–4 µg/g range; for the
congeners the detection limit was in the range 0.01–1 µg/g.  For the purpose of comparison, for
2,3,7,8-TCDD the detection limit would have been 0.00005 µg/g.
Correlations between serum PCB levels and hypertension or various hepatic indices (e.g., serum enzymes
and lipids) in people who were environmentally exposed to PCBs are also generally unclear due to
confounding variables (Kreiss et al. 1981; Stehr-Green et al. 1986a, 1986b; Steinberg et al. 1986).  These
exposures involved consuming contaminated fish or living or working near an electrical manufacturing
plant.      
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3.9 INTERACTIONS WITH OTHER CHEMICALS
As discussed in Section 3.5.2 (Mechanisms of Toxicity), PCBs represent a group of 209 structurally
related chemicals with several subgroups displaying biological actions involving different potential
mechanisms.  Some biological activities of PCBs involve initial Ah-receptor mediated mechanisms (e.g.,
induction of hepatic CYP1A oxygenases and Phase II enzymes such as UDP glucuronyl transferases,
epoxide hydrolases, or glutathione transferase, body wasting, thymic atrophy, and porphyria), other
activities involve Ah-receptor independent mechanisms (e.g., induction of CYP2B and CYP3A 
oxygenases, induction of changes in brain dopamine levels, and disruption of Ca+2 homeostasis), and
other biological activities of PCBs may involve both Ah-receptor dependent and independent mechanisms
(e.g., liver hypertrophy, disruption of steroid hormone homeostasis or thyroid hormone homeostasis,
disruption of immune functions, and induction and promotion of liver cancer).  Because of this diversity
in biological activities, there is a large potential for opportunities for PCB mixtures to alter the toxicity of
other chemicals or other chemicals to alter the toxicity of PCBs.  
Interactions Due to PCB Induction of Hepatic Enzymes    
One type of interaction that received considerable early research attention involves PCB-induced changes
in hepatic profiles of Phase I and II enzymes, leading to altered metabolism of other xenobiotic agents,
and subsequent alteration of their toxicity.  For example, observed effects of PCB pretreatment on toxicity
of other chemicals in animals include increased metabolism and excretion of pentobarbital and decreased
pentobarbital sleeping times (Villeneuve et al. 1972), increased genotoxicity of numerous carcinogens
(e.g., benzo[a]pyrene) in vitro (Hayes 1987; Hutton et al. 1979), increased duodenal ulcerogenicity of
acrylonitrile (Szabo et al. 1983), and increased renal toxicity of trichloroethylene (Kluwe et al. 1979). 
The capacity of PCB mixtures to induce cytochrome P-450 has resulted in increased toxicity of other
chemicals whose toxicity depends on metabolic activation.  For example, pretreating animals with PCB
mixtures resulted in increased hepatotoxicity due to halothane, vinylidene fluoride, diethylnitrosamine,
trichloroethylene, carbon tetrachloride, 1,1,2-trichloroethane, tetrachloroethylene, and
2,2,2-trifluoroethylvinyl ether (Conolly et al. 1979; Gans and Pintauro 1986; Kluwe et al. 1979; Moslen
et al. 1977; Murphy et al. 1979; Sipes et al. 1987).
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Interactions Between PCB Congeners, PCBs and CDDs, and PCBs, CDDs, and CDFs    
Research in the 1970s and 1980s focusing on mechanistic similarities between PCBs, CDDs, and CDFs
led to the development and use of a TEF approach to evaluating health hazards from complex
environmental mixtures of these halogenated aromatic hydrocarbons.  The approach relies on an
assumption that components in these complex mixtures jointly act in an additive manner through a
common Ah-receptor initial mechanism.  Concern about this assumption has led to several investigations
of possible interactions between specific PCB congeners, between some PCB congeners or PCB mixtures
and 2,3,7,8-TCDD, and among PCBs, CDDs, and CDFs.  Evidence for additivity and nonadditive
interactions (e.g., potentiation or antagonism) has been found depending on the PCB congeners involved,
end point examined, and dose levels of examined agents.  
Interactions Between PCB Congeners.  Observations of nonadditive interactions between specific PCB
congeners include: 2,2',4,4',5,5'-hexaCB (10–50 mg/kg) antagonism of embryo malformations, edema,
and liver lesions in chickens exposed to 2 µg/kg 3,3',4,4',5-pentaCB (Zhao et al. 1997a);
2,2',4,4',5,5'-hexaCB (271 mg/kg) antagonism of cleft palate formation in mice exposed to
0.78–1.04 mg/kg 3,3',4,4',5-pentaCB (Zhao et al. 1997b); 2,2',4,4',5,5'-hexaCB (18–72 mg/kg)
antagonism of impairment of immune response in mice exposed to 6–12 µg/kg 3,3',4,4',5-pentaCB
(Harper et al. 1995; Zhao et al. 1997b); synergism between 20 weekly subcutaneous doses of 5 mg/kg
2,2',4,4',5,5'-hexaCB and 1–10 µg/kg 3,3',4,4',5-pentaCB in promoting formation of γ-glutamyl
transpeptidase-positive hepatic foci in partially hepatectomized rats initiated with 30 mg/kg
nitrosodiethylamine (Bager et al. 1995); strong antagonism by 2,2',5,5'-tetraCB (10 or 25 µM) or
2,2',3,3',4,4'-hexaCB (12.5 or 25 µM) of luciferase expression induced by 3,3',4,4'-tetraCB (10 nM) in
cultured recombinant Hepa1c1cc7 mouse hepatoma cell lines, but not in guinea pig GPC16 colon
adenocarcinoma cells or human HepG2 hepatoma cells (Aarts et al. 1995); weak antagonism between
20 weekly subcutaneous doses of 0.13–6.6 µg/kg 3,3',4,4',5-pentaCB and 66–3,302 µg/kg
2,3,3',4,4'-pentaCB in promoting formation of γ-glutamyl transpeptidase-positive hepatic foci in partially
hepatectomized rats initiated with 30 mg/kg nitrosodiethylamine (Haag-Grönlund et al. 1998; Johansson
et al. 1999); and weak antagonism between 0.13–6.6-µg/kg doses of 3,3',4,4',5-pentaCB and
220–11,003-µg/kg doses of 2,2',4,4',5,5'-hexaCB in promoting formation of γ-glutamyl transpeptidase-
positive hepatic foci, in changing concentrations of plasma retinol and liver retinoids, in increasing
relative liver weight, and in inducing liver CYP2B1/2 activities (Haag-Grönlund et al. 1998; Johansson et
al. 1999).
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Interactions Between PCBs and CDDs.  Acute parenteral administration of several commercial PCB
mixtures (Aroclors 1242, 1248, 1254, and 1260) and a synthetic mixture of PCB congeners reflective of
PCBs detected in human milk antagonized 2,3,7,8-TCDD-induced impairment of the immune response to
SRBC in mice at PCB:TCDD dose ratios >1000:1 (Bannister et al. 1987; Davis and Safe 1989). 
Aroclor 1232 had no effect on TCDD-induced immunotoxicity in these studies (Davis and Safe 1989). 
Aroclor doses that antagonized the acute immunotoxicity of single doses of 0.0012 or 0.0036 mg/kg
2,3,7,8-TCDD ranged from about 1 to 50 mg/kg/day (Bannister et al. 1987; Davis and Safe 1989). 
Among seven individual PCB congeners examined for their ability to influence this immunotoxic action
of single intraperitoneal doses of 0.0012 µg/kg 2,3,7,8-TCDD in mice (six hexachlorobiphenyls and one
pentachlorobiphenyl with different chlorine substitution patterns), three were antagonistic (the
2,3,3',4,5,5'-, 2,3,3',4,5'- and 2,2',4,4',5,5'-congeners), and 4 showed no influence (the 2,3,3',4,4',5' -,
2,3',4,4',5',6-, 2,2',4,4',5,6'-, and 2,2',4,4',6,6'-congeners ) (Biegel et al. 1989b; Davis and Safe 1990;
Smialowicz et al. 1997).  In these studies, doses of individual PCB congeners ranged from about 1 to
100–300 mg/kg.
Oral co-exposure of pregnant mice to 244 mg/kg Aroclor 1254 and 0.020 mg/kg 2,3,7,8-TCDD, at an
Aroclor:TCDD dose ratio of 12,200:1, completely antagonized TCDD-induced cleft palate formation in
offspring (Haake et al. 1987). The complexity of interactions between PCBs and TCDD-induced
developmental toxicity is illustrated by observations that, among one tetrachlorobiphenyl and two
hexachlorobiphenyl congeners examined, one (the 2,3,3',4,4',5-congener) potentiated TCDD-induced cleft
palate formation (Birnbaum et al. 1985) and the other two (the 2,2',4,4'- and 2,2',4,4',5,5'-congeners)
antagonized TCDD’s actions (Biegel et al. 1989a, 1989b; Birnbaum et al. 1985; Morrissey et al. 1992). 
Antagonism of TCDD-induced cleft palate formation in mouse offspring by 2,2',4,4'-tetraCB and 
2,2',4,4',5,5'-hexaCB showed complex (i.e., inverted U-shape) relationships with dose (Morrissey et al.
1992).  For example, no antagonistic effect (against a TCDD dose of 0.0015 µg/kg) was produced by
10–20 mg/kg doses of 2,2',4,4',5,5'-hexaCB, but antagonism increased with increasing
2,2',4,4',5,5'-hexaCB dose to a maximum (500 mg/kg), and then declined to no antagonism at
1,000 mg/kg 2,2',4,4',5,5'-hexaCB (Morrissey et al. 1992).  2,2',4,4',5,5'- HexaCB also antagonized
TCDD-induced hydronephrosis in mouse offspring showing a similar inverted U-shape relationship with
dose (Biegel et al. 1989b; Morrissey et al. 1992).  In contrast, combined exposure of pregnant mice to
2,3,3',4,4',5-hexaCB and 2,3,4,7,8-pentachlorodibenzofuran appeared to additively produce
hydronephrosis and cleft palate in the offspring (Birnbaum et al. 1987). 
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Several 13-week oral exposure studies have examined possible binary interactions between three PCB
congeners (at several dietary concentrations delivering daily doses ranging from about 0.1 to
10 mg/kg/day) and 2,3,7,8-TCDD (at several dietary concentrations delivering daily doses ranging from
about 0.00003 to 0.3 mg/kg/day) in influencing several end points in rats (van Birgelen et al. 1992,
1994a, 1994b, 1996a; van der Kolk et al. 1992).  The PCB:TCDD concentration ratios administered in
these studies were selected to reflect relative concentrations in samples of human milk and fat. 
2,2',4,4',5,5'-HexaCB and 2,3,7,8-TCDD showed joint additive action in decreasing thyroid hormone
levels at 4 weeks, but synergistic action at 13 weeks (van Birgelen et al. 1992), whereas
2,3,3',4,4',5-hexaCB (van Birgelen et al. 1994a) and 3,3',4,4',5-pentaCB (van Birgelen et al. 1994b)
showed less-than-additive joint action with 2,3,7,8-TCDD in decreasing thyroid hormone levels. 
2,2',4,4',5-Hexachlorobiphenyl did not influence TCDD-induced effects on body weight and thymus
weight, and additively increased relative liver weight with TCDD (van der Kolk et al. 1992), whereas
2,3,3',4,4',5-hexaCB and 3,3',4,4',5-pentaCB showed less-than-additive joint action with TCDD on these
end points.  2,2',4,4',5,5'-hexaCB and 2,3,7,8-TCDD showed a distinct synergism in increasing hepatic
porphyrin levels, but 2,3,3',4,4',5-hexaCB and 3,3',4,4',5-pentaCB showed no such synergism with
2,3,7,8-TCDD (van Birgelen et al. 1996a).  All three of these congeners individually decreased hepatic
levels of retinol and retinylpalmitate. In combination with TCDD, less-than-additive joint actions were
noted, but TCDD doses used in these studies produced a near maximal response in decreasing retinoid
levels (van Birgelen et al. 1992, 1994a, 1994b).
Interactions Among PCBs, CDDs, and CDFs.  Liver tumor promotion activity was examined in partially
hepatectomized rats exposed to a mixture containing 68 ppm 2,3,7,8-TCDD, 223 ppm
1,2,3,7,8-pentachloro-p-dioxin, 1,151 ppm 2,3,4,7,8-pentachlorodibenzofuran, 4,130 ppm
3,3',4,4',5-pentaCB, 866,604 ppm 2,3',4,4',5-pentaCB, and 127,824 ppm 2,3,3',4,4',5-hexaCB and
compared with predicted tumor promotion activity using TEFs based on tumor promotion activity of the
individual components compared to TCDD activity (Van der Plas et al. 1999).  The mixture composition
was reflective of relative concentrations, and accounted for about 90% of total TCDD TEQs, found in
samples of Baltic Sea fish.  Observed tumor promotion activity of the mixture was about one-half of
predicted activity.  Another mixture, containing, in addition to the above components, 20,000 g
2,2',4,4',5,5'-hexaCB per g of 2,3,7,8-TCDD, showed a tumor promotion activity that was also less than
that predicted by the TEF approach.  A possible explanation of the differences between the observed and
TEF predicted values is that the components may have interacted in a less-than-additive manner (e.g., less
potent PCBs may antagonize tumor promotion by the more potent 2,3,7,8-TCDD), but equally as
plausible is the possibility that the TEFs are inaccurate and overestimate tumor promotion potencies (van 
3.  HEALTH EFFECTS - Interactions
PCBs 405
der Plas et al. 1999).  In related studies, 2,2',4,4',5,5'-hexaCB antagonized TCDD promotion of malignant
transformations of carcinogen-initiated mouse fibroblasts (Wolfe 1998), whereas 3,3',4,4',5-pentaCB
added to promotion of fibroblast transformation in the presence of 2,3,7,8-TCDD (Wolfe 1998) and to
promotion of liver tumors in rats with co-exposure to 2,3,7,8-TCDD (Hemming et al. 1985).  
The possibility that interactions among PCBs, CDDs, and CDFs may influence reproductive end points
(blockage of ovulation, reduction of ovarian weight gain, and changes in preovulatory hormone levels)
was examined in gonadotropin-primed immature female rats given single oral doses of
0.057–0.457 mg/kg 3,3',4,4',5-pentaCB (a PCB with known Ah receptor agonist activity) or
0.010–0.160 mg/kg 2,3,4,7,8-pentachlorodibenzofuran alone or together in combination with
2,3,7,8-TCDD, 1,2,3,7,8-pentachlorodibenzo-p-dioxin, and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin, all of
which were shown to be effective blockers of ovulation in this assay (Gao et al. 1999, 2000).  The
mixture was administered at TCDD-TEQ doses ranging from 0.0038 to 0.0303 mg/kg.  Parallel dose-
response relationships for inhibition of ovulation were found for the individual agents and for the
equipotent mixture.  This finding is consistent with the hypothesis that the agents in the tested mixture are
likely to block ovulation by additive joint action in a similar mechanism and supports the use of the TEF
approach for this type of endocrine disruption.  Another PCB congener, 2,2',4,4'-tetraCB (which has no
detectable Ah receptor agonist activity), was inactive at the dose examined in this assay (41.9 mg/kg). 
The effect of its presence in a mixture with effective components, however, was not studied (Gao et al.
2000). 
Interactions Between PCBs and Methylmercury    
PCBs and methylmercury represent a combination of agents of public health concern that are potential
neurotoxicants found in the complex mixture of biopersistent toxicants in contaminated fish from the U.S.
Great Lakes and the Baltic Sea.  Changes in neurological function or development from PCBs and
methylmercury have been proposed to at least partly involve disruption of calcium homeostatic
mechanisms in neural cells leading to changes in neurotransmitter release (e.g., dopamine) or cell
damage.  Exposure of rat striatal tissue for 4 hours with methylmercury alone at concentrations ranging
from 1 to 40 µM or a 1:1 mixture of Aroclors 1254 and 1260 at concentrations ranging from 10 to
200 ppm resulted in a significant, dose-dependent depletion of tissue dopamine levels (Bemis and Seegal
1999).  Bemis and Seegal (1999) noted that these concentrations were, in general, higher than those
measured in samples of Great Lakes fish (0.84–1.9 ppm PCBs and 0.34 ppm mercury).  Combined in
vitro exposure of rat striatal tissue to methylmercury and this 1:1 mixture of Aroclors 1254 and 1260 
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(10–200 ppm) synergistically depleted tissue levels of dopamine (Bemis and Seegal 1999).  For example,
combined exposure to 4 µM methylmercury and 200 ppm PCBs, or 10 µM methylmercury and 20, 40,
100, or 200 ppm PCBs, showed a significant statistical interaction (in an analysis of variance) indicative
of synergistic effects on depleting tissue dopamine levels.  These results suggest a possible synergism in
affecting neurological dysfunction and development, but no in vivo demonstration of such a synergism is
available. 
A study of combined oral exposure of pregnant female mice to methylmercury (0.4 or 4 mg/kg/day) and
Kanechlor 500 (about 940 mg/kg/day) from gestation day 15 to day 21 after delivery found no evidence
for obvious synergistic effects on righting and swimming ability, hindlimb support, general open field
activity, and learning ability in offspring evaluated at several postnatal periods or on reproductive
performance in the F0 and F1 generations (Tanimura et al. 1980).  Methylmercury, at 4 (but not 0.4) mg
Hg/kg/day, potentiated PCB-induced decreased postnatal survival in mice (Tanimura et al. 1980). 
Survival of male offspring in all Kanechlor groups showed a marked decline, compared with controls, at
about 5 weeks after birth; at 10 weeks after birth, male offspring survival percentages were about 60, 60,
and 40% for the groups with Kanechlor plus 0, 0.4, and 4 mg Hg/kg, compared with >90% in the control
and methylmercury alone groups.  Autopsies revealed no obvious or specific cause of death.  Survival
data for female offspring were reported to have been similar.  
In a study of minks, reproductive end points, serum thyroid hormone levels (T3 and T4), and histology of
brain, kidney, adrenals, pituitary, and thyroid were evaluated in groups of adult ranch-bred minks fed a
commercial mink food supplemented with 0 or 1 ppm Aroclor 1254, 1 ppm Hg as methylmercury, 1 ppm
Aroclor 1254 + 1 ppm methylmercury, or 0.5 ppm Aroclor 1254 + 0.5 ppm methylmercury for 8 months
that spanned one breeding period (December 1984 through June 1985) (Wren et al. 1987a, 1987b). 
Exposed groups contained 12 females and 4 males; control groups had 15 females and 5 males.  Food
intake and body weight data were not reported, but estimates of 0.2 mg/kg/day Aroclor 1254 and 0.2 mg
Hg/kg/day are derived for the 1-ppm treatment based on a food intake of 150 g/day and body weight of
0.9 kg for minks (Aulerich et al. 1987).   During the third month of exposure, eight females and one male
in the 1 ppm methylmercury group, and three females in the 1 ppm Aroclor + 1 ppm methylmercury
group, died, displaying convulsions, tremors, and lethargy.  The mortality was attributed to a combination
of cold stress and methylmercury poisoning, and surviving minks were fed diets containing 1 ppm
methylmercury every other day for the remainder of the study.   No exposure-related effects were found
on the thyroid, pituitary, adrenal glands, or serum T4 or T3 levels in adult minks that survived the 8-month
exposure period.  Fertility of adult male minks, percentage of females whelped, or number of offspring 
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born per female were not significantly affected by any of the treatments.  The average number of
offspring per female at weaning (5 weeks after birth) was significantly (p< 0.05) lower in the 1 ppm
Aroclor + 1 ppm methylmercury group (2.1 offspring/female) than in the control (4.5), 1 ppm
Aroclor (5.0), 1 ppm methylmercury (4.0), or 0.5 ppm Aroclor + 0.5 ppm methylmercury groups (3.6),
indicating that postnatal offspring mortalities were increased by combined exposure to the high levels of
methylmercury and Aroclor 1254.  
Wren et al. (1987b) concluded that these observations showed a synergistic effect of Aroclor 1254 and
methylmercury on decreased postnatal survival of mink offspring.  An alternative interpretation of the
results is that combined exposure induced postnatal mortality at concentrations of the individual agents
(1 ppm) that did not induce postnatal mortality, but it is not possible to discern if they acted together in a
less-than-additive, additive, or greater-than-additive manner without including treatments involving
2 ppm concentrations of the individual agents alone.  A clear demonstration of synergistic action would
have involved increased postnatal mortality produced by the 0.5 ppm Aroclor + 0.5 ppm methylmercury
treatment; however, postnatal mortality was not changed, compared with control, by this treatment.
Intermediate-duration exposures of quail to methylmercury or Aroclor 1260 in the diet led to
accumulation of porphyrins in liver; hepatic porphyrin levels in quail exposed to both agents
simultaneously were similar to levels predicted based on additivity of response (Leonzio 1996b).  
Combined exposure of rats or quail to commercial PCB mixtures and methylmercury appears to
counteract PCB induction of hepatic CYP enzymes (Leonzio et al. 1996a; Takabatake et al. 1980), but the
toxicological significance of this interaction is unclear.
Interactions Between PCBs and p,p’-DDE    
Results from animal (and some human) studies identify several sensitive shared targets of PCBs and
p,p’-DDE oral toxicity including the liver (hepatomegaly, degenerative histological effects, and liver
cancer), immune system (suppression of  cell-mediated immunological responses), neurological
development (altered neurobehavior in offspring exposed in utero or during nursing periods), and altered
reproductive function or development.  A limited amount of in vitro and in vivo data regarding possible
interactions between PCBs and p,p’-DDE are available as reviewed below.
Incubation of an estrogen receptor preparation from alligator oviducts with a mixture containing 18 µM
p,p’-DDE, 2.6 µM p,p’-DDD, 0.63 µM dieldrin, 0.53 µM Aroclor 1242, 0.25 µM trans nonachlor, 
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0.16 µM cis nonachlor, 0.22 µM chlordane, and 0.2 µM toxaphene inhibited the binding of tritium-
labeled 17β-estradiol to estrogen receptors by 57% (Vonier et al. 1996).  The individual agents, at the
concentrations used in this mixture, did not inhibit the in vitro binding of 17β-estradiol to the estrogen
receptors, with the exception that 2.6 µM p,p’-DDD inhibited binding by 20%.  Vonier et al. (1996)
concluded that combinations of these chemicals decreased estradiol binding “in a greater-than-additive
manner.”   Design limitations of this study, however, preclude drawing definitive conclusions whether the
mode of joint toxic action among these chemicals in this screening assay was less-than-additive, additive,
or greater-than-additive.
Combined dietary exposure of mallards to 40 ppm p,p’-DDE and Aroclor 1254 did not alter DDE-
induced egg shell thinning, but appeared to decrease the number of intact eggs that were produced
compared with values for control groups or groups exposed to either agent alone (Risebrough and
Anderson 1975).  Dietary exposure of groups of mallards (4 drakes and 10 hens) to 40 ppm p,p’-DDE or
40 ppm p,p’-DDE + 40 ppm Aroclor 1254 for 5 months caused 17 and 19%, respectively, reduction in
mean egg shell thickness compared with control groups (Risebrough and Anderson 1975).   Exposure to
40 ppm Aroclor 1254 alone did not affect egg shell thickness.  Combined exposure reduced total egg
production over the study period by about 35% compared with controls.  Egg production in the first
7 weeks was similar in all groups, but markedly dropped thereafter in the DDE+Aroclor 1254 group. 
About 25% of the decline in egg production in the combined exposure group was attributed to egg eating. 
Further information or studies regarding this apparent synergism between p,p’-DDE and Aroclor 1254
were not located.  Additional research may help to determine if a similar synergism may occur between
p,p’-DDE and PCBs in affecting reproductive function in mammals.
Interactions Between PCBs and Other Chemicals    
An initial report (Arnold et al. 1996) that binary mixtures of hydroxylated PCBs and weakly estrogenic
pesticides (dieldrin, endosulfan, toxaphene, and chlordane) resulted in synergistic increases in estrogen
receptor binding and reporter gene-expression in transfection-facilitated yeast and endometrial carcinoma-
derived cell cultures was subsequently withdrawn by the investigators due to the inability to reproduce
the results (McLachlan 1997).  A subsequent examination of possible synergy among binary mixtures of
two hydroxylated PCBs (2,4,6-trichloro-4'-biphenylol and 2,3,4,5-tetrachloro-4'-biphenylol) and two
pesticides (endosulfan and dieldrin) in two in vitro estrogenic activity assays (competitive estrogen
receptor binding and induction of multicellular nodules in human cancer-derived MCF-7 cells) found no
evidence for synergy between these hydroxylated PCBs, between these pesticides, or between 
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2,4,6-trichloro-4'-biphenylol and physiologically relevant concentrations of 17β-estradiol (Arcaro et al.
1998).  Likewise, no evidence for obvious synergy was found between tributyltin (50 nM) and
3,3',4,4',5-pentaCB (100 nM) or Aroclor 1016 (50 ppm) in inhibiting human natural killer cell in vitro
lytic actions against leukemia cells (Whalen et al. 1998) or among methylmercury (0.1–2 µg/mL), a
CDD/CDF mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,7,8-pentachlorodibenzo-p-dioxin,
1,2,3,4,7,8-hexachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and
1,2,3,7,8-pentachlorodibenzofuran (1–15 pg/mL), and three commercial PCB mixtures, Aroclor 1242,
1254, and 1260 (0.01–0.5 µg/mL) in altering several in vitro activities (mixed leukocyte reaction, natural
killer cell activity, and phagocytic activities) of rat leukocytes (Omara et al. 1998).
Simultaneous exposure of rats to Aroclor 1254 or 1260 and chemicals of environmental concern such as
the pesticides mirex, photomirex, and/or kepone in the diet resulted in increased severity of the liver
lesions attributed to exposure to chlorinated biphenyls alone (Chu et al. 1980).  Induction of hepatic AHH
activity by Aroclor 1254 in the diet of lactating rats was increased in an additive manner by simultaneous
dietary exposure to polybrominated biphenyls such as Firemaster BP-6 (McCormack et al. 1979).
The induction of liver carcinogenesis by Aroclor 1254 in C57BL/10ScSn mice is markedly increased by
iron (Madra et al. 1995).  A single dose of iron dextran in mice fed Aroclor resulted in a significant
increase in octoploid nuclei within 2 weeks; it persisted for 6 months and resulted in massive hepatic
porphyria.  In another study (Madra et al. 1996), the iron-enhanced toxicity appears to be due to the
induction of P-450 1A1 isoforms in the nuclear membrane as well as in the microsomes. 
Pretreatment of rats with Aroclor 1254 protected against hepatotoxicity due to inhalation of 1,1-dichloro-
ethylene, suggested that MFO induction by PCBs may be responsible for detoxification of 1,1-dichloro-
ethylene (Reynolds et al. 1975).  This detoxification might occur if the epoxide of 1,1-dichloroethylene
isomerizes rapidly to an aldehyde before reacting with tissues.
Increased dietary ascorbic acid may protect against some of the toxic effects of PCBs, such as altered
enzyme activity and liver histopathology, perhaps by inhibiting lipid peroxidation (Chakraborty et al.
1978; Kato et al. 1981a).  The exact mechanism is not known.
Co-administration of cadmium and Aroclor 1248 resulted in a significant increase in growth retardation
and plasma cholesterol, compared to controls or rats fed a diet containing cadmium or Aroclor 1248
alone.  The effects were found to be additive (Suzuki 1980).
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Pretreatment of rats with Aroclor 1254 markedly accelerated the biotransformation and bioactivation of
the industrial chemical 2,6-dinitrotoluene (Chadwick et al. 1993).  This resulted in an increased formation
and excretion of mutagenic metabolites in the urine.  Also, Aroclor 1254 potentiated the formation of
2,6-dinitrotoluene-derived DNA adducts in the liver.
PCBs can interact with structurally diverse carcinogens in various ways.  Oral studies have shown that
Aroclor 1254 and other PCBs with similar percentages of chlorine by weight (e.g., Kanechlor 500,
Clophen A50) promote the development of liver preneoplastic foci, liver tumors, and lung tumors in rats
or mice that have been treated with other carcinogens as initiators, including nitrosamines and
2-acetylaminofluorene (Anderson et al. 1986; Deml and Oesterle 1987; Kimura et al. 1976; Oesterle and
Deml 1983, 1984; Pereira et al. 1982; Preston et al. 1981; Tatematsu et al. 1979).  PCBs also can enhance
or inhibit the activity of other hepatocarcinogens when simultaneously administered orally (Ito et al.
1973; Kimura et al. 1976; Makiura et al. 1974).  There is no conclusive evidence that Aroclor is a skin
tumor promoter when repeatedly applied to the skin of mice that were initiated with DMBA or MNNG
(Berry et al. 1978, 1979; Poland et al. 1983), but a single dermal application of Aroclor 1254 to mice
showed weak initiator activity when promoted with TPA (DiGiovanni et al. 1977).  Pretreatment with a
single dermal dose of Aroclor 1254 inhibited skin tumor initiation by DMBA in mice (Berry et al. 1979). 
Intraperitoneal injection of Aroclor 1254 to mice on Gd 19 protected the offspring from lung tumors, but
increased the incidence of liver tumors, following injection of N-nitrosodimethylamine on
postnatal day 4 or 14 (Anderson et al. 1983).  The genotoxicity of numerous carcinogens is potentiated
in vitro by PCBs, but this does not indicate that PCBs should be regarded universally as tumor promoters
because of the protective role of PCBs against carcinogenicity of many genotoxic carcinogens in vivo
(Hayes 1987).
3.10 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
A susceptible population will exhibit a different or enhanced response to PCBs than will most persons
exposed to the same level of PCBs in the environment.  Reasons may include genetic makeup, age, health
and nutritional status, and exposure to other toxic substances (e.g., cigarette smoke).  These parameters
result in reduced detoxification or excretion of PCBs, or compromised function of organs affected by
PCBs.  Populations who are at greater risk due to their unusually high exposure to PCBs are discussed in
Section 5.7, Populations With Potentially High Exposures.
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The potential susceptibility of embryos, neonates, and children are discussed in detail in Section 3.7,
Children’s Susceptibility.
Other subpopulations that are potentially more susceptible to PCBs include those with incompletely
developed glucuronide conjugation mechanisms (Calabrese and Sorenson 1977; Lester and Schmid
1964), such as those with Gilbert’s Syndrome.  Gilbert’s Syndrome is a relatively common and benign
congenital liver disorder that is characterized by mild, fluctuating increase in serum bilirubin, and is
estimated to occur in 3–7% of the adult population (American Liver Foundation 2000).  Persons with
hepatic infections may have decreased glucuronide synthesis, making them more sensitive because of
their decreased capacity to detoxify and excrete PCBs (Calabrese and Sorenson 1977).  Those with
compromised liver function, such as in the case of liver cirrhosis or hepatitis B, could also be considered
more susceptible to PCB toxicity.  PCBs, via induction of ALA synthetase, might be capable of
precipitating an attack of porphyria in patients with acute intermittent porphyria.
3.11 METHODS FOR REDUCING TOXIC EFFECTS
This section will describe clinical practice and research concerning methods for reducing toxic effects of
exposure to PCBs.  However, because some of the treatments discussed may be experimental and
unproven, this section should not be used as a guide for treatment of exposures to PCBs.  When specific
exposures have occurred, poison control centers and medical toxicologists should be consulted for
medical advice.  No texts were found that provided specific information about treatment following
exposures to PCBs.
3.11.1 Reducing Peak Absorption Following Exposure
Human exposure to PCBs can occur by inhalation, ingestion, or by dermal contact.  PCBs are readily
absorbed through the gastrointestinal tract, respiratory system, and skin.  Data from animal studies
suggest that the rate of absorption following oral exposure is greater than that following inhalation or
dermal exposures.  Specific information regarding the prevention or reduction of toxicological effects
following acute exposure to PCBs was not located in the literature.  General recommendations for
reducing absorption of PCBs following acute exposure include removal of contaminated food, water, air,
and/or clothing from the exposed individual.  Multiple washes of contaminated skin with soap and water
immediately following dermal exposure to PCBs have also been recommended (HSDB 1995).  Washing
is most effective immediately following exposure, since PCBs are readily absorbed through the skin.  
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Trichlorobenzene and mineral oil have been found useful in decontaminating exposed areas of skin in rats
(Wester et al. 1990).  However, using hydrocarbon-based solvents to cleanse PCB-contaminated skin
could carry the risk of increasing the dermal absorption of those fat-soluble compounds in humans.  
Many of the clinical symptoms that result from PCB exposure, such as chloracne, are delayed in onset. 
Therefore, ingestion of PCBs is normally not recognized until long after the time when inducing emesis
might be beneficial.  In addition, emesis may result in aspiration of the lipid materials into the lungs,
possibly causing lipoid pneumonitis.  The value of administering activated charcoal to decrease the
absorption of PCBs is unknown, but is frequently recommended as a slurry, either aqueous or mixed with
a saline cathartic or sorbitol (HSDB 1995).  Repetitive administration of activated charcoal might be
useful in preventing reabsorption of metabolites.  In rats, rice bran fiber decreased absorption of PCBs in
the intestinal tract and had a stimulatory effect on fecal excretion of PCBs (Takenaka and Tarahashi
1991).  It is unclear that rice bran would be of benefit in PCB-poisoned humans.
3.11.2 Reducing Body Burden
There are no known treatment methods for reducing body burden of PCBs.  It should be noted that
significant amounts of PCBs can be eliminated through lactation (see Section 3.7, Children’s
Susceptibility), indicating that breast feeding can reduce maternal body burden of PCBs.  However, in
most cases, the benefits of breast feeding outweigh any possible PCB risks to the mother from the body
burden or to the child from exposure via the milk.
Limiting or preventing further exposures appears to be the most practical method for reducing body
burden of PCBs.  For the general population, especially subgroups that consume diets high in
contaminated fish (e.g., sport fisherman), this can be achieved through public health advisories on fish
consumption.  A listing of fish advisories for PCBs is provided in Chapter 8 (Table 8-1).
   
3.11.3 Interfering with the Mechanism of Action for Toxic Effects
No specific information was located regarding clinical methods of interfering with PCB mechanisms of
toxic action.  Some of the toxic effects, such as immunological effects, body weight loss, enzyme
induction and porphyria, appear to be mediated by a common initial mechanism involving the Ah
cytosolic receptor (Poland et al. 1976; Safe 1984, 1990), as discussed in Section 3.5.2 (Mechanisms of
Toxicity).  The responsiveness of a particular organ to PCB congeners may depend on the presence of 
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functional Ah receptors.  PCB binding to the Ah receptor is followed by a series of events that lead to the
accumulation of occupied nuclear receptor complexes and enhanced CYP1A gene expression.  Although
speculative, it is possible that interference with this mechanism may lead to a more specific treatment for
reducing some of the toxic effects of PCB congeners that exert this mechanism of toxic action.  Future
research on Ah receptor antagonists may provide new insight for clinical treatment of PCB Ah receptor-
mediated toxicity, but at present, only symptomatic and supporting therapy is available for PCB-exposed
humans.
Toxic effects of PCBs may also involve Ah-receptor independent mechanisms, or both Ah-receptor
dependent and independent mechanisms (see Section 3.5.2).  For example, PCBs can be metabolized to
reactive arene oxide intermediates that may alkylate critical cellular macromolecules and result in injury
(Gardner et al. 1973; Safe 1990).  Clinical intervention to interfere with Ah-receptor independent
mechanisms have not been developed.
In summary, presently no specific treatments are available for patients with acute or long-term exposure
to PCBs.  Additional research is necessary to develop specific methods to mitigate PCB toxicity.
3.12 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of polychlorinated biphenyls is available.  Where adequate
information is not available, ATSDR, in conjunction with the National Toxicology Program (NTP), is
required to assure the initiation of a program of research designed to determine the health effects (and
techniques for developing methods to determine such health effects) of polychlorinated biphenyls.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA.  They are defined as substance-specific informational needs that if met would
reduce the uncertainties of human health assessment.  This definition should not be interpreted to mean
that all data needs discussed in this section must be filled.  In the future, the identified data needs will be
evaluated and prioritized, and a substance-specific research agenda will be proposed.
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3.12.1 Existing Information on Health Effects of Polychlorinated Biphenyls
The existing data on health effects of inhalation, oral, and dermal exposure of humans and animals to
polychlorinated biphenyls are summarized in Figure 3-5.  The purpose of this figure is to illustrate the
existing information concerning the health effects of polychlorinated biphenyls.  Each dot in the figure
indicates that one or more studies provide information associated with that particular effect.  The dot does
not necessarily imply anything about the quality of the study or studies, nor should missing information in
this figure be interpreted as a “data need”.  A data need, as defined in ATSDR’s Decision Guide for
Identifying Substance-Specific Data Needs Related to Toxicological Profiles (ATSDR 1989), is
substance-specific information necessary to conduct comprehensive public health assessments. 
Generally, ATSDR defines a data gap more broadly as any substance-specific information missing from
the scientific literature.
This section identifies information needs regarding PCB mixtures which, if met, would contribute to a
more precise association between levels of exposure at hazardous waste sites and adverse health effects. 
Most of the information evaluated in this report has been obtained from studies in which commercial PCB
mixtures were used, and this is the most practical basis for hazard evaluation.  People are environmentally
exposed to PCB mixtures of different congeneric composition than commercial PCB mixtures.  Although
the toxicity of environmental PCB mixtures consequently may be increased or decreased compared to
commercial mixtures, there are insufficient mixture toxicity data on which to assess hazards and directly
base minimal risk levels for environmental PCBs.  One approach that has been widely considered for
estimating the risk from environmental exposure to PCBs is the TEF method.  As discussed in
Section 3.5.2, the TEF approach can be used to estimate the potency of PCB mixtures by comparing the
relative toxicity of individual PCB congeners to that of 2,3,7,8-TCDD, which is the most toxic and
extensively studied of these structurally-related halogenated aromatic hydrocarbons.  Although TEFs are
used to some extent to guide public health decisions because of the limited toxicological data for complex
environmental mixtures and many of their components, the approach has received limited validation and
has a number of limitations related to assumptions that the components jointly act in an additive manner
through a common Ah-receptor mechanism of toxicity.  In particular, the TEF approach does not account
for evidence that non-Ah-receptor-binding congeners are major components in PCB-containing
environmental mixtures that may contribute to induction of health effects. Due to evidence of non-
additive interactions between specific PCB congeners and between some PCB congeners and
2,3,7,8-TCDD (see Section 3.9), as well as increasing evidence that PCB-induced effects may involve 
3.  HEALTH EFFECTS - Adequacy of Database
PCBs 415
Figure 3-5.  Existing Information on Health Effects of Polychlorinated Biphenyls
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Ah-receptor-dependent mechanisms, Ah-receptor-independent mechanisms, or both Ah-receptor-
dependent and Ah-receptor-independent mechanisms (see Section 3.5.2), the accuracy of the TEF
approach is questionable.  Due to the current lack of any alternative validated congener-based risk
assessment methodology, and considering the likelihoods that (1) multiple mechanisms are involved in
PCB-induced health effects, (2) different PCB congeners may produce effects by different mechanisms,
and (3) humans are exposed to complex mixtures of interacting PCBs with differing biological activities,
it appears reasonable to use commercial mixtures as a surrogate for environmental mixtures in assessing
health risks from exposure to environmental mixtures of PCBs.  Because toxicity data on commercial
PCB mixtures are likely to provide a better approximation of the toxicity of environmental mixtures than
existing methods based on unmixed congeners, since a congener based approach would poorly reflect the
net contribution of components to the toxicity of a mixture, toxicity data on commercial mixtures are the
most appropriate basis for deriving minimal risk levels for environmental mixtures of PCBs. 
Consequently, although additional congener studies are necessary to further elucidate the significance and
mechanisms of neurological, immunological and other effects of concern, studies of commercial PCBs
and other relevant mixtures of congeners (e.g., the mixture simulating the congener composition of breast
milk used in the intermediate MRL study) are most relevant to human health risk assessment.
Information on the human health effects of PCBs containing low levels of CDF contaminants is primarily
available from occupational exposure studies of industries in which PCBs are no longer used. 
Information on effects in children exposed to PCBs during gestation and/or lactation also is available,
particularly regarding neurodevelopmental effects.  These studies examined the effects in children born to
women with no known high exposure to PCBs as well as children from women who consumed, for a long
time, fish contaminated with PCBs and other persistent chemicals, especially from areas surrounding the
Great Lakes. The relative contribution of the inhalation and dermal routes in the occupational exposures
is unknown, but existing information on health effects in exposed workers is included with inhalation
exposure in Figure 3-5.  Health effects information is available on humans who were exposed to heated
PCBs during the Yusho and Yu-Cheng incidents, but, as discussed in Section 3.1, CDFs are considered to
be the main causal agent due to relatively high levels of these contaminants.  The other human data are
generally limited by insufficient exposure information and other factors, but seem to be consistent with
effects observed in animals.  Information on health effects in animals is extensive and available for all
effect categories, but is almost completely limited to oral exposure studies.  This appears to reflect
experimental practicality and concern for what is thought to be the most prevalent and likely route of
environmental exposure.
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3.12.2 Identification of Data Needs
Acute-Duration Exposure.    The hepatotoxicity of PCBs in rats is reasonably well characterized for
acute-duration oral exposure (Carter 1984, 1985; Carter and Koo 1984; Kato and Yoshida 1980; Kling et
al. 1978; Price et al. 1988), but it is unclear if the liver is the most sensitive target organ for acute
exposure.  Other targets appear to include the kidneys, stomach, and thyroid (Bruckner et al. 1973;
Hansen et al. 1976; Kimbrough et al. 1972; Price et al. 1988), but insufficient information exists to
determine if effects in these or other tissues occur at lower doses or are more critical than effects in the
liver.  Acute oral studies in other species are needed to determine the most sensitive target and species for
acute exposure basis and the possible basis for an acute oral MRL.  Studies with monkeys would be
informative because intermediate- and chronic-duration studies indicate that this species is more sensitive
than the rat and that developmental, endocrinological, and immunological effects are particularly sensitive
end points.
Information on toxic effects of acute-duration exposure to PCBs by routes other than oral are limited to
LD50 values for dermal exposure (Fishbein 1974; Puhvel et al. 1982), but these data may not be reliable
due to possible delayed lethality.  PCBs are well absorbed after exposure by all routes, and distribution to
and retention by adipose tissue has been observed in humans after inhalation, oral, and/or dermal
exposure (Brown and Lawton 1984; Fait et al. 1989; Jensen 1987).  Mobilization of PCBs from adipose
tissue to target organs is likely to be similar regardless of the route of exposure.  Additional acute dermal
studies are relevant because the skin is a route of concern for exposure at or near hazardous waste sites,
particularly due to possibilities for brief contact.  Acute inhalation toxicity studies may be relevant due to
the potential for inhalation exposure from electrical appliances in buildings and downwind from PCB
disposal facilities and incinerators.
Intermediate-Duration Exposure.    The preponderance of toxicity data for PCBs is available from
animals exposed to PCBs in the diet in intermediate-duration studies.  Studies have been performed with
various species, but the rat, monkey, and mink have been tested most extensively, and the monkey and
mink consistently appear to be the most sensitive.  The liver, skin, and stomach are unequivocal targets,
but existing studies do not identify NOAELs for effects in these organs in monkeys and minks (Allen
1975; Allen and Norback 1973, 1976; Allen et al. 1973, 1974a; Andrews 1989; Barsotti et al. 1976;
Becker et al. 1979; Bell 1983; Bleavins et al. 1980; Bruckner et al. 1973, 1974, 1977; Goldstein et al.
1974; Hansen et al. 1976; Hornshaw et al. 1986; Kimbrough and Linder 1974; Kimbrough et al. 1972;
Kling et al. 1978; Koller 1977).  Anemia consistently occurs in monkeys at doses similar to those 
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producing other effects, but a NOAEL and the relative importance of this effect is not known (Allen
1975; Allen and Norback 1976; Allen et al. 1973, 1974a).  There is evidence suggesting that effects occur
in the thyroid and adrenal glands of rats at doses lower than those producing effects in other tissues in
monkeys and minks (Bruckner et al. 1973, 1974; Byrne et al. 1987, 1988; Collins and Capen 1980b,
1980c; Collins et al. 1977; Kasza et al. 1978; Kato et al. 1982a; Tryphonas et al. 1986a; Wassermann et
al. 1973), but these doses are in proximity to those producing developmental toxicity in monkeys.  A
series of intermediate-duration studies in infant monkeys found neurodevelopmental effects of a low dose
(7.5 µg/kg/day) of a congener mixture that simulated the congener composition of human breast milk
(Rice 1997, 1998, 1999b; Rice and Hayward 1997, 1999a).  The single dose level tested was a LOAEL
that was used as the basis for the intermediate MRL.  Additional intermediate-duration oral studies are
needed to better characterize the neurodevelopmental effects of similarly low doses of PCB mixtures as
well as the LOAEL region for immunological, endocrinological, and other sensitive end points. 
Additional studies could also corroborate evidence indicating PCB-related changes in bone structure in
growing rats (Andrew 1989) and on PCB-related endocrine disruption.
Some information is available on effects of PCBs in animals by inhalation (one study with rats, mice,
rabbits, and guinea pigs, and a second study with rats) (Casey et al. 1999; Treon et al. 1956) or dermal
exposure (two studies with rabbits, one study with mice) (Puhvel et al. 1982; Vos and Beems 1971; Vos
and Notenboom-Ram 1972) for intermediate durations.  Although limited by various study inadequacies
including insufficient numbers of animals, dose levels, end points and NOAEL data, this information is
essentially consistent with the oral data in indicating that the liver, kidneys, thyroid and skin are main
targets of toxicity.  The limitations of these studies and lack of intermediate-duration inhalation studies in
other species known from oral studies to be more sensitive than rats precludes the derivation of an MRL
for this route and duration.  Well-designed intermediate-duration studies in the more sensitive species,
particularly monkeys, are needed to determine thresholds for other targets.  Additional investigation could
help determine whether the respiratory system effects observed in workers exposed by inhalation
(Emmett et al. 1988a, 1988b; Fischbein et al. 1979; Lawton et al. 1986; Smith et al. 1982; Warshaw et al.
1979) were truly PCB effects or were caused by other contaminants.  Toxicity studies by the inhalation
route would be relevant due to the potential for environmental exposure by this route, particularly in the
vicinity of waste sites, but may not be practical due to low volatility.  Additional intermediate-duration
dermal studies, especially in sensitive species, are relevant because the skin is a route of concern for
exposure at or near hazardous waste sites.
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Chronic-Duration Exposure and Cancer.    Some epidemiological studies of PCB-exposed
workers, which involve inhalation and dermal exposure, have provided evidences that PCBs were
associated with adverse health effects, including hepatic and dermal changes (Alvares et al. 1977; Baker
et al. 1980; Bertazzi et al. 1987; Chase et al. 1982; Colombi et al. 1982; Emmett 1985; Emmett et al.
1988a, 1988b; Fischbein 1985; Fischbein et al. 1979, 1982, 1985; Kimbrough et al. 1999a, 1999b;
Lawton et al. 1985a, 1985b, 1986; Maroni et al. 1981a, 1981b; Meigs et al. 1954; Ouw et al. 1976, 1982;
Smith et al. 1982; Warshaw et al. 1979).  Reported effects on the respiratory system and gastrointestinal
tract in these workers are suggestive.  Hypertension in a population that consumed fish containing PCBs
and DDT or other environmentally-exposed populations cannot be attributed conclusively to PCBs
(Kreiss 1985; Kreiss et al. 1981; Massachusetts Department of Public Health 1987; Stehr-Green et al.
1986a).  As discussed in following subsections, there is growing evidence that immunologic,
reproductive, and thyroid effects are effects of concern in PCB-exposed populations.  Relatively few
toxicity studies of animals with chronic oral exposure to PCBs have been performed (Allen and Norback
1976; Arnold et al. 1993a, 1993b, 1995; General Electric Co. 1997a, 1997b; Kimbrough et al. 1975; Loo
et al. 1989; Mayes et al. 1998; NCI 1978; Phillips et al. 1972; Tryphonas et al. 1986a, 1986b, 1989,
1991b), and chronic inhalation and dermal toxicity studies with animals, which could support or refute the
findings of occupational studies, are lacking.  Although limited in quantity, the available chronic animal
oral toxicity data essentially corroborate the results of intermediate-duration studies with respect to effects
in the liver, skin, stomach, blood, and thyroid, but provide no information on renal effects.  Additional
studies could help explain a lack of adrenal effects in monkeys exposed chronically (Loo et al. 1989) and
changes in this organ in rats exposed in intermediate-duration studies.  Additional studies would be
necessary to determine the most sensitive animal target organ and species for chronic exposure and verify
that immunologic effects are the most appropriate basis for the MRL.  Additional human studies could
help verify and elucidate suggestive effects, including whether gastrointestinal symptoms in workers are
secondary to liver toxicity and the possible association between PCBs and hypertension. Additional
evaluations of the thyroid would be particularly informative because intermediate-duration animal studies
indicating that the thyroid may be a particularly sensitive target of toxicity in monkeys has limitations
(Tryphonas et al. 1986b).  Other chronic-duration exposure studies targeting the potential of specific PCB
congeners to act as endocrine disruptors would be useful.
There is sufficient evidence that commercial PCB mixtures containing 60% chlorine by weight are
carcinogenic in rats (General Electric Co. 1997a, 1997b; Kimbrough et al. 1975; Mayes et al. 1998;
Norback and Weltman 1985; Schaeffer et al. 1984).  Aroclor 1254 and other lower chlorinated
commercial PCB mixtures have a lower carcinogenic potential than the 60% chlorine mixtures (General 
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Electric Co. 1997a, 1997b; Ito et al. 1973; Kimbrough and Linder 1974; Kimbrough et al. 1972; Mayes et
al. 1998; Morgan et al. 1981; NCI 1978; Schaeffer et al. 1984; Ward 1985).  Although the evidence that
PCBs are carcinogenic in rats is conclusive, additional studies could provide information on interspecies
differences.  Further studies with PCB congeners aimed at elucidating the mechanism of promotion and
the possible role of intercellular communication in tumor promoting activity (Hemming et al. 1992)
would be valuable.
Human studies provide suggestive evidence that PCBs are carcinogenic.  The carcinogenicity of PCBs in
humans has been investigated in retrospective cohort mortality studies, which investigated cancer in
exposed workers, and in case-control studies of environmental exposure that examined associations
between serum or adipose tissue levels of PCBs and occurrence of cancer.  Some of the mortality studies
suggest that occupational exposures to PCBs were associated with cancer at several sites, particularly the
liver, biliary tract, intestines, and skin (melanoma) (Bahn et al. 1976, 1977; Bertazzi et al. 1987; Brown
and Jones 1981; Brown 1987b; Gustavsson and Hogstedt 1997; Gustavsson et al. 1986; Hardell et al.
1996; Hsieh et al. 1996; Kimbrough et al. 1999a, 1999b; Kuratsune et al. 1987; Loomis et al. 1997;
Nicholson and Landrigan 1994; Rothman et al. 1997; Shalat et al. 1989; Sinks et al. 1992; Tironi et al.
1996).  There is no clear association between occupational exposures to PCBs and cancer in other tissues,
including the brain, hematopoietic, and lymphatic (e.g., non-Hodgkin’s lymphoma).  The hypothesis that
environmental exposure to PCBs can cause breast cancer in humans is controversial and needs to be
further studied.  A number of case-control studies have investigated possible associations between breast
cancer and concentrations of PCBs in breast tissue or blood in the general population.  Breast adipose
levels of total PCBs or individual congeners were increased in women with breast cancer in some but not
all studies (Aronson et al. 2000; Dewailly et al. 1994; Falck et al. 1992; Guttes et al. 1998; Liljegren et al.
1998; Mussalo-Rauhamaa et al. 1990; Unger et al. 1984; Wasserman et al. 1976).  Other environmental
exposure studies used serum PCB concentrations as the marker of exposure with blood samples taken
after the diagnosis of breast cancer (Moysich et al. 1998, 1999; Wolff et al. 1993; Zheng et al. 2000), or
prospectively collected prior to diagnosis (Dorgan et al. 1999; Helzlsouer et al. 1999; Høyer et al. 1998;
Hunter et al. 1997; Krieger et al. 1994; Wolff et al. 2000).  None of the serum studies found significantly
different mean blood levels of PCBs in breast cancer cases and controls.  There also were no significant
associations between risk of breast cancer and serum PCBs in most of these studies, although some data
suggest that risk may be increased in some subgroups of postmenopausal women (Moysich et al. 1998,
1999).  Many of the better designed studies were prospective, and none of the prospective studies found
that PCBs were associated with the occurrence of breast cancer (Dorgan et al. 1999; Helzlsouer et al.
1999; Høyer et al. 1998; Hunter et al. 1997; Krieger et al. 1994; Wolff et al. 2000).  Additional studies,
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including follow-up of existing cohorts, are needed to better characterize the relationship between PCBs
and cancer in humans.
Genotoxicity.    An increased percentage of chromosomal aberrations was reported in a study in which
workers were exposed to PCBs for >10 years (Kalina et al. 1991).  However, there was simultaneous
exposure to benzene, which is known to cause genotoxic effects in humans.  A different study reported a
slight increase in the incidence of sister chromatid exchanges in 12 men exposed to PCBs following a fire
in an electric station (Melino et al. 1992).  It is quite possible, however, that toxic chlorinated dioxins
and/or furans were generated during the fire.  Studies with Aroclor 1254 in human lymphocytes in vitro
gave conflicting results; Hoopingarner et al. (1972) found no evidence of chromosomal damage at a
concentration of 100 µg/mL, whereas Sargent et al. (1989) observed chromosomal damage at a
concentration of 1.1 µg/mL.  Aroclors 1242 and 1254 were not genotoxic in rats and mice when
administered orally in acute- and intermediate-duration studies (Garthoff et al. 1977; Green et al. 1975a,
1975b; Robbiano and Pino 1981); however, longer term studies were not located.  Furthermore, other
PCB mixtures have not been tested.  Studies by the inhalation and dermal routes would help develop
dose-response relationships for these routes.  Available pharmacokinetic data do not suggest route-
specific target organs.  Aroclor 1254 was not mutagenic in Salmonella (Bruce and Heddle 1979; Heddle
and Bruce 1977; Schoeny et al. 1979).  Studies with other mixtures, and using other prokaryotes, would
provide information regarding differences in potencies of different mixtures and in the sensitivities of
different organisms.  Cytogenetic analysis of human populations exposed to PCBs in occupational
settings or exposed by consumption of food contaminated with PCBs would provide an opportunity to
assess the genotoxic potential of these compounds in humans.  However, the generally negative results of
in vitro and in vivo animal studies indicate that commercial PCB mixtures are not likely to pose a
genotoxic threat to humans.  
Reproductive Toxicity.    Limited information is available on reproductive effects of PCBs in humans. 
In women, there was no apparent effect of occupational exposure to various Aroclor mixtures on mean
number of pregnancies (Taylor et al. 1989).  Due to study limitations and lack of information on gravidity
in other studies, the effect of PCBs on human conception is unclear.  Studies that examined reproductive
end points in women whose diets contained Great Lakes fish found suggestive evidence that consumption
of the fish may be associated with a slightly shorter menstrual cycle length (Mendola et al. 1997), but not
with increased risk for spontaneous fetal death (Mendola et al. 1995a).  Studies of one cohort of Great
Lakes fisheaters indicated that women were more likely to have positive associations with conception
delay than their exposed husbands (Buck et al. 1997, 1999, 2000), although contrary results were found in 
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another cohort which found an association between conception delay and Great Lakes fish consumption
in exposed men, but not in their wives (Courval et al. 1999).  The strength of the human evidence that
consumption of Great Lakes fish may or may not be associated with adverse effects on conception and
other reproductive abilities is weak given the small magnitude of effects when they have been detected
and study limitations as discussed in Section 3.2.5.2.  Additional long-term prospective or longitudinal
epidemiology studies are needed are needed to follow these PCB-exposed populations for reproductive
end points as well as to assess the clinical relevance of the effects.
Oral studies with animals provide conclusive evidence for reproductive toxicity of PCBs in females of
various species and some evidence for effects in male rats.  Effects that have been induced in female
animals include estrus changes and reduced implantation rate in adult rats and/or their offspring,
decreased conception in mice, partial or total reproductive inhibition in minks, and menstrual alterations
and decreased fertility in monkeys (Allen et al. 1974a; Arnold et al. 1990, 1993a, 1993b, 1995; Aulerich
and Ringer 1977; Backlin and Bergman 1995; Backlin et al. 1997, 1998a, 1998b; Barsotti et al. 1976;
Brezner et al. 1984; Jones et al. 1997; Kihlstrom et al. 1992; Sager and Girard 1994; Welsch 1985). 
Monkeys (Rhesus) and minks are the most sensitive species tested, although reproductive effects were not
induced at doses quite as low as those inducing the critical neurobehavioral, immunological, and
dermal/ocular effects used to derive the intermediate and chronic MRLs.  In male animals, short-term
exposure to high oral doses of Aroclor 1254 induced no changes in the weight or histology of the testes or
accessory glands in adult rats (Dikshith et al. 1975; Sanders et al. 1974), although seminal vesicle weights
and caudal epididymal weights and sperm counts were reduced in rats that were exposed for several
months as weanlings (Gray et al. 1993).  No studies in male mice or rats evaluated reproductive
capability.  There is limited evidence of hypoactivity of the seminiferous tubules in monkeys that were
chronically exposed to a dose of Aroclor 1248 that also caused clinical signs of toxicity (Allen and
Norback 1976).  In contrast to the limited evidence for reproductive effects in male adult animals, fertility
was markedly reduced in male offspring of rats that were lactationally exposed to relatively high doses of
Aroclor 1254 (Sager 1983; Sager et al. 1987, 1991), and results of oral and subcutaneous studies with
single congeners have also shown that gestational and neonatal exposures can adversely affect
morphology and production of sperm and fertility in male rats and mice (Faqi et al. 1998; Huang et al.
1998a; Smits-van Prooije et al. 1993).  As discussed in Section 3.5.2, effects on male reproductive organs
appear to involve postnatal developmentally-specific vulnerable periods of responsiveness.  Additional
animal studies could help characterize effects on fertility in exposed adults, interspecies and sex
differences in sensitivity, and define the NOAEL region for reproductive effects.
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Developmental Toxicity.    There is mounting evidence that perinatal exposure to PCBs induces
adverse developmental effects in humans, specifically, but not limited to, neurobehavioral alterations in
newborn and children exposed during gestation and/or via breast milk.  This has been seen in children
born to mothers exposed to PCBs by consumption of contaminated fish from the Great Lakes (Fein et al.
1984a, 1984b; Jacobson et al. 1984a, 1990a, 1990b, 1992; Lonky et al.1996; Stewart et al. 1999, 2000b)
and in children from women with no known high-exposure to PCBs in North Carolina (Gladen et al.
1988; Rogan and Gladen 1991; Rogan et al. 1986a, 1986b, 1987), The Netherlands (Huisman et al.
1995a, 1996b; Koopman-Esseboom et al. 1996; Lanting et al. 1998a; Patandin et al. 1999), and Germany
(Winneke et al. 1998b).  In the various cohorts studied, some common findings of neurodevelopmental
effects have been reported, other affected end points have not been the same in all studies.  This is not
unexpected given the different degrees of control for confounders and the different measures of exposure
used.  Moreover, apparent inconsistencies between studies may reflect not only limitations in study
design, but also problems inherent in detecting neurobehavioral deficits at exposure levels near the
threshold for effects.  Effects associated with PCB exposure included abnormal reflexes and more motor
immaturity in newborns (Jacobson et al. 1984a; Lonky et al. 1996; Rogan et al. 1986b), altered PDI
scores at 1–2 years of age (Gladen et al. 1988; Koopman-Esseboom et al. 1996), and alterations in
memory functions at 7 months of age (Jacobson et al. 1985) and at 4 years of age (Jacobson et al. 1990a,
1990b, 1992) and in cognitive abilities at 42 months using the Kaufman Assessment Battery for Children
(Patandin et al. 1999).  It must be kept in mind, however, that in all of these studies, there is a possibility
that other lipophilic compounds may have contributed to the observed effects, particularly  in the studies
on consumption of Great Lakes fish contaminated with other chemicals such as CDDs, DDE, and
mercury.  It is expected that children from these prospective studies continue to be monitored in order to
assess the impact of these subtle neurobehavioral alterations as they grow older and their potential
implications at a population level.  It is also important to address the issue of continuity of effect over
time.  This means establishing whether the children who showed impaired performance in some tests at
18 and 24 months are the same who performed poorly in tests given as neonates.  This would help
interpretation of  the biological significance of the exposure.
Improvements in analytical methods for measuring PCBs should greatly facilitate analysis of PCB
congeners in cord blood, the most accurate surrogate of exposure during gestation.  This should allow
researchers to establish more precise potential associations between specific PCB congeners and health
outcomes, as done for example by Stewart et al. (2000b) in their study of Lake Ontario fisheaters.  It is
also important that researchers provide as much information as possible regarding not only the analytical 
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methods used for measuring PCBs, but also the methods for measuring lipids so that comparisons
between studies can be made.  
Studies in animals support the findings in humans.  Studies in rodents have provided valuable
information, but monkeys, whether exposed during gestation and/or during infancy, have proved to be
much more very sensitive to PCBs and some structurally-related chemicals.  Investigators should continue
efforts to develop an operant test battery that measures a variety of functions that can be validated for use
in rodents, monkeys, and humans and that can be applied in epidemiological studies.  Studies with single
congeners are valuable in that they provide information on possible mechanisms of action, but people,
specifically nursing infants, are exposed to a mixture of PCB congeners in the milk.  Therefore, further
studies that administer PCB mixtures of congeneric composition similar to that of human breast milk
represent the most relevant approach to mimicking real life exposure to infants.  Varying the congener
composition of the reconstituted milk sample may help associate specific PCB congeners with specific
neurodevelopmental outcomes. 
Some studies in humans have suggested that gestational exposure to PCBs and other chemicals can affect
the thyroid hormone system in infants (Koopman-Esseboom et al. 1994a; Nagayama et al. 1998a;
Winneke et al. 1998a).  These observations  have been extensively corroborated in experimental animals
(Collins and Capen 1980c; Corey et al. 1996; Goldey et al. 1995; Juarez de Ku et al. 1994; Li et al. 1998;
Morse et al. 1996b; Seo and Meserve 1995).  Yet, further information is needed comparing thyroid
hormone levels in the brain and histological changes of exposed animals during crucial periods of nerve
tract development and neuronal differentiation.  Normal thyroid status is also crucial for the normal
development and functioning of reproductive organs, and further research in this area is also needed. 
Perinatal exposure to PCBs also has been associated with alterations in immunocompetence in children
(Dewailly et al. 2000; Smith 1984; Weisglas-Kuperus 2000; Weisglas-Kuperus et al. 1995).  These
children should continue to be observed for any indication of reduced immunocompetence which may
potentially lead to increased incidence of illnesses.  The findings of immune alterations following PCB
exposure are consistent with observations in animals.  Immunological alterations have been reported in
adult monkeys and their offspring after long-term exposure to commercial PCB mixtures at doses as low
as 0.005 mg/kg/day (Arnold et al. 1995; Tryphonas et al. 1989, 1991a, 1991b).    
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Immunotoxicity.    There are indications of altered immune status in adult and infant human
populations who were orally exposed to mixtures of PCBs and other chemicals.  Information on
immunological effects of PCBs in humans is mainly available from studies of people exposed
occupationally (Chase et al. 1982; Emmett et al. 1988a, 1988b; Lawton et al. 1985a; Maroni et al. 1981b;
Smith et al. 1982), by consumption of contaminated fish and other marine foods (Dewailly et al. 2000;
Smith et al. 1984), by consumption of contaminated rice oil in the Yusho and Yu-Cheng poisoning
incidents (Chang et al. 1981, 1982a, 1982b; Chao et al. 1997; Kuratsune 1989; Lu and Wu 1985;
Nakanishi et al. 1985; Rogan 1989; Shigematsu et al. 1971; Yu et al. 1998), and via general
environmental exposures in a Dutch population (Weisglas-Kuperus et al. 1995).  The occupational studies
provide little information for assessing immunotoxicity because evaluations were essentially limited to
inconclusive routine clinical measurements of WBC counts and serum proteins with no investigations of
functional immune parameters.  The most conclusive findings were in the Yusho and Yu-Cheng
populations who experienced the highest levels of PCB exposure and least complex exposure mixture. 
Interpretation of the data from the other human studies is complicated by responses that were generally
subtle and exposures that included a number of persistent toxic substances in addition to PCBs that are
also potentially immunotoxic.  Overall, there appears to be a consistency of effects among the human
studies suggesting sensitivity of the immune system to PCBs and these other chemicals, particularly in
infants exposed in utero and/or via breast feeding.  For example, susceptibility to respiratory tract
infections was increased in Yusho/Yu-Cheng adults and their children, and there was an association
between infectious illnesses and PCBs in the children of mothers who consumed Lake Michigan or
Sheboygan River fish.  Children born to Yu-Cheng mothers also had an increased prevalence of middle
ear infections, and the incidence of acute otitis media was increased in Inuit infants of mothers whose
diets were based on marine mammal fat.  Serum IgA and/or IgM antibody levels were decreased in the
Yusho and Yu-Cheng populations as well as in the Inuit children.  Monocyte counts were reduced in
Yu-Cheng patients and the infants of the Dutch mother-child study, and changes in T lymphocyte subsets
were found in the Yu-Cheng, Inuit child, and Dutch child populations.  However, due to the mixed
chemical nature of the exposures and generally insufficient information on possible exposure-response
relationships, the human studies provide only limited evidence that exposed adults and infants exposed in
utero or via breast feeding may have compromised their immune system rendering them unable to
overcome infection.  Additional studies are needed to better characterize the immunologic potential of
PCBs in exposed humans, particularly by incorporating an immunological component in the early design
of epidemiologic studies, as well as establishing a broad database of normal values for clinical
immunology end points to which experimental results can be compared.  The hypothesis that a possible 
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relationship between PCBs and non-Hodgkin’s lymphoma could be related to the immunosuppressive
effects of PCBs is another area requiring further research.
The immunotoxicity of PCBs in animals has been documented in various species that were orally exposed
via commercial mixtures, mixtures of congeners analogous to human breast milk, Great Lakes fish, or
single congeners.  Studies in rats, mice, guinea pigs, and rabbits showed that intermediate-duration
exposures to relatively high doses of commercial PCB mixtures caused morphological and functional
alterations in the immune system.  Effects observed in these species included thymic and splenic atrophy,
reduced antibody responses to SRBC and other foreign antigens, increased susceptibility to infection by
viruses and other microbes, reduced skin reactivity to tuberculin, and increased proliferation of splenic
lymphocytes in response to mitogenic stimulation (Allen and Abrahamson 1973; Bonnyns and Bastomsky
1976; Exon et al. 1985; Imanishi et al. 1980; Koller 1977; Loose et al. 1977, 1978a, 1978b, 1979;
Smialowicz et al. 1989; Street and Sharma 1975; Talcott and Koller 1983; Talcott et al. 1985; Vos and
Van Driel-Grootenhuis 1972).  Immunological assessments of rats and mice that were fed diets containing
low doses of PCBs and other chemicals in Great Lakes fish were generally mixed, although some
alterations were found that are similar to those observed in the studies of commercial PCB mixtures
(Cleland et al. 1989; Tryphonas et al. 1998a, 1998b).
Oral studies of Aroclor mixtures in monkeys confirm the findings of immunotoxicity in the other species
and further indicate that the immune system of monkeys is particularly sensitive to PCBs.  Immunological
effects of PCBs in monkeys include decreased antibody responses to SRBC, increased susceptibility to
bacterial infections, altered lymphocyte T-cell subsets, decreased lymphoproliferative responsed to
mitogens, and histopathological changes in the thymus, spleen, and lymph nodes (Abrahamson and Allen
1973; Allen and Barsotti 1976; Allen et al. 1980; Barsotti et al. 1976; Thomas and Hinsdill 1978;
Truelove et al. 1982; Tryphonas et al. 1986a, 1989, 1991a, 1991b).  The parameters most consistently
affected in monkeys are reduced IgM and IgG antibody responses to SRBC, which were induced at
chronic oral doses as low as 0.005 mg/kg/day (Tryphonas et al. 1989, 1991a, 1991b).  Results of studies
in gestationally- and lactationally-exposed infant monkeys are consistent with the data in adult animals
showing immunosuppressive effects of PCBs (Aroclor 1254) at doses as low as 0.005 mg/kg/day, with
reductions in IgM and IgG antibody levels to SRBC and mitogen-induced lymphocyte transformation that
generally paralleled the findings in maternal animals (Arnold et al. 1995).  The 0.005 mg/kg/day LOAEL
for immunological effects in monkeys was used as the basis of the chronic oral MRL for PCBs.  Also,
minimal immunological alterations were induced in infant monkeys that were orally exposed to a similar
dose (0.0075 mg/kg/day) of a PCB congener mixture simulating the congener content of human milk for 
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the first 20 weeks of life (Arnold et al. 1999).  Additional immunological studies in animals are needed to
verify that the immune system is the most sensitive target of PCBs and the most appropriate basis for
chronic MRL derivation, as well as better characterize dose-response relationships in sensitive species
following intermediate-duration exposure.
Neurotoxicity.    As previously mentioned under Developmental Toxicity, one of the main focus of
research on PCBs has been the evaluation of a possible association between exposure to PCBs during
gestation and/or lactation and neurobehavioral alterations in newborn and young children. Thus far, there
is no evidence that PCBs at the levels found in the environment are neurotoxic to adults.  There is no
conclusive evidence that workers who were exposed to commercial PCB mixtures for long periods and
had high PCB body burdens developed neurological deficits (Emmett et al. 1988a; Fischbein et al. 1979;
Smith al. 1982).  However, sensory and motor nerve alterations were observed in Yusho and Yu-Cheng
patients who ingested rice oil contaminated with high amounts of PCBs, CDFs, and other structurally-
related chemicals (Chia and Chu 1984, 1985; Kuratsune 1989; Rogan 1989).  Evaluation of an adult
population on a visual-motor coordination test and a hand steadiness test revealed no significant effect
from exposure to PCB/DDE through long-term consumption of Lake Michigan fish (Schantz et al. 1999). 
The results from cognitive assessment of this cohort are expected to be available in the near future.  
The mechanism(s) of neurotoxicity of PCBs is not entirely clear, but evidence accumulated in recent
years suggests that multiple mechanisms may be involved including alterations in levels of
neurotransmitters in various brain areas, of calcium homeostasis (Kodavanti et al. 1993), inositol
phosphates (Shafer et al. 1996), protein kinase C (Kodavanti et al. 1995), ryanodine receptor binding
(Wong and Pessah 1996), and neutrophil activation (Ganey et al. 1993).  Continued research in these
areas is necessary to establish correlations between biochemical, morphological, and functional
alterations in the brain of PCB-exposed animals, as well as to determine possible preferential
accumulation of PCB congeners in specific brain areas that could be associated with specific
neurobehavioral effects.  Establishing relationships between in vitro and in vivo effects is important for
the development of appropriate in vitro preparations in which putative neurotoxicant PCBs can be easily
tested.
Epidemiological and Human Dosimetry Studies.    Consumption of contaminated food
(particularly diets high in fish from contaminated waters) and inhalation of indoor air in buildings that
have electrical parts that contain PCBs are the main sources of exposure for the general population.  PCBs
can pass across the placenta and also can accumulate in breast milk such that breast-fed infants and 
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unborn children are at risk of being exposed to PCBs (DeKoning and Karmaus 2000; Fein et al. 1984a,
1984b; Huisman et al. 1995a, 1996b; Jacobson et al. 1984a, 1990a, 1990b; Rogan et al. 1986a, 1986b,
1987).  Although PCBs are no longer manufactured in the United States, PCB-containing transformers
and capacitors remain in use.  Thus, occupational exposure may occur in workers during accidents or
repair of electrical equipment containing PCBs.  Present and future occupational exposure to PCBs may
also occur from residual PCBs in workplaces, from disposal of PCBs and/or contaminated equipment, or
during cleanup of hazardous waste sites.  A number of studies have examined possible associations
between health effects and exposure to PCBs, particularly in adults occupationally exposed to PCBs
(Alvares et al. 1977; Baker et al. 1980; Bertazzi et al. 1987; Chase et al. 1982; Colombi et al. 1982;
Emmett 1985; Emmett et al. 1988a, 1988b; Fischbein 1985; Fischbein et al. 1979, 1982, 1985;
Kimbrough et al. 1999a; Lawton et al. 1985a, 1985b, 1986; Maroni et al. 1981a, 1981b; Meigs et al.
1954; Ouw et al. 1976, 1982; Smith et al. 1982; Taylor et al. 1989; Warshaw et al. 1979), adults and/or
their children following maternal consumption of contaminated fish from the Great Lakes and other
waters (Buck et al. 1997, 1999, 2000; Courval et al. 1999; Dewailly et al. 2000; Fein et al. 1984a, 1984b;
Jacobson et al. 1984a, 1990a, 1990b, 1992; Kreiss 1985; Kreiss et al. 1981; Lonky et al. 1996; Mendola
et al. 1995a, 1997; Smith 1984; Stewart et al. 1999, 2000b), and in children from women in North
Carolina (Gladen et al. 1988; Rogan and Gladen 1991; Rogan et al. 1986a, 1986b, 1987), the Netherlands
(Huisman et al. 1995a, 1995b; Koopman-Esseboom et al. 1994a, 1996; Lanting et al. 1998; Patandin et al.
1999; Weisglas-Kuperus 2000; Weisglas-Kuperus et al. 1995), and Germany (Winneke et al. 1998b) with
no known high-exposure to PCBs.  Chloracne and other skin changes, and various hepatic alterations
including increased serum levels of liver enzymes and lipids have been associated with occupational
exposures.  There are also reports of respiratory, gastrointestinal, hematological, skeletal, developmental,
and neurological effects in exposed workers, but the evidence is not strong enough to conclusively
establish cause-effect relationships.  The epidemiologic studies of the contaminated fisheating populations
and people exposed via the general environment raise concern for reproductive effects in adults and
neurodevelopmental and immunological alterations in children of exposed parents, as discussed above in
the Reproductive Toxicity, Developmental Toxicity, Neurotoxicity, and Immunotoxicity data need
subsections.  Additional well conducted epidemiological investigations, particularly follow-up studies and
transgenerational studies of high risk populations, are needed to better characterize the potential for PCBs
to induce these effects.  These studies should also address limitations that constrain some of the existing
human studies, such as unmeasured PCB exposure concentrations, lack of controls for confounding co-
exposures, and lack of comparative population data.
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Concern that even low levels of PCBs transferred to the fetus across the placenta and that greater amounts
might be transferred to nursing infants via breast milk has triggered many of the epidemiological studies. 
The results from some of these studies suggest that perinatal exposure to PCBs may induce subtle long-
lasting neurological damage in children (Fein et al. 1984a, 1984b; Gladen et al. 1988; Huisman et al.
1995a, 1996b; Jacobson et al. 1984a, 1990a, 1990b, 1992; Koopman-Esseboom et al. 1996; Lanting et al.
1998a; Lonky et al. 1996; Patandin et al. 1999; Rogan and Gladen 1991; Rogan et al. 1986a, 1986b,
1987; Stewart et al. 1999, 2000b).  Suggestive evidence for immunological (Dewailly et al. 2000; Smith
1984; Weisglas-Kuperus et al. 1995; Weisglas-Kuperus 2000) and thyroid effects (Koopman-Esseboom
et al. 1994a; Nagayama et al. 1998a; Winneke et al. 1998a) in children also has been presented.  Many of
these are prospective studies that have followed-up the children for many years and are expected to
continue to do so in order to ascertain the duration and real life significance of these subtle alterations. 
Biomarkers of Exposure and Effect.    
Exposure.  PCBs are stored at highest concentrations in adipose tissue and are present in serum and
human milk.  Several studies have shown that serum and adipose PCB levels are biomarkers of exposure
(Brown and Lawton 1984; EPA 1984d; Fait et al. 1989; Jacobson et al. 1984b; Jan and Tratnik 1988;
Luotamo 1988; Safe et al. 1985b; Schecter et al. 1994; Steele et al. 1986; Wolff et al. 1982a).  It has been
proposed that measurement of PCB levels in both serum and adipose tissue may be more predictive of
body burden than each value separately, although either serum or adipose tissue PCB levels may serve as
useful biomarkers of body burden and/or exposure (Stellman et al. 1998).  Further studies on the
predictive value of levels of PCBs (particularly congeners) in serum and adipose tissue in individuals
exposed to PCBs for short, intermediate, and chronic durations would provide valuable information that
could lead to early detection of PCB exposure.
PCB residue data in humans and other animals (see Section 3.4.2, Distribution) suggest that tissue or
body burdens of PCBs should be based on individual congeners or groups of congeners and not based on
profiles of commercial PCB formulations.  The simplest approach involves using one congener as a
marker of total PCBs in a biological specimen.  For example, levels of 2,2',4,4',5,5'-hexaCB (PCB 153), a
very stable and often the most abundant congener, have been shown to correlate well with the total
amount of PCBs in human breast milk, plasma, or follicular fluid (Atuma and Aune 1999; Grimvall et al.
1997; Johansen et al. 1994; Pauwels et al. 1999).  However, if a more complete profile of congeners is
considered, the correlations are lower (Bachour et al. 1998; Hansen 1998, 1999).  Use of  PCB 153 or
congener groups as a marker of the total therefore could be a misleading indicator of the differential 
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exposure to other individual or groups of congeners of toxicological significance.  Further studies are
needed to assess the feasibility of using individual congeners or groups of congeners as a marker for total
exposure to PCBs.
Effect.  There are no specific biomarkers of effects for PCBs.  Numerous studies have attempted to
correlate serum PCB levels with liver-associated enzymes in PCB-exposed workers and general
population subjects; however, no conclusive association has been found (Baker et al. 1980; Emmett et al.
1988a, 1988b; Fischbein 1985; Fischbein et al. 1979; Kreiss et al. 1981; Lawton et al. 1985a, 1985b;
Smith et al. 1982; Stehr-Green et al. 1986a, 1986b; Steinberg et al. 1986).  Further studies to identify
specific biomarkers of effects of PCBs would facilitate medical surveillance leading to early detection of
potentially adverse health and possible treatment.  Congener-specific analysis combined with TEF
calculations may be useful for characterizing dioxin-like health effects.  However, as discussed in the
introduction to Section 3.11.1, use of congener-specific analyses is not yet practical for most laboratories,
and the TEF approach for PCBs is still under development and limited to dioxin-like congeners’ effects
only.
Absorption, Distribution, Metabolism, and Excretion.    There are no quantitative data regarding
absorption in humans by the inhalation or dermal route, but data from occupationally exposed individuals
suggest that PCBs are well absorbed by these routes (Wolff 1985).  Only one study was located that
provided quantitative oral absorption data in a volunteer (Buhler et al. 1988).  Schlummer et al. (1998)
used a mass balance approach to assess the gastrointestinal absorption of specific PCB congeners from
food in seven individuals, 24–81 years of age, with different contaminant body burdens.  Together, the
data support the passive diffusion model for gastrointestinal absorption, where the concentration of the
contaminant in the blood is the major factor determining absorption.  PCB congeners showing nearly
complete net absorption had very low or nondetectable levels in the serum lipids.  For other congeners,
there was a trend for decreasing net absorption and/or increasing net excretion with increasing congener
concentration in serum lipids.  Similar congener specific, mass balance human studies are needed to
confirm and extend these findings.  The animal data indicate that PCBs are efficiently absorbed by the
oral route (Albro and Fishbein 1972; Hansen 1999), but most of the information is derived from excretion
data.  Inhalation and dermal absorption data are limited.  No studies were located in which a range of
doses of PCB mixtures of different chlorine contents were administered by the inhalation, oral, and
dermal routes, and for various exposure periods.
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As with absorption, distribution data in humans are limited to serum, milk, and/or tissue PCB residue data
from occupationally and environmentally exposed subjects, and suggest that PCBs distribute
preferentially to tissues with high fat content regardless of the route of exposure (Brown and Lawton
1984; Fait et al. 1989; Jensen 1987).  As with other organisms, PCB residue levels in humans reflects
multiple exposure pathways, and congener-specific elimination.  PCB profiles in human serum
immediately following exposures reflect the profiles in the exposure sources; however, selective
metabolism and excretion begin to alter the congener profile within 4–24 hours (Hansen 1999).  In large
population based studies, it is often necessary to summarize large quantities of congener-specific data
from many individuals in order to highlight mean and range data for each PCB congener.  While this
approach is necessary to summarize data for publication, congener profiles for individuals are often never
reported.  Thus, it may not be possible to identify a few individuals that may have had an unusual profile
or elevated congener level due to a recent PCB exposure.  Human studies reporting congener specific
PCB residue data should consider citing electronic databases, which could contain the complete data set
for each subject in the study.  
Moysich et al. (1999) recently evaluated proposed frameworks for grouping PCBs, including a more
simple approach based on relative abundance and degree of chlorination.  McFarland and Clarke (1989)
proposed an approach to grouping PCB congeners based on their potential risk to the environment and
human health.  Another framework for grouping PCB was proposed by Wolff et al. (1997), based on the
biological activities of the congeners and their presence in house dust and humans.  Numerous factors,
such as the analytical methods used by various labs for sample preparation and analysis, the type of
human sample (milk, serum, plasma, adipose), sample size, year sample was collected, subject age, and
exposure history are all critical to the detection and quantification of a specific congener in a given
sample.  These factors need to be considered when adopting an optimal framework for grouping PCB
congeners to assess exposure and relative risk .
Recently, Dewailly et al. (1999) measured the concentration of 14 PCB congeners in subcutaneous fat,
omental fat, brain, and liver from autopsy tissue samples collected from Greenlanders between 1992 and
1994.  PCB concentrations (lipid basis) were similar in omental fat and subcutaneous abdominal fat,
while the hepatic concentrations were generally about 20% lower than fat.  PCB levels in brain (lipid
basis) were about 10–20% of the levels found in subcutaneous fat.  The lower concentration in brain
cannot be explained by the presence of the blood-brain barrier because PCBs are highly lipophilic and are
therefore expected to freely diffuse across this barrier.  The difference in accumulation may be due to the
nature of more polar brain lipids, which are mainly phospholipids.  PCBs may partition to a greater extent 
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into the triglycerides found in adipose tissue.  Further investigation is needed to understand factors
regulating the tissue specific distribution of PCB congeners, particularly to critical target organs such as
the brain.
Studies in animals that could provide a basis for assessing the comparative distribution of PCBs when
administered by the inhalation, oral, and dermal routes of exposure were not located.  A recent study in
ferrets by Apfelbach et al. (1998) reported for the first time that the olfactory system may be a potentially
significant portal for the entry of airborne PCBs.  The olfactory bulbs of the exposed ferrets had the
highest total PCB concentration (642 ng/g lipids), while the liver, adipose tissue, and brain had levels of
202, 303, and 170 ng/g lipids, respectively.  The data suggest that inhaled PCBs pass into the dentrites of
olfactory sensory neurons and are transported via olfactory axons directly to the bulbs where they
accumulate.  While the olfactory system appears to be a significant site for the disposition of airborne
PCBs, further studies are needed to confirm this observation and assess whether greater disposition in the
brain is associated with inhalation exposure.
Data derived from oral administration of PCBs to animals indicate that PCBs distribute first to liver and
muscle, and are subsequently translocated to adipose tissue and skin for storage (Allen et al. 1974b;
Curley et al. 1971; Hashimoto et al. 1976; Klasson-Wehler et al. 1989a).  Studies regarding distribution
through the placenta after inhalation and dermal exposures were not available.
Other than isolated studies with human microsomes (Schnellmann et al. 1983), data regarding biotrans-
formation of PCBs in humans are limited to information about occupationally exposed individuals, whose
PCB intake is assumed to derive mainly from inhalation and dermal exposure (Fait et al. 1989; Jensen and
Sundström 1974; Wolff et al. 1982b).  The use of human cell systems in culture might be considered a
useful alternative to studying the metabolic fate of PCBs, but limited expression of a complete profile of
enzymes reduces their value.  The metabolism of PCBs after oral administration in experimental animals
has been extensively studied (Safe 1989a).  Although information regarding metabolism following
inhalation or dermal exposure is lacking, there is no reason to believe that other pathways would operate
after exposure by these routes.
State of the art PCB exposure assessment utilizing  human serum, milk, and/or tissues should not only
include congener specific PCB analysis, but analyze persistent PCB metabolites.  Since certain
hydroxylated and methylsulfonyl (MeSO2) PCB metabolites are present in some cases at levels higher 
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than their respective parent compounds, it is necessary to further investigate the potential biological
and/or toxicological activities of these persistent metabolites.
Studies regarding urinary or fecal excretion of PCBs in humans were not located; however, elimination of
PCBs through maternal milk is well documented (Masuda et al. 1978; Mes et al. 1984).  Fecal excretion is
the main route of elimination of PCBs in animals after oral exposure (Lutz and Dedrick 1987).  Although
data regarding excretion in animals after inhalation exposure were not located, there is no reason to
suspect different patterns of excretion.  Dermal data suggest that excretion of certain PCBs may follow a
two-phase elimination process, as described for oral exposure, but this information is derived from a
single study (Wester et al. 1990).
Comparative Toxicokinetics.    The existing evidence suggests that qualitative differences in the
toxicokinetic disposition of PCBs exist among humans and the numerous animals species studied and also
among animal species (Lutz and Dedrick 1987; Safe 1989a; Sipes and Schnellmann 1987).  However,
these differences appear to be highly dependent on the specific congener or mixture studied.  Further
pharmacokinetic modeling studies with additional groups of PCB congeners would be valuable to
determine the validity of extrapolating data.  In addition, studies with human cell systems in vitro could
help estimate metabolic rate constants for use in pharmacokinetic models.  In general, all species absorb
PCBs efficiently and accumulate PCBs in tissues rich in fat.  Once absorbed, PCBs distribute in a
biphasic manner in all species examined (Lutz and Dedrick 1987).  Identification of metabolites in
humans and animals suggests that all species examined share some common biochemical reactions. 
Experimental data in animals indicate that fecal elimination is the main route of excretion (Bleavins et al.
1984; Klasson-Wehler et al. 1989a, 1989b; Mühlebach and Bickel 1981), but no human information was
located in the existing literature.  Analysis of the excreta of humans exposed in the workplace and near
hazardous waste sites would provide information regarding biotransformation and elimination kinetics in
humans.  In addition, similar target organs have been identified across animal species.  Monkeys and
minks are the most sensitive species tested regarding dioxin-like effects, but pharmacokinetic data in
minks are scant.  Although the toxicological data in humans (Emmett et al. 1988a; Fischbein et al. 1979)
are limited, adverse cutaneous reactions documented in humans are also seen in monkeys (Arnold 1993a,
1995), although at much lower doses.  This and other effects seen in monkeys, not observed in
populations occupationally or environmentally exposed to PCBs, have led some to suggest that monkeys
may not represent a suitable animal model (James et al. 1993; Kimbrough 1995).  However, the
clinicopathologic picture in monkeys is more like humans than any other species.  As these studies
suggest, the monkey is more sensitive than humans on a dose basis.  Attention must be paid to differences 
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between adults and immature animals of all species.  The more rapidly growing immature animals
generally have lower and distinct profiles of biotransformation enzymes as well as much smaller
peripheral fat depots for sequestering the lipophilic PCBs.
Methods for Reducing Toxic Effects.    The mechanism by which PCBs enter the blood stream in
humans is not known; consequently, there are no established methods for reducing absorption.  In
experimental animals, however, administration of rice bran fiber reduced gastrointestinal absorption
(Takenaka and Tarahashi 1991).  Identification of additional substances that could prevent or delay
absorption and that do not represent a toxic risk themselves would be valuable.  There are no established
methods for reducing body burden in humans, but a few reports have indicated that fasting may be
effective (Imamura and Tung 1984).  Studies examining the effect of fasting in animals exposed to PCBs
would provide useful information that can be used to better characterize the effectiveness of this
approach.  The metabolism of PCBs leads to the formation of highly reactive and potentially toxic
derivatives.  Thus, additional studies examining the feasibility of favoring metabolic pathways leading to
the formation of nontoxic metabolites would be valuable.  The mechanisms of toxic actions of PCBs are
not completely understood, and no methods exist to block the toxic response due to exposure to PCBs.
Further studies aimed at elucidating the mechanisms of action of PCBs would help in developing possible
methods for reducing toxic effects.
Children’s Susceptibility.    Data needs relating to developmental effects are discussed more
extensively above in the Developmental Toxicity subsection.  Prenatal exposure to PCBs has been
associated with neurodevelopmental effects.  However, many exposures to PCBs involve mixtures
including other chemicals.  Studies employing specific congeners of PCBs are needed to establish the
association between exposure, neurotransmitter and T4 levels in the brain, and neurobehavioral effects.
Experiments aimed at defining critical windows of PCB action in the developing organism would provide
valuable information, especially for pregnant women who may wish to alter their dietary habits during
pregnancy. In addition, studies to define the relationship of prenatal exposure to specific PCB congeners,
its activity as an endocrine disruptor, and effects on sexual differentiation are needed.  Continued
monitoring of children from the Dutch, Lake Michigan, Lake Ontario prospective studies is expected with
particular emphasis on evaluation of immune competence, thyroid function, and cognitive abilities. 
Development of PBPK models that could be used to predict PCB body burdens in neonates and infants as
a function of maternal body burden would be useful.  Studies of the pharmacokinetics of PCBs in the
fetus (i.e., assessment of placental permeability for individual congeners), infant, and child would be
useful in further defining the potential for toxic effects of these compounds.  Areas of focus include the
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effect of the developing and changing metabolic capacities of the fetus, neonate, and child on the
production of toxic metabolites and/or detoxification of the parent compound and metabolites.
Child health data needs relating to exposure are discussed in 6.8.1 Identification of Data Needs:
Exposures of Children.
3.12.3 Ongoing Studies
Table 3-15 lists ongoing studies on the health effects of PCBs identified from the Federal Research in
Progress database (FEDRIP 2000).  Ongoing studies from the ATSDR Great Lakes Human Health Effects
Research Program are listed in Table 3-16. 
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Table 3-15.  Ongoing Studies on the Health Effects of PCBs
 
Investigator Affiliation Title Sponsor
Aulerich, R Michigan State
University
East Lansing, MI
Fur animal studies (mink) USDA or
cooperating state
institutions
Berkowitz, Gertrud S Mount Sinai School of
Medicine of CUNY, 
New York, NY
Exposure of indoor pesticides
and PCBs—Effects on growth
and neurodevelopment
NIEHS
Bernstein, Leslie Univ of Southern Calif
Los Angeles
Organochlorine residue levels






Transgenic models of dioxin
action
NIEHS






Bursian, S Michigan State
University
The fate and biological effects




Carpenter, David O State University of
New York at Albany
Mechanisms responsible for 
cognitive impairment caused by
exposure to PCBs
NIEHS
Charles, MJ University of California
Davis
Exploration of linkages among
organochlorines, oxidative DNA




Chou, K Michigan State
University












Dean, Charles E Colorado State
University 
Promotion of hepatic neoplasia
by PCB mixtures
NIEHS





Dukelow, W Richard Michigan State
University 
Toxic chemical influences on in
vivo and in vitro reproduction
NIEHS
Finlay, Mary F Benedict College,
Columbia, SC
Pilot study—Toxicological
effects of PCB during
spermatogenesis
NCRR
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Table 3-15.  Ongoing Studies on the Health Effects of PCBs (continued)
 
Investigator Affiliation Title Sponsor
Gammon, Marilie D Columbia University Breast cancer and the
environment on Long Island
NCI









Gierthy, John F State Univ of New
York at Albany
PCB estrogenicity in human
breast cancer cells
NIEHS
Glauert, Howard P University of Kentucky Mechanisms of hepatic tumor
promotion by PCBs
NIEHS
Gore, Andrea Mount Sinai School of
Medicine of CUNY
Neuroendocrine mechanisms
of environmental toxicity during
early development
NIEHS
Grandjean, Phillippe Boston University Serum PCB as a risk indicator






Dioxin action in the alimentary
canal
NIEHS
Hansen, LG University of IL
Urbana






Harris, Craig Michigan State
University
PCB effects on uterine wall NIEHS
Hassoun, Ezdihar A University of Toledo,
Toledo, OH
TCDD induced oxidative stress
in the tissues
NIEHS
Hejtmancik, Milton Battelle Memorial
Institute, 
Columbus, OH
Evaluation of dioxin toxic
equivalency factors
NIEHS
Hennig, Bernhard University of Kentucky Superfund chemicals and
endothelial cell dysfunction
NIEHS





disruptors: effects and possible





Hertz-Picciotto, Irva University of North
Carolina 
Chapel Hill








to remediation decision making
NIEHS
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Table 3-15.  Ongoing Studies on the Health Effects of PCBs (continued)
 
Investigator Affiliation Title Sponsor
Hunter, David J Brigham and
Women's Hospital,
Boston, MA
Environmental risk factors and
breast cancer
NIEHS
Jefcoate, Colin R University of
Wisconsin Madison
Organochlorine compounds
and human breast cytochrome
P-450
NIEHS





Klaassen, Curtis D University of Kansas
Medical Center
Environmental hormones—
effects on thyroid function
NIEHS
Klebanoff, MA NICHD, NIH Fetal, neonatal  and  childhood
















Laessig, Susan A Marine Biological
Laboratory,
 Woods Hole, MA
Ortho-substituted PCB on
calcium homeostasis in aplysia
bag cell neurons
NCRR




Matte, Thomas Mount Sinai School of
Medicine of CUNY
Prenatal PCB exposure and
neurodevelopmental outcomes
in adolescence and adulthood
NIEHS
Mc Coy, George L Benedict College,
Columbia, SC
Pilot study—Toxic and
estrogenic actions of PCB in
reproduction
NCRR
Ozonoff, David M Boston University Superfund basic research
center at Boston University
NIEHS
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Table 3-15.  Ongoing Studies on the Health Effects of PCBs (continued)
 
Investigator Affiliation Title Sponsor












Robertson, Larry W University of Kentucky Activation of PCB's to
genotoxins in vivo
NIEHS











Safe, SH Texas A&M University Endocrine toxicology studies USDA or
cooperating state
institutions








Schantz, SL University of Illinois
Urbana
Developmental effects of




Schantz, SL University of IIlinois
Urbana
Developmental effects of





Schell, Lawrence M State University of
New York at Albany





Schwartz, Stephen M Fred  Hutchinson 







Seegal, Richard F Wadsworth Center,
Albany, NY
Developmental effects of fish
borne toxicants in the rat
NIEHS
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Table 3-15.  Ongoing Studies on the Health Effects of PCBs (continued)
 
Investigator Affiliation Title Sponsor
Spink, David C State University of





Stellman, Steven D American Health
Foundation, Valhalla,
NY
Epidemiology of breast cancer NCI











Weston, Ainsley Mount Sinai School of
Medicine of CUNY




Wolff, Mary S Mount Sinai School of
Medicine of CUNY











Zhu, Bao T University  of  South 
Carolina at Columbia
Effects of cigarette smoking or
PCBs on human estradiol
NCI
Zoeller, RT University of 
Massachusetts
PCB and thyroid hormone
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4.  CHEMICAL AND PHYSICAL INFORMATION
4.1 CHEMICAL IDENTITY
PCBs are a class of chemical compounds in which 2–10 chlorine atoms are attached to the biphenyl
molecule.  Monochlorinated biphenyls (i.e., one chlorine atom attached to the biphenyl molecule) are
often included when describing PCBs.  The general chemical structure of chlorinated biphenyls is shown
below.
It can be seen from the structure that a large number of chlorinated compounds are possible.  The
209 possible compounds are called congeners.  PCBs can also be categorized by degree of chlorination. 
The term “homolog” is used to refer to all PCBs with the same number of chlorines (e.g., trichloro-
biphenyls).  Homologs with different substitution patterns are referred to as isomers.  For example, the
dichlorophenyl homolog contains 12 isomers.
The numbering system for the PCBs is also shown above.  Positions 2, 2', 6, and 6' are called ortho
positions, positions 3, 3', 5, and 5' are called meta positions, and positions 4 and 4' are called para
positions.  The benzene rings can rotate around the bond connecting them; the two extreme configurations
are planar (the two benzene rings in the same plane) and the nonplanar in which the benzene rings are at a
90E angle to each other.  The degree of planarity is largely determined by the number of substitutions in
the ortho positions.  The replacement of hydrogen atoms in the ortho positions with larger chlorine atoms
forces the benzene rings to rotate out of the planar configuration.  The benzene rings of non-ortho
substituted PCBs, as well as mono-ortho substituted PCBs, may assume a planar configuration and are
referred to as planar or coplanar congeners; the benzene rings of other congeners cannot assume a planar
or coplanar configuration and are referred to as non-planar congeners. 
Monsanto Corporation, the major U.S. producer of PCBs from 1930 to 1977, marketed mixtures of PCBs
under the trade name Aroclor.  The Aroclors are identified by a four-digit numbering code in which the
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first two digits indicate the type of mixture and the last two digits indicate the approximate chlorine
content by weight percent.  Thus, Aroclor 1242 is a chlorinated biphenyl mixture of varying amounts of
mono- through heptachlorinated homologs with an average chlorine content of 42%.  The exception to
this code is Aroclor 1016, which contains mono- through hexachlorinated homologs with an average
chlorine content of 41% (Hutzinger et al. 1974).
The trade names of some commercial PCB mixtures manufactured in other countries are Clophen
(Germany), Fenclor (Italy), Kanechlor (Japan), and Phenoclor (France) (De Voogt and Brinkman 1989). 
The composition of commercial Clophen A-60 and Phenoclor DP-6 is similar to Aroclor 1260; that of
Kanechlor 500 is similar to Aroclor 1254.  Fenclor contains 100% decachlorobiphenyl (De Voogt and
Brinkman 1989).  The chemical identity of the Aroclors is summarized in Table 4-1.  The identity of the
209 PCB congeners is shown in Table 4-2.  The congeners are arranged in ascending numerical order
using a numbering system developed by Ballschmiter and Zell (1980) that follow the IUPAC rules of
substituent characterization in biphenyls.  The resulting PCB numbers, also referred to as congener,
IUPAC, or BZ numbers, are widely used for identifying individual congeners.  
4.2 PHYSICAL AND CHEMICAL PROPERTIES
Physical and chemical properties of the Aroclors are summarized in Table 4-3.  An important property of
PCBs is their general inertness; they resist both acids and alkalis and have thermal stability.  This made
them useful in a wide variety of applications, including dielectric fluids in transformers and capacitors,
heat transfer fluids, and lubricants (Afghan and Chau 1989).  In general, PCBs are relatively insoluble in
water, and the solubility decreases with increased chlorination (see Table 4-3).  PCBs are also freely
soluble in nonpolar organic solvents and biological lipids (EPA 1980b).  PCBs are combustible liquids,
and the products of combustion may be more hazardous than the material itself.  By-products of
combustion include hydrogen chloride, polychlorinated dibenzodioxins (PCDDs), and polychlorinated
dibenzofurans (PCDFs) (NFPA 1994).
The approximate weight percent of chlorobiphenyls in some commercial Aroclors is summarized in
Table 4-4, and the congener composition of Aroclors is shown in Table 4-5.  The congener composition
of commercial PCBs may vary from lot to lot even in products from the same manufacturer.  In addition,
no two descriptions of commercial PCB mixtures, even from the same lot or a manufactured product, are
identical because of slight differences in the conditions of the chlorination process or the use of different


















Table 4-1.  Chemical Identity of Selected Technical Polychlorinated Biphenyls or Aroclorsa,b 





















Registered trade name(s) Aroclorc Aroclor Aroclor Aroclor Aroclor
Chemical formula See Table 4-4 See Table 4-4 See Table 4-4 See Table 4-4 See Table 4-4
Chemical structure See Section 4.1 See Section 4.1 See Section 4.1 See Section 4.1 See Section 4.1
Identification numbers:
CAS registry 12674-11-2 11104-28-2 11141-16-5 53469-21-9 12672-29-6
NIOSH RTECS TQ1351000 TQ1352000 TQ1354000 TQ1356000 TQ1358000
EPA hazardous wasted 3502e 3502e 3502e 3502e 3502e
OHM/TADS 8500400f 8500401f 8500402f 8500403f 8500404f
DOT/UN/NA/IMCO
shipping
UN2315/IMO9.2g UN2315/IMO9.2g UN2315/IMO9.2g UN2315/IMO9.2g UN2315/IMO9.2g
HSDB 6352g 6353g 6354g 6355g 6356g


















Table 4-1.  Chemical Identity of Selected Technical Polychlorinated Biphenyls or Aroclors a,b (continued)

















Registered trade name(s) Aroclor Aroclor Aroclor Aroclor
Chemical formula See Table 4-4 See Table 4-4 See Table 4-4 See Table 4-4
Chemical structure See Section 4.1 See Section 4.1 See Section 4.1 See Section 4.1
Identification numbers:
CAS registry 11097-69-1 11096-82-5 37324-23-5 11100-14-4
NIOSH RTECS TQ1360000 TQ1362000 TQ1364000h No data
EPA hazardous wasted 3502e 3502e No data No data
OHM/TADS 8500405f 8500406f No data No data
DOT/UN/NA/IMO shipping UN2315/IMO9.2g UN2315/IMO9.2g UN2315h UN2315h
HSDB 6357g 1822g No data No data
NCI C02664i No data No data No data
aAll information obtained from SANSS 1990 and Hutzinger et al. 1974 except
where noted.
bChemical names used are those currently indexed by the Chemical
Abstracts Service.
cAroclor is the trade name for chlorinated biphenyls made by Monsanto
Chemical Company.






CAS = Chemical Abstracts Services; DOT/UN/NA/IMCO = Department of Transportation/United Nations/North America/International Maritime Dangerous Goods
Code; EPA = Environmental Protection Agency; HSDB = Hazardous Substances Data Bank; NCI = National Cancer Institute; NIOSH = National Institute for
Occupational Safety and Health; OHM/TADS = Oil and Hazardous Materials/Technical Assistance Data System; PCB = polychlorinated biphenyl;
RTECS = Registry of Toxic Effects of Chemical Substances
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Table 4-2.  Chemical Identity of Polychlorinated Biphenyl Congeners 
and Homologs
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Table 4-2.  Chemical Identity of Polychlorinated Biphenyl Congeners 
and Homologs (continued)
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Table 4-2.  Chemical Identity of Polychlorinated Biphenyl Congeners 
and Homologs (continued)
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Table 4-2.  Chemical Identity of Polychlorinated Biphenyl Congeners 
and Homologs (continued)
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Table 4-2.  Chemical Identity of Polychlorinated Biphenyl Congeners 
and Homologs (continued)
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Table 4-2.  Chemical Identity of Polychlorinated Biphenyl Congeners 
and Homologs (continued)















































Table 4-3.  Physical and Chemical Properties of Some Aroclorsa
Property Aroclor 1016 Aroclor 1221 Aroclor 1232 Aroclor 1242
Molecular weightb 257.9c 200.7c 232.2c 266.5c
Color Clear Clear Clear Clear
Physical state Oil Oil Oil Oil
Melting point, EC No data 1d No data No data
Boiling point, EC 325–356 275–320 290–325 325–366
Density, g/cm3 at 25 EC 1.37 1.18 1.26 1.38



































Vapor pressure, mm Hg at 25 EC 4x10-4 c 6.7x10-3 c 4.06x10-3 c 4.06x10-4 c
Henry’s law constant, atm-m3/mol at 25 ECi 2.9x10-4 3.5x10-3 No data 5.2x10-4
Autoignition temperature No data No data No data No data
Flashpoint, EC (Cleveland open cup) 170 141–150 152–154 176–180
Flammability limits, EC None to boiling point 176 328 None to boiling point
Conversion factors
Air (25 EC)j 1 mg/m3=0.095 ppm 1 mg/m3=0.12 ppm 1 mg/m3=0.105 ppm 1 mg/m3=0.092 ppm


















Table 4-3.  Physical and Chemical Properties of Some Aroclorsa (continued)
Property Aroclor 1254 Aroclor 1260 Aroclor 1262 Aroclor 1268
Molecular weightb 328c 357.7c 389 453
Color Light yellow Light yellow No data Cleark
Physical state Viscous liquid Sticky resin No data Viscous liquidk
Melting point No data No data No data No data
Boiling point, EC 365–390 385–420 390–425 435–450
Density, g/cm3 at 25 EC 1.54 1.62 1.64 1.81


































Vapor pressure, mm Hg at 25 EC 7.71x10-5 c 4.05x10-5 c No data No data
Henry’s law constant, atm-m3/mol at 25 ECi 2.0x10-3 4.6x10-3 No data No data
Autoignition temperature No data No data No data No data
Flashpoint EC (Cleveland open cup) No data No data 195E C 195E C
Table 4-3.  Physical and Chemical Properties of Some Aroclorsa (continued)


















Flammability limits, EC None to boiling point None to boiling point None to boiling point None to boiling point
Conversion factors, Air (25 EC)j 1 mg/m3=0.075 ppm 1 mg/m3=0.065 ppm 1 mg/m3=0.061 ppm 1 mg/m3=0.052 ppm
Explosive limits No data No data No data No data
aAll information obtained from Monsanto Chemical Company 1985 and Hutzinger et al. 1974 unless otherwise noted.
bAverage weight from Table 3-3.
cEPA 1979h; data on temperature not available.
dNIOSH 1997
eParis et al. 1978
fHollifield 1979
gEPA 1985b
hThese log Kow values represent an average value for the major components of the individual Aroclor.  Experimental values for the individual components were
obtained from Hansch and Leo 1985.
iThese Henry's law constants were estimated by dividing the vapor pressure by the water solubility.  The first water solubility given in this table was used for the
calculation.  The resulting estimated Henry's law constant is only an average for the entire mixture; the individual chlorobiphenyl isomers vary significantly from the
average.  Burkhard et al. (1985) estimated the following Henry's law constants (atm-m3/mol) for various Aroclors at 25 EC: 1221 (2.28x10-4), 1242 (3.43x10-4),
1248 (4.4x10-4), 1254 (2.83x10-4), and 1260 (4.15x10-4).
jThese air conversion factors were calculated by using the average molecular weight and ideal gas law.
kChemical Health and Safety Data; National Toxicology Program (http://ntp-server.niehs.nih.gov)
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C12H9Cl 0.70 60.06 27.55 0.75 0.07
C12H8Cl2 17.53 33.38 26.83 15.04 1.55
C12H7Cl3 54.67 4.22 25.64 44.91 21.27
C12H6Cl4 22.07 1.15 10.58 20.16 32.77
C12H5Cl5 5.07 1.23 9.39 18.85 42.92
C12H4Cl6 Not detected Not detected 0.21 0.31 1.64
C12H3Cl7 Not detected Not detected 0.03 Not detected 0.02
C12H2Cl8 Not detected Not detected Not detected Not detected Not detected
C12H1Cl9 Not detected Not detected Not detected Not detected Not detected
Average molecular












C12H9Cl 0.02 Not detected 0.02 0.02 No data
C12H8Cl2 0.09 0.24 0.08 0.27 No data
C12H7Cl3 0.39 1.26 0.21 0.98 No data
C12H6Cl4 4.86 10.25 0.35 0.49 No data
C12H5Cl5 71.44 59.12 8.74 3.35 No data
C12H4Cl6 21.97 26.76 43.35 26.43 No data
C12H3Cl7 1.36 2.66 38.54 48.48 No data
C12H2Cl8 Not detected 0.04 8.27 19.69 No data
C12H1Cl9 0.04 0.04 0.70 1.65 No data
Average molecular
mass 334 334 378 395 453
Source: Frame et al. (1996)
aLot A2 Aroclor 1016
bLot A1 Aroclor 1221
cLot A1.5 Aroclor 1232
dMean of three Lots
eLot A3.5 Aroclor 1248
fLot A4 Aroclor 1254 (Monsanto Lot KI-02-6024) from
abnormal late production (1974–1977)
gLot G4 Aroclor 1254 (GE/118-peak analytical
standard)
hLot A6 Aroclor 1262
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Table 4-5.  Polychlorinated Biphenyl Congener Compositions 
(in Weight Percent)a in Aroclorsb
PCB No. Chlorine positions
Aroclor
1016c 1242d 1248e 1248f
1254g
“Late” 1254h 1260i
1 2 0.52 0.54 0.05 0.02 0.02 — 0.02
2 3 0.02 0.03 — — — — —
3 4 0.15 0.18 0.01 — — —  —
4 2,2N 3.62 3.08 0.32 0.04 0.02 0.06 0.02
5 2,3 0.17 0.14 0.00 — — — — 
6 2,3N 1.64 1.43 0.13 0.00 0.01 0.02 0.01
7 2,4 0.29 0.26 0.02 — — — —
8 2,4N 8.29 7.05 0.81 0.26 0.05 0.13 0.04
9 2,5 0.58 0.50 0.04 — — — —
10 2,6 0.23 0.20 — — — — —
11 3,3N — — — — — — —
12 3,4 0.07 0.06 — — — — —
13 3,4N 0.24 0.22 0.02 — — — —
14 3,5 — — — — — — —
15 4,4N 2.40 2.10 0.22 0.06 0.01 0.03 0.01
16 2,2N,3 3.88 3.14 1.04 0.71 0.02 0.09 0.01
17 2,2N,4 3.98 3.13 1.05 0.93 0.02 0.08 0.02
18 2,2N,5 10.86 8.53 4.29 3.29 0.08 0.25 0.05
19 2,2N,6 0.99 0.80 0.22 0.14 — — — 
20 2,3,3N 0.88 0.72 0.14 0.08 — — —
21 2,3,4 NM NM — — — — —
22 2,3,4N 3.50 2.84 1.33 1.38 0.02 0.04 0.01
23 2,3,5 0.01 0.01 — 0.00 — — —
24 2,3,6 0.16 0.13 0.01 — — — —
25 2,3N,4 0.72 0.59 0.11 0.04 — — —
26 2,3N,5 1.57 1.28 0.40 0.23 — 0.03 —
27 2,3,6 0.51 0.41 0.12 0.07 — — —
28 2,4,4N 8.50 6.86 3.59 5.57 0.06 0.19 0.03
29 2,4,5 0.10 0.08 0.00 0.01 — — —
30 2,4,6 0.00 — — — — — —
31 2,4N,5 9.32 7.34 5.07 5.47 0.11 0.28 0.04
32 2,4N,6 2.37 1.90 0.88 0.93 0.01 0.05 0.01
33 2N,3,4 6.21 5.01 2.23 2.21 0.05 0.16 0.03
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Table 4-5.  Polychlorinated Biphenyl Congener Compositions 
(in Weight Percent)a in Aroclorsb (continued)
PCB No. Chlorine positions
Aroclor
1016c 1242d 1248e 1248f
1254g
“Late” 1254h 1260i
34 2N,3,5 0.03 0.02 0.00 0.00 — — —
35 3,3N,4 0.05 0.08 0.00 — — — —
36 3,3N,5 — — — — — — —
37 3,4,4N 1.02 2.03 0.79 0.95 0.01 0.07 0.01
38 3,4,5 — — — — — — —
39 3,4N,5 — — — — — — —
40 2,2N,3,3N 0.58 0.76 1.13 0.92 0.15 0.12 —
41 2,2N,3,4 0.76 0.68 0.77 0.75 0.02 0.01 —
42 2,2N,3,4N 1.59 1.19 1.67 1.79 0.09 0.15 0.01
43 2,2N,3,5 0.28 0.18 0.30 0.19 — — —
44 2,2N,3,5N 4.47 3.55 6.31 5.09 0.67 2.31 0.03
45 2,2N,3,6 1.23 0.89 1.09 0.91 0.02 0.05 —
46 2,2N,3,6N 0.49 0.36 0.47 0.39 — — —
47 2,2N,4,4N 1.26 0.93 1.49 2.41 0.07 0.14 —
48 2,2N,4,5 1.61 1.18 1.66 1.54 0.05 0.12 —
49 2,2N,4,5N 3.35 2.53 4.12 4.17 0.26 1.10 0.01
50 2,2N,4,6 0.01 0.00 — — — — —
51 2,2N,4,6N 0.32 0.23 0.30 0.31 — — —
52 2,2N,5,5N 4.63 3.53 6.93 5.58 0.83 5.38 0.24
53 2,2N,5,6N 0.95 0.71 1.05 0.88 0.04 0.12 —
54 2,2N,6,6N 0.01 0.01 — 0.01 — — —
55 2,3,3N,4 — 0.10 0.06 0.05 — — —
56 2,3,3N,4N 0.07 1.81 3.16 3.19 1.70 0.55 0.02
57 2,3,3N,5 0.01 0.02 0.02 0.02 — — —
58 2,3,3N,5N — — — — — — —
59 2,3,3N,6 0.41 0.32 0.37 0.23 0.01 0.02 —
60 2,3,4,4N 0.04 1.18 1.85 2.67 0.95 0.18 0.04
61 2,3,4,5 — — — — — — —
62 2,3,4,6 — — — — — — —
63 2,3,4N,5 0.06 0.12 0.17 0.19 0.07 0.02 —
64 2,3,4N,6 1.87 1.70 3.01 3.32 0.36 0.59 0.01
65 2,3,5,6 — — — — — — —
66 2,3N,4,4N 0.39 3.39 5.84 7.22 3.56 1.01 0.02
67 2,3N,4,5 0.06 0.16 0.13 0.10 0.01 — —
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Table 4-5.  Polychlorinated Biphenyl Congener Compositions 
(in Weight Percent)a in Aroclorsb (continued)
PCB No. Chlorine positions
Aroclor
1016c 1242d 1248e 1248f
1254g
“Late” 1254h 1260i
68 2,3N,4,5N — — — — — — —
69 2,3N,4,6 0.00 — — — — — —
70 2,3N,4N,5 0.59 3.73 7.28 7.39 6.83 3.49 0.04
71 2,3N,4N,6 1.16 1.03 1.67 1.86 0.11 0.15 0.01
72 2,3N,5,5N 0.00 0.01 0.02 0.01 — — —
73 2,3N,5N,6 0.00 0.00 — — — — —
74 2,4,4N,5 0.33 1.81 3.14 4.67 2.19 0.84 0.05
75 2,4,4N,6 0.06 0.04 0.08 0.08 — — —
76 2N,3,4,5 — 0.08 0.13 0.13 0.03 0.02 —
77 3,3N,4,4N — 0.31 0.41 0.52 0.20 0.03 —
78 3,3N,4,5 — — — — — — —
79 3,3N,4,5N — — — — — — —
80 3,3N,5,5N — — — — — — —
81 3,4,4N,5 — 0.01 0.01 0.02 0.00 — —
82 2,2N,3,3N,4 — 0.26 0.81 0.62 1.53 1.11 —
83 2,2N,3,3N,5 — 0.11 0.26 0.20 0.56 0.48 0.01
84 2,2N,3,3N,6 0.05 0.41 1.26 0.91 1.58 2.32 0.11
85 2,2N,3,4,4N — 0.31 0.98 1.14 2.49 1.28 0.01
86 2,2N,3,4,5 — 0.03 0.11 0.09 0.10 0.06 —
87 2,2N,3,4,5N — 0.46 1.45 1.11 3.41 3.99 0.41
88 2,2N,3,4,6 — 0.00 0.02 0.02 — — —
89 2,2N,3,4,6N — 0.09 0.20 0.17 0.11 0.09 —
90 2,2N,3,4N,5 — — NM NM NM NM —
91 2,2N,3,4N,6 0.06 0.21 0.63 0.56 0.53 0.93 0.01
92 2,2N,3,5,5N — 0.09 0.38 0.25 0.57 1.29 0.30
93 2,2N,3,5,6 — 0.00 0.04 0.03 — — —
94 2,2N,3,5,6N — 0.01 0.03 0.02 0.01 0.02 —
95 2,2N,3,5N,6 0.31 0.61 1.96 1.43 1.84 6.25 2.45
96 2,2N,3,6,6N 0.04 0.03 0.08 0.06 0.01 0.04 —
97 2,2N,3N,4,5 — 0.38 1.22 0.97 2.78 2.62 0.09
98 2,2N,3N,4,6 — — — — — — —
99 2,2N,3N,4N,5 0.01 0.46 1.47 1.81 4.53 3.02 0.04
100 2,2N,4N,4N,6 — — — — — — —
101 2,2N,4,5,5N 0.04 0.69 2.22 1.89 5.49 8.02 3.13
PCBs 460
4.  CHEMICAL AND PHYSICAL INFORMATION
Table 4-5.  Polychlorinated Biphenyl Congener Compositions 
(in Weight Percent)a in Aroclorsb (continued)
PCB No. Chlorine positions
Aroclor
1016c 1242d 1248e 1248f
1254g
“Late” 1254h 1260i
102 2,2N,4,5,6N 0.04 0.07 0.19 0.17 0.09 0.15 —
103 2,2N,4,5N,6 — — 0.02 0.01 — 0.03 —
104 2,2N,4,6,6N — — — — — — —
105 2,3,3N,4,4N 0.00 0.47 1.60 1.45 7.37 2.99 0.22
106 2,3,3N,4,5 — — — — — — —
107 2,3,3N,4N,5 — — — — — — —
108 2,3,3N,4,5N — — — — — — —
109 2,3,3N,4,6 — 0.06 0.18 0.13 0.78 0.37 0.01
110 2,3,3N,4N,6 — 0.83 2.97 2.55 8.42 9.29 1.33
111 2,3,3N,5,5N — — — — — — —
112 2,3,3N,5,6 — — — — — — —
113 2,3,3N,5N,6 — — — — 0.01 — —
114 2,3,4,4N,5 — 0.04 0.12 0.12 0.50 0.18 — 
115 2,3,4,4N,6 — 0.04 0.11 0.11 0.37 0.20 — 
116 2,3,4,5,6 — — — — — — —
117 2,3,4N,5,6 — 0.03 0.09 0.10 0.19 0.23 —
118 2,3N,4,4N,5 — 0.66 2.29 2.35 13.59 7.35 0.48
119 2,3N,4,4N,6 — — 0.06 0.06 0.12 0.08 —
120 2,3N,4,5,5N — — — — — — —
121 2,3N,4,5N,6 — — — — — — —
122 2N,3,3N,4,5 — 0.01 0.06 0.05 0.25 0.10 —
123 2N,3,4,4N,5 — 0.03 0.07 0.08 0.32 0.15 —
124 2N,3,4,5,5N — 0.03 0.10 0.07 0.47 0.29 0.01
125 2N,3,4,5,6N — 0.02 0.04 0.03 0.03 0.02 —
126 3,3N,4,4N,5 — — 0.00 0.00 0.02 0.00 —
127 3,3N,4,5,5N — — — — — — —
128 2,2N,3,3N,4,4N — 0.02 0.12 0.08 1.71 1.42 0.53
129 2,2N,3,3N,4,5 — — 0.02 0.39 0.38 0.14
130 2,2N,3,3N,4,5N — — 0.04 0.01 0.50 0.60 0.22
131 2,2N,3,3N,4,6 — — — — 0.14 0.19 0.07
132 2,2N,3,3N,4,6N — 0.04 0.15 0.14 1.50 2.29 2.90
133 2,2N,3,3N,5,5N — — — — — 0.11 0.07
134 2,2N,3,3N,5,6 — — — 0.01 0.20 0.37 0.34
135 2,2N,3,3N,5,6N — — 0.04 0.04 0.28 0.61 1.08
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Table 4-5.  Polychlorinated Biphenyl Congener Compositions 
(in Weight Percent)a in Aroclorsb (continued)
PCB No. Chlorine positions
Aroclor
1016c 1242d 1248e 1248f
1254g
“Late” 1254h 1260i
136 2,2N,3,3N,6,6N — — 0.05 0.06 0.24 0.70 1.46
137 2,2N,3,4,4N,5 — — 0.03 0.02 0.52 0.42 0.02
138 2,2N,3,4,4N,5N — 0.10 0.38 0.41 5.95 5.80 6.54
139 2,2N,3,4,4N,6 — — — — 0.14 0.15 —
140 2,2N,3,4,4N,6N — — — — — — —
141 2,2N,3,4,5,5N — 0.01 0.07 0.09 0.69 0.98 2.62
142 2,2N,3,4,5,6 — — — — — — —
143 2,2N,3,4,5,6N — — — — — — —
144 2,2N,3,4,5N,6 — — — 0.01 0.12 0.24 0.61
145 2,2N,3,4N,6,6N — — — — — — —
146 2,2N,3,4N,5,5N — — 0.04 0.05 0.45 0.67 1.15
147 2,2N,3,4N,5,6 — — — — 0.02 0.10 —
148 2,2N,3,4N,5,6N — — — — — — —
149 2,2N,3,4N,5N,6 — 0.06 0.24 0.33 1.82 3.65 8.75
150 2,2N,3,4N,5,6N — — — — — — —
151 2,2N,3,5,5N,6 — — 0.04 0.08 0.22 0.69 3.04
152 2,2N,3,5,6,6N — — — — — — —
153 2,2N,4,4N,5,5N — 0.06 0.23 0.43 3.29 3.77 9.39
154 2,2N,4,4N,5,6N — — — — 0.02 0.04 —
155 2,2N,4,4N,6,6N — — — — — — —
156 2,3,3N,4,4N,5 — 0.01 0.06 0.04 1.13 0.82 0.52
157 2,3,3N,4,4N,5N — — 0.01 0.00 0.30 0.19 0.02
158 2,3,3N,4,4N,6 — 0.01 0.04 0.04 0.90 0.81 0.58
159 2,3,3N,4,5,5N — — — — — — —
160 2,3,3N,4,5,6 — — — — — — —
161 2,3,3N,4,5N,6 — — — — — — —
162 2,3,3N,4N,5,5N — — — — — — —
163 2,3,3N,4N,5,6 — 0.01 0.06 0.08 0.70 1.03 2.42
164 2,3,3N,4N,5N,6 — — 0.02 0.03 0.31 0.40 0.69
165 2,3,3N,5,5N,6 — — — — — — —
166 2,3,4,4N,5,6 — — — — 0.05 0.05 —
167 2,3N,4,4N,5,5N — — 0.01 0.01 0.35 0.27 0.19
168 2,3N,4,4N,5N,6 — — — — — — —
169 3,3N,4,4N,5,5N — — — — — — —
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Table 4-5.  Polychlorinated Biphenyl Congener Compositions 
(in Weight Percent)a in Aroclorsb (continued)
PCB No. Chlorine positions
Aroclor
1016c 1242d 1248e 1248f
1254g
“Late” 1254h 1260i
170 2,2N,3,3N,4,4N,5 — — — 0.08 0.35 0.52 4.11
171 2,2N,3,3N,4,4N,6 — — — — 0.08 0.14 1.11
172 2,2N,3,3N,4,5,5N — — — — 0.03 0.07 0.70
173 2,2N,3,3N,4,5,6 — — — — — — 0.10
174 2,2N,3,3N,4,5,6N — — — 0.08 0.14 0.34 4.96
175 2,2N,3,3N,4,5N,6 — — — — — — 0.17
176 2,2N,3,3N,4,6,6N — — — — 0.01 0.04 0.59
177 2,2N,3,3N,4N,5,6 — — — 0.03 0.08 0.20 2.57
178 2,2N,3,3N,5,5N,6, — — — — — 0.03 0.83
179 2,2N,3,3N,5,6,6N — — — 0.02 0.02 0.10 2.03
180 2,2N,3,4,4N,5,5N — — 0.02 0.21 0.42 0.67 11.38
181 2,2N,3,4,4N,5,6 — — — — — — 0.01
182 2,2N,3,4,4N,5,6N — — — — — — —
183 2,2N,3,4,4N,5N,6 — — — 0.06 0.09 0.18 2.41
184 2,2N,3,4,4N,6,6N — — — — — — —
185 2,2N,3,4,5,5N,6 — — — — — — 0.55
186 2,2N,3,4,5,6,6N — — — — — — —
187 2,2N,3,4N,5,5N,6 — — — 0.09 0.09 0.25 5.40
188 2,2N,3,4N,5,6,6N — — — — — — —
189 2,3,3N,4,4N,5,5N — — — — 0.01 0.01 0.10
190 2,3,3N,4,4N,5,6 — — — — 0.05 0.07 0.82
191 2,3,3N,4,4N,5N,6 — — — — — — 0.17
192 2,3,3N,4,5,5N,6 — — — — — — —
193 2,3,3N,4N,5,5N,6 — — — — — 0.03 0.53
194 2,2N,3,3N,4,4N,5,5N — — — — — 0.01 2.07
195 2,2N,3,3N,4,4N,5,6 — — — — — — 0.84
196 2,2N,3,3N,4,4N,5,6N — — — — — — 1.09
197 2,2N,3,3N,4,4N,6,6N — — — — — — 0.07
198 2,2N,3,3N,4,5,5N,6 — — — — — — 0.10
199 2,2N,3,3N,4,5,5N,6N — — — — — 0.01 1.78
200 2,2N,3,3N,4,5,6,6N — — — — — — 0.25
201 2,2N,3,3N,4,5N,6,6N — — — — — — 0.24
202 2,2N,3,3N,5,5N,6,6N — — — — — — 0.33
203 2,2N,3,4,4N,5,5N,6 — — — — — 0.02 1.40
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Table 4-5.  Polychlorinated Biphenyl Congener Compositions 
(in Weight Percent)a in Aroclorsb (continued)
PCB No. Chlorine positions
Aroclor
1016c 1242d 1248e 1248f
1254g
“Late” 1254h 1260i
204 2,2N,3,4,4N,5,6,6N — — — — — — —
205 2,3,3N,4,4N,5,5N,6 — — — — — — 0.10
206 2,2N,3,3N,4,4N,5,5N,6 — — — — 0.03 0.03 0.53
207 2,2N,3,3N,4,4N,5,6,6N — — — — — — 0.05
208 2,2N,3,3N,4,5,5N,6,6N — — — — 0.01 0.01 0.13
209 2,2N,3,3N,4,4N,5,5N,6,6N — — — — — — NM
Sum of weight percents = 100.0 100.0 100.2 100.2 100.2 100.4 100.3
aWeight percent values in table are biased high with respect to mole percent values (not calculated).
bSource: Frame et al. (1996)
cLot A2 Aroclor 1016
dMean of three Lots of Aroclor 1242
eLot A3.5 Aroclor 1248
fLot G3.5 Aroclor 1248
gLot A4 Aroclor 1254 (Monsanto Lot KI-02-6024) from abnormal late production (1974–1977)
hLot G4 Aroclor 1254 (GE/118-peak analytical standard)
iMean of three Lots of Aroclor 1260
NM = congener not measured, but present at trace level.
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increased levels of the high TEF (i.e., 2,3,7,8-tetrachlorodibenzo-p-dioxin (“dioxin”) Equivalency Factor;
“T” often defined as “toxic”) chlorobiphenyls, were produced from 1974 to 1977 (see Section 5.1).
The pyrolysis of technical-grade PCB mixtures produces several PCDFs (Rappe et al. 1979; Schecter and
Charles 1991).  PCDFs are also produced during the commercial production and handling of PCBs.  The
amount of PCDFs formed depends upon the manufacturing conditions.  The concentrations of PCDF
impurities in various commercial Aroclors are shown in Table 4-6.  The impurities 2,3,7,8-tetrachloro-
dibenzofuran and 2,3,4,7,8-pentachlorodibenzofuran were found at concentrations of 0.33 and 0.83 ppm,
respectively, in Aroclor 1248; and at 0.11 and 0.12 ppm, respectively, in Aroclor 1254 (Van den Berg et
al. 1985).  Concentrations of PCDFs in commercial PCB mixtures including Clophen A-60, Pheno-
clor DP-6, and Kanechlor 400 have been reported (De Voogt and Brinkman 1989).
Physical properties such as solubility, vapor pressure, and Henry's law constant have been reported for
individual congeners (Dunnivant and Elzerman 1988; Dunnivant et al. 1992; Falconer and Bidleman
1994; Murphy et al. 1987; Sabljic and Güsten 1989).  Physical and chemical properties for several PCB
congeners are presented in Table 4-7 (Bidelman 1984; Dunnivant et al. 1992; Erikson 1986; Hansch and
Leo 1979;  Hutsinger et al. 1974; Mackay et al. 1992; Murray and Andren 1991; Yalkowsky et al. 1983). 
Experimentally determined log Kow values for 19 congeners and an estimation method for the
determination of log Kow values of other PCB congeners are also available (Sabljic et al. 1993).  The



















Table 4-6.  Concentrations of Chlorinated Dibenzofurans (CDFs) in Commercial 
Polychlorinated Biphenyl Mixturesa
PCB Tetra-CDF Penta-CDF Hexa-CDF Total (PCDFs)b
Aroclor 1016 (1977) Not detected Not detected Not detected –
Aroclor 1016 Not detected Not detected Not detected –
Aroclor 1242 0.07 0.03 0.003 0.15
Aroclor 1242 0.07 0.03 0.003 0.15
Aroclor 1242 2.3 2.2 Not detected 4.5
Aroclor 1254 (1969) 0.1 0.2 1.4 1.7
Aroclor 1254 (1970) 0.2 0.4 0.9 1.5
Aroclor 1254 0.02 0.2 0.4–0.6 0.8
Aroclor 1254 0.1 3.6 1.9 5.6
Aroclor 1260 (1969) 0.1 3.6 1.9 5.6
Aroclor 1260 (Lot AK3) 0.2 0.3 0.3 0.8
Aroclor 1260 0.3 1.0 1.1 3.8b
Aroclor 1260 0.8 0.9 0.5 2.2
Clopen A-60 1.4 5.0 2.2 8.6
Phenoclor DP-6 0.7 10.0 2.9 13.6
Kanechlor 400 – – – .20.0
Source: Adapted from de Voogt and Brinkman 1989
ain µg/g
bTotal includes quantities of tri-CDF and hepta-CDF isomers that were analyzed.


















Table 4-7.  Physical and Chemical Properties of Several Congeners of Polychlorinated Biphenyls
Property PCB 77 PCB 138 PCB 153 PCB 169 PCB 180
Molecular weight 291.98a 360.9b 360.88b 360.86a 395.32b
Molecular formula C12H6CI4b C12H4Cl6b C12H4Cl6b C12H4Cl6b C12H3Cl7b
Melting point EC 173c 78.5–80c 103–104c 201–202c 109–110b
Boiling point EC 360 (calc.)b 400 (calc.)b No data No data 240–280 (20 mmHg)b
Density g/cm3 at 25 EC 1.2024 (20 EC)b No data No data No data No data

































mm Hg at 25 EC
















Explosive limits No data No data No data No data No data
aHSDB 2000
bYalkowsky et al. 1983
cHutsinger et al. 1974
dMackay et al. 1992
eDunnivant et al. 1992
fErikson 1986
gHansch and Leo 1995
hBidelman 1984
iMurray and Andren 1991
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5.1 PRODUCTION
Prior to the public's outcry concerning the apparent link between PCBs and widespread environmental
problems and the discovery of their detrimental health effects, PCBs were produced commercially in the
United States from 1929 until 1977.  Marketed worldwide under trade names such as Aroclor, Askarel,
and Therminol, the annual U.S. production peaked in 1970 with a total production volume of 85 million
pounds (39 million kg) of Aroclors.  Between 1957 and 1971, 12 different types of Aroclors, with
chlorine contents ranging from 21 to 68% were produced in the United States.  The manufacturing
process for Aroclors involved the chlorination of biphenyl with anhydrous chlorine in the presence of a
catalyst, such as iron filings or ferric chloride.  The degree of chlorination, which determines the nature of
the Aroclor, was controlled by the chlorine-contact time (range, 12–36 hours) in the reactor.  Late
production Aroclor 1254 (Aroclor 1254 “Late”) was made by a two-stage chlorination procedure from
1974 to 1977.  In the first stage, biphenyl was chlorinated to 42% chlorine content by weight as for
Aroclor 1242 production.  This was then fractionated to give a distillate that was sold as Aroclor 1016 and
a residue that would have contained mostly the mono-ortho tetrachlorobiphenyls and higher homologs. 
In the second stage, this residue, which contained about 49% chlorine, was further chlorinated to 54%
chlorine by weight, resulting in an Aroclor 1254 lot (Monsanto Lot KI-02-6024) with greatly increased
levels of the high TEF (i.e., 2,3,7,8-tetrachlorodibenzo-p-dioxin (“dioxin”) Equivalency Factor; “T” often
defined as “toxic”) chlorobiphenyls.  While production records suggest that Aroclor 1254 “Late”
represented <1% of the total Aroclor 1254 production, the availability of this lot during the final years of
production resulted in the disproportionate use of Aroclor 1254 “Late” by standards suppliers and
researchers into Aroclor 1254 toxicity (Brinkman et al. 1995; Durfee 1976; Frame 1999; IARC 1978).
During production, Aroclor mixtures were contaminated by small amounts of polychlorinated
dibenzofurans (PCDFs) as impurities.  Although PCDFs are formed during the pyrolysis of PCBs, in the
absence of fire, PCDF levels do not appear to increase during the normal use of PCBs in electrical
equipment.  PCDFs have their own toxicological properties, which have been summarized in ATSDR
(1994).  The concentration levels for tetra-, penta-, hexa-, and total PCDFs found in commercial PCB
mixtures are shown in Table 4-6 (de Voogt and Brinkman 1989).
Approximately 99% of the PCBs used by U.S. industry were produced by the Monsanto Chemical
Company in Sauget, Illinois, until production was stopped in August 1977.  Prior to 1971, the Monsanto
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Chemical Company produced Aroclors 1221, 1232, 1242, 1248, 1254, 1260, 1262, and 1268; however, in
1971, the company voluntarily restricted the uses of PCBs and subsequently produced only Aroclor 1016,
1242, 1254, and small quantities of Aroclor 1221.  In 1974, the Monsanto Chemical Company produced
slightly more than 40 million pounds (18 million kg) of Aroclor mixtures.  Of the total volume of
Aroclors sold in the United States for that year, the percentages of the market for each of the Aroclors
were: Aroclor 1016, 64%; Aroclor 1242, 17.9%; Aroclor 1254, 17.9%; and Aroclor 1221, 0.1%.  The
estimated, cumulative production and consumption volumes (in millions of pounds) of PCBs in the
United States from 1930 to 1975 were:  total production, 1,400 (635 million kg); imports, 3 (1.4 million
kg); domestic sales, 1,253 (568 million kg); and exports, 150 (68 million kg).  Section 5.3 provides
information on amounts estimated for specific locations, as well as estimates of intermedia transfers of
PCBs (Durfee 1976; EPA 1976a; Hatton 1979; IARC 1978; Kimbrough 1987).  
In 1976, the U.S. Congress charged EPA with regulating the manufacture, processing, distribution in
commerce, and use of PCBs.  Currently regulated pursuant to the Toxic Substances Control Act (TSCA)
and the Resource Conservation and Recovery Act (RCRA), the first set of effluent standards for PCBs
was issued by EPA in 1977; manufacturing and importing limitations regarding PCBs were issued in
1979.  After subsequent amendments, the regulations stipulate that the production of PCBs in the United
States is generally banned, the use of PCB-containing materials still in service is restricted, the discharge
of PCB-containing effluents is prohibited, the disposal of materials contaminated by PCBs is regulated,
and the import or export of PCBs is only permitted through an exemption granted from EPA (EPA 1977b,
1979a, 1979f, 1979g, 1988c, 1988e, 1998a).
5.2 IMPORT/EXPORT
Currently, the United States neither imports nor exports PCBs.  Section 6(e)(3)(A) of TSCA (Pub. L.
94-969, 90 stat. 2003, 15 USC 2601 et. seq.) prohibited all manufacture and importation of PCBs after
January 1, 1979.  On January 2, 1979, however, EPA announced that companies that had filed petitions
for exemptions from the PCB manufacturing/importation ban could continue manufacturing or import
activity until EPA acted on the application petition.  As of July 7, 1997, the U.S. Court of Appeals for the
Ninth Circuit overturned the Import for Disposal Rule.  EPA can now only allow imports of PCBs by
issuing exemptions to importers via the petition process under Section 6(e) of TSCA.  See the
June 29, 1998 Federal Register for further discussion of EPA’s PCB export and import regulations (EPA
1979a, 1998a).
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In 1973 and 1974, the United States imported PCBs mainly from Italy as decachlorobiphenyl (Fenclor),
and France (Phenoclor) (Durfee 1976).  It is estimated that 180,000 kg (approximately 400,000 pounds)
of this compound were imported in 1974 (IARC 1978).  The volume of PCBs imported through principal
U.S. custom districts from unspecified countries decreased from 132,000 kg (291,000 pounds) in 1976
(IARC 1978) and 280,867 pounds (127,400 kg) in 1977 to only 11,000 pounds (5,000 kg) in 1981
(USITC 1978, 1979, 1980, 1982).  The Monsanto Chemical Company exported 5.4 million pounds
(2.45 million kg) of Aroclors 1016 and 1242 to unspecified countries in 1974 (Durfee 1976). 
5.3 USE
Prior to 1974, PCBs were used both for nominally closed applications (e.g., capacitor and transformers,
and heat transfer and hydraulic fluids) and in open-end applications (e.g., flame retardants, inks,
adhesives, microencapsulation of dyes for carbonless duplicating paper, paints, pesticide extenders,
plasticizers, polyolefin catalyst carriers, slide-mounting mediums for microscopes, surface coatings, wire
insulators, and metal coatings) (Durfee 1976; EPA 1976a, 1988c; IARC 1978; Orris et al. 1986; Safe
1984; Welsh 1995).  Table 5-1 summarizes the former uses of the various Aroclors.  Currently, under
40 CFR 761.80 (June 29, 1998), individual petitioners are granted 1-year exemptions to manufacture or
import PCB for use solely in the manufacture or importer’s own research for the development of PCB
disposal technologies.  Also under 40 CFR 761.30 (June 29, 1998), individual petitioners are granted
exemptions for the use of PCBs as a mounting medium in microscopy, as an immersion oil in low
fluorescence microscopy, and as an optical liquid, as well as for analytical samples and research and
development use (EPA 1998a). 
Except for the approximate 400,000 pounds (180,000 kg) of decachlorobiphenyl imported from Italy and
France used as filler for investment casting waxes (IARC 1978), most domestic use of PCBs was
restricted to nominally closed applications by 1974 (IARC 1978).  The production of capacitors and
transformers involved filling them with Aroclors through a small hole in the unit and then sealing the
hole.  While smaller capacitors contained smaller amounts, the production of large capacitors generally
required at least 2–3 pounds (1 kg) of Aroclors; many times that amount was required to produce the
transformers.  By 1976, only 5% of the transformers produced in the United States were filled with PCBs,
accounting for 30% of the Monsanto Chemical Company's domestic sales; however, 95% of the
capacitors produced in the United States were filled with PCBs, accounting for 70% of the company's
domestic sales (IARC 1978).  As of January 1979, Aroclors were no longer used in the production of






















Table 5-1.  Summary of Former End Uses for Various Aroclors
End use
Aroclor
1016 1221 1232 1242 1248 1254 1260 1262 1268
Capacitors • • • 
Transformers • • •
Heat transfer  • 
Hydraulics/lubricants
Hydraulic fluids  •  •  •  •  • 
Vacuum pumps • •
Gas-transmission turbines   •   • 
Plasticizers:
Rubbers  • • • • •  • 
Synthetic resins • • • • •
Carbonless paper •
Miscellaneous:
Adhesives • • • • •
Wax extenders •  •   •  




Sealants and caulking compounds •
Source: IARC 1979
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than 30 years, and the life expectancy of capacitors ranges from 10 to 20 years, depending on the
electrical application (IARC 1978).  In 1981, an estimated 131,200 transformers containing PCBs were in
service in the United States, representing approximately 1% of all operational transformers.  Currently,
the EPA maintains an up-to-date database containing the location and amount of PCBs in transformers
across the United States (EPA 1999b).
5.4 DISPOSAL
According to the Toxics Release Inventory (TRI), >99% of the total PCB wastes produced in the United
States in 1998 were released on-site to land.  About 3,742,000 pounds (1,698,000 kg) of PCB wastes were
released to land in 1998 (see Table 5-2) (TRI98 2000).
The concentration of PCBs in the environment in which some action should be considered (i.e., treatment
or containment) will depend primarily on the exposure estimate determined during the baseline risk
assessment for the site and on EPA’s 1996 cancer slope factor, reference dose (RfD), and exposure-
specific values (EPA 1990e, 1996c). 
PCBs were included among the contaminants of concern at 500 of the 1,598 Superfund sites (29%) as of
May 11, 2000 which were listed on the Final National Priorities List (HazDat 2000).  Remedial actions
taken at Superfund sites must meet the mandates of the National Contingency Plan (NCP), which
implements the requirements of the Comprehensive Environmental Response Compensation and Liability
Act (CERCLA) (EPA 1990e).  CERCLA Section 121 provides specific statutory requirements (cleanup
standards) for remediation that must be addressed when evaluating proposed remedial alternatives (U.S.
Congress 1980).  In order to ensure that the statutory requirements are met, the various proposed
alternatives are evaluated using nine evaluation criteria that reflect these statutory requirements (U.S.
Congress 1980; EPA 1988j, 1989d, 1990e).  The nine criteria are categorized into three groups: threshold
criteria, primary balancing criteria, and modifying criteria.  The threshold criteria include the
requirements to provide overall protection of human health and the environment, and to comply with
applicable or relevant and appropriate (ARARs) federal and state laws (EPA 1988j, 1989d).  The primary
balancing criteria include provisions for evaluating long-term effectiveness and permanence; the
reduction of contaminant toxicity, mobility, or volume; and short-term effectiveness for adverse health
effects from human exposure, implementability, and cost.  The modifying criteria include state acceptance
and community acceptance (EPA 1988j, 1989d).  While the primary balancing criteria are used to weigh




























Norcross Safety Prods. L.L.C. Rock Island, Illinois 100–999 Produce, by-product
Unison Transformer Services Henderson, Kentucky 1,000–9,999 Ancillary/other use
Noranda Aluminum Inc. New Madrid, Missouri 10,000–99,999 Ancillary/other use
Special Metals Corp. New Hartford, New York 10,000–99,999 Ancillary/other use
Northwest Aluminum Co., Inc. The Dalles, Oregon 10,000–99,999 Ancillary/other use
Source:  TRI96 1998
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until after public comments are received on the proposed remediation plans, an alternative must satisfy
the threshold criteria in order to be eligible for selection (EPA 1988j, 1989d). 
On April 18, 1978, EPA began to regulate the storage and disposal of PCBs.  These regulations specified
incineration as the only acceptable method of PCB disposal unless, by reason of the inability to dispose of
the waste or contaminated materials in this manner, clearance was obtained from EPA to dispose of the
materials in another way.  Although in March 1983 EPA issued a procedural amendment to the PCB rule
to enable new disposal technologies to receive approval on a nationwide basis, EPA's current PCB
disposal rules generally require that PCBs at concentrations of $50 ppm be disposed of in an incinerator
approved for that use (EPA 1998u).  The recommended combustion criteria for the disposal of liquid PCB
wastes by incineration is a 2-second dwell time at 1,200 EC (±100 EC) and 3% excess oxygen in the stack
gas; or a 1.5-second dwell time at 1,600 EC (±100 EC) and 2% excess oxygen (EPA 1979e).  Since
incineration of PCBs will produce chlorine-containing products (e.g., hydrochloric acid), it is required
that water scrubbers be used to remove these products before releasing the emissions into the atmosphere
(EPA 1998u).  Under TSCA (Toxic Substance and Control Act), the combustion efficiency of the
incinerator must be 99.9%  (EPA 1998u).  The general acceptance of incineration as a means of disposal
for PCB-contaminated materials has declined because of concerns about incomplete incineration and the
possible formation of highly toxic dioxins and dibenzofurans if the combustion temperature is not held
sufficiently high (Arbon et al. 1994; Chuang et al. 1995).  An evaluation of the applicability of oxy-fuel
technology to waste incineration conducted by Baukal et al. (1994) reported favorable results.  The test
results indicated that for simulated soils containing 1% PCBs and oil containing up to 40% PCBs, more
than 99.9999% of the PCBs were destroyed.  In controlled experiments conducted by Chuang et al.
(1995), significant dechlorination was noted at 300 EC and a fully dechlorinated product occurred at
400 EC when heating a mixture of PCBs (Aroclor 1221 and 1254) and iron metal powder (Fe0) in a
muffle furnace.
The regulatory requirements implemented pursuant to TSCA also provide that chemical waste landfills
and high-efficiency boilers meeting specified operating requirements are appropriate disposal facilities for
mineral oil dielectric fluid from PCB-contaminated electrical equipment containing PCBs at
concentrations $50 ppm, but <500 ppm.  Under the land disposal restrictions promulgated at 40 CFR part
268 pursuant to RCRA (Resource Conservation & Recovery Act), PCBs are regulated as halogenated
organic compounds (HOCs).  Types of waste for which land disposal is prohibited include liquid
hazardous wastes containing PCBs at concentrations of $50 ppm; nonliquid hazardous waste containing
HOCs in total concentration greater than or equal to 1,000 mg/kg (ppm); and liquid HOC-containing
PCBs 474
5.  PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL
waste that are primarily water and contain HOCs in the concentration range 1,000–10,000 mg/L (ppm)
HOCs.  The treatment standards expressed as specified technologies (e.g., chemical reduction, carbon
adsorption, biodegradation) require incineration of liquid hazardous waste containing PCBs at a
concentration of 500 ppm or greater, and HOC-containing waste prohibited from land disposal (EPA
1986i, 1987c, 1987d, 1998u). 
Although not widely adopted, other methods proposed for the destruction of PCBs have included wet air
oxidation, biodegradation, metal-promoted dehalogenation, and electrolytic reduction (Chuang et al.
1995).  Timberlake and Garbaciak (1995) detailed the results of a series of bench-scale tests applying
various technologies (thermal desorption, solvent extraction, wet air oxidation, and an incineration
process known as Anaerobic Thermal Process [ATP]) to PCB-contaminated sediment.  The thermal
desorption and solvent extraction technologies, though not designed to destroy the contaminants,
indirectly separate the contaminants from a solid matrix and concentrate them into smaller volumes of
treatable oily residues.  The removal efficiencies of these technologies when applied to three of the river
sediments tested ranged from 96 to 99%.  The wet air oxidation process, which uses elevated
temperatures and pressure to oxidize the organic constituents, was not very effective in destroying PCBs;
it achieved only a 34% removal efficiency (Timberlake and Garbaciak 1995).  Zhang and Rusling (1995)
investigated electrochemical catalytic dechlorination as a method for decontaminating soils.  The study
achieved a 94% dechlorination level using a lead cathode and a micro emulsion of didodecylmethyl-
ammonium bromide, dodecane, and water for soils containing 6.5% organic matter and contaminated with
14% Aroclor 1260 (84 mg of PCB).
A chemical destruction method that has been used for the treatment of PCBs in contaminated dielectric
liquids or soil is based on the reaction of a polyethylene glycol/potassium hydroxide mixture with PCBs
(De Filippis et al. 1997).  This method can be used successfully for the destruction of higher chlorinated
PCBs with an efficiency of >99%, but was found to be unsuitable for the treatment of di- and
trichlorobiphenyls due to low destruction efficiencies (Sabata et al. 1993).  Irradiation of PCBs in
isooctane and transformer oil by γ-radiation resulted in degradation of PCBs to less chlorinated PCBs and
PCB-solvent adducts (Arbon et al. 1996).  Supercritical fluid technology has shown promise as a method
for extraction of PCBs from soils, coupled with supercritical water oxidation of the extracted PCBs
(Tavlarides 1993, 1998a).  Hofelt and Shea (1997) demonstrated the use of semipermeable membrane
devices to accumulate PCBs from New Bedford Harbor, Massachusetts water.  Another method showing
some promise for the treatment of PCBs in water, soil, and sediment is titanium dioxide-catalyzed
photodecomposition with sunlight (Hong et al. 1998; Huang et al. 1996; Zhang and Rusling 1995; Zhang
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et al. 1993).  PCBs in used lubricating oils were destroyed and petroleum products, including lubricating
oils, were produced with catalytic vacuum distillation/hydrotreatment technology (Brinkman et al. 1995). 
Treatment with metallic sodium has been suggested for PCB wastes because it yields low molecular
weight polypropylene and sodium chloride which are less undesirable than products from incineration
(IRPTC 1985).  Bioremediation of PCB-contaminated soil has been suggested using a combination of
anaerobic and  aerobic treatments.  Aerobic treatments would metabolize the lower chlorinated homologs
(e.g., biphenyl;  mono- and di-ortho chloro-substituted CBs)  produced in soil from anaerobic
dechlorination  processes (Tiedje et al. 1993; see Section 6.3.2.3).  
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6.1 OVERVIEW
Polychlorinated biphenyls (PCBs) have been identified in at least 500 of the 1,598 hazardous waste sites
that have been proposed for inclusion on the EPA National Priorities List (NPL) (HazDat 2000). 
However, the number of sites evaluated for PCBs is not known.  The frequency of these sites can be seen
in Figure 6-1.  Of these sites, 499 are located within the United States and 1 is located in the U.S.
Territory of Guam (not shown).
PCBs have been released to the environment solely by human activity.  Aroclors are no longer produced
in the United States, except under exemption (see Section 5.3), and are no longer used in the manufacture
of new products.  Because PCBs are no longer manufactured or imported in large quantities, significant
releases of newly manufactured or imported materials to the environment do not occur.  Rather, PCBs
predominantly are redistributed from one environmental compartment to another (e.g., soil to water, water
to air, air to water, sediments to water) (Eisenreich et al. 1992; Larsson 1985; Larsson and Okla 1989; Lin
and Que Hee 1987; Mackay 1989; Murphy et al. 1985, 1987; Swackhamer and Armstrong 1986).  Thus,
for example, the majority of PCBs in air result from volatilization of PCBs from soil and water.  Some
PCBs may be released to the atmosphere from uncontrolled landfills and hazardous waste sites;
incineration of PCB-containing wastes; leakage from older electrical equipment in use; and improper
disposal or spills (Blumbach and Nethe 1996; Boers et al. 1994; Bremle and Larsson 1998; Eisenreich et
al. 1992; Hansen and O’Keefe 1996; Hansen et al. 1997; Hermanson and Hites 1989; Larsson 1985;
Lewis et al. 1985; Morselli et al. 1985, 1989; Murphy et al. 1985; Oehme et al. 1987; Sakai et al. 1993;
Sawhney and Hankin 1985; Swackhamer and Armstrong 1986; Tiernan et al. 1983; Wallace et al. 1996). 
PCBs may be released to water from accidental spillage of PCB-containing hydraulic fluids; improper
disposal; combined sewer overflows (CSOs) or storm water runoff; and from runoff and lechate from
PCB-contaminated sewage sludge applied to farmland (Crawford et al. 1995; Durell and Lizotte 1998;
Gan and Berthouex 1994; Gunkel et al. 1995; Loganathan et al. 1997; Pham and Proulx 1997; Shear et al.
1996).  PCBs may be released to soil from accidental leaks and spills; releases from contaminated soils in
landfills and hazardous waste sites; deposition of vehicular emissions near roadway soil; and land
application of sewage sludges containing PCBs (Alcock et al. 1995; Benfenati et al. 1992; Choi et al.
1974; Gan and Berthouex 1994; Gutenmann et al. 1994; Liberti et al. 1992; McLachlan et al. 1994;
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Derived from HazDat 2000
Figure 6-1.  Frequency of NPL Sites with PCB Contamination
Derived from HazDat 2000
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PCBs are globally circulated and are present in all environmental media.  Atmospheric transport is the
most important mechanism for global dispersion of PCBs.  Biphenyls with 0–1 chlorine atom remain in
the atmosphere, those with 1–4 chlorines gradually migrate toward polar latitudes in a series of
volatilization/deposition cycles, those with 4–8 chlorines remain in mid-latitudes, and those with
8–9 chlorines remain close to the source of contamination (Wania and Mackay 1996).  PCBs enter the
atmosphere from volatilization from both soil and water surfaces (Hansen 1999).  Once in the atmosphere,
PCBs are present both in the vapor phase and sorbed to particles.  PCBs in the vapor phase appear to be
more mobile and are transported further than particle-bound PCBs (Wania and Mackay 1996).  Wet and
dry deposition remove PCBs from the atmosphere (Dickhut and Gustafson 1995; Eisenreich et al. 1981;
Golomb et al. 1997; Hoff et al. 1996; Leister and Baker 1994; Nelson et al. 1998).  The dominant source
of PCBs to surface waters is atmospheric deposition; however, redissolution of sediment-bound PCBs
also accounts for water concentrations (Hansen 1999).  PCBs in water are transported by diffusion and
currents.  PCBs are removed from the water column by sorption to suspended solids and sediments as
well as by volatilization from water surfaces.  Higher chlorinated congeners are more likely to sorb, while
lower chlorinated congeners are more likely to volatilize (Eisenreich et al. 1983, 1992; Pearson 1996). 
PCBs also leave the water column by concentrating in biota.  PCBs accumulate most in higher trophic
levels through the consumption of contaminated food, a process referred to as biomagnification (EPA
1983c; Geyer et al. 1999; Koslowski et al. 1994; Looser and Ballschmiter 1998; Oliver and Niimi 1988;
Porte and Albaiges 1993; Willman et al. 1999; Wilson et al. 1995).  PCBs in soil are unlikely to migrate
to groundwater because of strong binding to soil (EPA 1979h, 1988a; Sklarew and Girvin 1987). 
Volatilization from soil appears to be an important loss mechanism; it is more important for the lower
chlorinated congeners than for the higher chlorinated congeners (Hansen 1999).  Vapor-phase PCBs
accumulate in the aerial parts of terrestrial vegetation and food crops by vapor-to-plant transfer (Bohm et
al. 1999). 
The ability of PCBs to be degraded or transformed in the environment depends on the degree of
chlorination of the biphenyl molecule as well as on the isomeric substitution pattern.  The vapor-phase
reaction of PCBs with hydroxyl radicals is the dominant transformation process in the atmosphere
(Brubaker and Hites 1998), while photolysis appears to be the only viable chemical degradation process
in water (EPA 1979h).  Biodegradation has been demonstrated under both aerobic (Dowling et al. 1993;
EPA 1983c, 1988a; Fava et al. 1993; Gibson et al. 1993; Haluska et al. 1995; Sugiura 1992; Thomas et al.
1992) and anaerobic conditions (Abramowicz 1990, 1995; Anid et al. 1993; Brown et al. 1988; Chen et
al. 1988; EPA 1983c, 1988a; Larsson and Lemkemeier 1989; Pardue et al. 1988; Rhee et al. 1989) and is
the major degradation process for PCBs in soil and sediment.
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Typical atmospheric concentrations of PCBs have been found to be much lower in rural locations
compared to urban locales.  For example, the concentration of PCBs in urban Baltimore, Maryland ranged
from 0.38 to 3.36 ng/m3, while in rural Baltimore, the concentration ranged from 0.02 to 0.34 ng/m3
(Offenberg and Baker 1999).  PCB levels in more remote areas are even lower with mean concentrations
ranging from 0.025 ng/m3 over the Norwegian Sea to 0.074 ng/m3 over the Eastern Arctic (Harner et al.
1998).  Monitoring studies conducted over the years have shown that atmospheric concentrations of PCBs
have decreased since the late 1970s.  Water monitoring studies indicate that PCB concentrations are
generally higher near sites of anthropogenic input and in in-shore waters.  The concentration of PCBs in
the waters of the Great Lakes (Superior, Michigan, Huron, Erie, and Ontario) typically range from
0.070 to 1.6 ng/L (Anderson et al. 1999).  Concentrations of PCBs in drinking water are generally
<0.1 µg/L and thus, drinking water is not considered a significant pathway for exposure.  Concentrations
of PCBs in most soils are generally <100 µg/kg; however, PCB concentrations in contaminated soils can
be several orders of magnitude higher.  Subsurface soil and sludge collected on-site at a New York
hazardous waste site near Akwesasne (a Native American community) had maximum concentrations of
750 mg/kg and 41,500 mg/kg, respectively (ATSDR 1995).  PCB concentrations in fish have been of
particular interest due to their influence on human exposure.  Composite fish samples from the U.S. North
Coast analyzed from 1988 to 1991 had a mean PCB concentration of 1.64 µg/g wet weight (Kennish and
Ruppel 1995).  Chinook salmon sampled from Lakes Ontario and Huron from 1991 to 1994 had mean
concentrations of 0.835 and 0.338 µg/g wet weight, respectively (Feeley and Jordan 1998).  Even in
remote areas, PCBs have been detected in fish tissue.  For example, lake trout caught in the Sierra Nevada
mountains from 1993 to 1994 had PCB concentrations ranging from 0.018 to 0.430 µg/g wet weight
(Datta et al. 1999).
The general population may be exposed to PCBs by ingesting contaminated food, especially fish from
contaminated waters, and by inhaling contaminated air.  Food consumption has and continues to be the
major contributor to body burden of PCBs in the general population.  The estimated dietary intake of
PCBs for an average adult was 0.027 µg/kg/day in 1978 and had declined to <0.001 µg/kg/day by 1991
(Gunderson 1995).  Several studies indicate that diets high in fish, from PCB-contaminated waters, can
significantly increase a persons dietary intake of PCBs.  For example, it was found that the mean
concentration of PCBs in blood of 252 males who frequently consumed contaminated fish was 4.8 ng/mL,
while in 57 males who were infrequent consumers, the mean concentration was 1.5 ng/mL (Hanrahan et
al. 1999).  In child-bearing women, this can be especially important since PCBs can concentrate in breast
milk.  Infants who are breast fed may therefore be at increased risk for PCB exposure if the mother has a
diet high in contaminated fish (Dewailly et al. 1993; Fitzgerald et al. 1998).  PCB exposure has also been
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attributed to inhalation of indoor air especially at locations which still use electrical equipment containing
PCBs. 
The detection of PCBs in blood, adipose tissue, breast milk, and other tissue samples from the general
population indicates widespread exposure to PCBs from environmental sources.  People who live near
hazardous waste sites where PCBs have been detected may be exposed primarily by consuming
contaminated fish from adjacent waterbodies and by breathing air that contains PCBs.  Children playing
near these sites or adults working near these sites may be exposed to additional PCBs by dermal contact
with PCB-contaminated soil and by ingesting contaminated soil from their unwashed hands.  Despite the
prohibition on production and the restrictions regarding PCB use (Section 5.3), occupational exposure to
PCBs can be orders of magnitude higher than general population exposure (Section 6.5).  
6.2 RELEASES TO THE ENVIRONMENT 
From 1929 until 1977, approximately 99% of all PCBs used by U.S. industries were manufactured by the
Monsanto Chemical Company at a production facility in Sauget, Illinois (Durfee 1976; IARC 1978). 
During that period, over 571,000 metric tons (1,250x106 pounds) of PCBs were produced and/or used in
the United States (Erickson 1997; Hansen 1999).  In 1976, the U.S. Congress banned the manufacture,
processing, distribution in commerce, and use of PCBs under the Toxic Substances Control Act (TSCA)
and the Resource Conservation and Recovery Act (RCRA).  Exemptions may be granted to individual
petitioners for use with optical microscopy, and for research and development (see Section 5.3; EPA
1998u).
Because PCBs are no longer manufactured or imported in large quantities, significant releases of newly
manufactured or imported materials to the environment do not occur.  Rather, PCBs predominantly are
redistributed from one environmental compartment to another (e.g., soil to water, water to air, sediments
to water) (Eisenreich et al. 1992; Larsson 1985; Larsson and Okla 1989; Lin and Que Hee 1987; Mackay
1989; Murphy et al. 1985, 1987; Swackhamer and Armstrong 1986).  Thus, for example, the majority of
PCBs in air result from volatilization of PCBs from soil and water.  Some PCBs may be released to the
atmosphere from uncontrolled landfills and hazardous waste sites; incineration of PCB-containing wastes;
leakage from older electrical equipment in use; and improper disposal or spills (Blumbach 1996; Boers et
al. 1994; Bremle and Larsson 1998; Eisenreich et al. 1992; Hansen et al. 1997; Hermanson and Hites
1989; Larsson 1985; Lewis et al. 1985; Morselli et al. 1985, 1989; Murphy et al. 1985; Oehme et al.
1987; Sakai et al. 1993; Sawhney and Hankin 1985; Swackhamer and Armstrong 1986; Tiernan et al.
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1983; Wallace et al. 1996).  PCBs may be released to water from accidental spillage of PCB-containing
hydraulic fluids; improper disposal; CSOs or storm water runoff; and from runoff and lechate from PCB-
contaminated sewage sludge applied to farmland (Crawford et al. 1995; Durell and Lizotte 1998; Gan and
Berthouex 1994; Gunkel et al. 1995; Loganathan et al. 1997; Pham and Proulx 1997; Shear et al. 1996). 
PCBs may be released to soil from accidental leaks and spills; releases from contaminated soils in
landfills and hazardous waste sites; deposition of vehicular emissions near roadway soil; and land
application of sewage sludges containing PCBs (Alcock et al. 1995; Benfenati et al. 1992; Choi et al.
1974; Gan and Berthouex 1994; Gutenmann et al. 1994; Liberti et al. 1992; McLachlan et al. 1994;
Morris and Lester 1994; O'Connor et al. 1990; Ohsaki and Matsueda 1994). 
6.2.1 Air
From 1929 to 1977, unknown quantities of PCBs were released to the air during Aroclor production and
processing and when PCB-contaminated equipment was incinerated (Durfee 1976).  Similarly,
transformer and capacitor producers discharged PCB-containing wastes to air during the various filling
processes (Durfee 1976).  Emissions are no longer discharged into the air through production activities; 
however, emissions may be discharged during the overhaul, repair, or reuse of materials containing PCBs. 
PCBs may have been released to the atmosphere from various past uses containing PCBs, for example,
plasticizers, surface coatings, inks, adhesives, flame retardants, pesticide extenders, paints, and micro-
encapsulation of dyes for carbonless duplicating paper; and, in addition, from the accidental losses of
PCB fluids from capacitors and transformers (EPA 1976a; IARC 1978; Safe 1984; Welsh 1995).
The major source of PCB release to the atmosphere (2 million pounds/year) is the redistribution of the
compounds that are already present in soil and water (Eisenreich et al. 1992; Murphy et al. 1985). 
Smaller amounts of PCBs may be released to the atmosphere from uncontrolled landfills and hazardous
waste sites containing transformers, capacitors, and other PCB wastes (Bremle and Larsson 1998; Hansen
and O’Keefe 1996; Hermanson and Hites 1989; Lewis et al. 1985; Murphy et al. 1985); incineration of
PCB-containing wastes due to incomplete combustion of PCBs (Blumbach 1996; Boers et al. 1994;
Kurokawa et al. 1996; Sakai et al. 1993); leakage from older electrical equipment still in use (Wallace et
al. 1996); explosions or overheating of transformers containing PCBs (Schecter and Charles 1991); and
improper (or illegal) disposal or spills of the compounds to open areas (Larsson 1985; Morselli et al.
1985, 1989; Murphy et al. 1985; Oehme et al. 1987; Sawhney and Hankin 1985; Swackhamer and
Armstrong 1986; Tiernan et al. 1983).  Historically, the amount of PCBs released from landfills and
incinerators have been estimated to be 10–100 kg/year (22–220 pounds/year) and 0.25 kg/stack/year
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(0.55 pounds/stack/year), respectively, and are small compared to the quantity of PCBs released into the
atmosphere through cycling from environmental processes (Murphy et al. 1985).  PCBs have been
identified in 31 air samples collected at 500 of the 1,598 NPL hazardous waste sites where they were
detected in some environmental media (HazDat 2000), as well as in the air surrounding landfills during
fires (Ruokojarvi et al. 1995).  EPA regulations under TSCA regarding the incineration of PCBs requires
that the combustion efficiency should be at least 99.9% (EPA 1998b); however, the small percentage of
the PCBs not destroyed by incineration will be released into the atmosphere.  According to the Toxics
Release Inventory (TRI), a total of 446 pounds of PCBs were directly released into the air by 10 of the
14 RCRA hazardous waste and solvent recovery industries that processed them in 1998 (TRI98 2000). 
The TRI data for 1998 (TRI98 2000) are shown in Table 6-1.  The TRI data should be used with caution
since only certain types of facilities are required to report.
6.2.2 Water
From 1929 to 1977, the Monsanto Chemical Company released some PCB-containing waste water to
municipal sewers during Aroclor production and processing.  Waterborne discharges of PCBs from the
Monsanto plant, estimated to be <1 pound/day (0.45 kg/day) in 1974, were greatly reduced over the years
leading up to production cessation (Durfee 1976).  Similarly, transformer and capacitor producers also
discharged PCB-containing wastes to municipal sewers (Durfee 1976).  High levels of PCBs were also
detected in waste water from the manufacture of carbonless copy papers; from leaking hydraulic fluids
used in, for example, die cast machines in iron, steel, and aluminum foundries; from pulp and paper mill
effluents due to recycling of waste papers containing carbonless copy papers; and from electrical industry
waste water contaminated by, for example, accidental loss of capacitor and transformer fluids.  These
waste waters may also have been discharged directly into surface waters.  Treated waste waters may also
have entered surface waters indirectly via effluents discharged from municipal publicly owned treatment
works (POTWs) and industrial treatment plants.
Currently, the major source of PCB release to surface water is the environmental cycling process (Larsson
1985; Lin and Que Hee 1987; Mackay 1989; Murphy et al. 1985, 1987; Swackhamer and Armstrong
1986).  Small amounts of PCBs may enter surface water by runoff of water from accidental spillage of
PCB-containing hydraulic fluids, disposal of waste oils into street drains, or from farmland to which
sewage sludge containing small quantities of PCBs has been applied (Gan and Berthouex 1994;Gunkel et
al. 1995).  PCBs may also reach surface waters via CSOs or storm water runoff (Crawford et al. 1995;
















Table 6-1.  Releases to the Environment from Facilities that Manufacture or Process Polychlorinated Biphenyls










Total on and  
off-site release
AL 1 5 0 0 579180 579185 0 579185
AZ 1 0 0 0 134160 134160 1 134161
CA 2 5 0 0 1691574 1691579 0 1691579
IL 1 0 0 0 0 0 130 130
KS 1 25 0 0 0 25 4525 4550
MI 2 10 0 0 72000 72010 95 72105
NV 1 0 0 0 5200 5200 0 5200
NY 2 1 1 0 870000 870002 1067 871069
OR 1 0 0 0 151435 151435 0 151435
SC 1 0 0 0 0 0 1 1
TN 1 0 0 0 0 0 0 0
TX 4 178 250 5 46561 46994 47 47041
UT 2 222 0 0 192026 192248 12106 204354
WI 1 0 0 0 0 0 0 0
Total 21 446 251 5 3742136 3742838 17972 3760810
Source:  TRI98 2000
aData in TRI are maximum amounts released by each facility.
bPost office state abbreviations are used.
cThe sum of fugitive and stack releases are included in releases to air by a given facility.
dThe sum of all releases of the chemical to air, land, water, and underground injection wells.
eTotal amount of chemical transferred off-site, including to publicly owned treatment works (POTWs). 
PCBs 485
6.  POTENTIAL FOR HUMAN EXPOSURE
in New York City and New Jersey to the New York/New Jersey Harbor Estuary is estimated to be 88 kg
(Durell and Lizotte 1998), while the Montreal, Quebec, waste water treatment plant contributed
approximately 1 kg PCBs per year in 1993 to the St. Lawrence River (Pham and Proulx 1997).  PCBs,
particularly the lower chlorinated congeners, may enter groundwater through leaching of land-applied
sewage sludge to soils containing low organic matter or through leaching from soils at hazardous waste
sites (Griffin and Chou 1981).  PCBs have been identified in 93 surface water and 192 groundwater
samples collected at 500 of the 1,598 NPL hazardous waste sites where they were detected in some
environmental media (HazDat 2000).  According to the TRI, 251 and 5 pounds of PCBs were respectively
discharged into surface water and injected into groundwater directly by RCRA hazardous waste and
solvent recovery industries in 1998 (TRI98 2000).  The TRI data for 1998 (TRI98 2000) are shown in
Table 6-1.  The TRI data should be used with caution, however, since only certain types of facilities are
required to report.  This is not an exhaustive list.
6.2.3 Soil
From 1929 to 1977, the Monsanto Chemical Company released some PCB-containing wastes to landfills
as a result of Aroclor production.  Similarly, transformer and capacitor producers disposed of PCB-
containing wastes (e.g., capacitors, solid wastes, Fuller’s earth media) directly into landfills (Durfee
1976).  The amount of PCBs released to soil has decreased over the years due to the prohibition on
production in the United States and the severe restrictions on processing and reuse of existing PCB-
containing materials.  PCBs may have been released to soils from various past uses containing PCBs (e.g.,
plasticizers, surface coatings, inks, adhesives, flame retardants, pesticide extenders, paints, and micro-
encapsulation of dyes for carbonless duplicating paper) and, in addition, from the accidental losses of
PCB fluids from capacitors and transformers (EPA 1976a; IARC 1978; Safe 1984; Welsh 1995).
Currently, the environmental cycling process involving deposition of atmospheric PCBs is expected to be
the major source of surface soil contamination (Larsson and Okla 1989).  Since PCBs are no longer
produced in the United States, accidental leaks and spills from old transformers and capacitors containing
PCBs and releases from containers in landfills and hazardous waste sites may be sources of PCBs in soil. 
Accidental spills of PCBs during transportation of electrical transformers and other PCB-containing
equipment (Liberti et al. 1992); vehicular emissions (Benfenati et al. 1992; Ohsaki and Matsueda 1994)
may also be sources of PCBs in soils.  PCBs accumulation in POTW sewage sludge originates from
domestic sources (e.g., human excretion from the recycling of PCB residues in foodstuffs) and from
industrial facilities (Choi et al. 1974; McIntyre and Lester 1982; Morris and Lester 1994).  Land
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application of municipal sludges results in elevated PCB concentrations in these soils (Alcock et al. 1995;
Gan and Berthouex 1994; Gutenmann et al. 1994; McLachlan et al. 1994; O'Connor et al. 1990).
PCB concentrations in sludge reported in the 1970s and 1980s varied from <0.01 to 1960 mg/kg (ppm)
(dry weight) (Jacobs et al. 1987), but median PCB concentration in municipal sludges was in the lower
end of this range, 0.99 (Clevenger et al. 1983) and 4 mg/kg (Furr et al. 1976).  However, total PCBs were
detected in only 1 out of 16 sewage sludge samples (4.6 ppm dry weight; limit of detection=0.25 ppm dry
weight) taken from large cites in the United States (Gutenmann et al. 1994).  PCBs have been identified in
465 soil samples and 219 sediment samples collected at 500 of the 1,598 NPL hazardous waste sites
where they were detected in some environmental media (HazDat 2000).  The amount of PCBs released to
land by industry has increased from 752 pounds (341 kg) in 1988 (TRI98 2000) to 134,160 pounds
(60,854 kg) in 1998 (TRI98 2000).  An additional 3,607,976 pounds were released to land in 1998 by
RCRA hazardous waste and solvent recovery industries not represented in the 1988 to 1997 TRI data. 
During 1998, PCBs were not discharged by industry into POTWs (TRI98 2000).  The TRI data for
1998 (TRI98 2000) are shown in Table 6-1.  The TRI data should be used with caution since only certain
types of facilities are required to report.  This is not an exhaustive list.
6.3 ENVIRONMENTAL FATE
6.3.1 Transport and Partitioning
PCBs are globally circulated and are present in all environmental media.  Atmospheric transport is the
most important mechanism for global dispersion of PCBs.  Biphenyls with 0–1 chlorine atoms remain in
the atmosphere, those with 1–4 chlorines gradually migrate toward polar latitudes in a series of
volatilization/deposition cycles, those with 4–8 chlorines remain in mid-latitudes, and those with
8–9 chlorines remain close to the source of contamination.  PCBs enter the atmosphere from volatilization
from both soil and water surfaces.  Once in the atmosphere, PCBs are present in both the vapor phase and
sorbed to particles.  PCBs in the vapor phase appear to be more mobile and transported further than
particle-bound PCBs.  Wet and dry deposition remove PCBs from the atmosphere.  The dominant source
of PCBs to surface waters is atmospheric deposition; however, redissolution of sediment-bound PCBs
also accounts for water concentrations.  PCBs in water are transported by diffusion and currents.  PCBs
are removed from the water column by sorption to suspended solids and sediments as well as from
volatilization from water surfaces.  Higher chlorinated congeners are more likely to sorb, while lower
chlorinated congeners are more likely to volatilize.  PCBs also leave the water column by concentrating in
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biota.  PCBs accumulate more in higher trophic levels through the consumption of contaminated food, a
process referred to as biomagnification.  PCBs in soil are unlikely to migrate to groundwater because of
strong binding to soil.  Volatilization from soil appears to be an important loss mechanism; it is more
important for the lower chlorinated congeners than for the higher chlorinated congeners.  Vapor-phase
PCBs accumulate in the aerial parts of terrestrial vegetation and food crops by vapor-to-plant transfer.
Wania and Mackay (1996) report that most PCBs are volatile enough to cycle between the air, water, and
soil at environmental temperatures, and that atmospheric transport is the most important mechanism for
the global movement of PCBs.  These authors further categorized the transport and partitioning behavior
of PCB congeners according to the number of chlorines present on the biphenyl molecule.  Volatile
mono-Bs remain primarily in the atmosphere.  PCBs that have 1–4 chlorines and are ortho-rich (i.e.,
number of ortho chlorines >1) congeners tend to migrate toward polar latitudes by a series of
volatilization/deposition cycles between the air and the water and/or soil.  PCBs with 4–8 chlorines
remain in mid-latitudes, and those with 8–9 chlorines remain close to the source of contamination.  The
more heavily chlorinated and ortho-poor (i.e., number of ortho chlorines #1)/para-rich (i.e., number of
para chlorines >1) PCBs are less volatile and more readily condensed from the atmosphere.  Thus, these
PCBs are considered less mobile (Macdonald et al. 2000; Wania and Mackay 1993, 1996).
The atmosphere is a net recipient of PCBs from soil, water, and (indirect) sediment fluxes (Hansen 1999). 
These fluxes are the highest in summer as a result of warmer temperatures (Hoff et al. 1992).  The
importance of volatilization to atmospheric concentrations of PCBs is well established.  This conclusion
is also supported by the estimated Henry's law constants for Aroclors and PCB congeners, which range
from 2.9x10-4 to 4.6x10-3 atm-m3/mol and 1.5x10-5 to 2.8x10-4 atm-m3/mol, respectively (see
Tables 4-3 and 4-7) (Thomas 1982).  The Great Lakes in particular appear to be a source of PCBs to the
atmosphere (Arimoto 1989; Hornbuckle et al. 1993; Swackhamer and Armstrong 1986).  The estimated
PCB gas fluxes out of the Great Lakes to the atmosphere in 1994 were 1,700, 2,700, 420, and 440 kg/year
for Lakes Superior, Michigan, Erie, and Ontario, respectively (Hoff et al. 1996).  A pseudo first-order rate
constant for the volatilization of total PCBs from Lake Superior is estimated to be 0.4/year (t½=2 years)
(Jeremiason et al. 1994).  This latter estimated rate indicates that approximately one-half of the total
water-borne mass of PCBs in Lake Superior enters the atmosphere over a 7-month period.
PCBs are transported from soil and sediment to the atmosphere.  In the absence of water, the rate of
movement of PCBs from the soil surface to the atmosphere is controlled by diffusive transfer (Cousins
and Jones 1998).  For example, Agrell et al. (1999) demonstrated that diffusive exchange from soils is the
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dominant transport mechanism of PCBs cycling between the atmosphere and terrestrial surfaces along the
Baltic Sea region.  As atmospheric sources of PCBs diminish, the flux between the atmosphere and soil
will eventually achieve equilibrium (i.e., fluxes in and out of soil will be equal).  For instance, Harner et
al. (1995) estimated the net volatilization/accumulation of PCBs from soil for four congeners (PCBs 28,
52, 138, and 153) during the period 1942 through 1992.  Presently, the more mobile PCBs 28 and
52 should have achieved equilibrium between the soil and air.  However, PCBs 138 and 153 are much
slower to volatilize from soil and will continue to slowly out-gas until equilibrium is attained. 
Contaminated sediments exposed directly to the atmosphere during water level changes (e.g., tidal
fluctuations) or during removal to landfills may rapidly transfer the volatile congeners directly to the air
through covaporization with water (Chiarenzelli et al. 1996, 1997).  This is illustrated by Bremle and
Larsson (1998), who studied the concentration of PCBs in air during the landfilling of wet contaminated
sediment.  They found that the overlying air was enriched in the more volatile, lower molecular weight
congeners compared to the deposited sediment, which suggests that volatilization was the major transport
process out of the sediment for these congeners.  However, other studies have demonstrated that once
sediments become dehydrated, the binding of PCBs is tighter and the net volatilization is reduced
(Chiarenzelli et al. 1996, 1997).
PCBs in air are present in both the vapor phase and adsorbed to aerosol particles (Eisenreich et al. 1981;
Hermanson and Hites 1989; Wania and Mackay 1996).  PCBs in the vapor phase appear to be more
mobile and are transported further than particle-bound PCBs, while the heavier and coplanar PCBs tend
to be particle-bound and/or more readily degraded in the atmosphere (Hansen 1999).  PCBs with vapor
pressures >10-4 mm Hg (mono- and di-CBs) appear to exist in the atmosphere almost entirely in the vapor
phase, while PCBs with vapor pressures <10-8 mm Hg appear to exist almost entirely in the adsorbed
phase, and PCBs with vapor pressures #10-4 and $10-8 mm Hg (tri- to hepta-CBs) exist in both the
adsorbed and vapor phase (Eisenreich et al. 1981; Erickson 1992).  The vapor pressures of the Aroclors
and several PCB congeners are found in Tables 4-2 and 4-7.  PCBs in the vapor phase are enriched
(relative to commercial Aroclor mixtures) in di- and tri-ortho congeners within each homolog group due
to their higher vapor pressures and limited tendency to bind to aerosol particulates.  Also, being less
volatile, coplanar non-ortho and higher chlorinated PCBs are present at very low proportions in the vapor
phase, and tend to be associated with aerosols, thereby increasing their chances of removal from the
atmosphere by wet and dry deposition (Falconer and Bidleman 1994; Hippelein and McLachlan 1998;
Jones et al. 1992; Monosmith and Hermanson 1996; Muir et al. 1996a, 1996b; Panshin and Hites 1994;
Simcik et al. 1998; Wania and Mackay 1993).  For example, Falconer and Bidleman (1995) reported
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preferential sorption of non- and mono-ortho PCBs to urban aerosols to a greater extent than multi-ortho
congeners of the same homolog.  
PCBs are physically removed from the atmosphere by wet deposition (i.e., rain and snow scavenging of
vapors and aerosols); by dry deposition of aerosols; and by vapor adsorption at the air-water, air-soil, and
air-plant interfaces (Cousins et al. 1999; Currado and Harrad 1999; Dickhut and Gustafson 1995;
Eisenreich et al. 1981; Franz and Eisenreich 1998; Golomb et al. 1997; Gregor et al. 1996; Hart et al.
1993; Hoff et al. 1996; Leister and Baker 1994; Nelson et al. 1998; Wania et al. 1999).  Wet deposition
occurs episodically by in-cloud scavenging or rain-out of vapor phase PCBs, and by below-cloud
scavenging or wash-out of aerosol PCBs.  At low temperatures, wet deposition may fall as snow.  Franz
and Eisenreich (1998) found that snow can be a very efficient medium for aerosol scavenging to an even
greater extent than for rain; and they found that aerosol washout accounted for between 79 and 88% of
the total PCB content in snow.  However, Wania et al. (1999) recently reevaluated this study and pointed
out that the contribution of gaseous scavenging may have been underestimated by these authors.  Also,
Wania et al. (1998) pointed out that adsorption of PCBs to ice surfaces is a major scavenging mechanism
for gaseous PCBs in the atmosphere.  In contrast to wet deposition, dry removal of PCBs from the
atmosphere results from the gravitational settling of particulate PCBs (i.e., dry particulate deposition) and
by the impaction of vapor phase PCBs on terrestrial or aquatic surfaces (i.e., dry gaseous deposition). 
Dry gaseous deposition is a complex process which depends on the physical-chemical properties of the
PCBs, characteristics of the adsorbing surface, and environmental conditions (e.g., windspeed).  In the
ambient atmosphere, dry particulate deposition is predominantly in the form of fine aerosols (<1 µm),
which deposit on surfaces by rapid, vibratory (Brownian) diffusion (Holsen and Noll 1992).  However, in
urban areas, PCBs are associated with course aerosols (>1 µm), and these particulates represent the
majority of the dry deposition flux even though PCBs are largely in the vapor phase (Holsen et al. 1991). 
PCB inputs into aquatic and marine reservoirs are predominantly from wet and dry deposition and from
the recycling of sediment-sorbed PCBs into the water column.  Eisenreich et al. (1983) demonstrated for
the Great Lakes water column that the concentration of PCBs is elevated at both the air/water and water/
sediment interfaces as a result of inputs from the atmosphere and sediments, respectively.  In addition,
Eisenreich et al. (1992) estimated that the upper Great Lakes receive the majority of the total inputs from
deposition from the atmosphere (Superior 90%, Michigan 58%, Huron 78%), while the lower Great Lakes
receive a lower but significant percentage from these sources (Erie 13%, Ontario 7%).  The lower lakes
receive a large loading of PCBs from the connecting channels (Detroit River and Niagara River) by
neighboring industrial discharges and leakage from waste dump sites.  In another study, Franz et al.
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(1998) concluded that dry deposition dominates atmospheric PCB loadings to Lake Michigan, suggesting
that these loadings are more than 3 times greater than loadings from wet deposition.  Similarities between
the pattern of PCB congeners in the dry deposition and surficial sediments, and also the magnitude of
their fluxes to the water column support their assertion.  However, Pearson et al. (1996) concluded that
input/output budgets for Lake Michigan also showed large imbalances, indicating failure to understand all
of the processes of PCB transport to the water column to this body of water.  For Lake Superior,
Jeremiason et al. (1994) estimated PCBs inputs for 1984 from riverine, wet deposition, dry deposition,
and other sources as 110 (36%), 125 (41%), 32 (10%), and 41 (13%) kg PCBs/year, respectively.  Thus,
wet deposition contributed the largest load of PCBs to this lake.  However, for all of the Great Lakes,
Hoff et al. (1996) noted that wet and dry deposition fluxes into the lakes appear to be getting smaller, and
the net PCB flux is out of the lakes, i.e., volatilization.
Recycling of PCBs, due to volatilization of PCBs from the water column and subsequent release of PCBs
from the sediments, occurs when inputs from the atmosphere decrease (Achman et al. 1996; Sanders et al.
1996).  The process of recycling tends to increase with higher PCB solubility (Sanders et al. 1996).  There
are several mechanisms by which PCBs can exchange between the sediment bed and the overlying water. 
For example, PCBs dissolved or associated with colloidal particles can exchange across the sediment-
water interface by diffusive and/or advective processes (Berner 1980; Formica et al. 1988).  The rate of
redissolution of PCBs from sediment to water will always be greater in summer than in winter because of
more rapid volatilization of PCBs from water with higher summer temperatures (Larsson and Sodergren
1987).  In summer, recycling of PCBs directly to the water column by dissolution appears to be the most
important process (Sanders et al. 1996), while in winter, sediment resuspension is the predominant
mechanism for recycling of PCBs (Sanders et al. 1996).  Environmental redistribution of PCBs from
aquatic sediment is most significant for the top sediment layers, while PCBs in the lower layers may be
effectively sequestered from redistribution (Baker et al. 1985; EPA 1979h, 1988a; Kleinert 1976;
Swackhamer and Armstrong 1986).  In the lower Hudson River estuary, a high surface sediment
concentration of PCBs resulted in the exchange of PCBs from sediment to water (Achman et al. 1996). 
The average fluxes from sediments were between 2 and  100 times more than the flux coming down the
river, and clearly dominated other fluxes from direct atmospheric deposition and waste water treatment
plant discharges. 
PCBs in water are transported by diffusion and currents.  PCBs in surface water essentially exist in three
phases: dissolved, particulate, and colloid associated (Baker and Eisenreich 1990).  The heavier and less
soluble congeners in the water column are more likely to be associated with particulates and colloids, and
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do not freely exchange into the vapor phase.  However, the more water soluble, lower chlorinated (and
ortho-rich) congeners are predominantly in the dissolved state in the water column and can readily
partition into the vapor phase.  In New Bedford Harbor, Massachusetts, Burgess et al. (1996) reported that
the ratio of colloid associated PCBs to freely dissolved PCBs increased from 1.2 to 8.0 (di-CBs to
octa-CBs, respectively) as the degree of chlorination increased.  However, at this site, the majority of the
PCBs were associated with the particulate phase regardless of solubility or chlorination.
Experimental and monitoring data have shown that PCB concentrations in sediment and suspended matter
are higher than in the associated water column (Eisenreich et al. 1983).  In a study of the Saginaw River
in Michigan, Verbrugge et al. (1995) reported that the ratio of the total PCBs bound to suspended
particulates relative to dissolved PCBs, was 2 to 1.  However, in a study examining the water column in
Lake Superior, 75% of PCBs were in the dissolved phase, while 25% exist in the suspended particulate
phase (Eisenreich et al. 1983).  These studies suggest that the partitioning behavior of PCBs in the water
column is location specific.
PCBs leave the water column by partitioning onto sediments and suspended particulates, and by
volatilization at the air/water interface.  PCBs can be immobilized for relatively long periods of time in
aquatic sediments.  The adsorption of dissolved PCBs onto solids (suspended particulates and sediments)
is greatest for solids composed primarily of organic matter and clay (EPA 1980b).  The more highly
chlorinated components (and ortho-poor) PCBs, which have lower water solubilities and higher octanol-
water partition coefficients (Kow), have a greater tendency to bind to solids as a result of strong
hydrophobic interactions (see Table 4-2).  In contrast, the low molecular weight PCBs, which have higher
water solubilities and lower Kows, sorb to a lesser extent on solids and remain largely in the water column
(see Table 4-2).  Volatilization of highly chlorinated PCBs in the water column is reduced significantly by
the sequestration on solids compared to the lightly chlorinated PCBs, in which volatilization may be only
slightly effected (EPA 1985b; Lee et al. 1979).  The estimated residence times (in years) of PCBs in the
water columns of the Great Lakes are: Superior (3.3), Michigan (1.3), Huron (1.0), Erie (0.2), and Ontario
(1.1); and the percent loss of PCBs from these lakes due to sedimentation, volatilization, and outflow to
other water bodies are summarized in Table 6-2 (Arimoto 1989; Eisenreich et al. 1992).  For PCBs in the
Great Lakes, sedimentation and volatilization were the primarily loss mechanisms, while the contribution
of outflow was comparatively low.  For Lake Michigan between 1980 and 1991, the calculated half-lives
for the PCB homologs (assuming a first-order processes; in years) due to both sedimentation and
volatilization were: di- (11), tri- (15), tetra- (10), penta- (12), hexa- (5.3), hepta- (7), and octa- (5)
(Pearson et al. 1996).
PCBs 492
6.  POTENTIAL FOR HUMAN EXPOSURE
Table 6-2.  Percentage of Loss of Polychlorinated Biphenyls 




Lake Superior 86.6 11.4 2.0
Lake Michigan 68.1 30.6 1.3
Lake Huron 75.3 19.4 5.3
Lake Erie 46.0 45.2 8.8
Lake Ontario 53.4 29.3 17.3
Source:  Eisenreich et al. 1992
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In addition to volatilization and sorption onto sediments, PCBs can leave the water column by
concentrating in biota directly from water (EPA 1983c; Porte and Albaiges 1993).  Bioconcentration is
defined as uptake of a chemical from water alone; and bioaccumulation is the result of combined uptake
via food, sediment, and water.  The bioconcentration factors (BCFs; ratio of the concentration of PCBs in
the organism over the concentration of PCBs in water) of PCBs in aquatic organisms are directly
proportional to partition coefficients and lipid contents of the organism, and are congener specific (Geyer
et al. 1999).  BCFs in various fresh water and marine species are generally in the range of 5x102–4x104
for lower chlorinated PCB congeners and about 1x103–3x105 for tetra- to hexa-PCBs (70, 101, 110, and
136) (Geyer et al. 1999; see Table 6-3).  Median BCFs for accumulation from water by phytoplankton
range from 1x104 to 1x106, and are generally the greatest for the tetra- to hepta-PCBs and for the coplanar
tri-, tetra-, and penta-PCBs (Willman et al. 1999).  Coplanar PCBs and the more highly chlorinated
congeners can have aquatic organism BCFs as high as 2x106 (Hansen 1999).  However, the BCFs for the
higher chlorinated homologs drop off after a certain point because these larger molecules do not readily
pass through biological membranes.  BCFs for freshwater and marine species are illustrated in
Tables 6-4 and 6-5, respectively, for Aroclors mixtures (ASTER 1996).
Bioaccumulation factors (BAFs; the ratio of the concentration of PCBs in the organism over the
combined concentration of PCBs in sediment, food, and water) of PCBs increase with higher chlorination
and lower water solubility (Coristine et al. 1996; Zhang et al. 1983).  In contrast to BCFs, a direct
relationship between bioaccumulation, partition coefficients, and organism lipid content does not always
exist, and other factors (e.g., reproductive cycles) may affect the uptake and accumulation of PCBs
(Hansen 1999; Stow et al. 1997).  Less chlorinated PCBs (1–4 chlorines) are readily taken up by
organisms, but are readily eliminated and metabolized.  Thus, these homologs are not bioaccumulated to a
great extent (see Section 6.3.2; McFarland and Clarke 1989).  The most highly chlorinated congeners
(7–10 chlorines) occur in low concentrations in the environment, and are tightly bound with soil,
sediment, and organic matter.  Thus, these PCBs are also not significantly bioaccumulated (Bergen et al.
1993; Lacorte and Eggens 1993; McFarland and Clarke 1989).  These PCBs, which have log Kow values
>5, appear to enter biota through food-web transfer from sediment, which is less efficient (Koslowski et
al. 1994).  On the other hand, the penta-, hexa-, and hepta-PCBs are both bioavailable and resistant to
degradation in organisms; and these PCB homologs bioaccumulate in organisms to the greatest extent
(see Section 6.3.2; Bremle et al. 1995; Koslowski et al. 1994; McFarland and Clarke 1989; Porte and
Albaiges 1993; Willman et al. 1997).  For example, the PCBs that dominate congener profiles in the
tissues of mussels, crabs, and seals are hexa-PCB isomers 138 and 153 (Hansen 1999; Porte and Albaiges
















Table 6-3.  Bioconcentration Factors (BCFs) and Bioaccumulation Factors (BAFs) for Select Congeners and Total






PCB 18 Rainbow trout (Oncorhynchus mykiss) 81,000 590,000 Lake Ontario Oliver and Niimi 1985
PCB 40 Rainbow trout (O. mykiss) 49000 240,000 Lake Ontario Oliver and Niimi 1985
PCB 52 Rainbow trout (O. mykiss) 200,000 1,900,000 Lake Ontario Oliver and Niimi 1985
PCB 101 Rainbow trout (O. mykiss) 200,000 8,400,000 Lake Ontario Oliver and Niimi 1985
PCB 153 Rainbow trout (O. mykiss) 740,000 10,000,000 Lake Ontario Oliver and Niimi 1985
Total Perch  (Perca fluviatilis) 2,050–7,580 Lake Jarnsjon, Sweden Bremle et al. 1995
Total Tilapia 
(Oreochromis mossambicus)
10,000 Shing Mun River, 
Hong Kong
Chui et al. 1991




Sloan et al. 1985
Total Amphipods (Pontoporeia affinis) 718,000 Lake Ontario Oliver and Niimi 1988
Total Oligochaetes (Tubifex tubifex and
Limnodrilus hoffmeisteri)
164,000 Lake Ontario Oliver and Niimi 1988
Total Slimy sculpin (Cottus cognatus) 1,450,000 Lake Ontario Oliver and Niimi 1988
Total Alewife 
(Alosa pseudoharengus)
1,180,000 Lake Ontario Oliver and Niimi 1988
Total Rainbow smelt (small) (Osmerus mordax) 564,000 Lake Ontario Oliver and Niimi 1988
Total Rainbow smelt (large) (O. mordax) 1,272,000 Lake Ontario Oliver and Niimi 1988
Total Salmonids 3,910,000 Lake Ontario Oliver and Niimi 1988
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Table 6-4.  Bioconcentration Factors (BCFs) for Various Aroclors 
in Fresh Water Species
Species BCF Duration (days)
Aroclor 1232
White sucker  (Catostomus commersoni) 5,500 30
Aroclor 1242
Scud (Gammarus pseudolimnaeus) 36,000 60
Fathead minnow (male) (Pimephales promelas) 274,000 255
Atlantic salmon (Salmo salar) 600 4
Aroclor 1248
Scud (G. pseudolimnaeus) 108,000 60
Fathead minnow (female) (P. promelas) 120,000 240
Channel catfish (Ictalurus punctatus) 56,400 77
Bluegill (Lepomis macrochirus) 52,000 77
Aroclor 1254
Cladoceran (Daphnia magna) 3,800 4
Scud (G. pseudolimnaeus) 6,200 21
Crayfish (Orconectes nais) 750 21
Dobsonfly (Corydalus cornutus) 1,500 7
Stonefly (Pteronarcys california) 740 21
Mosquito (Culex tarsalis) 3,500 7
Phantom midge (Chaoborus punctipennis) 2,700 14
Fathead minnow (female) (P. promelas) 238,000 240
Rainbow trout (Oncorhynchus mykiss) 46,000 30
Brook trout (Salvelinus fontinalis) 47,000 118
Brook trout (S. fontinalis) 42,000 500
Brook trout (S. fontinalis) 3,000a 500
Steelhead trout (Salmo gairdneri) 38,000 24
Channel catfish (I. punctatus) 61,200 77
Aroclor 1260
Fathead minnow (female) (P. promelas) 270,000 240
Source:  ASTER 1998
aFillet sample rather than whole body sample
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Table 6-5.  Bioconcentration Factors (BCFs) for Various Aroclors 
in Salt Water Species
Species BCF Duration (days)
Aroclor 1016
Eastern oyster (Crassostrea virginica) 13,000 84
Horseshoe crab (Limulus polyphemas) 1,298 96
Sheepshead minnow (adult) (Cyprinodon variegatus) 25,300 28
Sheepshead minnow (juvenile) (C. variegatus) 43,100 28
Sheepshead minnow (fry) (C. variegatus) 14,400 28
Pinfish (Lagodon rhomboides) 17,000 21–28
Aroclor 1242
Diatom (Cylindrotheca closterium) 1,000 14
Aroclor 1254
Ciliate protozoans (Tetrahymena pyriformis) 60 7
Eastern oyster (C. virginica) 8,100 2
Eastern oyster (C. virginica) 101,000 245
Polychaete (Arenicola marina) 236 5
Polychaete (Nereis diversicolor) 373 5
Grass shrimp (Palaemonetes pugio) 27,000 16
Pink shrimp (Penaeus duorarum) 140 2
Spot (Leiostomus xanthurus) 37,000 28
Sheepshead minnow (adult) (C. variegatus) 30,000 28
Pinfish (L. rhomboides) 980 2
Source:  ASTER 1996
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congener concentration profiles seen in the higher trophic levels.  PCB bioaccumulation is also effected
by the stereochemistry of the congener; optimal bioaccumulation occurs for planar molecules substituted
with 5 or 7 chlorines (Koslowski et al. 1994).  For instance, median BAFs for zooplankton and zebra
mussels ranged from 1x104 to 1x106, and were the greatest for the planar tetra- to hepta-PCBs, which had
54% larger BAFs compared to values for the non-coplanar homologs (Willman et al. 1999).  Typical
field- measured BAFs range from 2.1x103 to 3.9x106 for total PCBs (Table 6-3).  BAFs for PCB isomer
groups in a Lake Ontario food web ranged from 4.2x104 to 1.3x107 (Table 6-6).  The highest BAFs occur
at the lower end of the food chain.  For example, Oliver and Niimi (1988) determined that the water-
plankton-mysid food chain had the highest bioaccumulation of PCBs in the Lake Ontario trophic system. 
Bioaccumulation of PCBs in aquatic animals depends on the water zone in which the animals
predominantly reside and feed.  Certain benthic organisms, such as crabs, clams, sandworms, and grass
shrimp, accumulate PCBs from water at the water/sediment interface (PCB concentration is higher at this
interface than in the surrounding water column, see above) and via intake of phytoplankton and
zooplankton, which contain higher levels of PCBs than the water (Porte and Albaiges 1993; Pruell et al.
1993; Secor et al. 1993).  When airborne PCBs are deposited onto the surface of water, lower chlorinated
and ortho-rich congeners, especially, become enriched in the surface microlayer which results in
concentrations that are 500 times higher than the average concentration in water.  As a result,
bioaccumulation by fish is several orders of magnitude higher in this zone (Sodergren et al. 1990). 
Greater bioaccumulation will occur in the fatty tissues (lipids) than in the muscle or whole body of
aquatic organisms (EPA 1980b).  Thus, organisms with higher lipid concentrations will accumulate a
greater burden of PCBs via tropic transfer.  Fish species, such as lake trout (Salvelinius namaycush) and
coho salmon (Oncorhynchus kisutch), with high lipid contents, have a net trophic transfer efficiency from
food ranges of 75–89 and 38% (average for tetra-CBs; however, higher chlorinated congeners ranged
from 43 to 56%), respectively (Madenjian et al. 1999).  In addition, insects that have lipid-rich cuticular
(skin) layers can capture significant amounts of vapor-phase PCBs in their tissues and enter these PCBs
into the food chain (Saghir and Hansen 1999).
Biomagnification of PCBs within the aquatic food chain results from higher trophic transfer and has been
observed in aquatic organisms (Koslowski et al. 1994; Looser and Ballschmiter 1998; Oliver and Niimi
1988; Wilson et al. 1995).  Biomagnification is apparent in shellfish that accumulate PCBs from the
consumption of phytoplankton and zooplankton, and in marine mammals (seals, dolphins, and whales)
that accumulate PCBs from plankton and fish (Andersson et al. 1988; Kuehl and Haebler 1995; Lake et
al. 1995a; Salata et al. 1995; Schantz et al. 1993c; Secor et al. 1993).  Food chain biomagnification also 
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Table 6-6.  Field Measured Bioaccumulation Factors for Isomeric Groups 
of Polychlorinated Biphenyls
PCB Group
Organism Tri- Tetra- Penta- Hexa- Hepta- Octa-
Amphipods 387,000 667,000 615,000 938,000 2,400,000 1,400,000
Oligochaetes 127,000 180,000 154,000 150,000 259,000 310,000
Slimy sculpin 87,000 633,000 1,490,000 3,125,000 5,185,000 7,500,000
Alewife 173,000 833,000 1,380,000 2,125,000 2,960,000 3,100,000
Rainbow smelt
Small 42,000 367,000 590,000 1,063,000 1,590,000 1,600,000
Large 93,000 933,000 1,380,000 2,375,000 3,148,000 3,300,000
Salmonids 293,000 2,170,000 4,100,000 8,125,000 11,300,000 13,000,000
Source: Oliver and Niimi 1988
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occurs in several species of fish-consuming birds (Ankley et al. 1993; Hebert et al. 1994; Mackay 1989;
Metcalfe and Metcalfe 1997; Shaw and Connell 1982; Winter and Streit 1992).  Biomagnification of
PCBs in the aquatic food chain is congener specific and is more predominant for congeners with Kow
values between 5 and 7 (Koslowski et al. 1994; Metcalfe and Metcalfe 1997).  For example, in the food
web of the western basin of Lake Erie, concentrations of PCB 138 increased from plankton (14 µg/kg) to
piscivores (1.4x103 µg/kg in silver bass muscle tissue) to herring gulls (3.0x104 µg/kg) (Koslowski et al.
1994).  However, no biomagnification was observed for PCBs 77, 126, and 169 (Koslowski et al. 1994). 
As previously observed for bioaccumulation, differences in retention also account for differences in
congener biomagnification in higher trophic levels.
PCBs are strongly sorbed to soils as a result of low water solubility and high Kow (see Table 4-2), and will
not leach extensively (EPA 1979h, 1988a; Sklarew and Girvin 1987).  The tendency to leach will be
greatest among the least chlorinated congeners and is expected to be greatest in soil with low organic
carbon (Sklarew and Girvin 1987; Strek and Weber 1982a).  Leaching of PCBs in most soils should not
be extensive, particularly for the more highly chlorinated congeners.  However, PCBs will leach
significantly in the presence of organic solvents that may be present at municipal landfills or hazardous
waste sites (Griffin and Chou 1981).  Partition coefficients (Kd) for PCBs 8, 52, and 153 for sorption onto
soil with variable organic carbon content (0.2–2.3 by weight percent) are 74–825, 533–5,508, and
14,258–68,485 L/kg, respectively (Girvin and Scott 1997).  Soil and sediment sorption coefficients (Koc)
for biphenyl and PCB congeners are listed in Table 6-7.
Soils received net PCB inputs from water and air during the peak emissions of the 1960s and early 1970s. 
However, at present, soils appear to be reservoirs for releasing PCBs into the atmosphere (Hansen 1999). 
The mechanisms involved in the soil-to-air transfer of PCBs will involve a combination of direct soil
organic matter-to-air transfer and soil pore water-to-air transfer (Cousins et al. 1997).  Wicking (i.e., the
movement of a compound in solution to replace evaporative surface water loss) has been demonstrated as
a process that can increase the volatilization of PCBs from soil; thus, volatilization rates will be greatest
in moist soils from the co-vaporization of PCBs and water (Bushart et al. 1998; Chiarenzelli et al. 1996,
1997, 1998).  For example, Chiarenzelli et al. (1996, 1997) demonstrated that for small amounts of
St. Lawrence River solids originally contaminated with Aroclor 1248, several ortho-chlorinated
congeners were preferentially lost by volatilization, which could be positively correlated with water loss
by vaporization.  Soils with low organic carbon will have the greatest rate of volatilization of PCBs (Shen
and Tofflemire 1980).  For example, researchers at General Electric demonstrated that the rate of
volatilization of Aroclor 1242 from soil is much less from the organic topsoil than from the course sand 
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Table 6-7.  Observed Soil and Sediment Sorption Coefficients (Koc) 
for Polychlorinated Biphenyls Congeners
Compound Log Koc Reference(s)
Biphenyl 3.27 Meylan et al. 1992
2-CB 3.47 Chiou et al. 1983
2,2'-CB 3.92 Chiou et al. 1983
2,4'-CB 4.13
4.57, 4.56
Chiou et al. 1983
Girvin and Scott 1997
2,2',4-CB 4.84 Chiou et al. 1987
2,2',5-CB 4.57 Chin and Weber 1989





Haque and Schmedding 1976
Hassett et al. 1984
Chin and Weber 1989
Girvin and Scott 1997
2,2',6,6'-CB 5.11 Steen et al. 1978
2,3',4',5-CB 5.02 Steen et al. 1978
2,2',4,5,5'-CB 5.79, 5.93 Gschwend and Wu 1985





Horzempa and Di Toro 1983
Girvin and Scott 1997
2,2',4,4',6,6'-CB 6.08 Karichoff 1981
Sources: Saçan and Balcioğlu (1996); Sklarew and Girvin (1987); McGroddy et al. (1996)
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fraction (Shen and Tofflemire 1980).  In another study, Grundy et al. (1996) examined nine soil plots
treated with Aroclors 1254 and 1260 representing dry barren, dry moss, and wet grass cover in the
Canadian Arctic (Northwest Territory).  Rate constants (first-order processes) for loss of total PCBs of
approximately 0.5/year (t½ =1.1 year), with a range of 0.3–1.0/year for individual congeners, was
estimated.  For the dry barren area, loss was correlated with vapor pressure.  For the two vegetated areas,
the volatilization rate appeared to be reduced by organic matter from both living and dead vegetation. 
PCBs accumulate in terrestrial vegetation by the following possible mechanisms: (1) uptake from soil
through the roots; (2) dry deposition on aerial parts (particle-bound or gaseous); and (3) wet deposition on
aerial parts (particle-bound or solute).  The primary mode of uptake for total PCBs in terrestrial
vegetation is by vapor-to-plant transfer (Bohm et al. 1999; Lober et al. 1994; O’Connor et al. 1990;
Schönherr and Riederer 1989).  However, Bohm et al. (1999) reported that vapor-to-plant partioning is
most important for tri-CBs, while aerial dry deposition is most important for hepta- and octa-CBs.  For
example, Ye et al. (1992b) found that the more highly chlorinated congeners ($7 -chlorines) are adsorbed
by aerial plant tissues (e.g., tomato plant leaves) primarily by vapor-to-plant transfer, while the lower
chlorinated congeners (3–6 -chlorines) are both adsorbed on and absorbed in aerial plant tissues.  The
lower chlorinated (and ortho-enriched) congeners, which have the highest concentrations in the
atmosphere, are the most efficiently scavenged by terrestrial vegetation by vapor-to-plant transfer (Jones
and Duarte-Davidson 1997; Thomas et al. 1998); and leafy vegetation (e.g., lettuce, grass) appears to
accumulate the highest levels of total PCBs by this mechanism (Cullen et al. 1996).  The air-to-grass
transfer is the first link in the grass-to-cattle-to-human food chain, and this food chain provides an
appreciable fraction of human exposure to PCBs (Currado and Harrad 1999; see Section 6.4).  Strong
sorption of PCBs to soil organic matter and clay inhibits the uptake of PCBs in plants through the roots
(Bacci and Gaggi 1985; Chu et al. 1999; Gan and Berthouex 1994; Paterson et al. 1990; Strek et al.
1982b; Webber et al. 1994; Ye et al. 1992a).  As a result, below-ground vegetation, such as potatoes, will
accumulate the lowest levels of total PCBs, lower proportions of the more lightly chlorinated congeners,
and will predominately accumulate the moderately chlorinated congeners (e.g., penta-CBs 99, 101, and
110) directly from soil (Cullen et al. 1996).  However, higher uptake from soil can occur in certain root
crops (e.g., carrots) by the partitioning of PCBs into the lipid-rich epidermal layer (skin) or by soil
particles adhering to the root (Cullen et al. 1996; O’Connor et al. 1990; Pal et al. 1980).  Plants grown on
PCB-contaminated sludge or sludge-amended soils will be free of vapor-phase PCB contamination as a
result of strong sorption of PCBs to sludge organic matter (Gan and Berthouex 1994; O’Connor et al.
1990).  For example, Gan and Berthouex demonstrated that for corn grown on PCB contaminated sludge-
amended farmland, bioconcentration of PCBs did not occur in either the grain or stover.  Plant BCFs of
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PCBs from soil are summarized in Table 6-8, and are estimated to be <0.02 for most terrestrial plant
species (Cullen et al. 1996; O’Connor et al. 1990; Pal et al. 1980).
6.3.2 Transformation and Degradation
The ability of PCBs to be degraded or transformed in the environment depends on the degree of
chlorination of the biphenyl molecule as well as on the isomeric substitution pattern.  The vapor-phase
reaction of PCBs with hydroxyl radicals is the dominant transformation process in the atmosphere, while
photolysis appears to be the only viable abiotic degradation process in water.  Biodegradation in the
environment, although slow, occurs under both aerobic and anaerobic conditions.  In sediments, aside
from the aerobic surface layer, anaerobic microbial degradation will be primarily responsible for
transformation, particularly of the more highly chlorinated congeners.  Aerobic biodegradation in soil,
surface water, and sediments is limited to the less chlorinated congeners.
6.3.2.1  Air
In the atmosphere, the vapor-phase reaction of PCBs with hydroxyl radicals (photochemically formed by
sunlight) is the dominant transformation process (Brubaker and Hites 1998).  The calculated tropospheric
lifetime values for this reaction increases as the number of chlorine substitutions increases.  The
tropospheric lifetime values (determined using the calculated OH radical reaction rate constant and
assuming an annual diurnally averaged OH radical concentration of 5x105 molecule/cm3) are: 5–11 days
for monochlorobiphenyls, 8–17 days for dichlorobiphenyls, 14–30 days for trichlorobiphenyls,
25–60 days for tetrachlorobiphenyls, and 60–120 days for pentachlorobiphenyls (Atkinson 1987).  In
another study, the estimated tropospheric lifetimes of PCBs (calculated using the estimated OH radical
reaction rate constant and assuming a 24-hour average OH radical concentration of 9.7x105 molecule/cm3)
range from 2 days for biphenyl to 75 days for hexachlorobiphenyl, and a total global PCB loss rate of
8,300 tons/year was estimated (Anderson and Hites 1996; Atkinson 1996).  Rate constants for PCBs more
chlorinated than hexa are not easily measured due to their low vapor pressures.  It is difficult to introduce
a significant amount of these PCBs into the gas phase and to collect their gas phase reaction products
which could have even lower volatilities.  For the PCBs that do react with OH radicals, a possible reaction
scheme is the formation of a 2-hydroxybiphenyl intermediate, which quickly degrades by a series of dark
reactions to chlorinated benzoic acid (see Figure 6-2; Brubaker and Hites 1998).  The little information
available suggests that photolysis of gas-phase PCBs in the troposphere will be negligible for those PCBs
with #4 chlorine atoms, and this may be the case for the more chlorinated PCBs as well (Atkinson 1996). 
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Table 6-8.  Plant Uptake (Bioaccumulation) of PCBsa
Crop (growth media) Application rate BAFb Referencea
Carrot
(soil)
Aroclor 1254 at 100 ppm mixed
in top 6 inches of soil
<1 (Aroclor 1254)
#0.16 (roots)
Iwata et al. 1974
Carrot
(acid soil and brown
sand)
Aroclor 1254 at 0.05, 0.5, and
5 ppm (acid soil);
0.5 ppm (brown sand)




Wallnöfer et al. 1975
Carrot
(soil)
PCB 4 at 1 ppm in dry soil,




Moza et al. 1976
Carrot
(soil)




Cullen et al. 1996
Corn
(field)
Aroclor 1254 and 1260
contaminated sludge
(92–144 µg PCBs/L sludge)
<1 Lawrence et al. 1977
Lettuce
(soil)




Cullen et al. 1996
Potato
(soil)




Cullen et al. 1996
Radish
(acid soil and brown
sand)
Aroclor 1254 at 0.05 ppm (acid
soil or brown sand), 0.5 ppm
(acid soil); Aroclor 1224 at
0.2 ppm (brown sand);
Aroclor 1254 at 5 ppm (acid





Wallnöfer et al. 1975
Soybean sprouts
(sandy soil)
Aroclor 1242 at 100 ppm 0.002 Suzuki et al. 1977
Sugarbeet
(brown soil)




Wallnöfer et al. 1975
Sugarbeet
(field soil)
PCB 4 at 0.24 ppm in 0–10 cm
soil layer and 0.17 ppm in
10–20 cm soil layer
0.07 (roots)
0.03 (leaves)
Moza et al. 1976
Tomato
(soil and vermiculite)
PCB 4; PCB 7; PCB 18; PCB
52; PCB 101 (concentration not
specified)
0 for all PCBs 
(mature plants)
Pal et al. 1980
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Table 6-8.  Plant Uptake (Bioaccumulation) of PCBsa (continued)
Crop (growth media) Application Rate BAFb Referencea




Cullen et al. 1996
aSources: Cullen et al. 1996; Pal et al. 1980
















Source: Brubaker and Hites 1998








































Figure 6-2.  Pathways for OH Radical-initiated Reaction of 3-Chlorobiphenyl
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At the present time, insufficient data are available to assess the importance of photolysis and/or chemical
reactions of particle phase congeners, although studies of Tysklind and Rappe (1991) and Koester and
Hites (1992) on the photodegradation of polychlorinated dioxins and furans suggest that photolysis for
particulate phase PCBs is not important (Atkinson 1996).
6.3.2.2  Water
In water, abiotic transformation processes such as hydrolysis and oxidation do not significantly degrade
PCBs (EPA 1979h).  Photolysis appears to be the only significant abiotic degradation process in water
(EPA 1979h).  Photolysis of PCBs occurs by photolytic cleavage of a carbon-chlorine bond followed by a
stepwise replacement of chlorine with hydrogen which degrades PCBs (Barr et al. 1997; EPA 1979h).  In
all cases, the ring with the greatest degree of chlorination is the primary ring where dechlorination occurs. 
These dechlorination reactions have been reported to proceed by the loss of chlorine in the order of
ortho>para>meta (Barr et al. 1997).  Lepine et al. (1991) reported that for dechlorination of
Aroclor 1254 (in cyclohexane) under natural sunlight, preferential removal of ortho chlorines led not only
to decreases in many of the highly chlorinated PCB congeners but also to an increase in the
concentrations of the toxic non-ortho coplaner congeners, PCBs 77 and 126.  The estimated photolysis
half-lives of mono- through tetrachlorobiphenyls with summer sunlight at a shallow water depth (<0.5 m)
range from 17 to 210 days (EPA 1979h).  Photolysis rates with sunlight are slower during winter (EPA
1979h).  Nonetheless, as the number of chlorine substitutions increases, the light absorption band shifts
toward longer wavelengths, and the photolysis rate for hepta- through deca-chlorinated biphenyls
increases (EPA 1979h).  The estimated photolysis half-lives (first-order) of 4-monoCB, 2,4-diCB,
2,4,6-triCB, 2,2',5,5'-tetraCB, and decachloro-CB (in 75% acetonitrile) were 210, 17, 53, 180, and
<0.06 days, respectively (EPA 1983c).  Bunce et al. (1978) predicted that for PCBs in shallow waters, on
average up to 5% of the lightly chlorinated PCBs might lose a chlorine atom each year, but that at least
one chlorine should be lost from every highly chlorinated PCB molecule annually.  However, because the
conditions of their experiments do not represent actual conditions in the environment, the PCB photolysis
rate may be significantly lower. 
The rate of PCB biodegradation in water is dependent on both individual congener structure and
environmental conditions, as is explained in more detail in Section 6.3.2.3.  Biodegradation in surface
waters is primarily an aerobic process; in some, particularly oligotrophic waters, a substantial percentage
of the total PCB concentration can be found in the dissolved phase (see Section 6.3.1; Eisenreich et al.
1983).  The less chlorinated mono- and dichlorobiphenyl congeners are more likely to dissolve in water
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than the more chlorinated congeners.  These congeners are also more likely to biodegrade under aerobic
conditions (Bailey et al. 1983; Wong and Kaiser 1975).  In a river die-away study using filtered river
water, the individual monochlorobiphenyl congeners were degraded by 50% within 2–5 days (Bailey et
al. 1983).  However, 2,2',4,4'-tetrachlorobiphenyl was not degraded over the 98-day study.  The
biodegradation of Aroclor 1221 proceeded rapidly in unfiltered lake water after a 4-day lag phase; within
1 month, the original mixture was completely degraded into metabolites of lower molecular weight
(Wong and Kaiser 1975).  However, Aroclor 1260 was not degraded over a 12-week period in three
different unfiltered natural water samples (Oloffs et al. 1972).  An Aroclor 1254 mixture was not
mineralized over 96 days in a fresh water study; a further study using individual congeners,
2-chlorobiphenyl and 2,4'-dichlorobiphenyl, showed that the former was degraded to chlorobenzoic acid,
a common intermediate in the aerobic biodegradation of PCBs, while the latter was not biodegraded
(Shiarls and Sayler 1982).  In general, these results are similar to those reported in aerobic soil and
sediment studies where mono-, di-, and trichlorobiphenyl structures are fairly readily biodegraded,
biphenyl rings containing five or more chlorine substituents are considered to be persistent, and
tetrachlorobiphenyl congeners exhibit an intermediate persistence (Abramowitz 1990; Alcock et al. 1996;
EPA 1979i; Gan and Berthouex 1994).  Biodegradation rates in marine water may be slower than those
reported in freshwater.  The monochlorobiphenyl congeners had half-lives of approximately 8 months in
sea water incubated at 10 EC (Carey and Harvey 1978).  Aroclors 1221 and 1254 were individually added
to sea water and exposed for 4–8 weeks in enclosures in the North Sea; no degradation of either PCB
mixture was reported over this time (Kuiper and Hanstveit 1988).  Biodegradation is potentially a more
important process in soil and sediment than in water, particularly for the more highly-chlorinated
congeners, for at least three reasons: the higher numbers of microorganisms present, the opportunity for
anaerobic biodegradation, and the preferential partitioning of PCBs to soil and sediment (see
Section 6.3.2.3). 
6.3.2.3  Sediment and Soil
PCBs, particularly the highly chlorinated congeners, adsorb strongly to sediment and soil where they tend
to persist with half-lives on the order of months to years (see Section 6.3.1; Gan and Berthouex 1994;
Kohl and Rice 1998).  There is no abiotic process known that significantly degrades PCBs in soil and
sediment.  However, photolysis of PCBs from surface soil may occur, and PCBs may also undergo base-
catalyzed dechlorination (Chiarenzelli et al. 1995; Taniguchi et al. 1997); albeit, both of these processes
are likely to be insignificant removal mechanisms. 
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Biodegradation has been shown to occur under both aerobic and anaerobic conditions and is a major
degradation process for PCBs in soil and sediment, as reviewed by Higson (1992), Robinson and Lenn
(1994), Bedard and Quensen (1995), and most recently by Wiegel and Wu (2000).  While photolysis of
PCBs from soil surfaces may also occur, and PCBs may also undergo base-catalyzed dechlorination
(Chiarenzelli et al. 1995; Taniguchi et al. 1997), neither of these processes is likely to be a significant
removal mechanism in soil and sediment.
Numerous bacterial and some fungal isolates have been reported to aerobically biodegrade PCBs in the
literature (Abramowicz 1990).  Experiments with both pure and mixed microbial cultures show that some
congeners of PCBs, usually containing from one to four chlorine substituents, are readily biodegraded
aerobically (Abramowitz 1990), although biodegradation of congeners containing up to six or seven
chlorine atoms has been shown under enrichment conditions (Abramowitz 1990; EPA 1983c; Gibson et
al. 1993).  The most common process for the aerobic degradation of PCBs by bacterial cultures proceeds
in two distinct steps: first bioconversion to the corresponding chlorinated benzoic acid and secondly,
mineralization of the chlorobenzoate to carbon dioxide and inorganic chlorides (Robinson and Lenn
1994; Thomas et al. 1992).  Each step requires a separate group of genes (Afghan and Chau 1989;
Robinson and Lenn 1994; Sondossi et al. 1992; Unterman et al. 1989).  This pathway is further detailed in
Figure 6-3 (Abramowicz 1990; Robinson and Lenn 1994).  The initial attack of the biphenyl structure
involves addition of O2 by a biphenyl 2,3-oxygenase forming the corresponding unstable dihydro-
dihydroxybiphenyl, subsequent dehydrogenation to the dihydroxybiphenyl, followed by meta ring
cleavage to the corresponding chlorinated benzoic acid and a 5-carbon hydroxy-acid (Abramowicz 1990;
Flanagan and May 1993; Robinson and Lenn 1994; Sylvestre and Sondossi 1994; Thomas et al. 1992). 
Steric hindrance of 2,3-dioxygenation, where the chlorine substituents prevent access of the 2,3 carbon
atoms to the enzyme’s active site is believed to be responsible for the inability of many higher chlorinated
congeners to be oxidized (Abramowitz 1990; Sylvestre and Sondossi 1994).  Aerobic oxidation of PCBs
has been identified in the environment.  A study by Flanagan and May (1993) reported the presence of
chlorobenzoic acids, as well as other metabolites where the biphenyl ring is retained and in contaminated
sediment cores taken from the Hudson River, but not in uncontaminated cores obtained upstream from the
site of contamination.  2,3-Dioxygenase attack can also result in the formation of ring-chlorinated
acetophenone from 3-chlorophenyl, 2,5- or 2,4,5-chlorophenyl PCB rings (Bedard 1990; Bedard et al.
1987). 
Aerobic biodegradation of PCBs in the environment occurs mainly in soils and surficial sediments.  PCB


















































Figure 6-3.  Pathways for Aerobic Degradation of PCBs
Source: adapted from Adrigens et al. 1991; Robinson and Lenn 1994
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considered to be non-persistent, while those with five or more chlorines (major components in
Aroclors 1248, 1254, and 1260) are not readily degraded and considered to be persistent (Abramowitz
1990; Alcock et al. 1996; EPA 1979i; Gan and Berthouex 1994; Iwata et al. 1973).  Tetrachlorobiphenyls
(major components in Aroclors 1016 and 1242) are intermediate in persistence.  Thus, the addition of a
PCB mixture to an aerobic environment results in a fractionating effect where the less chlorinated species
biodegrade first and leave behind, for long-term build-up, the more highly chlorinated species.  For
example, Williams and May (1997) report that the addition of Aroclor 1242 to aerobic Hudson River
sediment samples and incubated at 4 EC for several months resulted in biodegradation following an initial
lag phase of 1.4 months.  More than 50% loss was reported in 5 months, particularly among specific di-
and trichlorobiphenyls.  A single added hexachlorobiphenyl congener (2,2',4,4',6,6'-hexachlorobiphenyl)
was not degraded over 300 days.  In sludge-amended soil, the dissipation half-lives (first-order kinetics)
of PCB 18 and 28, and total PCBs were reported to be on the order of <1–8.5 years (Alcock et al. 1996). 
Gan and Berthouex (1994) reported that the disappearance of PCBs in farmland soil amended with PCB-
contaminated sludge was slow with half-lives (first-order kinetics) of di-CBs ranging from 7 to
11 months, while the half-lives of the tri-CBs and tetra-CBs ranged from 5 to 17 months and from 11 to
58 months, respectively.  The mineralization of 2-, 3-, 4-, 2,2',5,5'-, 2,2',4,4'-, 2,2',3,3',5,5'-, and
2,2',4,4',5,5'-chlorobiphenyl was measured in a Flanagan silt loam containing 3% organic material; after
98 days, 19.7, 16.5, 16.1, 0.7, 0.4, 0.8, and 0.1% of the initially added radiolabel was found as CO2 (Fries
and Marrow 1984).  In addition to the degree of chlorination, the chlorine substitution pattern affects the
biodegradation rate of PCBs.  For example, Afghan and Chau (1989) and Furukawa and Matsumura
(1976) demonstrated that PCBs containing chlorine substituents on only one ring are degraded more
quickly than PCBs containing an equivalent number of chlorine substituents distributed between both
rings. Additionally, PCBs with chlorines found in ortho positions, such as 2,2'- and 2,6-dichlorobiphenyl,
are more resistant to aerobic biodegradation than those with chlorines found in either the para or meta
positions (Bedard and Haberl 1990; Furukawa et al. 1978; Robinson and Lenn 1994).  The incubation of
Aroclor 1242 in aerobic Hudson River sediment resulted in an enrichment of di- and trichlorobiphenyl
congeners with di-ortho chlorines on one ring or di-para chlorines; other di- and trichlorobiphenyls in the
mixture were readily degraded (Williams and May 1997).
Aerobic degradation rates of PCBs can be highly variable, depending not only on structural characteristics
as outlined above, but also on a number of other factors including previous exposure to PCBs or PCB-like
compounds, bioavailability, initial concentration, moisture, temperature, available nutrients such as
carbon sources, and the presence of inhibitory compounds.  Biodegradation of PCBs in aerobic soil is
slow, especially in soils that have a high organic carbon content.  PCBs that remain firmly bound in soil
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and sediment may not be bioavailable to the degrading organisms at sufficient concentrations.  For
example, in two soils containing >10% organic matter, only 5% biodegradation of Aroclor 1254 was
observed after 1 year (Iwata et al. 1973).  However, >25% biodegradation was observed after 1 year in a
loamy, sandy soil containing only 0.1% organic carbon.  In this study, the authors also observed that the
less chlorinated PCB congeners were biodegraded more rapidly than the more highly chlorinated and
tightly bound congeners (Iwata et al. 1973).  Temperature also influences the rate of aerobic degradation.
Williams and May (1997) evaluated the low temperature (4 EC) aerobic degradation of PCBs in sediment
using Aroclor 1242-spiked samples of PCB-contaminated sediment from the Hudson River for several
months.  A 3- to 4-fold decrease in the rate of degradation was noted for sediment samples incubated at
4 EC versus those incubated at 25 EC.  The aerobic biotransformation and biodegradation of PCBs can be
enhanced by the use of adapted (pre-exposed) microbial populations and the addition of amenable
substrates for co-metabolic and co-oxidative biotransformation.  In a controlled laboratory aerobic
microcosm sediment/water system, the half-lives (first-order kinetics) of Aroclors 1232, 1248, and
1254 were 61, 78, and 82 days, respectively, with no addition of substrates; 33, 39, and 36 days,
respectively, with the addition of an amenable substrate; and 27, 32, and 36 days, respectively, with the
addition of an amenable substrate and adapted microbes (Portier and Fujisaki 1988).  Biphenyl or
monochlorobiphenyls are commonly added as both growth substrates; they act to increase degradation
rates through a cometabolic effect (Hurme and Puhakka 1997), as well as to induce the catabolic pathway
required to sustain the growth of the PCB-degrading microbial population (Abramowicz 1990).  Other
studies report enhanced degradation rates in the presence of an added carbon source, such as sodium
acetate, due to cometabolism (Pal et al. 1980).  The efficiency of PCB degradation may also be controlled
by the metabolite production pattern.  Mono- and dichlorobenzoates, and possibly other higher
chlorobenzoates formed from aerobic degradation of PCBs, have been shown to act as inhibitors towards
further degradation of higher chlorinated PCBs (Guilbeault et al. 1994; Hickey et al. 1993; Robinson and
Lenn 1994). 
PCBs are slowly biodegraded in anaerobic environments by reductive dechlorination resulting in the
formation of less toxic mono- and dichlorobiphenyl congeners, which are aerobically biodegradable
(Abramowicz 1990, 1995; Anid et al. 1993; Brown et al. 1988; Chen et al. 1988; EPA 1983c; Larsson and
Lemkemeier 1989; Pardue et al. 1988; Rhee et al. 1989).  Until the 1980s, PCBs were not believed to be
susceptible to anaerobic biodegradation based on studies measuring total PCB concentrations over time. 
Previous studies measured PCB loss as the change in total number of moles of PCBs over time.  This
generally remained the same as the biphenyl ring is not metabolized and only chlorine is released during
reductive dechlorination.  However, the overall congener distribution profile is markedly different
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following anaerobic biodegradation.  The profile shows a decrease in concentration of the more highly
chlorinated congeners and a corresponding increase in overall proportion of the less chlorinated
congeners (Bedard and Quensen 1995).  For example, Aroclor 1242 added to anaerobic Hudson River
sediment was incubated for 73 weeks; at the end of this period, di-, tri-, tetra-, penta-, and hexachlorinated
congeners were reduced by 11, 73, 66, 73, and 94%, respectively, while the concentration of
monochlorobiphenyl congeners increased by 76% (Anid et al. 1993).  The original homolog distribution
of Aroclor 1254 versus that after 13 months incubation in anaerobic sediment (100 mg/L treatment) is as
follows (in mole percent):  tri-, 2 versus 18%; tetra-, 22 versus 51%; penta-, 48 versus 22%; hexa-,
21 versus 8.5%; hepta-, 6 versus 0.5% (Hurme and Puhakka 1997).  Microbial PCB dechlorination is
widespread in many anaerobic environments, including freshwater (pond, lake, and river) (Bedard and
Quensen 1995; Wiegel and Wu 2000), estuarine (Brown and Wagner 1990; Tiedje et al. 1993), and
marine sediments (Ofjord et al. 1994) for congeners with up to 10 chlorine substituents (Hartcamp-
Commandeur et al. 1996), although other authors report dechlorination occurring for up to 7 (Quensen et
al. 1990), 8 (Abramowitz 1990; Kuipers et al. 1999), or 9 (Kuipers et al. 1999) chlorines only.  During
reductive dechlorination, anaerobic bacteria use chlorine as the terminal electron acceptor in a two-
electron transfer reaction involving the addition of the electron to the carbon-chlorine bond, followed by
chlorine (Cl-) loss and subsequent hydrogen abstraction.  The process of reductive dechlorination is
illustrated in Figure 6-4 (Abramowicz 1990).  Hydrogen (H2) is assumed to be directly or indirectly the
electron donor and water the source of protons (Nies and Vogel 1991), although other sources are
possible.  For reductive dechlorination to occur, a low redox potential similar to methanogenesis
(Eh <-400 mV) and the absence of oxygen are thought to be required (May et al. 1992; Oremland 1988;
Ye et al. 1992a), although some studies have shown that sulfidogenic redox conditions may also allow
reductive dechlorination to proceed, but at a comparatively slower rate (Bedard and Quensen 1995;
Hartkamp-Commandeur et al. 1996).  
The most important structural factors determining whether a chlorine atom will be removed from a
particular congener during anaerobic biodegradation include the position of the chlorine in relation to the
opposite phenyl ring, the configuration of the surrounding chlorine atoms, the chlorine configuration of
the opposite ring and, as summarized above, the total number of chlorine atoms.  There are at least eight
distinct, documented, reductive dechlorination pathways or processes, each resulting in a different
congener distribution profile.  These processes, M, Q, H, H’, P, and N (and LP and T as in Wiegel and
Wu 2000) are summarized in Table 6-9 (Bedard and Quensen 1995; Wiegel and Wu 2000; Wu et al.
1997).  In any particular anaerobic environment, one or several of these processes may be occurring
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N 2, 4, 4N
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2, 2N, 4, 5N
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LP 2, 2N, 4
2, 2N, 5
2, 2N, 6
Flanked and unflanked para 1260 Woods Pond
T 2, 2N, 4, 4N, 5, 5N
2, 2N, 3N, 4, 4N, 5
2, 2N, 3, 4, 4N, 5N, 6
Flanked meta of 2, 3, 4, 5 group
in hepta- and octa-CBs
1260 Woods Pond
Source: Wiegel and Wu 2000; Wu et al. 1997; Bedard and Quensen 1995
aProducts will vary depending on the congener composition of the PCB mixture being dechlorinated.
bOverlapping gas chromatograph peaks
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Figure 6-4.  Possible Mechanism for Reductive Dechlorination by Anaerobic Microorganisms
PCBs 516
6.  POTENTIAL FOR HUMAN EXPOSURE
particular position or dechlorination of a particular type of PCB (Alder et al. 1993; Bedard and Quensen
1995; Kuipers et al. 1999; May et al. 1989; Morris et al. 1992; Quensen et al. 1998; Robinson and Lenn
1994; Sokol et al. 1994; Tiedje et al. 1993; Wiegel and Wu 2000; Ye et al. 1992a; Zwiernik et al. 1998).  
These processes can be combined at a single site producing different distribution profiles; combinations
of M and H or M and H’ have been observed (Bedard and Quensen 1995) as well as a combination of
processes M and Q commonly called process C (Bedard and Quensen 1995).  For example, it was
observed that chlorine substituents were removed from only meta and para positions in Hudson River
sediment contaminated with Aroclor 1242 resulting in a high proportion of ortho substituted mono- and
di-chlorinated PCBs.  The distribution profile of this sediment was believed to be due to dechlorination
processes M, Q, and H or H’ (Abramowicz et al. 1995; Bedard and Quensen 1995; Brown et al. 1984,
1987a, 1987b).  In Silver Lake sediment contaminated with both Aroclor 1254 and 1260, meta and para
chlorines were also preferentially removed (Williams 1994).  However, ortho dechlorination of 2,4,6-CB
was observed in cultures of Silver Lake sediment, suggesting a combination of dechlorination processes
H, P, N, M, and Q (Bedard and Quensen 1995; Brown et al., 1984, 1987a, 1987b).  While ortho
dechlorination has been shown in the environment (Berkaw et al. 1996; Van Dort and Bedard 1991; Wu
et al. 1998), most of the commonly reported processes outlined in Table 6-9 do not dechlorinate ortho
chlorines resulting in the accumulation of less chlorinated, primarily ortho-substituted, PCB congeners
due to anaerobic biodegradation (Abramowicz 1990, 1995; Bedard and May 1996; Berkaw et al. 1996;
Brown et al. 1987; David et al. 1994; Morris et al. 1992; Nies and Vogel 1990; Rhee et al. 1993a, 1993b;
Robinson and Lenn 1994; Tiedje et al. 1993; Van Dort and Bedard 1991; Wiegel and Wu 2000; Ye et al.
1992a). 
The rate, extent, and specificity of anaerobic dechlorination can vary greatly even in the same sediment
based on a number of environmental factors (Wiegel and Wu 2000).  These include previous exposure to
PCB or PCB-like compounds, electron acceptor availability, bioavailability, presence of co-contaminants,
oxygen tension, redox level, temperature, pH, salinity, inhibitory compounds, available carbon and
nutrients, and trace metals.  Optimum rates of PCB dechlorination usually occur in the concentration
range of 100–1,000 ppm (wet weight).  Below a certain threshold concentration (<50 ppm), the rate of
dechlorination is often very slow or non-quantifiable (Quensen et al. 1988; Rhee et al. 1993a; Robinson
and Lenn 1994; Sokol et al. 1995, 1998).  For example, Abramowicz et al. (1995) found that 93% of
sediment samples containing >100 µg/g PCBs were extensively dechlorinated compared with only 63%
of samples containing 5–10 µg/g.  However, it should be noted that the reductive dechlorination of many
PCB congeners in Aroclor mixtures has been observed even when their individual concentrations were
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<1 µg/g (Quensen et al. 1990; Schultz et al. 1989).  PCBs generally remain tightly bound in soil and
sediment, and may not be bioavailable to the biodegrading organisms even at optimum concentrations. 
The requirement of an optimum concentration (>50 ppm) may make this bioavailability factor critical for
dechlorination of PCBs (Robinson and Lenn 1994; Tiedje et al. 1993).  Bimodal desorption kinetics with
both PCB-spiked and environmental sediments has been observed; approximately 50% of the initially
present PCB mixture was found to be resistant to desorption with 50% of the resistant fraction desorbed
over the following 6 months (Carroll et al. 1994; Harkness et al. 1993).  Other authors report that
desorption may not be as important given the slow rate of dechlorination of the more chlorinated
congeners (Alder et al. 1993; Bedard et al. 1993).  Addition of compounds, such as sodium lignisulfonate,
that can increase the solubility of PCBs in soil and sediment has been shown to increase the rate of
biodegradation (Sugiura 1992).  Temperature is also an important factor controlling the rate of microbial
dechlorination (Tiedje et al. 1993; Wiegel and Wu 2000; Wu et al. 1996, 1997).  Temperatures in the
range of 12–25 EC supported dechlorination, while dechlorination was not observed at temperatures
>37 EC (Tiedje et al. 1993).  Wu et al. (1997) reported optimal temperatures for overall chlorine removal
of 20–27 EC in Woods Pond sediment contaminated with Aroclor 1260.  Acid/base conditions may also
affect the reductive dechlorination process.  For example, the optimal pH for removal of chlorines in
Woods Pond sediment contaminated with Aroclor 1260 and spiked with 2,3,4,6-tetraCB was
approximately 7.0–7.5 (Wiegel and Wu 2000).  The stereospecificity of dechlorination also varied as a
function of pH with flanked meta dechlorination (Process N) occurring at pH 5.0–8.0, unflanked para
dechlorination (Process LP) at pH 6.0–8.0, and ortho dechlorination at pH 6.0–7.5 (Wiegel and Wu
2000).  As PCB-dechlorinating microorganisms are not able to cleave and utilize the biphenyl ring as a
carbon and electron source, other compounds (e.g., mineral nutrients, electron donors, and carbon
compounds) are required to help co-metabolize PCBs (Alder et al. 1993; Klasson et al. 1996; Sugiura
1992; Tiedje et al. 1993; Wiegel and Wu 2000).  Alder et al. (1993) demonstrated that repeated addition
of fatty acids (e.g., acetate, propionate, butyrate, and hexanoic acid) stimulated dechlorination of PCBs in
carbon-limited sediment slurries, but not in sediment slurries with higher organic carbon contents.  The
omission of trace metals resulted in a slight reduction in the rate and extent of Aroclor 1242
dechlorination by Hudson River microorganisms (Abramowicz et al. 1993).  Inhibition of PCB
dechlorination can occur in the environment.  Sokol et al. (1994) reported that high concentrations of co-
contaminants at a site in the St. Lawrence River prevented dechlorination from occurring.  Electron
acceptors present in the environment may influence PCB reductive dechlorination.  While most studies
show reductive dechlorination of PCBs only under methanogenic and sometimes sulfidogenic conditions
(Kuo et al. 1999; Ye et al. 1999), Morris et al. (1992) reports that dechlorination was shown under
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denitrifying and iron(III) reducing conditions as well (Bedard and Quensen 1995).  Rates of
dechlorination have been shown to be fastest in methanogenic (the most reducing) environments. 
In the environment, aerobic and anaerobic biodegradation processes are often not readily separated and a
combination of the two may be fairly common in aquatic environments.  Hudson River sediment
microcosms, spiked with Aroclor 1242, were designed with an aerobic surface sediment layer overlying a
deeper anaerobic layer (Fish and Principe 1994).  The distribution profile of congeners following
degradation, was characterized by the authors as corresponding to a combination of process M
dechlorination and aerobic biodegradation.  Total PCB concentration decreased from 64.8 to
18.0 µmol/kg sediment in 140 days.  More recent studies have examined the potential of sequential
anaerobic-aerobic treatment to degrade PCBs.  As shown above, reductive dechlorination of PCBs in the
environment often results in the accumulation of mono- and dichlorobiphenyls, the most commonly
reported being the ortho-substituted congeners: 2-chlorobiphenyl, and 2,2'-, 2,4'-, 2,6-, 2,4-, and
2,3-dichlorobiphenyls (Adriaens and Grbic-Galic 1994).  Hudson River sediment, containing 700 µg/g
Aroclor 1242, showed 55% removal of total chlorine after 16 weeks, but only from meta and para
positions; the percentage of mono- and dichlorobiphenyls increased from 9 to 88% (Quensen et al. 1988). 
In a 73-day field study, aerobic biodegradation of a anaerobic sediment previously contaminated with
Aroclor 1242 (upon release containing 9%, but at the time of the study containing 62–73%, mono- and
dichlorobiphenyls) resulted in 35–55% further degradation of the less chlorinated PCBs, particularly
when oxygen, biphenyl, and inorganic nutrients were provided (Harkness et al. 1993).  However, the
extent and type of dechlorination is not predictable from site to site, and congeners remaining from
anaerobic biodegradation may also be resistant to aerobic biodegradation.  For example, dechlorination of
Aroclor 1254 in sediment resulted in the accumulation of tri- and tetrachlorobiphenyl congeners; they
were not dechlorinated further to mono- and dichlorobiphenyls in this sediment and would be expected to
be comparatively more resistant to aerobic biodegradation (Hurme and Puhakka 1997).   The reductive
dechlorination of Aroclor 1254 in a marine sediment system resulted in the accumulation of ortho tetra-
and pentachlorobiphenyls.  When this culture was then subjected to aerobic biodegradation, no
biodegradation was shown over 2 months.  Many of the remaining congeners had either two ortho or two
para groups, making them resistant to aerobic biodegradation as well (Mannisto et al. 1997).
Biodegradation of PCBs in aerobic or anaerobic groundwater has not been studied, although PCBs have
been reported in groundwater environments (Section 6.4.2).  In aerobic groundwater, the less-chlorinated
PCB congeners, which would be more likely to leach, would presumably degrade based on studies in
aerobic surface waters and soil.  However, groundwater is also commonly anaerobic and, as is covered in
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this section, microbial degradation under this oxygen condition proceeds for even the more highly
chlorinated congeners.  In a contaminant plume, as might be seen at a landfill site, sequential
dechlorination of the more highly chlorinated PCB congeners may occur in the anaerobic plume while
aerobic biodegradation at the anaerobic/aerobic interface of the plume edge may degrade some of the less
chlorinated PCBs. 
6.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
Reliable evaluation of the potential for human exposure to PCBs depends in part on the reliability of
supporting analytical data from environmental samples and biological specimens.  With respect to PCB
analysis, comparisons among various studies are complicated by the fact that authors may report PCB
concentrations as Aroclors, as homologs, or as congeners.  Historically, Aroclor analysis has been
performed by most laboratories.  This procedure can, however, result in significant error in determining
total PCB concentrations (Schwartz et al. 1987) and in assessing the toxicological significance of PCBs
because it is based on the assumption that distribution of PCB congeners in environmental samples and
parent Aroclors is similar.  The distribution of PCB congeners in Aroclors is, in fact, altered considerably
by physical, chemical, and biological processes after their release into the environment, particularly when
the process of biomagnification is involved (Oliver and Niimi 1988; Smith et al. 1990).  Only recently has
it become more common to determine the concentration of individual PCB congeners.  However, major
problems have been associated with the identification of the individual congeners, as only a limited
number of standards have been available (Larsen 1995).  In addition, in those studies that report results as
total PCBs, the definition of what constitutes total PCBs (i.e., how many and which congeners are
summed) is often not the same in the various studies.  Problems related to chemical analysis procedures
and reporting of total PCBs are discussed in greater detail in Chapter 7.  In reviewing data on levels
monitored or estimated in the environment, it should be noted that the amount of the chemical identified
analytically is not necessarily equivalent to the amount that is bioavailable.  Monitoring studies indicate
that atmospheric concentrations of PCBs tend to be dominated by lower chlorinated, more volatile
congeners, especially at northern latitudes (Halsall et al. 1999; Harner et al. 1998; Ockenden et al. 1998). 
Concentrations in soils and sediments, which are dominated by highly chlorinated congeners, have
followed a downward trend over time and appear to have reached a steady state concentration in several
locations (Bopp et al. 1998; Lead et al. 1997; Van Metre et al. 1998).  Water monitoring studies indicate
that PCB concentrations have also decreased since the late 1970s due to the cessation of production and
manufacturing (Anderson et al. 1999; Jeremiason et al. 1998).  Aquatic species, including fish and sea
mammals, have shown a similar downward trend in PCB contamination with highly chlorinated
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congeners being preferentially bioconcentrated (Troisi et al. 1998; Ylitalo et al. 1999; Young et al. 1998). 
Studies indicate that PCB concentrations increase with respect to trophic level; organisms that reside
higher on the food chain tend to have higher concentrations of PCBs (Kucklick and Baker 1998; Letcher
et al. 1998).
6.4.1 Air
PCB atmospheric concentrations have been detected in all areas of the world due to the high amount of
past usage and their great persistence.  Because of variations of several orders of magnitude, units in the
following section will vary; caution is recommend.  Based on several observations, atmospheric
concentrations of PCBs are generally higher during summer than winter months due to higher rates of
vaporization associated with higher summer temperatures (Franz and Eisenreich 1993; Haugen et al.
1999; Ockenden et al. 1998).  In studies that have consistently monitored PCB concentrations in a single
location, researchers have noticed a decreasing trend.  Due the high degree of PCB contamination, the
Great Lakes region of the United States has been closely monitored.  From 1991 to 1997, scientists
studied the change in atmospheric PCB concentration at the city of Chicago and Lakes Superior,
Michigan, and Erie (Simcik et al. 1999).  Gas-phase concentrations were found to have decreased in
Chicago and near Lake Michigan and Erie, but remained fairly constant near Lake Superior.  Atmospheric
half-lives for all individual congeners near Lake Michigan ranged from 0.5 to 5.9 years and averaged
2.1±0.1 years; half-lives at Lake Erie ranged from 0.7 to 7.5 years and averaged 2.6±0.1 years, while half-
lives at Chicago ranged from 0.6 to 5.6 years and averaged 2.7±1.3 years (Simcik et al. 1999).  In another
study, high volume air samples collected in Green Bay in 1989 and from several Great Lakes in
1990 were analyzed for PCB concentrations (McConnell et al. 1998).  The concentration of PCBs over
Green Bay ranged from 0.060 to 0.560 ng/m3, while over Lakes Michigan, Huron, Erie, and Ontario,
concentrations ranges were 0.17–0.44, 0.16–0.20, 0.12–1.30, and 0.24–0.37 ng/m3, respectively.  Air
concentrations of PCBs over Lake Huron were consistently lower than the other Great Lakes, while the
highest PCB concentrations were detected in the eastern- and western-most regions of Lake Erie, with
1.30 ng/m3 observed near Detroit, Michigan and 1.10 ng/m3 observed near Buffalo, New York
(McConnell et al. 1998).  Overall, the mean total concentration of PCBs over all five Great Lakes was
0.385 ng/m3.  Interestingly, the relative composition of PCBs detected over Green Bay was dominated by
tri- and tetrachlorinated biphenyls with these two homologs representing approximately 70–85% of total
PCBs.  Over the Great Lakes, however, researchers noticed a shift towards the higher chlorinated
congeners with tri-, tetra-, and pentachlorinated biphenyls contributing 25–35% each to total PCBs
(McConnell et al. 1998).  The difference in congener speciation in air samples is explained by increased
PCBs 521
6.  POTENTIAL FOR HUMAN EXPOSURE
air temperatures during air sampling done in summer over the Great Lakes compared to the measurements
taken during the winter and spring at Green Bay.  Wind direction has also been shown to play a role in
atmospheric PCB concentrations over the Great Lakes.  Atmospheric concentrations were measured from
1994 to 1995, 15 km from Chicago above Lake Michigan (Zhang et al. 1999).  Researchers found that the
concentration of PCBs ranged from 0.132 to 1.120 ng/m3.  During periods of southerly winds from urban
Chicago, researchers noticed that the average concentration of PCBs in the atmosphere became 5 times
higher (Zhang et al. 1999).  The same phenomenon was observed in Green Bay where atmospheric
concentrations of PCBs were elevated in samples taken closest to the city of Green Bay, Wisconsin. 
From late 1989 to mid 1990, air samples collected over water and nearby land in the Green Bay region
were analyzed for PCBs (Hornbuckle et al. 1993).  Researchers found that PCB concentrations were
greater in air samples collected from southern Green Bay (0.670–2.200 ng/m3) than over northern Green
Bay (0.160–0.520 ng/m3).  PCB concentrations detected over land ranged from 0.070 to 0.760 ng/m3.  At
all sites, tri-, tetra-, and pentachlorinated biphenyls were detected most frequently and at the highest
concentrations (Hornbuckle et al. 1993).  Analysis of Green Bay water samples revealed that the congener
distribution in the atmosphere directly correlated  with the congener distribution in adjacent water
samples.  
Inputs of PCBs to the Great Lakes region is influenced heavily by atmospheric transport and deposition
(Franz et al. 1998, Jeremiason et al. 1998).  Based on current and temporal studies, it appears that the
amount of PCBs being added to the Great Lakes region through dry deposition has decreased over time. 
From 1993 to 1995, the dry deposition of PCBs was studied for the Lake Michigan Air Basin (Franz et al.
1998).  The geometric mean fluxes of total PCBs at Chicago (Illinois), over Lake Michigan, South Haven
(Michigan), and Sleeping Bear Dunes (Michigan) were 0.21, 0.079, 0.14, and 0.057 µg/m2-day,
respectively.  Annually, PCB input to Lake Michigan by dry deposition is expected to be approximately
1,100 kg.  This is approximately 3 times less compared to measurements conducted in 1979.  The study
also found a strong correlation between sediment accumulation of PCBs and dry deposition to Lake
Michigan.  It suggests that dry deposition may account for most of the particulate PCBs accumulating in
the sediments of Lake Michigan (Franz et al. 1998).
The atmospheric concentration of PCBs in various geographic locations worldwide are summarized in
Table 6-10.  In general, atmospheric levels of PCBs appear to be decreasing over time with higher levels
of PCBs being detected in urban sites compared to rural locations.  For example, the atmospheric
concentrations of PCBs measured in urban and rural Baltimore locations in June of 1996 were
















Table 6-10.  Atmospheric Concentrations of Polychlorinated Biphenyls
Locationa Year Concentrationb (ng/m3) Reference
URBAN AREAS
Urban areas Late 1970s–early 1980s 5–10 (0.5–30) Eisenreich et al. 1981
Boston, MA 1978 7.1 Bidleman 1981
Columbia, SC 1978 4.4 Bidleman 1981
College Station, TX 1979–1980 0.29 (0.11–0.48) Atlas and Giam 1987
Columbia, SC 1985 2.3 Foreman and Bidleman 1987
Bloomington, IN 1986–1988 Summer: 1.74–3.84c, Winter: 0.31–0.62 Hermanson and Hites 1989
Newport News, VA 1988 0.39±0.434d Knap and Binkley 1991
Chicago, IL 1988 1.3 (geometric) (0.3–9.9) Cotham and Bidlemen 1995
Chicago, IL 1989–1990 13.5 (7.55–20.26) Holsen et al. 1991
Urban areas Late 1980s–early 1990s 5 (1–10) Eisenreich et al. 1992
Manchester, England 1991–1992 1.160 (0.223–2.260) Halsall et al. 1999
Cardiff, England 1991–1992 1.490 (0.415–3.710) Halsall et al. 1999
Chicago, IL 1994 (0.27–14) Simcik et al. 1997
New Bedford, MA 1994–1995 0.4–5.3, near harbor sediment remediation
0.1–8.2 background reference 
Vorhees et al. 1997
Baltimore, MD 1996 (0.38–3.36) Offenberg and Baker 1999
New Brunswick, NJ 1997 0.482 (0.092–3.200) Brunciak et al. 1999
Sturgeon Point, NY 1997 0.369 Brunciak et al. 1999
RURAL AREAS
Rural areas Late 1970s–early 1980s 0.8 (0.1–2) Eisenreich et al. 1981
















Table 6-10.  Atmospheric Concentrations of Polychlorinated Biphenyls (continued)
Locationa Year Concentrationb (ng/m3) Reference
RURAL AREAS (contd)
Ontario, Canada 1988–1989 0.2 (0.55–0.823) Hoff et al. 1992
Continental areas Late 1980s–early 1990s 0.5 (0.2–1.5) Eisenreich et al. 1992
Northwest England 1990–1991 (0.0463–0.471) Halsall et al. 1999
Lista, Norway 1992–1995 0.114 Haugen et al. 1999
Arctic Sites (Canada, Siberia) 1993 0.17, 0.34 Stern et al. 1997
Lake Tahoe Basin, CA, NV 1995 average 0.072 Datta et al. 1998a
Lancaster University, UK 1995 0.190 (summer), 0.080 (winter) Ockenden et al. 1998
Baltimore, MD 1996 (0.02–0.34) Offenberg and Baker 1999
MARINE/COASTAL AREAS
Marine Late 1970s–early 1980s 0.5 (0.05–2) Eisenreich et al. 1981
Bermuda 1986 0.2±0.175d Knap and Binkley 1991
Chesapeake Bay 1990–1991 0.21 (0.017–0.508) Leister and Baker 1994
Marine/coastal Late 1980s–early 1990s 0.1 (0.01–0.7) Eisenreich et al. 1992
Green Bay, WI 1989–1990 (0.070–0.760) Hornbuckle et al. 1993
Baltic Sea 1990–1993 0.057 (0.032–0.080) Agrell et al. 1999
Chesapeake Bay 1996 (0.21–0.74) Offenberg and Baker 1999
Chesapeake Bay 1997 0.210 Brunciak et al 1999
GREAT LAKES REGION
Great Lakes Late 1970s–early 1980s 1 (0.4–3.0) Eisenreich et al. 1981
Lake Superior 1986 1.25 Baker and Eisenreich 1990
Green Bay 1989 0.330 McConnell et al. 1998
Great Lakes Late 1980–early 1990s 1 (0.2–4.0) Eisenreich et al. 1992
Table 6-10.  Atmospheric Concentrations of Polychlorinated Biphenyls (continued)
















GREAT LAKES REGION (contd)
South Green Bay 1989–1990 (0.670–2.200) Hornbuckle et al. 1993
North Green Bay 1989–1990 (0.160–0.520) Hornbuckle et al. 1993
Lake Michigan 1990 (0.170–0.440) McConnell et al. 1998
Lake Huron 1990 (0.160–0.200) McConnell et al. 1998
Lake Erie 1990 (0.120–1.300) McConnell et al. 1998
Lake Ontario 1990 (0.240–0.370) McConnell et al. 1998
Great Lakes 1990 (0.089–0.370)e Hillery et al. 1997
Southern Lake Michigan 1994 (0.014–1.1) Simcik et al 1997
Lake Michigan 1994–1995 (0.132–1.120) Zhang et al. 1999
REMOTE AREAS
Remote areas Late 1970s–early 1980s 0.1 (0.02–0.5) Eisenreich et al. 1981
Antarctica 1981–1982 (0.02–0.18) Tanabe et al. 1983
Arctic 1986–1987 0.02 Baker and Eisenreich 1990
Barents Sea 1996 0.126 Harner et al. 1998
Eastern Arctic 1996 0.074 Harner et al. 1998
Norwegian Sea 1996 0.025 Harner et al. 1998
aPost office state abbreviations used
bValues are given as mean concentrations.  The ranges are given in parentheses unless otherwise noted.
cValues at three different sites
dStandard deviation
eValues for three sites 
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PCBs detected in air were dominated by tri- and tetrachlorinated congeners.  Atmospheric deposition of
PCBs to the New York/New Jersey Bight area were monitored in 1997 (Brunciak et al. 1999).  The
average atmospheric concentrations of total PCBs at New Brunswick New Jersey, Sturgeon Point, New
York, and Chesapeake Bay, Maryland were 0.482, 0.369, and 0.210 ng/m3, respectively.  From 1991 to
1992, air samples from the urban cities of Manchester and Cardiff, England and from three rural sites
located in northwestern England were analyzed for PCBs (Halsall et al. 1999).  As was expected, urban
locations had much higher PCB concentrations than rural sites.  The cities of Manchester and Cardiff had
average PCB concentrations of 1.160 ng/m3 (range, 0.223–2.360) and 1.490 ng/m3 (range, 0.415–3.710),
respectively, while rural sites had average PCB concentrations ranging from 0.0463 to 0.471 ng/m3. 
Irrespective of location, air samples were dominated by tri- and tetrachlorinated biphenyls (Halsall et al.
1999).  Air samples at a semirural site near Lancaster University, United Kingdom were monitored for
PCBs in 1995 (Ockenden et al. 1998).  The mean concentration of PCBs during the summer and winter
months were 0.190 and 0.080 ng/m3, respectively.  Concentrations of trichlorobiphenyls dominated both
the winter and summer sampling months.  A 4-year study monitored atmospheric concentrations each
week in Lista, Norway from 1992 to 1995 to determine temporal and seasonal changes in PCB
concentrations (Haugen et al. 1999).  The geometric mean concentration of PCBs was 0.114 ng/m3 with
concentrations approximately 3 times higher during summer than winter season.  The congeners found in
the highest concentrations were PCBs 101 (30.5% at 0.0482 ng/m3), 138/163 (33.2% at 0.0484 ng/m3),
and 153 (23.8% at 0.0373 ng/m3) (Haugen et al. 1999).  Overall, there was no significant change in total
PCB concentrations from 1992 to 1995.  
Even in remote areas of the world, atmospheric concentrations of PCBs have been observed.  From
1986 to 1987, the mean concentration of PCBs was 0.02 ng/m3 in the Arctic while from 1981 to 1982,
PCBs ranged from 0.02–0.18 ng/m3 in the Antarctic (Baker and Eisenreich 1990; Tanabe et al. 1983) (see
Table 6-10).  From 1988 to 1990, atmospheric levels of two pentachlorobiphenyls (PCBs 101 and 110) in
Antarctic air were 0.0025 and 0.0022 ng/m3, respectively, while two hexachlorobiphenyls (PCBs 135 and
153) were 0.0021 and 0.0023 ng/m3, respectively (Lohmann and Jones 1998).  Stern et al. (1997)
measured PCB levels in air at five Arctic locations in 1993 and reported that, while there was no
correlation with temperature, the atmospheric trichlorinated PCB congeners tended to be lower during the
warmer months than during colder months.  In the summer of 1996, researchers analyzed Arctic air
samples for PCB concentrations (Harner et al. 1998).  Average concentrations in the Barents Sea, eastern
Arctic, and Norwegian Sea were 0.126, 0.024, and 0.075 ng/m3, respectively.  The study also monitored
the levels of some of the more toxic coplanar PCBs.  It was found that the concentrations of PCBs 77 and
126 in Arctic air samples were 3–40 and 0.3–8 fg/m3, respectively.  These values were approximately an
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order of magnitude lower than levels found in urban areas.  For example, air samples obtained from
Chicago in 1995 had mean concentrations of PCBs 77 and 126 of 420 and 63 fg/m3, respectively (Harner
et al. 1998).  Interestingly, the northeast Arctic Ocean profile was dominated by lower molecular weight
tri- and tetrachlorinated biphenyls, while the more southern Barents Sea air samples were enriched in the
higher penta- and hexachlorinated biphenyls.
Several studies have indicated that indoor air concentrations of PCBs are generally greater than outdoor
concentrations.  In 1984, indoor air samples from seven public buildings in Minnesota were monitored for
several Aroclors (Oatman and Roy 1986).  The mean total Aroclor concentration in indoor air of the
three buildings using PCB transformers (457±223 ng/m3) was found to be nearly twice as high as that in
the air of the four buildings not using PCB transformers (229±106 ng/m3).  The Aroclor levels detected in
the indoor air of all seven buildings were significantly higher than those detected in ambient outdoor air
(Balfanz et al. 1993; Eisenreich et al. 1992; MacLeod 1981; Oatman and Roy 1986).  When the indoor air
in a number of laboratories, offices, and homes was monitored for various Aroclors, the "normal" indoor
air concentrations of PCBs were at least one order of magnitude higher than outdoor levels (MacLeod
1981).  For example, average PCB levels were 100 ng/m3 inside an industrial research building and
210 ng/m3 inside the laboratories themselves, compared to <20 ng/m3 in air samples from outside the
facility.  The mean PCB indoor air concentration in one home was 310 ng/m3, while the average air
concentration outside the home on the same day was 4 ng/m3.  Indoor air PCB concentrations measured in
public buildings in Bloomington, Indiana were 5–300 times greater than outdoor air concentrations
(6–310 ng/m3 indoor air averages, 1.5 ng/m3 outdoor air), with indoor air concentrations highest in older
buildings (Wallace et al. 1996).  It has been suggested that certain electrical appliances and devices (e.g.,
fluorescent lighting ballasts) and building materials (elastic sealant), which have PCB-containing
components, may emit PCBs into the indoor air, thereby elevating indoor PCB levels significantly above
outdoor background levels (Balfanz et al. 1993).  
Indoor air concentrations of PCBs in 34 homes near New Bedford Harbor, Massachusetts were measured
between April 1994 and April 1995 during the dredging of contaminated river sediments.  PCB levels in
indoor air samples ranged from 7.9 to 61 ng/m3 in homes closest to the dredging operation compared to
more distant houses which had levels ranging from 5.2 to 51 ng/m3 (Vorhees et al. 1997).  However, these
indoor concentrations exceeded outdoor concentrations by an average ratio of 32, indicating the
importance of indoor air concentrations to human exposures.  House dust was also analyzed for PCB
contamination at these homes (Vorhees et al. 1999).  House dust samples had PCB concentrations ranging
from 260 to 23,000 ng/g, but did not differ significantly between houses closest to the dredging operation
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and those a few miles away from the dredging operation.  In general, the house dust samples contained
higher concentrations of the more volatile, less chlorinated PCBs.  The results of the house dust data were
then compared to house dust samples from homes that were not located near known PCB sources.  In nine
Seattle, Washington homes, house dust had PCB concentrations ranging from 240 to 760 ng/g and in
eight Columbus, Ohio homes, concentrations ranged from 210 to 1,900 ng/g (Vorhees et al. 1999).  It
appeared that PCB concentrations were generally lower in these locations compared to the New Bedford
Harbor neighborhood homes. 
In 1987, PCB concentrations in the workplace air of unspecified PCB disposal facilities in the United
States ranged from 850 to 4,000 ng/m3; in 95 of the 96 air samples collected for analysis, PCB
concentrations exceeded the NIOSH-recommended exposure limit of 1,000 ng/m3 (Bryant et al. 1989;
NIOSH 1992).  The average PCB concentration (Aroclors 1242 and 1260) emitted from gas vents at a
hazardous waste landfill in North Carolina was 126,000 ng/m3 (Lewis et al. 1985).  The maximum total
PCB concentration detected in air samples collected at Raquette Point within the Mohawk Nation
Reservation at Akwesasne, New York (adjacent to a Superfund site) was 50 ng/m3 (ATSDR 1995).
Even though the production and use of PCBs has been discontinued in the United States, PCBs are still
released during some industrial processes.  It is well known that PCBs may be formed whenever a carbon
source and chlorine are combusted together, such as during municipal and hazardous waste incineration
(Alcock et al. 1999; Bergman et al. 1984; Brown et al. 1995).  However, depending upon the combustion
conditions, the distribution of PCB congeners can vary greatly.  For example, some combustion
conditions support the production of the lower chlorinated congeners, while other conditions mainly
produce nona- and decachlorobiphenyls (Brown et al. 1995).  PCB concentrations ranged from 0.01 to
1.5 µg/m3 in fly ash from five municipal incinerators operating under different technological and working
conditions (Morselli et al. 1985).  Stack effluents from several Midwest municipal refuse and sewage
incinerators contained PCB concentrations of 0.3–3.0 µg/m3 (Murphy et al. 1985).  The total PCB
concentration measured in the flue gas effluent from a municipal waste incinerator in Ohio was
0.26 µg/m3 (Tiernan et al. 1983).  PCB concentrations ranged from 0.002 to 0.010 µg/m3 in effluents from
coal and refuse combustion in Ames, Iowa (EPA 1988a).  From 1995 to 1997, atmospheric PCB
concentrations were measured from cement kilns and sinter plant operations located in the United
Kingdom (Alcock et al. 1999).  Emissions from cement kilns contained PCB concentrations ranging from
1.3x10-5 to 2.5x10-5 µg/m3, while from sinter plants, the mean PCB concentration was 1.9 µg/m3.  Tri-,
tetra-, and pentachlorinated congeners contributed between 65 and 85% of total PCBs in sinter plant
emissions with PCB 28 being detected at the highest concentrations.
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6.4.2 Water
Assessing the PCB contamination of surface waters has been of great interest due to the environmental
and health risks PCBs present for the human populations living near them.  Countless studies have been
conducted that describe the ambient levels found in aquatic systems across the United States.  The Great
Lakes, in particular, have been monitored extensively due to the widespread PCB contamination and
proximity to residential areas.  Several studies indicate that PCB concentrations have continued to
decrease in the Great Lakes since the early 1980s.  Table 6-11 displays the change in PCB concentrations
in water over time in several of the Great Lakes.  In those lakes with water analyses over several years,
PCB concentrations appear to be decreasing over time.  In the spring of 1993, water samples were
collected and analyzed for PCB concentrations from all five Great Lakes (Anderson et al. 1999).  It was
found that Lake Erie had the highest degree of contamination with total PCB concentrations ranging from
0.20 to 1.6 ng/L, while Lake Superior had the lowest concentrations ranging from 0.070 to 0.10 ng/L.  In
1980, the average PCB concentration measured in Lake Michigan was 1.8 ng/L, with higher levels in
near-shore samples (3.2 ng/L) than in open lake samples (1.2 ng/L) (Swackhamer and Armstrong 1987). 
Comparison of Lake Michigan water samples from 1980 to 1993 indicated a decline in PCB
concentrations according to a first-order rate constant of 0.078/year.  Average total PCB concentrations in
water decreased from 1.2 ng/L in 1980 to 0.47 ng/L in 1991 and ranged from 0.17 to 0.27 ng/L in
1993 (Anderson et al. 1999; Pearson et al. 1996).  Mean PCB concentrations of 0.63–3.3 ng/L were
detected in the waters of western Lake Superior during 1978–1983 (Baker et al. 1985).  PCB
concentrations in Lake Superior surface waters decreased from 2.4 to 0.18 ng/L at a first-order rate of
0.20/year between 1980 and 1992 (Jeremiason et al. 1998).  Volatilization was the dominant removal
mechanism over this time period, while permanent sediment burial was of minor importance (Jeremiason
et al. 1998).  Sediment traps were also used to study the flux of PCB deposition in Lake Superior from
1987 to 1991.  Total PCB settling fluxes from the upper 35 m of water averaged 121± 40 ng/m2Cd in
1987 and 48±23 ng/m2Cd in 1991 (Jeremiason et al. 1998).  The major PCB congeners detected in settling
solids were tri- to pentachlorobiphenyls.  A mean concentration of 0.49 ng/L was detected in the water
column of Lake Huron in 1981 (Rodgers and Swain 1983).  For the San Francisco Bay and estuary, water
samples collected from 1993 to 1995 had total PCB concentrations ranging from 340 to 1,600 ng/L in
combined dissolved and particulate fractions (Jarman et al. 1997).  Total PCB concentrations studied from
1990 to 1991 in the Saginaw River ranged from 11 to 31 ng/L, with 1.9–16 ng/L detected in the dissolved
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Erie 1993 52–330 45–250 (0.20–1.6) Anderson et al. 1999
Ontario 1993 110–190 75–160 (0.19–0.25) Anderson et al. 1999
aRanges presented in parenthesis
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The world’s oceans have also been monitored for PCB concentrations.  PCB levels reported in sea water
from various oceans include 0.04–0.59 ng/L in the north Pacific, 0.02–0.20 ng/L in the north Atlantic, and
0.035–0.069 ng/L in the Antarctic (Giam et al. 1978; Tanabe et al. 1983, 1984).  PCB levels were several
orders of magnitude higher in sea-surface microlayer samples taken from industrial areas, compared to
sites further offshore (Cross et al. 1987).  PCB concentrations of 0.3–3 ng/L, have been detected in sea
water from the North Sea (Boon and Duinker 1986).
Although PCBs are widely found in surface waters, their low solubility generally prevents them from
reaching high concentrations, especially in groundwater (EPA 1980b).  However, under extreme
conditions, such as at hazardous waste sites, PCB contamination of groundwater can occur.  A maximum
total PCB concentration of 1,200 µg/L was detected in groundwater samples collected on-site at the
General Motors Foundry Operation, a Superfund site only 100 yards from the boundary of the Mohawk
Nation Reservation at Akwesasne.  The maximum off-site groundwater concentration of PCBs (3 ppb)
was collected at nearby Raquette Point, New York, which is within the Mohawk Nation Reservation at
Akwesasne (ATSDR 1995).  In the Mezquital Valley of Mexico, untreated waste water from Mexico City
is used to irrigate croplands (Downs et al. 1999).  Excess irrigation, however, has resulted in recharging
near-surface aquifers used as domestic water supplies.  To determine the potential for PCB exposure,
researchers analyzed groundwater samples and found that levels of PCBs were #36 pg/L.  In general,
groundwater is not expected to be significantly impacted by PCB contamination.
Due to the presence of PCBs in the atmosphere, they are often associated with precipitation.  In
Table 6-12, typical mean PCB concentrations in rain water from various locations are presented.  PCB
concentrations measured in the late 1970s to early 1980s declined by a factor of 4–10 compared to those
measured in the late 1980s and early 1990s (Eisenreich et al. 1981, 1992).  Although PCB levels appear to
have decreased during this time, more recent studies show both decreasing and steady state conditions. 
Precipitation sampled from the Great Lakes region from 1991 to 1997 was studied for temporal trends in
PCB concentrations (Simcik et al. 2000).  It was found that PCB concentrations decreased in precipitation
collected over Lakes Michigan and Ontario; data collected for Lakes Michigan and Ontario showed half-
lives of 6.9±3.5 and 4.0±1.4 years, respectively.  Lakes Erie, Huron, and Superior, however, did not show
any significant decrease in PCB concentrations in precipitation.  The study also compared its results to
other research that has monitored temporal trends in PCB concentrations over the Great Lakes.  It was
determined that the deposition rate of PCBs from the atmosphere to the Great Lakes is approximately
equal to the amount evaporating from the lakes to the atmosphere.  This suggests that a steady state
equilibrium of PCBs has developed in the Great Lakes ecosphere (Simcik et al. 2000).
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Table 6-12.  Comparison of PCB Levels (ng/L) in Rainwater Samples 






Remote 5 (1–30) No data
Rural/continental 20 (1–50) 5 (0.5–20)
Great Lakes 20–50 (10–150) 5 (0.5–20)
Urban 50 (10–250) 10
Marine/coastal 1–5 (0.5–10) 0.5 (0.1–1.0)
alate 1970s to early 1980s (Eisenreich et al. 1981)
blate 1980s to early 1990s (Eisenreich et al. 1992)
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Some recent studies have reported the following mean concentrations of total PCBs in rain water: sites
along the eastern shore of Green Bay had a mean PCB concentration of 2.2 ng/L (range, 0.9–11.7 ng/L)
(Franz and Eisenreich 1993); on Lake Michigan near Chicago, 4.1–189 ng/L in 1994/1995 (Offenberg
and Baker 1997); Chesapeake Bay, 1.6 ng/L (range, 0.04–34 ng/L) (Leister and Baker 1994); and Pelee
Island on the western end of Lake Erie, 10.2 ng/L, and Wolfe Island on the eastern end of Lake Ontario,
8.7 ng/L from 1986 to 1991 (Chan et al. 1994).  Concentrations of PCBs have also been determined in
remote regions of the world.  In snow collected from the Antarctic, PCB concentrations ranged from 
0.16 to 1.0 ng/L (Tanabe et al. 1983).  In a study conducted in 1996, PCB concentrations in snow samples
from western Canada’s mountain ranges were twice as high in higher altitudes compared to lower
altitudes (Blais et al. 1998).  For example, the concentrations of di-, tri-, tetra-, penta-, hexa-, and
heptachlorobiphenyls in snow samples from Saskatchewan River Crossing (elevation of 1,402 meters
above sea level (masl)) in Alberta, Canada were 0.05, 0.15, 0.25, 0.35, 0.15, and 0.10 ng/L, respectively. 
At Parker Ridge, which has an elevation of 2,011, the concentrations for di-, tri-, tetra-, penta-, hexa-, and
heptachlorobiphenyls were 0.30, 0.25, 0.15, 0.15, 0.10, and 0.05 ng/L, respectively (Blais et al. 1998).  It
was also noted that at higher elevations, di- and trichlorinated congeners dominated total PCBs while at
lower altitudes, tetra- and pentachlorinated congeners were higher.
In a literature review of 140 articles containing information on urban storm water quality, Makepeace et
al. (1995) reported that total PCB concentrations in urban storm water ranged from 27 to 1,100 ng/L. 
From 1995 to 1996, PCB concentrations in water samples collected from the Trenton Channel stretch of
the Detroit River, Michigan, ranged from <5 to 22 ng/L in particulate and from <5 to 13 ng/L in dissolved
fractions of water (Froese et al. 1997).  It was estimated that 600 kg of PCBs passed through the Channel
in 1995.  A maximum total PCB concentration of 15,000 ng/L was detected in surface water samples from
the St. Lawrence River downstream from a Superfund site (General Motors Foundry Division) (ATSDR
1995).  Based on large-volume water sampling from the ship canal between Hamilton Harbor and the start
of the St. Lawrence River, an annual PCB loading of 2.8 kg/year was estimated for Lake Ontario (Fox et
al. 1996).
6.4.3 Sediment and Soil
PCB levels in soils and sediments have decreased in many areas across the United States since its ban in
the late 1970s.  Sediment core samples were used to study the temporal change of PCB deposition at
11 riverine systems located in Texas, Florida, Iowa, Virginia, New Mexico, and Georgia (Van Metre et al.
1998).  In almost every sediment core sample, PCB concentrations peaked around 1970 and decreased
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linearly afterwards.  The only sediment sample that did not have a downward trend in PCB concentration
was at Lake Seminole in Florida, where the PCB concentration did not decrease or increase significantly
from 1955 to 1995.  Overall, the mean half-life of PCBs in riverine sediments was calculated to be
9.5 (±2.2) years.  To determine the temporal change in PCB concentrations within the Hudson River
basin, researchers obtained sediment core samples from 18 locations and analyzed them for PCBs (Bopp
et al. 1998).  The study found that from the mid-1960s to early 1990s, PCB concentrations decreased
significantly over time.  For example, PCB concentrations in the upper Hudson River were 350 ppm in
the mid-1960s compared to 34 ppm in 1991.  In sediment samples taken from the base of the Hudson
River, sediment core samples had a mean concentration of 3.03 ppm in the mid-1960s which decreased to
0.80 ppm by 1992 (Bopp et al. 1998).  The historic profiles of PCB concentrations in sediments of the
lower Passaic River, New York were also studied.  The authors concluded that total PCB sediment
concentrations peaked in the 1970s and that PCB concentrations declined dramatically from 4.7 mg/kg
(dry weight) in the 1970s to 1.1 mg/kg (dry weight) in the 1990s (Wenning et al. 1994).  A similar study
of dated sediments from the Newark Bay Estuary, New Jersey (including the Passaic River), also reported
that the highest concentration of PCBs occurred in buried sediments (0–140 cm) from the Passaic River
and Newark Bay at depths corresponding to historic deposition during the 1960s and 1970s, the peak
manufacturing period for Aroclors (Iannuzzi et al. 1995).  Surficial sediments were analyzed for PCBs
from Lake Ontario from 1982 to 1986 (Oliver et al. 1989).  Concentrations decreased from
1,300–1,900 ng/g in 1982/1983 to 80–290 ng/g in 1985/1986.  Researchers determined that the
percentage of lower chlorinated congeners (tri to penta) decreased with depth, while hexachlorobiphenyls
remained fairly constant throughout and the concentration of highly chlorinated congeners increased with
depth (Oliver et al. 1989).  Archived soil samples collected in the United Kingdom between 1951 and
1968 were analyzed for PCB concentrations and compared to soil samples from the same region collected
in 1993 (Lead et al. 1997).  The study found that in 9 out of 10 cases, PCB concentrations decreased over
time.  Differences in concentrations ranged from 3.6 ng/g measured in 1953 to 1.1 ng/g in 1993 as well as
1,400 ng/g measured in 1966 to 2.6 ng/g in 1993 (Lead et al. 1997).  While the tri-chlorinated congeners
decreased by a factor of approximately 1,000 between 1968 and 1993, octachlorinated biphenyls only
decreased by a factor of approximately 5 over the same time period.  The researchers contributed the high
degree of loss for the lower chlorinated biphenyls to higher rates of volatilization and biodegradation
(Lead et al. 1997).  These decreasing trends in sediment and soil samples, however, have not been
observed in all parts of the world.  PCB concentrations in sediment samples taken from the Seine River in
France were studied from 1984 to 1992 to determine temporal changes (Chevreuil et al. 1998).  In
Europe, the Seine River is known for having some of the highest levels of PCBs.  During the course of
the 9-year study, no significant change in PCB concentration was observed.
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The concentrations and congener profile of PCBs in sediments depend on the depth at which the samples
are collected (Lake et al. 1992; Pereira et al. 1994).  In 1988, the concentration of PCBs in surface core
sediments (0–2.5 cm) from heavily contaminated upper New Bedford Harbor, Massachusetts, ranged
from 1.02x106 to 9.12x106 ng/g (Lake et al. 1992).  At a depth of 15–17.5 cm, PCB concentrations ranged
from 7.53x106 to 2.96x107 ng/g.  At greater depths, however, the concentration of PCBs in sediment cores
decreased.  The concentration range of surficial bed sediments collected from San Francisco Bay ranged
from 1.3 to 8.1 ng/g dry weight (Pereira et al. 1994).
In 1972, upper sediment layers from the Hudson River and New York Harbor contained PCB
concentrations ranging from 560 to 1,950 ng/g (Aroclor 1254) and from 3,950 to 33,300 ng/g
(Aroclor 1242), respectively (Bopp et al. 1982).  From 1968 to 1975, surface sediments from the Great
Lakes contained Aroclor 1254 concentrations ranging from 2.5 to 251.7 ng/g, with the highest
concentrations detected in Lake Erie (Thomas and Frank 1981).  In 1976, PCB concentrations monitored
in sediments from 13 streams in the Potomac River Basin ranged from 10 to 1,200 ng/g (Feltz 1980). 
Sediment samples collected in 1979 from Gill Creek adjacent to a hazardous waste site near Niagara
Falls, New York contained 1.0x106 ng/g dichloro-, 3.0x106 ng/g trichloro-, 6.0x106 ng/g tetrachloro-,
3.0x106 ng/g pentachloro-, and 3.0x106 ng/g hexachlorobiphenyl (Elder et al. 1981).  In 1980, an average
Aroclor 1260 concentration of 120 ng/g was detected in sediment samples from eight sites along the coast
of Maine (Ray et al. 1983).  The mean concentrations of PCBs (ng/g dry weight) measured from 1980 to
1982 in sediments from the Great Lakes were as follows: southern Lake Huron, 34; Lake St. Clair, 29;
western Lake Erie, 300; central Lake Erie, 131; and eastern Lake Erie, 91 (Oliver and Bourbonniere
1985).  From 1987 to 1990, approximately 1,000 sediment samples from Green Bay, Lake Michigan,
were analyzed to map the areal distribution of PCBs in the bay sediments (Manchester-Neesvig et al.
1996).  The Bay sediments were estimated to contain a total of 8,500 kg of PCBs.  The PCBs in these
sediments are not evenly distributed, and an estimated 50% of the total PCB mass is located in the
southern portion of the Bay (closest to the city of Green Bay) in an area representing 3% of the total area. 
An analysis of PCB homolog groups revealed that tri-, tetra-, and pentabiphenyls represented 30.8, 40.6,
and 13.5%, respectively, of total PCBs detected in Green Bay sediments (Manchester-Neesvig et al.
1996).
Sediments downstream from highly contaminated sites may also be affected by PCB residues.  Maximum
total PCB concentrations of 5,700,000 and 36,000 ng/g were detected in sediments from the St. Lawrence
River and Raquette River, respectively; these sites are within the boundaries of Akwesasne, New York, a
Native American community downstream from a Superfund site (ATSDR 1995).  Vanier et al. (1996)
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measured PCB concentrations at three sites along the St. Lawrence River exposed to high potential PCB
contamination, including two in urban Montreal, Quebec.  PCB concentrations in the top 10 cm of the
sediment were 3,800–16,000 ng/g dry weight Aroclor 1254 equivalent.  In the most contaminated site,
located in an industrial area, PCB inputs appear to have been relatively constant since about 1982.  Di-
and tri-chlorinated congeners make up more than 70% of the profile in the more concentrated area and
less elsewhere along the river.
Although the use of PCBs has been discontinued by many countries, they are still detected in sediments
from around the world.  In September of 1994, researchers obtained sediment core samples along the
Dnipro River in the Ukraine and analyzed them for PCB residues (Lockhart et al. 1998).  In two core
samples, one from the Zaporizhzhia reservoir and one from the Kakhovka reservoir along the Dnipro
River, the total concentrations of PCBs were 48.1 and 30.6 ng/g, respectively.  The study also found that
penta- and hexachlorobiphenyls were detected more frequently than any other PCB congeners at both
sites.  In 1996, sediment samples from 17 sites within the Bay of Chetumal, Mexico, were analyzed for
PCBs (Norena-Barroso et al. 1998).  Concentrations of total PCBs ranged from 1.23 to 9.28 ng/g with a
median value of 2.96 ng/g.  In North Vietnam, sediment samples from the Red River Delta and the coastal
area of the Thai Binh province were analyzed for PCB residues from 1995 to 1996 (Nhan et al. 1998). 
The mean concentration of total PCBs detected for all sediment samples was 2.12 ng/g dry weight.
In arctic regions, PCB concentrations are highest in surface sediments representing inputs from the 1980s
and early 1990s.  These observations support the hypothesis of a gradual movement of contaminants
northward, caused by temperature-dependent partitioning (Wania and Mackay 1996).  PCB
concentrations ranging from 98 to 540 ng/g were detected in sediments from four remote, high-altitude
lakes in Rocky Mountain National Park (Heit et al. 1984).  Considering that there were no anthropogenic
sources of PCBs in the vicinity, PCBs most likely accumulated via atmospheric deposition.  The same
phenomenon was observed in four lakes located in remote areas of Alaska where the concentration of
total PCBs averaged 0.12 ng/g dry weight (Allen-Gil et al. 1997). 
In contrast to sediment, PCB concentrations in soil have not been closely monitored.  Of soil samples
collected from three unspecified PCB disposal facilities, 74% had PCB concentrations >100 µg/m2
(NIOSH 1977).  The PCB concentrations at these sites ranged from 4 to 180,000 µg/m2 (Bryant et al.
1989).  Subsurface soils and sludges collected on-site at the General Motors Foundry Operation (a
Superfund site in New York) had maximum concentrations of 750 and 41,500 ppm, respectively (ATSDR
1995).  In the Canadian Arctic, a string of 21 radar stations called The Distant Early Warning (DEW)
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Line stretches along 3,000 km and has been in operation since the 1950s.  These radar stations have been
associated with former PCB use and contamination (Bright et al. 1995a, 1995b).  Site samples from the
21 DEW Line facilities, plus 3 additional Arctic radar installations, were collected from 1989 to 1992. 
PCBs were detected in undisturbed soils near the 21 DEW Line sites and as far as 5 km, but were not
detected in soil 20 km from site.  Concentrations ranged from not detected (detection limit=0.1–5.3 ng/g)
to 45 ng/g in soil.  These data indicate short-range redistribution of PCBs in a terrestrial environment.
6.4.4 Other Environmental Media
In order to fully assess human exposure to PCBs, several human diet studies have been conducted to
monitor for PCB residues.  In some cases, the analytical methodology and detection limits rendered these
results inconsistent with more recent studies and some judgement is necessary.  A 10-year study of ready-
to-eat foods conducted by the U.S. Food and Drug Administration (FDA) from 1982 to 1991 found PCB
residues 27 times out of 17,050 foods sampled (KAN-DO Office and Pesticides Team 1995).  The study
included 234 food items that represented about 5,000 food types in American diets covering all age
groups.  The average concentration of PCBs in those foods with detectable quantities was 0.0179 µg/g
wet weight.  The concentration of dioxin-like PCBs (including PCBs 77, 105, 118, 126, 156, 157, and
169) was studied in composite pasteurized milk samples collected in the United States from 1996 to
1997 (Lorber et al. 1998).  The study found that out of a total of 48 samples, the average PCB
concentration was 0.50 pg/g lipid weight.  An earlier study conducted from 1969 to 1976 monitored PCBs
in raw foods.  They were analyzed as part of a federal monitoring programs conducted by the FDA and
the U.S. Department of Agriculture (USDA).  Data from this study can be found on Table 6-13.  Based on
this report, fish products clearly contained the highest levels of PCBs.  Food either grown or processed
abroad and imported into the United States is another potential source of human exposure (Kannan et al.
1997).  Various fish oils used as dietary supplements were collected from around the world and analyzed
for PCB levels (Jacobs et al. 1998).  Researchers found that PCB congeners 138, 153, and especially
118 were detected most frequently and in the highest concentrations.  None of the samples, however,
exceeded the FDA regulatory limit of 2.0 mg/L for total PCBs for animal feed.  In fact, total PCB
concentrations ranged from not detected to 1.132 mg/L with a mean value of 0.332 mg/L (Jacobs et al.
1998).  PCB concentrations measured in Australian crop products were <0.01–11 ng/g wet weight and
dairy products, were 1.2–8.2 ng/g wet weight.
As previous monitoring sections have demonstrated, PCBs can be found throughout the world. 
Consequently, this has led to significant levels of PCBs bioaccumulating in aquatic organisms exposed to 
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Table 6-13.  Polychlorinated Biphenyl Residues in Domestic











Fish 2,901 46.0 0.892
Shellfish 291 18.2 0.056
Eggs 2,303 9.6 0.072
Red meatb 15,200 0.4 0.008
Poultryb 11,340 0.6 0.006
Fluid milk 4,638 4.1 0.067
Cheese 784 0.9 0.011
Source: derived from Duggan et al. 1983
aAverage of all samples, both positive and negative (zero values were used for all
samples not containing polychlorinated biphenyls).  Detection limit is 0.001 ppm.
bFiscal years 1972–1976
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PCB-contaminated waters (EPA 1980b).  PCB concentrations in seafood have therefore been closely
monitored over the years.  Although, in the past, PCB monitoring consisted of comparing PCB residues to
Aroclor mixtures, more recent studies have concentrated on determining PCBs on a congener-specific
basis (Bush et al. 1989; Huckins et al. 1988; Maack and Sonzogni 1988).  Overall, the most commonly
detected PCB congeners in fish samples are PCBs 138, 153, 180, 118, 110, 101, and 95 (Giesy et al.
1997; Hansen 1999; Hilbert et al. 1998; Jacobs et al. 1998; Qi et al. 1997; Ylitalo et al. 1999).  Due to
their high persistence and low potential for biodegradation, these PCB congeners are generally detected in
the highest concentrations in biological tissues.  In general, fish bioconcentrate more highly chlorinated
congeners, such as penta-, hexa-, and heptachlorinated biphenyls (Datta et al. 1999, Qi et al. 1997, Ylitalo
et al. 1999).  In a study of bullhead fish from Bear Lake, researchers found that the relative concentrations
of di-, tri-, tetra-, penta-, hexa-, hepta-, octa-, and nonachlorobiphenyls were 0.003, 0.019, 0.015, 0.165,
0.085, 0.075, 0.018, and 0.002 µg/g dry weight, respectively (Qi et al. 1997).  The same distribution of
PCB homolog groups was also observed in Northern Pike and Walleye from the same lake.  Similarly,
rats have been shown to preferentially bioconcentrate highly chlorinated PCBs.  In rats given gavage
doses of Aroclor 1254 (comprised of 2.1% mono-, di-, and tri-chlorinated PCB congeners, 19.1% tetra-,
49.6% penta-, 25.9% hexa-, 2.9% hepta-, and 0.5% octa- and nona-chlorinated PCB congeners), heavily
chlorinated congeners (with 6–9 chlorines) accounted for greater percentages of total PCBs in analyzed
tissues than in Aroclor 1254 itself (Kodavanti et al. 1998).
The dioxin-like PCB congeners, such as PCBs 77, 126, and 169, generally make up <1% of the total
amount of PCBs detected in fish (Ylitalo et al. 1999).  For instance, of the three dioxin-like PCB
congeners (77, 126, and 169), PCB 169 was not detected in fish and mussels collected in 1990 from
marine and estuarine waters from New York State, and the sum of the concentrations of the other two
congeners was <1% of the total PCB concentration (Hong et al. 1992b).  In another study, PCB congeners
were detected in oysters (Crassostrea virginica) from Galveston and Tampa Bays, but the sum of their
concentrations represented <1.5% of the total PCB concentration (Sericano et al. 1992).  Two of these
coplanar PCB congeners (77 and 126) were retained longer than those corresponding to different PCBs
within the same group when the oysters were moved to a clean water site.  Because of their dioxin-like
toxicity, these PCB congeners could constitute a potential health hazard to humans.  These studies
illustrate the importance of determining the concentration of specific congeners, in addition to the
concentration of total PCBs, in fish and shellfish tissues.
Using more complete congener profiles, including PCBs 95, 101, and 110 (see below), levels of PCBs
have been shown to increase with respect to the trophic level of the organism being studied.  In 1994,
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researchers monitored the concentration of PCBs in Lake Superior’s food web to determine differences in
accumulation between trophic levels (Kucklick and Baker 1998).  The concentration of total PCBs ranged
from 0.0056 µg/g wet weight in Mysis relicta to 0.180 µg/g wet weight in bloater fish.  Total PCBs in all
biota were dominated by hexa-, penta-, and heptachlorobiphenyl congeners, with only minor
contributions from the di-, tri-, and tetrachlorobiphenyl congeners that dominate the lake’s water column
(Kucklick and Baker 1998).  Based on their observations, researchers discovered that the increase in total
PCB residues was influenced both by the organisms lipid content and trophic position.  It was also noted
that the relative percentage of PCB congeners did not vary significantly between trophic levels.  When
comparing the levels of PCBs detected in sediment to the levels found in benthic organisms, researchers
found that the amount of PCBs accumulated by the benthic organisms could not be solely explained by
exposure to contaminated sediments, but was also influenced by PCB concentrations in feed and water
(Kucklick and Baker 1998).  The same increase in PCB concentration with respect to trophic level was
observed in the remote regions of the Canadian Arctic.  Researchers analyzed several animals from the
Canadian Arctic in April 1993 to determine the relative concentrations of PCBs stored in lipid tissues
(Letcher et al. 1998).  As in other food chains, PCB concentrations appeared to increase at higher trophic
levels.  The study found that the concentrations of total PCBs in Arctic cod, female ringed seal, male
ringed seal, and polar bear were 0.0718, 0.387±73, 0.447±92, and 6.207±948 µg/g lipid weight (Letcher
et al. 1998).  Of the 72 PCB congeners that were analyzed for in polar bear fat samples, only 20 were
found above the detection limit (5.0x10-5 µg/g lipid weight).  Of these, PCBs 153, 180, and 138 were
found in the highest concentrations.  Interestingly, cod and ringed seal contained 47 and 53 congeners,
respectively, above the detection limit.  For Arctic cod, PCBs 110, 101, 153, and 95 were detected in high
concentrations, while ringed seal contained high levels of PCBs 153, 138, and 101.  On a PCB congener-
specific basis, the concentration of PCBs decreased from cod to seal and finally to polar bear, revealing
an increasingly simplified number of PCB congeners bioaccumulating (Letcher et al. 1998).
Eight commercially and recreationally important marine species were collected in 1993 and 1994 from
30 locations along the Atlantic and Pacific coastal regions of the contiguous United States and analyzed
only for dioxin-like PCB residues (Ylitalo et al. 1999).  All marine species analyzed contained 1, often
$6, dioxin-like PCB congeners.  Researchers noted that higher concentrations were detected in marine
species collected near urban areas (Ylitalo et al. 1999).  The total mean concentration of PCBs in marine
tissues ranged from 0.0035 to 8.800 µg/g, wet weight.  The most commonly detected PCB congeners
were PCBs 153, 138, and 128.  For example, in fish species, PCB 153 represented 9.3–22% of the mean
total amount of PCBs detected in muscle (Ylitalo et al. 1999).  Dioxin-like PCBs that were detected most
frequently included PCBs 118, 105, 170, and 180.  Certain dioxin-like congeners (PCBs 77 and 126) were
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also detected in several tissues containing high lipid levels such as crab and lobster hepatopancrease
(Ylitalo et al. 1999).  However, these congeners were minor contributors to total PCB concentrations and
were usually <1% of the total.  The di-ortho-substituted congeners comprised 0.70–26% of the total PCB
concentrations while mono-ortho-substituted PCBs contributed 4.8–31% (Ylitalo et al. 1999).  Although
PCBs were the most frequently detected contaminant in environmental samples, the concentrations
usually fell well below the FDA tolerance limit of 2.0 µg/g wet weight in edible tissues of fish and
shellfish from the United States (Ylitalo et al. 1999).  The highest levels of PCBs occurred in
hepatopancreas samples from crustaceans, which are typically not consumed.
The Great Lakes region has accumulated persistent toxic substances, including PCBs, to the extent that
fish, other wildlife, and human populations face potentially high exposures to these constituents (Hicks
1996).  The concern for potential exposures of human populations to PCBs as well as other persistent
constituents in fish has spawned a number of studies of fish PCB body-burdens.  A survey of salmonid
species (chinook salmon, coho salmon, lake trout, brown trout, rainbow trout, and brook trout) in the
sport catch from western Lake Michigan showed significant interspecies differences in PCB residues
(Miller et al. 1993a).  When standardized to fish length, the maximum PCB concentration in muscle was
found in lake trout, followed by brown trout, chinook salmon, brook trout, rainbow trout, and coho
salmon.  However, in all species of fish surveyed, the levels of PCBs in 1990 declined 20–50% from
levels found in 1985.  Stow (1995a) evaluated data for these same five species, collected from Lake
Michigan from 1972 through 1992 and found that PCB levels have remained fairly constant since the
early 1980s when corrected for differences in species, location, and length.
Other studies support the downward trend in PCB concentration in fish from the Great Lakes region. 
Total PCB concentrations were studied from 1985 to 1992 in Coho salmon and rainbow trout caught near
various Wisconsin Lake Michigan fishing ports (Eggold et al. 1996).  The mean PCB concentrations in
Coho salmon in 1985, 1990, and 1992 were 0.99±0.6, 0.83±0.25, and 0.78±0.29 µg/g wet weight,
respectively while the mean PCB concentrations in rainbow trout in 1985, 1990, and 1992 were
1.13±1.38, 0.61± 0.33, and 0.44±0.19 µg/g wet weight, respectively.  One study followed the change in
PCB concentrations in sport fish and juvenile forage fish in the Canadian waters of the Great Lakes over a
15–20 year period (Scheider et al. 1998).  According to the study, the concentrations of PCBs in sport fish
declined in both Lake Huron and Lake Ontario from 1976 to 1994.  Mean concentrations of PCBs in
65 cm lake trout from southern Lake Huron declined from 8.07 ppm in 1976 to 0.47 ppm in
1994 (Scheider et al. 1998).  The same pattern was observed in 60 cm rainbow trout from Lake Ontario
where PCB concentrations declined from 3.9 ppm in 1976 to 0.97 ppm in 1994.  Among trout from Lake
PCBs 541
6.  POTENTIAL FOR HUMAN EXPOSURE
Ontario, PCB concentrations (total and individual congeners) have decreased by as much as 80% between
1977 (9.06 µg/g) and 1993 (1.72 µg/g) (Huestis et al. 1996).  For more information concerning PCB
concentrations in fish from the Great Lakes region, refer to Table 6-14.
A study was begun in 1975 by the New Jersey Department of Environmental Protection (NJDEP) to
monitor the concentration of PCBs in fish from the estuarine and coastal marine waters of New Jersey
(Kennish and Ruppel 1996).  The NJDEP monitored the concentration of PCB congeners exclusively
found in Aroclors1248, 1254, and 1260.  Although their studies indicate that PCB contamination is
highest in the Hudson-Raritan estuary, there is evidence that PCB concentrations are declining in some
fish species.  For example, the mean PCB level for striped bass and white perch decreased from 2.14 to
1.80 ppm wet weight and from 2.06 to 1.28 ppm wet weight, respectively, between the 1986–1987 and
1988–1991 survey periods (Kennish and Ruppel 1996).  However, the proportion of striped bass in the
1986–1987 study that exceeded the U.S. proposed action level of 2.0 ppm was 38%, while the
1988–1991 study showed relatively the same result with 36% exceeding 2.0 ppm.  The mean PCB
concentration for composite fish samples from the North Coast region also declined.  While the
1986–1987 study found a mean concentration of 2.33 ppm wet weight, the 1988–1991 study had a mean
concentration of 1.64 ppm wet weight.  Also, the percentage of samples with concentrations exceeding
2.0 ppm was lower in the 1988–1991 (33%) study than in the 1986–1987 (70%) study.  The Belgian
Fisheries Research Station monitored PCB concentrations in marine samples from 1983 to 1993 and
noticed a similar downward trend in PCB contamination (Roose et al. 1998).  The study followed four
different species: cod, flounder, blue mussel, and brown shrimp.  All species, except blue mussel, showed
a statistically significant decrease in PCB concentration.  In 1983, the median PCB concentration in cod
muscle tissue was 0.81±0.34 µg/g, while by 1993, the median concentration declined to 0.40±0.15 µg/g;
flounder muscle tissue had a median concentration of 3.3±0.8 µg/g in 1983, while by 1993, the median
concentration declined to 0.9±2.0 µg/g; blue mussel had a median PCB concentration of 2.4±0.3 µg/g in
1983, while by 1993, the median concentration declined to 1.6±0.1 µg/g; and for brown shrimp, the
median PCB concentration was 0.49±0.08 µg/g in 1983, while by 1993, the median concentration
declined to 0.28±0.05 µg/g (Roose et al. 1998).  Several studies support a gradual decrease in PCB
concentrations in fish tissue over time.  For more information concerning PCB concentrations in fish
species, refer to Table 6-15.
Decreasing PCB concentrations in fish, however, has not always been observed.  For instance, cod liver
oil samples from the Baltic Sea, were collected and analyzed for PCB concentrations every 5 years from
















Table 6-14.  Mean PCB Concentrations in Fish from the Great Lakes Region
Species Location Year
PCB concentration
µg/g (wet weight)a Source






Eggold et al. 1996
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Scheider et al. 1998
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Huestis et al. 1996
Forage fish Tittabawassee River 1990 (0.408–3.445) Giesy et al. 1997
Forage fish Saginaw River 1990 (0.452–1.875) Giesy et al. 1997
Forage fish Saginaw Bay 1990 (0.349–0.523) Giesy et al. 1997
Forage fish Lower Green Bay 1991 (0.048–0.458)b Brazner and De Vita 1998
Forage fish Middle Green Bay 1991 (0.040–0.078)b Brazner and De Vita 1998
Forage fish Upper Green Bay 1991 (0.003–0.011)b Brazner and De Vita 1998
Chinook salmon Lake Huron 1991–1994 0.338 Feeley and Jordan 1998
Chinook salmon Lake Ontario 1991–1994 0.835 Feeley and Jordan 1998 
Whitefish Lakes Superior, Huron, and Michigan 1994 (0.0711–0.2025) Dellinger et al. 1996


















Table 6-15.  Mean PCB Concentrations in Fish
Species Location Year
PCB concentration
µg/g (wet weight)a Source








Schmitt et al. 1985




Roose et al. 1998
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Striped bass Eastern Long Island 1985 1.8±0.4 Bush et al. 1989
Striped bass Western Long Island 1985 1.9±0.2 Bush et al. 1989
Striped bass Eastern Atlantic Shore 1985 3.0±0.5 Bush et al. 1989
Striped bass Western Atlantic Shore 1985 7.5±1.9 Bush et al. 1989
Striped bass Hudson River 1985 15.0±3.0 Bush et al. 1989




Kennish and Ruppel 1996




Kennish and Ruppel 1996




Kennish and Ruppel 1996
Young carp Buffalo River 1991 2.40 Loganathan et al. 1995
Middle-aged carp Buffalo River 1991 4.30 Loganathan et al. 1995
Old carp Buffalo River 1991 5.00 Loganathan et al. 1995
















Table 6-15.  Mean PCB Concentrations in Fish (continued)
Species Location Year
PCB concentration
µg/g (wet weight)a Source
Perch Baltic Sea 1991–1992 (1.034–5.418)b Strandberg et al. 1998
Deep sea fish Suruga Bay, Japan 1993 0.910 Takahashi et al. 1998
Deep sea velvet fish Nordfjord, Norway 1993 2.39b Berg et al. 1998
Deep sea tusk fish Nordfjord, Norway 1993 11.7b Berg et al. 1998
Fish Kremenchuck Reservoir, Ukraine 1994 (0.0107–0.0196) Lockhart et al. 1998
Fish Kakhovka Reservoir, Ukraine 1994 (0.0437–0.0767) Lockhart et al. 1998
Northern pike Bear Lake, Michigan 1995 (0.161–0.275)c Qi et al. 1997
Walleye Bear Lake, Michigan 1995 (0.156–209)c Qi et al. 1997
Bullhead Bear Lake, Michigan 1995 (0.0727–0.473)c Qi et al. 1997
Brook trout Kaweah River, California 1996 (0.0049–0.0081) Datta et al. 1998a
Fish Brunswick River 1996 (0.0025–0.48) Maruya and Lee 1998
Bullhead Lac St-Louis/St Lawrence Seaway 1996–1997 0.029 Chan et al. 1999
Perch Lac St-Louis/St Lawrence Seaway 1996–1997 0.070 Chan et al. 1999
Pike Lac St-Louis/St Lawrence Seaway 1996–1997 0.050 Chan et al. 1999
Smallmouth bass Lac St-Louis/St Lawrence Seaway 1996–1997 0.115 Chan et al. 1999
Sturgeon Lac St-Louis/St Lawrence Seaway 1996–1997 0.154 Chan et al. 1999
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early 1970s to the late 1980s and that they appeared to have been in a steady state condition.  For
example, the concentration of hexachlorobiphenyls in cod-liver oil were 3.2 (1971), 2.5 (1975),
7.3 (1980), 3.3 (1985), 4.0 (1986), and 3.8 µg/g (1989).  In general, the hexa- and pentachlorobiphenyls
were most predominant in the cod liver oil samples (Falandysz 1994).
Proximity to industrialized regions has been shown to influence PCB concentrations in fish.  Forage fish
collected in 1991 from coastal wetlands and beaches in Green Bay, Lake Michigan were analyzed for
PCB concentrations (Brazner and DeVita 1998).  The concentration of PCBs in fish species appeared to
vary spatially within Green Bay, according to proximity to the city.  For example, PCB concentrations in
fish (lipid normalized) ranged from 0.048 to 0.458 µg/g in the lower bay (closest to the city),
0.040–0.078 µg/g in middle bay, and 0.003–0.011 µg/g in the upper bay (furthest from the city).  Mean
levels of PCBs were also measured in fish above and below dams on rivers that feed into Lakes Michigan
and Huron (Giesy et al. 1995).  Researchers found that concentrations were higher downstream from the
dams than upstream.  For example, mean PCB concentrations in fish below dams found along the
Manistee, Muskegon and Au Sable Rivers were 1.90, 3.40, and 1.10 µg/g wet weight, respectively, while
above the dam, mean concentrations were 0.020, 0.195, and 0.061 µg/g wet weight, respectively.  In a
National Study of Chemical Residues in Fish conducted by EPA between 1986 and 1989, PCBs were
detected at a mean concentration of 1.90 µg/g in bottom-feeding and game fish collected from 91% of
362 sites surveyed (EPA 1992c; Kuehl et al. 1994).  Fish collected from 26% of the sites contained PCB
residues >1 µg/g, and fish from 2.5% of the sites contained PCB residues at >10.0 µg/g.  Fish collected at
sites near wood-preserving facilities, industrial/urban areas, pulp and paper mills, refineries/other
industrial sites, and Superfund sites were more highly contaminated with PCBs than fish collected near
agricultural areas, near POTW sites, or at U.S. Geologic Survey (USGS) National Stream Quality
Accounting Network sites (EPA 1992c; Kuehl et al. 1994).  Concentration patterns of various homologs
in fish tissues were as follows: mean concentrations of total mono-, di-, octa-, nona-, and
decachlorobiphenyl were <0.025 ppm; mean concentrations of total tri- and heptachlorobiphenyl were
<0.150 ppm; and mean concentrations of total tetra-, penta-, and hexachlorobiphenyl were 0.699, 0.565,
and 0.356 ppm, respectively (EPA 1992c).  Table 6-16 compares PCB concentrations in tissues of
six species of fish collected near the Mohawk Reservation at Akwesasne adjacent to the PCB
contaminated General Motors Foundry site and downstream in the St. Lawrence River and its tributaries
(ATSDR 1995).  The highest mean concentration of PCBs in standard fillet tissues (20.55 µg/g) was
detected in brown bullheads collected at the General Motors Corporation site.  These values are far higher
than the background concentrations of <0.100 µg/g for the total PCBs in fish fillets in New York State
(Sloan and Jock 1990). 
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Table 6-16.  Mean Total PCB Levels in Standard Fillets of Fish Collected 




St. Lawrence River and tributariesc
mean (range)b
Brown bullhead 20.55 (<0.15–81.49) 1.82 (<0.15–10.73)
Northern pike 2.73 (0.48–5.12) 0.42 (<0.15–3.52)
Rock bass 1.04 (<0.15–4.02) 0.18 (0.15–0.86)
White sucker 6.39 (0.29–11.0) 0.17 (<0.15–0.63)
Yellow perch 3.41 (0.20–12.26) 0.61 (0.15–0.86)
Source: ATSDR 1995
aGeneral Motors Corporation/Central Foundry Division, Massena, New York, plant is a Superfund site adjoining
the Mohawk Indian Nation at Akwesasne.  Fish and wildlife studies and human health studies have been
conducted at this site.
b(ppm, wet/weight)
cPCB contamination has been detected within the Akwesasne reservation boundaries in the St. Lawrence River
and several tributaries downstream from the General Motors Corporation site.
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Fish that inhabit remote areas of the world have also been shown to bioaccumulate PCBs.  From 1993 to
1994, PCB residues were evaluated in Kokanee fish and lake trout from the Sierra Nevada ecosystem to
determine the extent of organochlorine pollution in high altitude, alpine regions (Datta et al. 1999). 
Analysis of fish muscle revealed that the concentration of total PCBs ranged from 0.018 to 0.430 µg/g
wet weight for lake trout.  Compared to trout, Kokanee fish generally had lower PCB concentrations
ranging from 0.013 to 0.044 µg/g wet weight.  Residue analysis indicated that the congeners most
commonly found ranged from penta- to heptachlorobiphenyls (Datta et al. 1999).  Although Lake Tahoe
does not have any known point sources of pollution from industry or agriculture, the levels of PCBs in
lake trout samples were approximately equal to or slightly lower than those found in lake trout from Lake
Superior.  This suggests that PCBs have been introduced to Lake Tahoe through atmospheric deposition. 
For further information, refer to Table 6-17.   
The remediation of contaminated sediments has been shown to decrease PCB concentrations in fish
inhabiting contaminated rivers.  For example, one study monitored PCB concentrations in fish before and
after remediation of PCB contaminated sediment (Bremle and Larsson 1998).  It was found that PCB
concentrations in lake water decreased from 0.0086 to 0.0027 µg/L, while concentrations in fish were
halved after remediation was completed.  Although concentrations of PCBs in fish decreased after
remediation, the relative composition of PCB congeners remained relatively the same as before
remediation.  Fish still concentrated higher chlorinated congeners relative to levels detected in lake water
(Bremle and Larsson 1998).
PCB concentrations have also been monitored in zebra mussels collected from the lower Saginaw River
and Saginaw Bay, Michigan in the winter of 1991 (Endicott et al. 1998).  The results indicated that the
concentration of PCBs decreased in zebra mussels collected further away from the mouth of the Saginaw
River.  For example, the PCB concentration in zebra mussels from the mouth of the river was
approximately 1.1 µg/g, while concentration in zebra mussels collected 20 km away was approximately
0.45 µg/g.  The same concentration gradient was also observed in water samples taken from the zebra
mussel collection sites.  This suggests that PCB levels in zebra mussels are directly related to PCB
concentrations in water (Endicott et al. 1998).  Data from the Mussel Watch, plus additional data on
shellfish (oysters) from North and South American coastal locations, indicate PCB congeners in shellfish
were highest from South American locations and lowest in Central America (Sericano et al. 1995). 
Among 51 sites along the north Gulf of Mexico coast, samples with concentrations >0.100 µg/g were
















Table 6-17.  Mean PCB Concentrations in Fish from Remote Areas
Species Location Year
PCB concentration
µg/g (wet weight)a Source
Char Arctic Quebec, Canada 1989–1990 0.152 ± 0.042b Dewailly et al. 1993
Trout Schrader Lake in the Alaskan Arctic 1992 0.0066 Wilson et al. 1995
Grayling Schrader Lake in the Alaskan Arctic 1992 0.0013 Wilson et al. 1995
Lake trout Sierra Nevadas 1993–1994 0.018–0.430 Datta et al. 1999
Kokanee fish Sierra Nevadas 1993–1994 0.013–0.044 Datta et al. 1999
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Mexico sites decreased between 1986 and 1993.  For more information on PCB concentrations in
crustaceans, refer to Table 6-18.
PCB concentrations in the tissues of edible turtles, and in some cases frogs, are also of concern with
respect to human exposure, particularly for populations engaged in recreational and subsistence hunting. 
Hebert et al. (1993) evaluated the concentrations of PCBs in muscle tissue of 78 adult snapping turtles
collected from 16 sites in southern Ontario, Canada.  Mean concentrations (wet weight) of PCBs from all
16 sites ranged from <0.200 to 0.655 µg/g.  Skinner (1992) also reported concentrations of PCBs in fat,
liver, and muscle tissue from snapping turtles collected near Akwesasne, where turtles are a source of
food for a Native American community of nearly 10,000 people.  This author reported concentrations of
total PCBs (wet weight) ranging from 36.10 to 1,347 ppm in fat, 2.85–94.77 ppm in liver tissue, and not
detected to 2.98 ppm in muscle tissue of snapping turtles.  Northern leopard frogs from six wetlands
located along the Fox River and around Green Bay were collected from 1994 to 1995 and analyzed for
total PCB concentrations (Huang et al. 1999).  PCB levels in frog tissues ranged from 0.002 to 0.200 µg/g
wet weight with the highest concentrations found in frogs from the upper Fox River, furthest away from
Green Bay, Wisconsin.  Mean residues of Aroclors 1254 and 1260 in tissues of frogs, collected along the
Canadian shores of Lakes Erie and Ontario, and the St. Lawrence River, ranged from 0.310 to 1.699 µg/g
lipid weight in green frogs and 0.276–1.566 µg/g lipid for leopard frogs (Gillan et al. 1998).  Based on
frog tissue content and sediment PCB content, biota-sediment accumulation factors of 33.28–1.06 and
23.02–0.42 were calculated for leopard frogs and green frogs, respectively.
PCB concentrations were analyzed in fat, liver, and muscle tissue of commonly hunted red and grey
squirrels, beaver, muskrat, snowshoe hares, cottontail rabbits, and white-tailed deer (Skinner 1992). 
PCBs were typically found only in fatty tissues and occasionally in liver tissues, but were not detected in
muscle tissue.  Only two liver-tissue samples from muskrats contained detectable concentrations of PCBs. 
The highest concentration 0.7 µg/g wet weight was detected in a male muskrat.  Total PCBs were above
detection limits more frequently in mammalian fatty tissues, but only in muskrat and cottontail rabbits. 
Maximum concentrations of 0.8 µg/g wet weight and 4.0 µg/g lipid weight occurred in male muskrat
from the St. Lawrence River near Raquette Point and the St. Regis River, respectively (both sites are
within the New York State portion of the Mohawk Nation Reservation at Akwesasne).  Wild game
provides an important food source for both recreational and subsistence hunters; eating wild game is also
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Jackson et al. 1998
Mussels/Oysters U.S. Nationwide 1986 (0.009–6.808)a Sericano et al. 1995
Blue mussels Nordic Seas 1989–1990 (0.038–3.3) Gustavson and
Jonsson 1999
Zebra mussels Mouth of Saginaw
River
1991 1.1 Endicott et al. 1998
Zebra mussels Saginaw Bay 
(59 km from mouth of
Saginaw River)
1991 0.076 Endicott et al. 1998
Flat tree oysters Morrocoy National
Park, Venezuela
1991 (0.0006–0.012) Jaffe et al. 1998
Zebra mussels Saginaw Bay 1991 0.45 Endicott et al. 1998
Grass shrimp Coastal Georgia 1996 0.33 Maruya and Lee 1998
Gei wai shrimp Mai Po, Hong Kong 1997 0.0064 Liang et al. 1999
Caridean shrimp Mai Po, Hong Kong 1997 0.0046 Liang et al. 1999
aDry weight; Ranges in parenthesis
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Waterfowl may also be an important source of human exposure, especially for avid hunters.  Table 6-19
presents temporal PCB concentrations found in several species.  Tissues of fish- and shellfish-eating
waterfowl (i.e., goldeneye and mergansers) contained significantly higher PCB concentrations than
tissues of dabbling ducks (i.e., black ducks and mallards), which, in turn, contained higher concentrations
of PCBs than tissues of grazers (i.e., Canada geese) whose food preferences include aquatic vegetation,
upland grass, and grain (Rathke and McRae 1989).  The concentration of total PCBs was determined in
breast meat of Canadian geese collected from northeastern Illinois in 1994 (Levengood et al. 1999). 
Breast meat samples were baked, allowing fat to drip free, and assayed for PCB residues.  Overall, PCBs
were detected in only 5 of 87 tissue samples in baked breast meat (detection limit 0.01 µg/g) with residues
occurring more frequently in muscle than in skin.  PCB concentrations ranged from 0.114 to 0.480 µg/g
(Levengood et al. 1999).
 
Herring gull eggs have routinely been collected by the Canadian Wildlife Service since 1974 to monitor
contaminant trends.  The PCB concentrations in eggs taken from several nesting colonies on the Great
Lakes decreased from 1974 to 1986 (Rathke and McRae 1989).  The trend analysis determined that the
PCB concentration in herring gull eggs taken from two colonies on Lake Ontario was .140 mg/kg wet
weight in 1974 and fell to approximately 40 mg/kg in 1986.  Similarly, the concentration of PCBs in eggs
from a colony on Lake Erie was 60 mg/kg in 1974, but fell to <40 mg/kg in 1986.  An analysis of PCB
concentration in gull eggs in the Great Lakes from 1978 to 1992 indicates that egg concentrations have
stabilized (Stow 1995b).  Similar conclusions have been determined by other research efforts.  Levels of
PCBs in herring gull eggs from Great Lakes breeding colonies declined rapidly following the ban of
PCBs in 1972.  Since the mid 1980s, however, the concentration of PCBs in gull eggs has essentially
stabilized in Lakes Superior, Michigan, Huron, and Ontario (Donaldson et al. 1999).  In Lake Ontario,
herring gull egg PCB concentrations show annual variation due to increased feeding on alewives during
colder weather when alewives are particularly abundant (Hebert et al. 1997).  Unhatched eggs and plasma
samples from prefledged bald eagles were analyzed for PCB concentrations in the Canadian Great lakes
Basin (Donaldson et al. 1999).  The study found the mean PCB concentration in unhatched bald eagle
eggs collected along Lake Erie from 1974 to 1980 was 84 mg/kg wet weight and decreased to 26.4 mg/kg
wet weight from 1989 to 1994.  From 1990 to 1996, however, no significant decrease in plasma residue
levels was observed from either Lake Erie or Lake Superior (Donaldson et al. 1999).
Bottlenose dolphins (Tursipos truncatus) collected during a 1990 mortality event along the Gulf Coast of
the United States contained mean PCB concentrations of 93, 7.2, 49, 21, and 4 µg/g lipid basis in adult
males, adult females, immature dolphins, suckling dolphins, and fetuses, respectively (Kuehl and Haebler 
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µg/g (wet weight)a Source
Bufflehead
duck
New York State 1983–1984 0.15±0.19 Foley 1992
Scaup duck New York State 1983–1984 0.13±0.12 Foley 1992
Mallard duck New York State 1983–1984 0.08±0.06 Foley 1992
Black duck New York State 1983–1984 0.07±0.07 Foley 1992
Wood duck New York State 1983–1984 0.05±0.01 Foley 1992
Canada
geese
New York State 1983–1984 0.05±0.01 Foley 1992
Waterfowl Eastern Lake Ontario/
St. Lawrence River
1983–1985 (<0.01–0.27) Rathke and McRae
1989
Mallard duck Wisconsin 1984–1989 (ND–0.021) Botero et al. 1996
Grebe duck British Columbia 1989 0.542 (liver tissue) Elliott and Martin
1998
Seaduck British Columbia 1989 1.770 (liver tissue) Elliott and Martin
1998
Polar bear Arctic Quebec 1989–1990 7.002±1.276
(lipid weight)
Dewailly et al. 1993
Mink Georgia 1989–1991 0.154 (liver tissue) Osowski et al. 1995
Mink South Carolina 1989–1991 0.219 (liver tissue) Osowski et al. 1995
Mink North Carolina 1989–1991 0.216 (liver tissue) Osowski et al. 1995
Mallard duck Hamilton Harbor,
Canada






Poole et al. 1998
Sea otters Aleutian Islands 1992–1998 0.310±0.480 Bacon et al. 1999
Sea otters California Coast 1992–1998 0.190±0.350 Bacon et al. 1999
Sea otters Southeast Alaska 1992–1998 0.008±0.014 Bacon et al. 1999
aRanges in parenthesis
ND = not detected
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1995).  This trend generally reflects increased accumulation with age, with the exception of the adult
females.  The lower PCB residues in adult females are possibly due to the loss of PCBs via placental
transfer and via lactation by the adult females who are suckling their young (Kuehl and Haebler 1995).  In
a similar study with stranded bottlenose dolphins, Salata et al. (1995) reported a mean total PCB
concentration of 36.1 µg/g.  The mean concentrations of homolog groups di-, tri-, tetra-, penta-, hexa-,
hepta-, octa-, nona-, and decachlorobiphenyls were 0.046, 1.1, 2.2, 6.16, 15.1, 8.58, 2.23, 0.42, and
0.264 µg/g, respectively.  Similar to what is observed in other aquatic organisms, highly chlorinated PCB
congeners are preferentially bioconcentrated.  Blubber and liver samples from six striped dolphins found
dead in the Mediterranean sea from 1989 to 1990 were analyzed for PCBs (Reich et al. 1999). 
Researchers found that the mean concentration of total PCBs in dolphin blubber was 35.6±47.7 µg/g wet
weight and in liver samples was 8.74±11.7 µg/g wet weight.  Of the 37 congeners monitored in dolphin
tissue, PCBs 138, 153, 170, and 180 comprised approximately 60% of total PCBs (Reich et al. 1999). 
Non-ortho and mono-ortho PCB congeners, however, contributed <1% of total PCBs in blubber and liver
tissues.  Of these, PCB 77 was detected most frequently and in the highest concentrations.
By comparing concentrations of PCBs in a mother dolphin and her unborn calf, the authors determined
that the mother transferred 3.7% of her total PCB body burden to the calf during her pregnancy.  It was
also found that the lower molecular weight PCB congeners were more easily transferred than the higher
molecular weight congeners and that congeners with 9 or 10 chlorine atoms may not have been
transferred at all transplacentally.  PCB concentrations were measured in milk from five captive
bottlenose dolphins originally collected in the Gulf of Mexico (Ridgway and Reddy 1995).  Maximum
concentrations of PCBs in the milk were 4.45 ppm wet weight (14.1 ppm lipid weight) as Aroclor 1254,
found in the milk produced by a 34-year-old female, the oldest of the population sampled.  The lowest
concentration, 0.281 ppm wet weight (1.38 ppm lipid weight), was in milk from one of the youngest, a
16-year-old female.  For more information concerning PCB concentrations detected in blubber of several
sea mammals, see Table 6-20.  Based on a review of the literature on PCB residues in mammalian
species, Kamrin and Ringer (1994) concluded that the lowest residues were found in the Antarctic, while
the highest were in northern latitudes, particularly the Baltic Sea, with overall trends showing decreasing
residues of PCBs over the past 10–15 years.  Among male beluga whales from the St. Lawrence River
estuary, tissue PCB concentrations decreased by a factor of 1.9 from 1982 to 1994 (Muir et al. 1996a).  In
the 1993–1994 samples, male and female beluga whales had geometric mean total PCB concentrations of
29.6 and 78.9 µg/g lipid basis, respectively (Muir et al. 1996b).  PCB 126 was detected most often and in
















Table 6-20.  Mean PCB Concentrations in Blubber of Sea Mammals
                                       
Species
                                 
Location








                                          
Source




13±5.2 Berggrena et al. 1999
Porpoise Irish Sea 1987–1989 6.19 Troisi et al. 1998
Dolphin Irish Sea 1987–1989 (2.80–15.48) Troisi et al. 1998
Striped dolphin Mediterranean Sea 1989–1990 35.6±47.7 Reich et al. 1999
Beluga whale Arctic Quebec 1989–1990 1.002±0.469 Dewailly et al. 1993
Seal Arctic Quebec 1989–1990 0.527±0.692 Dewailly et al. 1993
Bottlenose dolphin
(adult male) U.S. Gulf Coast 1990 93 Kuehl and Haebler 1995
Bottlenose dolphin
(adult female) U.S. Gulf Coast 1990 7.2 Kuehl and Haebler 1995
Bottlenose dolphin
(juvenile) U.S. Gulf Coast 1990 49 Kuehl and Haebler 1995
Bottlenose dolphin
(suckling) U.S. Gulf Coast 1990 21 Kuehl and Haebler 1995
Bottlenose dolphin
(fetus) U.S. Gulf Coast 1990 4 Kuehl and Haebler 1995
Harbor seal pup Mouth of Puget Sound 1990 (1.3–2.1) Hong et al. 1996
Harbor seal pup Head of Puget Sound 1990 (9.2–16) Hong et al. 1996
Adult harbor seal Mouth of Puget Sound 1990 (0.17–0.32) Hong et al. 1996
















Table 6-20.  Mean PCB Concentrations in Blubber of Sea Mammals (continued)
                                       
Species
                                 
Location








                                          
Source
Striped dolphin Aegean Sea 1991 21.52±2.76 Troisi et al. 1998
Harbor seal San Francisco Bay 1991–1992 0.050a Young et al. 1998
Beluga whale
(fetus) Alaskan North Coast 1992 1.35 Wade et al. 1997
Beluga whale
(adult female) Alaskan North Coast 1992 (0.70–2.16) Wade et al. 1997
Beluga whale
(adult male) Alaskan North Coast 1992 (5.24–9.42) Wade et al. 1997
Ringed seal
(female) Canadian Arctic 1993 0.387±0.073 Letcher et al. 1998
Ringed seal
(male) Canadian Arctic 1993 0.447±0.092 Letcher et al. 1998
Beluga whale
(adult male) St. Lawrence River 1993–1994 29.6 Muir et al. 1996b
Beluga whale
(adult female) St. Lawrence River 1993–1994 78.9 Muir et al. 1996b
Sperm whale
(male) North Sea 1994–1995 4.5 Holsbeek et al. 1999
Seal Caspian Sea 1996–1997 (1.12–19.08) Hall et al. 1999
aConcentration reported in blood; ranges in parenthesis
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PCBs have also been detected in several consumer products manufactured outside the United States.  PCB
concentrations in recycled paper products (envelopes, toilet paper, tissue paper, and cardboard boxes) of
central European origin were in the range of 5–6,000 µg/kg (ppb) (Welling et al. 1992).  PCBs
(Aroclor 1254) also were detected in both anhydrous lanolin and lanocerin and in finished cosmetic
products produced in Italy (Mariani et al. 1994).  PCB concentrations detected in the various products
included 1.2 ppm in anhydrous lanolin, 4.8 ppm in lanocerin, 0.64 ppm in anhydrous cream for children,
0.52 ppm in oil/water emulsion-emollient cream, and 3.8 ppm in water/oil emulsion-emollient cream.
6.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
PCBs are no longer manufactured or used (except under exemption) in the United States.  Nonetheless,
PCBs are present in the environment due to the recycling of the compounds released into the environment
by historic anthropogenic production activities.  The general population may be exposed to PCBs
primarily via consumption of contaminated foods, particularly fish, meat, and poultry, and inhalation
(Gunderson 1988).  No known consumer product currently manufactured in the United States contains
PCBs.  Exposure of the general population to PCBs is evidenced by the body burden of the compounds
among the nonoccupationally exposed population.  PCBs have been detected in the blood, adipose tissue,
and breast milk of nonoccupationally exposed members of the general population (EPA 1986b;
Greizerstein et al. 1999; Gunderson 1995; Ouw et al. 1976).  Overall, PCBs 138, 153, and 180 are the
most consistently detected and quantitatively dominant congeners found in human tissues (Hansen 1998). 
These three congeners have been used to monitor both geographical and temporal trends in human
exposure studies due to their high prevalence and persistence (Koopman-Esseboom et al. 1994a, 1994b;
Schecter et al. 1989).  Other congeners that are commonly detected include PCBs 28, 118, and 170.  As
the summaries in Section 6.4 indicate, there is a general overall trend for decreasing concentrations of
PCBs in most environmental media over the past 2 decades; air concentrations have decreased slightly,
and levels in water, sediments, and fish have decreased, in some cases significantly.  As noted in this
section, PCB body burdens in humans also have decreased, as evidenced by lower levels reported in
human adipose tissue, blood serum, and breast milk. 
The National Human Adipose Tissue Survey (NHATS), conducted in 1982 using packed column gas
chromatography (GC), found that the concentrations of total PCBs in composite human adipose tissue
ranged from 14 to 1,700 ng/g (0.014–1.7 ppm) (lipid basis) (EPA 1986b).  The maximum concentration
was found in a sample composite collected from the South Atlantic region (Virginia, North Carolina,
South Carolina, Georgia, and Florida).  PCBs were detected in 83% of 46 composite samples analyzed in
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the NHATS study.  In a subsequent study, Kutz et al. (1991) reported that an examination of the NHATS
data from 1970 to 1983 revealed that 93.5% of the U.S. population had detectable concentrations of
PCBs, 66.4% had concentrations <1 ppm, 28.9% had concentrations >1 ppm, and 5.1% had
concentrations >3 ppm.  The 0–14-year-old age group had the smallest percentage of individuals with
detectable concentrations of PCBs and the smallest percentage of individuals exceeding the 1 and 3 ppm
PCB concentrations; males had a higher percentage of individuals exceeding 1 ppm PCBs than did
females; and the Northeast Census Region had the greatest percentage of individuals exceeding 3 ppm.  A
time-trend analysis of the data also revealed that the percentage of the population having PCB
concentrations from 1 to 3 ppm steadily declined from over 62% in 1972 to <2% in 1984.  The percentage
of the population that had tissue levels >3 ppm also declined during this same period from a high near
10% in 1978 to zero in 1984 (Fensterheim 1993).  PCB concentrations in human adipose tissues in the
United States appear to have decreased significantly over the years.
Results of congener-specific analysis of PCBs in human adipose tissues obtained from Atlanta, Georgia,
in 1986 have been reported (Lordo et al. 1996; Patterson et al. 1994).  The sums of three coplanar PCB
congeners (77, 126, and 169) were 0.24 ng/g in 14 males with a mean age of 43 and 0.18 ng/g in
14 females with a mean age of 54.  Age was significantly correlated with the concentrations of the three
congeners such that older people had higher concentrations of PCBs than did younger individuals.  From
1990 to 1994, 105 autopsied bodies from Greenland were analyzed for PCBs (Dewailly et al. 1999). 
Researchers also found that the mean concentration of total PCBs in omental fat increased with age.  The
study found that in people ages 41–54, 55–69, and $70, mean PCB concentrations were 4,909, 5,337, and
7,357 ng/g lipid weight, respectively.  The concentrations of congener-specific PCBs in intra-abdominal,
subcutaneous, adrenal, liver, kidney, muscle, and spleen tissues obtained from five North American
patients with no known occupational exposure are also available (Schecter et al. 1989, 1994).  Differences
were observed in the PCB congener pattern of distribution within a given tissue and between the various
tissues of the donors.  On a lipid weight basis, the highest concentrations of PCBs typically were detected
in the adipose and liver tissue.  Preferential accumulation in adipose tissue was also noticed in the
Dewailly et al. (1999) study.
PCB serum levels measured from 1973 to 1996 in the general population are summarized in Table 6-21. 
Since the 1970s, researchers have noticed a decrease in PCB concentrations in human blood serum.  In a
study of 1,631 individuals from 1978 to 1979 living in the United States, the mean PCB concentration in
















Table 6-21. Serum Polychlorinated Biphenyl (PCB) Levels in Non-occupationally Exposed U.S. Populations 
That Do Not Consume Fish from PCB-Contaminated Waters (1973–1996)


















Great Lakes sport fish
41 1996 1.2 0.46–2.9 Anderson et al. 1998
Infrequent male
consumers of Great
Lakes sport caught fish
57 1994–1995 1.5 0.5–9.7 Hanrahan et al. 1999
Infrequent female
consumers of Great
Lakes sport caught fish
















59 1983 5.8 4.4 6.5 4–8 1–45 Welty 1983
Fairmont, West
Virginia, volunteers
























Table 6-21. Serum Polychlorinated Biphenyl (PCB) Levels in Non-occupationally Exposed U.S. Populations 
That Do Not Consume Fish from PCB-Contaminated Waters (1973–1996) (continued)




















71 1982 4 – – – – Schwartz et al. 1983
Lake Michigan random
nonfisheaters








17 1979 7.5 5.8 6.8 4–11 2–30 Drotman 1981
Franklin, Idaho,
volunteers




19 1979 12 – – – 10–27 Chase et al. 1982
Newton, Kansas,
volunteers
7 1979 4.9 4.2 3.1 2–8 2–11 Vernon 1981
Michigan PBB cohort 1,631 1978–1979 7.7 6.4 – – <1–57 Kreiss et al. 1982
Bloomington, Indiana,
volunteers and controls
110 1977 18.8 – 10.8 17–21 6–79 Baker et al. 1980
Lake Michigan random
nonfisheaters
29 1973 17.3 15b – – <5–41 Humphrey 1983
Source:  Adapted from Kreiss 1985; Massachusetts Department of Public Health 1987; Sahl et al. 1985a, 1985b
aPre-employment survey of utility company workers
bMedian
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0.9 to 1.5 ng/mL in individuals who do not have a diet high in fish, especially fish from the Great Lakes
(Anderson et al. 1998; Hanrahan et al. 1999). 
Congener-specific analysis of PCBs in serum show that the mean concentration of three coplanar
congeners (77, 126, and 169) in the general population in the United States (sampled in 1988) is 176 pg/g
(ppt) (lipid basis) (Patterson et al. 1994).  Analysis of pooled serum samples show a decrease in the level
of three coplanar (77, 126, and 169) PCBs from 1982 to 1989 (Patterson et al. 1994).  The mean
concentration of the total non-ortho-, mono-ortho-, and di-ortho-substituted PCBs in the whole blood of
50 Vietnam veterans in Michigan measured in 1991–1992 was 167 ng/g (ppb) with a concentration range
of 50–628 ng/g (ppb) (Schecter et al. 1993).  A breakdown of total PCBs revealed that 0.227 ng/g were
contributed by the coplanar PCBs (77, 126, and 169), 50 ng/g by the mono-ortho PCBs (28, 74, 105, 118,
and 156), and 117 ng/g by the di-ortho PCBs (99, 128, 138, 153, 170, 180, 183, 185, and 187) (Schecter
et al. 1993).  The three most predominant congeners in the whole blood samples were congener
153 (40 ppb), 138 (26 ppb), and 180 (19 ppb).  The PCB levels in the veterans did not reflect exposure in
Vietnam (Schecter et al. 1993). 
PCB concentrations in human breast milk have also been closely monitored since the early 1970s (Mes
and Davies 1979; Mes et al. 1986; Newsome and Ryan 1999).  Temporal trend studies indicate that the
PCB levels detected in human breast milk have decreased over time (Lunden and Noren 1998; Schade
and Heinzon 1998).  Recent studies indicate that the mean concentration of PCBs in human breast milk
appears to range from 238 to 271 ng/g lipid weight (Kostyniak et al. 1999; Newsome et al. 1995).  For
more information concerning concentrations in human breast milk, please refer to Section 6.6 Exposures
of Children.
Since the early 1960s, the FDA has conducted Total Diet Studies, also known as the Market Basket
Surveys.  These annual studies analyze ready-to-eat foods collected in markets from cities nationwide to
determine the intake of selected contaminants in the American diet.  Tables 6-22 through 6-25 present the
results of the Total Diet Studies from 1976 to 1997 with respect to PCBs.  Since the mid-1970s,
individual diets for adult males, toddlers, and infants have been analyzed, and the total PCB levels have
shown a downward trend in concentration from the mid-1970s to the mid-1980s.  For example, the
estimated daily dietary intake of PCBs in an adult diet in 1977 was 0.016 µg/kg/day while in the study
from 1982 to 1984, the estimated daily intake was 0.0005 µg/kg/day (Gartrell et al. 1985a, 1985b, 1986a).
Temporal monitoring studies of PCBs in Total Diet Studies from 1982 to 1997 have revealed that PCB
intake has remained relatively steady (Bolger 1999; Gunderson 1995).  For example, total diet studies 
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Table 6-22.  Estimated Daily Dietary Intake (µg/kg/day) of Polychlorinated
Biphenyls for Adults, Toddlers, and Infantsa
Fiscal year Adult Toddler Infant
1982–1984 0.0005 0.0008 0.0012
1981–1982 0.003 Not detected Not detected
1980 0.008 Not detected Not detected
1979 0.014   Not detected Not detected
1978 0.027 0.099 0.011
1977 0.016 0.030 0.025
1976 Trace Not detected Trace
Source: Derived from Gartrell et al. 1985a, 1985b, 1986a, 1986b; Gunderson 1988
















Table 6-23.  Mean Daily Intakes of PCBs Per Unit of Body Weight (µg/kg body weight/day)a,b
Children Adult males
6 months 2 years 14–16 years 25–30 years
82/84 84/86 86/91 82/84 84/86 86/91 82/84 84/86 86/91 82/84 84/86 86/91
0.001 0.001 <0.001 0.001 0.002 0.002 <0.001 0.002 <0.001 <0.001 0.001 <0.001
aGunderson 1995
















Table 6-24.  Children Total Diet Studies — PCB Intakes from 265 Foods for the Years 1991–1997a
Dietary intake of PCBs µg/kg/day
6–11 months 2 years 6 years 10 year 14–16 years 14–16 years
Total Diet Study Infant Child Child Child Female Male
1991 (3rd quarter) 0.002 0.015 0.023 0.021 0.013 0.013
1993 (1st quarter) <0.001 0.003 <0.001 <0.001 <0.001 0.002
1993 (2nd quarter) 0.001 0.011 <0.001 <0.001 0.002 <0.001
1994 (1st quarter) 0.001 0.034 0.018 0.018 0.010 0.011
1994 (2nd quarter) 0.003 0.002 0.002 0.002 <0.001 <0.001
1995 (1st quarter) 0.008 0.006 0.007 0.004 0.001 0.003
1997 (3rd quarter) <0.001 0.008 0.003 0.003 0.001 0.003

















Table 6-25.  Adult Total Diet Studies — PCB Intakes from 265 Foods for the Years 1991–1997a
Dietary intake of PCBs µg/kg/day
25–30 years 40–45 years 60–65 years 70 years
Total Diet Study Female Male Female Male Female Male Female Male
1991 (3rd quarter) 0.007 0.008 0.006 0.009 0.008 0.012 0.008 0.012
1993 (1st quarter) <0.001 <0.001 <0.001 <0.001 0.001 0.001 0.001 0.001
1993 (2nd quarter) <0.001 0.001 0.001 0.001 <0.001 0.001 0.001 0.001
1994 (1st quarter) 0.012 0.013 0.011 0.015 0.012 0.014 0.011 0.010
1994 (2nd quarter) <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
1995 (1st quarter) 0.003 0.002 0.004 0.003 0.004 0.005 0.002 0.004
1997 (3rd quarter) 0.002 0.002 0.001 0.002 0.002 0.003 0.001 0.003
Average intake 0.004 0.004 0.003 0.004 0.004 0.005 0.003 0.004
a Bolger 1999c
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conducted from 1982 to 1984 for adults between the ages of 25 and 30 indicated that the mean daily
intake of PCBs was <0.001 µg/kg body weight/day while in the 1997 study, the mean was 0.002 µg/kg
body weight/day.  The FDA reported that the source of PCBs in the past was the meat-fish-poultry
composite (63–100% of total dietary intake) with fish being the major contributing source (Jelinek and
Corneliussen 1976).  This observation appears to have continued in the recent Total Diet Studies
conducted from 1991 to 1997 where meat, fish, and poultry remain the primary sources of PCBs in the
human diet with fish being the major contributing factor (Bolger 1999).  A recent market-basket study
analyzed PCB congener levels in pooled food samples from supermarkets in five U.S. cities representing
the northeast, mid-south, south, mid-west, and west (Schecter et al. 1997).  Coplanar PCB concentrations
ranged from 0.2 pg/g wet weight in a simulated vegetarian diet to 531.4 pg/g wet weight in fresh fish. 
Mono-ortho PCBs ranged from 15 pg/g wet weight in a vegetarian diet to 2,350 pg/g wet weight in fresh
fish.  Di-ortho PCBs ranged from 144 pg/g in a vegetarian diet to 4,600 pg/g in fresh fish.  Schecter and
Lingjun (1995) measured levels of mono-ortho and di-ortho PCBs in three types of fast foods sampled at
the same five representative U.S. cities.  Average total concentrations for mono-ortho PCBs were 380,
440, and 500 pg/g for hamburger, pizza, and chicken, respectively, and for di-ortho PCBs were 577, 740,
and 670 pg/g for hamburger, pizza, and chicken, respectively.  
As is the case with U.S. dietary exposure, PCB exposure via ingestion of drinking water and inhalation
has also decreased over time.  The average adult inhales .20 m3 of air per day while the average numbers
of hours a person spends outdoors, within vehicles, and indoors are approximately 1.77, 1.77, and
20.4 hours, respectively (EPA 1997d).  Assuming that outdoor air at a typical urban location contains an
average PCB concentration of 5 ng/m3 (range, 1–10 ng/m3) (Eisenreich et al. 1992), the average daily
exposure via inhalation would be 100 ng (range, 20–200 ng).  However, the concentrations of PCBs in
indoor air can be at least an order of magnitude higher than outdoor air concentrations (see Section 6.4.1)
(Balfanz et al. 1993; MacLeod 1981; Wallace et al. 1996).  It has been suggested that the emissions from
certain appliances and devices (e.g., fluorescent lighting ballasts) that have PCB-containing components
contribute to these higher indoor air concentrations.  Individuals who spend more time indoors in these
types of surroundings may be exposed to higher PCB concentrations than people who spend more time
outdoors.  The exact inhalation exposure for the general population depends on the amount of time an
individual spends outdoors and indoors.
The general population is exposed to <200 ng/day PCBs from drinking water (assuming drinking water
concentrations of <0.1 µg/L [ppb] PCBs and a consumption rate of 2 L/day).  However, the daily
exposure to PCBs via most drinking water in the United States is likely to be much lower than 200 ng,
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since PCBs were detected in only one finished groundwater supply and two finished surface water
supplies surveyed in NOMS I and II out of 113 cities surveyed nationwide.  This value (<0.1 µg/L) is
based on the NOMS study conducted from 1975 to 1977.  A study of municipal drinking water sources in
Canada from 1985 to 1988 detected PCBs in only 1 out of 280 water samples at a concentration of
0.006 µg/L (O’Neill et al. 1992).  Consequently, for persons in the general population, food consumption
and inhalation appear to represent greater sources of human exposure to PCBs than ingestion of drinking
water.
From 1970 to 1976, occupational exposure to PCBs in the United States may have affected
.12,000 individuals per year (NIOSH 1977).  PCB levels in blood, plasma, serum, and body tissues were
10–1,000 times higher in individuals exposed to PCBs in the workplace than in nonoccupationally
exposed individuals (Wolff 1985; Yakushiji et al. 1978).  Serum PCB levels in some occupationally
exposed populations are reported in Table 6-26.  Within 46 months following the cessation of PCB use,
serum PCB levels of the lower chlorinated (mostly tri- and tetra-chlorinated) PCBs in capacitor
manufacturing workers in the United States decreased by an average of 25–90%, although the higher
chlorinated congeners did not decrease significantly (Wolff et al. 1992).  A study conducted in Finland
found that the median serum levels of three co-planar PCB congeners (77, 126, and 169) in capacitor
manufacturing workers were 3–20 times higher than levels in the control population (Luotamo et al.
1993).  The same congeners in the blood of exposed Finnish laboratory personnel, however, were not
elevated above those of a control group (Hesso et al. 1992).  PCB blood levels were compared for
employees in the scrap metal industry where soils were contaminated with PCBs (Malkin 1995).  Serum
PCB levels of <1–65.3 µg/L were observed.  No difference in PCB serum levels were found between
outdoor or indoor workers.  This lack of difference was associated with the workers’ practice of eating
lunch outdoors and consequent hand-to-mouth transmission.
Occupational exposure to PCBs via inhalation was estimated to be more than an order of magnitude
higher than exposure via dermal contact in workers at a facility that recovers PCBs from transformers
(Perkins and Knight 1989).  Although occupational exposure to PCBs in the United States is no longer
due to the production of PCBs or PCB-containing products (e.g., capacitors, transformers, and electrical
equipment), it may still occur as a result of repairing electrical equipment that contains PCBs or accidents
















Table 6-26.  Serum Polychlorinated Biphenyl (PCB) Levels in Populations with Occupational Exposure












Railway car maintenance 86 33.4 – – 10–312 Chase et al. 1982
Capacitor plant 34 394.0a – 234–554 trace–1,700 Ouw et al. 1976, 1979
Capacitor plant 290 48.0a 21.0b 38–546b 1–546c Wolff et al. 1982a
Capacitor plant 80 342.0a – – 41–1,319 Maroni et al. 1981a
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Smith et al. 1982
Transformer repair workers
(recent exposure)
35 – 43.7d – 4.3–253 Fait et al. 1989
Transformer repair workers
(past exposure)
17 – 30.0c – 1.5–143 Fait et al. 1989
Scavenging copper from PCB-
contaminated capacitors at
waste sites
11 – 12.0 – – Stehr-Green et al. 1986b






Smith et al. 1982
Utility 1,058 4.0 3.0d 3.65f <1–26 Sahl et al. 1985b
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In addition, occupational exposure to PCBs may occur as a result of waste site cleanup or disposal
activities.  The median serum levels of two PCB congeners (77 and 81) in Finnish workers at a hazardous
waste incinerator site where PCB-containing capacitors are destroyed were 3–4 times higher than control
population levels (Luotamo et al. 1993).  The serum levels of two other coplanar congeners (126 and 169)
in incinerator workers were not significantly different from control population levels.  Elevated PCB
levels in blood (compared with background levels) were found in some exposed workers, including
firefighters, electricians, and others who entered the building following the Binghamton State Office
Building transformer fire in Binghamton, New York (Schecter 1987).  In seven firefighters, the serum
PCB levels measured approximately 10 months after the fire decreased by 20–95% from levels measured
immediately after the exposure (Schecter et al. 1994).  Compared to persons not occupationally exposed
to PCBs, electrical workers appeared to retain more of PCB congener 126 after exposure than any other
congener; however, the unusually high concentration of PCB 126 in serum of electrical workers was later
attributed to an unidentified peak by the analyst (see Hansen 1999, Appendix Table 5) (Fait et al. 1989). 
Maintenance workers and welders who work with metals coated with PCB-containing paints may also be
at higher risk of exposure because scraps from different railroad car paints were found to contain
4–625 mg/kg of Aroclor 1254 (Welsh 1995).
According to the National Occupational Exposure Study (NOES) conducted by NIOSH from 1981 to
1983, the following estimated number of workers were potentially exposed to Aroclors in the workplace:
2,214 to Aroclor 1242; 3,702 to Aroclor 1254; 991 to Aroclor 1260; and 1,558 to Aroclor 1016 (NIOSH
1989).  Occupational exposure to Aroclors occurs in miscellaneous workers in the transformer industry,
noncellulose fiber industry, semiconductor and related industries, and in sawmills and planing mills.  It
also occurs in clinical laboratory technicians and technologists of general medical and surgical hospitals. 
The NOES database does not contain information on the frequency, concentration, or duration of
occupational exposure to any of the chemicals listed.  The survey provides estimations of the numbers of
workers for whom potential exposure in the workplace is an issue.  Since this study was conducted from
1981 to 1983, it does not accurately represent current workplace exposure to PCBs. 
6.6 EXPOSURES OF CHILDREN
This section focuses on exposures from conception to maturity at 18 years in humans.  Differences from
adults in susceptibility to hazardous substances are discussed in Section 3.7 Children’s Susceptibility.
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Children are not small adults.  A child’s exposure may differ from an adult’s exposure in many ways. 
Children drink more fluids, eat more food, breathe more air per kilogram of body weight, and have a
larger skin surface in proportion to their body volume.  A child’s diet often differs from that of adults. 
The developing human’s source of nutrition changes with age: from placental nourishment to breast milk
or formula to the diet of older children who eat more of certain types of foods than adults.  A child’s
behavior and lifestyle also influence exposure.  Children crawl on the floor, put things in their mouths,
sometimes eat inappropriate things (such as dirt or paint chips), and spend more time outdoors.  Children
also are closer to the ground, and they do not use the judgment of adults to avoid hazards (NRC 1993).
Children are exposed to PCBs in the same manner as the general population—primarily via consumption
of contaminated foods, particularly meat, fish, and poultry (Bolger 1999; Gunderson 1985).  Infants and
young children consume a greater amount of food per kilogram of body weight and, therefore, may have a
proportionately greater exposure to PCBs than adults (Cordle et al. 1982).  Infants and children also have
different diets than adults due to their age.  This has been reflected in the FDA total diet studies
(Gunderson et al. 1995).  Breast-fed infants may be exposed to higher than average concentrations of
PCBs because PCBs tend to accumulate in breast milk fat.  Factors that can affect the levels of PCBs in
human breast milk include mother’s age, number of deliveries and lactations, place of residence, and
changes in the mother’s weight during lactation (Czaja et al. 1999a, 1999b).  Women with the highest
number of deliveries have higher levels of PCBs in their breast milk (Czaja et al. 1997a).  However, while
lactation may be one of the means of excreting PCBs from the body, it is age rather than the number of
deliveries that seems to affect the concentration of PCBs with older women having higher concentrations. 
Also, women in industrial areas can have elevated levels of PCBs in their breast milk compared to women
living in rural areas (Czaja et al. 1997b).  It is estimated that an infant that is breast fed for 6 months will
receive 6.8–12% of its lifetime PCB body burden (Kimbrough 1995; Patandin et al. 1999).  Blood
samples were taken from 80 full-term German neonates within the first 12 hours of life, before the first
oral feeding (Lackmann et al. 1999).  The median serum concentration of total PCBs was 0.96 µg/L
(<0.30–3.14, range), with PCBs 138, 153, and 180 detected at median levels of 0.34 (<0.10–1.01),
0.42 (<0.10–1.42), and 0.17 (<0.10–0.78) µg/L, respectively.  Lanting et al. (1998a) measured the levels
of PCB congeners 118, 138, 153, and 180 in plasma from 42-month-old children (n=126) living in the
Groningen area, The Netherlands.  In 42-month-old children who were fully breast-fed for at least
6 weeks, the median total plasma PCB level 0.81 µg/L (range, 0.23–2.2), compared to the formula-fed
children that had levels of 0.18 µg/L (range, 0.07–1.49) (see Section 3.7).  
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A recent study conducted from 1991 to 1993 of human breast milk from 213 women living along Lake
Ontario in New York State determined that the mean concentration of PCBs was 271±116 ng/g lipid
weight (Kostyniak et al. 1999).  In 1992, breast milk from 497 women living in Canada had a mean PCB
concentration of 238 ng/g lipid weight (Newsome et al. 1995).  Several studies indicate that PCB
concentrations in human breast milk have decreased since the early 1970s (Hansen 1999; Lunden and
Noren 1998).  For example, in a study of human breast milk of Swedish women studied from 1972 to
1992, researchers determined that the concentration of PCBs decreased over time.  PCB concentrations in
1972, 1980, 1984–1985, 1990, and 1992 were 1,090, 780, 600, 510, and 380 ng/g lipid weight,
respectively (Lunden and Noren 1998).  In Germany, researchers studied PCB levels from 1986 to
1996 in human breast milk of women between the ages of 27 and 31 who had only given birth once. 
They found that the concentrations of PCBs in 1986, 1988, 1990, 1992, 1994, and 1996 were 1,300,
1,050, 1,000, 750, 650, and 450 ng/g lipid weight, respectively (Schade and Heinzow 1998).  Congener-
specific analysis of human milk indicates that the congeners 138, 153, 118, 180, and 105 are most
prevalent and that the three coplanar congeners (77, 126, and 169) were either not detected or detected at
concentrations <1 ng/g (ppb) on a milk fat basis (Bohm et al. 1993; Mes et al. 1993).  For a representative
trend analysis of PCB concentrations in human breast milk over time, please refer to Table 6-27.  PCB
exposure of infants whose mothers have a diet high in fish is discussed in Section 3.7 and 6.7.  In general,
mothers who consume fish contaminated with PCBs have higher levels in their breast milk compared to
nonconsumers.
Unborn children may also be at risk of higher PCB exposure, especially in areas that have been heavily
contaminated with PCBs.  To illustrate this, researchers analyzed placental cord serum of 755 infants born
to mothers residing in towns adjacent to a PCB-contaminated harbor in southeastern Massachusetts
(Altshul et al. 1999).  Infants whose cord serum was analyzed were born between 1993 and 1998 in the
towns of New Bedford, Acushnet, Fairhaven, and Dartmouth, Massachusetts.  Of the 51 PCB congeners
analyzed, only 13 were above the detection limit (0.01 ng/g serum).  The median concentration of PCBs
was 0.56 ng/g serum (Altshul et al. 1999).  Researchers found that the relative predominance of less
chlorinated congeners in the cord blood was generally consistent with the characteristics of the
contaminated site.  PCB concentrations were also measured in cord blood from both 134 women who
consumed Great Lakes fish and 145 women who had never consumed Great Lakes fish (Stewart et al.
1999).  Although researchers did not find any difference between fish consumption levels and total PCBs
in umbilical cord serum, it was established that fish eaters had marked elevations of the most heavily
chlorinated PCB homologues.  In particular, levels of hepta- to nonachlorobiphenyls were greater in fish
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16 Counties in New York state
adjacent to Lake Ontario
213 1991–1993 271±116 8.28±4.66 Kostyniak et al. 1999
New York State 7 1991–1993 (239–428) 3.5–14.1 Greizerstein et al. 1999
Helsinki, Finland (urban) 20 1992–1994 296 Kiviranta et al. 1999




4 1993 (1,107–2,379) Korrick and Altshul 1998
Murmansk, Russia
(industrialized area)
15 1993 429.4 Polder et al. 1998
Monchegorsk, Russia
(industrialized area)
15 1993 490.5 Polder et al. 1998
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stillborn fetuses from the Netherlands in 1993 and found that median (range) concentration of PCBs in
adipose tissue was 235 (97–768) ng/g lipid weight (Lanting et al. 1998b). 
As indicated above, PCB measurements of breast milk and placental cord blood have been used as
surrogate measures of exposure in studies of children.  Cord blood is the most direct marker of fetal
exposure, but because of its relatively low fat content, it requires sensitive analytical methods for accurate
PCB analysis; analysis of breast milk does not present this difficulty.  Analytical techniques have
improved enormously in recent years, such that cord blood analysis of PCBs is now more accurate and
reliable, but still of concern due to the low concentration of fat in cord blood.
For most young children, it appears that the dietary intake of PCBs has reached a steady state in the
United States.  During the 1980s, dietary intake of PCBs for infants (6–11 months) declined from 0.011 to
0.0012 µg/kg/day, and dietary intake of PCBs for toddlers (2 years) declined from 0.099 to
0.0008 µg/kg/day (Gartrell et al. 1985a, 1985b, 1986a, 1986b; Gunderson 1988).  In the most recent study
conducted in 1997, the estimated dietary intakes for infants (6 months) and toddlers (2 years) are
<0.001 and 0.008 µg/kg/day, respectively (Bolger 1999).  Assuming that the average infant weighs 9 kg,
the average daily dietary exposure would be <0.009 µg.  Assuming that the average toddler weighs 13 kg,
the average daily dietary exposure would be 0.104 µg.  See Tables 6-22 through 6-25 in Section 6.5 for
more details.  A potential source of dietary intake of PCBs for infants may also come from the
consumption of contaminated baby formulas.  In a study of eight soybean infant formulas obtained in
Spain, researchers discovered detectable quantities of PCBs (Ramos et al. 1998).  The mean total
concentration of PCBs in soybean infant formula was 10.25 ng/g lipid weight.  Of the 15 congeners
analyzed for, PCB 101 contributed the most to the total amount of PCBs.
Additional exposure to PCBs could occur for children who live near hazardous waste sites.  Since
children spend a lot of time playing on the ground, both indoors and out, they come into more contact
with contaminants found on dust and dirt particles.  They may be exposed to PCBs by dermal contact
with PCB-contaminated soil and by ingesting contaminated soil from their unwashed hands and other
hand-to-mouth behavior.  The determination of PCBs in dust and dirt can therefore be important for
predicting children’s exposure.  However, quantitative information regarding the bioavailability and
amount of PCBs that children are exposed to through contact with contaminated soils are unavailable.
Between 1994 and 1995, house dust and yard soil were analyzed for PCB concentrations from 34 homes
surrounding New Bedford Harbor, Massachusetts during the dredging of PCB-contaminated sediments
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(Vorhees et al. 1999).  House dust samples were collected from the carpet, while yard soil was collected
from the main entryway.  The results indicated that house dust samples were 10 times higher
(260–23,000 ng/g) than yard soil concentrations (15–1,800 ng/g).  Although yard soil concentrations from
neighborhoods closest to the harbor were significantly higher than comparison neighborhoods distant
from the harbor, house dust concentrations did not differ significantly between the two locales (Vorhees
et al. 1999).  In general, the house dust samples contained higher concentrations of the more volatile, less
chlorinated PCBs than the soil samples.  The results of the house dust data were compared to results
obtained from homes that were not located near known PCB sources.  PCBs measured in house dust in
nine Seattle, Washington homes had concentrations ranging from 240 to 760 ng/g and eight Columbus,
Ohio, homes had concentrations ranging from 210 to 1,900 ng/g (Vorhees et al. 1999).  Clearly, PCB
concentrations were generally lower in these locations compared to the New Bedford Harbor
neighborhood homes.  Street dust and dirt samples, analyzed in August 1993, from the streets of Buffalo,
New York, also contained detectable amounts of PCBs (Irvine and Loganathan 1998).  Total PCB
concentrations for the dust and dirt samples ranged from 90 to 1,700 ng/g, dry weight.  In every case, the
higher-chlorinated congeners were detected more frequently and in greater concentrations.  In particular,
PCBs 153, 138, 101, 118, and 180 contributed >50% of the  total concentration of PCBs in each sample
(Irvine and Loganathan 1998).  Residing in proximity to incinerators may also increase exposure levels
for children.  Blood samples from 298 children living near a toxic waste incinerator in Germany had a
mean concentration of PCBs of 0.49 µg/L (Osius et al. 1999).  Given that PCB congeners have logKoc
values ranging from 3.27 to 6.87 (Horzempa and DiToro 1983; Meylan et al. 1992), they will generally
adsorb strongly to soil and dust particles.  This should decrease bioavailability of PCBs.  More scientific
data, however, are necessary to determine the degree of PCB exposure through hand-to-mouth activities. 
This is suggested as a data need for future study.
Consumption of contaminated groundwater may be an additional source of PCB exposure for children. 
PCBs have been detected in groundwater samples at 500 of the 1,598 NPL sites where they were detected
in some environmental media (HazDat 2000). 
Indoor air at schools could be a potential source of PCB exposure for children.  Indoor air in seven public
buildings (schools and offices) in Minnesota was monitored during 1984 for Aroclors 1242, 1254, and
1260 (Oatman and Roy 1986).  The mean total Aroclor concentration (±1 standard deviation) in the
indoor air of the three buildings using PCB transformers (457±223 ng/m3) was found to be nearly twice as
high as that in the air of the four buildings not using PCB transformers (229±106 ng/m3).  The Aroclor
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levels detected in the indoor air of all seven buildings were significantly higher than those detected in
ambient outdoor air (Balfanz et al. 1993; Eisenreich et al. 1992; MacLeod 1981; Oatman and Roy 1986).  
Children may also be exposed to PCBs through play activities involving PCB containing materials. 
Children who had played with parts of a capacitor that had once contained PCBs had elevated serum PCB
(similar to Aroclor 1242) levels compared with a background population consisting of other household
members and a reference group of persons in the same geographical area (Wolff and Schecter 1991).  The
serum PCB levels in the exposed children declined to about half of the initial values over a period of
11 months.  Exposure could also occur if children were to play near an area where there was a transformer
fire.  Although there are no data on children, elevated PCB levels in blood were found in some workers
who entered a building following a transformer fire (Schecter 1987).  
PCBs have been detected in several consumer products manufactured outside the United States, and it has
not been determined whether any of these products would be likely to be imported into the United States. 
Many of these products could be used by children.  PCB concentrations detected in various products
include 1.2 ppm in anhydrous lanolin, 4.8 ppm in lanocerin, 0.64 ppm in anhydrous cream for children,
0.52 ppm in oil/water emulsion-emollient cream, and 3.8 ppm in water/oil emulsion-emollient cream
(Welling et al. 1992).  Various fish oils used as dietary supplements were collected from around the world
between 1994 and 1995 and analyzed for PCB levels (Jacobs et al. 1998).  Researchers found that PCB
congeners 138, 153, and especially 118 were detected most frequently and in the highest concentrations. 
None of the samples, however, exceeded the FDA regulatory limit of 2.0 ppm for total PCBs.  In fact,
total PCB concentrations ranged from <5 to 1,132 µg/L with a mean of 332.0 µg/L (Jacobs et al. 1998). 
Due to the lack of data concerning the amount of these products that are used by children, it is difficult to
determine the degree of importance these items have on a child’s exposure to PCBs.
Studies also have indicated that PCBs may be transported from the workplace to the home.  Children
living with parents who work with PCBs (i.e., occupations associated with hazardous waste) may have
higher exposure levels.  There have been several cases reported of the transport of PCBs from the
workplace to the home and in some cases, the secondary exposure of family members.  PCBs with a
pattern resembling Aroclor 1254 were found in the blood of two railway maintenance workers who
repaired transformers (77 and 101 ng/mL).  The PCB levels for the wives who laundered their husbands’
clothes were not elevated, but their PCB pattern resembled the Aroclor 1254 pattern of their husbands,
suggesting that the PCBs found in the women’s blood were derived from contact with their husbands
(Fischbein and Wolff 1987).  In Indiana, PCBs were released into the municipal sewage treatment plant
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by an electrical manufacturing firm.  PCBs were found in the blood serum of sewage treatment workers
(75.1 ppb), their family members (33.6 ppb), community residents (24.4 ppb), and people who applied
sludge from the plant in their yards (17.4 ppb) (Baker et al. 1980).  Thus, the worker’s family members
had higher concentrations of PCBs in their blood serum than the other nonoccupational groups.  Based on
these observations, children living in homes of parents who are exposed to PCBs may in turn be exposed
through contaminated clothing and shoes.
6.7 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES
In addition to individuals who are occupationally exposed to PCBs (Section 6.5), there are several groups
within the general population with potentially high exposures (higher than background levels) to PCBs. 
These groups include recreational and subsistence fishers who typically consume larger amounts of
locally caught fish than the general population; Native American populations such as the North American
Inuits or other subsistence hunters/fishers; breast-fed infants of mothers who consume large amounts of
contaminated fish or wild game; farmers and their families who were exposed to PCB-contaminated foods
via food stored in PCB contaminated silos; and individuals living in proximity to incinerators, other PCB-
disposal facilities, or the 500 current or former NPL hazardous waste sites where PCBs have been
detected (HazDat 2000).
Consumption of sportfish, particularly from waters contaminated with PCBs, will increase the level of
human exposure to PCBs.  PCB exposures for adults and children associated with the consumption of
contaminated fish are available for residents of the Great Lakes region (Anderson et al. 1999; Hanrahan et
al. 1999), Massachusetts (Massachusetts Department of Public Health 1987), Michigan (Anderson 1989;
Courval et al. 1996; Hovinga et al. 1992; Humphrey 1983; Humphrey and Budd 1996; Schwartz et al.
1983), New York (Fitzgerald et al. 1996); Wisconsin (Anderson 1989; Fiore et al. 1989), northern Illinois
(Pellettieri et al. 1996), and Alabama (Anderson 1989; Kreiss et al. 1981) as well as for populations in
Canada (Ryan et al. 1997).  Direct relationships are found between serum PCB levels and the quantities of
fish consumed or numbers of fish meals consumed (Fiore et al. 1989; Hovinga et al. 1993; Humphrey and
Budd 1996; Schwartz et al. 1983).  One recent study monitored the PCB concentrations in blood serum
from both frequent and infrequent consumers of Great Lakes sport fish (Hanrahan et al. 1999).  It was
found that the mean concentration of PCBs in blood of 252 males who were frequent consumers was
4.8 ng/mL while in 57 males who were infrequent consumers, the concentration was 1.5 ng/mL.  A
similar study conducted in 1992 compared PCB blood serum levels between males from Cornwall and
Mississauga, Canada who consumed waterfowl and fish from Lake Ontario and non-consumers (Kearney
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et al. 1999).  The PCB concentrations in blood serum of 101 male consumers and 45 non-consumers were
5.5 and 3.9 ng/mL wet weight, respectively.  A multivariate regression analysis was used to show that the
significantly elevated serum PCB levels observed in sportfish eaters in Michigan compared with controls
was due to historic fish consumption rather than recent consumption (Hovinga et al. 1993).  In a study of
maternity patients from western Michigan, Schwartz et al. (1983) reported an increase in serum PCB
levels in women who consumed larger numbers of fish meals per year than those who consumed no fish
meals per year.  For example, in the control group of non-fish eaters, the mean serum PCB level was
4 ppb.  However, for women consuming 6–11, 12–23, 24–51, and 52–183 fish meals per year, the mean
serum PCB levels were 5.5, 5.5, 5.9, and 9.0 ppb, respectively.  A recent multimedia study characterized
environmental exposures to PCBs among residents in nine homes in the Lower Rio Grand Valley of
Texas (Berry et al. 1997; Butler et al. 1997).  As part of this study, PCB blood serum concentrations were
obtained and compared to the National Health and Nutrition Examination Survey II (NHANES II) 95th
percentile.  Blood plasma PCB concentrations for two individuals with maximum values, as
Aroclor 1260, exceeded the NHANES II 95th percentile for PCBs.  Upon further investigation, it was
found that the residents caught and ate carp from a nearby irrigation ditch.  Analysis of the fish showed
high PCB concentrations of 399 mg/kg (ppm), indicating a likely source for the high blood serum
concentration in these individuals.  For all of the other participants in the study, blood serum PCB
concentrations were less than 4.2 µg/L, the NHANES II median value.  PCBs were not detected in
drinking water or dietary samples other than the fish samples.  Serum PCB levels were 2.5 times higher in
people who regularly eat fish (consumption rate of >24 pounds/year [>11 kg/year]) compared to those
who occasionally or never eat fish (consumption rate of 0–6 pounds/year [0–2.7 kg/year]) (Humphrey
1988).  For more information concerning PCB serum levels in people who consume fish, please refer to
Table 6-28. 
Recreational and subsistence fishers within the general population consume larger quantities of fish and
shellfish than the general population.  Because of this, these populations are at greater risk of exposure to
PCBs and other chemical contaminants if the waters they fish frequently are contaminated.  The EPA
advises states to use a screening value of 0.01 ppm of total PCBs (sum of Aroclors) as a criteria to
evaluate their fishable waterbodies (EPA 1993h).  Currently, 678 advisories have been issued by
35 states, the District of Columbia, and American Samoa restricting the consumption of PCB-
contaminated fish and shellfish (EPA 1999l).  In one study, however, of 8,306 Great Lakes sportfishers
















Table 6-28.  Serum Polychlorinated Biphenyl (PCB) Levels in Non-occupationally Exposed 
U.S. Populations that Consume Fish from PCB-contaminated Waters (1973–1995)
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Table 6-28. Serum Polychlorinated Biphenyl (PCB) Levels in Non-occupationally Exposed U.S.
Populations that Consume Fish from PCB-contaminated Waters (1973–1995) (continued)
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193 1982 5.5 4.6a 3.7 – Schwartz et al.
1983
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Table 6-28. Serum Polychlorinated Biphenyl (PCB) Levels in Non-occupationally Exposed U.S.
Populations that Consume Fish from PCB-contaminated Waters (1973–1995) (continued)












































458 1973 22.2 17.2 22.3 3–158 Kreiss et al.
1981
Source:  Adapted from Kreiss 1985; Massachusetts Department of Public Health 1987; Sahl et al. 1985a, 1985b
aMedian
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58% of males were aware of a health advisory, while only 39% of women were aware of a health
advisory.  It appears that although health advisories do exist, there is a need to better communicate these
warnings to the public.  The number of waterbodies under advisory for PCBs in each state is shown in
Figure 6-5.     
Elevated PCB concentrations have also been detected in human adipose tissue from populations with diets
high in fish and seafood.  Levels of PCBs were determined in liver, brain, omental fat, and subcutaneous
abdominal fat samples collected from 105 deceased Inuit Greenlanders between 1992 and 1994 (Dewailly
et al. 1999).  The population studied represented individuals who had a history of a diet high in sea
mammal fat and fish.  Of the 14 congeners analyzed for, PCBs 138, 153, and 180 were found in the
highest concentrations in all tissue samples and represented 63–68% of total PCB concentration.  The
mean concentration of total PCBs in omental fat samples from 41 Greenlanders was 5,719 µg/kg lipid
basis (range=1,019–12,716 µg/kg lipid basis).  Using the same analytical methods, the total
concentrations of PCBs 138, 153, and 180 were compared to adipose tissue from 17 women living in
Quebec City, Canada from 1991 to 1992.  Researchers found that PCB concentrations in the Greenlanders
were 18 times higher than those from Canada.  The study also found that older individuals had higher
levels of PCBs in their adipose tissue.  For example, the mean PCB concentrations for people ages 41–54,
55–69, and $70 years were 4,909, 5,337, and 7,357 µg/kg lipid basis, respectively (Dewailly et al. 1999). 
In general, PCBs accumulated preferentially in omental/subcutaneous fat followed by liver, and
accumulated the least in brain tissue.
Fat extracted from the Ooligan fish is a widely consumed traditional condiment and medicine among the
indigenous people of coastal British Columbia.  The average total PCB concentrations of 24–57 ng/g
(ppb) lipid were reported in Ooligan fish fat and in fish from various coastal locations in the region (Chan
et al. 1996).  High consumption patterns of these products could increase PCB exposure of the native
peoples of this region.  In the summer of 1996, research was conducted to estimate the daily average
intake of PCBs from consumption of local fish by the Mohawk community at the Kahnawake reservation,
located south of Montreal, Canada (Chan et al. 1999).  A total of 131 fish, representing 6 species, were
caught and analyzed for total PCB concentrations.  The mean concentration of PCBs in the fish ranged
from 29.23 to 153.89 ng/g wet weight.  Based on an average diet of 23 g of fish/day (compared to
1.2 g/day in the average Canadian diet), the estimated daily intake of PCBs were 0.026 µg/kg body
weight/day for men and 0.033 µg/kg body weight/day for women.  Based on an average body weight of
81 kg for men and 65 kg for women, the daily intake of PCBs for the Mohawk Indians would be
2.106 and 2.145 µg, respectively (Chan et al. 1999).  Similar results were found in a study conducted in 



















































Figure 6-5.  1998 Fish Advisories for Polychlorinated Biphenyls
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1994 of the Dene and Metis Inuits of Western Northwest Territories, Canada whose diet consists mainly
of herbivorous animals and fish (Berti et al. 1998).  Researchers analyzed their dietary intake and found
that the mean dietary intake of PCBs was 0.023 µg/kg/day.  Researchers noted that individuals with diets
high in whale blubber were at increased risk of high PCB exposure.  Some examples of other populations
that have diets high in fish and sea mammals include Alaskan Inuits who consume 304 g/day (Wolfe and
Walker 1987), recreational anglers from Michigan who consume 27 g/day (Hovinga et al. 1992), and
Indian tribes from Oregon and Washington who consume 58.7 g/day (CRITFC 1994).  Since the average
daily intake of fish in the U.S. diet is 6.2 g/day (EPA 1993h), these high fish consuming populations
represent communities at higher risk for PCB exposure.
Infants that are breast fed by women living in the these communities may also be exposed to higher PCB
concentrations.  It is estimated that an infant that is breast fed for 6 months will receive 6.8–12% of its
lifetime PCB body burden in that period (Kimbrough 1995; Patandin et al. 1999).  For example, the diet
of the Mohawk Indians from the Akwesasne reservation in New York has been impacted by the General
Motors Foundry Mill, which released PCBs into the St. Lawrence River (Fitzgerald et al. 1998).  Fish
consumed by the Mohawk Indians come from the St. Lawrence River and have consequently been
contaminated.  Comparison studies were conducted to determine whether PCB levels in breast milk
differed from that of the general population that was not affected by the mill.  The study found that in
milk samples collected in 1986–1989, the mean concentration of PCBs in American Indian milk was
602 ng/g lipid weight, while in the control group, the mean concentration was 375 ng/g lipid weight
(Fitzgerald et al. 1998).  From 1991 to 1992, however, PCB levels decreased to a mean of 254 ng/g lipid
in Mohawk Indian breast milk, while in the control group, it only decreased to 318 ng/g lipid weight.  The
reduction in breast milk PCB concentrations paralleled a corresponding decrease in local fish
consumption (Fitzgerald et al. 1998).  The authors found that from 1986 to 1992, the number of fish
meals consumed by pregnant Mohawk women decreased from 10.7 meals per year in 1986–1989, to
3.6 meals per year in 1990, and to 0.9 meals per year in 1991–1992.  No such decreasing trend in
consumption was noted among the Caucasian control group whose PCB levels did not change
significantly over the course of the study.  The mean concentration of total PCBs in human milk from
native Inuit women who consumed large quantities of marine mammal tissue was 1,052 ng/g lipid weight
in a 1989–1990 study (Dewailly et al. 1993).  This was 7 times greater than levels measured in Caucasian
women from southern Quebec (157 ng/g, lipid basis).  The concentrations of PCB congeners in breast
milk from a remote maritime population from Arctic Quebec (Inuit women) were compared with those of
control Caucasian women in Quebec, Canada (Dewailly et al. 1994).  Di-ortho congeners (138, 153, 170,
and 180), mono-ortho congener (118), and non-ortho coplanar congeners (126 and 169) were detected at
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concentrations of 862.5, 58.7, and 0.455 ng/g lipid weight in Inuit women compared to 106, 17.4, and
0.121 ng/g lipid weight in Caucasian women.  Because of their high consumption of marine mammal
tissues and seafood, the Inuit women have high concentrations of PCBs in their breast milk, in spite of the
remoteness of Arctic Quebec (Dewailly et al. 1993, 1994).  Daily PCB intake for native northern Quebec
women was calculated to be 0.3 µg/kg (ppb) body weight while daily intake among infants was calculated
to be 10 µg/kg due to breast feeding.  This level is 143 times greater than the reference dose (RfD) of
0.07 µg/kg body weight established by the EPA (Ayotte et al. 1995).  In general, these studies indicate
that lactating women whose diets are high in contaminated fish can potentially increase the PCB exposure
for their breast-fed infants.  For more information concerning PCB concentrations in human breast milk,
please refer to Table 6-27 in Section 6.6.
Unborn children may also be at risk of higher PCB exposure, especially in areas that have been heavily
contaminated with PCBs.  To illustrate this, researchers analyzed placental cord serum of 755 infants born
to mothers residing in towns adjacent to a PCB-contaminated harbor in southeastern Massachusetts
(Altshul et al. 1999).  Infants whose cord serum was analyzed were born between 1993 and 1998 in the
towns of New Bedford, Acushnet, Fairhaven, and Dartmouth, Massachusetts.  Of the 51 PCB congeners
analyzed, only 13 were above the detection limit (0.01 ng/g serum).  The median concentration of PCBs
was 0.56 ng/g serum (Altshul et al. 1999).  Researchers found that the relative predominance of less
chlorinated congeners in the cord blood was generally consistent with the characteristics of the
contaminated site.  PCB concentrations were also measured in cord blood from both 134 women who
consumed Great Lakes fish and 145 women who had never consumed Great Lakes fish (Stewart et al.
1999).  Although researchers did not find any difference between fish consumption levels and total PCBs
in umbilical cord serum, it was established that fish eaters had marked elevations of the most heavily
chlorinated PCB homologues.  In particular, levels of hepta- to nonachlorobiphenyls were greater in fish
eaters than non-fish eaters (Stewart et al. 1999).  Another study examined PCB concentrations in nine
stillborn fetuses from the Netherlands in 1993 and found that median (range) concentration of PCBs in
adipose tissue was 235 (97–768) ng/g lipid weight (Lanting et al. 1998b). 
Similarly, Native American populations such as the Inuit of Alaska or other subsistence hunters
(particularly those living in high-latitude areas of the United States) may be exposed to higher levels of
PCBs in wild game (e.g., beluga whales, seals, polar bears, and other game species) (Dewailly et al. 1993;
Kuhnlein et al. 1995; Schantz et al. 1993c).  Because these populations typically are hunters of the highest
trophic levels, they are particularly exposed to PCBs (Ayotte et al. 1995).  Kuhnlein et al. (1995)
compared PCB concentrations in the diet of Arctic indigenous women from both eastern and western
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Canada.  These authors reported that PCB intakes in the western Arctic population were lower than the
eastern Arctic population because of the food preferences for caribou, moose, and fish as compared to
ringed seals, caribou, narwhal, and walrus.  Mean total blood plasma PCB concentrations among
499 Inuit adults from Nunavik in the Quebec Arctic was 4.1 mg/kg (ppm) lipid weight, compared to
0.13 mg/kg lipid weight for control samples from individuals in southern Quebec (Ayotte et al. 1997). 
Hing (1998) summarized data from northern and Arctic Canadian studies associated with exposure to
PCBs from consumption of native foods.  Mean total PCB concentrations in traditional foods, expressed
as µg/g (ppm) wet weight, were 0.080, 1.90, 0.006, 0.010, 0.052, 0.290, and 0.006, respectively, for
marine mammal meat, marine mammal blubber, terrestrial mammal meat, terrestrial mammal organs, fish,
birds, and plants.  Based on dietary habits among two individual communities, total dietary PCB intakes
were estimated to be 16 µg/day from marine mammal meat, 57 µg/day from marine mammal blubber,
1.2 µg/day from terrestrial mammal meat, 0.3 µg/day from terrestrial mammal organs, 0.4 µg/day for fish,
0.4 µg/day for birds, and 0 µg/day for plants.  Total estimated PCB intakes for the two communities were
6.0 and 7 µg/day, respectively.  Samples from herds of Yukon Territory and Northwest Territory caribou
in Canada showed relatively low non-ortho PCB concentrations, considered equivalent to background
levels, although PCB congener 126 and 169 concentrations were higher among caribou sampled from
eastern herds (Bathurst, Northwest Territory), probably due to differences in atmospheric transport
patterns (Hebert et al. 1996).  Wilson et al. (1995) also reported high concentrations of PCBs in two fish
species from remote Arctic lakes in Alaska.  The most abundant group of organochlorine compounds
detected in the fish were PCBs.  Concentrations of 6.6 and 1.3 ng/g (ppb) wet weight were detected in
lake trout and grayling muscle tissue, respectively.  While the problem of PCB contamination in the
Arctic is clearly greater in the eastern Arctic, it is increasingly being detected in Alaska as well.  Clearly,
increased exposure of native hunting and fishing peoples to PCBs can occur, and their infants are also at
risk of greater exposure via consumption of PCB-contaminated breast milk. 
During the 1940s and 1950s, concrete silos on many Midwest farms were coated on the inside with
sealants containing the PCB mixture Aroclor 1254.  Over time, the sealant peeled off and became mixed
with silage used to feed beef and dairy cattle.  Farmers and their families who lived on farms where PCB-
containing sealants were used in silo construction, and who regularly ate beef and dairy products
produced on their own farms, were exposed to PCB-contaminated foods (Hansen 1987a; Humphrey
1983).  Most of these silos, however, have been dismantled and removed.  The high serum PCB levels
(100–200 µg/L [ppb]) detected in the most exposed individuals, however, suggests that monitoring should
be continued (Humphrey 1983).  Schantz et al. (1994) monitored serum PCB levels in Michigan mothers
and children from farms with PCB-contaminated silos.  These authors reported blood serum PCB levels
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of 9.6 ng/mL (ppb) for mothers and 6.8 ng/mL (ppb) for children.  Maternal serum PCB levels and the
number of weeks of breast-feeding accounted for 47% of the variance in the children's serum PCB levels,
confirming that breast milk was a primary source of the PCB exposure for the children.  
Another population that may receive higher PCB exposures than the general population includes people
who live in the vicinity of incinerators, PCB disposal facilities, or hazardous waste sites.  PCB
concentrations measured downwind from a landfill were at least an order of magnitude higher than those
measured upwind from the landfill, although effective dilution reduced concentrations of PCBs in air
samples monitored 15 km from the landfill to a level comparable or even slightly lower than urban air
levels (Hermanson and Hites 1989).  This dilution effect was also evident from the observed decrease in
the atmospheric concentrations of PCBs within a short distance from another landfill during remediation
(Hermanson and Hites 1989).  This study suggests that people who reside in the immediate vicinity of
PCB-containing landfills may be exposed to PCBs in the air at levels higher than the general population. 
Despite the potential for individuals living near processing facilities or hazardous waste sites to be
exposed to higher levels of PCBs in air, water, and soil, higher PCB levels in human tissues have not been
conclusively demonstrated (i.e., elevated levels of PCBs in the serum/blood of the susceptible
population).  One possible explanation for the low prevalence of elevated PCB levels in the serum/blood
of people who live near these contaminated sites is that most of these people are not exposed to PCBs at
elevated levels or that the PCB concentrations to which they are exposed are not completely bioavailable. 
Another explanation is that, unlike occupational exposure scenarios where concentrations can be orders of
magnitude higher than background levels, slightly elevated environmental exposure may not result in
appreciable elevation of PCB levels in serum/blood.  Beginning in 1982, pilot studies involving a total of
766 subjects were conducted at 12 hazardous waste sites in the United States to determine human
exposure to PCBs (Stehr-Green et al. 1988).  Although environmental PCB contamination levels as high
as 2.5 ppb in well water and 330,000 ppb in soil samples were measured, serum PCB levels in people
from 10 of the 12 sites were not any higher than serum PCB levels in unexposed individuals in the
general population.  The higher serum PCB levels found in people at two sites may be attributable to the
historic prevalence of occupationally related exposures.  Another study that evaluated the PCB exposure
of 89 individuals living near a toxic waste site in Paoli, Pennsylvania, also reported similar serum PCB
levels in exposed individuals and unexposed populations (ATSDR 1987). 
Individuals living near processing sites or NPL sites where PCBs have been detected may also be exposed
to higher levels of PCBs in their drinking water if they obtain tap water from wells located near these
sites.  PCBs have been detected in groundwater samples at 192 of the 500 NPL sites where they were
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detected in some environmental media (HazDat 2000).  Consumption of contaminated groundwater,
therefore, may be an additional source of PCB exposure for both adults and children.  Children and adults
may also receive higher PCB exposures from dermal contact if they play or work with PCB-contaminated
soils.  In an in vivo study with Rhesus monkeys, percutaneous absorption of Aroclor 1242 and 1254 from
a clay loam soil containing 0.9% organic matter was determined to be in the range of 13.8–14.1% (Wester
et al. 1993).  In addition, children and adults may receive potentially higher oral exposures from ingestion
of PCB-contaminated soils from their unwashed hands, while playing or working in PCB-contaminated
areas.
6.8 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of PCBs is available.  Where adequate information is not
available, ATSDR, in conjunction with the National Toxicology Program (NTP), is required to assure the
initiation of a program of research designed to determine the health effects (and techniques for developing
methods to determine such health effects) of PCBs.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA.  They are defined as substance-specific informational needs that if met would
reduce the uncertainties of human health assessment.  This definition should not be interpreted to mean
that all data needs discussed in this section must be filled.  In the future, the identified data needs will be
evaluated and prioritized, and a substance-specific research agenda will be proposed. 
6.8.1 Identification of Data Needs
Physical and Chemical Properties.    Some of the physical and chemical properties (i.e.,
octanol/water partition coefficient [Kow], Henry's law constant, reaction rate constants) often useful in
estimating environmental fate and transport processes for PCBs are available primarily for the Aroclors as
mixtures and not for the individual congeners (see Table 4-2) (Burkhard et al. 1985; EPA 1979h, 1985b;
Hollifield 1979; Paris et al. 1978).  The experimental determination of the physical and chemical
properties of many more of the individual congeners is needed for accurately predicting the
environmental fate of the individual congeners.
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Production, Import/Export, Use, and Release and Disposal.    PCBs are no longer produced,
imported/exported, or used on an industrial scale in the United States.  The available literature contains
adequate documentation of their past production (Durfee 1976; EPA 1976a; IARC 1978; Kimbrough
1987), import/export volume (Durfee 1976; EPA 1988c; IARC 1978; USITC 1978, 1979, 1980, 1982),
use (EPA 1976a; IARC 1978; Safe 1984; Welsh 1995), release (Durfee 1976; EPA 1979e; Larsson 1985;
Liberti et al. 1992; Mackay 1989; Morselli et al. 1985; Murphy et al. 1985; Swackhamer and Armstrong
1986; Tiernan et al. 1983; TRI93 1995), and disposal (Arbon et al. 1994; Baukal et al. 1994; Chuang et al.
1995; EPA 1979e, 1995a; IRPTC 1985; Timberlake and Garbaciak 1995; TRI93 1995; Zhang and
Rusling 1995; Zhang et al. 1993).  There are current EPA regulations regarding the disposal of PCBs;
however, information on current disposal practices in the case of accidental transformer leakage would be
useful. 
Environmental Fate.    A number of studies indicate that PCBs are very persistent in the environment
(Brown et al. 1988; EPA 1979h, 1983c; Gan and Berthouex 1994; Portier and Fujisaki 1988).  The
volatilization of PCBs from soil and water, followed by dry/wet deposition of airborne PCBs into soil and
water, results in the continuous recycling of undegraded PCBs in the environment (Macdonald et al.
2000; Wania and Mackay 1993, 1996).  Sediment is a repository for PCBs that can later be released to air
and water.  However, some critical data regarding the potential for long-term release of PCBs from
sediments and the role of deep ocean sediments as an ultimate sink for PCBs are lacking.  There is a lack
of quantitative data on the photodegradation potential of PCBs in air, water, and soil in the presence of
natural sunlight.  Information on the concentrations of chlorinated benzoic acids in the vicinity of PCB
sources is need to access the degree of importance of OH-radical reactions in the atmosphere for
degrading PCBs (Brubaker and Hites 1998).  No extensive and systematic studies have been done on the
influence of different types of soil/sediment (including with different PCB adsorption properties) on the
reductive dehalogenation of PCBs (Wiegel and Wu 2000).  Since the toxicity and the environmental fate
of PCBs depend on specific PCB congeners, development of more data regarding congener-specific fate
and transport of PCBs in the environment are needed.
Bioavailability from Environmental Media.    The absorption and distribution of PCBs as a result of
inhalation, ingestion, and dermal exposure are discussed in Sections 3.3.1, 3.3.2, and 3.3.3.  Few studies
that describe the bioavailability of PCBs from ambient air, surface water and groundwater, or soil exist. 
Additional studies determining the effect of particle size and organic matter content on the bioavailability
of PCBs from soil and the role of microparticle-sorbed PCBs on the bioavailability of PCBs from
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drinking water are needed.  Such studies would be useful in assessing the health effects of PCBs on
people living near hazardous waste sites.
Food Chain Bioaccumulation.    Based on available information, estimates can be made about the
bioaccumulation of PCBs in fish, shellfish, and marine mammals (Andersson et al. 1988; ASTER 1996;
EPA 1983c; Kuehl and Haebler 1995; Kuehl et al. 1994; Lake et al. 1995a, 1995b; Porte and Albaiges
1993; Salata et al. 1995; Schantz et al. 1993a; Zhang et al. 1983), the bioconcentration potential from soil
to plants (Bohm et al. 1999; Lober et al. 1994; O’Connor et al. 1990; Schönherr and Riederer 1989) and
from atmospheric vapors and particulates to plants (Jones and Duarte-Davidson 1997; O’Connor et al.
1990; Thomas et al. 1998; Ye et al. 1992a).  The existing data indicate that PCBs bioaccumulate
significantly in aquatic and terrestrial food chains and biomagnify in predators, due to consumption of
contaminated prey.  More information on bioaccumulation and biomagnification of PCB congeners in
edible fish and shellfish species is needed in assessing human health risks.
Exposure Levels in Environmental Media.    The relative importance of different routes of
exposure to PCBs in the past (late 1970s through early 1980s) is detailed in the current literature.  FDA
studies indicate that the dietary intake of PCBs has steadily decreased since 1978 (Gartrell et al. 1985a,
1985b, 1986a).  According to these studies, the major contributing factor in dietary PCB intake has
changed from fish to meat in recent years (Gunderson 1988).  However, the FDA dietary intake values are
estimated for marketed foods and do not provide an indication of PCB intake from consumption of fish
obtained by sport and subsistence fishing.  Despite recent studies by Berry et al. (1997) and Buckley et al.
(1997), more recent data on the concentrations of PCBs in foods, collected using a market-basket
approach, are needed to determine whether concentrations of PCBs in foods consumed by the general
population have declined further since the mid-1980s.  Data on the PCB concentrations in foods grown in
contaminated areas, particularly in the vicinity of hazardous waste sites, are also needed.  Also, more data
on congener-specific PCB analysis of food, especially plant products, would be useful.  Recent
investigations also show that the concentration of PCBs in indoor air can be at least an order of magnitude
higher than outdoor air (Balfanz et al. 1993; Vorhees et al. 1997; Wallace et al. 1996).  Therefore, due to
the decreased intake of PCBs from food in recent years, it is possible that the intake from inhalation
exposure may currently exceed PCB intake from food.  However, a direct comparison of the importance
of exposure from inhalation and diet is difficult because the reported data do not always include the same
PCBs (e.g., Aroclor 1016, 1254, etc.) for the purpose of quantifying the total PCB concentrations and in
evaluating the subsequent intake.  It would be useful to conduct further research to resolve this important
issue.  More recent monitoring data on the concentrations of total PCBs as well as congeners in air in
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urban areas near hazardous waste sites and incinerators are needed.  More recent survey data on PCB
concentrations in finished drinking water nationwide would be helpful in assessing the importance of this
exposure route.  Congener-specific analysis of drinking water would also be useful in determining
exposure risks, particularly for the dioxin-like congeners.
Exposure Levels in Humans.    PCB levels are reported in the current literature for blood (Schecter
et al. 1993, 1994), serum (Anderson et al. 1998; Fitzgerald et al. 1999; Hanrahan et al. 1999; Hovinga et
al. 1992, 1993; Kearney et al. 1999; Massachusetts Department of Public Health 1987; Patterson et al.
1994), breast milk (Dekoning and Karmaus 2000; Fitzgerald et al. 1998; Kostyniak et al. 1999; Newsome
and Ryan 1999; Newsome et al. 1995; Schade and Heinzow 1998), and adipose tissue of the general
population (Dewailly et al. 1999; EPA 1986b; Fensterheim 1993; Jensen 1989; Kutz et al. 1991; Ouw et
al. 1976; Patterson et al. 1994; Schecter et al. 1989, 1991, 1994) and occupationally exposed individuals
(Fait et al. 1989; Perkins and Knight 1989; Schecter and Charles 1991; Schecter et al. 1994; Welsh 1995;
Wolff 1985; Yakushiji et al. 1978).  However, few systematic surveys have ever been conducted in the
United States to evaluate the trend of PCB concentrations in human tissues over the years, and the reasons
for the apparent slower decrease in PCB concentrations in tissues (compared to the more rapid decrease in
environmental levels) are not completely known.  It would be helpful to develop a database of
information on congener-specific PCB levels in tissues of exposed and control cases for studying clinical
and epidemiological outcomes.  In particular, a comprehensive study that monitors congener specific
concentrations in fish species and relates them directly to congener levels in human tissue would be
extremely useful.  Additional data regarding the concentrations of PCBs in body fluids or tissues of
people who reside near hazardous waste sites are needed.  This information is necessary for assessing the
need to conduct health studies on these populations.
Exposures of Children.    Children may be exposed to PCBs by a variety of exposure pathways.  The
most important pathway appears to be consumption of contaminated foods, particularly meat, fish, and
poultry (Gunderson 1988).  Children can also be exposed to PCBs from mother’s milk (Fitzgerald et al.
1998; Kimbrough 1995; Patandin et al. 1999; Rogan et al. 1987; Wickizer et al. 1981).  More data are
needed on the levels of PCB exposure in nursing women from occupational situations or consumption of
fish or wild game and of from those of the general population.  Exposure and body burden studies related
to consumption of fish in the U.S. population are needed to determine exposure levels, particularly in
children of recreational and subsistence fishers.  Exposure and body burden studies are also needed in
Native American communities that consume high levels of game and marine mammals.  Information
related to the exposure of children living near hazardous waste sites is also needed.  In particular,
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information related to the potential for children to be exposed to PCBs bound to soil and dust particles
through pica or unintentional hand-to-mouth activity within homes located in these areas.  Quantitative
information regarding the bioavailability and amount of PCBs that children are exposed to through
contact with contaminated soils are unavailable.  Therefore, any information concerning this subject
would be useful in evaluating children’s exposure.
Additional information on weight-adjusted intakes would be helpful for determining the health risks for
young children, particularly those in Native American populations.  Infants and young children consume
a greater amount of food per kilogram of body weight and, therefore, may have a proportionately greater
exposure to PCBs than adults (Cordle et al. 1982).  
Child health data needs relating to susceptibility are discussed in Section 3.12.2 Identification of Data
Needs: Children’s Susceptibility.
Exposure Registries.    No exposure registries for PCBs were located.  This substance is not currently
one of the compounds for which a subregistry has been established in the National Exposure Registry. 
The substance will be considered in the future when chemical selection is made for subregistries to be
established.  The information that is amassed in the National Exposure Registry facilitates the
epidemiological research needed to assess adverse health outcomes that may be related to the exposure to
this substance.
Information is particularly needed on the size of the populations potentially exposed to PCBs through
contact with contaminated media in the vicinity of hazardous waste sites.  The development of an
exposure registry would provide a useful reference tool in assessing exposure levels and frequencies.  It
would also facilitate the conduct of epidemiological or health studies to assess any adverse health effects
resulting from exposure to PCBs.  In addition, a registry developed on the basis of exposure sources
would allow an assessment of the variations in exposure levels from one source to another and the effect
of geographical, seasonal, and regulatory action on the level of exposure within a certain source.  These
assessments, in turn, would provide a better understanding of the needs for research or data acquisition on
the current exposure levels.
PCBs 592
6.  POTENTIAL FOR HUMAN EXPOSURE
6.8.2 Ongoing Studies
A search in Federal Research in Progress (FEDRIP 2000) identified ongoing research studies that may fill
some of the data needs discussed in Section 6.8.1.  These studies are listed in Table 6-29.
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Table 6-29.  Ongoing Studies on Environmental Fate and Treatment of
Polychlorinated Biphenyls
Investigator Affiliation Title Sponsor
Bopp, Richard Mount Sinai School of
Medicine
New York, New York
Sources and pathways of persistent
chlorinated hydrocarbon exposure in New
York City
NIEHS




Custer, Christine M Upper Midwest
Environmental Sciences
Center
Bioaccumulation and effects of PCBs on




Fish and Wildlife Service
Estes, James A Western Ecological
Research Center
Monitoring program for environmental
contaminants in the nearshore marine




Fischer, Lawrence Michigan State University Health hazards from groundwater
contamination
NIEHS
Hansen, LG Veterinary Bioscience,
University of Illinois
Identification of PCB congeners




Hickey, William J University of Wisconsin
Madison, Wisconsin
Research on molecular and biochemical




Hong, Chia-swee State University of New
York 
Albany, New York
Photocatalytic remediation of  PCB-
contaminated water and sediment
NIEHS
Huwe, JK Agricultural Researcher
Service




Landrigan, Philip J Mount Sinai School of
Medicine
New York, New York
Study the current urban sources,
environmental distribution and toxic





Manny, Bruce A Great Lakes Science
Center
Contamination of surface soils and
wildcelery tubers at Grassy Island in the





Matthews, HB NIEHS, NIH
RTP, North Carolina
Bioavailability of PCBs from soil NIEHS
Mora, Miguel A Columbia Environmental
Researcher Center
Effects of environmental contaminants on




Rhee, G-Yull State University of New
York 
Albany, New York
Bioremediation of  PCB- contaminated
sediments in the St. Lawrence River
NIEHS
Richmond, Milo E New York Cooperative
Fish and Wildlife
Research Unit
Organochlorine and metal contaminants
in Hudson River mammals
New York State
Santerre, CR Food and Nutrition
Purdue University
Xenobiotics in farm-raised and wild fish Indiana State
Sarofim, Adel F Massachusetts Institute
of Technology
The formation of PCBs during the
pyrolysis and oxidation of wastes at
Superfund sites
NIEHS
Table 6-29.  Ongoing Studies on Environmental Fate and Treatment of
Polychlorinated Biphenyls (continued)
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Investigator Affiliation Title Sponsor
Tiedje, J Michigan State
University, Crop and Soil
Sciences
East Lansing, Michigan






EPA = Environmental Protection Agency; NIEHS = National Institute of Environmental Health Sciences;
NIH = National Institute of Health; NSF = National Science Foundation; RTP = Research Triangle Park
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7.  ANALYTICAL METHODS
The purpose of this chapter is to describe the analytical methods that are available for detecting, and/or
measuring, and/or monitoring PCBs, its metabolites, and other biomarkers of exposure and effect to
PCBs.  The intent is not to provide an exhaustive list of analytical methods.  Rather, the intention is to
identify well-established methods that are used as the standard methods of analysis.  Many of the
analytical methods used for environmental samples are the methods approved by federal agencies and
organizations such as EPA and the National Institute for Occupational Safety and Health (NIOSH).  Other
methods presented in this chapter are those that are approved by groups such as the Association of
Official Analytical Chemists (AOAC) and the American Public Health Association (APHA). 
Additionally, analytical methods are included that modify previously used methods to obtain lower
detection limits, and/or to improve accuracy and precision.
Methodology for PCB analysis includes several steps: sample collection and storage, extraction, cleanup,
and determination (EPA 1995c, 1999k; Hess et al. 1995).  Care must be taken to assure that the sample
collection follows quality assurance protocols and that equipment and containers are free from
contamination.  Most sample collections are by grab sampling; however, PCBs may be concentrated from
water or air onto sorbents.  PCBs are typically separated from the sample matrix by solid-phase extraction
(SPE), separatory funnel extraction, continuous liquid/liquid extraction (CLLE), Soxhlet extraction, or
Soxhlet/Dean-Stark extraction.  PCBs may be difficult to extract from oily matrices in which they are
soluble.  Some problems that may occur during extraction include evaporative losses during
concentration, sorption onto labware, and contamination of samples.  Cleanup steps are necessary to
remove compounds that may interfere with the determination.  Chromatography (e.g., gel permeation,
silica gel, Florisil, activated carbon, high-performance liquid) is often used to remove matrix
interferences, and sometimes to fractionate PCBs into several groups.  Cleanup by chromatography has
been used extensively to separate the non-ortho and the mono-ortho CBs from the remaining congeners
before quantitative analysis (Hess et al. 1995).  The identification and quantitation of PCBs are most often
accomplished by gas chromatographic (GC) techniques.  Capillary or high resolution gas chromatography
(HRGC) columns capable of separating a substantial proportion of the congeners are indispensable, and
GC detectors possessing high selectivity and sensitivity for the PCBs are required.  The more universal
and less sensitive flame-ionization detector (FID) is used much less often than the electron capture
detector (ECD), which has exceptional sensitivity to multiply chlorinated compounds.  The mass
spectrometer-selected-ion-monitoring (MS-SIM) or ion-trap mass spectrometer (ITMS) detectors have
sensitivities somewhat lower than ECD, and they have even greater selectivity for PCBs and can
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distinguish and individually measure homologs that may coelute on a particular HRGC column (EPA
1999k). 
Some methods in use are multi-residue methods in which PCBs along with many other analytes such as
pesticides, are determined.  In general, PCB methods analyze for Aroclor mixtures, PCB homologs, or
individual PCB congeners.  Until recently, packed column GC/ECD was used most often for the
determination of PCBs as Aroclor mixtures.  The Webb-McCall technique was used for quantitation.  The
weight percent and homolog identification were determined for several Aroclors.  Response factors were
generated to calculate the amount in each sample peak; with packed columns, each peak contains several
congeners.  The amounts found in each sample peak were then summed (Webb-McCall 1973). 
Alternately, the total area in the Aroclor region of the chromatogram was used for quantitation.  However,
Aroclor analyses are estimations that are prone to error as a result of the subjective assignment of Aroclor
speciation and response factors.  Also, the practice of comparing CB patterns in environmental samples
with those of technical mixtures can be misleading since mixtures emanating from different sources are
mixed at differing rates by diffusion, evaporation, and adsorption onto solids.  Many congeners are
metabolized, while others bioconcentrate in lipophilic material.  Therefore, the final pattern in the
environment is often highly modified and may not resemble the original commercial formulation or
mixture of formulations (Draper et al. 1991; Duinker and Hillebrand 1979; Hess et al. 1995).  The
maximum detection limits (MCLs) for Aroclors vary in the range of 0.054–0.90 µg/L in water and
57–70 µg/kg in soils (EPA 1995c).  Another approach is to determine PCBs by level of chlorination (or
homolog group).  One PCB for each homolog (isomer group) is typically used for calibration.  Total PCB
concentration is obtained by summing isomer group concentrations (Alford-Stevens et al. 1986). 
However, since the congener distribution is not determined with this method, an accurate calculation of
PCB toxic equivalency (TEQ) can not be accessed.  Recently, capillary or HRGC has made it possible to
achieve lower detection limits and better separation of individual PCB congeners for quantitation (Frame
1997; Mullin et al. 1984; Newman et al. 1998), although complete separation of all PCB congeners on a
single column has not yet been achieved (Duebeleis et al. 1989).  The commonly used capillary columns
(DB-5, C-18, DB-1701, SE-54, SIL-8, SP-2330, and CP-SIL-8) provide poor or no resolution for the
following groups of congeners: 15/18, 28/31, 49/52, 66/95, 77/110, 84/90/101, 118/149, 138/163/164,
105/132/153, 170/190, and 182/187 (Liem 1999; Schantz et al. 1993b).  Nevertheless, the trend is toward
congener-specific analysis by HRGC.  Recent advances include analytical methods that are able to
quantify individual PCBs congeners to enable TEQ calculations (EPA 1999k;  Frame 1999; Patterson et
al. 1994).  EPA Method 1668 (Revision A ) is the current methodology used to measure individual PCB
congeners in water, soil, sediment, and tissue by HRGC/high resolution mass spectrometry (HRMS) 
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(EPA 1999k).  Estimated detection limits (EDL) of selected PCB congeners range from 109 to 193 pg/L
for water and 11–19 ng/kg for soil, tissue, and  mixed-phase samples.  EDLs are listed in Table 7-1 for
EPA Method 1668 (Revision A; EPA 1999k).  This method has been used to measure specific PCBs in
EPA projects such as the assessment of PCBs in fish consumed by four Native American tribes in the
Columbia River Basin in Washington state (EPA 1996f).  As for all analytical methods, determining the
quality and usability of Aroclor, PCB homolog, or specific congener data by formal data validation
procedures is recommended; EPA has developed data validation guidelines for HRGC/ECD Aroclor data
and HRGC/LRMS (low resolution mass spectrometry) PCB specific congener data (EPA 1994h, 1995g). 
7.1 BIOLOGICAL SAMPLES
The quantitation of PCBs in biological samples usually consists of three distinct steps: extraction of PCBs
from the sample matrix by a solvent or a combination of solvents; cleanup of PCBs from impurities on
single or multiple columns; and finally, quantitation by GC with a suitable detector.  A summary of some
available methods for biological samples is shown in Table 7-2.
PCBs are extracted from blood or serum by solvent extraction techniques using hexane (EPA 1980;
Needham et al. 1980), benzene (Mes et al. 1994, 1995a, 1995b, 1995c), or mixed solvents such as
hexane/ethyl ether (Koopman-Esseboom et al. 1994b; Luotamo et al. 1985; Needham et al. 1981), or by
solid phase micro-extraction techniques (Poon et al. 1999).  A variety of adsorbents may be used for
cleanup and/or fractionation of extracts: deactivated silica gel (Burse et al. 1989), Florisil (Mes et al.
1994, 1995a, 1995b, 1995c), alumina (Koopman-Esseboom et al. 1994b), or multiple columns (Patterson
et al. 1989).  GC/ECD is used most often for determination of biological samples (Burse et al. 1989; Mes
et al. 1994, 1995a, 1995b; NIOSH 1984b; Schantz et al. 1994).  Confirmation by mass spectrometry is
recommended (Burse et al. 1994; Mes et al. 1994).  Detection limits are in the low- to sub-ppb range
(Luotamo et al. 1985; Mes et al. 1994, 1995a, 1995b; Needham et al. 1981; NIOSH 1984b; Poon et al.
1999).  Recovery, where reported, ranges from .80 to 96% (Koopman-Esseboom et al. 1994b; Mes et al.
1994; Needham et al. 1980, 1981; NIOSH 1984b; Poon et al. 1999).  The accuracy and precision of the
results of PCB analysis in serum using a packed column GC/ECD method were studied in a collaborative
study.  The mean recovery (for Aroclor 1254) was 82.2%; inter-laboratory precision was <21% for
samples spiked at 10–100 ng/mL (Burse et al. 1989).  Cord blood, which is the most direct marker of fetal
exposure, requires especially sensitive analytical methods for accurate PCB analysis because of its 
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Table 7-1.  EPA Method 1668-Estimated Method Detection Limits (EMDL) and
Estimated Minimal Levels (EML) of Selected PCB Congenersa,b
Detection limits and minimal levels-matrix and concentrationc
Water (pg/L) Otherd (ng/kg) Extract (pg/µL)
Congener EMDL EML EMDL EML EML
77 169 500 17 50 20
105 109 200 11 20 10
114 120 500 12 50 20
118 193 500 19 50 20
123 150 500 15 50 20
126 136 500 14 50 20
156 132 500 13 50 20
157 132 500 13 50 20
167 115 500 11 50 20
169 161 500 16 50 20
180 136 500 14 50 20
189 177 500 18 50 20
aSource: EPA 1999k
bfor SPB-Octyl gas chromatography column
cEMDLs and EMLs with common laboratory interferences present.  Without interferences, EMDLs and EMLs will be
respectively, 5 and 10 pg/L for aqueous samples, and 0.5 and 1.0 ng/kg for soil, tissue, and mixed-phase samples,
and EMLs for extracts will be 0.5 pg/µL.
dsoil, tissue, and mixed-phase samples












Table 7-2.  Analytical Methods for Determining Polychlorinated Biphenyls in Biological Samples





Serum Extraction with mixed solvents;
treatment with methanolic KOH;
extraction with hexane; cleanup on
silica gel column
HRGC/ECD 1.0 ng/mL on
1 mL sample
>80 at 25–400 ng/mL NIOSH 1984b
(method 8004)
Serum Extraction with mixed solvents;
cleanup on silica gel column
GC/ECD No data 82.2 (average) Burse et al. 1989
Serum Solvent extraction; cleanup on
10% silver nitrate on silica gel
column
GC/ECD No data 93.7 at 41 µg/L Needham et al.
1980
Serum Extraction with mixed solvents;
cleanup on hydrated silica gel
column for separation of PCBs
from PBBs
GC/ECD 2.5 ng/mL 95.3 at 100 µg/L and
105–127 at 10 µg/L
Needham et al.
1981
Serum Extraction with diethyl ether and
hexane; wash of extract with
sulfuric acid; cleanup on silica
column 




Addition of surrogate congener
standard PCB 46 and 142,
extraction with hexane, cleanup
with Florisil.
HRGC/ECD 1 pg/g (PCB
200) - 634 pg/g
(PCB 99)
95.1±12.5 (PCB 153) Greizerstein et
al. 1997
Serum Extraction with SPME; thermal
desorption of PCBs into GC
column
GC/ECD 1.0 ppb (total
PCBs)
<93 Poon et al. 1999





2 ng/g 81–96 Mes et al. 1994

















Table 7-2.  Analytical Methods for Determining Polychlorinated Biphenyls in Biological Samples (continued)







Extraction of 13C-labeled PCB-
spiked sample with ethanol/
hexane; wash of extract with
concentrated sulfuric acid; cleanup




2 ppq 605 for PCB-77a, 48 for




Blood Methanolic KOH hydrolysis;
extraction with hexane; cleanup on
silica gel and alumina column if
necessary
GC/ECD 2 pg 100±4 at 1.09–109 ng/g Que Hee et al.
1983
Adipose tissue Solvent extraction; cleanup on
sulfuric acid/silica gel and 10%
silver nitrate/silica gel columns
GC/ECD No data 91–93 at 3 µg/g Smrek and
Needham 1982
Adipose tissue Extraction with acetone/hexane;










Extraction of 13C-labeled PCB-
spiked sample with ethanol/
hexane; wash of extract with
concentrated sulfuric acid; cleanup
and fractionation by multi-column
chromatography
HRGC/ID/HRMS No data No data Patterson et al.
1994
Human milk Extraction with mixed solvents;
cleanup on Florisil-silicic acid
column
HRGC/ECD No data 94 at ng/mL Mes et al. 1984;





clean up on Florisil column;
fractionation on porous graphitic
carbon





Addition of surrogate congener
standard PCB 46 and 142,
extraction with hexane, cleanup
with Florisil.
HRGC/ECD 1 pg/g (PCB
200) - 129 pg/g
(PCB 48)
No data Greizerstein et
al. 1997
Table 7-2.  Analytical Methods for Determining Polychlorinated Biphenyls in Biological Samples (continued)















Human milk Fat separation; cleanup on
adsorption columns






acetone/hexane; wash of extract
with concentrated sulfuric acid and
alkaline hydrolysis; cleanup on
Florisil column; fractionation on
carbon column






extraction; cleanup on Florisil






using Soxhlet extractor; cleanup
using sulfuric acid and
chromatography
HRGC/HRMS See Table 7-1 No data EPA 1999k
(method 1668)
aThe high recovery for PCB 77 was due to interference from other congeners. The low recovery for PCB 126 and PCB-169 is not critical since ID/MS makes
correction for recovery unnecessary.
ECD = electron capture detector; GC = gas chromatography; GPC = gel permeation chromatography; HRGC = high resolution gas chromatography; HRMS=high
resolution mass spectroscopy; ID/HRMS = isotope dilution high resolution mass spectrometry; IDMS = isotope dilution mass spectrometry; KOH = potassium
hydroxide; MS = mass spectrometry; MS-SIM = mass spectrometer-selected-ion-monitoring; NICI/MS = negative ion chemical ionization mass spectrometry;
PBBs = polybrominated biphenyls; PCBs = polychlorinated biphenyls
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relatively low fat content.  Analysis of breast milk does not present this difficulty.  While analytical
techniques have improved enormously in recent years, the low concentration of fat in cord blood may still
present difficulties in achieving accurate and reliable PCB levels. 
Methods for determining PCBs in adipose tissue are similar to those for blood.  Solvent extraction is used
to separate the PCBs along with other soluble organics from the tissue.  The PCBs are then separated
from the lipids, usually by column chromatographic techniques.  Most procedures include a step for
determining the percent fat since results are often reported on a percent fat basis.  Very little performance
data are available for PCBs in adipose tissue.  Detection limits of 51–144 ng/g have been reported for
adipose tissue from Rhesus monkeys (Mes et al. 1994, 1995b).
A congener-specific analysis of a commercial PCB preparation and the PCB composition of a human milk
sample were reported originally by Safe et al. (1985b).  Recent studies have demonstrated the analysis of
non-ortho coplanar and mono-ortho coplanar PCBs in breast milk (Dewailly et al. 1991) and coplanar
PCBs in serum and adipose tissue (Patterson et al. 1994).  Determination of these congeners (PCBs 77,
126, 169) is useful in assessing the toxic potential of breast milk for infants.
Recently, supercritical fluid extraction (SFE) has been utilized for extraction and cleanup of biological
samples.  The procedure is quick and avoids the use of flammable or toxic organic solvents (Anitescu and
Tavlarides 1998; Djordjevic et al. 1994).  Packed-column GC techniques are still widely used; however,
HRGC has made it possible to achieve better separation of PCB congeners for quantitation (Ballschmiter
and Zell 1980; Mullin et al. 1984).
The congeners to be determined in samples may be selected on the basis of their abundance in the
samples, their toxicity, or the availability of analytical standards.  The coplanar, non-ortho-substituted
congeners are PCB-77, PCB-126, and PCB-169.  The mono-ortho-substituted congeners, PCB-28,
PCB-74, PCB-105, PCB-118, and PCB-156, are also frequently determined, along with the non-ortho-
substituted PCB congeners.  PCBs 138, 153, and 180 are frequently measured in higher amounts than
other congeners (Safe 1993; Schecter et al. 1994) and are often included in sets of congeners for
quantitation.
Variables in sampling methods greatly influence results.  For example, PCB levels in milk fat may
decrease during lactation, with maternal age and weight, and with number of children born (Jensen 1987). 
It has been shown by Lawton et al. (1985b) that random error, inter-laboratory variations in procedure, 
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and methods used for reporting data may have considerable impact on the reported PCB levels in human
tissues.  Caution should be exercised when comparing exposure estimates or health effect studies reported
by different investigators unless similar analysis methodologies are employed.  Also, without the
separation and quantitation of individual PCB congeners during analysis, PCB concentrations can not be
directly correlated to toxic equivalency.  Currently, EPA Method 1668 (Revision A) is a standard method
for analysis of individual PCB congeners  in biological tissues (EPA 1999k).
7.2 ENVIRONMENTAL SAMPLES
An overview of PCB analysis, including sampling technique, extraction, cleanup procedures, and
quantification is reported in EPA Method 1668 (Revision A; EPA 1999k).  A summary of representative
methods is shown in Table 7-3.  The table includes methods that have been standardized by NIOSH,
EPA, American Society for Testing and Materials (ASTM), AOAC, and Food and Drug Administration
(FDA).  Most of these methods were developed for the determination of Aroclors (noncongener-specific
PCBs) in environmental samples.
Air samples are usually collected by pumping air through a sampler containing a glass fiber filter and
adsorbent trap to separate the particle bound and vapor phase fractions.  Adsorbents used most often
include Florisil (Lin and Que Hee 1985, 1987; NIOSH 1984a), XAD-2 (EPA 1988b; Hippelein et al.
1993), and polyurethane foam (PUF) (Bremle and Larsson 1998; EPA 1988b).  Florisil traps are solvent
desorbed (Lin and Que Hee 1985, 1987; NIOSH 1984a) and XAD-2 traps are Soxhlet extracted (Bremle
and Larsson 1998; EPA 1988b; Hippelein et al. 1993).  PCBs are determined by GC/ECD (Bremle and
Larsson 1998; EPA 1988b; Irvine and Loganathan 1998; Lin and Que Hee 1985, 1987; NIOSH 1984a) or
HRGC/MS (Hippelein et al. 1993).  Detection limits depend upon the volume of air sampled; however,
detection limits in the low ng/m3 (EPA 1988b) to low pg/m3 (Hippelein et al. 1993) have been reported. 
Recovery, where reported, is good (>80%) (Bremle and Larsson 1998; Brownlow and Que Hee 1985;
EPA 1988b; Irvine and Loganathan 1998; Lee et al. 1996; Lin and Que Hee 1985, 1987).
EPA Method 1668 (Revision A ) is the current methodology used to measure specific toxic, dioxin-like
PCB congeners in surface, ground, and drinking water by HRGC/HRMS (EPA 1999k).  Drinking water
samples are typically extracted with solvent prior to analysis by GC/ECD,  HRGC/ECD, and
HRGC/HRMS (EPA 1989c, 1999k).  Detection limits are in the sub-ppb range and recovery is good
(>80%) (EPA 1989c).  Preconcentration techniques may be used for extraction of large water volumes,











Table 7-3.  Analytical Methods for Determining Polychlorinated Biphenyls in 
Environmental Samples





Air (occupational) Adsorption on glass fiber filter and Florisil;
hexane desorption
GC/ECD 0.0006 mg/m3 for
50 L sample
No data NIOSH 1984a
(method 5503)
Air Adsorption on water-deactivated Florisil;
hexane desorption; perchlorination 
GC/ECD No data 84–103 at
4–49 µg/m3
Lin and Que Hee
1985, 1987
Air Adsorption on Florisil or Chromosorb 102 or
Tenax GC or XAD-2; hexane desorption
GC/ECD 10 µg/m3 for
4 L sample
>80 at 300 µg/m3 Brownlow and 
Que Hee 1985
Ambient Air Sample collection on glass fiber filter and
PUF cartridge; Soxhlet extraction; alumina
column cleanup





Sample collection on glass fiber filter and
XAD-2 trap; Soxhlet extraction; adsorption
column cleanup and fractionation
HRGC/MS low pg/m3
(calculated)
No data Hippelein et al. 1993
Water (congener
specific)
Extracted using SPE, SFE, CLLE; cleanup
using sulfuric acid and chromatography
HRGC/HRMS See Table 7-1 No data EPA 1999k (method
1668)





Extraction with methylene chloride; solvent
exchange to methyl tert-butyl ether
GC/ECD or
HRGC/ECD




Extraction with methylene chloride; solvent




0.14–0.23 µg/L 82–136 ng/g EPA 1989c (method
508A)
Drinking water Extraction on SPE cartridges or disks;
elution with methylene chloride





Sample spiked with 13C-labeled PCBs;
solvent extraction of sample (filtered water
and particles); cleanup and fractionation by
adsorption chromatography 











Table 7-3.  Analytical Methods for Determining Polychlorinated Biphenyls in 
Environmental Samples (continued)








Passage through filter and XAD-2 resin;




<1–30 pg/L 79–83 Leister and Baker
1994
Waste water Extraction with methylene chloride;
exchange to hexane; cleanup on Florisil














Lake water Passage through glass fiber filter and
XAD-2; Soxhlet extraction; cleanup on
alumina and silica gel column





Collection of particulate and filtered water in
a pressurized extraction-filtration system;
cleanup with sodium hydroxide, alumina,
and silica column




Extraction with hexane/acetone; cleanup on
Florisil column; desulfurization if necessary







Filtered and homogenized; extracted using
Soxhlet/Dean-Stark extractor; cleanup
using sulfuric acid and chromatography
















Extraction with hexane/acetone; cleanup on
silica gel column; desulfurization by copper
or mercury if necessary
HRGC/ECD 60–70 µg/kg 104–107 (for soil) Lopez-Avila et al.
1988
Table 7-3.  Analytical Methods for Determining Polychlorinated Biphenyls in 
Environmental Samples (continued)

















Extraction with methylene chloride/acetone
(1:1); cleanup by gel permeation and micro-
alumina column
GC/ECD 80 µg/kg (required
quantitation limit)




Ultrasonic extraction with acetone/hexane;
sulfur removal; cleanup on Florisil;
fractionation by HPLC 
HRGC/ECD No data 70–93 Fuoco et al. 1993
Sediment Supercritical fluid extraction; mini-Florisil
column cleanup sulfur removal
HRGC/ECD;
confirmation by MS
No data .90 Lee and Peart 1994
Railcar paint
scrapings
Extraction with 90% methylene
chloride/10% methanol; cleanup on Florisil
column 
HRGC/ECD 1 mg/kg 74–86 Welsh 1995
Fly ash Soxhlet extraction; optional column cleanup GC/ECD or GC/MS-
SIM
No data 80–100 Ko…an et al. 1994
Fish (congener
specific)
Extraction of homogenized tissue with
petroleum ether/ethyl acetate; cleanup by
gel permeation chromatography




Homogenized; extracted in methylene
chloride:hexane (1:1) using Soxhlet
extractor; cleanup using sulfuric acid and
chromatography






Extraction of homogenized 13C-PCB labeled
tissues with methylene chloride; removal of
lipid by gel permeation or dialysis; cleanup
by multi-layer and multiple chromatography;
fractionation by HPLC 
HRGC/ECD 0.1–0.73 ng/g
(lipid)
62–92 Schwartz et al. 1993




30 µg/kg 95.2 (mean) Newman et al. 1994




Mixing of sample fortified with 13C-labeled
PCBs with sodium oxalate and methanol;
solvent extraction; cleanup and
fractionation by porous carbon and alumina
HRGC/MS 0.1–0.5 pg/g (fat)
for tetra- to hexa-
congeners of PCB
50–60 Van der Velde et al.
1994
Table 7-3.  Analytical Methods for Determining Polychlorinated Biphenyls in 
Environmental Samples (continued)















Eggs, fish Supercritical fluid extraction combined with
Florisil separation
GC/ECD No data 91–95 Alley and Lu 1995
Fatty foods Solvent extraction; liquid-liquid partitioning;
cleanup on Florisil column
GC/ECD No data No data AOAC 1990
aThis method converts the different congeners to decachlorobiphenyl and cannot differentiate between commercial mixtures (e.g., Aroclor 1242, 1260).
bAs required by Contract Laboratory Program
cMethod 8080A is proposed for deletion from SW-846; method 8082 is proposed for inclusion in SW-846.
CLLE = continuous liquid/liquid extraction; ECD = electron capture detection; GC = gas chromatography; HPLC = high performance liquid chromatography; HRGC = high resolution
gas chromatography; HRMS = high resolution mass spectrometry; MS = mass spectrometry; NICI/MS = negative ion chemical ionization mass spectrometry; ng = nanogram (10-9 g);
pg = picogram (10-12 g); PUF = polyurethane foam; SIM = selected ion monitoring; SFE= separatory funnel extraction; SPE = solid phase extraction
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Detection limits in the low pg/L range have been reported (Leister and Baker 1994).  Some of the
methods are noncongener-specific; that is, the results are reported as PCB mixtures (Aroclors) (EPA
1982a, 1989c), and some are congener-specific (EPA 1987f, 1999k; Kelly et al. 1993; Leister and Baker
1994; Miyata et al. 1993).  EPA Method 508A, which converts all of the PCBs to decachlorobiphenyl, is
a screening method for quantifying total PCBs (EPA 1989c).  The method is likely to show interference
due to perchlorination of biphenyl or related compounds (EPA 1991b) and the method cannot quantify
individual commercial Aroclors in a PCB mixture.  Some waters, particularly surface and waste waters,
may require cleanup on adsorption columns prior to analysis (EPA 1982a, 1988b; Miyata et al. 1993). 
SPE media may be used, reducing the use of flammable or toxic solvents (EPA 1987f).
Soil, sediment, and solid waste samples are usually Soxhlet extracted (EPA 1994f, 1995c, 1999k). 
Ultrasonic extraction with various solvent combinations (Fuoco et al. 1993) and SFE (Lee and Peart
1994) are utilized as well.  Recoveries using these methods are comparable to Soxhlet extraction
(80–100%).  Cleanup procedures include sulfur removal (EPA 1994f; Fuoco et al. 1993; Lee and Peart
1994; Lopez-Avila et al. 1988) and separation on adsorbent columns (Bandh et al. 1996; EPA 1994f;
Fuoco et al. 1993; Lee and Peart 1994; Lopez-Avila et al. 1988).  HRGC/ECD is used most often for
determination of PCBs (Fuoco et al. 1993; Lee and Peart 1994; Lopez-Avila et al. 1988).  Detection limits
are generally in the ppb range (60–80 µg/kg) (EPA 1987a, 1995c; Lopez-Avila et al. 1988).  Recovery of
62–125% of PCBs in clay and soil samples has been reported for a multiple lab study (EPA 1995c). 
Methods using the enzyme-linked immunosorbent assay are commercially available for screening PCB
contamination in soils (Baek 1993; EPA 1995d).  These methods are inexpensive and have a fast
turnaround time.  
Methods are available for measuring the concentration of PCBs in fish and animal tissues.  Tissues are
homogenized, and then dried by blending with anhydrous sodium sulfate prior to Soxhlet or column
extraction (EPA 1999k; Newman et al. 1994).  Direct extraction has also been utilized (Schwartz et al.
1993).  After cleanup, PCBs are determined by HRGC/ECD (Schwartz et al. 1993), dual column
HRGC/ECD (Newman et al. 1994), or HRGC/MS (Schmidt and Hesselberg 1992).  A micro extraction
method for very small sample masses (25 µg) has been developed (Wirth et al. 1994).  A limit of
detection of 1 ng/kg sample, and good recovery (95%) and precision were reported (Wirth et al. 1994). 
Few methods are available for the determination of PCBs in foods.  Little performance data have been
reported as well.  A method is available for the determination of Aroclors in poultry fat, fish, and dairy
products (AOAC 1990).
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A number of Standard Reference Materials (SRMs) with certified PCB congener concentrations are
available from the National Institute of Standards and Technology (NIST); these include SRM 1588,
PCBs in Cod Liver Oil; SRM 1939, PCBs in River Sediment; SRM 1941, PCBs in Marine Sediment; and
SRM 1974, PCBs in Mussel Tissue (Schantz et al. 1993a, 1993b).  These SRMs are useful in validating
the accuracy of methods for the determination of PCBs, and for verifying that the method remains within
acceptable levels of error in during analysis.  A summary of available SRMs with certified PCB
concentrations is shown in Table 7-4.  SRMs with non-certified concentration data for PCBs are included
in the table as well.
7.3 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of PCBs is available.  Where adequate information is not
available, ATSDR, in conjunction with the National Toxicology Program (NTP), is required to assure the
initiation of a program of research designed to determine the health effects (and techniques for developing
methods to determine such health effects) of PCBs. 
 
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA.  They are defined as substance-specific informational needs that if met would
reduce the uncertainties of human health assessment.  This definition should not be interpreted to mean
that all data needs discussed in this section must be filled.  In the future, the identified data needs will be
evaluated and prioritized, and a substance-specific research agenda will be proposed. 
7.3.1 Identification of Data Needs
Methods for Determining Biomarkers of Exposure and Effect.    Several investigators have
used whole blood, serum, breast milk, and hair as biomarkers for environmental exposure to PCBs
(Brown and Lawton 1984; Fait et al. 1989; Furst et al. 1994; Luotamo 1988; Safe et al. 1985b; Zupancic-
Kralj et al. 1992).  Consequently, levels of PCBs in these media can provide estimates of exposure to
PCBs.  Analytical methods of satisfactory accuracy are available for determining congener- and
noncongener-specific PCBs in blood, serum, breast milk, and human hair; these methods are shown in
Table 7-2.  Some methods for determining biomarkers are shown in Table 7-5.  The method developed by











Table 7-4.  NIST Standard Reference Materials for the Determination of Polychlorinated Biphenyls (PCBs)a
SRM Description PCBs certified PCBs quantified
1589 PCBs (as Aroclor 1260) in human serum 1b
1588 Organics in cod liver oil Surrogate for a tissue extract with high lipid
content
4 43
1649 Urban dust/organics Air particulate material 10
1939 PCB congeners in river sediment Sediment with high levels of PCB congeners 3 17
1941a Organics in marine sediment Collected in Baltimore Harbor 15
1974 Organics in mussel tissue Frozen powder-like homogenate 13
1945 Whale blubber Frozen blubber homogenate 26
aSource: Schantz et al. 1993a
bcertified as Aroclor 1260











Table 7-5.  Analytical Methods for Determining Biomarkers for Polychlorinated Biphenyls














removal of lipids by dialysis;
cleanup by gel permeation
chromatography; fractionation on
carbon and Florisil columns








No data low nmol/mL Morse et al. 1995
ECD = electron capture detection; ECNI = electron capture negative ionization; HRGC = high resolution gas chromatography; MS = mass spectrometry
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(77, 126, and 169) in human milk, adipose tissue, and serum at levels normally found in these tissues of
control population (Harrad et al. 1992; Hong et al. 1992a; Patterson et al. 1989, 1994). 
While blood, serum, breast milk, adipose tissue, and hair have been used as biomarkers of exposure, the
possible equivalency of these biomarkers has not been intensively investigated.  At least two of these
biomarkers, serum and breast milk, did not appear to give equivalent measures of exposure even when
expressed on a lipid basis.  (The theory of equivalency is based on the assumption that the steady state
concentration of a persistent lipophilic substance in different body compartments is the same when
expressed on a lipid basis.)  Greizerstein et al. (1999) compared levels of PCB congeners between serum
and milk from seven women in the New York Angler Study.  The congener profiles for serum and milk
samples were similar for each individual, but different among all subjects.  The sum of the congener
concentrations was used to estimate the total PCB concentration.  The ratio of serum to milk
concentrations in the women ranged from 0.18 to 1.66 with a mean of 0.65±0.49, showing no consistency
among individuals.  Considerable differences were also found in the lipid-adjusted concentrations of
PCBs among individuals.  The range of lipid-adjusted serum-to-milk ratios was 1.1–2.8 with a mean of
1.9±0.5.  The lipid-adjusted serum levels were also >1 for the most abundant congeners, PCBs 118, 153,
138, and 180.  The lipid-adjusted ratios of these four non-planar congeners in serum and milk were
similar to those found by Koopman-Esseboom et al. (1994b) in a study involving 418 mother-infant pairs. 
This latter study found that correlation coefficients between PCB congener levels (PCBs 118, 138, 153,
and 180) in maternal plasma, human milk (lipid-basis), and cord plasma were highly significant within
one biological sample (0.71–0.98) as well as between different biological samples.  However, the
correlation between other PCB congeners in human milk varied considerably.  The study by Greizerstein
et al. (1999) was small and collection of blood and milk samples was not uniform for all subjects. 
Therefore, more data are needed to establish whether equivalency factors can be established between
various measures of body burden so as to allow normalization of measurements between different studies.
Biomarkers of effects of exposure to PCBs are detailed Chapter 3 (Section 3.8.1).  No single effect or
combination of effects that could be used specifically as an indicator of exposure to PCBs are being
developed to screen large numbers of food samples for PCBs and related compounds (J.K. Huwe et al. of
Agricultural Research Service, Fargo, North Dakota).  New screening methods for trace detection of
PCBs in the environment and feeds are being developed by M. Franek et al. (Ministerstvo Zemedelstvi,
Czech Republic).  Development and application of semipermeable membrane devices (SPMDs) as
environmental dosimeters for PCB contaminants in water, air, sediment, and soil is the subject of ongoing
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research by Huckins and Petty at Columbia Environmental Research Center in Missouri.  Also at the
Columbia Environmental Research Center, C. Orazio et al. are developing analytical methods for
determining PCBs in environmental matrices.  A reliable method for continuous monitoring of PCBs in
incinerator stack gas emissions using resonance-enhanced multiphoton ionization spectroscopy in
conjunction with time-of-flight mass spectroscopy (REMPI/TOFMS) is the topic of current research by
T.A. Cool at Cornell University.  No additional information or ongoing studies regarding analytical
methods for determining PCBs in environmental and biological samples resulting from exposure were
located.  Accordingly, new and improved analytical methods for trace detection of PCBs that could be
used specifically as indicators of exposure in environmental and biological samples to PCBs are needed.
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Table 8-1 summarizes international, national, and state regulations and guidelines on human exposure to
PCBs.
ATSDR has derived an MRL of 0.03 µg/kg/day for intermediate-duration oral exposure to PCBs.  The
intermediate oral MRL is based on a LOAEL of 0.0075 mg/kg/day for neurobehavioral effects in infant
monkeys that were exposed to a PCB congener mixture representing 80% of the congeners typically
found in human breast milk from birth to 20 weeks of age (Rice 1997, 1998, 1999b; Rice and Hayward
1997, 1999a).  An uncertainty factor of 300 was applied (10 for extrapolating from a LOAEL to a
NOAEL, 3 for extrapolating from monkeys to humans, and 10 for human variability).
ATSDR has derived an MRL of 0.02 µg/kg/day for chronic-duration oral exposure to PCBs.  The chronic
oral MRL is based on a LOAEL of 0.005 mg/kg/day for immunological effects in adult monkeys that
were evaluated after 23 and 55 months of exposure to Aroclor 1254 (Tryphonas et al. 1989, 1991a).  An
uncertainty factor of 300 was applied (10 for extrapolating from a LOAEL to a NOAEL, 3 for
extrapolating from monkeys to humans, and 10 for human variability).
EPA has verified an oral reference dose (RfD) of 0.02 µg/kg/day for Aroclor 1254 (IRIS 2000) based on
dermal/ocular and immunological effects in monkeys, and an oral RfD of 0.07 µg/kg/day for Aroclor
1016 based on reduced birth weight in monkeys (IRIS 2000).
The EPA has determined that PCBs are probable human carcinogens and assigns them the cancer weight-
of-evidence classification B2 (IRIS 2000).  The EPA has developed an approach for assessing cancer risk
from environmental PCBs by considering both toxicity and environmental processes (Cogliano 1998;
EPA 1996c; IRIS 2000). This approach uses animal studies of commercial PCB mixtures to develop a
range of human cancer potency estimates and then considers the effect of environmental processes to
determine appropriate values for representative classes of environmental mixtures.  Additional discussion
on EPA’s cancer risk assessment, including the cancer slope factors and their corresponding exposure
pathways, is provided in Chapter 3 (Section 3.2.8.3.2).  IARC has determined that PCBs are probably
carcinogenic to humans (Group 2A) (IARC 1987).  The Department of Health and Human Services
(DHHS) concluded that PCBs are reasonably anticipated to be carcinogenic in humans based on sufficient
evidence of carcinogenicity in animals (NTP 2000).
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OSHA requires employers of workers who are occupationally exposed to PCBs to institute engineering
controls and work practices to reduce and maintain employee exposure at or below permissible exposure
limits (PELs).  The employer must use engineering and work practice controls, if feasible, to reduce
exposure to or below an 8-hour time-weighted average (TWA) of 1 mg/m3 for chlorodiphenyl (54%
chlorine).  Respirators must be provided and used during the time period necessary to install or implement
feasible engineering and work practice controls (OSHA 1998a).
The Food and Drug Administration (FDA) sets tolerance limits for PCBs as “unavoidable poisonous or
deleterious substances” in both animal and human food, and food-packaging materials (FDA 1998c).
PCBs haves been designated as a hazardous substance pursuant to the Comprehensive Environmental
Response, Compensation, and Liability Act (CERCLA) of 1980 (EPA 1998i) and as a toxic chemical
under Section 313 of Title III of the Superfund Amendments and Reauthorization Act (SARA) of 1986
(EPA 1998i).  Title III of SARA is also known as "The Emergency Planning and Community Right-to-
Know Act (EPCRA) of 1986."  As a chemical subject to the emergency planning and release reporting
requirements of EPCRA, owners and operators of certain facilities that have PCBs on their sites in
amounts exceeding a specified reporting threshold are required to report annually releases of PCBs to any
environmental medium (EPA 1998d).  The owners and operators of these facilities are also required to
immediately report releases of PCBs to any environmental media if the amount released exceeds the
“reportable quantity” of 1 pound (0.454 kg) (EPA 1998h).  The statutory sources for designating PCBs as
CERCLA hazardous substance are sections 311(b)(4) and 307(a) of the Clean Water Act (CWA), and
section 112 of the Clean Air Act (CAA).  The statutory reportable quantity for PCBs established by
Section 102 of CERCLA is 10 pounds (4.54 kg) (EPA 1998h).
PCBs are regulated by the Clean Water Effluent Guidelines as stated in Title 40.  Sections 400–475, of
the Code of Federal Regulations (CFR).  For each point source category, PCBs may be regulated as a
group of chemicals controlled as Total Toxic Organics or may have a specific Regulatory Limitation. 
The point source categories for which PCBs are controlled as a Total Toxic Organic include
electroplating (EPA 1981) and metal finishing (EPA 1983a).  The point source category for which PCBs
has a specific regulatory limitation is steam electric power generating (EPA 1982b).
If waters and their sediments become contaminated from sources such as atmospheric deposition and
discharges from industrial, municipal, or agricultural operations, toxic substances could concentrate in the
tissue of fish and wildlife.  Currently, 679 advisories restricting the consumption of PCB-contaminated
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fish, shellfish, and wildlife have been issued in 37 states and in one U.S. Territory (American Samoa)
(EPA 2000b).
The Toxic Substances Control Act (TSCA) bans manufacturing, processing, and distributing PCBs in
commerce.  It also bans the use of PCBs outside of totally enclosed systems (EPA 1998a).  In addition to
authorizing the EPA to regulate PCBs, TSCA also provides the EPA with the authority to modify these
bans if it is shown that such modifications would not present unreasonable risks to human health and the
environment.  On June 29, 1998, the EPA published amendments in the Federal Register to the regulatory
requirements for the manufacture, processing, distribution in commerce, use, cleanup, storage, and
disposal of PCBs (EPA 1998a).  These amendments add regulatory provisions authorizing certain uses of
PCBs; authorizing the manufacture, processing, and distribution in commerce of PCBs for use in research
and development activities; specifying additional alternatives for the cleanup and disposal of PCBs; and
clarifying the processing for disposal exemption.  These amendments also add sections establishing
standards and procedures for disposing of PCB remediation waste and certain products manufactured with
PCBs; establishing procedures for determining PCB concentration; establishing standards and procedures
for decontamination; establishing controls over the storage of PCBs for reuse; and establishing a
mechanism for coordinating TSCA disposal approvals for the management of PCB wastes among various
Federal programs.  They also update several marking, recordkeeping, and reporting requirements.
The amendments contained in the final rule will be codified in the CFR at 40 CFR 750 and 40 CFR 761. 
The final rule authorizes certain uses of PCBs and materials contaminated with PCBs to continue if
exposures can be controlled, and if removal and disposal of the material would be costly or impractical. 
More flexibility in selecting disposal technologies for PCBs is also allowed, and the list of available
decontamination procedures has been expanded.  The final rule allows disposal of PCBs from
decontamination activities, but does not require previously needed disposal approval (EPA 1998a).  The
amendments add provisions for disposing of PCB remediation waste and certain products containing
PCBs.  TSCA does not allow state disposal rules for PCBs to be preempted, particularly if the method of
disposal is described.
Some of the substances regulated by the requirements in 40 CFR 761 are dielectric fluids, solvents, oil,
waste oils, heat transfer fluids, hydraulic fluids, paints or coatings, sludges, slurries, sediments, dredge
spoils, soils, and materials containing PCBs as a result of spills.  The regulatory applicability for these
substances depends in part on the concentration of PCBs present (EPA 1998a).  Numerical standards are
usually expressed as the weight of PCBs per weight of liquid (e.g., milligrams per liter) or non-liquid 
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matrix (e.g., milligrams per kilogram).  The final rule provides two option for determining what
regulatory requirements apply to materials PCB-containing materials.  The first option requires that the
PCB concentration be determined (weight-to-weight or weight-to-volume) and then the regulatory
requirements for the found concentration and the type of material are applied.  Unless it is otherwise
noted in the regulation, the weight or volume is determined using the total weight of the material and not
the calculated weight or volume of PCBs within the substance.  For non-liquid PCBs, the concentration
must be determined on a dry weight basis.  The concentration of PCBs in liquids and multi-phasic
materials must determined on a wet weight basis and an analysis of each phase, respectively.  The second
option allows an assumption to be made that the PCB concentration is $500 ppm.  When the second
option is chosen, it would not be necessary to determine the PCB concentration; however, the most
restrictive regulatory requirements will need to be met.
Although there are exceptions, such as waste oils used for energy recovery, PCB wastes are generally
regulated for disposal under TSCA at concentrations of $50 ppm.  The requirements for the disposal of
PCB liquids and PCB items will be codified at 40 CFR 761.60.  Disposal requirements for PCB
remediation waste or PCB bulk product waste will be codified in 40 CFR 761.61 and 761.62,
respectively.  When the components of a waste are PCBs and non-PCB contaminants, and the PCB
component is approved for disposal, the non-PCB component must meet the requirements of all other
applicable statues or regulatory authorities prior to disposal (EPA 1998a). 
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Table 8-1.  Regulations and Guidelines Applicable to PCBs
Agency Description Information References
INTERNATIONAL
Guidelines:
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EPA Drinking water standard for
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40 CFR
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40 CFR
141.61
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Table 8-1.  Regulations and Guidelines Applicable to PCBs (continued)
Agency Description Information References
NATIONAL (cont’d)
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Table 8-1.  Regulations and Guidelines Applicable to PCBs (continued)
Agency Description Information References
NATIONAL (cont’d)
c. Food
Animal feed components of
animal origin, including fishmeal
and other by-products of marine
origin and in finished animal
feed concentrates, supplements,




intended for or used with
finished animal feed and any
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Table 8-1.  Regulations and Guidelines Applicable to PCBs (continued)
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Section 311 of the Clean Water
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311(b)(2)(A) of the Act
Yes EPA 1999i
40 CFR 116.4
Hazardous constituent Yes EPA 1998r
40 CFR 261,
app. viii
Application to land used for the




USC List of hazardous air pollutants Yes USC 1999
42 USC 7412
Manufacture of PCB
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Table 8-1.  Regulations and Guidelines Applicable to PCBs (continued)





HI List of hazardous air pollutants Yes UATW 1999d
AL Human health consumption of:
water and organismh
organism onlyi



















CO Groundwater for PCBs (1336-
36-3)
0.005 µg/L CDC 1999c























Fish consumption 7.9x10-5 µg/L
ID Primary water standard 5x10-4 mg/L UATW 1999e
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Table 8-1.  Regulations and Guidelines Applicable to PCBs (continued)
Agency Description Information References
STATE (cont’d)












NJ Groundwater quality criteria
for PCBs (1336-36-3)
0.02 µg/L CDC 1999a
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Table 8-1.  Regulations and Guidelines Applicable to PCBs (continued)
Agency Description Information References
STATE (cont’d)




aProbably carcinogenic to humans
bSufficient evidence from animal studies to assume probable human carcinogen
cThis criterion is based on carcinogenicity of 10-6 risk.  Alternate risk levels may be obtained by moving the decimal
point (e.g., for a risk level of 10-5, move the decimal point in the recommended criterion one place to the right.)
dPQL: practical quantitation limit; this PQL is an average value for PCB congeners.
eThe waste water and non-waste water standard applies to all PCB isomers.
fConfirmed animal carcinogen with unknown relevance to humans
gProbable human carcinogen
hderived from equation 18 for consumption of water and fish which is as follows:
Conc. (mg/L) = (HBW x RL)/(CPF x [(FCR x BCF) + WCR])
Where: 
HBW = human body weight, set at 70 kg
RL = risk level, 1x10-5 
CPF = cancer potency factor, 7.7 (kg-day)/mg
FCR = fish consumption rate, set at 0.030 kg/day
BCF = bioconcentration factor, given in appendix A, 31200 l/kg
WCR = water consumption rate, 2 l/kg
iderived from equation 19 for consumption of fish only which is as follows:
Conc. (mg/L) = {HBW x RL}/(CPF x FCR x BCF)
Where:
HBW = human body weight, set at 70 kg
RL = risk level, 1x10-5 
CPF = cancer potency factor, 7.7 (kg-day)/mg
FCR = fish consumption rate, set at 0.030 kg/day
BCF = bioconcentration factor, given in appendix A, 31200 l/kg
jThis information, current as of 2000, is based on the EPA Fish and Wildlife Advisory Database searched 8/00 on
the Internet at http://www.epa.gov/OST/fishadvice/.   For more detailed information, consult your state public health
or natural resources department.  A fish or wildlife advisory will specify the bodies of water or hunting areas with
restrictions.  The advisory will indicate the species and size of fish or game of concern.  The advisory may
completely ban consumption or recommend limiting the number of servings of a certain fish or wildlife species to
less than a particular frequency.  The advisory may indicate that only certain parts of the fish or game should be
consumed and recommend preparation methods to minimize exposure.  The advisory may have stricter
restrictions than for the general public to protect pregnant women, nursing mothers, and young children.  Each
state, Native American tribe, or U.S. territory chooses its own criteria for issuing fish and wildlife advisories.
CFR = Code of Federal Regulations; EPA = Environmental Protection Agency; FDA = Food and Drug
Administration; HBGL = health based guidance levels for drinking water; IARC = International Agency for
Research on Cancer; IRIS = Integrated Risk Information System; MCL = maximum contaminant limit;
MCLG = maximum contaminant limit goal; NIOSH = National Institute of Occupational Safety and Health;
OSHA = Occupational Safety and Health Administration; PEL = permissible exposure limit; PQL = practical
quantitation limit; RfD = oral reference dose; REL = recommended exposure release; TLV = threshold limit value;
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Absorption—The taking up of liquids by solids, or of gases by solids or liquids.
Acute Exposure—Exposure to a chemical for a duration of 14 days or less, as specified in the
Toxicological Profiles.
Adsorption—The adhesion in an extremely thin layer of molecules (as of gases, solutes, or liquids) to the
surfaces of solid bodies or liquids with which they are in contact.
Adsorption Coefficient (Koc)—The ratio of the amount of a chemical adsorbed per unit weight of
organic carbon in the soil or sediment to the concentration of the chemical in solution at equilibrium.
Adsorption Ratio (Kd)—The amount of a chemical adsorbed by a sediment or soil (i.e., the solid phase)
divided by the amount of chemical in the solution phase, which is in equilibrium with the solid phase, at a
fixed solid/solution ratio.  It is generally expressed in micrograms of chemical sorbed per gram of soil or
sediment.
Benchmark Dose (BMD)—Usually defined as the lower confidence limit on the dose that produces a
specified magnitude of changes in a specified adverse response.  For example, a BMD10  would be the
dose at the 95% lower confidence limit on a 10% response, and the benchmark response (BMR) would be
10%. The BMD is determined by modeling the dose response curve in the region of the dose response
relationship where biologically observable data are feasible.   
Benchmark Dose Model—A statistical dose-response model applied to either experimental toxicological
or epidemiological data to calculate a BMD.
Bioconcentration Factor (BCF)—The quotient of the concentration of a chemical in aquatic organisms
at a specific time or during a discrete time period of exposure divided by the concentration in the
surrounding water at the same time or during the same period.
Biomarkers—Broadly defined as indicators signaling events in biologic systems or samples.  They have
been classified as markers of exposure, markers of effect, and markers of susceptibility.
BZ number—A system of sequential numbers for the 209 PCB congeners introduced in 1980 by
Ballschmiter and Zell that identifies a given congener simply and precisely.  Also referred to as congener,
IUPAC, or PCB number.
Cancer Effect Level (CEL)—The lowest dose of chemical in a study, or group of studies, that produces
significant increases in the incidence of cancer (or tumors) between the exposed population and its
appropriate control.
Carcinogen—A chemical capable of inducing cancer.
Case-Control Study—A type of epidemiological study which examines the relationship between a
particular outcome (disease or condition) and a variety of potential causative agents (such as toxic
chemicals).  In a case-controlled study, a group of people with a specified and well-defined outcome is
identified and compared to a similar group of people without outcome.
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Case Report—Describes a single individual with a particular disease or exposure.  These may suggest
some potential topics for scientific research but are not actual research studies.
Case Series—Describes the experience of a small number of individuals with the same disease or
exposure.  These may suggest potential topics for scientific research but are not actual research studies.
Ceiling Value—A concentration of a substance that should not be exceeded, even instantaneously.
Chronic Exposure—Exposure to a chemical for 365 days or more, as specified in the Toxicological
Profiles.
Cohort Study—A type of epidemiological study of a specific group or groups of people who have had a
common insult (e.g., exposure to an agent suspected of causing disease or a common disease) and are
followed forward from exposure to outcome.  At least one exposed group is compared to one unexposed
group.
Congener—A single, unique, well-defined chemical compound in the PCB category.  The name of the
congener specifies the total number of chlorine substituents and the position of each chlorine.
Congener number—A system of sequential numbers for the 209 PCB congeners introduced in 1980 by
Ballschmiter and Zell that identifies a given congener simply and precisely.  Also referred to as BZ, PCB,
or IUPAC number.
Cross-sectional Study—A type of epidemiological study of a group or groups which examines the
relationship between exposure and outcome to a chemical or to chemicals at one point in time.
Data Needs—Substance-specific informational needs that if met would reduce the uncertainties of human
health assessment.
Developmental Toxicity—The occurrence of adverse effects on the developing organism that may result
from exposure to a chemical prior to conception (either parent), during prenatal development, or
postnatally to the time of sexual maturation.  Adverse developmental effects may be detected at any point
in the life span of the organism.
Dose-Response Relationship—The quantitative relationship between the amount of exposure to a
toxicant and the incidence of the adverse effects.
Embryotoxicity and Fetotoxicity—Any toxic effect on the conceptus as a result of prenatal exposure to
a chemical; the distinguishing feature between the two terms is the stage of development during which the
insult occurs.  The terms, as used here, include malformations and variations, altered growth, and in utero
death.
Environmental Protection Agency (EPA) Health Advisory—An estimate of acceptable drinking water
levels for a chemical substance based on health effects information.  A health advisory is not a legally
enforceable federal standard, but serves as technical guidance to assist federal, state, and local officials.
Epidemiology—Refers to the investigation of factors that determine the frequency and distribution of
disease or other health-related conditions within a defined human population during a specified period.  
PCBs 761
10.  GLOSSARY
Genotoxicity—A specific adverse effect on the genome of living cells that, upon the duplication of
affected cells, can be expressed as a mutagenic, clastogenic or carcinogenic event because of specific
alteration of the molecular structure of the genome.
Half-life—A  measure of rate for the time required to eliminate one half of a quantity of a chemical from
the body or environmental media.
Homolog—Subcategories of PCB congeners having the same number of chlorine substituents.  For
example, the 42 tetrachlorobiphenyls are congeners with 4 chlorine substituents in all possible
arrangements.
Immediately Dangerous to Life or Health (IDLH)—The maximum environmental concentration of a
contaminant from which one could escape within 30 minutes without any escape-impairing symptoms or
irreversible health effects.
Incidence—The ratio of individuals in a population who develop a specified condition to the total
number of individuals in that population who could have developed that condition in a specified time
period. 
Intermediate Exposure—Exposure to a chemical for a duration of 15–364 days, as specified in the
Toxicological Profiles.
Immunologic Toxicity—The occurrence of adverse effects on the immune system that may result from
exposure to environmental agents such as chemicals.
Immunological Effects—Functional changes in the immune response.
In Vitro—Isolated from the living organism and artificially maintained, as in a test tube.
In Vivo—Occurring within the living organism.
IUPAC number—A system of sequential numbers for the 209 PCB congeners introduced in 1980 by
Ballschmiter and Zell that identifies a given congener simply and precisely.  Also referred to as BZ,
congener, or PCB number.
Lethal Concentration(LO) (LCLO)—The lowest concentration of a chemical in air which has been
reported to have caused death in humans or animals.
Lethal Concentration(50) (LC50)—A calculated concentration of a chemical in air to which exposure for a
specific length of time is expected to cause death in 50% of a defined experimental animal population.
Lethal Dose(LO) (LDLO)—The lowest dose of a chemical introduced by a route other than inhalation that
has been reported to have caused death in humans or animals.
Lethal Dose(50) (LD50)—The dose of a chemical which has been calculated to cause death in 50% of a
defined experimental animal population.
Lethal Time(50) (LT50)—A calculated period of time within which a specific concentration of a chemical
is expected to cause death in 50% of a defined experimental animal population.
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Lowest-Observed-Adverse-Effect Level (LOAEL)—The lowest exposure level of chemical in a study,
or group of studies, that produces statistically or biologically significant increases in frequency or severity
of adverse effects between the exposed population and its appropriate control.
Lymphoreticular Effects—Represent morphological effects involving lymphatic tissues such as the
lymph nodes, spleen, and thymus.
Malformations—Permanent structural changes that may adversely affect survival, development, or
function.
Minimal Risk Level (MRL)—An estimate of daily human exposure to a hazardous substance that is
likely to be without an appreciable risk of adverse noncancer health effects over a specified route and
duration of exposure.
Modifying Factor (MF)—A value (greater than zero) that is applied to the derivation of a minimal risk
level (MRL) to reflect additional concerns about the database that are not covered by the uncertainty
factors. The default value for a MF is 1.
Morbidity—State of being diseased; morbidity rate is the incidence or prevalence of disease in a specific
population.
Mortality—Death; mortality rate is a measure of the number of deaths in a population during a specified 
interval of time.
Mutagen—A substance that causes mutations.  A mutation is a change in the DNA sequence of a cell’s
DNA.  Mutations can lead to birth defects, miscarriages, or cancer.
Necropsy—The gross examination of the organs and tissues of a dead body to determine the cause of
death or pathological conditions.
Neurotoxicity—The occurrence of adverse effects on the nervous system following exposure to a
chemical.
No-Observed-Adverse-Effect Level (NOAEL)—The dose of a chemical at which there were no
statistically or biologically significant increases in frequency or severity of adverse effects seen between
the exposed population and its appropriate control.  Effects may be produced at this dose, but they are not
considered to be adverse.
Octanol-Water Partition Coefficient (Kow)—The equilibrium ratio of the concentrations of a chemical
in n-octanol and water, in dilute solution.
Odds Ratio (OR)—A means of measuring the association between an exposure (such as toxic substances
and a disease or condition) which represents the best estimate of relative risk (risk as a ratio of the
incidence among subjects exposed to a particular risk factor divided by the incidence among subjects who
were not exposed to the risk factor).  An odds ratio of greater than 1 is considered to indicate greater risk
of disease in the exposed group compared to the unexposed.
Organophosphate or Organophosphorus Compound—A phosphorus containing organic compound
and especially a pesticide that acts by inhibiting cholinesterase.
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Permissible Exposure Limit (PEL)—An Occupational Safety and Health Administration (OSHA)
allowable exposure level in workplace air averaged over an 8-hour shift of a 40-hour workweek.
Pesticide—General classification of chemicals specifically developed and produced for use in the control
of agricultural and public health pests.
Pharmacokinetics—The science of quantitatively predicting the fate (disposition) of an exogenous
substance in an organism. Utilizing computational techniques, it provides the means of studying the
absorption, distribution, metabolism and excretion of chemicals by the body.
Pharmacokinetic Model—A set of equations that can be used to describe the time course of a parent
chemical or metabolite in an animal system.  There are two types of pharmacokinetic models: data-based
and physiologically-based.  A data-based model divides the animal system into a series of compartments
which, in general, do not represent real, identifiable anatomic regions of the body whereby the
physiologically-based model compartments represent real anatomic regions of the body.
Physiologically Based Pharmacodynamic (PBPD) Model—A type of physiologically-based dose-
response model which quantitatively describes the relationship between target tissue dose and toxic end
points.  These models advance the importance of physiologically based models in that they clearly
describe the biological effect (response) produced by the system following exposure to an exogenous
substance. 
Physiologically Based Pharmacokinetic (PBPK) Model—Comprised of a series of compartments
representing organs or tissue groups with realistic weights and blood flows.  These models require a
variety of physiological information: tissue volumes, blood flow rates to tissues, cardiac output, alveolar
ventilation rates and, possibly membrane permeabilities.  The models also utilize biochemical information
such as air/blood partition coefficients, and metabolic parameters.  PBPK models are also called
biologically based tissue dosimetry models.
Prevalence—The number of cases of a disease or condition in a population at one point in time. 
Prospective Study—A type of cohort study in which the pertinent observations are made on events
occurring after the start of the study.  A group is followed over time.
q1*—The upper-bound estimate of the low-dose slope of the dose-response curve as determined by the
multistage procedure.  The q1* can be used to calculate an estimate of carcinogenic potency, the
incremental excess cancer risk per unit of exposure (usually µg/L for water, mg/kg/day for food, and
µg/m3 for air).
Recommended Exposure Limit (REL)—A National Institute for Occupational Safety and Health
(NIOSH) time-weighted average (TWA) concentrations for up to a 10-hour workday during a 40-hour
workweek.
Reference Concentration (RfC)—An estimate (with uncertainty spanning perhaps an order of
magnitude) of a continuous inhalation exposure to the human population (including sensitive subgroups)
that is likely to be without an appreciable risk of deleterious noncancer health effects during a lifetime. 
The inhalation reference concentration is for continuous inhalation exposures and is appropriately
expressed in units of mg/m3 or ppm.
Reference Dose (RfD)—An estimate (with uncertainty spanning perhaps an order of magnitude) of the
daily exposure of the human population to a potential hazard that is likely to be without risk of deleterious
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 effects during a lifetime.  The RfD is operationally derived from the no-observed-adverse-effect level
(NOAEL-from animal and human studies) by a consistent application of uncertainty factors that reflect
various types of data used to estimate RfDs and an additional modifying factor, which is based on a
professional judgment of the entire database on the chemical.  The RfDs are not applicable to
nonthreshold effects such as cancer.
Reportable Quantity (RQ)—The quantity of a hazardous substance that is considered reportable under
the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA).  Reportable
quantities are (1) 1 pound or greater or (2) for selected substances, an amount established by regulation
either under CERCLA or under Section 311 of the Clean Water Act.  Quantities are measured over a
24-hour period.
Reproductive Toxicity—The occurrence of adverse effects on the reproductive system that may result
from exposure to a chemical.  The toxicity may be directed to the reproductive organs and/or the related
endocrine system.  The manifestation of such toxicity may be noted as alterations in sexual behavior,
fertility, pregnancy outcomes, or modifications in other functions that are dependent on the integrity of
this system.
Retrospective Study—A type of cohort study based on a group of persons known to have been exposed
at some time in the past.  Data are collected from routinely recorded events, up to the time the study is
undertaken.  Retrospective studies are limited to causal factors that can be ascertained from existing
records and/or examining survivors of the cohort.
Risk—The possibility or chance that some adverse effect will result from a given exposure to a chemical.
Risk Factor—An aspect of personal behavior or lifestyle, an environmental exposure, or an inborn or
inherited characteristic, that is associated with an increased occurrence of disease or other health-related
event or condition.
Risk Ratio—The ratio of the risk among persons with specific risk factors compared to the risk among
persons without risk factors.  A risk ratio greater than 1 indicates greater risk of disease in the exposed
group compared to the unexposed.
Short-Term Exposure Limit (STEL)—The American Conference of Governmental Industrial
Hygienists (ACGIH) maximum concentration to which workers can be exposed for up to 15 min
continually.  No more than four excursions are allowed per day, and there must be at least 60 min
between exposure periods.  The daily Threshold Limit Value - Time Weighted Average (TLV-TWA) may
not be exceeded.
Target Organ Toxicity—This term covers a broad range of adverse effects on target organs or
physiological systems (e.g., renal, cardiovascular) extending from those arising through a single limited
exposure to those assumed over a lifetime of exposure to a chemical.
Teratogen—A chemical that causes structural defects that affect the development of an organism.
Threshold Limit Value (TLV)—An American Conference of Governmental Industrial Hygienists
(ACGIH) concentration of a substance to which most workers can be exposed without adverse effect. 
The TLV may be expressed as a Time Weighted Average (TWA), as a Short-Term Exposure Limit
(STEL), or as a ceiling limit (CL).
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Time-Weighted Average (TWA)—An allowable exposure concentration averaged over a normal 8-hour
workday or 40-hour workweek.
Toxic Dose(50) (TD50)—A calculated dose of a chemical, introduced by a route other than inhalation,
which is expected to cause a specific toxic effect in 50% of a defined experimental animal population.
Toxicokinetic—The study of the absorption, distribution and elimination of toxic compounds in the
living organism.
Uncertainty Factor (UF)—A factor used in operationally deriving the Minimal Risk Level (MRL) or
Reference Dose (RfD) or Reference Concentration (RfC) from experimental data.  UFs are intended to
account for (1) the variation in sensitivity among the members of the human population, (2) the
uncertainty in extrapolating animal data to the case of human, (3) the uncertainty in extrapolating from
data obtained in a study that is of less than lifetime exposure, and (4) the uncertainty in using lowest-
observed-adverse-effect level (LOAEL) data rather than no-observed-adverse-effect level (NOAEL) data. 
A default for each individual UF is 10; if complete certainty in data exists, a value of one can be used;
however a reduced UF of three may be used on a case-by-case basis, three being the approximate
logarithmic average of 10 and 1.




ATSDR MINIMAL RISK LEVEL AND WORKSHEETS
The Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) [42 U.S.C.
9601 et seq.], as amended by the Superfund Amendments and Reauthorization Act (SARA) [Pub. L.
99–499], requires that the Agency for Toxic Substances and Disease Registry (ATSDR) develop jointly
with the U.S. Environmental Protection Agency (EPA), in order of priority, a list of hazardous substances
most commonly found at facilities on the CERCLA National Priorities List (NPL); prepare toxicological
profiles for each substance included on the priority list of hazardous substances; and assure the initiation
of a research program to fill identified data needs associated with the substances.
The toxicological profiles include an examination, summary, and interpretation of available toxicological
information and epidemiologic evaluations of a hazardous substance.  During the development of
toxicological profiles, Minimal Risk Levels (MRLs) are derived when reliable and sufficient data exist to
identify the target organ(s) of effect or the most sensitive health effect(s) for a specific duration for a
given route of exposure.  An MRL is an estimate of the daily human exposure to a hazardous substance
that is likely to be without appreciable risk of adverse noncancer health effects over a specified duration
of exposure.  MRLs are based on noncancer health effects only and are not based on a consideration of
cancer effects.  These substance-specific estimates, which are intended to serve as screening levels, are
used by ATSDR health assessors to identify contaminants and potential health effects that may be of
concern at hazardous waste sites.  It is important to note that MRLs are not intended to define clean-up or
action levels.
MRLs are derived for hazardous substances using the no-observed-adverse-effect level/uncertainty factor
approach.  They are below levels that might cause adverse health effects in the people most sensitive to
such chemical-induced effects.  MRLs are derived for acute (1–14 days), intermediate (15–364 days), and
chronic (365 days and longer) durations and for the oral and inhalation routes of exposure.  Currently,
MRLs for the dermal route of exposure are not derived because ATSDR has not yet identified a method
suitable for this route of exposure.  MRLs are generally based on the most sensitive chemical-induced end
point considered to be of relevance to humans.  Serious health effects (such as irreparable damage to the
liver or kidneys, or birth defects) are not used as a basis for establishing MRLs.  Exposure to a level
above the MRL does not mean that adverse health effects will occur.
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MRLs are intended only to serve as a screening tool to help public health professionals decide where to
look more closely.  They may also be viewed as a mechanism to identify those hazardous waste sites that
are not expected to cause adverse health effects.  Most MRLs contain a degree of uncertainty because of
the lack of precise toxicological information on the people who might be most sensitive (e.g., infants,
elderly, nutritionally or immunologically compromised) to the effects of hazardous substances.  ATSDR
uses a conservative (i.e., protective) approach to address this uncertainty consistent with the public health
principle of prevention.  Although human data are preferred, MRLs often must be based on animal studies
because relevant human studies are lacking.  In the absence of evidence to the contrary, ATSDR assumes
that humans are more sensitive to the effects of hazardous substance than animals and that certain persons
may be particularly sensitive.  Thus, the resulting MRL may be as much as a hundredfold below levels
that have been shown to be nontoxic in laboratory animals.
Proposed MRLs undergo a rigorous review process:  Health Effects/MRL Workgroup reviews within the
Division of Toxicology, expert panel peer reviews, and agencywide MRL Workgroup reviews, with
participation from other federal agencies and comments from the public.  They are subject to change as
new information becomes available concomitant with updating the toxicological profiles.  Thus, MRLs in
the most recent toxicological profiles supersede previously published levels.  For additional information
regarding MRLs, please contact the Division of Toxicology, Agency for Toxic Substances and Disease
Registry, 1600 Clifton Road, Mailstop E-29, Atlanta, Georgia 30333.
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MINIMAL RISK LEVEL (MRL) WORKSHEET




Route: [ ] Inhalation   [X] Oral
Duration: [ ] Acute   [ X] Intermediate   [ ] Chronic
Key to Figure: 87k
Species: Monkey
Minimal Risk Level:  0.03   [X] µg/kg/day   [ ] ppm
Reference:  Rice 1997, 1998, 1999b; Rice and Hayward 1997, 1999a
Experimental design:  A series of studies were conducted that investigated effects of postnatal exposure to
a PCB congener mixture, representing 80% of the congeners present in breast milk in Canadian women,
on learning in monkeys.  Groups of five and eight male monkeys were orally administered doses of 0 or
0.0075 mg/kg/day, respectively, from birth to 20 weeks of age.  The daily dose was divided into thirds
and administered prior to the first three daily feedings via syringe to the back of the mouth.  The dose
level represents the approximate daily intake of a nursing human infant whose mother’s milk contained
50 ppb PCBs (the Health Canada guideline for maximum concentration in breast milk).  At the end of the
dosing period (i.e., at 20 weeks of age), the levels of PCBs in fat and blood in the treated monkeys were
1.7–3.5 ppm and 1.84–2.84 ppb, respectively.  Corresponding values in the control monkeys were
0.05–0.20 ppm and 0.30–0.37 ppb.  Beginning at 3 years of age, the monkeys were tested on a series of
nonspatial discrimination reversal problems followed by a spatial delayed alternation task.  Additional
testing was done at 4.5 and 5 years of age.
Effects noted in study and corresponding doses:    Treated monkeys showed decreased median response
latencies and variable increases in mean response latencies across three tasks of nonspatial discrimination
reversal.  There was no difference in overall accuracy of the tests or correlation between performance and
tissue levels of PCBs.  Treated monkeys also displayed retarded acquisition of a delayed alternation task
and increased errors at short delay task responses.  These findings were interpreted as a
learning/performance decrement rather than an effect on memory per se.  In a separate portion of this
study (Rice 1997), treated monkeys displayed shorter mean interresponse times when compared with
controls.  The increase in pause time for fixed-interval performance emerged more slowly across
48 sessions in treated monkeys.  For fixed-ratio performance tasks, the control monkeys decreased their
mean pause time across 10 sessions, whereas the treated monkeys did not.  Rice (1997) interpreted these
results as suggesting learning deficit, perseveration, and/or inability to inhibit inappropriate responding as
a result of postnatal PCB exposure.  Testing of these monkeys at 4.5–5 years of age showed that treated
animals performed in a less efficient manner than controls under a differential reinforcement of low rate
(DRL) schedule of reinforcement (Rice 1998).  There were no differences between groups on the
accuracy of performance on a series of spatial discrimination reversal tasks, although some treated
monkeys made more errors than others on certain parts of the experiment.  Further tests conducted at
about 5 years of age did not find treatment-related effects on a series of concurrent RI-RI (random
interval) schedules of reinforcement (Rice and Hayward 1999a).  This schedule was designed to study
behavior in transition (learning) as well as at steady state.  However, there was a difference between
treated and control monkeys on performance on a progressive ratio (PR) schedule.  Rice and Hayward
(1999a) stated that this finding may be indicative of retarded acquisition of the steady-state PR
performance in treated monkeys.
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Dose and end point used for MRL derivation:  The tested dose level, 0.0075 mg/kg/day, is a less serious
LOAEL for neurobehavioral toxicity.  This LOAEL is a particularly appropriate basis for MRL derivation
due to the human relevance of the tested PCB mixture (a congener mixture analogous to that in human
breast milk), dose level (approximate daily intake of a nursing human infant whose mother’s milk
contained 50 ppb PCBs), and resulting PCB tissue and blood levels (near background concentrations
found in the general human population).  Support for the LOAEL is provided by the occurrence of
minimal immunological alterations in the same monkeys at 0.0075 mg/kg/day (Arnold et al. 1999), as
well as clinical signs of toxicity (ocular and dermal changes) and decreased antibody responses in
offspring of monkeys that were exposed to a similar dose level of Aroclor 1254 (0.005 mg/kg/day) for
approximately 46 weeks during gestation and nursing (Arnold et al. 1995); these studies are summarized
below in the other pertinent information section. 
[ ] NOAEL   [X] LOAEL
Uncertainty Factors used in MRL derivation:
[X]  10 for use of a LOAEL
[X]   3 for extrapolation from animals to humans
[X]  10 for human variability
Was a conversion factor used from ppm in food or water to a mg/body weight dose?
No
If an inhalation study in animals, list conversion factors used in determining human equivalent dose:  
NA
Was a conversion used from intermittent to continuous exposure?  
No
Other additional studies or pertinent information that lend support to this MRL:
The monkeys that were evaluated for neurodevelopmental toxicity by Rice and coworkers were also
tested for other kinds of effects earlier in life (Arnold et al. 1999).  Following exposure to
0.0075 mg/kg/day of the simulated human milk congener mixture during the first 20 weeks of life, the
monkeys were periodically examined for the following endpoints for at least the following 46 weeks:
bone development (at birth); general health status; formula intake; food and water consumption; body
weight; tooth eruption; somatic measurements; and hematology, serum biochemistry, and immunology
indices.  Immunological assessment of the infants was started at 22 weeks of age and included IgM and
IgG antibody production following immunization with SRBC, lymphoproliferative activity of peripheral
leucocytes in response to mitogens (PHA, ConA, and PWM), numbers of peripheral leucocytes and their
subsets, and NK cell activity.  Few statistically significant changes were observed in any of the monitored
parameters.  Anti-SRBC titers were reduced in the treated monkeys but not significantly different from
controls.  Absolute mean numbers of B lymphocytes were significantly lower in treated monkeys (no
change in mean percent), but the effect was transient because it was not observed when re-evaluated in
the monkeys at 1 year of age.  The investigators concluded that, overall, the effects on the infant immune
system were mild and of unclear biological significance due to large inter-animal variability related to
small numbers of animals.
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In another study (Arnold et al. 1995), oral exposure of adult female monkeys for approximately
44 months (total exposure; pre-conception, gestation, and lactation) to a similarly low dose
(0.005 mg/kg/day) of an Aroclor PCB mixture resulted in immunological and dermal/ocular effects in
their offspring.  Groups of 16 female Rhesus monkeys self-ingested capsules containing Aroclor 1254 in
a glycerol/corn oil mixture (1:1) in doses of 0, 0.005, 0.02, 0.04, or 0.08 mg/kg/day.  After 25 months of
exposure, approximately 90% of the animals had attained an apparent pharmacokinetic steady state with
respect to adipose concentrations of PCBs.  After 37 months of exposure, the females were mated with
untreated males, and dosing was continued throughout breeding and gestation and into the first part of the
lactation period.  Maternal treatment was discontinued when the infants were 7 weeks old (to preclude
ingestion of the mother’s dosing capsule) and resumed after the infants were weaned at age 22 weeks. 
Mothers were dosed with PCBs for 37 months prior to mating, and infants born to these mothers were
exposed for a duration of approximately 46 weeks (average 24 weeks gestation plus 22 weeks nursing). 
Study end points included numbers of impregnations, live infants, postpartum deaths, abortions,
suspected resorptions, stillbirths, and gestation length.  On the day of parturition all infants were x-rayed
to ascertain osseus development.  Body weight, clinical health, hematology, and serum biochemistry were
periodically evaluated in the infants and maternal animals during the lactation period, and subsequently in
the dams until the infants were 78 weeks old and in the infants until they were 122 weeks old.  The
offspring were also evaluated for changes in tooth eruption and anthropometric measurements throughout
the study, and immunological changes when they were 20 and 60 weeks old.  Four immunological tests
were performed: IgM and IgG antibodies to SRBC; lymphocyte proliferation response to PHA, ConA,
and PWM mitogens; mixed lymphocyte culture assay (one-way); and natural killer cell activity.  Most of
the control and all treated offspring were autopsied at 122 weeks of age. 
PCB-related effects were induced in the adult monkeys and their offspring (Arnold et al. 1995). 
Conception rate was significantly reduced at 0.02 mg/kg/day and higher doses.  Because this effect
occurred in the adult animals that were mated after 37 months of exposure, 0.02 mg/kg/day is a serious
LOAEL for reproductive toxicity for chronic-duration exposure.  Exposure during gestation and lactation
resulted in both fetal toxicity and postnatal effects in the offspring.  Fetal mortality was increased at
0.02 mg/kg/day and higher doses.  Incidence rates for fetal mortality (combined abortions, suspected
resorptions, and stillbirths) were 2/11, 5/10, 3/4, 2/6, and 4/5 in impregnated monkeys in the 0, 0.005,
0.02, 0.04, and 0.08 mg/kg/day groups, respectively, and displayed a significant increasing dose-related
trend (p=0.040).  Statistical comparison of the treated and control groups showed that the fetal mortality
incidence rates were increased at 0.02 mg/kg/day (p=0.077) and significantly increased at 0.08 mg/kg/day
(p=0.036).  The precision of this statistical comparison is limited by the small numbers of animals, which
obscures the high response rate in the 0.02 mg/kg/day group (i.e., that there were 3 fetal deaths in
4 impregnated animals, and that the combined incidence of fetal and neonatal deaths was 4/4).  Evaluation
of the offspring, limited by the small numbers of surviving animals, showed mild clinical manifestations
of PCB exposure and some immunological test differences at 0.005 and 0.04 mg/kg/day (no infants
survived beyond postpartum week 2 in the other dose groups).  The major clinical signs in the surviving
exposed offspring were inflammation and/or enlargement of the tarsal (Meibomian) gland, nail lesions,
and gum recession.  For example, in the control, 0.005, and 0.04 mg/kg/day dose groups, incidences of
tarsal gland inflammation and/or enlargement were 1/9, 4/4, and 3/3; incidences of nail bed prominence
were 0/9, 3/4, and 3/3; incidences of elevated nails were 0/9, 2/4, and 2/3; incidences of nails folding on
themselves were 0/9, 1/4, and 3/3; and incidences of gum recession were 0/9, 1/4, and 2/3. 
Immunological alterations in the exposed offspring mainly included suppressed antibody responses to
SRBC.  IgM antibody levels to SRBCs were significantly reduced in comparison to controls at 0.005 and
0.04 mg/kg/day at week 22 (p=0.056 and 0.023, respectively) and week 23 (p=0.043 and 0.029,
respectively), and at 0.005 mg/kg/day at weeks 61, 62, and 63 (p=0.028, 0.043, and 0.056, respectively). 
IgM titers were also suppressed at 0.04 mg/kg/day during weeks 61, 62, and 63, but statistical
significance was precluded by the small number of infants (n=2) in this group.  Other immunological
changes included significantly reduced mitogen (ConA)-induced lymphocyte proliferation compared to
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controls at 0.04 mg/kg/day at weeks 28 and 60 (p=0.036 and 0.053, respectively).  Although evaluation of
the offspring data is complicated by the small number of animals, it is highly relevant that the clinical and
immunological effects in the infants are similar to those observed in their chronically exposed dams at the
same dose levels as low as 0.005 mg/kg/day (Arnold et al. 1993a, 1993b; Tryphonas et al. 1989, 1991a,
1991b).  The effects on the dams are detailed in the in the worksheet for the chronic oral MRL.
Evidence that the 0.0075 mg/kg/day less serious LOAEL is an appropriate dose level for intermediate-
duration MRL derivation is provided by the observation that the next highest tested dose level in monkeys
(or any other species) is 0.02 mg/kg/day (Arnold et al. 1995), which is a serious LOAEL for fetal
mortality as indicated above.
Agency Contact (Chemical Manager):  Obaid Faroon
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MINIMAL RISK LEVEL (MRL) WORKSHEET




Route: [ ] Inhalation   [X] Oral
Duration: [ ] Acute   [ ] Intermediate   [X] Chronic
Key to Figure: 148k
Species: Monkey
Minimal Risk Level:  0.02   [X] µg/kg/day   [ ] ppm
Reference:  Tryphonas et al. 1989, 1991a
Experimental design: (human study details or strain, number of animals per exposure/control groups, sex,
dose administration details):
Groups of 16 female Rhesus monkeys self-ingested capsules containing Aroclor 1254 in a glycerol/corn
oil mixture (1:1) in doses of 0, 0.005, 0.02, 0.04, or 0.08 mg/kg/day.  The monkeys were challenged with
injected sheep red blood cells (SRBC) at 23 months of exposure and received a secondary challenge with
SRBC at 55 months.  The animals had achieved an apparent pharmacokinetic steady state at 23 months
based on PCB concentrations in blood and fat.  End points examined at 23 months (Tryphonas et al.
1989) included:  antibody titers (IgG and IgM) to SRBC, lymphocyte transformation in response to two
mitogens (PHA and ConA), quantitation of T- and B-lymphocytes, total serum immunoglobulin levels
(IgG, IgM, and IgA), serum proteins, and serum hydrocortisone level.  End points examined at 55 months
(Tryphonas et al. 1991a, 1991b) included: body weights, IgM and IgG titers in response to secondary
immunization with SRBC, lymphocyte proliferation in response to three mitogens (PHA, ConA, and
PWM), mix lymphocyte culture assay, phagocytic activity of peripheral blood monocytes following
stimulation with phorbol myristate acetate (PMA) or Zymosan, interleukin 1 production in response to
E. coli, lymphocyte subpopulation analysis, antibody response to pneumococcus antigens, serum
hydrocortisone level, serum complement activity, natural killer cell activity, levels of serum thymosins,
interferon production by Con A-stimulated leukocytes, and tumor necrosis factor production.  As
indicated below in the other pertinent information section, clinical health findings (Arnold et al. 1993a)
and reproduction and offspring findings (Arnold et al. 1995) were also reported for the monkeys that were
tested for immunotoxicity.
Effects noted in study and corresponding doses:
IgM (all doses except 0.02 mg/kg/day) and IgG (all doses) antibody levels to SRBC were significantly
reduced compared to controls after 23 months, although no clear dose-response relationships were
observed (Tryphonas et al. 1989).  Secondary challenge with SRBC after 55 months showed decreasing
dose-related trends in the IgM and IgG anamnestic responses, although only IgM was significantly lower
than controls at all dose levels (Tryphonas et al. 1991a).  Other immunologic changes included alterations
in lymphocyte T-cell subsets characterized by a significantly decreased ratio of T-inducer/helper (CD4)
cells to T-cytotoxic/suppressor (CD8) cells, due to reduced CD4 and increased CD8 cells, at
0.08 mg/kg/day (not tested at lower doses) after 23 months.  No effects on total lymphocytes or B-cells
were found, indicating that T-cells were preferentially affected by the PCBs, although there were no
exposure-related changes in T-cell subsets after 55 months suggesting that adaptation had occurred. 
Statistically significant dose-related trends, but no significant differences between exposed and control
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groups, were observed after 55 months for decreasing lymphocyte proliferation in response to mitogens
(PHA and ConA, but not PWM), increasing NK cell activity, increasing levels of serum thymosin
alpha-1, decreasing phagocytic activity of peripheral blood monocytes following activation with PMA,
and increasing total serum complement activity.
Dose and end point used for MRL derivation:  The lowest dose level tested, 0.005 mg/kg/day, is a
LOAEL for decreased antibody response.  Interpretation of the adversity of this effect is complicated by a
lack of data on immunocompetence and the essentially inconclusive findings in the other tested end
points; however, support for the 0.005 mg/kg/day LOAEL is provided by mild clinical manifestations of
toxicity at the same dose.  As indicated below in the other pertinent information section, eyelid and
toe/finger nail changes were observed in some monkeys at doses as low as 0.005 mg/kg/day (Arnold et al.
1993a).
[ ] NOAEL   [X] LOAEL
Uncertainty Factors used in MRL derivation:
[X]  10 for use of a LOAEL
[X]   3 for extrapolation from animals to humans
[X]  10 for human variability
Was a conversion factor used from ppm in food or water to a mg/body weight dose?
No
If an inhalation study in animals, list conversion factors used in determining human equivalent dose:  
NA
Was a conversion used from intermittent to continuous exposure?  
No
Other additional studies or pertinent information that lend support to this MRL:
No other studies investigated immunological effects of chronic exposure to PCBs.  Intermediate-duration
studies, however, have conclusively shown that oral exposure to commercial PCB mixtures can induce
morphological and functional alterations in the immune system of rats, mice, guinea pigs, and monkeys. 
Effects in the non-primate species occurred at relatively high doses (generally $4 mg/kg/day) and
included decreased thymus and spleen weights in rats, mice, and guinea pigs exposed to Aroclors 1260,
1254, or 1248 (Allen and Abrahamson 1973; Bonnyns and Bastomsky 1976; Smialowicz et al. 1989;
Street and Sharma 1975; Vos and Van Driel-Grootenhuis 1972); reduced antibody responses to tetanus
toxoid in guinea pigs exposed to Clopen A-60, keyhole limpet hemocyanin in rats exposed to
Aroclor 1254, and SRBC in mice exposed to Aroclor 1242 (Exon et al. 1985; Loose et al. 1977, 1978a,
1978b, 1979; Vos and Van Driel-Grootenhuis 1972); increased susceptibility to infection by Moloney
leukemia virus in mice exposed to Aroclor 1254 or 1242, herpes simplex virus in mice exposed to
Kanechlor 500, and bacterial endotoxin and malarial parasite in mice exposed to Aroclor 1242 (Imanishi
et al. 1980; Koller 1977; Loose et al. 1979); reduced skin reactivity to tuberculin in guinea pigs exposed
to Clopen A-60 (Vos and Van Driel-Grootenhuis 1972); and reduced NK cell activity in rats exposed to
Aroclor 1254 (Smialowicz et al. 1989; Talcott et al. 1985).
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Intermediate-duration oral studies of Aroclors in monkeys confirm the observations of PCB
immunotoxicity in rats, mice, and guinea pigs, indicate that non-human primates are more sensitive than
the other species, and support the findings of the chronic immunotoxicity study in monkeys (Tryphonas et
al. 1989, 1991a, 1991b) used as the basis of the chronic oral MRL.  Results of intermediate-duration
studies in monkeys included decreased antibody responses to SRBC, increased susceptibility to bacterial
infections, and/or histopathological changes in the thymus, spleen, and lymph nodes in adult monkeys
and their offspring at 0.1–0.2 mg/kg/day doses of Aroclor 1254 and 1248 (Abrahamson and Allen 1973;
Allen and Barsotti 1976; Allen et al. 1980; Barsotti et al. 1976; Thomas and Hinsdill 1978; Truelove et al.
1982; Tryphonas et al. 1986a).  Additionally, results of studies in infant monkeys are consistent with the
data in adults showing immunosuppressive effects of Aroclor 1254 at doses as low as 0.005 mg/kg/day. 
Evaluation of in utero and lactationally exposed offspring from the monkeys in the Tryphonas et al.
(1989, 1991a, 1991b) studies indicated exposure-related reductions in IgM antibody levels to SRBC and
mitogen-induced lymphocyte transformation that paralleled the findings in the maternal animals (Arnold
et al. 1995).
Support for the chronic LOAEL of 0.005 mg/kg/day is provided by clinical observations on the same
monkeys that were immunologically evaluated by Tryphonas et al. (1989, 1991a, 1991b).  Examinations
of the monkeys exposed to 0.005–0.08 mg/kg/day Aroclor 1254 during the first 37 months of the study
showed characteristic dose-related ocular and dermal effects, including eye exudate, inflammation and/or
prominence of the tarsal (Meibomian) glands, and various finger and toe nail changes (Arnold et al.
1993a).  Statistical analyses found significant increasing dose-related trends in incidence rates, total
frequency of observed occurrences and/or onset times for these effects, with some treated and control
group comparisons showing significant differences at doses as low as 0.005 mg/kg/day.  Effects that were
significantly increased in the 0.005 mg/kg/day group included increased total frequencies of inflamed
and/or prominent tarsal glands, toenail separations, and elevated toenails.  Additionally, monkeys from
this study that were mated after 37 months of exposure and continued to be exposed to $0.005 mg/kg/day
Aroclor 1254 through gestation and lactation had offspring with clear clinical signs of PCB intoxication,
manifested as inflammation and/or enlargement of the tarsal glands, nail lesions, and gum recession
(Arnold et al. 1995).  Further, the next highest dose level in this study (0.02 mg/kg/day) is a chronic
serious LOAEL for reproductive toxicity (reduced conception rate) (Arnold et al. 1995).  Conception rate,
adjusted for the total number of matings, was significantly lower than controls at 0.02, 0.04, and
0.08 mg/kg/day (p=0.009, 0.039, and 0.005, respectively), but not at 0.005 mg/kg/day (p=0.085).  Similar
results were noted after adjustment for the number of matings with positive sires.  There was a significant
(p=0.017) decrease in conception rate with increasing dose with both types of mating adjustments. 
Percentages of impregnations (number impregnated/number available) in the 0, 0.005, 0.02, 0.04, and
0.08 mg/kg/day groups were 69, 63, 27, 43, and 33%, respectively.  The $0.02 mg/kg/day doses in this
study are also serious effect levels for developmental toxicity (fetal mortality), as discussed in the
worksheet for the intermediate-duration oral MRL.  



























































This chapter of the profile is a health effects summary written in non-technical language.  Its intended
audience is the general public especially people living in the vicinity of a hazardous waste site or
chemical release.  If the Public Health Statement were removed from the rest of the document, it would
still communicate to the lay public essential information about the chemical.
The major headings in the Public Health Statement are useful to find specific topics of concern.  The
topics are written in a question and answer format.  The answer to each question includes a sentence that
will direct the reader to chapters in the profile that will provide more information on the given topic.
Chapter 2
Relevance to Public Health
The Relevance to Public Health section provides a health effects summary based on evaluations of
existing toxicologic, epidemiologic, and toxicokinetic information.  This summary is designed to present
interpretive, weight-of-evidence discussions for human health endpoints by addressing the following
questions.
1. What effects are known to occur in humans?
2. What effects observed in animals are likely to be of concern to humans?
3. What exposure conditions are likely to be of concern to humans, especially around hazardous
waste sites?
The section covers endpoints in the same order they appear within the Discussion of Health Effects by
Route of Exposure section, by route (inhalation, oral, dermal) and within route by effect.  Human data are
presented first, then animal data.  Both are organized by duration (acute, intermediate, chronic).  In vitro
data and data from parenteral routes (intramuscular, intravenous, subcutaneous, etc.) are also considered
in this section.  If data are located in the scientific literature, a table of genotoxicity information is
included.
The carcinogenic potential of the profiled substance is qualitatively evaluated, when appropriate, using
existing toxicokinetic, genotoxic, and carcinogenic data.  ATSDR does not currently assess cancer
potency or perform cancer risk assessments.  Minimal risk levels (MRLs) for noncancer end points (if
derived) and the end points from which they were derived are indicated and discussed.
Limitations to existing scientific literature that prevent a satisfactory evaluation of the relevance to public
health are identified in the Data Needs section.































































































